
<html lang="en"     class="pb-page"  data-request-id="baef216f-bf7f-475b-a94f-334049030fb8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-15;article:article:10.1021/acs.jmedchem.8b00180;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations" /></meta><meta name="dc.Creator" content="Robert J.  Young" /></meta><meta name="dc.Creator" content="Paul D.  Leeson" /></meta><meta name="dc.Description" content="The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompass..." /></meta><meta name="Description" content="The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompass..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00180" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00180" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00180" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00180" /></link>
        
    
    

<title>Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00180" /></meta><meta property="og:title" content="Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0052.jpeg" /></meta><meta property="og:description" content="The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technology) and types of molecules, including those beyond the rule of five. The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable. What is clear is that while targets are different, successful molecules are almost invariably among the most efficient for their target, even at the extremes. Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technology) and types of molecules, including those beyond the rule of five. The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable. What is clear is that while targets are different, successful molecules are almost invariably among the most efficient for their target, even at the extremes. Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0052.jpeg" /></meta><meta name="twitter:title" content="Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00180"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00180">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00180&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00180&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00180&amp;href=/doi/10.1021/acs.jmedchem.8b00180" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6421-6467</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00077" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00782" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Robert J. Young</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert J. Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>R.J.Y.: e-mail, <a href="/cdn-cgi/l/email-protection#25574a470b4f0b5c4a504b426542564e0b464a48"><span class="__cf_email__" data-cfemail="f98b969bd793d780968c979eb99e8a92d79a9694">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Young">Robert J. Young</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7763-0575" title="Orcid link">http://orcid.org/0000-0002-7763-0575</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Paul D. Leeson</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul D. Leeson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Paul Leeson Consulting Ltd., The Malt House, Main Street, Congerstone, Nuneaton, Warwickshire CV13 6LZ, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>P.D.L.: e-mail, <a href="/cdn-cgi/l/email-protection#1d7178786e72736d795d7a707c7471337e7270"><span class="__cf_email__" data-cfemail="1f737a7a6c70716f7b5f78727e7673317c7072">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+D.++Leeson">Paul D. Leeson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0212-3437" title="Orcid link">http://orcid.org/0000-0003-0212-3437</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00180&amp;href=/doi/10.1021%2Facs.jmedchem.8b00180" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6421–6467</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 5, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2018</li><li><span class="item_label"><b>Published</b> online</span>5 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6421%26pageCount%3D47%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BJ.%2BYoung%252C%2BPaul%2BD.%2BLeeson%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D15%26contentID%3Dacs.jmedchem.8b00180%26title%3DMapping%2Bthe%2BEfficiency%2Band%2BPhysicochemical%2BTrajectories%2Bof%2BSuccessful%2BOptimizations%26numPages%3D47%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6467%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00180"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">9241</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00180" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Young&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;D. Leeson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6421-6467&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00180&quot;},&quot;abstract&quot;:&quot;The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technology) and types of molecules, including those beyond the rule of five. The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable. What is clear is that while targets are different, successful molecules are almost invariably among the most efficient for their target, even at the extremes. Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00180&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00180" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00180&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00180" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00180&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00180" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00180&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00180&amp;href=/doi/10.1021/acs.jmedchem.8b00180" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00180" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00180" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26pmid%3D29620890%26genre%3Darticle%26aulast%3DYoung%26date%3D2018%26atitle%3DMapping%2Bthe%2BEfficiency%2Band%2BPhysicochemical%2BTrajectories%2Bof%2BSuccessful%2BOptimizations%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292588" title="Partition coefficient">Partition coefficient</a>,</li><li><a href="/action/doSearch?ConceptID=290888" title="Liquid liquid equilibrium">Liquid liquid equilibrium</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/15" title="Go to Volume 61, Issue 15"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/jmcmar.2018.61.issue-15/20180809/jmcmar.2018.61.issue-15.largecover.jpg" alt="Go to Volume 61, Issue 15"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0052.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The practices and tactics employed in successful optimizations are examined, judged from the trajectories of ligand efficiency and property evolution. A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technology) and types of molecules, including those beyond the rule of five. The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable. What is clear is that while targets are different, successful molecules are almost invariably among the most efficient for their target, even at the extremes. Trajectory mapping, <i>based on principles rather than rules</i>, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Identification of small molecule leads in drug discovery over the past 20 years has been largely dependent on high throughput screening (HTS)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> against target proteins. The challenges associated with the introduction of HTS more than 2 decades ago led practitioners to define useful chemical quality guidelines and specific criteria at each step, from the identification of active compounds to confirmed hits, then from optimization to leads.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Quality leads were sought, with the potential to deliver candidates in shortened time frames, driven by high throughput chemistry, to feed hungry drug development pipelines suffering high attrition rates. “Fail early, fail fast” was the mantra of the day. It is recognized now that this “high speed” approach contributed to further clinical attrition,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> but it is wrong to lay the blame at the door of HTS.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The rule of five (Ro5)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> emerged because the HTS hits pursued at Pfizer<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> in 1990s, while potent, tended to have poor solubility and permeability; this was not caused by HTS but by the decision-making processes employed in the selection of hits and their optimization.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Candid retrospective analyses from large pharmaceutical companies, covering the period 2000–2010, have acknowledged that root causes of attrition in the clinic were often due to compound quality issues, including lack of exposure,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> known preclinical toxicity risk,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and poor solubility.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Many of these failings could have been addressed during the less expensive lead optimization phase. Encouragingly, the lessons are being learnt as demonstrated by increased focus on quality leading to improved success rates within a smaller, more focused discovery pipeline.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">The aim of hit and lead optimization efforts is to identify a molecule of appropriate affinity, selectivity, and efficacy (e.g., agonist or antagonist) for the desired target while ensuring this can be achieved with acceptable pharmacokinetics, nontarget mediated toxicity, solubility, and permeability. When these parameters have been optimized, consequent candidate drug molecules should possess profiles that provide high confidence that, when administered to humans by the preferred route, the drug will reach and occupy the biological target for the required time at an acceptable dose and frequency, eliciting the desired pharmacological response with a suitable, disease-dependent, therapeutic index. Multiparameter optimization is necessary to achieve these aims; this is inherently complex, challenging to execute, frequently frustrating, and often unpredictable.</div><div class="NLM_p">Although full prediction of the effects of molecular structure on biological activity is likely to remain elusive, it is axiomatic that the molecular properties of drugs underlie their pharmacodynamic, pharmacokinetic, and toxicological behavior.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A focus on measurable, predictable, and quantifiable physicochemical properties has established their value as indicators of compound quality and predictors of likely outcomes in their pharmacokinetic and pharmacological behavior.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18">(13−18)</a> These studies provided helpful guidelines for the medicinal chemist, including, inter alia, the principle of minimal hydrophobicity,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the Ro5,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> leadlike properties,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> and complexity;<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> the rule of 3 for fragments;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> measures of ligand efficiency;<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> drug efficiency;<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> three-dimensionality as measured by fraction of sp<sup>3</sup> carbon atoms,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> and aromatic ring count.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> Taken together, a combination of dose, lipophilicity, and solubility criteria has been established as an indicator of high quality oral candidates;<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> such guidelines fit with the principle of lower systemic exposure to reduce toxicity risk.</div><div class="NLM_p">Predictive ADMET models provide correlations with single or multiple physical properties<a onclick="showRef(event, 'ref16 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref16 ref33 ref34">(16,33,34)</a> but show broad ranges of significance. There are limitations; for example, bulk physical properties do not differentiate ADME effects between enantiomers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> However, in general, the <i>probability</i> of progression though ADMET screens generally improves with optimal physical properties, of which lipophilicity,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> ionization state,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and solubility have been shown to be the most important.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Ten years after the Ro5 publication,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> we noted that the physicochemical properties of compounds in pharmaceutical company patents,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> while varying across the four companies examined, were inflated when compared with contemporary marketed oral drugs and could be contributing to increased risk of attrition (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a for oral drug and patent trends). We asked if it could be that the widely accepted Ro5 might not yet be impacting drug discovery practices.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In this Perspective, we develop the theme further, this time with a focus on <i>target-specific</i> optimization, based on physicochemical properties and efficiency metrics,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><i>which we propose is more useful than pursuing absolute criteria such as the Ro5, establishing principles rather than rules</i>. In addition to analyzing optimizations based on HTS output, we also consider starting points based on fragments<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and encoded library technology (ELT),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> some with direct comparisons to HTS.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization trends and physical properties. (a) Median cLogP and molecular weight of oral drugs and patented compounds: (in black) oral drugs by literature publication<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> decade, updated to mid-2016 launches and restricted to drugs with available oral doses; (in red) median of median target data for 18 companies with >50 compounds patented per target in 2000–2010.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (b) Median cLogP and molecular weight of “start to finish” optimization pairs. In blue: leads to drugs: (A,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> B<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) historical drugs; (C) drugs launched post-1990;<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (D) first in class to follow-on drug.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In red: literature optimizations: (E) early 2000s literature;<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (F) HTS hit-to-lead, 2000s literature;<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (G) 2014 literature not using lipophilicity.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In green: property-aware optimizations: (H) 2014 literature using lipophilicity;<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (I) late 2000s literature using lipophilic ligand efficiency (LLE).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (c) Median cLogP and molecular weight of screening sets and derived compounds: (in green) fragment hits and their optimizations<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and fragment-derived candidate drugs (calculated from the list in ref <a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>); (in red) HTS collections, leads from them, and linked patents [collected HTS and lead 2009 median data from GlaxoSmithKline, Novartis, Sanofi-Aventis, and Wyeth (HTS) and GlaxoSmithKline, Novartis, and Wyeth (leads)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and corresponding median patent data<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> for GlaxoSmithKline, Novartis, and Wyeth, 2000–2010]; (in black) leads from DNA-encoded libraries (calculated from the list in ref <a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>). (d) Median LE and LLE (based on cLogP) values of 480 target-assay pairs having ≥100 published compounds with potency values.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Targets highlighted are discussed in this paper. Figure adapted from ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Evident Practices in Medicinal Chemistry Optimizations</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The concept of leadlikeness, published in 1999,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was based on the authors’ experience that optimization frequently resulted in increased molecular properties, noticing that lower molecular weight (MW) leads, which could be increased in size, often proved simpler and faster to optimize compared with higher MW leads. The ideal screening library was proposed to have a MW of 100–350 and a 1-octanol–water partition coefficient (log <i>P</i>) of 1–3 so that hits could be “expanded” during optimization into the druglike space defined by the rule of 5. Compared to druglike molecules, smaller leadlike molecules are likely to have lower potency (typically >100 nM) but would be more likely to bind to targets and to offer more scope for multiparameter optimization. The emphasis on properties foreshadowed ligand efficiency measures: “The relative values of active compounds emerging from a high-throughput screen can usefully be assessed on the basis of biological activity per unit of molecular weight and lipophilicity.”<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Subsequent studies with larger data sets of both lead–drug and “start–finish” optimization pairs have confirmed the underlying leadlike hypothesis that increases in calculated log <i>P</i> (cLogP) and MW in optimization are dominant (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b) and established the concept that increased complexity reduces the likelihood of finding hits. Among the cited lead-to-drug optimization sets<a onclick="showRef(event, 'ref22 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref22 ref42 ref43 ref44">(22,42−44)</a> (entries A–D in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), MW is increased in 78% of cases, more often than cLogP, which was increased in 58% of cases. Little or no change in cLogP is seen in studies (entries C and D in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b) respectively reporting lead–drug pairs since 1990<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and first-in-class disclosures to follow-on drugs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">Looking at literature-derived optimizations (entries E,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> F,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and G<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> of <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), it is striking that the median starting points are not leadlike, yet the magnitude of the property increases is nevertheless similar to the lead–drug pairs A and B. These observations are consistent with trends in progression of properties from HTS screening files, leads,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and patents<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> of four pharmaceutical companies (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). The HTS file properties reflect a combination of more recent enhancement, including physical property restraints and leadlike compounds, as well as historical project compounds. Unsurprisingly fragments display the lowest physical properties and their optimization displays the largest median change (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). Fragment based optimization<a onclick="showRef(event, 'ref40 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref40 ref49 ref50">(40,49,50)</a> has come of age in the past decade, exploiting the principle that many fewer compounds are required to identify hits (albeit much less potent ones) based on the principles<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> underpinned by complexity. Fragment libraries are not large, usually a few thousand molecules, but the sampling of available chemical diversity is assisted because of the low MW. The articulation of all possible theoretical molecules with fewer than 17 heavy atoms has been achieved,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> providing a source of inspiration for novel leadlike and fragment molecules and indeed overlapping with low MW druglike space. Fragment hit growth and optimization routinely use X-ray protein–ligand structures,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> which can result in improved druglike outcomes versus other methods of lead generation, if performed with concomitant control of physical properties.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> It can be easy to add lipophilicity to molecules to improve activity but not so easy to incorporate polar functionality without loss of activity; the thermodynamic basis of such interactions has been well-studied.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> There is great promise in DNA-encoded libraries<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (vide infra), although the hits recently summarized<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> clearly show increased MW relative to other starting points (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c).</div><div class="NLM_p">Optimization strategy and awareness of physical properties influence outcomes. For example, using lipophilic efficiency<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or simply lipophilicity itself<a onclick="showRef(event, 'ref26 ref47'); return false;" href="javascript:void(0);" class="ref ref26 ref47">(26,47)</a> in optimization (entries I and H, respectively, of <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b) resulted in a lowered lipophilicity, whereas there was an increase in lipophilicity (entry G, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b) when physical properties were not considered. In all these cases, median MW was increased. In entries G and H (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), from the 2014 literature, there was a notable contrast in use of physical properties between industry (40% of papers) and academia (15%).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> These observations led us to question whether the community is sufficiently aware of property-based optimization. These concerns are supported by the observation that only 1.1% of 2015 papers from United States universities discussed physical properties, in comparison with 37.1% from other countries.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Oral drugs invented post-1990, together with compounds from the patents of 18 pharmaceutical companies in the period 2000–2010, show increased physical properties versus older oral drugs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a).<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> We have hypothesized<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> that the most time-resistant properties<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> in oral drugs are the most important: for rule of 5 properties these are lipophilicity and hydrogen bond donor count. Practices leading to molecular inflation or obesity<a onclick="showRef(event, 'ref39 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref39 ref61 ref62">(39,61,62)</a> include (i) selecting potent but high MW and/or lipophilic hits from screens, (ii) focusing on optimization of in vitro potency rather than multiparameter optimization, (iii) using favored but limited chemical synthetic procedures,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (iv) tactics used to obtain intellectual property on competitive targets, and (v) cultural organizational differences<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> in research strategy and acceptance of physical property risk. External influences have a significant impact, including the appearance of targets that require larger and more lipophilic ligands,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> for example, antivirals and protein–protein interactions and disease risk–benefit considerations.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The Ro5 may inadvertently have contributed to property inflation, as many misinterpreted a guideline for achieving acceptable permeation or absorption as a “rule” for drug discovery and that reaching its cutoff limits was acceptable practice.</div><div class="NLM_p last">The newest oral drugs, invented post-2000, most closely reflect recent patent practice (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a), and in this group, risk–benefit considerations have increased influence on property inflation. For example, 34 of 60 oral drugs approved by the FDA in 2011–2013 had indications, such as cancer and human immunodeficiency virus (HIV), where the clinical need was commensurate with greater risk or dosing inconvenience. Compared to the other 26 drugs, these 34 showed greater lipophilicity and molecular weight, poorer solubility, greater likelihood of food-altering pharmacokinetics, and more off-target labeled safety warnings.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Evident Contemporary Practices: Efficiency Metrics and Lipophilicity Control</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compound quality literature has focused recently on ligand efficiency metrics, which quantify binding affinity per unit of physical property.<a onclick="showRef(event, 'ref26 ref64'); return false;" href="javascript:void(0);" class="ref ref26 ref64">(26,64)</a> Among a number of measures proposed, ligand efficiency (LE, binding energy in kcal/mol per heavy atom) = pXC<sub>50</sub> × 1.37/heavy atom count (HAC)<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and lipophilic ligand efficiency (LLE or LipE, unitless) = pX<sub>50</sub> – log <i>P</i> (or log <i>D</i><sub>7.4</sub>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> have attracted the most attention, as well as various criticisms,<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66−68)</a> some of which provoked a response.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> LE, despite limitations that include a nonlinear relationship to HAC, has found utility in hit selection and, particularly, fragment based drug discovery.<a onclick="showRef(event, 'ref40 ref69'); return false;" href="javascript:void(0);" class="ref ref40 ref69">(40,69)</a> Because small molecule binding sites vary in size according to the target, optimal LE values are target-dependent.<a onclick="showRef(event, 'ref26 ref70'); return false;" href="javascript:void(0);" class="ref ref26 ref70">(26,70)</a> There is more general agreement that increasing LLE, an approximate measure of specificity and the quantitative embodiment of Hansch’s 30-year-old suggestion that “molecules should be made as hydrophilic as possible without loss of efficacy,”<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> is important in lead optimization.<a onclick="showRef(event, 'ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref73">(71−73)</a> LLE is linearly related to lipophilicity, and a thermodynamic basis for its application has been proposed.<a onclick="showRef(event, 'ref71 ref74'); return false;" href="javascript:void(0);" class="ref ref71 ref74">(71,74)</a> In general, reducing lipophilicity (and increasing LLE) tends to increase free drug levels;<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> LLE has been correlated with drug efficiency, a measure utilizing potency and fraction of the dose that becomes available for drug action.<a onclick="showRef(event, 'ref27 ref76'); return false;" href="javascript:void(0);" class="ref ref27 ref76">(27,76)</a> Among marketed vascular endothelial growth factor receptor (VEGFR) kinase inhibitors, clinical response was linked to LLE,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> which could be exposure driven.</div><div class="NLM_p">An analysis of combined LE and LLE values of a set of 46 oral drugs acting on 25 targets, when compared with those of other molecules acting at the same targets, suggested that both of these efficiency metrics could be important in candidate drug selection.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The mean fractions of molecules with LE and LLE better than the drug were 2.7% for GPCRs, proteases, PDEs, and others (17 targets), 22% for kinases (8 targets), and 1.5% for only in-class targets. Significantly in this analysis, LE and LLE contributed equally.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The lower score for the kinases, predominantly cancer targets, could result from optimization of kinome selectivity profiles,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> as well as acceptance of higher risk–benefit ratios in the clinic.</div><div class="NLM_p last">We use the “% better” LE/LLE metric in several examples (see later), but there are caveats in its use of literature data to note. First, published compounds are often selected from a larger group leading to possible bias; second, with sources such as CHEMBL, biological data frequently come from different assay formats; third, calculated lipophilicities may not be accurate (see below); fourth, there is possible redundancy since the measure uses potency twice, and HA count and lipophilicity often broadly correlate; and fifth, the value will change over time as new molecules are published. The “% better” measure is not a property or physicochemical parameter but a time-related guide to relative compound quality for the target in question. Median LE and LLE values vary substantially according to the target (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d), and in addition, significant correlations between potency and size or lipophilicity are infrequent.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The results with drugs are consistent and suggest that the combination of values of size, lipophilicity, and in vitro potency, relative to optimal values for the specific target, can provide a useful measure of both druglikeness and progress in a drug discovery project.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The obvious challenge for less or unprecedented targets is that the optimal property profile will be unknown at the outset. Nevertheless, depending on the profile of the lead compounds, improved physical properties and optimization trajectories to achieve them can be identified from the outset. By following these principles, the “desirable property and efficiency envelope” of targets can be expanded to increase LE and LLE, as we have observed earlier with cholesterol ester transfer protein (CETP) inhibitors<a onclick="showRef(event, 'ref26 ref39'); return false;" href="javascript:void(0);" class="ref ref26 ref39">(26,39)</a> and factor Xa inhibitors.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> We further elaborate on the use of these concepts in the accompanying examples, exploring optimizations from a variety of hit sources including HTS, fragments, and DNA-encoded library technologies (ELT). In doing so, hits and leads were identified possessing a range of properties in terms of size, lipophilicity, and potency.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Lipophilicity Measures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lipophilicity<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> is the vital element in this review, and the influence of both the partition coefficient, expressed as log <i>P</i>, a constant, and the distribution coefficient at pH 7.4, log <i>D</i><sub>7.4</sub>, a pH-dependent value for ionizable compounds (log <i>P</i> is the asymptote of the neutral form), is investigated.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Historically, these values were defined for drug discovery as measurements between 1-octanol and aqueous buffers (OW). In the past decade, high throughput chromatographic methods have been developed and shown to be more reliable estimates of lipophilicity, irrespective of solubility;<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> it was established at GSK that traditional shake flask 1-octanol–aqueous buffer measurements had an upper limit of log <i>D</i> ≈ 4 and were particularly unreliable for poorly soluble compounds.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Importantly, clearer resolutions of lipophilicity-related observations were evident in comparison to OW measurements and predicted values, with the outcomes showing enhanced statistical significance between adjacent binned values in box–whisker plots.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Lipophilicity is probably the most important driver of suboptimal profiles but is not the only important parameter. Many studies have established the principle that the more lipophilic is a compound, the higher is the risk of encountering problems due to one or all of low solubility, high clearance, poor absorption, high protein binding, and promiscuity.<a onclick="showRef(event, 'ref13 ref14 ref36'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref36">(13,14,36)</a> Additionally, chromatographic measurements of surrogates for membrane and protein binding can usefully generate free drug estimates.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">In different scenarios, both log <i>P</i> and log <i>D</i> (at pH 7.4 and other pH values) are important in drug discovery.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In general, log <i>D</i><sub>7.4</sub> is important for ADME parameters while log <i>P</i> is often important for target binding and selectivity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> For oral drug candidates, values of log <i>D</i><sub>7.4</sub> in the range ∼1–3 have been recommended to reduce known risks of downstream failure.<a onclick="showRef(event, 'ref33 ref34 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref36">(33,34,36)</a> By necessity, most compounds in this review are presented with calculated lipophilicity values. This is not always accurate, depending on the structure,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> although the continued assiduous curation of the BioByte database (<a href="http://www.biobyte.com" class="extLink">www.biobyte.com</a>) pioneered by Hansch and Leo provides an enduring gold standard in cLogP prediction. In some cases, ALogP, based on refinements of the Ghose/Crippen atomic contribution method,<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> extracted with ChEMBL data, is also quoted. Additionally, some ChemAxon cLogD<sub>7.4</sub> data are presented, although most log <i>D</i><sub>7.4</sub> data were calculated using the most recent update of the GSK chromatographic log <i>D</i><sub>7.4</sub> predictor. It should be noted that Chrom log <i>D</i><sub>7.4</sub> values are typically 1.5–2 log units higher than the OW scale based on the deliberate calibration, chosen to avoid confusion between the methods.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">Examples are included that illustrate shortcomings with some calculations, but despite these issues, patterns are obvious; where measured data are included, the differentiations are invariably clearer. Recommending best practice is logical: there is no substitute for generating measured data, so this should be gathered wherever practicable and compared to calculations within given series/programs. By establishing confidence in predictions and, if necessary, building local models on measurements, quality profiling of virtual compounds can be made to minimize synthesis of those analogs with little chance of progression.</div><div class="NLM_p last">Additionally, the GSK Property Forecast Index (formally, PFI = chromatographic log <i>D</i><sub>7.4</sub> + aromatic ring count, ideal value is <7), is used as an indicator of quality and risk.<a onclick="showRef(event, 'ref10 ref82'); return false;" href="javascript:void(0);" class="ref ref10 ref82">(10,82)</a> The principle behind PFI reflects orthogonal contributions of aromaticity and lipophilicity (by any measure or estimate) to increased risk in developability assays, and this summation often provided greater resolution than log <i>D</i><sub>7.4</sub> or log <i>P</i> alone in various analyses, particularly with chromatographic measures.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> This suggests that lipophilicity from aromatic carbon atoms has a greater negative impact on ADMET properties than does aliphatic carbon-based lipophilicity.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Molecules with higher fractions of sp<sup>3</sup> hybridized carbon atoms tend to have fewer aromatic rings<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and are associated with increased solubility<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and receptor binding specificity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Concept of Trajectories in Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The journey followed in an optimization program can be represented prosaically by a plot of activity (usually represented as pIC<sub>50</sub>, – 1 log<sub>10</sub>(molar IC<sub>50</sub>) against a given property descriptor. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> uses log <i>P</i> as the <i>X</i>-axis, thus illustrating an upper left box containing more potent compounds with lower lipophilicity. The parallel lines represent constant LLE (pIC<sub>50</sub> – log <i>P</i>) values. The same principle applies should the <i>X</i>-axis be log <i>D</i><sub>7.4</sub>, PFI, MW, heavy atom count (HA), or any physicochemical parameter or descriptor. Mapping drug discovery trajectories using various combinations of ligand efficiency metrics based on size and polar surface area has been discussed previously;<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> interestingly the authors did not use LLE. In this respect, it is important to remember that the fundamental properties of molecular weight, polarity (hydrogen bonding and polar surface area), and lipophilicity, which are commonly used independently, are inter-related. Thus, Cramer had shown that many physicochemical properties are so highly related that they can be reduced to two main principal components,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and Abraham and co-workers demonstrated that log <i>P</i> is dependent on other properties, namely, molecular size, polarity, and H-bonding acidity and basicity.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> A principal component analysis of ∼30 000 preclinical compounds indicated that the most meaningful nonredundant descriptors are MW, lipophilicity, hydrogen bond donors, and ionization state.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Shape is also very likely to be important, as analyses of aromatic ring count<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> and Fsp<sup>3</sup> proportion<a onclick="showRef(event, 'ref28 ref29 ref60'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref60">(28,29,60)</a> have shown. The impact of MW in analyses is a subject of debate. MW per se has no influence on solubility in druglike molecules,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> but in combination with lipophilicity it affects permeability in CACO-2 cells and metabolic stability,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> and when lipophilicity is matched, high MW (>1000) and volume reduce passive permeability.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The frequent correlation of MW with other parameters (e.g., lipophilicity and rotatable bond count) suggest it may also act as a surrogate for parameters not so well-defined or measured, for example, log <i>P</i> in OW for poorly soluble compounds. Across all CHEMBL data there is an upward trend in potency with increasing heavy atom count,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> but when analyzed by individual targets, significant potency versus size correlations are uncommon.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Generic potency versus lipophilicity plot, with parallel lines showing constant LLE values and thresholds for an illustrative desirable potency of 10 nM or pIC<sub>50</sub> > 8 and cLogP < 3. A case can be made for lower activity thresholds for more hydrophilic compounds, based on their likely higher drug efficiency.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this Perspective, we show optimization trajectories using standard potency (in vitro) versus lipophilicity and size plots for many examples. The exemplified plots and analyses are intended to illustrate principles and not to be prescriptive in any way. Lipophilicity measures used include cLogP, PFI, chromatographic log <i>D</i><sub>7.4</sub>, and measured log <i>D</i><sub>7.4</sub>. LLE can be calculated using any of these properties. We also use LE versus LLE (based on cLogP) plots, which are a useful means of capturing overall progression of size, lipophilicity, and potency. LLE<sub>AT</sub>, which combines LE and LLE, is also employed.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> We use HA count as a size metric because it is used for LE calculation, but other measures of size including MW, molar volume, molar refraction, surface area, and shape can be used directly or be converted to efficiency measures. Examples are also given of “traffic light” visualization, highlighting changes to multiple properties. Users should apply whatever trajectory analysis works most effectively for their own specific targets, chemical series, and optimization issues faced.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Examples of Optimization Trajectory Analysis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The following examples are retrospective analyses of targets belonging to several classes that have produced marketed drugs, together with examples from hit and lead optimization projects in GSK. The targets cover a representative range of median LE and LLE values (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d).</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">i.  C–C Chemokine Receptor Type 5 (CCR5) Antagonists</h3><div class="NLM_p">Although not a recent target, work in this area defined application of property-based design in 1990–2000, and the story of maraviroc’s <b>1</b> discovery provides a reference point for good practice in drug design.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Our earlier analysis of the CCR5 patent estates of four companies,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> competing in pursuit of an identical <i>N</i>-phenpropylpiperidine CCR5 core structure, revealed significant differences in physical property profiles indicative of varying design strategies and approaches to risk assessment (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a><named-content content-type="anchor" rid="tbl2" type="simple"></named-content>). Since that study, Pfizer’s maraviroc <b>1</b> was approved for HIV treatment, a backup <b>2</b> was identified,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and the structures of candidates were disclosed by Merck (<b>3</b>, HIV),<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> GlaxoSmithKline (<b>4</b>, HIV),<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and AstraZeneca (<b>5)</b>, for rheumatoid arthritis (RA; see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Merck’s <b>3</b> was discontinued because of preclinical hepatotoxicity,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and clinical development of GlaxoSmithKline’s <b>4</b> was stopped. AstraZeneca’s <b>5</b> was ineffective clinically in RA, despite providing full blockade of CCR5 function in patients;<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> other CCR5 antagonists<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> including <b>1</b> also failed in RA.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> In vitro potency versus property trajectories of the initial hits and key lead compounds identified by each company are shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physical Properties of CCR5 Antagonists and Candidate Drugs Containing a Common <i>N</i>-Phenylpropylpiperidine Pharmacophore, from Four Companies</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0038.gif" alt="" id="gr38" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">From ref <a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">See <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Experimental values, refs <a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and <a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a>.</p></div></div><div></div></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery of CCR5 Antagonists Based on the <i>N</i>-Phenylpropylpiperidine Pharmacophore (in Red), from Hit or Lead to Candidate Drug<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Compounds selected are those highlighted in the inventors’ publications. (a) <b>1</b> maraviroc (Pfizer); (b) <b>5</b> AZD5672 (AstraZeneca); (c) <b>3</b> MrKA (Merck); (d) <b>4</b> GSK163929 (GSK). AV = antiviral potency.</p></p></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plots of CCR5 antagonist pIC<sub>50</sub> values versus and cLogP (a) and heavy atom count (b). Values are from CHEMBL and the literature. The key compounds in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> are connected to show the discovery trajectories for each candidate drug. The percentages of compounds in the background CCR5 data having better combined LE and LLE versus the candidate drugs are the following: maraviroc <b>1</b>, 2.7%; AZD5672 <b>5</b>, 1.4%; MrKA <b>3</b>, 14%; GSK 163929 <b>4</b>, 54%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The discovery of maraviroc <b>1</b> started from two molecules <b>6</b> and <b>7</b> chosen from a meager HTS output “neither of (which) could be considered to be ideal, having high molecular weight and lipophilicity, polypharmacology, weak binding affinity, and no measurable antiviral activity”.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> However, <b>6</b> was reasonably ligand efficient (LE = 0.29 (kcal/mol)/HA), giving a reason to believe; consequently, the two were merged to provide an amide lead <b>8</b>,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> which displayed improved binding and antiviral activity (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a). Next, reducing hERG inhibition and improving absorption of <b>8</b> led to triazole <b>9</b>, and finally amide modification to <b>1</b> eliminated hERG activity while retaining other desirable properties.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Restricting experimental log <i>D</i><sub>7.4</sub> in the range 1.5–2.5, controlling MW, and optimizing LE were drivers for optimization.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> The discovery of backup <b>2</b> followed similar principles.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> The discovery of <b>1</b> took 2.5 years and 965 analogs were made; the authors stated “at times it appeared impossible to achieve the delicate balance of antiviral activity, metabolic stability, absorption and ion channel activity.”<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> A sentiment commonly felt in medicinal chemistry! It is notable that both <b>1</b> and <b>2</b> were progressed despite having poor rat pharmacokinetics (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and the oral bioavailability of <b>1</b> in humans turned out to be modest, at 23%.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The advantageous slow dissociation kinetics of <b>1</b> (<i>t</i><sub>1/2</sub> > 11 h), found postdiscovery, may be a class effect.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The structure of <b>1</b> bound to CCR5<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> demonstrates highly efficient interactions, reflecting the quality of the design process. Polar interactions occur with five of the seven available heteroatoms and nonpolar interactions with each of the phenyl, tropane, isopropyl, and cyclohexyl moieties.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. PK Parameters of CCR5 Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">PK parameters: rat, dog</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Cl, mL min<sup>–1</sup> kg<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">Vd<sub>ss</sub>, L/kg</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub>, h</th><th class="colsep0 rowsep0" align="center"><i>F</i>, %</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">74, 21</td><td class="colsep0 rowsep0" align="left">–, 4.3</td><td class="colsep0 rowsep0" align="left">2.3, 2.3</td><td class="colsep0 rowsep0" align="left">6, 42</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">201, 36</td><td class="colsep0 rowsep0" align="left">–, 10.5</td><td class="colsep0 rowsep0" align="left">1.4, 3.4</td><td class="colsep0 rowsep0" align="left"><5, 31</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">3.2/12, 3.5</td><td class="colsep0 rowsep0" align="left">0.28/0.6, 0.6</td><td class="colsep0 rowsep0" align="left">1.4/1.5, 3.4</td><td class="colsep0 rowsep0" align="left">11/35, 20</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">22, –</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5–19, –</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">38, 19</td><td class="colsep0 rowsep0" align="left">5.0, 5.2</td><td class="colsep0 rowsep0" align="left">2.1, 3.9</td><td class="colsep0 rowsep0" align="left">41, 49</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></td></tr></tbody></table></div></div><div class="NLM_p">The optimization toward the AstraZeneca candidate, clinically evaluated for RA, had the advantage versus competitors of not requiring antiviral activity. From HTS hit <b>10</b>,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> optimizing the amide side chain to <b>11</b>,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> then the diphenylmethane substituents,<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a> each provided 100-fold potency improvements, leading to compounds such as <b>12</b> with improved rat pharmacokinetics (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> However, the hERG activity of <b>12</b> (7.3 μM; hERG/C<sub>max free</sub> ratio of 250) was considered risky, and further optimization, achieved by balancing hERG inhibition, absorption, and lipophilicity, provided the sulfonyl piperidyl candidate AZD 5672 <b>5</b> (hERG 24 μM; hERG/C<sub>max free</sub> of 6400).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">The Merck candidate <b>3</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> was derived from multiple iterations of HTS hit <b>13</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>c).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Although LLE is improved in <b>3</b> versus <b>13</b>, physical properties did not appear to be actively employed in its discovery. The physicochemical trajectory was shorter than competitors (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), but extensive changes to the lead structure were explored while preserving the common pharmacophore. Optimization of antiviral potency, selectivity, and pharmacokinetics was pursued; in vivo clearance in the rat was central to the end game,<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> where small molecular changes to identify <b>3</b> had significant impact.</div><div class="NLM_p">At GlaxoSmithKline, CCR5 leads were generated using pharmacophore models based on known ligands.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Tropane <b>14</b> was identified as an advanced lead with acceptable rat PK and good antiviral activity. Reducing hERG binding combined with optimization of exposure in the rat<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> led to the candidate sulfonamide GSK163929 <b>4</b>,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> albeit with a high predicted dose in man (900 mg u.i.d.).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Attention to physicochemical properties was not mentioned in publications, and the trajectory saw little change to LLE, in contrast to the outcomes in the Pfizer and AZ optimizations (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><div class="NLM_p last">Compounds <b>1</b> and <b>5</b> have better combined LE and LLE values versus <b>3</b> and <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). While many marketed drugs have low ‘”% better” values, helping justify the measure, LE and LLE alone provide guidance<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> but cannot precisely predict relative ADMET properties. For example, AZD 5672 <b>5</b> and MrkA <b>3</b> both have better rat PK profiles than maraviroc <b>1</b> or its backup <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). However, the relative candidate drug physical properties are indicative of their originating patent estates (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and the discoveries of maraviroc <b>1</b> and AZD 5672 <b>5</b> showed the largest changes in LE and LLE during optimization. On the basis of their relative efficiency values, <b>1</b> and <b>5</b> can be considered more optimized for CCR5 versus MrKA <b>3</b> and GSK163929 <b>4</b>; moreover, they also advanced further in the clinic and maraviroc <b>1</b> is a successful medicine.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">ii.  Coagulation Factor Xa Inhibitors</h3><div class="NLM_p">Antithrombotic agents, specifically those targeting individual enzymes in the coagulation cascade, were heavily researched around the turn of the millennium, and several drugs are now marketed. Inhibition of the various trypsin-like serine proteases involved in the cascade presented particular challenges for oral medicines; notably attention to physicochemical properties was a key driver toward success and the marketed drugs (rivaroxaban <b>15</b>,<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> apixaban <b>16</b>,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> edoxaban <b>17</b>,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and betrixaban<b>18</b><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a>) are clearly differentiated from the many published inhibitors using efficiency and property metrics.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> For these plasma-based targets, better physicochemical properties demonstrably reduced plasma protein binding, which equated to a higher free fraction and consequent increased translation of intrinsic potency into anticoagulant activity.</div><div class="NLM_p">The identification of two clinical candidates <b>19</b><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and <b>20</b><a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) at GSK was achieved with close attention to physical properties, yet with hindsight and more up-to-date thinking, increased use of predictive methods would have circumnavigated several retrospectively identified blind alleys.<a onclick="showRef(event, 'ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119">(117−119)</a> The representative lead structure <b>21</b> was identified from a combinatorial array,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> possessing modest potency in a factor Xa assay and relatively poor physical properties. However, retrospective analysis indicated that <b>21</b> was reasonably ligand efficient, a metric not appreciated at the time. Minor structural changes identified homochiral <b>22</b> as a potent analog but with little demonstrable anticoagulant activity in term of prothrombin time extension; it was at this time that a data review established the benefits of reducing lipophilicity. Accordingly, a design guide of ACD cLogD<sub>7.4</sub> < 3.5 was employed, leading to potent molecules with better translation of potency into anticoagulant activity and improved microsomal clearance. This culminated with the discovery of <b>19</b><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> 28 months and some 400 compounds after <b>21</b> was identified. <b>19</b> progressed to phase II trials before termination during a strategic review of the GSK portfolio.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exemplars Used in the Hit to Candidates Profiling of the GSK Factor Xa Program, with Calculated Physicochemical Properties (Using the Most Recent Versions of GSK Predictors) and Derived Efficiency Metrics<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0039.gif" alt="" id="gr39" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">It is notable that all parameters for the candidates meet (or are very close to) cut-offs assigned to FXa molecules. LLE<sub>AT</sub> is the Astex ligand efficiency parameter,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> effectively LE corrected for lipophilicity, defined as 0.111 + (1.37 × LLE/HA).</p></div></div><div></div></div><div class="NLM_p">The identification of a second candidate took another 40 months and about 600 compounds, perhaps due to the seductive high potencies of the more aromatic-rich compounds such as <b>23</b><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> and ignoring aspirational lipophilicity goals in some series, which diverted the group from the retrospectively plotted journey (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Ultimately, semisaturated groups, which bound in the S4 pocket, such as tetrahydroisoquinoline <b>24</b> and benzazepine <b>20</b> delivered desired levels of potency.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The second candidate <b>20</b> necessitated use of the chlorothienylvinyl sulfonamide motif to achieve the required balance of potency, selectivity, and oral exposure. The mildly basic center in <b>20</b> contributed to low plasma protein binding and an increased volume of distribution, contributing to an elongated half-life commensurate with once daily dosing (<b>19</b> was projected as a twice daily, although formulation appeared to enable once daily). Interestingly, the ligand efficiency was improved with progression in the series, given reduced size and more optimal fit of the best ligands in the key binding pockets.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) pKi<sub>50</sub> vs cPFI and (b) LE vs LLE (pIC<sub>50</sub> – cLogP) plot for representative factor Xa inhibitors described in ref <a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a>, with four marketed drugs (diamonds) and illustrative examples from the BMS (blue) and GSK program highlighted (candidates, stars; hit, cross; others, circles). Betrixaban was the most recently approved drug, which is a low dose oral molecule (taken 80 mg u.i.d. with food) with relatively poor predicted physical properties, but has a high LLE of 6.3 (based on cLogP).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With subsequent learnings, such as the value of chromatographic lipophilicity measures with improved predictions (established after completion of the work), plus an understanding of their interplay with aromatic ring count, goals could have been achieved with fewer molecules. Such practice would have been further enhanced with application of ligand efficiency measures, which were also not appreciated at the time. The trajectories of these FXa molecules have been reviewed previously,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> but it is interesting to compare the journey from BMS clinical assets DPC423 <b>25</b> and razaxaban <b>26</b>, all highly potent but with poorer properties (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This analysis also noted better translation of intrinsic FXa potency of the molecules with lower PFI into anticoagulant activity, attributed to lower plasma protein binding, such that the GSK compounds had similar 1.5× PT/aPPT extensions to apixaban <b>16</b> despite lesser intrinsic potency.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency, Efficiency, and Calculated Physicochemical Data for the Four Marketed FXa Drugs and Two BMS Terminated Candidates, for Comparison with <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0040.gif" alt="" id="gr40" /></img><div></div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">iii.  Phosphodiesterase-V (PDE-V) Inhibitors</h3><div class="NLM_p">The discovery of the second generation PDE-V inhibitor PF-489791 <b>27</b> presents an interesting trajectory (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), given the objectives for the program, including once daily dosing and enhanced PDE-subtype selectivity. The tactics employed gave a clinical candidate that compared favorably with first generation marketed drugs.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The HTS hit <b>28</b> was reasonably potent but poorly ligand efficient and had poor properties. A focused library based on structural knowledge quickly improved properties and efficiency, in what could be termed a combinatorial fragmentation exercise using the quinazoline core to probe two binding vectors. Structure-guided growth from the core-modified <b>29</b> led to many potent compounds with broadly similar ligand efficiencies, which were optimized by balancing of physicochemical and pharmacokinetic profiles.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Noteworthy observations on the practice are that opportunities for modulation of physical properties were presented with both basic (e.g., <b>30</b>) and acidic motifs, with a number of such variations retaining potency. This offered a range of physicochemical makeups, providing contrasting opportunities to tune the pharmacokinetic profile; the acyl sulfonamide is a good example of exploiting an acyclic carboxylic acid isostere. The clinical candidate <b>27</b> PF-489791 was suitable for once daily oral dosing with improved selectivity profile and notably occupies better efficiency space than the marketed drugs</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PDE-V inhibitors (a) pIC<sub>50</sub> vs cPFI and (b) LE vs LLE (cLogP derived) of PDE-V inhibitors in ChEMBL with three marketed drugs sildenafil, vardenafil, tadalafil (hits, ×; drugs, stars) and illustrative examples from the second-generation program (<b>27</b> PF-489791 = triangle). It is interesting to note a relatively narrow band of ligand efficiency in the second-generation series once the two key substituents were identified.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Activity, Efficiency, and Calculated PFI Data for the Second Generation PDE-V Inhibitors That Led to PF-489791 <b>27</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is interesting to look further back at the differing trajectories that led to the discoveries of the marketed drugs sildenafil, vardenafil, and tadalafil, which predate widespread use of HTS and optimization “rules”. Nonetheless, the elaboration of the antiallergy agent zaprinast into sildenafil is an example of the optimization of a leadlike starting point.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Thus, the modestly potent (PDE-V IC<sub>50</sub> = 2 μM) but highly ligand efficient zaprinast was optimized to <b>31</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) with an increase in potency and maintenance of LE (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Addition of the piperazine sulfonamide both dramatically improved potency and reduced lipophilicity, although it did decrease the LE of sildenafil. Vardenafil<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> is a more potent close analog of sildenafil with consequent improved ligand efficiency. The discovery of tadalafil<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> started from a highly aromatic and lipophilic, but highly ligand efficient hit, ethyl β-carboline-3-carboxylate <b>32</b>, leading to advanced leads such as <b>33</b> with one of the carboline rings saturated and further lipophilicity added (<b>33</b>, cPFI = 9.1). Maintenance of the good potency while markedly reducing lipophilicity led to the low-dose, long-acting medicine tadalafil.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Representative Activity, Efficiency, and Calculated PFI Data for Hits and Key Intermediates En Route to the Three Marketed PDE-V Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">iv.  β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) Inhibitors</h3><div class="NLM_p">An important target for Alzheimer’s disease (AD), BACE-1 is an aspartyl protease that cleaves amyloid precursor protein, and inhibitors need to cross the blood–brain barrier. This requirement essentially rules out the potent but high MW substrate-based peptidomimetic inhibitors that were found initially.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Achieving high potency with low MW and CNS-penetrant molecules appeared to be a major challenge, compounded by the large size of the BACE-1 binding site as shown by X-ray crystallography, with two aspartic acid residues in the catalytic site. However, the importance of the target for AD attracted massive drug design efforts<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a> and the breakthrough came from fragment screening, which identified low MW cyclic amidine hits which bind to the aspartate dyad.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Subsequently, many cyclic and bicyclic amidine BACE-1 scaffolds have been identified,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> from which 13 molecules entered clinical trials of which five are still active; the six candidate drugs with published structures are shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. BACE-1 Inhibitors with Known Structures That Have Reached Clinical Trials<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0041.gif" alt="" id="gr41" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup><sup>a</sup></sup><p class="last">The common cyclic imine is shown in red. The structures of E2609, JNJ-54861911, and CNP520, which are progressing in the clinic, have not been reported.</p></div></div><div></div></div><div class="NLM_p">Among the first fragments identified as BACE-1 inhibitors was the isocytosine <b>34</b> and its phenyl analog <b>35</b>,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> which were starting points for the AstraZeneca structure-based drug design program leading to AZD3289 <b>36</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> In contrast, directly optimizing potency and LE led to the dihydroisocytosine <b>37</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> To improve permeability and CNS penetration, other cyclic imine structures were explored, first hydantoins (<b>38</b>) and then aminoisoindoles (<b>39</b>), from which <b>36</b> emerged. The discovery trajectory shows that a sharp improvement in LLE from hydantoin <b>38</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was achieved while maintaining LE.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Discovery of AZD 3839 <b>36</b> from Early Fragment Hits, Isocytosines <b>34</b> and <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery trajectories of <b>40</b> and <b>36</b>, using <i>K</i><sub>i</sub> values, and properties of other BACE-1 inhibitors: (a) potency vs cLogP; (b) potency vs HA count. Note inhibitor affinity linearly increases up to HA count of ∼20, and sub-10 nM affinity is seen over a wide lipophilicity range (cLogP of 1–6). The “% better” LE and LLE values versus background data are the following: verubecestat <b>40</b>, 0.0%; AZD3293 <b>45</b>, 0.5%; LY2811376 <b>48</b>, 1.7%; LY2886721 <b>46</b>, 2.0%; RG7129 <b>47</b>, 5.2%; AZD3839 <b>36</b>, 6.4%. Data are <i>K</i><sub>i</sub> and IC<sub>50</sub> values from CHEMBL (<i>n</i> = 5490).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the discovery of verubecestat <b>40</b> at Schering (now Merck),<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> consideration of CNS druglike properties, together with structure-based drug design, played a key role throughout the optimization, starting from fragment <b>41</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Iminohydantoin <b>42</b> was selected as a lead based on its BACE-1 potency with high LE, selectivity over the related aspartyl protease cathepsin D, and favorable pharmacokinetic properties; initial optimization led to <b>43</b>.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The approach thereafter was the following: “To maximize the probability of identifying inhibitors with high CNS exposure, our optimization strategy was to adhere to the design principles of maintaining or improving LE while limiting MW, restricting cLogP in a desirable range (≤4), and avoiding additional H-bond donors to minimize PGP activity and polar surface area.”<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Identification of the iminothiadiazinane <b>44</b> was a key step leading to verubecestat <b>40</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Aspects of competitor molecules (such as <b>45</b> and <b>46</b>) appear to have been capitalized in the pyridyl and phenylamide moieties of <b>44</b><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and <b>40</b>.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The optimization trajectory from <b>40</b> to <b>46</b>, via the key published compounds, is exemplary and consistent with the proposed strategy, tracking optimal LE for the target and achieving an LLE increase of 6 units (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Discovery of Verubecesat <b>40</b> from Fragment <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Note the aryl amidine framework in red in the hit is retained in the drug candidate.</p></p></figure><div class="NLM_p last">All six known BACE-1 clinical candidates are high quality with “% better” LE/LLE values of <10% (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Verubecestat <b>40</b> and AZD3293 <b>45</b> stand out as more potent, with few published molecules having better combined LE and LLE values (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). <b>40</b> displayed dose-dependent reduction of Aβ40 in patients reaching 94%,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> yet despite this, a phase III trial on <b>40</b> was terminated because of lack of efficacy.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> The result appears to cast doubt on the role of BACE-1 in AD.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">v.  Mitochondrial Branched Chain Amino Acid Hydrolase (BCATm) Inhibitors</h3><div class="NLM_p">The discovery of BCATm inhibitors provides an interesting comparison in trajectories between parallel efforts using a hybridization strategy between a fragment and a leadlike HTS hit and two series of rather larger molecules derived from encoded library technology (ELT). The fragment guided optimization, which exploited a crossover between fragment<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> and HTS hits with keen attention to properties (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>), gave potent compounds <b>50</b> and <b>51</b> with good physicochemical and efficiency properties,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> manifested as low PFI (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a), good solubility, and high LE and LLE (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b). Notably, calculated lipophilicity data in this series were sensitive to the input tautomer (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), although measured data and structural observations through H-bonding patterns in crystals were aligned. These compounds were identified in relatively few iterations, and reasonable potencies and properties were secured with a number of analogs. Thereafter, once issues with salt formulation were addressed, desirable levels of oral pharmacokinetic exposure were quickly achieved. These physical and efficiency data compared favorably with those of the much larger and more lipophilic structures in the two ELT series.<a onclick="showRef(event, 'ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref138 ref139">(138,139)</a> However, the in vivo pharmacological profile of the most potent ELT exemplar <b>52</b><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> was not that dissimilar to the hybrids <b>50</b> and <b>51</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) despite much less pharmacokinetic exposure, an outcome attributable to the more favorable binding kinetics of <b>52</b> with BCATm, that indicated a slower off-rate. The binding modes of the compounds, while dissimilar to some other structures obtained, indicated similarity in that distal halogens bound into the same pocket and the alkyl tails of <b>50</b> and <b>51</b> bound in a similar region to the pyridyl of <b>53</b>. However, the pendant biaryl (including the carboxamide that was the attachment point to DNA) caused a structural shift in that region of the protein, the likely stability of which probably contributed to a slower off-rate. The program did not progress any further, but this illustrates an interesting conundrum for PK/PD modeling: Would it be better to progress a compound with better exposure and likely more predictable pharmacokinetics (PK) versus one with lesser exposure, thus probably less predictable PK, but enhanced pharmacodynamic (PD) response?</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) pIC<sub>50</sub> vs PFI and (b) LE vs LLE (based on cLogP) plot for three series of GSK BCATm inhibitors derived from fragment guided optimization (green)<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and two ELT series (orange<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> and blue<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a>): fragments, +; key hybrids, △; hits, ×; best balanced exemplars, stars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Comparative Calculated and Measured Lipophilicity Data for Compounds <b>50</b> and <b>51</b> and Their Respective Tautomers<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0042.gif" alt="" id="gr42" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup><sup>a</sup></sup><p class="last">Structural evidence supported the pyrimidinone form vs the hydroxy tautomer.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Activity, Physicochemical Properties, and Efficiency Metrics for the Three Key BCATm Exemplars Progressed to in Vivo Studies</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0043.gif" alt="" id="GRAPHIC-d53e2080-autogenerated" /></img><div></div></div><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Summary of Fragment Guided Optimization Indicating Hits from Fragment Screen and HTS, Plus ELT Off-DNA Hits <b>59</b> and <b>60</b> (Colored as in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">vi.  Poly-ADP Ribose Polymerase (PARP1 and -2) Inhibitors</h3><div class="NLM_p">This target is a recent success story, with three drugs approved for ovarian cancer since 2014 and two more in phase III (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). It is an example with low molecular weight, leadlike starting points. A single key compound, the benzimidazole amide <b>61</b>,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> reported by a team at Newcastle University in 2000, was the progenitor of four of the five drugs. The other, olaparib <b>62</b>,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> came from a medium throughput screen, yet contains the same phenyl carboxamide motif as the other drugs, which mimics the nicotinamide moiety of the PARP substrate, nicotinamide adenine dinucleotide (NAD<sup>+</sup>).</div><figure id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Key Compounds in the Discovery of Poly(ADP-ribose) Polymerase-1 (PARP-1) and PARP-2 Inhibitors, as an Example of Progression of Leadlike Chemical Starting Points<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Discovery of olaparib (<b>62</b>) from the medium throughput screening hit, phthalazine-2-one <b>68</b>.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> (b) Benzimidazole amides <b>61</b> and <b>65</b>, reported in 2000,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> were developed to provide rucaparib (<b>63</b>)<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> and inspired the discoveries of veliparib (<b>64</b>)<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and niraparib (<b>66</b>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Attempts to merge <b>68</b> and <b>65</b> by cyclizing <b>68</b> to an indolenine led instead to <b>72</b>, which was optimized to talazoparib (<b>67</b>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Open arrows are design steps; closed arrows are optimization steps.</p></p></figure><div class="NLM_p">Leadlike starting points provide opportunities for size increases during optimization while remaining within druglike bounds, and this trajectory is exemplified by all the PARP drugs (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The origin of rucaparib <b>63</b><a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> and veliparib <b>64</b><a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> was the highly ligand efficient lead <b>61</b>, and the impressive optimizations closely follow the “leading edge” of the potency versus HAC plot, even though LE values did reduce. This observed LE reduction is not surprising when the starting point <b>61</b> is essentially a fragment with the very high LE of 0.77 (kcal/mol)/HA. The other drugs made use of the 2-phenyl group in <b>65</b> which increased affinity 10-fold versus <b>61</b>, although this increase was insufficient to maintain LE<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> or LLE. However, in all cases, LLE values were either increased or maintained when starting points and drugs are compared (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), and all drugs had cLogP values of 3 or less. In addition, compared with the background data, four of the five drugs have “% better” combined LLE (based on cLogP) and LE values of <10%, the exception being niraparib <b>66</b> (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> We explored the impact of other calculated lipophilicity values on LLE, and the resulting “% better” values are reasonably consistent except for the low value (0.23%) for talazoparib <b>67</b><a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> based on cLogP (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).</div><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery trajectories of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Data are p<i>K</i><sub>i</sub> (<i>n</i> = 359) and pIC<sub>50</sub> (<i>n</i> = 1520) values from CHEMBL. The discovery trajectories for the drugs in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a> are shown; all are IC<sub>50</sub> values except for rucaparib where <i>K</i><sub>i</sub> values are used. Note that potency of >8 is achievable in the cLogP range −0.5 to 5.0. In contrast, the maximum achievable potency increases linearly as the HA count increases to ∼20 and then does not increase further.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Lipophilicities, “% Better” LE and LLE Values, Discovery and Marketing Dates, and Human Doses of Poly(ADP-ribose) Polymerase-1 (PARP-1) and PARP-2 Inhibitors<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0055.gif" alt="" id="GRAPHIC-d53e2280-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup><sup>a</sup></sup><p class="last">“% better” LE and LLE values are reasonably consistent with different lipophilicity measures except for talazoparib, which has a relatively low cLogP. Talazoparib has the lowest reported human dose as well as the lowest clearance in rats.</p></div></div><div></div></div><div class="NLM_p last">Even though the PARP drugs are highly ligand efficient, with good druglike properties, this did not guarantee a low dose in humans. All drugs have good bioavailability in rats with volumes of distribution consistent with their neutral or basic ionization class. Talazoparib <b>67</b> stands out from the other drugs with >10-fold reduction in clearance in the rat and >100-fold lower human dose (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">vii.  Human Immunodeficiency Virus (HIV) Integrase Inhibitors</h3><div class="NLM_p">A major challenge with this target was the identification of selective starting points.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> HIV integrase and hepatitis C virus (HCV) NS5b polymerase both use two magnesium ions in their catalytic active sites, and the breakthrough came when 4-aryl-2,4-diketobutanoic acids were initially discovered, from HTS, to inhibit both enzymes.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Converting these structures to heterocycles possessing the dual metal chelating capability eventually provided the first integrase selective lead, <b>73</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>)<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> which was originally made in Merck’s HCV NS5b polymerase program,<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> and optimization provided the first marketed HIV integrase inhibitor raltegravir <b>74</b>.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> The design of the dolutegravir (<b>75</b>)<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> lead <b>76</b><a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> was influenced by the earlier discovery of <b>73</b>. In contrast, for elvitegravir (<b>77</b>), the designed quinolone lead <b>78</b><a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> was less potent than <b>73</b> and <b>76</b>, possibly because it lacks an optimal second metal chelating site.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> The HA counts of all three leads are comparable and leadlike and in each case were increased in optimization, though with loss of LE for <b>74</b> and <b>75</b>. The lipophilicities of <b>74</b> and <b>75</b> were reduced in optimization, increasing LLE by >4 units leading to <b>74</b> and >1 unit to <b>75</b>. In contrast, there was no change in LLE leading to <b>77</b>, the most lipophilic of the three drugs; in contrast to <b>74</b> and <b>75</b>, pharmacokinetic or metabolic optimization was not described in the discovery of <b>77</b>. The potency of amide analogs of <b>74</b> in a HIV-1 strand transfer assay was correlated with lipophilicity;<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> the reduction in lipophilicity in the discovery of raltegravir <b>74</b> was ultimately driven by the key observation that the thiophene in <b>73</b> could be removed without loss of potency. Subsequently, polar basic and amidic replacements of the thiophene resulted in reduced protein binding, increased solubility, and good antiviral potency in a HIV spread assay.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> As a lead compound, the dolutegravir precursor <b>76</b> had outstanding properties with high LLE and LE, potent antiviral activity, and candidate-like pharmacokinetics in rats: clearance of 1.2 mL min<sup>–1</sup> kg<sup>–1</sup>, half-life of 4.7 h, and bioavailability 53%.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Moving from <b>76</b> to <b>75</b> was complex synthetically with the installation and optimization of the chiral tricyclic moiety,<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> but it is the shortest “property journey” of the three drugs (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. HIV Integrase Drug Discovery, Showing Key Lead Compounds and Their Properties</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. HIV integrase trajectories shown on a background literature data of mean IC<sub>50</sub> values (all HCV replicons/mutants) from CHEMBL (<i>n</i> = 1877): (a) potency vs cLogP; (b) potency vs HA count. Structures are shown in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Elvitegravir <b>77</b> is only available as a fixed combination, and while it has a lower dose (100 mg daily) than raltegravir <b>74</b> (400 mg twice daily), it requires coadministration of a pharmacokinetic booster, ritonavir, to inhibit CYP3A4-induced oxidation, the major pathway of metabolism. Dolutegravir <b>75</b> can claim to be the class leader, with the lowest dose (50 mg daily) and better potencies against the major mutant integrase viruses. Dolutegravir <b>75</b> has the lowest LE and LLE “% better” metric, the values being the followng: <b>75</b>, 0.04%; <b>74</b>, 3.5%; <b>77</b>, 22%. Dolutegravir <b>75</b> has the highest LLE value of the drugs, whether based on cLogP or experimental values. cLogP and measured chromatographic log <i>D</i><sub>7.4</sub> <a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> values are respectively the following: dolutegravir, −0.4 and 3.7; raltegravir, 1.2 and 3.3; elvitegravir, 4.6 and 6.4. Follow-on drugs invariably benefit from preceding knowledge and results, and in this case, an advanced lead <b>76</b> with superior ligand efficiencies ultimately provided the better drug.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">viii.  Hits and Leads from Encoded Library Technology (ELT)</h3><div class="NLM_p">The use of ELT is ever-expanding, and its impact has particularly been fueled by increasing structural diversity due to expansions in feasible on-DNA aqueous reactions and available monomers.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> The physicochemical quality of the libraries has improved, which is evident in the reduced lipophilicity of the hits being identified, even if MW generally remains high. Very large numbers of DNA-barcoded compounds can be rapidly screened for binding to immobilized protein with additional, informative selections made feasible using competition from known binders. It is interesting to compare the properties of the set of compounds described in a recent review of the published ELT hits,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> including exemplar compounds described in the BCATm (<b>59</b>, <b>60</b>), RIP-1 (<b>80</b>), and P38 (<b>81</b>) sections. <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> compares molar refraction and lipophilicity, a useful guide to oral absorption prediction, long established within GSK<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (molar refraction correlates with MW; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf" class="ext-link">Supporting Information Figures S.1 and S.2</a>). The spread of the ETL-derived compound properties illustrates the challenges and opportunities that hits from the technique present.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The ELT hits are characterized by, on average, increased size and lipophilicity when compared with a representative set of marketed oral drugs (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). Outliers in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> are larger molecules with oral exposure that is probably transporter-facilitated. Such molecules are almost invariably natural products, including the cardiac glycoside digoxin, tetracycline/β-lactam antibiotics, and macrolides. Macrocyclic compounds can change between hydrophobic and hydrophilic molecular conformations, depending on the local environment, which, inter alia, enables passage through membranes. Most of the rest of the ELT hit molecules exemplified are to the right of the plot in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, albeit in a region where drugs do reside, although it would be advisible to aim to truncate such structures during optimization. <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a> also illustrates how much more lipophilic and aromatic these ELT hits are in comparison to the oral drug set and emphasizes their clear distinction from leadlike molecules.</div><figure id="fig10" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plot of calculated Chrom log <i>D</i><sub>7.4</sub> versus calculated molar refraction (cmr, a good surrogate for size; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf" class="ext-link">Supporting Information Figures S.1 and S.2</a>) for exemplars in the ELT review<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (×), overlaid on a GSK training set of marketed oral dug molecules with % bioavailability of >30% (green ○) and <30% (red ○). The solid line is a statistically derived linear discriminant function (LDF), which differentiates higher from lower bioavailability; the dotted lines (LDF values of ±0.3) represent regions where the predictivity has borderline confidence based on the underlying statistics of the model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Average Values of Predicted Physicochemical Parameters for ELT Exemplars and a GSK Training Set of Marketed Oral Drug Molecules</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">data</th><th class="colsep0 rowsep0" align="center">drugs <i>F</i> < 30%, <i>n</i> = 67</th><th class="colsep0 rowsep0" align="center">drugs <i>F</i> > 30%, <i>n</i> = 372</th><th class="colsep0 rowsep0" align="center">ELT exemplars,<i>n</i> = 20</th><th class="colsep0 rowsep0" align="center">leadlike ranges</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cChrom log <i>D</i><sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">2.0–4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cLogP</td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">1–3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">–0.1</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">401</td><td class="colsep0 rowsep0" align="left">312</td><td class="colsep0 rowsep0" align="left">592</td><td class="colsep0 rowsep0" align="left">100–350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">406</td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="left">517</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">calcd molar refraction</td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">13.9</td><td class="colsep0 rowsep0" align="left">4–11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">8.40</td><td class="colsep0 rowsep0" align="left">14.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. Ar rings</td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1.58</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">1–3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PFI</td><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">4–6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">median</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p last">Attention to library design will be a key objective in future success of the technique; the careful design of the Vipergen Library that led to the P38 inhibitor (<b>81</b>) showed what can be achieved.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> As average molecular size increases (necessarily, in order to generate large numbers in the libraries), it should be noted that complexity increases and the chance of finding a hit reduces. At the levels typically screened, nM to pM concentrations, even if all reactions had worked perfectly, the number of instances of each structure is diminishing, and these represent a fraction of Avogadro’s number (10<sup>23</sup>), which remains a small sampling of the ∼10<sup>60</sup> apparently feasible druglike molecules.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">ix.  Receptor Interacting Protein Kinase-1 (RIP-1) Inhibitors</h3><div class="NLM_p">The identification of the RIP-1 inhibitor <b>82</b> (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>),<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> which is progressing in clinical trials, represents a triumph for hit identification using encoded library technology, where the hit <b>80</b> proved to be highly potent and ligand efficient when synthesized off-DNA.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Strikingly, the candidate molecule <b>82</b> and hit <b>80</b> differed by only two atoms, although this modest change caused a profound improvement in measured physical properties and thus pharmacological behavior. Analysis of the trajectories followed illustrates some particularly pertinent learnings and indicators where application of improved in silico predictions of both activity and properties might reduce cycle times in future. Despite the seemingly modest changes, the optimization was achieved by a large team and several hundred compounds were synthesized, albeit with 18 months of the first off-DNA synthesis.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. RIP-1 Activity (FP Assay), Lipophilicity, and Efficiency Data, Colored To Reflect Relative Quality for the Target<a class="ref internalNav" href="#tbl10-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0044.gif" alt="" id="gr43" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl10-fn1"><div class="footnote" id="tbl10-fn1"><sup><sup>a</sup></sup><p class="last">mChrom log <i>P</i> and mPFI values are measured. Calculated Chrom log <i>P</i> for <b>82</b>, based on the 4<i>H</i>-1,2,4-triazole tautomer (with good agreement), but it is interesting to note that the 1<i>H</i>-1,2,4-triazole depicted appeared likely from structural work, which gives the following calculated data: cLogP = 2.6; cChrom log <i>P</i> = 3.7; cChrom log <i>D</i><sub>7.4</sub> = 4.5.</p></div></div><div></div></div><div class="NLM_p">This series of RIP-1 inhibitors binds at a unique allosteric region close to the ATP binding site in RIP-1, where an earlier series of RIP-1 inhibitors, known as “necrostatins”,<a onclick="showRef(event, 'ref162 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref162 ref163 ref164">(162−164)</a> were also found to bind, enabling exquisite kinome selectivity. The difficulty in securing selectivity over structurally and functionally related kinases is well-documented. A consequence of the necessary size inflation often required to achieve this is one reason that in LE/LLE analyses many kinase inhibitor drugs and candidates, acting by classical kinase hinge-binding interactions, are not among the most optimal for the particular target.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It is interesting to contrast the much lower efficiency and poorer physical properties of the “traditional” RIP-1 hinge binding inhibitors such as <b>83</b> (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>),<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> perhaps reflecting the difficulties encountered in this approach (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). Of course, the inherent binding dynamics of the distinct pockets are likely to be different; thus efficiency expectations and opportunities will differ, but the physicochemical properties of the active drugs will differentiate the desirability, assuming similar efficacy. Mapping trajectories and other parameters (such as selectivity) will help in understanding progress toward goals and ranking of compounds.</div><figure id="fig11" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. RIP-1 FP pIC<sub>50</sub> versus calculated PFI data: candidate <b>82</b> (purple star), ELT hit <b>80</b> (blue ×), analogs of these compounds in the hits to lead (yellow triangles) and LO disclosures (green circles). Hinge binding series related to the in vivo active <b>83</b> (red). The lines representing ligand lipophilic efficiency are based on pIC<sub>50</sub> – cPFI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. RIP-1 LE vs LLE data colored as <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. Cross lines are LE = 0.35 and LLE (pIC<sub>50</sub> – cLogP) = 5.0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> and <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a> illustrate the value of measured physical data in honing assessment of lipophilicity. Interestingly, the GSK Chrom log <i>D</i><sub>7.4</sub> predictor correlates very well with measurements<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> for the successful series (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), posing the question as to whether stricter property based design might have reduced the number of compounds synthesized and profiled in optimization efforts. In this example, Chrom log <i>D</i><sub>7.4</sub> was more representative than cLogP, emphasizing the value in collecting and analyzing measured data. This can be used to build bespoke predictive models based on the measurements for a given series, with attention to the tautomeric forms used to generate predictions (see notes in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>).</div><figure id="fig13" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. RIP-1 LE vs LLE derived from measured Chrom log <i>P</i> data: star is <b>82</b>, ELT hit X is <b>80</b>, colors as in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. Cross lines are LE = 0.35 and LLE (pIC<sub>50</sub> – mChrom log P) = 3.0 (lipophilicities not measured for <b>83</b> and analogs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Measured vs predicted Chrom log <i>D</i><sub>7.4</sub> values in the necrostatin-site series including <b>82</b> and <b>80</b> (line of unity and line of best fit, <i>r</i><sup>2</sup> = 0.969). Colors as in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35">x.  P38α Mitogen-Activated Protein Kinase Inhibitors</h3><div class="NLM_p">With a pivotal role in inflammatory cell signaling, P38α kinase has been a broadly pursued target for autoimmune and inflammatory conditions and a number of candidates progressed to clinical trials.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> As a kinase target, it is unsurprising to observe a plethora of literature on prototypical large and predominantly aromatic molecules. Among reported advanced molecules, different thinking and tactics are evident in the optimization trajectories (see <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>–<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a><named-content content-type="anchor" rid="fig16" type="simple"></named-content><named-content content-type="anchor" rid="fig17" type="simple"></named-content><named-content content-type="anchor" rid="fig18" type="simple"></named-content>show starting points that led to advanced molecules and clinical candidates, chosen to contrast different practices and attention (or not) to physicochemical properties and ligand efficiency. An early fragment approach from Astex gave two reasonably potent and efficient leads.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> However, with three and four aromatic rings contributing to high predicted PFI values, the Astex molecules <b>84</b> and <b>85</b> (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>) could not be described as among the “best”, although they were not fully optimized. This illustrates that even using fragment leads, attention to properties is continually required. Interestingly, the Vipergen example <b>81</b><a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>), identified by ELT, is predicted to possess reasonable properties although it is relatively large, with similar ligand efficiency to <b>84</b>. Attention paid to properties and efficiency is clearly evident in the optimizations by Pfizer (<b>86</b>, <b>87</b>)<a onclick="showRef(event, 'ref168 ref169 ref170'); return false;" href="javascript:void(0);" class="ref ref168 ref169 ref170">(168−170)</a> and GSK (<b>88</b>)<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> in each analysis. To an extent, the Scios/J&J work to <b>89</b><a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> maintained ligand efficiency, but the relatively highly lipophilicity of the hit was not reduced. A modest change to ligand efficiency, mostly due to enhanced potency with little property modulation, was made during the Vertex optimization to <b>90</b>.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Potency, with no property modulation, appeared to be the main driver for the Boehringer trajectory to the allosteric inhibitor <b>91</b> from a small and lipophilic hit (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> A modest drop in ligand efficiency was observed in a growth from 21 to 39 heavy atoms, with a modest growth in LLE (+0.9) in spite of an increase in cLogP of 3.</div><figure id="fig15" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. pIC50 vs HAC for the P38α compounds, illustrating the marked difference in tactics achieved in the GSK optimization to losmapimod (<b>88</b>) (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig16" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. pIC<sub>50</sub> vs cLogP for the P38α compounds, noting that except for the Boehringer molecule <b>91</b> (blue), most optimizations were achieved with modest increases in cLogP (or a decrease in one Pfizer example, <b>86</b> (red)). The Vipergen ELT product <b>81</b> (light purple) scores well in this analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. pIC<sub>50</sub> vs cPFI for the P38α compounds, where the focus on properties was evident at Pfizer (red) and GSK (green). The Pfizer reductions (<b>86</b>, <b>87</b>) (red) were achieved by lipophilicity modulation. Removal of two aromatic rings was the most notable feature of the optimization leading to <b>88</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig18" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. LE vs LLE for the P38α compounds, where the focus on properties and efficiency gave molecules from Pfizer (red) and GSK (green) (<b>86</b>, <b>87</b>, <b>88</b>) at the top right of the graph where the % better than values are optimal. In terms of LLE the Vipergen compound <b>81</b> scores well.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Summary of P38α Inhibitors, Start Points, and Most Advanced Compounds with Their Properties, As Used in the Trajectories Analyses in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>–<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a><a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0045.gif" alt="" id="gr44" /></img><div></div></div><div class="NLM_p">The tactics of the GSK optimization leading to losmapimod <b>88</b> provided an interesting trajectory, achieved in a program that focused on properties and efficiency, delivering a molecule that progressed to phase III trials.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> The hit <b>92</b> (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>),<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> identified by a pharmacophoric search, was not particularly attractive in terms of efficiency or properties, although an X-ray crystal structure of <b>92</b> bound to P38α indicated portions of the structure apparently contributing little to binding. Truncation led to <b>93</b>,<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> which showed a modest increase in potency but much improved efficiency and properties. Replacing the oxadiazole ring radically improved potency in <b>94</b> and improved efficiency; subsequently, further property modulation and fine-tuning of substituents delivered several molecules with encouraging profiles (e.g., <b>95</b>, <b>96</b>)<a onclick="showRef(event, 'ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref177 ref178">(177,178)</a> from which losmapimod <b>88</b> emerged with the best-balanced profile for progression. The trajectory of this optimization in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a> could be described as orthogonal to the others reviewed. Losmapimod <b>88</b> is the only example with a marked reduction in HAC, while the design improved activity, thus giving much improved ligand efficiency. All the other examples improved on hit potency by addition of varying numbers of heavy atoms, with relatively modest shifts in LE during the optimizations.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Activity, Efficiency, and Physicochemical Data on the Discovery of GSK P38α Candidate, Losmapimod <b>88</b>, Emphasizing the Tactics of Using Structural Guidance to Cutting Down in Size, Then Optimizing, a Modest Lead <b>92</b> with Poor Properties and Efficiency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0046.gif" alt="" id="gr45" /></img><div></div></div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">xi.  Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors with Selectivity for the T790M/L858R Double Mutant</h3><div class="NLM_p">The efficacy of the first generation of EGFR kinase inhibitors in non-small-cell lung cancer, including erlotinib and gefitinib, depends on the presence of an activating loop mutation (L858R), but disease progression is associated with a secondary mutation to the kinase domain “gatekeeper” residue T790M. Because side effects are associated with inhibition of wild-type (WT) EGFR, identification of selective T790M/L858R double mutant EGFR inhibitors versus WT became a highly attractive goal. In this example, optimization of LLE based on cellular potency inhibition was achieved despite the fact that this measure will be affected by target binding, access to the target, and competition with ATP.</div><div class="NLM_p">Osimertinib <b>98</b><a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> from AstraZeneca was approved in 2015, and Pfizer identified two candidate drugs, <b>99</b><a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> and <b>100</b><a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). All three compounds use a vinyl amide motif to enable covalent binding to EGFR, by targeting Cys-797. The discoveries of <b>98</b>, <b>99</b>, and <b>100</b> are exemplars of current drug discovery, employing structure-based design and multiparameter optimization of physical properties, reactivity, metabolism, pharmacokinetics, cross-kinase selectivity, and toxicity. In each case, the lead compounds <b>101</b>, <b>102</b>, and <b>103</b> were identified from legacy kinase projects. Optimal warhead electrophilicity was assessed directly using <i>K</i><sub>i</sub>/<i>K</i><sub>inact</sub> estimates or by a physicochemical model<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> that measured half-lives in glutathione solution. The covalent strategy improved cell potency of leads <b>101</b> and <b>102</b> probably because it overcomes competition with intracellular ATP concentrations.</div><figure id="sch9" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0033.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Issues Overcome in the Discoveries of EGFR Double Mutant Candidates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Hinge binding sites shown by blue arrows.</p></p></figure><div class="NLM_p">A significant number of issues were overcome in optimization (summarized in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). Despite optimization of log <i>D</i> and LLE being pursued in the discovery of <b>98</b>, closely related compounds with higher LLE were rejected because of lack of kinase selectivity versus IGFR1 and INSR, as well as hERG binding.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In common with many other marketed kinase inhibitors, <b>98</b> is therefore less optimized for its target according to the “% better” LE and LLE (based on cLogP) metric (39% versus 544 double mutant EGFR inhibitors reported in CHEMBL). In contrast, <b>99</b> and <b>100</b>, which have different hinge-binding modes (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>), both have higher LLE values and are more optimized (% better values are 4.6% and 0.5%, respectively). Structural features, including H-bonding, drive cross-kinase selectivity (see below) more than size or lipophilicity.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a><b>98</b> contains a 2-anilino-6-arylpyrimidine, a substructure frequently appearing in kinase inhibitors and that may be the source of selectivity issues in the <b>98</b> series. Improving kinase selectivity across a panel of 38 kinases was also required in the discovery of <b>100</b>,<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> where the 2-methoxy group in the pyrazole ring made a >4-fold improvement in selectivity in the <i>N</i>-isopropylpurine compounds. This was designed by targeting an interaction with Leu-792 in the hinge binding region, where many other kinases have a bulkier Tyr or Phe residue.</div><figure id="fig19" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Cellular EGFR double mutant potencies versus measured log <i>D</i> for compounds cited in the discoveries of <b>98</b>, <b>99</b>, and <b>100</b>. LLE<sub>D</sub> = cell pIC<sub>50</sub> – log <i>D</i><sub>7.4</sub>. The “% better” LE and LLE values (based on cLogP) versus background data from CHEMBL (<i>n</i> = 544, not shown) are the following: osimertinib <b>98</b>, 39%; PF-06459988 <b>99</b>, 4.6%; PF-06747775 <b>100</b>, 0.5%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This example shows that physical properties of kinase inhibitors may sometimes need to be compromised to some extent to achieve adequate kinome selectivity, but this tactic has not prevented progression of many molecules for cancer indications.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> However, both optimal physical properties and kinome selectivity can be achieved in alternative core scaffolds. Covalent kinase inhibitors using Michael acceptors can react with thiol-containing non-kinase targets. For example, by use of mass spectrometry, <b>98</b> was shown to bind to cathepsins while <b>100</b> does not.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Ultimately, it is of course clinical efficacy that will decide value and the eventual comparisons of <b>98</b> with <b>100</b> and other progressing covalent<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> or noncovalent<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> dual mutant inhibitors will be revealing.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">xii.  5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK) Activators</h3><div class="NLM_p">AMPK is a serine/threonine protein kinase composed of three subunits, which exists as 12 isoforms.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> It is a primary mechanism for maintenance of cellular energy homeostasis, and activators have potential for treatment of metabolic diseases. This target allows another look at the practices of drug discovery within Merck and Pfizer, where a number of interesting comparisons have been made previously.<a onclick="showRef(event, 'ref6 ref38 ref48'); return false;" href="javascript:void(0);" class="ref ref6 ref38 ref48">(6,38,48)</a></div><div class="NLM_p">HTS in Merck failed to provide hits, but an “informer library”, containing molecules bridging fragment and leadlike space, provided the activator hit benzimidazole <b>104</b><a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>). Optimization of <b>104</b> relied on increasing size and lipophilicity, with no less than three phenyl rings added to give <b>105</b>.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> Despite having no measurable free fraction in plasma, <b>105</b> provided proof of concept in preliminary in vivo studies.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Further development focused on increasing free fraction and access to muscle, leading to <b>106</b>,<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> where the sorbate moiety acts as a neutral carboxyl mimic, replacing the benzoic acid of <b>105</b>. Compound <b>106</b> is a pan-AMPK activator, which in animal models improved glucose homeostasis but showed cardiovascular hypertrophy.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></div><figure id="sch10" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0034.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Discovery of AMPK Kinase Activators in Merck and Pfizer</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In Pfizer, HTS provided the hit <b>107</b>.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Modeling overlays of <b>107</b> and A-769622 (<b>108</b>), a known AMPK activator,<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> led to the hypothesis that the benzyl amide group of <b>107</b> was not required and instead a carboxyl group was predicted to mimic the acidic hydroxyl of <b>108</b>. The resultant acid derivative <b>109</b> was indeed a more potent activator than <b>107</b>, and further optimization led to the development candidate indole <b>110</b>.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> X-ray crystallography showed that <b>110</b>, <b>108</b>, and an analog of Merck’s <b>105</b> all bind to the same allosteric site on the AMPK1 α1β1γ1 isoform, located between the α- and β-subunits. There was variation in the location of the acidic groups of the three molecules, due to flexibility of interactions with three neighboring lysine residues located near the solvent front; this aspect is likely to facilitate the binding of the carboxyl replacement in <b>106</b>.</div><div class="NLM_p">The trajectories in LE and LLE space of the compounds in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a> are shown in <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>. The Merck program initially took a backward step in efficiency space with compound <b>105</b>, which was then reversed significantly in <b>106</b>. Because Pfizer hit <b>107</b> could be cut down, LE was greatly improved in <b>109</b>, and yet both LE and LLE were improved further in <b>110</b>. Interestingly, Merck’s hit <b>104</b> and the Pfizer lead <b>109</b> have the same LE and LLE values; yet their optimization proceeded along different paths and ultimately provided compounds <b>106</b> and <b>110</b> with comparable LLE values. Merck did acknowledge the lack of LLE improvement in reaching <b>105</b>,<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> and we note with interest that the organization is now often applying efficiency measures (e.g., <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a>, entries 12, 15, 20, 32). Pfizer was an early adopter of property optimization,<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> and the use of efficiency metrics, especially LLE (or LiPE), appears to be routine (e.g., <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a>, entries 1, 7, 8, 10, 14, 15, 34, 35, 37).</div><figure id="fig20" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Trajectories in LE vs LLE space of the Merck and Pfizer AMPK kinase projects. Structures are shown in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>. LLE = α2β1γ1 EC<sub>50</sub> – cLogP. EC<sub>50</sub> of the HTS hit <b>106</b> is approximated to 40 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">xiii.  Observations on Kinase Inhibitors</h3><div class="NLM_p">To date, 37 licensed drugs and 243 clinical investigations have emerged from the many programs targeting the 518 kinases encoded in the human genome. Evaluation of the target landscape of the clinical molecules indicated that many are not so selective, explaining some off-target effects and highlighting potential for repurposing.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The clear majority focused on the “traditional” approach of targeting the ATP-recognizing hinge motif of the active site, often reworking old hits and drawing on experience,<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> then optimizing growth into the sugar/back-pocket and displacing so-called gatekeeper residues to achieve potency and, sometimes, selectivity over the many related structures in the kinome. Mimicking ATP and the ease of growing from ensuing aromatic heterocycles using S<sub>N</sub>Ar and cross-coupling methodologies was a fruitful tactic that delivered the first generation of drugs. The necessary increase in MW of molecules to achieve selectivity contributed to progressed molecules not necessarily being the best for target in terms of “% better” on LE vs LLE plots.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This is corroborated by an analysis of the data in ref <a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf" class="ext-link">Supporting Information Table S.1</a>) indicating little change of kinome selectivity with respect to physical properties, which is contrary to the relationships evident for more general off-target effects.<a onclick="showRef(event, 'ref82 ref195'); return false;" href="javascript:void(0);" class="ref ref82 ref195">(82,195)</a> A notable milestone in efficiency-based design practice was noted with the improved clinical outcomes and lower dose of the VEGFR inhibitor axitinib.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Subsequently, further examples emerged where efficiency and property-based design delivered clinical assets, as exemplified by the P38α examples above.</div><div class="NLM_p last">The RIP-1 example shows a markedly different approach, exploiting an often searched for but rarely found allosteric pocket, enabling good properties, efficiency, and exquisite selectivity. The role of ELT here was key, and the Vipergen P38α example adds a further example of a potent molecule with reasonable properties. It is interesting to see an increasing number of smaller, highly efficient kinase inhibitors emerge for EGFR (covalent inhibitors, <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>), IRAK-4 (<a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a> entry 1), GSK-3β (<a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a> entry 30), and JAK-1 (<a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a> entry 32), a common feature of these being highly engineered functionalized aliphatic heterocycles. Such motifs improved the quality of these molecules, and it will be interesting to follow their progression.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43">xiv.  Hepatitis C Virus: Nonstructural Protein 3/4A (NS3/4A) Protease Inhibitors</h3><div class="NLM_p">Spectacular recent contributions from medicinal chemistry teams enabled the discovery of several combination products, containing NS3/4A protease inhibitors and NS5A inhibitors, with hepatitis C virus (HCV) disease-curing capability.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The first generation NS3/4A protease inhibitors boceprevir <b>111</b><a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> and telaprevir <b>112</b><a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> required very high doses or repeated administration and bind covalently to the active site serine (<a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a></a>). Our survey of combined drug LE/LLE measures<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> showed telaprevir <b>112</b> to be notably less ligand efficient than <b>111</b> and many other drugs; poor solubility (“less soluble than marble”<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a>) and consequent challenges and delays in its development were significant issues.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> Nevertheless, telaprevir played an important role in pioneering transformational HCV treatment regimes, although the risk of being replaced by more optimal compounds was clear and, indeed, marketing of telaprevir <b>112</b> was discontinued.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. First Generation Covalent HCV NS3/4A Protease Inhibitors<a class="ref internalNav" href="#tbl13-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0047.gif" alt="" id="gr46" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl13-fn1"><div class="footnote" id="tbl13-fn1"><sup><sup>a</sup></sup><p class="last">Telaprevir has aqueous solubility of 4.7 μg/mL, requiring spray-dried formulation.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> It is dosed with peginterferon alfa and ribavirin, with high fat food, and has a boxed warning for serious skin reactions.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a></p></div></div><div></div></div><div class="NLM_p">The second generation of NS3/4A inhibitors are noncovalent macrocyclic structures with reduced human doses versus the first generation drugs (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>).<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> These were all inspired by the progenitor macrocycle BILN-2061 (<b>11</b>3),<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> itself discovered from a linear hexapeptide inhibitor.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> In a key step, Merck scientists used structure-based design to open the macrocycle in <b>113</b> and form a new macrocycle between the carbamate and the pendant heterocycle.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Additional replacement of the carboxyl of <b>113</b> with a sulfonamide isostere provided a new macrocyclic lead structure <b>114</b>. Optimization of the carbamate to proline linker in <b>114</b><a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> provided the two Merck drugs vaniprevir <b>115</b><a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> and grazoprevir <b>116</b>,<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> as well as volixaprevir <b>117</b><a onclick="showRef(event, 'ref205 ref206'); return false;" href="javascript:void(0);" class="ref ref205 ref206">(205,206)</a> and glecaprevir <b>118</b><a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> from competitors. Two further drugs, simeprevir <b>119</b><a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> and paritaprevir <b>120</b>,<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> make direct use of the BILN-2061 <b>113</b> macrocycle.</div><figure id="sch11" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0035.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Second Generation Macrocyclic HCV NS3/4A Protease Inhibitors and Human Doses<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Blue structures retain the BILN-2061 <b>113</b> substructure, and red compounds have Merck substructure <b>114</b> in common. Simeprevir, paritaprevir, grazoprevir, voxilaprevir, and glecaprevir are approved by the FDA. Vaniprevir is approved in Japan.</p></p></figure><div class="NLM_p">These macrocyclic drugs break the Ro5, but this was necessary since sub-nM compounds for this target require heavy atom counts of >46 (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>). In general, macrocycles do not express their full calculated physical properties<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> because of intramolecular interactions, restricted solvent-accessible surface areas, and constrained conformational flexibility; all these factors may assist permeability.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> While property-based design did not feature strongly, the optimizations inspired by BILN-2061 <b>113</b> nevertheless resulted in reduced lipophilicity and increased LLE in all cases and increased LE in five of the six cases (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>). Overall, the “% better” LE/LLE (based on cLogP) measure versus background inhibitors, while admittedly not spectacular, are in the top 20% and improved on telaprevir <b>112</b> (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>). This bRo5 target, like others (vide infra), therefore also seems to conform to the efficiency principles observed for targets with more druglike ligands. Several groups have tried to rationalize the observed effects of macrocycles and other bRo5 molecules, but general principles remain unclear.<a onclick="showRef(event, 'ref210 ref212 ref213'); return false;" href="javascript:void(0);" class="ref ref210 ref212 ref213">(210,212,213)</a> Such molecules likely lie outside the size/property domain of cytochrome P450s, and it has been suggested that bigger molecules necessarily require higher lipophilicity to achieve intestinal absorption (cf. <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref33 ref214'); return false;" href="javascript:void(0);" class="ref ref33 ref214">(33,214)</a></div><figure id="fig21" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Discovery trajectories of macrocyclic inhibitors of HCV NS3/4A protease from the lead BILN-2061 <b>113</b>: (a) potency vs cLogP; (b) potency vs HA count. The “% better” LE and LLE values versus the background of NS3/4A inhibitors from CHEMBL (<i>n</i> = 1305) are improved with the macrocycles versus the first generation drug telaprevir <b>112</b> (36%): simeprevir <b>119</b>, 8.7%; glecaprevir <b>118</b>, 11%; paritaprevir <b>120</b>, 14%; voxilaprevir <b>117</b>, 15%; grazoprevir <b>116</b>, 17%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46">xv.  Hepatitis C Virus: Nonstructural Protein 5A (NS5A) Replication Complex Inhibitors</h3><div class="NLM_p">In searching for functional inhibitors of the HCV virus, using a cellular screen to identify inhibitors of the GT-1b replicon, Bristol-Myers Squibb found iminothiazolidinone <b>121</b> (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>), the only hit from in excess of one million compounds screened.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> While <b>121</b> did not have desirable properties (MW = 587 and cLogP > 5) and readily epimerized, a minor change to the phenyl acetamide <b>122</b> encouragingly improved activity 100-fold.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> What followed is a tour de force of recent drug discovery.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> Compound <b>122</b> was unstable in solution, forming two dimeric isomers <b>123</b>, which were biologically active. The hypothesis that the heterocycles in <b>123</b> served the purpose of spacers between the pair of key pharmacophoric dipeptide groups was confirmed when their inspired replacement with a biaryl linker provided the highly potent, C2-symmetric lead <b>124</b> (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>). The optimization of <b>124</b><a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> still posed substantial challenges: reduction of lipophilicity and increasing solubility to improve ADME, removal of potentially mutagenic aniline nitrogens (imidazoles exploited as amide bioisosteres), refinement of the biaryl spacer, and optimization of the dipeptide. The trajectory in efficiency space is shown in <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>. The resulting drug, daclatasvir <b>125</b>, retained C2-symmetry and is an effective pan-genotype HCV inhibitor.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> Despite being a bRo5 drug, with modest amorphous solubility (0.014 mg/mL at pH 6.5), <b>125</b> had 50% bioavailability in rats. Liver is the target organ, and the liver to plasma ratio for <b>125</b> was ∼5 in the rat.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> Target engagement with NS5A protein was demonstrated using a biotinylated analog as a probe,<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> suggesting <b>125</b> may act by inhibiting RNA binding to NS5A.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> Models of binding of <b>125</b> to crystallized dimeric NS5A domains have been proposed, but intriguingly, the mechanism of action of <b>125</b> is nonstoichiometric relative to NS5A, since the ratio of NS5A molecules to <b>125</b> at its EC<sub>50</sub> in a replicon is estimated to be ∼10<sup>2</sup>–10<sup>3</sup>.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> Alternatively, <b>125</b> could have other antiviral actions.</div><figure id="sch12" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0036.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Discovery of Daclatasvir <b>125</b> from Screening Hit <b>121</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig22" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Trajectory in LE and LLE space for discovery of daclarasvir (<b>125</b>) and values for the other NS5A inhibitors derived from <b>125</b>. The background data show <b>125</b> substructures from CHEMBL (<i>n</i> = 356; the assay is phenotypic and full CHEMBL searches retrieve non-NS5A antivirals).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other classes of NS5A inhibitors have been found,<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> but none yet possess the antiviral efficacy of daclatasvir <b>125</b> analogs. The impact of <b>125</b> was profound: within ∼4 years of its discovery, competitors had patented no less than five future follow-on drugs <b>126</b>–<b>130</b><a onclick="showRef(event, 'ref221 ref222 ref223 ref224 ref225'); return false;" href="javascript:void(0);" class="ref ref221 ref222 ref223 ref224 ref225">(221−225)</a> derived from it (<a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a></a>). Minor changes only to the dipeptide side chains of <b>125</b> were feasible, but the major differentiators are polyaryl variants of the biphenyl spacer (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>) including an exotic high MW solution in pibrentasvir (<b>130</b>).<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Long half-lives in humans<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> together with very high potency, location of the target in the liver, and a unique biological mechanism all contribute to the success of these extraordinary molecules. In combination treatments with NS3/4A protease and NS5B polymerase inhibitors, NS5A inhibitors are helping to cure HCV infection. This is indeed a triumph for medicinal chemistry.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> It is notable that all five follow-on drugs are highly potent with comparable doses, yet are even larger and more lipophilic than <b>125</b>, resulting in lower LE and LLE values (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a></a>).<named-content content-type="anchor" rid="tbl15" type="simple"></named-content></div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Physical Properties and Discovery Timelines of HCV NS5A Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug</th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center" char=".">MW</th><th class="colsep0 rowsep0" align="center" char=".">pEC<sub>50</sub> GT-1a</th><th class="colsep0 rowsep0" align="center" char=".">LE</th><th class="colsep0 rowsep0" align="center" char=".">LLE<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">% better LE and LLE<a class="ref internalNav" href="#t14fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">dose, mg u.i.d.</th><th class="colsep0 rowsep0" align="center">first patent</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">daclatasvir <b>125</b></td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">739</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="left">Feb 21, 2008, WO 2008021927 A2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ledipasvir <b>127</b></td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">889</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="left">Nov 18, 2010, WO 2010132601 A1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ombitasvir <b>129</b></td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">894</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="left">Dec 15, 2011, WO 2011156578 A1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pibrentasvir <b>130</b></td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">1113</td><td class="colsep0 rowsep0" align="char" char=".">11.7</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="left">Jan 5, 2012, US 20120004196 A1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">elbasvir <b>126</b></td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">882</td><td class="colsep0 rowsep0" align="char" char=".">11.4</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="left">Apr 5, 2012, WO 2012041014 A1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">velpatasvir <b>128</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">883</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">May 24, 2012, WO 2012068234 A2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup><sup>a</sup></sup><p class="last">Based on cLogP.</p></div><div class="footnote" id="t14fn2"><sup><sup>b</sup></sup><p class="last">% compounds with better LE and LLE values among 356 daclatasvir (<b>125</b>) substructures from CHEMBL (the assay is phenotypic, and CHEMBL searches include non-NS5A antivirals).</p></div></div></div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Structures of Marketed HCV NS5A Inhibitors<a class="ref internalNav" href="#tbl15-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0048.gif" alt="" id="gr47" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl15-fn1"><div class="footnote" id="tbl15-fn1"><sup><sup>a</sup></sup><p class="last"><b>126–130</b> followed after the first approved drug, daclatasvir <b>125</b>, and all drugs contain a common dipeptide carbamate motif, shown in red.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. Recent Optimizations That Utilized Ligand Lipophilic Efficiency (LLE)<a class="ref internalNav" href="#tbl16-fn1" aria-label="a">a</a><a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">()</a><a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">()</a><a onclick="showRef(event, 'ref253'); return false;" href="javascript:void(0);" class="ref ref253">()</a><a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">()</a><a onclick="showRef(event, 'ref255'); return false;" href="javascript:void(0);" class="ref ref255">()</a><a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">()</a><a onclick="showRef(event, 'ref257'); return false;" href="javascript:void(0);" class="ref ref257">()</a><a onclick="showRef(event, 'ref258'); return false;" href="javascript:void(0);" class="ref ref258">()</a><a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">()</a><a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">()</a><a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">()</a><a onclick="showRef(event, 'ref262'); return false;" href="javascript:void(0);" class="ref ref262">()</a><a onclick="showRef(event, 'ref263'); return false;" href="javascript:void(0);" class="ref ref263">()</a><a onclick="showRef(event, 'ref264'); return false;" href="javascript:void(0);" class="ref ref264">()</a><a onclick="showRef(event, 'ref265'); return false;" href="javascript:void(0);" class="ref ref265">()</a><a onclick="showRef(event, 'ref266'); return false;" href="javascript:void(0);" class="ref ref266">()</a><a onclick="showRef(event, 'ref267'); return false;" href="javascript:void(0);" class="ref ref267">()</a><a onclick="showRef(event, 'ref268'); return false;" href="javascript:void(0);" class="ref ref268">()</a><a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">()</a><a onclick="showRef(event, 'ref270'); return false;" href="javascript:void(0);" class="ref ref270">()</a><a onclick="showRef(event, 'ref271'); return false;" href="javascript:void(0);" class="ref ref271">()</a><a onclick="showRef(event, 'ref272'); return false;" href="javascript:void(0);" class="ref ref272">()</a><a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">()</a><a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">()</a><a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">()</a><a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">()</a><a onclick="showRef(event, 'ref277'); return false;" href="javascript:void(0);" class="ref ref277">()</a><a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">()</a><a onclick="showRef(event, 'ref279'); return false;" href="javascript:void(0);" class="ref ref279">()</a><a onclick="showRef(event, 'ref280'); return false;" href="javascript:void(0);" class="ref ref280">()</a><a onclick="showRef(event, 'ref281'); return false;" href="javascript:void(0);" class="ref ref281">()</a><a onclick="showRef(event, 'ref282'); return false;" href="javascript:void(0);" class="ref ref282">()</a><a onclick="showRef(event, 'ref283'); return false;" href="javascript:void(0);" class="ref ref283">()</a><a onclick="showRef(event, 'ref284'); return false;" href="javascript:void(0);" class="ref ref284">()</a><a onclick="showRef(event, 'ref285'); return false;" href="javascript:void(0);" class="ref ref285">()</a><a onclick="showRef(event, 'ref286'); return false;" href="javascript:void(0);" class="ref ref286">()</a><a onclick="showRef(event, 'ref287'); return false;" href="javascript:void(0);" class="ref ref287">()</a><a onclick="showRef(event, 'ref288'); return false;" href="javascript:void(0);" class="ref ref288">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0049.gif" alt="" id="gr48" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0050.gif" alt="" id="GRAPHIC-d53e4441-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0051.gif" alt="" id="GRAPHIC-d53e4442-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl16-fn1"><div class="footnote" id="tbl16-fn1"><sup><sup>a</sup></sup><p class="last">Of the 38 examples, 14 provided candidate drugs and 16 were in vivo tool compounds. Entries are categorized by hit or lead origin as follows: <b>1–7</b>, fragment hits or fragment derived leads; <b>8</b> and <b>9</b>, leads from designed libraries; <b>9</b> and <b>10</b>, targeted screening hits; <b>10–18</b>, HTS/screening hits; <b>19–32</b>, earlier identified leads; <b>34–36</b>, literature or competitor-derived; <b>37</b> and <b>38</b>, drug or clinical candidate derived. Median potency, cLogP, and MW start/finish values are 7.1/8.2, 3.3/2.1, and 380/427, respectively, consistent with trends in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b for lipophilicity and LLE optimizations. LLE<sub>AT</sub>, which is equal to 0.111 + (1.37 × LLE/HA), is included for the fragment hit optimizations<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> in entries 1–5.</p></div></div><div></div></div><div class="NLM_p last">Do the NS5A drugs demonstrate that druglikeness extends well beyond the rule of five (bRo5), or does their unique modes of action suggest they are true outliers?<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a> The near-unchanged dipeptides imply strict requirements, and membrane permeability shows subtle SAR in the dipeptide moiety, where intramolecular H-bonding was proposed,<a onclick="showRef(event, 'ref228'); return false;" href="javascript:void(0);" class="ref ref228">(228)</a> a feature seen in other bRo5 molecules such as cyclosporin.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Studies of N-methylated cyclic peptides showed a sharp fall in passive permeability at MW > 1000 but also that MW 500–1000 could provide acceptable passive permeability.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Among AbbVie’s bRo5 compounds,<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> compiled from many projects and including <b>129</b> and <b>130</b>, bioavailability was linked to physical properties familiar within Ro5 druglike space: optimal log <i>D</i>, aromatic ring count, and number of rotatable bonds. While more data are needed to understand successful features of bRo5 space,<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> we note that among <b>125</b> dipeptide substructures reported to date in CHEMBL (<i>n</i> = 359), the drugs replicate the now-familiar pattern seen with other targets, lying within the top 15% having the best combined LE and LLE values (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a></a>).</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51">xvi.  B-Cell Lymphoma-2 (BCL-2) Inhibitors</h3><div class="NLM_p">Venetoclax <b>131</b> became the first marketed BCL-2 inhibitor in 2016 for treatment of chronic lymphocytic leukemia in patients who bear the 17p deletion genetic mutation. It is the culmination of 2 decades of committed research and development in AbbVie on this target,<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> which depends on a protein–protein interaction and began with the identification of fragment hits <b>132</b> and <b>133</b> with different binding sites, using NMR (<a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>).<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a> The fragments were linked, then further optimization gave initial lead <b>134</b>, from which the first clinical candidate ABT-737 <b>135</b> was discovered. Improvements of bioavailability led to navitoclax <b>136</b><a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> and finally to venetoclax <b>131</b>,<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> which had improved selectivity (<a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>). Structure-based drug design played a key role in late optimization, leading to the introduction of an azaindole side chain in <b>130</b>. From the patent dates, optimizing <b>134</b> to <b>131</b> took 5–6 years.</div><figure id="sch13" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0037.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Discovery, Timelines (from Patents), and Optimization Strategy of BCL-2 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Venetoclax <b>131</b> is highly potent with <i>K</i><sub>i</sub> ≤ 0.01 nM for BCL-2.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> With experimental log <i>D</i><sub>7.4</sub> = 5.4, cLogP = 10.3, MW = 868, O + N = 14 and OH + NH = 3, it exists outside of bRo5 chemical space.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Moreover, <b>131</b> is a zwitterion with p<i>K</i><sub>a</sub> values of 4.3 and 8.0, a feature associated with increased attrition due to poor pharmacokinetics,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and it contains an aniline and a nitro group which can bear risks for mutagenicity. It is a high risk oral candidate using the GSK guidelines of dose, solubility, and lipophilicity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The human dose of <b>131</b> is 400 mg,<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> but the predictably poor solubilities of 0.0004 mg/mL (at pH 7.4) and 0.011 mg/mL (FaSSIF; dose to FASSIF solubility ratio of 36.4L) required an amorphous solid dispersion formulation, in which any conversion to the crystalline form would decrease bioavailability.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> Low-fat and high-fat meals increase exposures of <b>131</b> by 3.4- and 5.2-fold respectively.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a></div><div class="NLM_p">The discovery trajectory (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a><named-content content-type="anchor" rid="tbl16" type="simple"></named-content>) shows linear increases in cLogP and HA count, up to navitoclax <b>136</b>; final optimization to <b>131</b> reduced size and lipophilicity.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> The background BCL-2 <i>K</i><sub>i</sub> data from CHEMBL show strong dependency on potency with increasing physicochemical properties, which is rare among drug discovery targets.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In this case, sub-nM potency required cLogP > 8 and HA count of >55. This is most probably a result of the requirement to bind to the elongated, but shallow BH3 peptide binding site.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> Despite inherently reduced LE due to its size, <b>131</b> has a combined LE/LLE “% better” value versus background compounds of ≤8.3%, ≤3.0%, ≤1.6%, and ≤1.0%, where LLE is based on cLogP, ALogP, cLogD<sub>7.4</sub>, and cChromLogD, respectively. Hence the basic efficiency principles for optimized drugs we see with more druglike targets also appear to apply to this bRo5 target and indicate highly effective efficiency-optimization in the discovery of <b>131</b>.</div><figure id="fig23" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Trajectory of the discovery of venetoclax (<b>131</b>): (a) potency vs cLogP; (b) potency vs HA count. Structures are shown in <a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>. The background data are BCL-2 compounds extracted from CHEMBL (<i>n</i> = 699). The <i>K</i><sub>i</sub> for <b>131</b> is reported to be <0.01 nM; a value of 0.01 nM is used in the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53">xvii.  Recent Examples of Lipophilic Efficiency Optimization (<a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a>)</h3><div class="NLM_p">A brief survey of recent literature examples (published in 2015–2017) explicitly describing application of LLE helps illustrate the chemical strategies employed. The major strategies used in this set include adding an aromatic or aliphatic heterocycle, changing a phenyl to a heterocycle, and adding polar substituents. Optimizing heteroaromatics and polar groups is also common. Less common, but highly effective when it works out, is the cutting down in size or removal of a phenyl ring or other group. An example is the discovery of lorlatinib from the existing drug crizotinib (entry 37), through the construction of a macrocyclic lactam, thus allowing concomitant removal of a piperidine ring. In the morpholine-based GSK-3β kinase inhibitor, entry 30, a phenyl ring was effectively replaced by hydrogen, with an adjacent methylation used to improve affinity 10-fold. Together, the changes enabled incorporation of a more lipophilic distal 4-pyridyl substituent. The replacement of a phenyl with a polar hydroxyethyl motif features in the mTORC1/2 example, entry 27; here the interesting solubility efficiency metric, [pIC<sub>50</sub> – pSolubility], was used.</div><div class="NLM_p">Fragment examples (entries 1–5) show the expected increase in MW while offering opportunities to demonstrate lipophilicity control. LLE improvements can come exclusively from cLogP reduction, as exemplified by the TarO inhibitor (entry 12), NK3 antagonist (entry 25), IGF-1R inhibitor (entry 31), and EP3 antagonist (entry 34) where potencies did not change appreciably. Reducing LLE, resulting in low cLogP, can lead to a loss of permeability (entry 11), though this tactic can also help to reduce CNS penetration (entry 13). Improvement of already high LLE improved the selectivity of JAK-1 inhibitors by replacing a cyclohexyl with a pyran (entry 32).</div><div class="NLM_p last">Matched pair analysis can assist in decision-making in design,<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> and large databases showing outcomes of common changes on ADME properties are becoming available.<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> Some small changes to a structure can have large impact<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> and should always be considered primary guidance in achieving lower LLE and improving solubility.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a> Late-stage functionalization methods<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a> offer opportunities for methylation, fluorination, and hydroxylation. Four simple but valuable tactics follow. These were highlighted among potential areas where synthetic innovation would impact on future drug discovery.<a onclick="showRef(event, 'ref242'); return false;" href="javascript:void(0);" class="ref ref242">(242)</a><table class="listgroup" border="0" width="95%" id="list1" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Seek “necessary” nitrogens<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> by replacing aromatic C by aromatic N. cLogP will typically be lowered by ∼1 unit, and 10-fold potency improvements occur in 8% of examples. A typical aromatic lead should contain several options for enabling this change.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Methylate. This will increase cLogP by about 0.5 but 10-fold potency increases may compensate, and these occur with a frequency of 8.5%. The approach is particularly recommended for saturated cyclic systems, where conformational effects can be profound: the “magic” methyl effect can increase affinity by several-hundred-fold.<a onclick="showRef(event, 'ref244 ref245 ref246'); return false;" href="javascript:void(0);" class="ref ref244 ref245 ref246">(244−246)</a></p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Fluorinate. Aromatic fluorine substitution has negligible effect on lipophilicity while aliphatic substitution reduces it, depending on the context. Aliphatic F has significant influence on ring and chain conformation.<a onclick="showRef(event, 'ref247 ref248'); return false;" href="javascript:void(0);" class="ref ref247 ref248">(247,248)</a></p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Hydroxylate. Hydroxyl groups are the most common functional group in drugs, appearing in 33% of oral drugs,<a onclick="showRef(event, 'ref249'); return false;" href="javascript:void(0);" class="ref ref249">(249)</a> and aliphatic hydroxyls reduce cLogP by >1 unit. Poor metabolism, notably phase II conjugation, is a risk but is context dependent and not always an issue.<a onclick="showRef(event, 'ref250'); return false;" href="javascript:void(0);" class="ref ref250">(250)</a></p></td></tr></table></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The examples we have shown illustrate differences in practices in optimization programs, set against a backdrop of attention to physicochemical quality and tracking of ligand efficiency measures. We note that successful optimizations tend to converge toward optimal ligand efficiency values for the target, and this occurs irrespective of whether physical properties are actively optimized or not. We propose that such monitoring of progress can speed up the optimization process by providing useful guidance to help objective decision-making while paying attention to the quality of measurements and predictions (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).</div><div class="NLM_p">Successful case histories tell us something about the paths to success, which we believe is best set in the context of each specific target; <i>generic, prescriptive, property, and efficiency goals are not the way to proceed</i>. In this respect our thinking has been influenced by the observation that while oral drugs have differing physicochemical profiles, they frequently possess optimal combined LE and LLE values versus the estate of published compounds active at their biological specific target.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This applies also to several further examples shown here, including targets where the drugs lie in bRo5 space. Seeking optimum efficiencies and physicochemical properties are guiding principles and not rules. The likely achievable ligand efficiency is defined by the target,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> so optimizations should seek to maximize the LE vs LLE combination. The requirements for effective drug exposure by whatever route of administration is sought will <i>constrain</i> the physicochemical space available. Collection of key ADMET data pertinent to the program enables an assessment of progress toward these latter goals.</div><div class="NLM_p">Good practice entails using combinations of the various efficiency plots to assess progress, to map the journey, and to benchmark versus competitors. Creating potency versus property or LE versus LLE plots is simple to do. <i>Predictions are necessary to prioritize decisions, and these should not be prescriptive</i> but ensure a clear focus is kept on the destination. Knowing this allows a path to be mapped from the outset, which will differ in direction according to the properties of the chemical starting point. Starting points from screens are often lipophilic (cLogP ≈ 4),<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> and increasing leadlikeness as an initial goal is the recommended approach. When it is deliberately sought, there is abundant evidence that it may not be difficult to radically reduce lipophilicity or increase sp<sup>3</sup> character. Structure-based drug design offers the opportunity to maximize and tailor polar contacts with the target protein.<a onclick="showRef(event, 'ref289'); return false;" href="javascript:void(0);" class="ref ref289">(289)</a> Mapping of progress against a given target may also help differentiate binding modes when unusual SAR or marked shifts in efficiency might indicate a change in binding mode or kinetics. Ultimately, choosing series based on efficiency and identifying where other parameters (e.g., selectivity) can be used to differentiate between structures will pay dividends, not forgetting physical quality. Together, these are key elements of multiparameter optimization.</div><div class="NLM_p">Trends in properties of patented compounds encompassing oral drugs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a) suggest medicinal chemists might have forgotten how to find small and hydrophilic molecules. We discussed above the reasons for molecular inflation: older drugs, which are smaller and less lipophilic than recent drugs, were largely discovered by mimicking natural ligands with optimization of in vivo activity. This approach is rarely used today because opportunities for exploitation of small, hydrophilic, endogenous transmitters, such as serotonin, dopamine, and acetylcholine, are becoming mined out. Low MW hits may be dismissed because they are not potent, and using LE to rank HTS output is necessary good practice. There is general agreement that leadlike compounds, giving “headroom” for optimization, should enhance HTS screening sets and have higher chances of success based on complexity criteria. While the evidence that leadlike hits accelerate candidate discovery remains anecdotal, the PARP and HIV integrase examples shown above demonstrate the value the approach. However, a clear value of low MW hits has been shown in fragment based drug discovery (FBDD),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> especially when using X-ray guided optimization with careful control of LE, and FBDD is delivering more druglike candidates versus HTS (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c). Libraries crossing over between fragment and leadlike space have found utility. All possible stable, synthetically feasible, and medicinal chemistry friendly molecules with HA count of up to 17,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> some 166.4 billion in total, have been identified, and exploiting this resource will assist selection of novel fragment and leadlike libraries.</div><div class="NLM_p">Without precompetitive disclosure of all compounds made in lead optimization campaigns, it is impossible to assess if practices really do expedite delivery. Anecdotally and in our experience, they do, but further improvement in physicochemical design practices would see fewer or, at the very least, better focused compounds made. Making fewer compounds with high probability of poor properties is good practice;<a onclick="showRef(event, 'ref290'); return false;" href="javascript:void(0);" class="ref ref290">(290)</a> it saves time and costs and is an ultimate implementation of green chemistry thinking.<a onclick="showRef(event, 'ref291'); return false;" href="javascript:void(0);" class="ref ref291">(291)</a></div><div class="NLM_p">Screening larger, more complex molecules brings risks of poor solubility, false negatives, and assay interference, but could these be the best option for some difficult targets? Complex, high MW compounds also have much less chance of finding a fit and giving activity, but in this respect, ELT technology has shown promise, as it offers much larger numbers of compounds to screen. In our experience, high MW hits with modest potency that cannot be “pruned” without dramatic loss of activity are very difficult to advance further. Designing high MW libraries to probe bRo5 space is sensible only if library members can demonstrate good ADME characteristics. Highly complex bRo5 molecules could theoretically have the advantage of reduced promiscuity, but there is insufficient knowledge for successful design principles to emerge so far. Natural product bRo5 drugs are chemically complex<a onclick="showRef(event, 'ref292'); return false;" href="javascript:void(0);" class="ref ref292">(292)</a> but generally hydrophilic,<a onclick="showRef(event, 'ref39 ref293'); return false;" href="javascript:void(0);" class="ref ref39 ref293">(39,293)</a> and the area is arguably underexploited.<a onclick="showRef(event, 'ref294'); return false;" href="javascript:void(0);" class="ref ref294">(294)</a> Nevertheless, drugs frequently rely on natural product part-structures<a onclick="showRef(event, 'ref292 ref295'); return false;" href="javascript:void(0);" class="ref ref292 ref295">(292,295)</a> and using libraries based on natural product scaffolds has long been attractive.<a onclick="showRef(event, 'ref296'); return false;" href="javascript:void(0);" class="ref ref296">(296)</a> The challenging synthesis often required appears to have deterred significant efforts within the pharmaceutical industry.</div><div class="NLM_p">Medicinal chemistry teams must deliver high quality candidates, which will not suffer development delay and shorten patent life for obvious reasons, such as poor solubility. The general success of HTS and FBDD suggests that perhaps fewer roadblocks exist in seeking viable chemical starting points than in optimizing them, with major challenges faced in seeking balanced biological, pharmacokinetic, and physical properties. Time frames are short, and most often, teams are small and therefore need to be efficient in their planning and execution. Obviously, it is desirable to reach optimized compounds by the shortest trajectory, making the fewest number of molecules possible to test each hypothesis (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Developing detailed SAR understanding is attractive to medicinal chemists, but this may not necessarily progress projects. For example, increased LLE will be seen when a new polar group makes a favorable binding interaction, and by definition, that will change SAR. It is important to recognize that such changes can provide a “step-jump” to a new lead series, which often brings late stage lead optimization projects very close to candidate drugs.<a onclick="showRef(event, 'ref297'); return false;" href="javascript:void(0);" class="ref ref297">(297)</a></div><figure id="fig24" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Optimization trajectories according to hit properties, exemplified with a generic potency versus lipophilicity plot showing “ideal” oral druglikeness range as the goal. Fragment (a) or leadlike (b) starting points can be “grown” into optimal druglike space. For typical HTS hits, seeking reduced lipophilicity from the outset (c) will develop improved leadlike characteristics and new SAR. Increasing potency by increasing lipophilicity of HTS hits (d) is risky, since lipophilicity will have to be reduced ultimately and could be difficult if potency depends on it. With potent lipophilic hits, seeking to reduce lipophilicity (e) is the most viable approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The appearance of quality guidance recognizing past problems should begin to make an impact on marketed drugs in the next few years. At the very least, we must now expect to see more targets clinically validated or disproved with quality molecules.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> If not, could patience with small molecule drug discovery soon run out? After all, the community has had the Ro5 and leadlikeness for 2 decades and ligand efficiency metrics for more than 1 decade. However, we do think that medicinal chemists are “upping” their game, as judged by the increased frequency of publications addressing the themes of this Perspective,<a onclick="showRef(event, 'ref298'); return false;" href="javascript:void(0);" class="ref ref298">(298)</a> including several of the excellent examples above.</div><div class="NLM_p">Dose prediction, which summarizes key preclinical data, combining potency, absorption, clearance, and volume of distribution in one valuable metric, is probably not used enough as an optimization tool. Better quality compounds progress more quickly through development because their human pharmacokinetics are more predictable;<a onclick="showRef(event, 'ref299'); return false;" href="javascript:void(0);" class="ref ref299">(299)</a> examples of the opposite case appear above, such as telaprevir and the extended timelines to secure venetoclax. The role of quantitative and translational pharmacology is to better understand the quantitative relationship between drug exposure, target engagement, efficacy, and safety across species in order to better predict human outcomes. In a recent review,<a onclick="showRef(event, 'ref300'); return false;" href="javascript:void(0);" class="ref ref300">(300)</a> it was interesting to note key variables that can be modulated by medicinal chemists to establish favorable pharmacokinetic–pharmacodynamic (PKPD) outcomes. All of the key PK drivers are controlled by physical properties, while PD is most dependent on affinity and efficacy. The PD impact of longer target residence times was noted, something highlighted in section examples; this is notoriously hard to achieve or design for, but if secured, it can markedly improve PD efficacy.<a onclick="showRef(event, 'ref301'); return false;" href="javascript:void(0);" class="ref ref301">(301)</a> Dissociating PK and PD properties, if a strategy can be found, is a means to address otherwise poorly tractable targets and could provide exceptions to the general principles discussed here. An example is the use of bifunctional bRo5 molecules, Protacs, to degrade protein targets by via the ubiquitin proteasome system. The catalytic mode of action of Protacs may help compensate for their nondruglike properties.<a onclick="showRef(event, 'ref302'); return false;" href="javascript:void(0);" class="ref ref302">(302)</a></div><div class="NLM_p">We rely on the benefits of institutional experience and learning,<a onclick="showRef(event, 'ref194 ref297'); return false;" href="javascript:void(0);" class="ref ref194 ref297">(194,297)</a> but the age of “big data” and machine learning is dawning for drug discovery.<a onclick="showRef(event, 'ref303'); return false;" href="javascript:void(0);" class="ref ref303">(303)</a> Synthesis prediction advances<a onclick="showRef(event, 'ref304'); return false;" href="javascript:void(0);" class="ref ref304">(304)</a> have clear potential not only for improving routes but also for providing fresh optimization opportunities. Chemists cannot know all available SAR data (in the broadest sense), but tools are becoming available that can do so and should assist better quality compound design and decision making. An early player is matched pair analysis, where companies have collaborated to pool learning.<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> Further insights into important unsolved problems, such as better understanding of promiscuity,<a onclick="showRef(event, 'ref305'); return false;" href="javascript:void(0);" class="ref ref305">(305)</a> can be expected. In most hit optimizations, the final optimized molecule or candidate bears some structural resemblance to the hit, as shown by the bulk of the examples we cite. Remembering this is important during optimization, and while scaffold-hopping can be feasible, identifying structurally different leads usually requires a new hit identification campaign. Radically evolving a lead series to a different class happens rarely; it will probably take too long to achieve. Could machine learning in future reproducibly design novel starting points for any target? We do not know if the medicinal chemist will be replaced in the future by machines; it is currently acknowledged that chemist and machine together will always outcompete either one on its own.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> But to compete in the future, medicinal chemists will need to continue to exercise maximum design capability and efficiency.<a onclick="showRef(event, 'ref306'); return false;" href="javascript:void(0);" class="ref ref306">(306)</a> With attention to efficiency metrics and judicious implementation of lipophilicity predictions, enhanced by empirical data, better design can be achieved. It will be interesting to watch developments and learn how much the big data revolution might add over and above the principles and practices highlighted herein.</div><div class="NLM_p last">We conclude with the prescient thoughts of the pioneering investigators of drug action, Brown and Fraser, published 150 years ago.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> “Although we cannot obtain a rational explanation of the connection between the chemical and physiological characters of a substance until we know more of the modus operandi of poisons, it might be supposed that a careful examination and comparison of known facts would lead to the discovery of some empirical law or laws by means of which we could deduce the action from the chemical constitution.” They conclude “This investigation has done little more than merely introduce us into a vast field of inquiry, but it has justified us in expecting that important fruits may be obtained by further and careful cultivation.” We now have many more known facts, and important fruits have appeared. Laws still elude us, yet continuing careful cultivation will undoubtedly yield more insights and guiding principles.</div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d53e4889-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00180" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00180" class="ext-link">10.1021/acs.jmedchem.8b00180</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Correlation of selectivity parameters, data of <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> vs MW, and correlation of MW with refraction (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf">jm8b00180_si_001.pdf (302.06 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00180" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Young</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7763-0575" title="Orcid link">http://orcid.org/0000-0002-7763-0575</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7b09141955115502140e151c3b1c081055181416"><span class="__cf_email__" data-cfemail="ec9e838ec286c2958399828bac8b9f87c28f8381">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul D. Leeson</span> - <span class="hlFld-Affiliation affiliation">Paul
Leeson Consulting Ltd., The Malt House, Main Street, Congerstone, Nuneaton, Warwickshire CV13 6LZ, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0212-3437" title="Orcid link">http://orcid.org/0000-0003-0212-3437</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f5999090869a9b8591b59298949c99db969a98"><span class="__cf_email__" data-cfemail="90fcf5f5e3fffee0f4d0f7fdf1f9fcbef3fffd">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Robert J. Young</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=BIO-d53e5058-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Robert J. Young</b> joined Wellcome in 1990 after completing undergraduate and D.Phil. studies at Oxford University and a post doc at The Ben May Institute, University of Chicago. His subsequent medicinal chemistry career has seen many changes, mergers, and acquisitions at GlaxoWellcome/GSK, encompassing significant roles toward six development candidates before a move to early stage discovery (2006), with contributions across numerous H2L programs optimizing hits from HTS, fragments, and ELT methodologies. A long-term interest in physicochemical properties and partnership with Alan Hill produced impactful findings and well-cited publications. He is an author/inventor on >80 publications/patents, an elected member of the GSK Fellowship, Fellow of The Royal Society of Chemistry, and an Honorary Visiting Professor at the University of St. Andrews.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Paul D. Leeson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=BIO-d53e5063-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paul D. Leeson</b> is a medicinal chemistry consultant with >35 years’ experience in major pharmaceutical companies: Smith, Kline and French; Merck Sharp and Dohme; Wyeth (USA); AstraZeneca; and GlaxoSmithKline. Since 2014 he has advised pharmaceutical companies, start-ups, and academia. At AstraZeneca (1997–2011) Paul was head of medicinal chemistry at the Charnwood site and he led AstraZeneca’s Global Chemistry Forum. Paul’s drug discovery contributions have been in the cardiovascular, neuroscience, respiratory, and inflammation therapy areas. He has a special interest in compound quality, and in 2014 he received the Nauta Award from the European Federation of Medicinal Chemistry. Paul has a Ph.D. from the University of Cambridge and holds an honorary professorship at the University of Nottingham.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank so many colleagues and friends for their help and insights over the many years of gestation for this review, many of whom are in the cited references, although Natalie Theodoulou, Phil Harris, Brian Johns, Vipul Patel, Mike Hann, Hongfeng Deng, Ryan Bingham, Jennifer Borthwick, Sophie Bertrand, Andy Bell, Tony Wood, Darren Green, Chiara Zecchin, and Shenaz Bunally have made contributions to help us achieve our aims within.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">bRo5</td><td class="NLM_def"><p class="first last">beyond the rule of five</p></td></tr><tr><td class="NLM_term">ELT</td><td class="NLM_def"><p class="first last">encoded library technology</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug design</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene potassium channel</p></td></tr><tr><td class="NLM_term">HAC</td><td class="NLM_def"><p class="first last">heavy atom count</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand lipophilic efficiency</p></td></tr><tr><td class="NLM_term">LLE<sub>AT</sub></td><td class="NLM_def"><p class="first last">Astex LE corrected for lipophilicity</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PFI</td><td class="NLM_def"><p class="first last">property forecast index</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PKPD</td><td class="NLM_def"><p class="first last">pharmacokinetics–pharmacodynamics</p></td></tr><tr><td class="NLM_term">Ro5</td><td class="NLM_def"><p class="first last">rule of five</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 306 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macarron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirovic, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garyantes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paslay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span></span> <span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1038/nrd3368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&issue=3&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research&doi=10.1038%2Fnrd3368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0lgaNtCCUzLSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D3%26spage%3D188%26epage%3D195%26doi%3D10.1038%2Fnrd3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bleicher, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanine, A. I.</span></span> <span> </span><span class="NLM_article-title">Hit and lead generation: beyond high-throughput screening</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1038/nrd1086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd1086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=12750740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=369-378&issue=5&author=K.+H.+Bleicherauthor=H.+J.+Bohmauthor=K.+Mullerauthor=A.+I.+Alanine&title=Hit+and+lead+generation%3A+beyond+high-throughput+screening&doi=10.1038%2Fnrd1086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A guide to drug discovery: Hit and lead generation: beyond high-throughput screening</span></div><div class="casAuthors">Bleicher, Konrad H.; Boehm, Hans-Joachim; Mueller, Klaus; Alanine, Alexander I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-378</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of small-mol. modulators of protein function, and the process of transforming these into high-content lead series, are key activities in modern drug discovery.  The decisions taken during this process have far-reaching consequences for success later in lead optimization and even more crucially in clin. development.  Recently, there has been an increased focus on these activities due to escalating downstream costs resulting from high clin. failure rates.  In addn., the vast emerging opportunities from efforts in functional genomics and proteomics demands a departure from the linear process of identification, evaluation and refinement activities towards a more integrated parallel process.  This calls for flexible, fast and cost-effective strategies to meet the demands of producing high-content lead series with improved prospects for clin. success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9IQCsTR8tobVg90H21EOLACvtfcHk0lgaNtCCUzLSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtb8%253D&md5=b54e55c1f0d34fbd172c8aa9b996591d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1086%26sid%3Dliteratum%253Aachs%26aulast%3DBleicher%26aufirst%3DK.%2BH.%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DAlanine%26aufirst%3DA.%2BI.%26atitle%3DHit%2520and%2520lead%2520generation%253A%2520beyond%2520high-throughput%2520screening%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D5%26spage%3D369%26epage%3D378%26doi%3D10.1038%2Fnrd1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinker, A.</span></span> <span> </span><span class="NLM_article-title">Components of successful lead generation</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/1568026053828411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F1568026053828411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15892684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=421-439&issue=4&author=A.+Davisauthor=D.+Keelingauthor=J.+Steeleauthor=N.+Tomkinsonauthor=A.+Tinker&title=Components+of+successful+lead+generation&doi=10.2174%2F1568026053828411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Components of successful lead generation</span></div><div class="casAuthors">Davis, Andrew M.; Keeling, David J.; Steele, John; Tomkinson, Nicholas P.; Tinker, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-439</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review aims to give an overview of current good practice in the prosecution of Lead Generation.  It will assess experiences across the field as judged from the contents of the limited no. of peer-review disclosures to date.  It will also rely heavily on the experiences of the authors from many campaigns within this organization.  Its focus will be on the assembly of an appropriate compd. collection for application in High Throughput Screening (HTS), the prosecution of HTS, the profiling of HTS output and, lastly the Hit-to-Lead optimization of selected HTS output.  Excluded from the scope are detailed aspects of library design [1], parallel synthesis [2], virtual library applications [3], virtual screening [4] and fragment screening [5] approaches, all of which have been the subject of recent reviews.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5UYz5NF4m7Vg90H21EOLACvtfcHk0lgaNtCCUzLSmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D&md5=ef29c85464f4ecbc63787210fda1b778</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053828411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828411%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DKeeling%26aufirst%3DD.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTomkinson%26aufirst%3DN.%26aulast%3DTinker%26aufirst%3DA.%26atitle%3DComponents%2520of%2520successful%2520lead%2520generation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D4%26spage%3D421%26epage%3D439%26doi%3D10.2174%2F1568026053828411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&issue=7&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+analysis+of+the+attrition+of+drug+candidates+from+four+major+pharmaceutical+companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0lhTaWtuEY6D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520attrition%2520of%2520drug%2520candidates%2520from%2520four%2520major%2520pharmaceutical%2520companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D7%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lhTaWtuEY6D9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Druglike properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&issue=1&author=C.+A.+Lipinski&title=Druglike+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eZr8y6aIFKvlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDruglike%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26issue%3D1%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">A sorcerer’s apprentice and the rule of five: from rule-of-thumb to commandment and beyond</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23–24</span>),  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2007.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2007.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18061876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2sjivVGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=995-997&issue=23%E2%80%9324&author=C.+Abad-Zapatero&title=A+sorcerer%E2%80%99s+apprentice+and+the+rule+of+five%3A+from+rule-of-thumb+to+commandment+and+beyond&doi=10.1016%2Fj.drudis.2007.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond</span></div><div class="casAuthors">Abad-Zapatero Cele</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">995-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4k8xMsSJHYGLFM_lbR1VmfW6udTcc2eYeTU8zcnmhW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjivVGrtQ%253D%253D&md5=d09c56d696d2977f7a4e5f16992631a4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DA%2520sorcerer%25E2%2580%2599s%2520apprentice%2520and%2520the%2520rule%2520of%2520five%253A%2520from%2520rule-of-thumb%2520to%2520commandment%2520and%2520beyond%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26issue%3D23%25E2%2580%259324%26spage%3D995%26epage%3D997%26doi%3D10.1016%2Fj.drudis.2007.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Graaf, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, S. D.</span></span> <span> </span><span class="NLM_article-title">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9–10</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22227532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=419-424&issue=9%E2%80%9310&author=P.+Morganauthor=P.+H.+Van+Der+Graafauthor=J.+Arrowsmithauthor=D.+E.+Feltnerauthor=K.+S.+Drummondauthor=C.+D.+Wegnerauthor=S.+D.+Street&title=Can+the+flow+of+medicines+be+improved%3F+Fundamental+pharmacokinetic+and+pharmacological+principles+toward+improving+Phase+II+survival&doi=10.1016%2Fj.drudis.2011.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span></div><div class="casAuthors">Morgan, Paul; Van Der Graaf, Piet H.; Arrowsmith, John; Feltner, Doug E.; Drummond, Kira S.; Wegner, Craig D.; Street, Steve D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">419-424</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to uncover systematic learnings that can be applied to improve compd. survival, an anal. was performed on data from Phase II decisions for 44 programs at Pfizer.  It was found that not only were the majority of failures caused by lack of efficacy but also that, in a large no. of cases (43%), it was not possible to conclude whether the mechanism had been tested adequately.  A key finding was that an integrated understanding of the fundamental pharmacokinetic/pharmacodynamic principles of exposure at the site of action, target binding and expression of functional pharmacol. activity (termed together as the three Pillars of survival') all det. the likelihood of candidate survival in Phase II trials and improve the chance of progression to Phase III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFyWWmU_ARMLVg90H21EOLACvtfcHk0livdgs7qEbVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D&md5=18816036124edb3d50c4e063fdc40614</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DVan%2BDer%2BGraaf%26aufirst%3DP.%2BH.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DFeltner%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DK.%2BS.%26aulast%3DWegner%26aufirst%3DC.%2BD.%26aulast%3DStreet%26aufirst%3DS.%2BD.%26atitle%3DCan%2520the%2520flow%2520of%2520medicines%2520be%2520improved%253F%2520Fundamental%2520pharmacokinetic%2520and%2520pharmacological%2520principles%2520toward%2520improving%2520Phase%2520II%2520survival%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26issue%3D9%25E2%2580%259310%26spage%3D419%26epage%3D424%26doi%3D10.1016%2Fj.drudis.2011.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satterthwaite, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24833294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&issue=6&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five-dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework</span></div><div class="casAuthors">Cook, David; Brown, Dearg; Alexander, Robert; March, Ruth; Morgan, Paul; Satterthwaite, Gemma; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Maintaining research and development (R&D) productivity at a sustainable level is one of the main challenges currently facing the pharmaceutical industry.  In this article, we discuss the results of a comprehensive longitudinal review of AstraZeneca's small-mol. drug projects from 2005 to 2010.  The anal. allowed us to establish a framework based on the five most important tech. determinants of project success and pipeline quality, which we describe as the five 'R's: the right target, the right patient, the right tissue, the right safety and the right com. potential.  A sixth factor - the right culture - is also crucial in encouraging effective decision-making based on these tech. determinants.  AstraZeneca is currently applying this framework to guide its R&D teams, and although it is too early to demonstrate whether this has improved the company's R&D productivity, we present our data and anal. here in the hope that it may assist the industry overall in addressing this key challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yhPFZOUNO7Vg90H21EOLACvtfcHk0livdgs7qEbVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D&md5=746a86c7223f170f7e6c4f9817760e5b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five-dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. J.</span></span> <span> </span><span class="NLM_article-title">Quality guidelines for oral drug candidates: dose, solubility and lipophilicity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1727</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27423371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1719-1727&issue=10&author=M.+K.+Baylissauthor=J.+Butlerauthor=P.+L.+Feldmanauthor=D.+V.+Greenauthor=P.+D.+Leesonauthor=M.+R.+Palovichauthor=A.+J.+Taylor&title=Quality+guidelines+for+oral+drug+candidates%3A+dose%2C+solubility+and+lipophilicity&doi=10.1016%2Fj.drudis.2016.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quality guidelines for oral drug candidates: dose, solubility and lipophilicity</span></div><div class="casAuthors">Bayliss, Martin K.; Butler, James; Feldman, Paul L.; Green, Darren V. S.; Leeson, Paul D.; Palovich, Michael R.; Taylor, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1719-1727</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In an attempt to seek increased understanding of compd. attributes that influence successful drug pipeline progression, GlaxoSmithKline's portfolio of oral candidates was compared with ref. sets of marketed oral drugs.  The approach differs from other attrition studies by explicitly focusing on choosing 'the right compd.' by applying relevant, exptl. derived properties.  The anal. led to four proposed compd. quality categories, created by combining specific criteria for three measures: dose, soly. and the property forecast index, a composite measure of lipophilicity using chromatog. detd. Log D and aromaticity.  The 'three properties' provide benchmarked guidelines for project teams to use when seeking and selecting clin. candidates, because they reflect the property distribution of marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMpjV3EZ_4rVg90H21EOLACvtfcHk0livdgs7qEbVTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisb%252FK&md5=d9d145b1ee399b6ad54cdc55fff43c48</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DM.%2BK.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DPalovich%26aufirst%3DM.%2BR.%26aulast%3DTaylor%26aufirst%3DA.%2BJ.%26atitle%3DQuality%2520guidelines%2520for%2520oral%2520drug%2520candidates%253A%2520dose%252C%2520solubility%2520and%2520lipophilicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1719%26epage%3D1727%26doi%3D10.1016%2Fj.drudis.2016.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matcham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettetal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowden, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Impact of a five-dimensional framework on R&D productivity at AstraZeneca</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29348681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=167-181&issue=3&author=P.+Morganauthor=D.+G.+Brownauthor=S.+Lennardauthor=M.+J.+Andertonauthor=J.+C.+Barrettauthor=U.+Erikssonauthor=M.+Fidockauthor=B.+Hamrenauthor=A.+Johnsonauthor=R.+E.+Marchauthor=J.+Matchamauthor=J.+Mettetalauthor=D.+J.+Nichollsauthor=S.+Platzauthor=S.+Reesauthor=M.+A.+Snowdenauthor=M.+N.+Pangalos&title=Impact+of+a+five-dimensional+framework+on+R%26D+productivity+at+AstraZeneca&doi=10.1038%2Fnrd.2017.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of a five-dimensional framework on R&D productivity at AstraZeneca</span></div><div class="casAuthors">Morgan, Paul; Brown, Dean G.; Lennard, Simon; Anderton, Mark J.; Barrett, J. Carl; Eriksson, Ulf; Fidock, Mark; Hamren, Bengt; Johnson, Anthony; March, Ruth E.; Matcham, James; Mettetal, Jerome; Nicholls, David J.; Platz, Stefan; Rees, Steve; Snowden, Michael A.; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">In 2011, AstraZeneca embarked on a major revision of its research and development (R&D) strategy with the aim of improving R&D productivity, which was below industry avs. in 2005-2010.  A cornerstone of the revised strategy was to focus decision-making on five tech. determinants (the right target, right tissue, right safety, right patient and right com. potential).  In this article, we describe the progress made using this '5R framework' in the hope that our experience could be useful to other companies tackling R&D productivity issues.  We focus on the evolution of our approach to target validation, hit and lead optimization, pharmacokinetic/pharmacodynamic modeling and drug safety testing, which have helped improve the quality of candidate drug nomination, as well as the development of the right culture, where 'truth seeking' is encouraged by more rigorous and quant. decision-making.  We also discuss where the approach has failed and the lessons learned.  Overall, the continued evolution and application of the 5R framework are beginning to have an impact, with success rates from candidate drug nomination to phase III completion improving from 4% in 2005-2010 to 19% in 2012-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwdx6OlRZpzrVg90H21EOLACvtfcHk0lglQI5uPgpTHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SitL4%253D&md5=06906e0bc59dc715941998660a514ffe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.244%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DLennard%26aufirst%3DS.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DEriksson%26aufirst%3DU.%26aulast%3DFidock%26aufirst%3DM.%26aulast%3DHamren%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DMarch%26aufirst%3DR.%2BE.%26aulast%3DMatcham%26aufirst%3DJ.%26aulast%3DMettetal%26aufirst%3DJ.%26aulast%3DNicholls%26aufirst%3DD.%2BJ.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DSnowden%26aufirst%3DM.%2BA.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DImpact%2520of%2520a%2520five-dimensional%2520framework%2520on%2520R%2526D%2520productivity%2520at%2520AstraZeneca%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D167%26epage%3D181%26doi%3D10.1038%2Fnrd.2017.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, T. R.</span></span> <span> </span><span class="NLM_article-title">On the connection between chemical constitution and physiological action; with special reference to the physiological action of the salts of the ammonium bases derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia</span>. <i>J. Anat. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1868</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17230757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FotlyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1868&pages=224-242&issue=2&author=A.+C.+Brownauthor=T.+R.+Fraser&title=On+the+connection+between+chemical+constitution+and+physiological+action%3B+with+special+reference+to+the+physiological+action+of+the+salts+of+the+ammonium+bases+derived+from+Strychnia%2C+Brucia%2C+Thebaia%2C+Codeia%2C+Morphia%2C+and+Nicotia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">On the Connection between Chemical Constitution and Physiological Action; with special reference to the Physiological Action of the Salts of the Ammonium Bases derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia</span></div><div class="casAuthors">Brown A C; Fraser T R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of anatomy and physiology</span>
        (<span class="NLM_cas:date">1868</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdcJThMZbycw5nADWVYHg1fW6udTcc2eaA53Gz5Qtsqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FotlyjtQ%253D%253D&md5=e564284cb1cf489e53aaf6a8890bd7ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BC.%26aulast%3DFraser%26aufirst%3DT.%2BR.%26atitle%3DOn%2520the%2520connection%2520between%2520chemical%2520constitution%2520and%2520physiological%2520action%253B%2520with%2520special%2520reference%2520to%2520the%2520physiological%2520action%2520of%2520the%2520salts%2520of%2520the%2520ammonium%2520bases%2520derived%2520from%2520Strychnia%252C%2520Brucia%252C%2520Thebaia%252C%2520Codeia%252C%2520Morphia%252C%2520and%2520Nicotia%26jtitle%3DJ.%2520Anat.%2520Physiol.%26date%3D1868%26volume%3D2%26issue%3D2%26spage%3D224%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&issue=9&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0lisHjntvM5Z0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D9%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Physical properties in drug design</span>. In  <i>Tactics in Contemporary Drug Design</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>, Ed.; <span class="NLM_publisher-name">Springer Berlin Heidelberg</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">68</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2F7355_2013_35" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=1-68&author=R.+J.+Youngauthor=N.+A.+Meanwell&title=Tactics+in+Contemporary+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2F7355_2013_35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2013_35%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DPhysical%2520properties%2520in%2520drug%2520design%26btitle%3DTactics%2520in%2520Contemporary%2520Drug%2520Design%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26pub%3DSpringer%2520Berlin%2520Heidelberg%26date%3D2014%26spage%3D1%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J.</span></span> <span> </span><span class="NLM_article-title">Probing the links between in vitro potency, ADMET and physicochemical parameters</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nrd3367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21358739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFemsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=197-208&issue=3&author=M.+P.+Gleesonauthor=A.+Herseyauthor=D.+Montanariauthor=J.+Overington&title=Probing+the+links+between+in+vitro+potency%2C+ADMET+and+physicochemical+parameters&doi=10.1038%2Fnrd3367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the links between in vitro potency, ADMET and physicochemical parameters</span></div><div class="casAuthors">Gleeson, M. Paul; Hersey, Anne; Montanari, Dino; Overington, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-208</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A common underlying assumption in current drug discovery strategies is that compds. with higher in vitro potency at their target(s) have greater potential to translate into successful, low-dose therapeutics.  This has led to the development of screening cascades with in vitro potency embedded as an early filter.  However, this approach is beginning to be questioned, given the bias in physicochem. properties that it can introduce early in lead generation and optimization, which is due to the often diametrically opposed relationship between physicochem. parameters assocd. with high in vitro potency and those assocd. with desirable absorption, distribution, metab., excretion and toxicity (ADMET) characteristics.  Here, we describe analyses that probe these issues further using the ChEMBL database, which includes more than 500,000 drug discovery and marketed oral drug compds.  Key findings include: first, that oral drugs seldom possess nanomolar potency (50 nM on av.); second, that many oral drugs have considerable off-target activity; and third, that in vitro potency does not correlate strongly with the therapeutic dose.  These findings suggest that the perceived benefit of high in vitro potency may be negated by poorer ADMET properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOslFSgIkUbVg90H21EOLACvtfcHk0lisHjntvM5Z0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFemsr8%253D&md5=e275044516e9b0245b71c9603477ef74</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd3367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3367%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DOverington%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520links%2520between%2520in%2520vitro%2520potency%252C%2520ADMET%2520and%2520physicochemical%2520parameters%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D3%26spage%3D197%26epage%3D208%26doi%3D10.1038%2Fnrd3367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lisHjntvM5Z0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span>; <span class="NLM_string-name">Leeson, P. D.</span>; <span class="NLM_string-name">Waterbeemd, H. v. d.</span></span> <span> </span><span class="NLM_article-title">Physicochemical properties and compound quality</span>. In  <i>The Handbook of Medicinal Chemistry: Principles and Practice</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span>, <span class="NLM_string-name">Ward, S.
E.</span></span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">31</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2F9781782621836-00001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1-31&author=M.+P.+Gleeson&author=P.+D.+Leeson&author=H.+v.+d.+Waterbeemdauthor=A.+Davis&author=S.%0AE.+Ward&title=The+Handbook+of+Medicinal+Chemistry%3A+Principles+and+Practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2F9781782621836-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781782621836-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DPhysicochemical%2520properties%2520and%2520compound%2520quality%26btitle%3DThe%2520Handbook%2520of%2520Medicinal%2520Chemistry%253A%2520Principles%2520and%2520Practice%26aulast%3DDavis%26aufirst%3DA.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2015%26spage%3D1%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug design: an update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in nontraditional drug space</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=564-616&issue=4&author=N.+A.+Meanwell&title=Improving+drug+design%3A+an+update+on+recent+applications+of+efficiency+metrics%2C+strategies+for+replacing+problematic+elements%2C+and+compounds+in+nontraditional+drug+space&doi=10.1021%2Facs.chemrestox.6b00043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-616</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery and development is a complex and lengthy enterprise that suffers from high rates of candidate attrition at all stages of the process.  The phys., biol., and toxicol. properties of a drug candidate are inextricably linked to its structure, and once a mol. has been synthesized, all subsequent studies along the development path are focused only on assessing and understanding its properties in greater detail.  Unfortunately, a full prediction of the biol. properties of a mol. from an anal. of its 2- or 3-dimensional structure is currently beyond our expertise.  This backdrop mandates that considerable care be taken at the design stage if a mol. is to be successful in testing a mechanistic concept underlying a disease process and to progress into late stage clin. trials and, ultimately, marketing approval.  While there are multiple potential causes of candidate attrition, an introspective anal. of drug design practices over the past decade has focused attention on the perception that contemporary mols. are unnecessarily obese, burdened by high mol. wt. and excessive lipophilicity.  This practice is believed to have its roots in the singular pursuit of enhancing potency during lead optimization rather than adopting a more holistic approach to drug design that gives broader consideration to how structural features affect developability properties.  In an effort to provide the medicinal chem. community with practical guideposts to enhancing compd. quality in the drug design phase and which can readily be applied, a series of efficiency indexes have been proposed that attempt to define aspects of compd. quality in the context of a series of physicochem. parameters.  Of these metrics, lipophilic ligand efficiency (LLE or LipE), which provides an index of the dependence of the potency of a mol. on its intrinsic lipophilicity, has been characterized as the most robust metric that has potential for broad-based application.  In this review, after describing the background literature behind the derivation of efficiency metrics and approaches to assessing compd. aesthetics, synopses of some recent practical application in lead optimization campaigns are presented.  However, mols. that fall into space beyond that assocd. with traditional drug-like properties are an important part of the current and future landscape, exemplified by the summary of direct acting hepatitis C virus NS3 and NS5A inhibitors that have transformed clin. therapy for this chronic disease.  While drug development in nontraditional drug-like space is more challenging and the rules for compd. quality will be different with much still to be understood, careful and disciplined drug design practices will be an essential element of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotJb_EhGoW7Vg90H21EOLACvtfcHk0lgoXpEjurEBJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D&md5=aef48399fb698b5f958c1cc11e1d25aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520design%253A%2520an%2520update%2520on%2520recent%2520applications%2520of%2520efficiency%2520metrics%252C%2520strategies%2520for%2520replacing%2520problematic%2520elements%252C%2520and%2520compounds%2520in%2520nontraditional%2520drug%2520space%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616%26doi%3D10.1021%2Facs.chemrestox.6b00043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkroth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1002/jps.2600760902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.2600760902" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1987&pages=663-687&issue=9&author=C.+Hanschauthor=J.+P.+Bjorkrothauthor=A.+Leo&title=Hydrophobicity+and+central+nervous+system+agents%3A+on+the+principle+of+minimal+hydrophobicity+in+drug+design&doi=10.1002%2Fjps.2600760902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600760902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600760902%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DBjorkroth%26aufirst%3DJ.%2BP.%26aulast%3DLeo%26aufirst%3DA.%26atitle%3DHydrophobicity%2520and%2520central%2520nervous%2520system%2520agents%253A%2520on%2520the%2520principle%2520of%2520minimal%2520hydrophobicity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1987%26volume%3D76%26issue%3D9%26spage%3D663%26epage%3D687%26doi%3D10.1002%2Fjps.2600760902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T.</span></span> <span> </span><span class="NLM_article-title">The design of leadlike combinatorial libraries</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3743</span>– <span class="NLM_lpage">3748</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3743-3748&issue=24&author=S.+J.+Teagueauthor=A.+M.+Davisauthor=P.+D.+Leesonauthor=T.+Oprea&title=The+design+of+leadlike+combinatorial+libraries&doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991216%252938%253A24%253C3743%253A%253AAID-ANIE3743%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DOprea%26aufirst%3DT.%26atitle%3DThe%2520design%2520of%2520leadlike%2520combinatorial%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26issue%3D24%26spage%3D3743%26epage%3D3748%26doi%3D10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span> <span> </span><span class="NLM_article-title">Pursuing the leadlikeness concept in pharmaceutical research</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2004.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.cbpa.2004.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15183323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslWqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=255-263&issue=3&author=M.+M.+Hannauthor=T.+I.+Oprea&title=Pursuing+the+leadlikeness+concept+in+pharmaceutical+research&doi=10.1016%2Fj.cbpa.2004.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pursuing the leadlikeness concept in pharmaceutical research</span></div><div class="casAuthors">Hann, Mike M.; Oprea, Tudor I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Lipinski and others, through concepts such as drug-likeness, re-focussed drug discovery back to the principles of medicinal chem. in the high-throughput era as key to reducing attrition.  More recently, the need to go further in defining what makes a good lead has been recognized with the concept of leadlikeness.  Leadlikeness implies cut-off values in the physico-chem. profile of chem. libraries such that they have reduced complexity (e.g. MW below <400) and other more restricted properties.  We examine these concepts in the context of Virtual (theor. possible), Tangible (chem. feasible) and Real (phys. available) worlds of mols.  In a thought expt., we take the HTS concept to the extreme: screening an estd. 60 million Global Collection' on 5000 targets and realizing that perhaps millions of drug candidates might be found that could not possibly be handled in reality.  Sampling of the Virtual and Tangible worlds is therefore a necessity.  We show that the world of Reals is significantly under-sampled as the MW of compds. increases.  This supports the design and screening of reduced complexity' (leadlike) compd. libraries, preferably with synthetic handles available for rapid chem. iteration and detected as interesting by careful screening or biophys. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd8ecCArzZ2bVg90H21EOLACvtfcHk0lgoXpEjurEBJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslWqsrk%253D&md5=c78783585a60d3deee3b0513fe7300e9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2004.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2004.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26atitle%3DPursuing%2520the%2520leadlikeness%2520concept%2520in%2520pharmaceutical%2520research%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2004%26volume%3D8%26issue%3D3%26spage%3D255%26epage%3D263%26doi%3D10.1016%2Fj.cbpa.2004.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, G.</span></span> <span> </span><span class="NLM_article-title">Molecular complexity and its impact on the probability of finding leads for drug discovery</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1021/ci000403i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci000403i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=856-864&issue=3&author=M.+M.+Hannauthor=A.+R.+Leachauthor=G.+Harper&title=Molecular+complexity+and+its+impact+on+the+probability+of+finding+leads+for+drug+discovery&doi=10.1021%2Fci000403i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span></div><div class="casAuthors">Hann, Michael M.; Leach, Andrew R.; Harper, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a simple model of ligand-receptor interactions, the interactions between ligands and receptors of varying complexities are studied and the probabilities of binding calcd.  It is obsd. that as the systems become more complex the chance of observing a useful interaction for a randomly chosen ligand falls dramatically.  The implications of this for the design of combinatorial libraries is explored.  A large set of drug leads and optimized compds. is profiled using several different properties relevant to mol. recognition.  The changes obsd. for these properties during the drug optimization phase support the hypothesis that less complex mols. are more common starting points for the discovery of drugs.  An extreme example of the use of simple mols. for directed screening against thrombin is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ed40mt9qb7Vg90H21EOLACvtfcHk0libN4M0Hna3vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D&md5=e89e76c8fb83fc5012369ae30f20e6b7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fci000403i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000403i%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHarper%26aufirst%3DG.%26atitle%3DMolecular%2520complexity%2520and%2520its%2520impact%2520on%2520the%2520probability%2520of%2520finding%2520leads%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26issue%3D3%26spage%3D856%26epage%3D864%26doi%3D10.1021%2Fci000403i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular complexity and fragment-based drug discovery: ten years on</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2011.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.cbpa.2011.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21665521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=489-496&issue=4&author=A.+R.+Leachauthor=M.+M.+Hann&title=Molecular+complexity+and+fragment-based+drug+discovery%3A+ten+years+on&doi=10.1016%2Fj.cbpa.2011.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular complexity and fragment-based drug discovery: ten years on</span></div><div class="casAuthors">Leach, Andrew R.; Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-496</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We review the concept of mol. complexity in the context of the very simple model of mol. interactions that we introduced over 10 years ago.  A summary is presented of efforts to validate this simple model using screening data.  The relationship between the complexity model and the problem of sampling chem. space is discussed, together with the relevance of these theor. concepts to fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcMgTT6eLC7Vg90H21EOLACvtfcHk0libN4M0Hna3vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCltrg%253D&md5=19c2d65de80a8bab1059468828da6ce2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520complexity%2520and%2520fragment-based%2520drug%2520discovery%253A%2520ten%2520years%2520on%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26issue%3D4%26spage%3D489%26epage%3D496%26doi%3D10.1016%2Fj.cbpa.2011.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">A ‘Rule of three’ for fragment-based lead discovery?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&issue=19&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%98Rule+of+three%E2%80%99+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eZFSdlvE26Ba7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%2598Rule%2520of%2520three%25E2%2580%2599%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26issue%3D19%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&issue=6&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D6%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&issue=2&author=A.%0AL.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lgvJmw5EyYE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span> <span> </span><span class="NLM_article-title">In vitro measurement of drug efficiency index to aid early lead optimization</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4169</span>, <span class="refDoi"> DOI: 10.1002/jps.23305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.23305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4155-4169&issue=11&author=K.+Valkoauthor=E.+Chiarparinauthor=S.+Nunhuckauthor=D.+Montanari&title=In+vitro+measurement+of+drug+efficiency+index+to+aid+early+lead+optimization&doi=10.1002%2Fjps.23305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fjps.23305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23305%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DMontanari%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520measurement%2520of%2520drug%2520efficiency%2520index%2520to%2520aid%2520early%2520lead%2520optimization%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D11%26spage%3D4155%26epage%3D4169%26doi%3D10.1002%2Fjps.23305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland 2: complexity and promiscuity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1039/c2md20347b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc2md20347b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=515-519&issue=3&author=F.+Lovering&title=Escape+from+flatland+2%3A+complexity+and+promiscuity&doi=10.1039%2Fc2md20347b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland 2: complexity and promiscuity</span></div><div class="casAuthors">Lovering, Frank</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-519</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toxicity plays a major role in attrition in the clinic and promiscuity has been linked to toxicity.  A no. of mol. descriptors have been identified that contribute to promiscuity including ionization and logP.  In this study we report on the relationship between complexity, as measured by two descriptors [fraction sp3 (Fsp3) where Fsp3 = (no. of sp3 hybridized carbons/total carbon count) and chiral carbon count], and promiscuity as well as Cyp450 inhibition.  We find that increasing complexity reduces promiscuity and Cyp450 inhibition.  As an understanding of key property descriptors has helped the pharmaceutical industry to address some of the deficiencies of compds. as pertains to bioavailability, awareness of the descriptors that impact promiscuity should allow us to better address toxicity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJfDH0430P-bVg90H21EOLACvtfcHk0lgvJmw5EyYE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D&md5=c03d3b99da22a684cbbbb00fb1633342</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc2md20347b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20347b%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26atitle%3DEscape%2520from%2520flatland%25202%253A%2520complexity%2520and%2520promiscuity%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D3%26spage%3D515%26epage%3D519%26doi%3D10.1039%2Fc2md20347b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgvJmw5EyYE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability—Are too many aromatic rings a liability in drug design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&issue=21%E2%80%9322&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%94Are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0ljSudZDVuxOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2594Are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26issue%3D21%25E2%2580%259322%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo-and hetero-aromatic and-aliphatic ring types</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&issue=3&author=T.+J.+Ritchieauthor=S.+J.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-and+hetero-aromatic+and-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0ljSudZDVuxOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-and%2520hetero-aromatic%2520and-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D3%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">Physicochemical descriptors of aromatic character and their use in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7215</span>, <span class="refDoi"> DOI: 10.1021/jm500515d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500515d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7206-7215&issue=17&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=Physicochemical+descriptors+of+aromatic+character+and+their+use+in+drug+discovery&doi=10.1021%2Fjm500515d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500515d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500515d%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DPhysicochemical%2520descriptors%2520of%2520aromatic%2520character%2520and%2520their%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D17%26spage%3D7206%26epage%3D7215%26doi%3D10.1021%2Fjm500515d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M.
J.</span></span> <span> </span><span class="NLM_article-title">Defining optimum lipophilicity and molecular weight ranges for drug candidates - molecular weight dependent lower logD limits based on permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2844</span>– <span class="NLM_lpage">2851</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2844-2851&author=M.%0AJ.+Waring&title=Defining+optimum+lipophilicity+and+molecular+weight+ranges+for+drug+candidates+-+molecular+weight+dependent+lower+logD+limits+based+on+permeability&doi=10.1016%2Fj.bmcl.2009.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520optimum%2520lipophilicity%2520and%2520molecular%2520weight%2520ranges%2520for%2520drug%2520candidates%2520-%2520molecular%2520weight%2520dependent%2520lower%2520logD%2520limits%2520based%2520on%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2844%26epage%3D2851%26doi%3D10.1016%2Fj.bmcl.2009.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5560</span>– <span class="NLM_lpage">5564</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabow, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buurma, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narduolo, S.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric pairs reveal that key medicinal chemistry parameters vary more than simple physical property based models can explain</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1039/c2md20010d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc2md20010d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=528-540&issue=5&author=A.+G.+Leachauthor=E.+A.+Pillingauthor=A.+A.+Rabowauthor=S.+Tomasiauthor=N.+Asaadauthor=N.+J.+Buurmaauthor=A.+Ballardauthor=S.+Narduolo&title=Enantiomeric+pairs+reveal+that+key+medicinal+chemistry+parameters+vary+more+than+simple+physical+property+based+models+can+explain&doi=10.1039%2Fc2md20010d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc2md20010d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20010d%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DPilling%26aufirst%3DE.%2BA.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DTomasi%26aufirst%3DS.%26aulast%3DAsaad%26aufirst%3DN.%26aulast%3DBuurma%26aufirst%3DN.%2BJ.%26aulast%3DBallard%26aufirst%3DA.%26aulast%3DNarduolo%26aufirst%3DS.%26atitle%3DEnantiomeric%2520pairs%2520reveal%2520that%2520key%2520medicinal%2520chemistry%2520parameters%2520vary%2520more%2520than%2520simple%2520physical%2520property%2520based%2520models%2520can%2520explain%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D5%26spage%3D528%26epage%3D540%26doi%3D10.1039%2Fc2md20010d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&issue=3&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liW1imJPN6DfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26issue%3D3%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span> <span> </span><span class="NLM_article-title">Acidic and basic drugs in medicinal chemistry: a perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1021/jm501000a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501000a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOnt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9701-9717&issue=23&author=P.+S.+Charifsonauthor=W.+P.+Walters&title=Acidic+and+basic+drugs+in+medicinal+chemistry%3A+a+perspective&doi=10.1021%2Fjm501000a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic and Basic Drugs in Medicinal Chemistry: A Perspective</span></div><div class="casAuthors">Charifson, Paul S.; Walters, W. Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The acid/base properties of a mol. are among the most fundamental for drug action.  However, they are often overlooked in a prospective design manner unless it has been established that a certain ionization state (e.g., quaternary base or presence of a carboxylic acid) appears to be required for activity.  In medicinal chem. optimization programs it is relatively common to attenuate basicity to circumvent undesired effects such as lack of biol. selectivity or safety risks such as hERG or phospholipidosis.  However, teams may not prospectively explore a range of carefully chosen compd. pKa values as part of an overall chem. strategy or design hypothesis.  This review summarizes the potential advantages and disadvantages of both acidic and basic drugs and provides some new analyses based on recently available public data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDorb0LfJ8PrVg90H21EOLACvtfcHk0liW1imJPN6DfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOnt7jN&md5=51a3cb91be42ddd1a784afe737c64c60</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm501000a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501000a%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DWalters%26aufirst%3DW.%2BP.%26atitle%3DAcidic%2520and%2520basic%2520drugs%2520in%2520medicinal%2520chemistry%253A%2520a%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D23%26spage%3D9701%26epage%3D9717%26doi%3D10.1021%2Fjm501000a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of druglike concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&issue=11&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+druglike+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520druglike%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P.
D.</span></span> <span> </span><span class="NLM_article-title">Molecular inflation, attrition and the rule of five</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">Suppl. C</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.addr.2016.01.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=22-33&issue=Suppl.+C&author=P.%0AD.+Leeson&title=Molecular+inflation%2C+attrition+and+the+rule+of+five&doi=10.1016%2Fj.addr.2016.01.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMolecular%2520inflation%252C%2520attrition%2520and%2520the%2520rule%2520of%2520five%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26issue%3DSuppl.%2520C%26spage%3D22%26epage%3D33%26doi%3D10.1016%2Fj.addr.2016.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&issue=9&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0liW1imJPN6DfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D9%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&issue=2&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0lgvOwHXxd3gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Is There a difference between leads and drugs? A historical perspective</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1021/ci010366a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&issue=5&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+Leeson&title=Is+There+a+difference+between+leads+and+drugs%3F+A+historical+perspective&doi=10.1021%2Fci010366a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ΔMW = 69; ΔCMR = 1.8; ΔRNG = ΔHAC =1; ΔRTB = 2; ΔCLogP = 0.43; ΔLogD74 = 0.97; ΔHDO = 0; ΔDFPS = 0.15; ΔPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0lgvOwHXxd3gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DIs%2520There%2520a%2520difference%2520between%2520leads%2520and%2520drugs%253F%2520A%2520historical%2520perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26issue%3D5%26spage%3D1308%26epage%3D1315%26doi%3D10.1021%2Fci010366a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span> <span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2986</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&issue=7&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span> <span> </span><span class="NLM_article-title">Follow-on drugs: how far should chemists look?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">15–16</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21658467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=722-732&issue=15%E2%80%9316&author=F.+Giordanettoauthor=J.+Bostromauthor=C.+Tyrchan&title=Follow-on+drugs%3A+how+far+should+chemists+look%3F&doi=10.1016%2Fj.drudis.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Follow-on drugs: how far should chemists look?</span></div><div class="casAuthors">Giordanetto Fabrizio; Bostrom Jonas; Tyrchan Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">722-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A major remark made by observers relates to the focus of the pharmaceutical industry on 'me-too' drugs rather than 'first-in-class' drugs, the latter are considered to be 'truly' innovative medicines.  Although the subject is heavily debated, chemists in project teams around the globe are routinely following up compounds from competitors.  An important strategic consideration is the degree of chemical modification of the original structure required for success.  Here, we present an analysis of the DiMasi and Faden set of first-in-class and follow-on drug pairs (n=74); showing that 70% of them are structurally very similar, meaning that they are characterized by minimal structural variations.  This highlights the fact that even simple atomic variations can cause drastic changes in molecular properties responsible for therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-qG0lyy9NOLt9HypzAgQfW6udTcc2eaaG1b9I5XyCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D&md5=dd6c836d380d44bb7c704e3bd39cc99e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26atitle%3DFollow-on%2520drugs%253A%2520how%2520far%2520should%2520chemists%2520look%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D15%25E2%2580%259316%26spage%3D722%26epage%3D732%26doi%3D10.1016%2Fj.drudis.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span> <span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm0512185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&issue=10&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds&doi=10.1021%2Fjm0512185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D10%26spage%3D2969%26epage%3D2978%26doi%3D10.1021%2Fjm0512185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1038/nrd2796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&issue=3&author=G.%0AM.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates&doi=10.1038%2Fnrd2796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2ebXnr64nSTLFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D3%26spage%3D203%26epage%3D212%26doi%3D10.1038%2Fnrd2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&issue=7&author=P.%0AD.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0lhIBCI9-uI0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D7%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span> <span> </span><span class="NLM_article-title">The influence of the “organizational factor” on compound quality in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1038/nrd3552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=749-765&author=P.+D.+Leesonauthor=S.+A.+St-Gallay&title=The+influence+of+the+%E2%80%9Corganizational+factor%E2%80%9D+on+compound+quality+in+drug+discovery&doi=10.1038%2Fnrd3552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd3552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3552%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26atitle%3DThe%2520influence%2520of%2520the%2520%25E2%2580%259Corganizational%2520factor%25E2%2580%259D%2520on%2520compound%2520quality%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D749%26epage%3D765%26doi%3D10.1038%2Fnrd3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery grows up</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1038/nrd3926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23274457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFOi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=5-7&issue=1&author=M.+Baker&title=Fragment-based+lead+discovery+grows+up&doi=10.1038%2Fnrd3926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery grows up</span></div><div class="casAuthors">Baker, Monya</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-7</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">With multiple drug candidates in the clinic that originated from fragment-based lead discovery, the approach of starting small has become big.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxKfzq4txN2bVg90H21EOLACvtfcHk0lhIBCI9-uI0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFOi&md5=854c670bd7388d04f76867d5818a5191</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrd3926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3926%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DM.%26atitle%3DFragment-based%2520lead%2520discovery%2520grows%2520up%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D1%26spage%3D5%26epage%3D7%26doi%3D10.1038%2Fnrd3926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Efficient exploration of chemical space by fragment-based screening</span>. <i>Prog. Biophys. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2014.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.pbiomolbio.2014.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25268064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ymu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=82-91&issue=2%E2%80%933&author=R.+J.+Hallauthor=P.+N.+Mortensonauthor=C.+W.+Murray&title=Efficient+exploration+of+chemical+space+by+fragment-based+screening&doi=10.1016%2Fj.pbiomolbio.2014.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient exploration of chemical space by fragment-based screening</span></div><div class="casAuthors">Hall, Richard J.; Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Screening methods seek to sample a vast chem. space in order to identify starting points for further chem. optimization.  Fragment based drug discovery exploits the superior sampling of chem. space that can be achieved when the mol. wt. is restricted.  Here we show that com. available fragment space is still relatively poorly sampled and argue for highly sensitive screening methods to allow the detection of smaller fragments.  We analyze the properties of our fragment library vs. the properties of X-ray hits derived from the library.  We particularly consider properties related to the degree of planarity of the fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdghyX93HMZLVg90H21EOLACvtfcHk0lhqcU1VUs-ThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ymu7zO&md5=a63e451443207393b781d3d68b10bcd1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2014.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2014.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DR.%2BJ.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DEfficient%2520exploration%2520of%2520chemical%2520space%2520by%2520fragment-based%2520screening%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D116%26issue%3D2%25E2%2580%25933%26spage%3D82%26epage%3D91%26doi%3D10.1016%2Fj.pbiomolbio.2014.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">The chemical space project</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1021/ar500432k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500432k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=722-730&issue=3&author=J.+L.+Reymond&title=The+chemical+space+project&doi=10.1021%2Far500432k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemical Space Project</span></div><div class="casAuthors">Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">722-730</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the simplest questions that can be asked about mol. diversity is how many org. mols. are possible in total.  To answer this question, my research group has computationally enumerated all possible org. mols. up to a certain size to gain an unbiased insight into the entire chem. space.  Our latest database, GDB-17, contains 166.4 billion mols. of up to 17 atoms of C, N, O, S, and halogens, by far the largest small mol. database reported to date.  Mols. allowed by valency rules but unstable or nonsynthesizable due to strained topologies or reactive functional groups were not considered, which reduced the enumeration by at least 10 orders of magnitude and was essential to arrive at a manageable database size.  Despite these restrictions, GDB-17 is highly relevant with respect to known mols.  Beyond enumeration, understanding and exploiting GDBs (generated databases) led us to develop methods for virtual screening and visualization of very large databases in the form of a "periodic system of mols." comprising six different fingerprint spaces, with web-browsers for nearest neighbor searches, and the MQN- and SMIfp-Mapplet application for exploring color-coded principal component maps of GDB and other large databases.  Proof-of-concept applications of GDB for drug discovery were realized by combining virtual screening with chem. synthesis and activity testing for neurotransmitter receptor and transporter ligands.  One surprising lesson from using GDB for drug analog searches is the incredible depth of chem. space, i.e., the fact that millions of very close analogs of any mol. can be readily identified by nearest-neighbor searches in the MQN-space of the various GDBs.  The chem. space project has opened an unprecedented door on chem. diversity.  Ongoing and yet unmet challenges concern enumerating mols. beyond 17 atoms and synthesizing GDB mols. with innovative scaffolds and pharmacophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxJYiz7ZE3ALVg90H21EOLACvtfcHk0lhqcU1VUs-ThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWisb4%253D&md5=d3199b2273a0e8d92a4b1ffa59c6dffc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Far500432k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500432k%26sid%3Dliteratum%253Aachs%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520chemical%2520space%2520project%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26issue%3D3%26spage%3D722%26epage%3D730%26doi%3D10.1021%2Far500432k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery using X-ray crystallography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1021/jm0495778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0495778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=403-413&issue=2&author=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=A.+Cleasbyauthor=M.+Fredericksonauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Fragment-based+lead+discovery+using+X-ray+crystallography&doi=10.1021%2Fjm0495778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0495778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0495778%26sid%3Dliteratum%253Aachs%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DFragment-based%2520lead%2520discovery%2520using%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D2%26spage%3D403%26epage%3D413%26doi%3D10.1021%2Fjm0495778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">How are fragments optimized? A retrospective analysis of 145 fragment optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2478</span>– <span class="NLM_lpage">2486</span>, <span class="refDoi"> DOI: 10.1021/jm301851v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301851v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2478-2486&issue=6&author=G.%0AG.+Ferenczyauthor=G.+M.+Keseru&title=How+are+fragments+optimized%3F+A+retrospective+analysis+of+145+fragment+optimizations&doi=10.1021%2Fjm301851v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm301851v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301851v%26sid%3Dliteratum%253Aachs%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DHow%2520are%2520fragments%2520optimized%253F%2520A%2520retrospective%2520analysis%2520of%2520145%2520fragment%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D6%26spage%3D2478%26epage%3D2486%26doi%3D10.1021%2Fjm301851v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics guided lead discovery and optimization</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20801227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=919-932&issue=21%E2%80%9322&author=G.%0AG.+Ferenczyauthor=G.+M.+Keseru&title=Thermodynamics+guided+lead+discovery+and+optimization&doi=10.1016%2Fj.drudis.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamics guided lead discovery and optimization</span></div><div class="casAuthors">Ferenczy, Gyoergy G.; Keseru, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">919-932</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The documented unfavorable changes of physicochem. properties during lead discovery and optimization prompted us to investigate the present practice of medicinal chem. optimization from a thermodn. perspective.  Basic principles of binding thermodn. suggest that discriminating between enthalpy-driven and entropy-driven optimizations could be beneficial.  We hypothesize that entropy-driven optimizations might be responsible for the undesirable trend obsd. in physicochem. properties.  Consequently, we suggest that enthalpy-driven optimizations are preferred because they provide better quality compds.  Monitoring binding thermodn. during optimization programs initiated from thermodynamically characterized hits or leads, therefore, could improve the success of discovery programs.  Here, we summarize common industry practices for tackling optimization challenges and review how the assessment of binding thermodn. could support medicinal chem. efforts.  This review focuses on the thermodn. basis of the unfavorable changes obsd. in physicochem. properties in lead discovery and optimization programs and suggests that monitoring binding thermodn. could contribute to an improvement in the quality of compds. identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVvS8oK_KMrbVg90H21EOLACvtfcHk0liDf8HdAw4CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsrfI&md5=fc4a9091229212bb9a845ef9d9e747c3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DThermodynamics%2520guided%2520lead%2520discovery%2520and%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D21%25E2%2580%259322%26spage%3D919%26epage%3D932%26doi%3D10.1016%2Fj.drudis.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">A thermodynamic approach to the affinity optimization of drug candidates</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2009.00880.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fj.1747-0285.2009.00880.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19793186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlehu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=468-472&issue=5&author=E.+Freire&title=A+thermodynamic+approach+to+the+affinity+optimization+of+drug+candidates&doi=10.1111%2Fj.1747-0285.2009.00880.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A thermodynamic approach to the affinity optimization of drug candidates</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">468-472</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">High throughput screening and other techniques commonly used to identify lead candidates for drug development usually yield compds. with binding affinities to their intended targets in the mid-micromolar range.  The affinity of these mols. needs to be improved by several orders of magnitude before they become viable drug candidates.  Traditionally, this task has been accomplished by establishing structure activity relationships to guide chem. modifications and improve the binding affinity of the compds.  As the binding affinity is a function of two quantities, the binding enthalpy and the binding entropy, it is evident that a more efficient optimization would be accomplished if both quantities were considered and improved simultaneously.  Here, an optimization algorithm based upon enthalpic and entropic information generated by Isothermal Titrn. Calorimetry is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbjArg6CTsLVg90H21EOLACvtfcHk0liDf8HdAw4CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlehu7vI&md5=c927114da9f3bfdde1002f039165706b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00880.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00880.x%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DA%2520thermodynamic%2520approach%2520to%2520the%2520affinity%2520optimization%2520of%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26issue%3D5%26spage%3D468%26epage%3D472%26doi%3D10.1111%2Fj.1747-0285.2009.00880.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span> <span> </span><span class="NLM_article-title">The thermodynamics of protein-ligand interaction and solvation: insights for ligand design</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>384</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.09.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.jmb.2008.09.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18930735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2008&pages=1002-1017&issue=4&author=T.+S.+Olssonauthor=M.+A.+Williamsauthor=W.+R.+Pittauthor=J.+E.+Ladbury&title=The+thermodynamics+of+protein-ligand+interaction+and+solvation%3A+insights+for+ligand+design&doi=10.1016%2Fj.jmb.2008.09.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design</span></div><div class="casAuthors">Olsson, Tjelvar S. G.; Williams, Mark A.; Pitt, William R.; Ladbury, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1002-1017</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry is able to provide accurate information on the thermodn. contributions of enthalpy and entropy changes to free energies of binding.  The Structure/Calorimetry of Reported Protein Interactions Online (SCORPIO) database of published isothermal titrn. calorimetry studies and structural information on the interactions between proteins and small-mol. ligands is used here to reveal general thermodn. properties of protein-ligand interactions and to investigate correlations with changes in solvation.  The overwhelming majority of interactions are found to be enthalpically favored.  Synthetic inhibitors and biol. ligands form two distinct subpopulations in the data, with the former having greater av. affinity due to more favorable entropy changes on binding.  The greatest correlation is found between the binding free energy and apolar surface burial upon complex formation.  However, the free energy contribution per unit area buried is only 30-50% of that expected from earlier studies of transfer free energies of small mols.  A simple probability-based estimator for the maximal affinity of a binding site in terms of its apolar surface area is proposed.  Polar surface area burial also contributes substantially to affinity but is difficult to express in terms of unit area due to the small variation in the amt. of polar surface buried and a tendency for cancellation of its enthalpic and entropic contributions.  Conventionally, the contribution of apolar desolvation to affinity is attributed to gain of entropy due to solvent release.  Although data presented here are supportive of this notion, because the correlation of entropy change with apolar surface burial is relatively weak, it cannot, on present evidence, be confidently considered to be correct.  Further, thermodn. changes arising from small differences between ligands binding to individual proteins are relatively large and, in general, uncorrelated with changes in solvation, suggesting that trends identified across widely differing proteins are of limited use in explaining or predicting the effects of ligand modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xdclY7Rk_bVg90H21EOLACvtfcHk0liDf8HdAw4CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7zO&md5=f9d6d3e8a7fd85d7ff7a6dc6acf7309b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.09.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.09.073%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DT.%2BS.%26aulast%3DWilliams%26aufirst%3DM.%2BA.%26aulast%3DPitt%26aufirst%3DW.%2BR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520thermodynamics%2520of%2520protein-ligand%2520interaction%2520and%2520solvation%253A%2520insights%2520for%2520ligand%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D384%26issue%3D4%26spage%3D1002%26epage%3D1017%26doi%3D10.1016%2Fj.jmb.2008.09.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franzini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span> <span> </span><span class="NLM_article-title">Chemical space of DNA-encoded libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6629</span>– <span class="NLM_lpage">6644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6629-6644&issue=14&author=R.+M.+Franziniauthor=C.+Randolph&title=Chemical+space+of+DNA-encoded+libraries&doi=10.1021%2Facs.jmedchem.5b01874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space of DNA-Encoded Libraries</span></div><div class="casAuthors">Franzini, Raphael M.; Randolph, Cassie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6629-6644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, DNA-encoded chem. libraries (DECLs) have attracted considerable attention as a potential discovery tool in drug development.  Screening encoded libraries may offer advantages over conventional hit discovery approaches and has the potential to complement such methods in pharmaceutical research.  As a result of the increased application of encoded libraries in drug discovery, a growing no. of hit compds. are emerging in scientific literature.  In this review we evaluate reported encoded library-derived structures and identify general trends of these compds. in relation to library design parameters.  We in particular emphasize the combinatorial nature of these libraries.  Generally, the reported mols. demonstrate the ability of this technol. to afford hits suitable for further lead development, and on the basis of them, we derive guidelines for DECL design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLvieeEe9dd7Vg90H21EOLACvtfcHk0liDf8HdAw4CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D&md5=f037f9866a0161730c9f34a105ca34c8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01874%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DR.%2BM.%26aulast%3DRandolph%26aufirst%3DC.%26atitle%3DChemical%2520space%2520of%2520DNA-encoded%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D14%26spage%3D6629%26epage%3D6644%26doi%3D10.1021%2Facs.jmedchem.5b01874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rafferty, M. F.</span></span> <span> </span><span class="NLM_article-title">No denying it: medicinal chemistry training is in big trouble</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10859</span>– <span class="NLM_lpage">10864</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00741</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00741" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10859-10864&issue=24&author=M.+F.+Rafferty&title=No+denying+it%3A+medicinal+chemistry+training+is+in+big+trouble&doi=10.1021%2Facs.jmedchem.6b00741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">No Denying It: Medicinal Chemistry Training Is in Big Trouble</span></div><div class="casAuthors">Rafferty, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10859-10864</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There has been little consensus between the pharmaceutical industry and academic communities concerning the best approach to train medicinal chemists for drug discovery.  For decades the pharmaceutical industry has shown preference for synthetic org. graduates over candidates with degrees from medicinal chem. programs on the assumption that medicinal chem. expertise will be acquired on the job.  However, ongoing changes to pharmaceutical drug discovery organizations and practices threaten to undermine this training model.  There is a compelling argument to be made for establishment of a strong industry-academic partnership to train new candidates with sophisticated knowledge of contemporary drug design concepts and techniques to ensure that the future needs of both industry and academic drug discovery research can be served.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgSt0oxSWvabVg90H21EOLACvtfcHk0lj9Mbe8_dBJAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmsLjO&md5=7c5583586b8d6939bc2a52cb4a033455</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00741%26sid%3Dliteratum%253Aachs%26aulast%3DRafferty%26aufirst%3DM.%2BF.%26atitle%3DNo%2520denying%2520it%253A%2520medicinal%2520chemistry%2520training%2520is%2520in%2520big%2520trouble%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D10859%26epage%3D10864%26doi%3D10.1021%2Facs.jmedchem.6b00741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span> <span> </span><span class="NLM_article-title">Time-related differences in the physical property profiles of oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">6338</span>– <span class="NLM_lpage">6348</span>, <span class="refDoi"> DOI: 10.1021/jm049717d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049717d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6338-6348&issue=25&author=P.+D.+Leesonauthor=A.+M.+Davis&title=Time-related+differences+in+the+physical+property+profiles+of+oral+drugs&doi=10.1021%2Fjm049717d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Related Differences in the Physical Property Profiles of Oral Drugs</span></div><div class="casAuthors">Leeson, Paul D.; Davis, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6338-6348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparisons of the calcd. physicochem. properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral drug-like phys. properties.  In contrast, mean values of mol. wt. and the nos. of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%).  Anal. of the 1983-2002 oral drugs by therapy area shows that anti-infectives and nervous system drugs have the most extreme phys. property profiles.  Cardiovascular drugs show increasing mol. wt. with year of publication, primarily a consequence of focusing on clin. proven mechanisms, with limited chem. diversity.  Drug classes other than anti-infectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irresp. of the drug's target.  The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtNkiWH6Bl6bVg90H21EOLACvtfcHk0lj9Mbe8_dBJAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D&md5=edd5cceab1ccfe3542cb4df180e3c160</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm049717d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049717d%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26atitle%3DTime-related%2520differences%2520in%2520the%2520physical%2520property%2520profiles%2520of%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D25%26spage%3D6338%26epage%3D6348%26doi%3D10.1021%2Fjm049717d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">Impact of ion class and time on oral drug molecular properties</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1039/C0MD00157K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC0MD00157K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-105&author=P.+D.+Leesonauthor=S.+A.+St-Gallayauthor=M.+C.+Wenlock&title=Impact+of+ion+class+and+time+on+oral+drug+molecular+properties&doi=10.1039%2FC0MD00157K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of ion class and time on oral drug molecular properties</span></div><div class="casAuthors">Leeson, Paul D.; St-Gallay, Stephen A.; Wenlock, Mark C.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-105</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Using databases of oral drugs and recent compds. from the patents of major pharmaceutical companies, trends in mol. properties over time are identified.  It is shown that the phys. property profiles of oral drugs are not abs., but depend on both ion class and the time of the drug invention.  Properties examd. include lipophilicity, mol. wt., hydrogen bond donors and acceptors, polar surface area, aromaticity, chirality and tetrahedral (sp3) carbon atom count.  Lipophilicity is increasing over time in oral drugs that are neutral or acidic, but not in basic drugs, and has been converging in all ion classes towards a common const. range since the 1960s.  In contrast, mol. wt. is increasing over time in all ion classes.  Hydrogen bond donors (OH + NH group count) are stable over time but hydrogen bond acceptors (O + N atom count) are increasing over time.  It is shown that measures using sp3 atom and arom. atom counts are inversely related and a new parameter, Ar atom count - sp3 atom count (Ar-sp3), describing shape or arom./aliph. balance, is introduced.  Ar-sp3 is const. over time in oral drugs, but is higher in patented compds., independently of mol. wt. and lipophilicity.  The ion classes in patent compds. occupy distinct mol. wt./lipophilicity/shape chem. space.  These properties are significantly increased vs. oral drugs, with the exception of the most recently discovered acidic drugs, and occur in most, but not all target classes.  While ceilings for lipophilicity in acids and neutral compds. may not have been reached, the design of potential drug mols. with reduced ADMET risk is indicated by a seeking a better balance between lipophilicity, 3-dimensionality and aromaticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8hD5yPUXDCbVg90H21EOLACvtfcHk0lj9Mbe8_dBJAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbo%253D&md5=06f976e54fe8783d0f5ebabc3915620d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC0MD00157K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MD00157K%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26atitle%3DImpact%2520of%2520ion%2520class%2520and%2520time%2520on%2520oral%2520drug%2520molecular%2520properties%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D105%26doi%3D10.1039%2FC0MD00157K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1039/c1md00017a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery&doi=10.1039%2Fc1md00017a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0lj9Mbe8_dBJAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355%26doi%3D10.1039%2Fc1md00017a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/nrd3701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22543468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=355-365&issue=5&author=M.+M.+Hannauthor=G.+M.+Keseru&title=Finding+the+sweet+spot%3A+the+role+of+nature+and+nurture+in+medicinal+chemistry&doi=10.1038%2Fnrd3701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span></div><div class="casAuthors">Hann, Michael M.; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Given its position at the heart of small-mol. drug discovery, medicinal chem. has an important role in tackling the well-known productivity challenges in pharmaceutical research and development.  In recent years, extensive analyses of successful and failed discovery compds. and drug candidates have improved our understanding of the role of physicochem. properties in drug attrition.  Based on the clarified challenges in finding the 'sweet spot' in medicinal chem. programs, we suggest that this goal can be achieved through a combination of first identifying chem. starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization.  Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chem. practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURciGjB2A3LVg90H21EOLACvtfcHk0liLhJmaryVPnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D&md5=90170e3f4e69e52bfa38667df380516a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrd3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3701%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DFinding%2520the%2520sweet%2520spot%253A%2520the%2520role%2520of%2520nature%2520and%2520nurture%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D5%26spage%3D355%26epage%3D365%26doi%3D10.1038%2Fnrd3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span> <span> </span><span class="NLM_article-title">Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4443</span>– <span class="NLM_lpage">4458</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01409</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01409" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4443-4458&issue=10&author=D.+G.+Brownauthor=J.+Bostrom&title=Analysis+of+past+and+present+synthetic+methodologies+on+medicinal+chemistry%3A+where+have+all+the+new+reactions+gone%3F&doi=10.1021%2Facs.jmedchem.5b01409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?</span></div><div class="casAuthors">Brown, Dean G.; Bostrom, Jonas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4443-4458</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An anal. of chem. reactions used in current medicinal chem. (2014), three decades ago (1984), and in natural product total synthesis has been conducted.  The anal. revealed that of the current most frequently used synthetic reactions, none were discovered within the past 20 years and only two in the 1980s and 1990s (Suzuki-Miyaura and Buchwald-Hartwig).  This suggests an inherent high bar of impact for new synthetic reactions in drug discovery.  The most frequently used reactions were amide bond formation, Suzuki-Miyaura coupling, and SNAr reactions, most likely due to com. availability of reagents, high chemoselectivity, and a pressure on delivery.  The authors show that these practices result in overpopulation of certain types of mol. shapes to the exclusion of others using simple PMI plots.  The authors hope that these results will help catalyze improvements in integration of new synthetic methodologies as well as new library design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLWvt5DxktAbVg90H21EOLACvtfcHk0lguOIZBo1erRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsrzM&md5=fd56ba8418f6d4e8c271f4e977ee2a93</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01409%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBostrom%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520past%2520and%2520present%2520synthetic%2520methodologies%2520on%2520medicinal%2520chemistry%253A%2520where%2520have%2520all%2520the%2520new%2520reactions%2520gone%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4443%26epage%3D4458%26doi%3D10.1021%2Facs.jmedchem.5b01409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.4.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&issue=4&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery&doi=10.1517%2F17460441.2.4.469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26issue%3D4%26spage%3D469%26epage%3D488%26doi%3D10.1517%2F17460441.2.4.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb0cIewDR-OE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency metrics considered harmful</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9757-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs10822-014-9757-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=699-710&issue=7&author=P.+W.+Kennyauthor=A.+Leitaoauthor=C.+A.+Montanari&title=Ligand+efficiency+metrics+considered+harmful&doi=10.1007%2Fs10822-014-9757-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9757-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9757-8%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520efficiency%2520metrics%2520considered%2520harmful%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26issue%3D7%26spage%3D699%26epage%3D710%26doi%3D10.1007%2Fs10822-014-9757-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting expectations in molecular optimizations: strengths and limitations of commonly used composite parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+expectations+in+molecular+optimizations%3A+strengths+and+limitations+of+commonly+used+composite+parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0lhhmFB9_YejQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520expectations%2520in%2520molecular%2520optimizations%253A%2520strengths%2520and%2520limitations%2520of%2520commonly%2520used%2520composite%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Improving the plausibility of success with inefficient metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1021/ml4004638</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVajtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2-5&issue=1&author=M.+D.+Shultz&title=Improving+the+plausibility+of+success+with+inefficient+metrics&doi=10.1021%2Fml4004638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Plausibility of Success with Inefficient Metrics</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-5</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  To increase the probability of success in drug discovery, the concept of drug-like properties was introduced.  Efficiency metrics that normalize potency against these properties could help reach drug-like space more efficiently.  Potential reasons for the inefficient use of metrics and suboptimal decision making are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokUcqughsg0LVg90H21EOLACvtfcHk0lhhmFB9_YejQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVajtLjP&md5=de1493d6fa4e894b078b8b020ad4b3eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fml4004638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004638%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DImproving%2520the%2520plausibility%2520of%2520success%2520with%2520inefficient%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D1%26spage%3D2%26epage%3D5%26doi%3D10.1021%2Fml4004638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Assessing the lipophilicity of fragments and early hits</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&issue=7&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+lipophilicity+of+fragments+and+early+hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0lhhmFB9_YejQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520lipophilicity%2520of%2520fragments%2520and%2520early%2520hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26issue%3D7%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span> <span> </span><span class="NLM_article-title">Group additivity in ligand binding affinity: an alternative approach to ligand efficiency</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3093</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.7b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKmtb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=3086-3093&issue=12&author=C.+H.+Reynoldsauthor=R.+C.+Reynolds&title=Group+additivity+in+ligand+binding+affinity%3A+an+alternative+approach+to+ligand+efficiency&doi=10.1021%2Facs.jcim.7b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand Efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Reynolds, Ryan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3086-3093</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Group additivity is a concept that has been successfully applied to a variety of thermochem. and kinetic properties.  This includes drug discovery, where functional group additivity is often assumed in ligand binding.  Ligand efficiency can be recast as a special case of group additivity where ΔG/HA is the group equiv. (HA is the no. of nonhydrogen atoms in a ligand).  Anal. of a large data set of protein-ligand binding affinities (Ki) for diverse targets shows that in general ligand binding is distinctly nonlinear.  It is possible to create a group equiv. scheme for ligand binding, but only in the context of closely related proteins, at least with regard to size.  This finding has broad implications for drug design from both exptl. and computational points of view.  It also offers a path forward for a more general scheme to assess the efficiency of ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-RkF5xQLcbVg90H21EOLACvtfcHk0lhhmFB9_YejQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKmtb7N&md5=ef5cb4cf3216dedc72445df7d900821b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00381%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DGroup%2520additivity%2520in%2520ligand%2520binding%2520affinity%253A%2520an%2520alternative%2520approach%2520to%2520ligand%2520efficiency%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26issue%3D12%26spage%3D3086%26epage%3D3093%26doi%3D10.1021%2Facs.jcim.7b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5992</span>– <span class="NLM_lpage">6000</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2013.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24054120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5992-6000&author=M.+D.+Shultz&title=The+thermodynamic+basis+for+the+use+of+lipophilic+efficiency+%28LipE%29+in+enthalpic+optimizations&doi=10.1016%2Fj.bmcl.2013.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5992-6000</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Approaches to improve the efficiency of mol. optimizations have received great attention and numerous efficiency metrics have been introduced to assist in this effort.  Optimization of properties is equally important to optimization of potency and therefore these metrics contain potency vs. property calcns.  Widespread use of a metric does not guarantee its accuracy and a further understanding of which, if any, metric increases the probability of success was sought.  An anal. of LE, LELP and LipE based on theor. and exptl. data was performed demonstrating that LipE most strongly correlates with compd. quality as defined by enthalpy-driven binding.  The basis for the prioritization of LipE over other metrics in enthalpic optimizations is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuMO74LdKnbVg90H21EOLACvtfcHk0lhAT4yEPJR47g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P&md5=23d948d1135eeefdfebc60846f28ec2b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DThe%2520thermodynamic%2520basis%2520for%2520the%2520use%2520of%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520in%2520enthalpic%2520optimizations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5992%26epage%3D6000%26doi%3D10.1016%2Fj.bmcl.2013.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/jm201388p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&issue=3&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality&doi=10.1021%2Fjm201388p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D3%26spage%3D1252%26epage%3D1260%26doi%3D10.1021%2Fjm201388p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+the+most+important+efficiency+metric+in+medicinal+chemistry&doi=10.4155%2Ffmc.12.208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0lhAT4yEPJR47g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520the%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D113%26epage%3D115%26doi%3D10.4155%2Ffmc.12.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27916639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2mtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=681-689&issue=4&author=G.+Williamsauthor=G.+G.+Ferenczyauthor=J.+Ulanderauthor=G.+M.+Keseru&title=Binding+thermodynamics+discriminates+fragments+from+druglike+compounds%3A+a+thermodynamic+description+of+fragment-based+drug+discovery&doi=10.1016%2Fj.drudis.2016.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery</span></div><div class="casAuthors">Williams, Glyn; Ferenczy, Gyorgy G.; Ulander, Johan; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">681-689</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Small is beautiful reducing the size and complexity of chem. starting points for drug design allows better sampling of chem. space, reveals the most energetically important interactions within protein-binding sites and can lead to improvements in the physicochem. properties of the final drug.  The impact of fragment-based drug discovery (FBDD) on recent drug discovery projects and our improved knowledge of the structural and thermodn. details of ligand binding has prompted us to explore the relationships between ligand-binding thermodn. and FBDD.  Information on binding thermodn. can give insights into the contributions to protein-ligand interactions and could therefore be used to prioritise compds. with a high degree of specificity in forming key interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKkCmjC-T97Vg90H21EOLACvtfcHk0lhAT4yEPJR47g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2mtLbL&md5=070fe84d5a511b8d7acad48dd8d05057</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DBinding%2520thermodynamics%2520discriminates%2520fragments%2520from%2520druglike%2520compounds%253A%2520a%2520thermodynamic%2520description%2520of%2520fragment-based%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26issue%3D4%26spage%3D681%26epage%3D689%26doi%3D10.1016%2Fj.drudis.2016.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">Profiling the estimated plasma concentrations of 215 marketed oral drugs</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1039/C5MD00583C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC5MD00583C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=706-719&issue=4&author=M.+C.+Wenlock&title=Profiling+the+estimated+plasma+concentrations+of+215+marketed+oral+drugs&doi=10.1039%2FC5MD00583C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2FC5MD00583C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00583C%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26atitle%3DProfiling%2520the%2520estimated%2520plasma%2520concentrations%2520of%2520215%2520marketed%2520oral%2520drugs%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D706%26epage%3D719%26doi%3D10.1039%2FC5MD00583C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidgeon, C.</span></span> <span> </span><span class="NLM_article-title">In vitro membrane binding and protein binding (IAM MB/PB technology) to estimate in vivo distribution: applications in early drug discovery</span>. <i>ADMET DMPK</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.5599/admet.5.1.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.5599%2Fadmet.5.1.373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=14-38&issue=1&author=K.+L.+Valkoauthor=S.+P.+Teagueauthor=C.+Pidgeon&title=In+vitro+membrane+binding+and+protein+binding+%28IAM+MB%2FPB+technology%29+to+estimate+in+vivo+distribution%3A+applications+in+early+drug+discovery&doi=10.5599%2Fadmet.5.1.373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.5599%2Fadmet.5.1.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5599%252Fadmet.5.1.373%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%2BL.%26aulast%3DTeague%26aufirst%3DS.%2BP.%26aulast%3DPidgeon%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520membrane%2520binding%2520and%2520protein%2520binding%2520%2528IAM%2520MB%252FPB%2520technology%2529%2520to%2520estimate%2520in%2520vivo%2520distribution%253A%2520applications%2520in%2520early%2520drug%2520discovery%26jtitle%3DADMET%2520DMPK%26date%3D2017%26volume%3D5%26issue%3D1%26spage%3D14%26epage%3D38%26doi%3D10.5599%2Fadmet.5.1.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span> <span> </span><span class="NLM_article-title">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">18281</span>– <span class="NLM_lpage">18289</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207759109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1073%2Fpnas.1207759109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22988103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18281-18289&issue=45&author=M.+McTigueauthor=B.+W.+Murrayauthor=J.+H.+Chenauthor=Y.+L.+Dengauthor=J.+Solowiejauthor=R.+S.+Kania&title=Molecular+conformations%2C+interactions%2C+and+properties+associated+with+drug+efficiency+and+clinical+performance+among+VEGFR+TK+inhibitors&doi=10.1073%2Fpnas.1207759109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span></div><div class="casAuthors">McTigue, Michele; Murray, Brion William; Chen, Jeffrey H.; Deng, Ya-Li; Solowiej, James; Kania, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18281-18289, S18281/1-S18281/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Analyses of compds. in clin. development have shown that ligand efficient-mols. with privileged phys. properties and low dose are less likely to fail in the various stages of clin. testing, have fewer postapproval withdrawals, and are less likely to receive black box safety warnings.  However, detailed side-by-side examn. of mol. interactions and properties within single drug classes are lacking.  As a class, VEGF receptor tyrosine kinase inhibitors (VEGFR TKIs) have changed the landscape of how cancer is treated, particularly in clear cell renal cell carcinoma, which is molecularly linked to the VEGF signaling axis.  Despite the clear role of the mol. target, member mols. of this validated drug class exhibit distinct clin. efficacy and safety profiles in comparable renal cell carcinoma clin. studies.  The first head-to-head randomized phase III comparative study between active VEGFR TKIs has confirmed significant differences in clin. performance.  To elucidate how fundamental drug potency-efficiency is achieved and impacts differentiation within the VEGFR TKI class, we detd. potencies, time dependence, selectivities, and X-ray structures of the drug-kinase complexes using a VEGFR2 TK construct inclusive of the important juxtamembrane domain.  Collectively, the studies elucidate unique drug-kinase interactions that are dependent on distinct juxtamembrane domain conformations, resulting in significant potency and ligand efficiency differences.  The identified structural trends are consistent with in vitro measurements, which translate well to clin. performance, underscoring a principle that may be broadly applicable to prospective drug design for optimal in vivo performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsIUWiD4sXtbVg90H21EOLACvtfcHk0lgs_A-ftsJpTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I&md5=4a5ec677298a8c924c0f9557ca688a79</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207759109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207759109%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520conformations%252C%2520interactions%252C%2520and%2520properties%2520associated%2520with%2520drug%2520efficiency%2520and%2520clinical%2520performance%2520among%2520VEGFR%2520TK%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D45%26spage%3D18281%26epage%3D18289%26doi%3D10.1073%2Fpnas.1207759109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tõnisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The target landscape of clinical kinase drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span> (<span class="NLM_issue">6367</span>),  <span class="NLM_fpage">eaan4368</span>, <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=eaan4368&issue=6367&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.-A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.-K.+Garzauthor=B.-O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+T%C3%B5nissonauthor=K.+Kramerauthor=K.+G%C3%B6tzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.-C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+M%C3%A9dardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+target+landscape+of+clinical+kinase+drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.-A.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.-K.%26aulast%3DGohlke%26aufirst%3DB.-O.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DT%25C3%25B5nisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.-C.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DM%25C3%25A9dard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520target%2520landscape%2520of%2520clinical%2520kinase%2520drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26issue%3D6367%26spage%3Deaan4368%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6228</span>– <span class="NLM_lpage">6235</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.08.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6228-6235&issue=21&author=R.+J.+Young&title=The+successful+quest+for+oral+factor+Xa+inhibitors%3B+learnings+for+all+of+medicinal+chemistry%3F&doi=10.1016%2Fj.bmcl.2011.08.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520successful%2520quest%2520for%2520oral%2520factor%2520Xa%2520inhibitors%253B%2520learnings%2520for%2520all%2520of%2520medicinal%2520chemistry%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6228%26epage%3D6235%26doi%3D10.1016%2Fj.bmcl.2011.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planey, S. L.</span></span> <span> </span><span class="NLM_article-title">The influence of lipophilicity in drug discovery and design</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.714363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441.2012.714363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22992175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=863-875&issue=10&author=J.+A.+Arnottauthor=S.+L.+Planey&title=The+influence+of+lipophilicity+in+drug+discovery+and+design&doi=10.1517%2F17460441.2012.714363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lipophilicity in drug discovery and design</span></div><div class="casAuthors">Arnott, John A.; Planey, Sonia Lobo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of lipophilicity in drug discovery and design is a crit. one.  Lipophilicity is a key physicochem. property that plays a crucial role in detg. ADMET (absorption, distribution, metab., excretion, and toxicity) properties and the overall suitability of drug candidates.  There is increasing evidence to suggest that control of physicochem. properties such as lipophilicity, within a defined optimal range, can improve compd. quality and the likelihood of therapeutic success.Areas covered: This review focuses on understanding lipophilicity, techniques used to measure lipophilicity, and summarizes the importance of lipophilicity in drug discovery and development, including a discussion of its impact on individual ADMET parameters as well as its overall influence on the drug discovery and design process, specifically within the past 15 years.Expert opinion: A current review of the literature reveals a continued reliance on the synthesis of novel structures with increased potency, rather than a focus on maintaining optimal physicochem. properties assocd. with ADMET throughout drug optimization.  Particular attention to the optimum region of lipophilicity, as well as monitoring of lipophilic efficiency indexes, may contribute significantly to the overall quality of candidate drugs at different stages of discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWJgvv9yK87Vg90H21EOLACvtfcHk0liy1UalOn5q6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ&md5=4dc5d7268216c9a59fcbd841fbf66735</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.714363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.714363%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DJ.%2BA.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26atitle%3DThe%2520influence%2520of%2520lipophilicity%2520in%2520drug%2520discovery%2520and%2520design%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26issue%3D10%26spage%3D863%26epage%3D875%26doi%3D10.1517%2F17460441.2012.714363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">15–16</span>),  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&issue=15%E2%80%9316&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity&doi=10.1016%2Fj.drudis.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0liy1UalOn5q6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D15%25E2%2580%259316%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.drudis.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17–18</span>),  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&issue=17%E2%80%9318&author=R.+J.+Youngauthor=D.+V.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0liy1UalOn5q6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D17%25E2%2580%259318%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mannhold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poda, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Calculation of molecular lipophilicity: state-of-the-art and comparison of logP methods on more than 96,000 compounds</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1002/jps.21494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.21494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18683876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1eisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=861-893&author=R.+Mannholdauthor=G.+I.+Podaauthor=C.+Ostermannauthor=I.+V.+Tetko&title=Calculation+of+molecular+lipophilicity%3A+state-of-the-art+and+comparison+of+logP+methods+on+more+than+96%2C000+compounds&doi=10.1002%2Fjps.21494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Calculation of molecular lipophilicity: state-of-the-art and comparison of logP methods on more than 96,000 compounds</span></div><div class="casAuthors">Mannhold, Raimund; Poda, Gennadiy I.; Ostermann, Cluade; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">861-893</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  We first review the state-of-the-art in development of logP prediction approaches falling in two major categories: substructure-based and property-based methods.  Then, we compare the predictive power of representative methods for one public (N = 266) and two in house datasets from Nycomed (N = 882) and Pfizer (N = 95809).  A total of 30 and 18 methods were tested for public and industrial datasets, resp.  Accuracy of models declined with the no. of nonhydrogen atoms.  The Arithmetic Av. Model (AAM), which predicts the same value (the arithmetic mean) for all compds., was used as a baseline model for comparison.  Methods with Root Mean Squared Error (RMSE) greater than RMSE produced by the AAM were considered as unacceptable.  The majority of analyzed methods produced reasonable results for the public dataset but only seven methods were successful on the both in house datasets.  We proposed a simple equation based on the no. of carbon atoms, NC, and the no. of hetero atoms, NHET: logP = 1.46(+0.02) + 0.11(±0.001) NC - 0.11(±0.001) NHEET.  This equation outperformed a large no. of programs benchmarked in this study.  Factors influencing the accuracy of logP predictions were elucidated and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR3RAtmKwEZ7Vg90H21EOLACvtfcHk0liE79WKRbn6OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1eisLo%253D&md5=8ae19379316c226dc75ec057006b0e8c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fjps.21494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21494%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DOstermann%26aufirst%3DC.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DCalculation%2520of%2520molecular%2520lipophilicity%253A%2520state-of-the-art%2520and%2520comparison%2520of%2520logP%2520methods%2520on%2520more%2520than%252096%252C000%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D861%26epage%3D893%26doi%3D10.1002%2Fjps.21494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhan, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendoloski, J. J.</span></span> <span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods:  an analysis of ALOGP and CLOGP methods</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3772</span>, <span class="refDoi"> DOI: 10.1021/jp980230o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&issue=21&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A%E2%80%89+an+analysis+of+ALOGP+and+CLOGP+methods&doi=10.1021%2Fjp980230o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%25E2%2580%2589%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26issue%3D21%26spage%3D3762%26epage%3D3772%26doi%3D10.1021%2Fjp980230o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crippen, G. M.</span></span> <span> </span><span class="NLM_article-title">Prediction of physicochemical parameters by atomic contributions</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1021/ci990307l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci990307l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1WjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=868-873&issue=5&author=S.+A.+Wildmanauthor=G.+M.+Crippen&title=Prediction+of+physicochemical+parameters+by+atomic+contributions&doi=10.1021%2Fci990307l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Physicochemical Parameters by Atomic Contributions</span></div><div class="casAuthors">Wildman, Scott A.; Crippen, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">868-873</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a new atom type classification system for use in atom-based calcn. of partition coeff. (log P) and molar refractivity (MR) designed in part to address published concerns of previous at. methods.  The 68 at. contributions to log P have been detd. by fitting an extensive training set of 9920 mols., with r2 = 0.918 and σ = 0.677.  A sep. set of 3412 mols. was used for the detn. of contributions to MR with r2 = 0.997 and σ = 1.43.  Both calcns. are shown to have high predictive ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBe2sxWdEMsbVg90H21EOLACvtfcHk0liE79WKRbn6OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1WjtbY%253D&md5=5eb46da66f7861906be7078f0b7e1b95</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fci990307l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci990307l%26sid%3Dliteratum%253Aachs%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DCrippen%26aufirst%3DG.%2BM.%26atitle%3DPrediction%2520of%2520physicochemical%2520parameters%2520by%2520atomic%2520contributions%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1999%26volume%3D39%26issue%3D5%26spage%3D868%26epage%3D873%26doi%3D10.1021%2Fci990307l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christmann-Franck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">Time-trajectories in efficiency maps as effective guides for drug discovery efforts</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1002/minf.201000158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fminf.201000158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27466765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=137-144&issue=2%E2%80%933&author=S.+Christmann-Franckauthor=D.+Cravoauthor=C.+Abad-Zapatero&title=Time-trajectories+in+efficiency+maps+as+effective+guides+for+drug+discovery+efforts&doi=10.1002%2Fminf.201000158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Trajectories in Efficiency Maps as Effective Guides for Drug Discovery Efforts</span></div><div class="casAuthors">Christmann-Franck, Serge; Cravo, Daniel; Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This article summarizes the definitions of the most relevant ligand efficiency indexes (LEIs), present the initial and the most recent two-dimensional maps in the LEIs space, and introduce a representation of the drug discovery effort as a 'time-trajectory' in these maps.  It is suggested that this representation is a means to fruitfully complement the traditional SAR tables by permitting to follow the design sequence of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9vzDkfOSLB7Vg90H21EOLACvtfcHk0liE79WKRbn6OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wru7w%253D&md5=1ca530e1d2760b73439768e7ae65a059</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000158%26sid%3Dliteratum%253Aachs%26aulast%3DChristmann-Franck%26aufirst%3DS.%26aulast%3DCravo%26aufirst%3DD.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DTime-trajectories%2520in%2520efficiency%2520maps%2520as%2520effective%2520guides%2520for%2520drug%2520discovery%2520efforts%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26issue%3D2%25E2%2580%25933%26spage%3D137%26epage%3D144%26doi%3D10.1002%2Fminf.201000158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, R. D.</span></span> <span> </span><span class="NLM_article-title">BC(DEF) parameters. 1. The intrinsic dimensionality of intermolecular interactions in the liquid state</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1021/ja00526a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00526a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=1837-1849&issue=6&author=R.+D.+Cramer&title=BC%28DEF%29+parameters.+1.+The+intrinsic+dimensionality+of+intermolecular+interactions+in+the+liquid+state&doi=10.1021%2Fja00526a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja00526a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00526a013%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26atitle%3DBC%2528DEF%2529%2520parameters.%25201.%2520The%2520intrinsic%2520dimensionality%2520of%2520intermolecular%2520interactions%2520in%2520the%2520liquid%2520state%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26issue%3D6%26spage%3D1837%26epage%3D1849%26doi%3D10.1021%2Fja00526a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadha, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. C.</span></span> <span> </span><span class="NLM_article-title">Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of Seiler</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1002/jps.2600830806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.2600830806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1085-1100&issue=8&author=M.+H.+Abrahamauthor=H.+S.+Chadhaauthor=G.+S.+Whitingauthor=R.+C.+Mitchell&title=Hydrogen+bonding.+32.+An+analysis+of+water-octanol+and+water-alkane+partitioning+and+the+delta+log+P+parameter+of+Seiler&doi=10.1002%2Fjps.2600830806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600830806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600830806%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DChadha%26aufirst%3DH.%2BS.%26aulast%3DWhiting%26aufirst%3DG.%2BS.%26aulast%3DMitchell%26aufirst%3DR.%2BC.%26atitle%3DHydrogen%2520bonding.%252032.%2520An%2520analysis%2520of%2520water-octanol%2520and%2520water-alkane%2520partitioning%2520and%2520the%2520delta%2520log%2520P%2520parameter%2520of%2520Seiler%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26issue%3D8%26spage%3D1085%26epage%3D1100%26doi%3D10.1002%2Fjps.2600830806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pye, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Nonclassical size dependence of permeation defines bounds for passive adsorption of large drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslajtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1665-1672&issue=5&author=C.+R.+Pyeauthor=W.+M.+Hewittauthor=J.+Schwochertauthor=T.+D.+Haddadauthor=C.+E.+Townsendauthor=L.+Etienneauthor=Y.+Laoauthor=C.+Limberakisauthor=A.+Furukawaauthor=A.+M.+Mathiowetzauthor=D.+A.+Priceauthor=S.+Lirasauthor=R.+S.+Lokey&title=Nonclassical+size+dependence+of+permeation+defines+bounds+for+passive+adsorption+of+large+drug+molecules&doi=10.1021%2Facs.jmedchem.6b01483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules</span></div><div class="casAuthors">Pye, Cameron R.; Hewitt, William M.; Schwochert, Joshua; Haddad, Terra D.; Townsend, Chad E.; Etienne, Lyns; Lao, Yongtong; Limberakis, Chris; Furukawa, Akihiro; Mathiowetz, Alan M.; Price, David A.; Liras, Spiros; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1665-1672</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a growing no. of intracellular protein-protein interactions (PPI's) with potential therapeutic importance that demand larger ligands than those that neatly fit into most common criteria for "drug-likeness".  Macrocyclic peptides pro-vide the large surface area required to inhibit PPIs and, in principle, avoid many of the pitfalls assocd. with peptides, including low stability and membrane permeability.  However, the design of passively cell-permeable mols. in this space remains a great challenge due to the poorly understood roles of mol. size and lipophilicity in detg. passive membrane permeability above MW ∼500.  Using split-pool combinatorial synthesis, we constructed a library of cyclic, per-N-methlyated peptides spanning a wide range of calcd. lipohilicities (0 < AlogP < 8) and mol. wts. (∼800 Da < MW < ∼1200 Da).  Assaying mixts. of compds. using the Parallel Artificial Membrane Assay (PAMPA) revealed a steep drop-off in apparent passive permeability with increasing size and a bilinear relationship with lipophilicity.  We obsd. a size dependence of permeability that is in stark disagreement with current permeation models.  The lipophilicities required to overcome this size penalty led to poor aq. soly., effectively bounding the chem. space of likely passively permeable mols.  This understanding provides a new set of design criteria for achieving permeability in larger mol. size regimes and suggests an operational cut-off beyond which passive permeability is constrained by a sharply increasing penalty on permeation through the system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXD-PeEQUtu7Vg90H21EOLACvtfcHk0ljgHiPC9uV09Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslajtw%253D%253D&md5=7b51a3c8fe24560c9445d8d32bf3b70f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01483%26sid%3Dliteratum%253Aachs%26aulast%3DPye%26aufirst%3DC.%2BR.%26aulast%3DHewitt%26aufirst%3DW.%2BM.%26aulast%3DSchwochert%26aufirst%3DJ.%26aulast%3DHaddad%26aufirst%3DT.%2BD.%26aulast%3DTownsend%26aufirst%3DC.%2BE.%26aulast%3DEtienne%26aufirst%3DL.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DFurukawa%26aufirst%3DA.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DNonclassical%2520size%2520dependence%2520of%2520permeation%2520defines%2520bounds%2520for%2520passive%2520adsorption%2520of%2520large%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1665%26epage%3D1672%26doi%3D10.1021%2Facs.jmedchem.6b01483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span>; <span class="NLM_string-name">Armour, D.</span></span> <span> </span><span class="NLM_article-title">The Discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span>. In  <i>Progress in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F. D.</span>, <span class="NLM_string-name">Lawton, G.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2005</span>; Vol.  <span class="NLM_volume">43</span>, pp  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">271</span>, DOI: <span class="refDoi"> DOI: 10.1016/S0079-6468(05)43007-6</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=239-271&author=A.+Wood&author=D.+Armourauthor=F.+D.+King&author=G.+Lawton&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DKing%26aufirst%3DF.%2BD.%26pub%3DElsevier%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271%26doi%3D10.1016%2FS0079-6468%2805%2943007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corless, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perruccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platts, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydr o-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/jm100978n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100978n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=67-77&issue=1&author=P.+A.+Stuppleauthor=D.+V.+Batchelorauthor=M.+Corlessauthor=P.+K.+Dorrauthor=D.+Ellisauthor=D.+R.+Fenwickauthor=S.+R.+Galanauthor=R.+M.+Jonesauthor=H.+J.+Masonauthor=D.+S.+Middletonauthor=M.+Perrosauthor=F.+Perruccioauthor=M.+Y.+Plattsauthor=D.+C.+Prydeauthor=D.+Rodriguesauthor=N.+N.+Smithauthor=P.+T.+Stephensonauthor=R.+Websterauthor=M.+Westbyauthor=A.+Wood&title=An+imidazopiperidine+series+of+CCR5+antagonists+for+the+treatment+of+HIV%3A+the+discovery+of+N-%7B%281S%29-1-%283-fluorophenyl%29-3-%5B%283-endo%29-3-%285-isobutyryl-2-methyl-4%2C5%2C6%2C7-tetrahydr+o-1H-imidazo%5B4%2C5-c%5Dpyridin-1-yl%29-8-azabicyclo%5B3.2.1%5Doct-8-yl%5Dpropyl%7Dacetamide+%28PF-232798%29&doi=10.1021%2Fjm100978n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm100978n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100978n%26sid%3Dliteratum%253Aachs%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%2BV.%26aulast%3DCorless%26aufirst%3DM.%26aulast%3DDorr%26aufirst%3DP.%2BK.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DFenwick%26aufirst%3DD.%2BR.%26aulast%3DGalan%26aufirst%3DS.%2BR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMason%26aufirst%3DH.%2BJ.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DPlatts%26aufirst%3DM.%2BY.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DN.%2BN.%26aulast%3DStephenson%26aufirst%3DP.%2BT.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DAn%2520imidazopiperidine%2520series%2520of%2520CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%253A%2520the%2520discovery%2520of%2520N-%257B%25281S%2529-1-%25283-fluorophenyl%2529-3-%255B%25283-endo%2529-3-%25285-isobutyryl-2-methyl-4%252C5%252C6%252C7-tetrahydr%2520o-1H-imidazo%255B4%252C5-c%255Dpyridin-1-yl%2529-8-azabicyclo%255B3.2.1%255Doct-8-yl%255Dpropyl%257Dacetamide%2520%2528PF-232798%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D67%26epage%3D77%26doi%3D10.1021%2Fjm100978n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkowitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivnichny, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danzeisen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span> <span> </span><span class="NLM_article-title">Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2003.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=941-945&issue=4&author=D.+M.+Shenauthor=M.+Shuauthor=C.+A.+Willoughbyauthor=S.+Shahauthor=C.+L.+Lynchauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=K.+T.+Chapmanauthor=L.+Malkowitzauthor=M.+S.+Springerauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=S.+J.+Sicilianoauthor=K.+Lyonsauthor=J.+V.+Pivnichnyauthor=G.+Y.+Kweiauthor=A.+Carellaauthor=G.+Carverauthor=K.+Holmesauthor=W.+A.+Schleifauthor=R.+Danzeisenauthor=D.+Hazudaauthor=J.+Kesslerauthor=J.+Linebergerauthor=M.+D.+Millerauthor=E.+A.+Emini&title=Antagonists+of+human+CCR5+receptor+containing+4-%28pyrazolyl%29piperidine+side+chains.+Part+2%3A+Discovery+of+potent%2C+selective%2C+and+orally+bioavailable+compounds&doi=10.1016%2Fj.bmcl.2003.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BM.%26aulast%3DShu%26aufirst%3DM.%26aulast%3DWilloughby%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSiciliano%26aufirst%3DS.%2BJ.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DAntagonists%2520of%2520human%2520CCR5%2520receptor%2520containing%25204-%2528pyrazolyl%2529piperidine%2520side%2520chains.%2520Part%25202%253A%2520Discovery%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D4%26spage%3D941%26epage%3D945%26doi%3D10.1016%2Fj.bmcl.2003.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliff, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didolkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>304</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.045096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1124%2Fjpet.102.045096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=12604693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1eis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=1161-1171&issue=3&author=S.+Kumarauthor=G.+Y.+Kweiauthor=G.+K.+Poonauthor=S.+A.+Iliffauthor=Y.+Wangauthor=Q.+Chenauthor=R.+B.+Franklinauthor=V.+Didolkarauthor=R.+W.+Wangauthor=M.+Yamazakiauthor=S.+H.+Chiuauthor=J.+H.+Linauthor=P.+G.+Pearsonauthor=T.+A.+Baillie&title=Pharmacokinetics+and+interactions+of+a+novel+antagonist+of+chemokine+receptor+5+%28CCR5%29+with+ritonavir+in+rats+and+monkeys%3A+role+of+CYP3A+and+P-glycoprotein&doi=10.1124%2Fjpet.102.045096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: Role of CYP3A and P-glycoprotein</span></div><div class="casAuthors">Kumar, Sanjeev; Kwei, Gloria Y.; Poon, Grace K.; Iliff, Susan A.; Wang, Yanfeng; Chen, Qing; Franklin, Ronald B.; Didolkar, Varsha; Wang, Regina W.; Yamazaki, Masayo; Chiu, Shuet-Hing Lee; Lin, Jiunn H.; Pearson, Paul G.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1161-1171</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mechanisms of pharmacokinetic interactions of a novel anti-human immunodeficiency virus (anti-HIV-1) antagonist of chemokine receptor 5 (CCR5) [2-(R)-[N-methyl-N-(1-(R)-3-(S)-((4- (3-benzyl-1-ethyl-(1H)-pyrazol-5-yl) piperidin-1-yl)methyl)-4-(S)-(3- fluorophenyl)cyclopent-1-yl)amino]-3-methylbutanoic acid (MRK-1)] with ritonavir were evaluated in rats and monkeys.  MRK-1 was a good substrate for the human (MDR1) and mouse (Mdr1a) multidrug resistance protein transporters and was metabolized by CYP3A isoenzymes in rat, monkey, and human liver microsomes.  Both the in vitro MDR1-mediated transport and oxidative metab. of MRK-1 were inhibited by ritonavir.  Although the systemic pharmacokinetics of MRK-1 in rats and monkeys were linear, the oral bioavailability increased with an increase in dose from 2 to 10 mg/kg.  The area under the plasma concn.-time curve (AUC) of MRK-1 was increased 4- to 6-fold when a 2 or 10 mg/kg dose was orally coadministered with 10 mg/kg ritonavir.  Further pharmacokinetic studies in rats indicated that P-glycoprotein (P-gp) inhibition by ritonavir increased the intestinal absorption of 2 mg/kg MRK-1 maximally by ∼30 to 40%, and a major component of the interaction likely resulted from its reduced systemic clearance via the inhibition of CYP3A isoenzymes.  Oral coadministration of quinidine (10 and 30 mg/kg) increased both the extent and the first-order rate of absorption of MRK-1 (2 mg/kg) by ∼40 to 50% and ∼100 to 300%, resp., in rats, thus further substantiating the role of P-gp in modulating the intestinal absorption of MRK-1 in this species.  At the 10 mg/kg MRK-1 dose, however, the entire increase in its AUC upon coadministration with ritonavir or quinidine could be attributed to a reduced systemic clearance, and no effects on intestinal absorption were apparent.  In contrast to rats, the effects of P-gp in detg. the intestinal absorption of MRK-1 appeared less significant in rhesus monkeys at either dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_bgeg7trkiLVg90H21EOLACvtfcHk0lhJt33bahr2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1eis70%253D&md5=8183cf909cd56e35df74a56281cf9fc9</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.045096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.045096%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DPoon%26aufirst%3DG.%2BK.%26aulast%3DIliff%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DFranklin%26aufirst%3DR.%2BB.%26aulast%3DDidolkar%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DR.%2BW.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DChiu%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DPharmacokinetics%2520and%2520interactions%2520of%2520a%2520novel%2520antagonist%2520of%2520chemokine%2520receptor%25205%2520%2528CCR5%2529%2520with%2520ritonavir%2520in%2520rats%2520and%2520monkeys%253A%2520role%2520of%2520CYP3A%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26issue%3D3%26spage%3D1161%26epage%3D1171%26doi%3D10.1124%2Fjpet.102.045096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danehower, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elitzin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, M.</span></span> <span> </span><span class="NLM_article-title">Biological and structural characterization of rotamers of C-C chemokine receptor type 5 (CCR5) inhibitor GSK214096</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1021/ml5004124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1296-1299&issue=12&author=W.+M.+Kazmierskiauthor=S.+Danehowerauthor=M.+Duanauthor=R.+G.+Ferrisauthor=V.+Elitzinauthor=D.+Minickauthor=M.+Sharpauthor=E.+Stewartauthor=M.+Villeneuve&title=Biological+and+structural+characterization+of+rotamers+of+C-C+chemokine+receptor+type+5+%28CCR5%29+inhibitor+GSK214096&doi=10.1021%2Fml5004124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fml5004124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004124%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DDanehower%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%2BG.%26aulast%3DElitzin%26aufirst%3DV.%26aulast%3DMinick%26aufirst%3DD.%26aulast%3DSharp%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DE.%26aulast%3DVilleneuve%26aufirst%3DM.%26atitle%3DBiological%2520and%2520structural%2520characterization%2520of%2520rotamers%2520of%2520C-C%2520chemokine%2520receptor%2520type%25205%2520%2528CCR5%2529%2520inhibitor%2520GSK214096%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1296%26epage%3D1299%26doi%3D10.1021%2Fml5004124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J.</span></span> <span> </span><span class="NLM_article-title">Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.12.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1655-1659&issue=4&author=J.+G.+Cummingauthor=H.+Tuckerauthor=J.+Oldfieldauthor=C.+Fieldingauthor=A.+Hightonauthor=A.+Faullauthor=M.+Wildauthor=D.+Brownauthor=S.+Wellsauthor=J.+Shaw&title=Balancing+hERG+affinity+and+absorption+in+the+discovery+of+AZD5672%2C+an+orally+active+CCR5+antagonist+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2011.12.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DFielding%26aufirst%3DC.%26aulast%3DHighton%26aufirst%3DA.%26aulast%3DFaull%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DJ.%26atitle%3DBalancing%2520hERG%2520affinity%2520and%2520absorption%2520in%2520the%2520discovery%2520of%2520AZD5672%252C%2520an%2520orally%2520active%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1655%26epage%3D1659%26doi%3D10.1016%2Fj.bmcl.2011.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornwell, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span> <span> </span><span class="NLM_article-title">Investigating the mechanistic basis for hepatic toxicity induced by an experimental chemokine receptor 5 (CCR5) antagonist using a compendium of gene expression profiles</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1080/01926230701383194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1080%2F01926230701383194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17654398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=576-588&issue=4&author=P.+D.+Cornwellauthor=R.+G.+Ulrich&title=Investigating+the+mechanistic+basis+for+hepatic+toxicity+induced+by+an+experimental+chemokine+receptor+5+%28CCR5%29+antagonist+using+a+compendium+of+gene+expression+profiles&doi=10.1080%2F01926230701383194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the Mechanistic Basis for Hepatic Toxicity Induced by an Experimental Chemokine Receptor 5 (CCR5) Antagonist Using a Compendium of Gene Expression Profiles</span></div><div class="casAuthors">Cornwell, Paul D.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">576-588</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A compendium of hepatic gene expression signatures was used to identify a mechanistic basis for the hepatic toxicity of an exptl. CCR5 antagonist (MrkA).  Development of MrkA, a potential HIV therapeutic, was discontinued due to hepatotoxicity in preclin. studies.  Rats were treated with MrkA at 3 dose levels (50, 250, and 500 mg/kg) for 1, 3, or 7 days.  Hepatic toxicity (vacuolation, consistent with steatosis, and elevated serum transaminase levels) was obsd. at 250 and 500 mg/kg, but not at 50 mg/kg.  Hepatic gene expression profiles were compared to a compendium of hepatic expression profiles.  MrkA was similar to 3 β-oxidn. inhibitors (valproate, cyclopropane carboxylate, pivalate), 8 PPARα agonists (fenofibrate, bezafibrate and 6 fibrate analogs), and 3 other diverse compds. (diethylnitrosamine, microcystin LR & actinomycin D).  These data indicate MrkA to be a mitochondrial inhibitor, and activation of PPARα-regulated transcription was thought to be due to an accumulation of endogenous ligands.  While mitochondrial inhibition was likely responsible for steatosis, canonical pathway anal. revealed that progression to liver injury may be mediated by activation of the innate immune system primarily through NF-kB pathways.  These results demonstrate the utility of a gene expression response compendium in developing transcriptional biomarkers and identifying the mechanistic basis for toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu3ygIjrif37Vg90H21EOLACvtfcHk0lg-_5z7uFOQ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFSrs70%253D&md5=659478a939da2531873cdf1485aca09e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F01926230701383194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701383194%26sid%3Dliteratum%253Aachs%26aulast%3DCornwell%26aufirst%3DP.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DInvestigating%2520the%2520mechanistic%2520basis%2520for%2520hepatic%2520toxicity%2520induced%2520by%2520an%2520experimental%2520chemokine%2520receptor%25205%2520%2528CCR5%2529%2520antagonist%2520using%2520a%2520compendium%2520of%2520gene%2520expression%2520profiles%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D576%26epage%3D588%26doi%3D10.1080%2F01926230701383194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerlag, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vencovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekanecz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braddock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3154</span>– <span class="NLM_lpage">3160</span>, <span class="refDoi"> DOI: 10.1002/art.27652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fart.27652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20662070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3154-3160&issue=11&author=D.+M.+Gerlagauthor=S.+Hollisauthor=M.+Laytonauthor=J.+Vencovskyauthor=Z.+Szekaneczauthor=M.+Braddockauthor=P.+P.+Tak&title=Preclinical+and+clinical+investigation+of+a+CCR5+antagonist%2C+AZD5672%2C+in+patients+with+rheumatoid+arthritis+receiving+methotrexate&doi=10.1002%2Fart.27652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate</span></div><div class="casAuthors">Gerlag, Danielle M.; Hollis, Sally; Layton, Mark; Vencovsky, Jiri; Szekanecz, Zoltan; Braddock, Martin; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3154-3160</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To investigate both the preclin. effects of blocking the chemokine receptor CCR5 and the clin. effects of this approach on the signs and symptoms of rheumatoid arthritis (RA) in patients with active disease.  Methods. Preclin. evaluations of AZD5672, a small-mol. antagonist of CCR5, were performed, including studies of ligand binding and chemotaxis.  The pharmacokinetics of AZD5672 were assessed in both single- and multiple-dose studies in healthy volunteers.  A randomized, placebo-controlled, phase IIb study was conducted in patients with active RA receiving methotrexate.  Treatment arms were AZD5672 (20, 50, 100, or 150 mg orally, once daily), matched placebo, or open-label etanercept (50 mg s.c., once weekly).  The primary end point was the proportion of patients achieving a 20% improvement response on the American College of Rheumatol. improvement criteria (ACR20) at week 12.  Secondary end points included the ACR20 over time, as well as 50% (ACR50) and 70% (ACR70) improvement responses, changes in individual components of the ACR improvement criteria, and disease activity measured with the Disease Activity Score based on the 28-joint count.  Results. AZD5672 was a highly potent and selective antagonist of CCR5, displaying nonproportional steady-state pharmacokinetics while inhibiting internalization of CCR5 in an ex vivo macrophage inflammatory protein 1β stimulation assay in which AZD5672 was evaluated over the 20-150-mg dose range.  In the phase IIb study testing this dose range in patients with RA (n = 371 patients randomized to received treatment), AZD5672 was generally well tolerated, with no unexpected adverse events.  There was no statistically significant difference in the proportion of patients achieving an ACR20 response at week 12 between those receiving any dose of AZD5672 and those receiving placebo; etanercept was significantly more efficacious than AZD5672 and placebo.  Conclusion. Despite a clear rationale for targeting CCR5, this clin. study showed that AZD5672, administered orally, did not have any clin. benefit, suggesting that CCR5 antagonism alone is unlikely to be a viable therapeutic strategy in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMtJlWPEReLVg90H21EOLACvtfcHk0lg-_5z7uFOQ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrrP&md5=78b9ccb1c6e3fd325a5abe24c703751b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fart.27652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27652%26sid%3Dliteratum%253Aachs%26aulast%3DGerlag%26aufirst%3DD.%2BM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DVencovsky%26aufirst%3DJ.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DPreclinical%2520and%2520clinical%2520investigation%2520of%2520a%2520CCR5%2520antagonist%252C%2520AZD5672%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520receiving%2520methotrexate%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D11%26spage%3D3154%26epage%3D3160%26doi%3D10.1002%2Fart.27652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemoine, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span> <span> </span><span class="NLM_article-title">Small molecule antagonists of the chemokine receptor CCR5</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.2174/156802610791561219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F156802610791561219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20536424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSktb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1299-1338&issue=13&author=R.+C.+Lemoineauthor=J.+Wanner&title=Small+molecule+antagonists+of+the+chemokine+receptor+CCR5&doi=10.2174%2F156802610791561219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule antagonists of the chemokine receptor CCR5</span></div><div class="casAuthors">Lemoine, Remy C.; Wanner, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1299-1338</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review will focus on the discovery and clin. development of small mol. antagonists of CCR5 for the treatment of HIV-1/AIDS, as well as for the potential treatment of inflammatory diseases.  In particular, we will focus on the specific medicinal chem. problems that were faced during the discovery of the mols.  We will also describe limited data from clin. development phases focusing on specific issues that arose during the clin. trials.  Finally, we will touch on the mechanism of action of CCR5 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRvsf2tx0zVLVg90H21EOLACvtfcHk0lg-_5z7uFOQ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSktb7F&md5=ed99662e8895e84757d6900a7c8c3fb8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.2174%2F156802610791561219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791561219%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DR.%2BC.%26aulast%3DWanner%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520antagonists%2520of%2520the%2520chemokine%2520receptor%2520CCR5%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26issue%3D13%26spage%3D1299%26epage%3D1338%26doi%3D10.2174%2F156802610791561219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horuk, R.</span></span> <span> </span><span class="NLM_article-title">Chemokine receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9363</span>– <span class="NLM_lpage">9392</span>, <span class="refDoi"> DOI: 10.1021/jm300682j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300682j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9363-9392&issue=22&author=J.+Peaseauthor=R.+Horuk&title=Chemokine+receptor+antagonists&doi=10.1021%2Fjm300682j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine Receptor Antagonists</span></div><div class="casAuthors">Pease, James; Horuk, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9363-9392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Millions suffer from autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and asthma.  Because of their important role in host defense, chemokine receptors have been closely scrutinized as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGh07JisdDNrVg90H21EOLACvtfcHk0lg-_5z7uFOQ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLvK&md5=f0bcefb613d599cd45c110660f846dd7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm300682j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300682j%26sid%3Dliteratum%253Aachs%26aulast%3DPease%26aufirst%3DJ.%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DChemokine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D22%26spage%3D9363%26epage%3D9392%26doi%3D10.1021%2Fjm300682j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of CCR5 receptor antagonists for the treatment of HIV infection: hit-to-lead studies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.200600031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=706-709&issue=7&author=D.+Armourauthor=M.+J.+de+Grootauthor=M.+Edwardsauthor=M.+Perrosauthor=D.+A.+Priceauthor=B.+L.+Stammenauthor=A.+Wood&title=The+discovery+of+CCR5+receptor+antagonists+for+the+treatment+of+HIV+infection%3A+hit-to-lead+studies&doi=10.1002%2Fcmdc.200600031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600031%26sid%3Dliteratum%253Aachs%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DEdwards%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520CCR5%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%253A%2520hit-to-lead%2520studies%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26issue%3D7%26spage%3D706%26epage%3D709%26doi%3D10.1002%2Fcmdc.200600031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4633</span>– <span class="NLM_lpage">4637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.06.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4633-4637&issue=17&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+HERG+affinity+in+the+discovery+of+the+CCR5+antagonist+maraviroc&doi=10.1016%2Fj.bmcl.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520HERG%2520affinity%2520in%2520the%2520discovery%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D17%26spage%3D4633%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2008.03137.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fj.1365-2125.2008.03137.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18333867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Cgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=60-67&issue=Suppl.+1&author=S.+Abelauthor=D.+Russellauthor=L.+A.+Whitlockauthor=C.+E.+Ridgwayauthor=A.+N.+Neddermanauthor=D.+K.+Walker&title=Assessment+of+the+absorption%2C+metabolism+and+absolute+bioavailability+of+maraviroc+in+healthy+male+subjects&doi=10.1111%2Fj.1365-2125.2008.03137.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects</span></div><div class="casAuthors">Abel, Samantha; Russell, Deborah; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Nedderman, Angus N. R.; Walker, Donald K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Two studies were conducted to: (i) quantify the amt. of drug-related radioactivity in blood, plasma, urine and feces following a 14C-labeled dose of maraviroc; and (ii) investigate the pharmacokinetics, safety and tolerability of i.v. maraviroc and det. the abs. bioavailability of oral maraviroc.  Metabolite profiling was also conducted.  Data from both of these studies were used to construct a mass-balance model for maraviroc.  Study 1 was an open-label study in three healthy male subjects.  All subjects received a single 300-mg oral soln. dose of 14C-labeled maraviroc.  Study 2 included two cohorts of subjects.  Cohort 1 involved a double-blind (third party open), four-way crossover study where eight subjects received escalating i.v. doses of maraviroc (3, 10 and 30 mg) with placebo insertion.  Cohort 2 involved an open, two-way crossover study where 12 subjects received 30 mg maraviroc by i.v. infusion and 100 mg maraviroc orally in random order.  In study 1, blood samples and all urine and feces were collected up to at least 120 h postdose.  In study 2, blood samples were taken at intervals up to 48 h postdose.  Urine was also collected up to 24 h postdose in cohort 1 only.  After oral administration in study 1, maraviroc was rapidly absorbed with a plasma Tmax reached by 2 h postdose for all three subjects.  The max. concns. of radioactivity also occurred within 2 h for all subjects.  There was a higher amt. of radioactivity in plasma than in blood (blood/plasma ratio ∼0.6 for AUCt and Cmax).  Unchanged maraviroc was the major circulating component in plasma, accounting for ∼42% of the circulating radioactivity.  Following a 300-mg 14C-labeled maraviroc dose, means of 76.4% and 19.6% of radioactivity were recovered in the feces and urine, resp.  The mean total recovery of dosed radioactivity was 96%, with the majority of radioactivity being recovered within 96 h postdose.  Profiling of the urine and feces showed similar and extensive metab. in all subjects.  Unchanged maraviroc was the major excreted component (33%).  The major metabolic pathways were detd. and involved oxidn. and N-dealkylation.  I.v. doses of maraviroc (3-30 mg) were well tolerated in study 2, and drug exposure was approx. proportional to dose within the studied range.  Approx. 23% of total clearance (44 l h-1) was accounted for by renal clearance (10.2 l h-1).  Mean vol. of distribution at steady state was 194 l.  Abs. bioavailability of a 100-mg oral tablet dose, by comparison with a 30-mg i.v. dose, was calcd. to be 23.1%.  Maraviroc is rapidly absorbed and extensively metabolized, although unchanged maraviroc is the major circulating component in plasma and is the major excreted component after oral dosing.  The pharmacokinetics of maraviroc after i.v. administration is approx. proportional over the dose range studied.  Renal clearance contributes 23% of total clearance.  The abs. bioavailability of 100 mg oral maraviroc is 23%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_haZCWmuLi7Vg90H21EOLACvtfcHk0ljeJ6XTEfabuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Cgt7k%253D&md5=304dfef653a9fe80b4a102550e9e0d23</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2008.03137.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2008.03137.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DWhitlock%26aufirst%3DL.%2BA.%26aulast%3DRidgway%26aufirst%3DC.%2BE.%26aulast%3DNedderman%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DAssessment%2520of%2520the%2520absorption%252C%2520metabolism%2520and%2520absolute%2520bioavailability%2520of%2520maraviroc%2520in%2520healthy%2520male%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D65%26issue%3DSuppl.%25201%26spage%3D60%26epage%3D67%26doi%3D10.1111%2Fj.1365-2125.2008.03137.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dioszegi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravendran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vauquelin, G.</span></span> <span> </span><span class="NLM_article-title">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3364</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1111/bph.12683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fbph.12683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24628038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3364-3375&issue=14&author=D.+C.+Swinneyauthor=P.+Beavisauthor=K.+T.+Chuangauthor=Y.+Zhengauthor=I.+Leeauthor=P.+Geeauthor=J.+Devalauthor=D.+M.+Rotsteinauthor=M.+Dioszegiauthor=P.+Ravendranauthor=J.+Zhangauthor=S.+Sankuratriauthor=R.+Kondruauthor=G.+Vauquelin&title=A+study+of+the+molecular+mechanism+of+binding+kinetics+and+long+residence+times+of+human+CCR5+receptor+small+molecule+allosteric+ligands&doi=10.1111%2Fbph.12683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span></div><div class="casAuthors">Swinney, David C.; Beavis, Paul; Chuang, Kai-Ting; Zheng, Yue; Lee, Ina; Gee, Peter; Deval, Jerome; Rotstein, David M.; Dioszegi, Marianna; Ravendran, Palani; Zhang, Jun; Sankuratri, Surya; Kondru, Rama; Vauquelin, Georges</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3364-3375</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The human CCR5 receptor is a co-receptor for HIV-1 infection and a target for anti-viral therapy.  A greater understanding of the binding kinetics of small mol. allosteric ligand interactions with CCR5 will lead to a better understanding of the binding process and may help discover new mols. that avoid resistance.  Exptl. Approach : Using [3H] maraviroc as a radioligand, a no. of different binding protocols were employed in conjunction with simulations to det. rate consts., kinetic mechanism and mutant kinetic fingerprints for wild-type and mutant human CCR5 with maraviroc, aplaviroc and vicriviroc.  Key Results : Kinetic characterization of maraviroc binding to the wild-type CCR5 was consistent with a two-step kinetic mechanism that involved an initial receptor-ligand complex (RA), which transitioned to a more stable complex, R'A, with at least a 13-fold increase in affinity.  The dissocn. rate from R'A, k-2, was 1.2 × 10-3 min-1.  The maraviroc time-dependent transition was influenced by F85L, W86A, Y108A, I198A and Y251A mutations of CCR5.  Conclusions and Implications : The interaction between maraviroc and CCR5 proceeded according to a multi-step kinetic mechanism, whereby initial mass action binding and later reorganizations of the initial maraviroc-receptor complex lead to a complex with longer residence time.  Site-directed mutagenesis identified a kinetic fingerprint of residues that affected the binding kinetics, leading to the conclusion that allosteric ligand binding to CCR5 involved the rearrangement of the binding site in a manner specific to each allosteric ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ko1PQQH-V7Vg90H21EOLACvtfcHk0ljeJ6XTEfabuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK&md5=400071d4fb6418a133752ddcd95a0d9c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fbph.12683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12683%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DBeavis%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DK.%2BT.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DRavendran%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DVauquelin%26aufirst%3DG.%26atitle%3DA%2520study%2520of%2520the%2520molecular%2520mechanism%2520of%2520binding%2520kinetics%2520and%2520long%2520residence%2520times%2520of%2520human%2520CCR5%2520receptor%2520small%2520molecule%2520allosteric%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D14%26spage%3D3364%26epage%3D3375%26doi%3D10.1111%2Fbph.12683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span> (<span class="NLM_issue">6152</span>),  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&issue=6152&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0limMxdSuRtuoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26issue%3D6152%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 1: Discovery and initial SAR of 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.10.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2004.10.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=25-28&issue=1&author=J.+N.+Burrowsauthor=J.+G.+Cummingauthor=S.+M.+Filleryauthor=G.+A.+Hamlinauthor=J.+A.+Hudsonauthor=R.+J.+Jacksonauthor=S.+McLaughlinauthor=J.+S.+Shaw&title=Modulators+of+the+human+CCR5+receptor.+Part+1%3A+Discovery+and+initial+SAR+of+1-%283%2C3-diphenylpropyl%29-piperidinyl+amides+and+ureas&doi=10.1016%2Fj.bmcl.2004.10.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.10.044%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DFillery%26aufirst%3DS.%2BM.%26aulast%3DHamlin%26aufirst%3DG.%2BA.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DJackson%26aufirst%3DR.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25201%253A%2520Discovery%2520and%2520initial%2520SAR%2520of%25201-%25283%252C3-diphenylpropyl%2529-piperidinyl%2520amides%2520and%2520ureas%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D1%26spage%3D25%26epage%3D28%26doi%3D10.1016%2Fj.bmcl.2004.10.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5012</span>– <span class="NLM_lpage">5015</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2005.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5012-5015&issue=22&author=J.+G.+Cummingauthor=A.+E.+Cooperauthor=K.+Grimeauthor=C.+J.+Loganauthor=S.+McLaughlinauthor=J.+Oldfieldauthor=J.+S.+Shawauthor=H.+Tuckerauthor=J.+Winterauthor=D.+Whittaker&title=Modulators+of+the+human+CCR5+receptor.+Part+2%3A+SAR+of+substituted+1-%283%2C3-diphenylpropyl%29-piperidinyl+phenylacetamides&doi=10.1016%2Fj.bmcl.2005.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DC.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DJ.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25202%253A%2520SAR%2520of%2520substituted%25201-%25283%252C3-diphenylpropyl%2529-piperidinyl%2520phenylacetamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D22%26spage%3D5012%26epage%3D5015%26doi%3D10.1016%2Fj.bmcl.2005.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3533</span>– <span class="NLM_lpage">3536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.03.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.03.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3533-3536&issue=13&author=J.+G.+Cummingauthor=S.+J.+Brownauthor=A.+E.+Cooperauthor=A.+W.+Faullauthor=A.+P.+Flynnauthor=K.+Grimeauthor=J.+Oldfieldauthor=J.+S.+Shawauthor=E.+Shepherdauthor=H.+Tuckerauthor=D.+Whittaker&title=Modulators+of+the+human+CCR5+receptor.+Part+3%3A+SAR+of+substituted+1-%5B3-%284-methanesulfonylphenyl%29-3-phenylpropyl%5D-piperidinyl+phenylacetamides&doi=10.1016%2Fj.bmcl.2006.03.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFaull%26aufirst%3DA.%2BW.%26aulast%3DFlynn%26aufirst%3DA.%2BP.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DShepherd%26aufirst%3DE.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25203%253A%2520SAR%2520of%2520substituted%25201-%255B3-%25284-methanesulfonylphenyl%2529-3-phenylpropyl%255D-piperidinyl%2520phenylacetamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D13%26spage%3D3533%26epage%3D3536%26doi%3D10.1016%2Fj.bmcl.2006.03.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finke, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhu, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkowitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugherty, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danzeisen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span> <span> </span><span class="NLM_article-title">Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure–activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00637-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2800%2900637-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=259-264&issue=2&author=C.+P.+Dornauthor=P.+E.+Finkeauthor=B.+Oatesauthor=R.+J.+Budhuauthor=S.+G.+Millsauthor=M.+MacCossauthor=L.+Malkowitzauthor=M.+S.+Springerauthor=B.+L.+Daughertyauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=S.+J.+Sicilianoauthor=A.+Carellaauthor=G.+Carverauthor=K.+Holmesauthor=R.+Danzeisenauthor=D.+Hazudaauthor=J.+Kesslerauthor=J.+Linebergerauthor=M.+Millerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Antagonists+of+the+human+CCR5+receptor+as+anti-HIV-1+agents.+Part+1%3A+Discovery+and+initial+structure%E2%80%93activity+relationships+for+1-amino-2-phenyl-4-%28piperidin-1-yl%29butanes&doi=10.1016%2FS0960-894X%2800%2900637-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900637-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900637-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DOates%26aufirst%3DB.%26aulast%3DBudhu%26aufirst%3DR.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DDaugherty%26aufirst%3DB.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSiciliano%26aufirst%3DS.%2BJ.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DAntagonists%2520of%2520the%2520human%2520CCR5%2520receptor%2520as%2520anti-HIV-1%2520agents.%2520Part%25201%253A%2520Discovery%2520and%2520initial%2520structure%25E2%2580%2593activity%2520relationships%2520for%25201-amino-2-phenyl-4-%2528piperidin-1-yl%2529butanes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D2%26spage%3D259%26epage%3D264%26doi%3D10.1016%2FS0960-894X%2800%2900637-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deanda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones-Hertzog, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngman, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6538</span>– <span class="NLM_lpage">6546</span>, <span class="refDoi"> DOI: 10.1021/jm800598a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800598a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6538-6546&issue=20&author=W.+M.+Kazmierskiauthor=C.+Aquinoauthor=B.+A.+Chauderauthor=F.+Deandaauthor=R.+Ferrisauthor=D.+K.+Jones-Hertzogauthor=T.+Kenakinauthor=C.+S.+Kobleauthor=C.+Watsonauthor=P.+Wheelanauthor=H.+Yangauthor=M.+Youngman&title=Discovery+of+bioavailable+4%2C4-disubstituted+piperidines+as+potent+ligands+of+the+chemokine+receptor+5+and+inhibitors+of+the+human+immunodeficiency+virus-1&doi=10.1021%2Fjm800598a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm800598a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800598a%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DAquino%26aufirst%3DC.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DDeanda%26aufirst%3DF.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DJones-Hertzog%26aufirst%3DD.%2BK.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520bioavailable%25204%252C4-disubstituted%2520piperidines%2520as%2520potent%2520ligands%2520of%2520the%2520chemokine%2520receptor%25205%2520and%2520inhibitors%2520of%2520the%2520human%2520immunodeficiency%2520virus-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D20%26spage%3D6538%26epage%3D6546%26doi%3D10.1021%2Fjm800598a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peckham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaltenstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wire, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svolto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngman, M.</span></span> <span> </span><span class="NLM_article-title">Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1021/jm200279v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200279v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3756-3767&issue=11&author=W.+M.+Kazmierskiauthor=D.+L.+Andersonauthor=C.+Aquinoauthor=B.+A.+Chauderauthor=M.+Duanauthor=R.+Ferrisauthor=T.+Kenakinauthor=C.+S.+Kobleauthor=D.+G.+Langauthor=M.+S.+McIntyreauthor=J.+Peckhamauthor=C.+Watsonauthor=P.+Wheelanauthor=A.+Spaltensteinauthor=M.+B.+Wireauthor=A.+Svoltoauthor=M.+Youngman&title=Novel+4%2C4-disubstituted+piperidine-based+C-C+chemokine+receptor-5+inhibitors+with+high+potency+against+human+immunodeficiency+virus-1+and+an+improved+human+ether-a-go-go+related+gene+%28hERG%29+profile&doi=10.1021%2Fjm200279v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm200279v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200279v%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DAquino%26aufirst%3DC.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DLang%26aufirst%3DD.%2BG.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DPeckham%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DWire%26aufirst%3DM.%2BB.%26aulast%3DSvolto%26aufirst%3DA.%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DNovel%25204%252C4-disubstituted%2520piperidine-based%2520C-C%2520chemokine%2520receptor-5%2520inhibitors%2520with%2520high%2520potency%2520against%2520human%2520immunodeficiency%2520virus-1%2520and%2520an%2520improved%2520human%2520ether-a-go-go%2520related%2520gene%2520%2528hERG%2529%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D11%26spage%3D3756%26epage%3D3767%26doi%3D10.1021%2Fjm200279v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perzborn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roehrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubitza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misselwitz, F.</span></span> <span> </span><span class="NLM_article-title">The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1038/nrd3185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3185" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=61-75&issue=1&author=E.+Perzbornauthor=S.+Roehrigauthor=A.+Straubauthor=D.+Kubitzaauthor=F.+Misselwitz&title=The+discovery+and+development+of+rivaroxaban%2C+an+oral%2C+direct+factor+Xa+inhibitor&doi=10.1038%2Fnrd3185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnrd3185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3185%26sid%3Dliteratum%253Aachs%26aulast%3DPerzborn%26aufirst%3DE.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DKubitza%26aufirst%3DD.%26aulast%3DMisselwitz%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520rivaroxaban%252C%2520an%2520oral%252C%2520direct%2520factor%2520Xa%2520inhibitor%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D1%26spage%3D61%26epage%3D75%26doi%3D10.1038%2Fnrd3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor</span>. <i>J. Thromb. Thrombolysis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1007/s11239-011-0551-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs11239-011-0551-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21318583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFSqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=478-492&issue=4&author=P.+C.+Wongauthor=D.+J.+Pintoauthor=D.+Zhang&title=Preclinical+discovery+of+apixaban%2C+a+direct+and+orally+bioavailable+factor+Xa+inhibitor&doi=10.1007%2Fs11239-011-0551-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor</span></div><div class="casAuthors">Wong, Pancras C.; Pinto, Donald J. P.; Zhang, Donglu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">478-492</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide), a direct inhibitor of activated factor X (FXa), is in development for the prevention and treatment of various thromboembolic diseases.  With an inhibitory const. of 0.08 nM for human FXa, apixaban has greater than 30,000-fold selectivity for FXa over other human coagulation proteases.  It produces a rapid onset of inhibition of FXa with assocn. rate const. of 20 μM-1/s approx. and inhibits free as well as prothrombinase- and clot-bound FXa activity in vitro.  Apixaban also inhibits FXa from rabbits, rats and dogs, an activity which parallels its antithrombotic potency in these species.  Although apixaban has no direct effects on platelet aggregation, it indirectly inhibits this process by reducing thrombin generation.  Pre-clin. studies of apixaban in animal models have demonstrated dose-dependent antithrombotic efficacy at doses that preserved hemostasis.  Apixaban improves pre-clin. antithrombotic activity, without excessive increases in bleeding times, when added on top of aspirin or aspirin plus clopidogrel at their clin. relevant doses.  Apixaban has good bioavailability, low clearance and a small vol. of distribution in animals and humans, and a low potential for drug-drug interactions.  Elimination pathways for apixaban include renal excretion, metab. and biliary/intestinal excretion.  Although a sulfate conjugate of O-demethyl apixaban (O-demethyl apixaban sulfate) has been identified as the major circulating metabolite of apixaban in humans, it is inactive against human FXa.  Together, these non-clin. findings have established the favorable pharmacol. profile of apixaban, and support the potential use of apixaban in the clinic for the prevention and treatment of various thromboembolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosf70y5okLwbVg90H21EOLACvtfcHk0lh1Uu-M5gNIag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFSqtb4%253D&md5=97a2b3fa9a43f0eda48f19ba6e015d84</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs11239-011-0551-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11239-011-0551-3%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DPreclinical%2520discovery%2520of%2520apixaban%252C%2520a%2520direct%2520and%2520orally%2520bioavailable%2520factor%2520Xa%2520inhibitor%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2011%26volume%3D31%26issue%3D4%26spage%3D478%26epage%3D492%26doi%3D10.1007%2Fs11239-011-0551-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, R. A.</span></span> <span> </span><span class="NLM_article-title">Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1160/TH04-05-0289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1160%2FTH04-05-0289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15583722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptFOrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=1182-1193&issue=6&author=R.+C.+Beckerauthor=J.+Alexanderauthor=C.+K.+Dykeauthor=R.+A.+Harrington&title=Development+of+DX-9065a%2C+a+novel+direct+factor+Xa+antagonist%2C+in+cardiovascular+disease&doi=10.1160%2FTH04-05-0289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease</span></div><div class="casAuthors">Becker, Richard C.; Alexander, John; Dyke, Christopher K.; Harrington, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1182-1193</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  The development of anticoagulants for treating patients with atherothrombotic disorders of the arterial circulatory system has focused, either directly or indirectly, on thrombin - a pleuripotential effector enzyme with prothrombotic and proinflammatory properties.  The pivotal role of factor (f) Xa in thrombin generation, coupled with its direct cellular effects and widely recognized limitations of currently available anticoagulants, has led to the development of pharmacol. inhibitors of this important protease.  The following review focuses on DX-9065a - first in a class of direct, selective and reversible fXa antagonists - and its potential applications in the management of patients with cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpepKXfPUOGTbVg90H21EOLACvtfcHk0li7JfCIjk-IDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptFOrtg%253D%253D&md5=7a3651eac9cc89c33c1b4d42df5bb682</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1160%2FTH04-05-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH04-05-0289%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DDyke%26aufirst%3DC.%2BK.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26atitle%3DDevelopment%2520of%2520DX-9065a%252C%2520a%2520novel%2520direct%2520factor%2520Xa%2520antagonist%252C%2520in%2520cardiovascular%2520disease%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D92%26issue%3D6%26spage%3D1182%26epage%3D1193%26doi%3D10.1160%2FTH04-05-0289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfsten, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clizbe, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchaleelaha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambing, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenz amide, a highly potent, selective, and orally efficacious factor Xa inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.02.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2179-2185&issue=8&author=P.+Zhangauthor=W.+Huangauthor=L.+Wangauthor=L.+Baoauthor=Z.+J.+Jiaauthor=S.+M.+Bauerauthor=E.+A.+Goldmanauthor=G.+D.+Probstauthor=Y.+Songauthor=T.+Suauthor=J.+Fanauthor=Y.+Wuauthor=W.+Liauthor=J.+Woolfreyauthor=U.+Sinhaauthor=P.+W.+Wongauthor=S.+T.+Edwardsauthor=A.+E.+Arfstenauthor=L.+A.+Clizbeauthor=J.+Kanterauthor=A.+Pandeyauthor=G.+Parkauthor=A.+Hutchaleelahaauthor=J.+L.+Lambingauthor=S.+J.+Hollenbachauthor=R.+M.+Scarboroughauthor=B.+Y.+Zhu&title=Discovery+of+betrixaban+%28PRT054021%29%2C+N-%285-chloropyridin-2-yl%29-2-%284-%28N%2CN-dimethylcarbamimidoyl%29benzamido%29-5-methoxybenz+amide%2C+a+highly+potent%2C+selective%2C+and+orally+efficacious+factor+Xa+inhibitor&doi=10.1016%2Fj.bmcl.2009.02.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DGoldman%26aufirst%3DE.%2BA.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWoolfrey%26aufirst%3DJ.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DWong%26aufirst%3DP.%2BW.%26aulast%3DEdwards%26aufirst%3DS.%2BT.%26aulast%3DArfsten%26aufirst%3DA.%2BE.%26aulast%3DClizbe%26aufirst%3DL.%2BA.%26aulast%3DKanter%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DHutchaleelaha%26aufirst%3DA.%26aulast%3DLambing%26aufirst%3DJ.%2BL.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DDiscovery%2520of%2520betrixaban%2520%2528PRT054021%2529%252C%2520N-%25285-chloropyridin-2-yl%2529-2-%25284-%2528N%252CN-dimethylcarbamimidoyl%2529benzamido%2529-5-methoxybenz%2520amide%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520factor%2520Xa%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D2179%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2009.02.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfon amides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1021/jm060870c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060870c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1546-1557&issue=7&author=C.+Chanauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=L.+Chaudryauthor=C.+W.+Chungauthor=M.+A.+Converyauthor=J.+N.+Hamblinauthor=L.+Johnstoneauthor=H.+A.+Kellyauthor=S.+Kleanthousauthor=A.+Patikisauthor=C.+Patelauthor=A.+J.+Patemanauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Westonauthor=C.+Whitworthauthor=R.+J.+Youngauthor=P.+Zhou&title=Factor+Xa+inhibitors%3A+S1+binding+interactions+of+a+series+of+N-%7B%283S%29-1-%5B%281S%29-1-methyl-2-morpholin-4-yl-2-oxoethyl%5D-2-oxopyrrolidin-3-yl%7Dsulfon+amides&doi=10.1021%2Fjm060870c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm060870c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060870c%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DJohnstone%26aufirst%3DL.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DPatikis%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DFactor%2520Xa%2520inhibitors%253A%2520S1%2520binding%2520interactions%2520of%2520a%2520series%2520of%2520N-%257B%25283S%2529-1-%255B%25281S%2529-1-methyl-2-morpholin-4-yl-2-oxoethyl%255D-2-oxopyrrolidin-3-yl%257Dsulfon%2520amides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D7%26spage%3D1546%26epage%3D1557%26doi%3D10.1021%2Fjm060870c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exall, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLay, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1588</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1588-1592&issue=6&author=N.+S.+Watsonauthor=C.+Adamsauthor=D.+Beltonauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=L.+Chaudryauthor=C.+Chanauthor=M.+A.+Converyauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=J.+D.+Harlingauthor=S.+Irvineauthor=W.+R.+Irvingauthor=S.+Kleanthousauthor=I.+M.+McLayauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=T.+J.+Roethkeauthor=S.+Sengerauthor=G.+J.+Stelmanauthor=J.+R.+Toomeyauthor=R.+I.+Westauthor=C.+Whittakerauthor=P.+Zhouauthor=R.+J.+Young&title=The+discovery+of+potent+and+long-acting+oral+factor+Xa+inhibitors+with+tetrahydroisoquinoline+and+benzazepine+P4+motifs&doi=10.1016%2Fj.bmcl.2011.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DBelton%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DIrvine%26aufirst%3DS.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DStelman%26aufirst%3DG.%2BJ.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWest%26aufirst%3DR.%2BI.%26aulast%3DWhittaker%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520potent%2520and%2520long-acting%2520oral%2520factor%2520Xa%2520inhibitors%2520with%2520tetrahydroisoquinoline%2520and%2520benzazepine%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D1588%26epage%3D1592%26doi%3D10.1016%2Fj.bmcl.2011.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbaut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul King, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18054228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Sqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=23-27&issue=1&author=R.+J.+Youngauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=C.+Chanauthor=M.+Charbautauthor=C.+W.+Chungauthor=M.+A.+Converyauthor=H.+A.+Kellyauthor=N.+Paul+Kingauthor=S.+Kleanthousauthor=A.+M.+Masonauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Weston&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+pyrrolidin-2-ones+with+biaryl+P4+motifs&doi=10.1016%2Fj.bmcl.2007.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs</span></div><div class="casAuthors">Young, Robert J.; Borthwick, Alan D.; Brown, David; Burns-Kurtis, Cynthia L.; Campbell, Matthew; Chan, Chuen; Charbaut, Marie; Chung, Chun-wa; Convery, Maire A.; Kelly, Henry A.; King, N. Paul; Kleanthous, Savvas; Mason, Andrew M.; Pateman, Anthony J.; Patikis, Angela N.; Pinto, Ivan L.; Pollard, Derek R.; Senger, Stefan; Shah, Gita P.; Toomey, John R.; Watson, Nigel S.; Weston, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors.  By incorporating biaryl P4 groups, a series of highly potent inhibitors, e.g., I, was obtained with encouraging oral pharmacokinetic profiles and significant but sub-optimal anticoagulant activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodg91ZXDFpYrVg90H21EOLACvtfcHk0lhB-jCbYymClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Sqtg%253D%253D&md5=a5f6a28d12df20bca8578f42d374fc80</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharbaut%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DPaul%2BKing%26aufirst%3DN.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520pyrrolidin-2-ones%2520with%2520biaryl%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D23%26epage%3D27%26doi%3D10.1016%2Fj.bmcl.2007.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbaut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diallo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortense, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.11.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=28-33&issue=1&author=R.+J.+Youngauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=C.+Chanauthor=M.+Charbautauthor=M.+A.+Converyauthor=H.+Dialloauthor=E.+Hortenseauthor=W.+R.+Irvingauthor=H.+A.+Kellyauthor=N.+P.+Kingauthor=S.+Kleanthousauthor=A.+M.+Masonauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Westonauthor=P.+Zhou&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+biaryl+pyrrolidin-2-ones+incorporating+basic+heterocyclic+motifs&doi=10.1016%2Fj.bmcl.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharbaut%26aufirst%3DM.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DHortense%26aufirst%3DE.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520biaryl%2520pyrrolidin-2-ones%2520incorporating%2520basic%2520heterocyclic%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D28%26epage%3D33%26doi%3D10.1016%2Fj.bmcl.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarte, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortense, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethka, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.11.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=618-622&issue=2&author=S.+Kleanthousauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=L.+Chaudryauthor=C.+Chanauthor=M.+O.+Clarteauthor=M.+A.+Converyauthor=J.+D.+Harlingauthor=E.+Hortenseauthor=W.+R.+Irvingauthor=S.+Irvineauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=T.+J.+Roethkaauthor=S.+Sengerauthor=G.+P.+Shahauthor=G.+J.+Stelmanauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=R.+I.+Westauthor=C.+Whittakerauthor=P.+Zhouauthor=R.+J.+Young&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+pyrrolidin-2-ones+with+monoaryl+P4+motifs&doi=10.1016%2Fj.bmcl.2009.11.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.077%26sid%3Dliteratum%253Aachs%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DClarte%26aufirst%3DM.%2BO.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DHortense%26aufirst%3DE.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DIrvine%26aufirst%3DS.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DRoethka%26aufirst%3DT.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DStelman%26aufirst%3DG.%2BJ.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWest%26aufirst%3DR.%2BI.%26aulast%3DWhittaker%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520pyrrolidin-2-ones%2520with%2520monoaryl%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D618%26epage%3D622%26doi%3D10.1016%2Fj.bmcl.2009.11.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchee, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3784</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.04.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3784-3788&issue=14&author=N.+S.+Watsonauthor=D.+Brownauthor=M.+Campbellauthor=C.+Chanauthor=L.+Chaudryauthor=M.+A.+Converyauthor=R.+Fenwickauthor=J.+N.+Hamblinauthor=C.+Haslamauthor=H.+A.+Kellyauthor=N.+P.+Kingauthor=C.+L.+Kurtisauthor=A.+R.+Leachauthor=G.+R.+Mancheeauthor=A.+M.+Masonauthor=C.+Mitchellauthor=C.+Patelauthor=V.+K.+Patelauthor=S.+Sengerauthor=G.+P.+Shahauthor=H.+E.+Westonauthor=C.+Whitworthauthor=R.+J.+Young&title=Design+and+synthesis+of+orally+active+pyrrolidin-2-one-based+factor+Xa+inhibitors&doi=10.1016%2Fj.bmcl.2006.04.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.053%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DFenwick%26aufirst%3DR.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DHaslam%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKurtis%26aufirst%3DC.%2BL.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DManchee%26aufirst%3DG.%2BR.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DMitchell%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520orally%2520active%2520pyrrolidin-2-one-based%2520factor%2520Xa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D14%26spage%3D3784%26epage%3D3788%26doi%3D10.1016%2Fj.bmcl.2006.04.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Palmer, M. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of the long-acting PDE5 inhibitor PF-489791 for the treatment of pulmonary hypertension</span>. In  <i>Accounts in Drug Discovery: Case Studies in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span>, <span class="NLM_string-name">Carter, P.</span>, <span class="NLM_string-name">Cheng, P.</span>, <span class="NLM_string-name">Zahler, R.</span></span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>, <span class="NLM_year">2010</span>; Chapter 8, pp  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">182</span>, DOI: <span class="refDoi"> DOI: 10.1039/9781849731980-00166</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2F9781849731980-00166" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=166-182&author=A.+S.+Bell&author=M.+J.+Palmerauthor=J.+Barrish&author=P.+Carter&author=P.+Cheng&author=R.+Zahler&title=Accounts+in+Drug+Discovery%3A+Case+Studies+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2F9781849731980-00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731980-00166%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DThe%2520discovery%2520of%2520the%2520long-acting%2520PDE5%2520inhibitor%2520PF-489791%2520for%2520the%2520treatment%2520of%2520pulmonary%2520hypertension%26btitle%3DAccounts%2520in%2520Drug%2520Discovery%253A%2520Case%2520Studies%2520in%2520Medicinal%2520Chemistry%26aulast%3DBarrish%26aufirst%3DJ.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2010%26spage%3D166%26epage%3D182%26doi%3D10.1039%2F9781849731980-00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span> <span> </span><span class="NLM_article-title">Design of second generation phosphodiesterase 5 inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.2174/156802607779941288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F156802607779941288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17305582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=405-419&issue=4&author=M.+Palmerauthor=A.+Bellauthor=D.+Foxauthor=D.+Brown&title=Design+of+second+generation+phosphodiesterase+5+inhibitors&doi=10.2174%2F156802607779941288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Design of second generation phosphodiesterase 5 inhibitors</span></div><div class="casAuthors">Palmer, Michael J.; Bell, Andrew S.; Fox, David N. A.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. significance of phosphodiesterase 5 (PDE5) inhibition is increasingly understood following the pioneering work with sildenafil, and the continuing development programs for both sildenafil and other marketed inhibitors.  Since the initial launch of sildenafil for male erectile dysfunction (MED), approval has now been granted for treatment of pulmonary hypertension, while ongoing studies have indicated the potential of PDE5 inhibition for the treatment of a range of addnl. indications including cardioprotection, memory retention and diabetes.  Many of these addnl. indications are best suited to chronic oral dosing and emphasize the need for highly selective inhibitors with extended duration of action.  This article will focus on a research program aimed at the discovery of improved second-generation PDE5 inhibitors.  Essential features of these new PDE5 inhibitors would be enhanced selectivity across the whole PDE family and pharmacokinetics compatible with once daily dosing.  Key elements used in this program are high throughput screening (HTS), exploitation of co-crystal structural information for bound inhibitor in the PDE5 active site, and employment of parallel chem. to speed progress.  Under the guidance of co-crystal structural information, a non-selective HTS hit with poor physicochem. was initially modified using parallel chem. to give a lead compd. (3) that established a new PDE5 inhibitor series.  Notably, (3) displayed physicochem. compatible with a long plasma half-life, and wide chem. scope.  Subsequent optimization of (3) using crystal structure information to guide design, led rapidly to highly potent and selective PDE5 inhibitors (47, 50).  Continued focus on phys. properties through ligand efficiency evaluation and lipophilicity (cLogP), maintained the inherently desirable physicochem. of the initial lead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodkBVE07EUs7Vg90H21EOLACvtfcHk0lgkNvkOoREDWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gs70%253D&md5=89706f83e903a5c98ea5309857540253</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2174%2F156802607779941288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607779941288%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26atitle%3DDesign%2520of%2520second%2520generation%2520phosphodiesterase%25205%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D405%26epage%3D419%26doi%3D10.2174%2F156802607779941288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P.</span></span> <span> </span><span class="NLM_article-title">Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1824</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(96)00323-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2F0960-894X%2896%2900323-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1819-1824&issue=15&author=N.+K.+Terrettauthor=A.+S.+Bellauthor=D.+Brownauthor=P.+Ellis&title=Sildenafil+%28VIAGRATM%29%2C+a+potent+and+selective+inhibitor+of+type+5+cGMP+phosphodiesterase+with+utility+for+the+treatment+of+male+erectile+dysfunction&doi=10.1016%2F0960-894X%2896%2900323-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2896%2900323-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252896%252900323-X%26sid%3Dliteratum%253Aachs%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DP.%26atitle%3DSildenafil%2520%2528VIAGRATM%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520type%25205%2520cGMP%2520phosphodiesterase%2520with%2520utility%2520for%2520the%2520treatment%2520of%2520male%2520erectile%2520dysfunction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26issue%3D15%26spage%3D1819%26epage%3D1824%26doi%3D10.1016%2F0960-894X%2896%2900323-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haning, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewöhner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Es-Sayed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lampe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, E.</span></span> <span> </span><span class="NLM_article-title">Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00030-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2802%2900030-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=865-868&issue=6&author=H.+Haningauthor=U.+Niew%C3%B6hnerauthor=T.+Schenkeauthor=M.+Es-Sayedauthor=G.+Schmidtauthor=T.+Lampeauthor=E.+Bischoff&title=Imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4%283H%29-ones%2C+a+new+class+of+potent+PDE+5+inhibitors&doi=10.1016%2FS0960-894X%2802%2900030-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900030-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900030-6%26sid%3Dliteratum%253Aachs%26aulast%3DHaning%26aufirst%3DH.%26aulast%3DNiew%25C3%25B6hner%26aufirst%3DU.%26aulast%3DSchenke%26aufirst%3DT.%26aulast%3DEs-Sayed%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DLampe%26aufirst%3DT.%26aulast%3DBischoff%26aufirst%3DE.%26atitle%3DImidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4%25283H%2529-ones%252C%2520a%2520new%2520class%2520of%2520potent%2520PDE%25205%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D6%26spage%3D865%26epage%3D868%26doi%3D10.1016%2FS0960-894X%2802%2900030-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier
de Gouville, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudiniere, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1:5,6,11,11a-tetrahydro-1H-imidazo[1′,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1021/jm030056e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030056e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4525-4532&issue=21&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.+C.+Le+Monnier%0Ade+Gouvilleauthor=H.+Costeauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudiniere&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+1%3A5%2C6%2C11%2C11a-tetrahydro-1H-imidazo%5B1%E2%80%B2%2C5%E2%80%B2%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C3%282H%29-dione+analogues&doi=10.1021%2Fjm030056e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm030056e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030056e%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudiniere%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25201%253A5%252C6%252C11%252C11a-tetrahydro-1H-imidazo%255B1%25E2%2580%25B2%252C5%25E2%2580%25B2%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C3%25282H%2529-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D21%26spage%3D4525%26epage%3D4532%26doi%3D10.1021%2Fjm030056e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span>; <span class="NLM_string-name">Cárdenas, E. L.</span>; <span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">The design, development, and evaluation of BACE1 inhibitors for the treatment of Alzheimer’s disease</span>. In  <i>Alzheimer’s Disease II</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, M. S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, DOI: <span class="refDoi"> DOI: 10.1007/7355_2016_16</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2F7355_2016_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=27-85&author=A.+K.+Ghosh&author=E.+L.+C%C3%A1rdenas&author=H.+L.+Osswaldauthor=M.+S.+Wolfe&title=Alzheimer%E2%80%99s+Disease+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1007%2F7355_2016_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2016_16%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26atitle%3DThe%2520design%252C%2520development%252C%2520and%2520evaluation%2520of%2520BACE1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520II%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2016%26spage%3D27%26epage%3D85%26doi%3D10.1007%2F7355_2016_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&issue=9&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">BACE-1 Inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=619-637&author=F.+Pratiauthor=G.+Bottegoniauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=BACE-1+Inhibitors%3A+from+recent+single-target+molecules+to+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; Bottegoni, Giovanni; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer's disease (AD), leading to many small-mol. and biol. drug candidates.  One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors.  The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment.  It also suggests new possibilities for discovering BACE-1-targeted compds. with more complex mechanisms of actions and improved efficacy.  Herein, the authors review the major advances in BACE-1 drug discovery, from single-target small mol. inhibitors to multitarget compds.  The authors discuss these compds. as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIKti01PzWrVg90H21EOLACvtfcHk0liuxiFfxSndRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO&md5=a30fe7a54f34206355c6380eb9eacbe4</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DBACE-1%2520Inhibitors%253A%2520from%2520recent%2520single-target%2520molecules%2520to%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D619%26epage%3D637%26doi%3D10.1021%2Facs.jmedchem.7b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deinum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel warhead against beta-secretase through fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5903</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1021/jm070825k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&issue=24&author=S.+Geschwindnerauthor=L.+L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+Folmer&title=Discovery+of+a+novel+warhead+against+beta-secretase+through+fragment-based+lead+generation&doi=10.1021%2Fjm070825k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520beta-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D5903%26epage%3D5911%26doi%3D10.1021%2Fjm070825k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesater, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&issue=49&author=F.+Jeppssonauthor=S.+Eketjallauthor=J.+Jansonauthor=S.+Karlstromauthor=S.+Gustavssonauthor=L.+L.+Olssonauthor=A.+C.+Radesaterauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.+M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+Falting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketjall%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstrom%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DFalting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D49%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharony, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koether, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumrine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span> <span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5912</span>– <span class="NLM_lpage">5925</span>, <span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&issue=24&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+beta-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520beta-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-a beta-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&issue=23&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-a+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-a%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2449</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&issue=7&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor&doi=10.1016%2Fj.bmcl.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0ljpaX4uLd7KYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D2444%26epage%3D2449%26doi%3D10.1016%2Fj.bmcl.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Abeta reduction</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&issue=11&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">BACE inhibitor bust in Alzheimer trial</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">155</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.43" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=155&issue=3&author=A.+Mullard&title=BACE+inhibitor+bust+in+Alzheimer+trial&doi=10.1038%2Fnrd.2017.43"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.43%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DBACE%2520inhibitor%2520bust%2520in%2520Alzheimer%2520trial%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D3%26spage%3D155%26doi%3D10.1038%2Fnrd.2017.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Structurally diverse mitochondrial branched chain aminotransferase (BCATm) leads with varying binding modes identified by fragment screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2452</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01607</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01607" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2452-2467&issue=6&author=J.+A.+Borthwickauthor=N.+Ancellinauthor=S.+M.+Bertrandauthor=R.+P.+Binghamauthor=P.+S.+Carterauthor=C.+W.+Chungauthor=I.+Churcherauthor=N.+Dodicauthor=C.+Fournierauthor=P.+L.+Francisauthor=A.+Hobbsauthor=C.+Jamiesonauthor=S.+D.+Pickettauthor=S.+E.+Smithauthor=D.+O.+Somersauthor=C.+Spitzfadenauthor=C.+J.+Sucklingauthor=R.+J.+Young&title=Structurally+diverse+mitochondrial+branched+chain+aminotransferase+%28BCATm%29+leads+with+varying+binding+modes+identified+by+fragment+screening&doi=10.1021%2Facs.jmedchem.5b01607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01607%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DJ.%2BA.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DS.%2BM.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DStructurally%2520diverse%2520mitochondrial%2520branched%2520chain%2520aminotransferase%2520%2528BCATm%2529%2520leads%2520with%2520varying%2520binding%2520modes%2520identified%2520by%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2452%26epage%3D2467%26doi%3D10.1021%2Facs.jmedchem.5b01607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gummer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of in vivo active mitochondrial branched-chain aminotransferase (BCATm) inhibitors by hybridizing fragment and HTS hits</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7140</span>– <span class="NLM_lpage">7163</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7140-7163&issue=18&author=S.+M.+Bertrandauthor=N.+Ancellinauthor=B.+Beaufilsauthor=R.+P.+Binghamauthor=J.+A.+Borthwickauthor=A.+B.+Boullayauthor=E.+Boursierauthor=P.+S.+Carterauthor=C.+W.+Chungauthor=I.+Churcherauthor=N.+Dodicauthor=M.+H.+Fouchetauthor=C.+Fournierauthor=P.+L.+Francisauthor=L.+A.+Gummerauthor=K.+Herryauthor=A.+Hobbsauthor=C.+I.+Hobbsauthor=P.+Homesauthor=C.+Jamiesonauthor=E.+Nicodemeauthor=S.+D.+Pickettauthor=I.+H.+Reidauthor=G.+L.+Simpsonauthor=L.+A.+Sloanauthor=S.+E.+Smithauthor=D.+O.+Somersauthor=C.+Spitzfadenauthor=C.+J.+Sucklingauthor=K.+Valkoauthor=Y.+Washioauthor=R.+J.+Young&title=The+discovery+of+in+vivo+active+mitochondrial+branched-chain+aminotransferase+%28BCATm%29+inhibitors+by+hybridizing+fragment+and+HTS+hits&doi=10.1021%2Facs.jmedchem.5b00313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00313%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DS.%2BM.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBeaufils%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DBorthwick%26aufirst%3DJ.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26aulast%3DGummer%26aufirst%3DL.%2BA.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DReid%26aufirst%3DI.%2BH.%26aulast%3DSimpson%26aufirst%3DG.%2BL.%26aulast%3DSloan%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DValko%26aufirst%3DK.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520in%2520vivo%2520active%2520mitochondrial%2520branched-chain%2520aminotransferase%2520%2528BCATm%2529%2520inhibitors%2520by%2520hybridizing%2520fragment%2520and%2520HTS%2520hits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7140%26epage%3D7163%26doi%3D10.1021%2Facs.jmedchem.5b00313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundersingh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothier
Kaushansky, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery, SAR, and X-ray binding mode study of BCATm inhibitors from a novel DNA-encoded library</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=919-924&issue=8&author=H.+Dengauthor=J.+Zhouauthor=F.+S.+Sundersinghauthor=J.+Summerfieldauthor=D.+Somersauthor=J.+A.+Messerauthor=A.+L.+Satzauthor=N.+Ancellinauthor=C.+C.+Arico-Muendelauthor=K.+L.+Sargent+Bedardauthor=A.+Beljeanauthor=S.+L.+Belyanskayaauthor=R.+Binghamauthor=S.+E.+Smithauthor=E.+Boursierauthor=P.+Carterauthor=P.+A.+Centrellaauthor=M.+A.+Clarkauthor=C.+W.+Chungauthor=C.+P.+Davieauthor=J.+L.+Deloreyauthor=Y.+Dingauthor=G.+J.+Franklinauthor=L.+C.+Gradyauthor=K.+Herryauthor=C.+Hobbsauthor=C.+S.+Kollmannauthor=B.+A.+Morganauthor=L.+J.+Pothier%0AKaushanskyauthor=Q.+Zhou&title=Discovery%2C+SAR%2C+and+X-ray+binding+mode+study+of+BCATm+inhibitors+from+a+novel+DNA-encoded+library&doi=10.1021%2Facsmedchemlett.5b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, SAR, and X-ray Binding Mode Study of BCATm Inhibitors from a Novel DNA-Encoded Library</span></div><div class="casAuthors">Deng, Hongfeng; Zhou, Jingye; Sundersingh, Flora S.; Summerfield, Jennifer; Somers, Don; Messer, Jeffrey A.; Satz, Alexander L.; Ancellin, Nicolas; Arico-Muendel, Christopher C.; Bedard, Katie L.; Beljean, Arthur; Belyanskaya, Svetlana L.; Bingham, Ryan; Smith, Sarah E.; Boursier, Eric; Carter, Paul; Centrella, Paolo A.; Clark, Matthew A.; Chung, Chun-wa; Davie, Christopher P.; Delorey, Jennifer L.; Ding, Yun; Franklin, G. Joseph; Grady, LaShadric C.; Herry, Kenny; Hobbs, Clare; Kollmann, Christopher S.; Morgan, Barry A.; Kaushansky, Laura J.; Zhou, Quan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">919-924</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a potential target for obesity, human BCATm was screened against more than 14 billion DNA encoded compds. of distinct scaffolds followed by off-DNA synthesis and activity confirmation.  As a consequence, several series of BCATm inhibitors were discovered.  One representative compd. I from a novel compd. library synthesized via on-DNA Suzuki-Miyaura cross-coupling showed BCATm inhibitory activity with IC50 = 2.0 μM.  A protein crystal structure of I revealed that it binds to BCATm within the catalytic site adjacent to the PLP cofactor.  The identification of this novel inhibitor series plus the establishment of a BCATm protein structure provided a good starting point for future structure-based discovery of BCATm inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxzUuENOvoCrVg90H21EOLACvtfcHk0ljiMX11F1Oo5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77L&md5=85fb50b6ee9c5b4ed3d1afd0bc9face6</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00179%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DSundersingh%26aufirst%3DF.%2BS.%26aulast%3DSummerfield%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DD.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DSargent%2BBedard%26aufirst%3DK.%2BL.%26aulast%3DBeljean%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBingham%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DDelorey%26aufirst%3DJ.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DKollmann%26aufirst%3DC.%2BS.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DPothier%2BKaushansky%26aufirst%3DL.%2BJ.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DDiscovery%252C%2520SAR%252C%2520and%2520X-ray%2520binding%2520mode%2520study%2520of%2520BCATm%2520inhibitors%2520from%2520a%2520novel%2520DNA-encoded%2520library%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D8%26spage%3D919%26epage%3D924%26doi%3D10.1021%2Facsmedchemlett.5b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundersingh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of potent, selective, and in vivo efficacious 2-aryl benzimidazole BCATm inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=379-384&issue=4&author=H.+Dengauthor=J.+Zhouauthor=F.+Sundersinghauthor=J.+A.+Messerauthor=D.+O.+Somersauthor=M.+Ajakaneauthor=C.+C.+Arico-Muendelauthor=A.+Beljeanauthor=S.+L.+Belyanskayaauthor=R.+Binghamauthor=E.+Blazenskyauthor=A.+B.+Boullayauthor=E.+Boursierauthor=J.+Chaiauthor=P.+Carterauthor=C.+W.+Chungauthor=A.+Dauganauthor=Y.+Dingauthor=K.+Herryauthor=C.+Hobbsauthor=E.+Humphriesauthor=C.+Kollmannauthor=V.+L.+Nguyenauthor=E.+Nicodemeauthor=S.+E.+Smithauthor=N.+Dodicauthor=N.+Ancellin&title=Discovery+and+optimization+of+potent%2C+selective%2C+and+in+vivo+efficacious+2-aryl+benzimidazole+BCATm+inhibitors&doi=10.1021%2Facsmedchemlett.5b00389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00389%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DSundersingh%26aufirst%3DF.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DBeljean%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBingham%26aufirst%3DR.%26aulast%3DBlazensky%26aufirst%3DE.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DHumphries%26aufirst%3DE.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DAncellin%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520in%2520vivo%2520efficacious%25202-aryl%2520benzimidazole%2520BCATm%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D379%26epage%3D384%26doi%3D10.1021%2Facsmedchemlett.5b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almassy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvert, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostomsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span> <span> </span><span class="NLM_article-title">Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4084</span>– <span class="NLM_lpage">4097</span>, <span class="refDoi"> DOI: 10.1021/jm000950v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000950v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4084-4097&issue=22&author=A.+W.+Whiteauthor=R.+Almassyauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=R.+J.+Griffinauthor=Z.+Hostomskyauthor=K.+Maegleyauthor=D.+R.+Newellauthor=S.+Srinivasanauthor=B.+T.+Golding&title=Resistance-modifying+agents.+9.+Synthesis+and+biological+properties+of+benzimidazole+inhibitors+of+the+DNA+repair+enzyme+poly%28ADP-ribose%29+polymerase&doi=10.1021%2Fjm000950v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm000950v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000950v%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BW.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DResistance-modifying%2520agents.%25209.%2520Synthesis%2520and%2520biological%2520properties%2520of%2520benzimidazole%2520inhibitors%2520of%2520the%2520DNA%2520repair%2520enzyme%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D22%26spage%3D4084%26epage%3D4097%26doi%3D10.1021%2Fjm000950v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menear, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockcroft, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copsey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cranston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drzewiecki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaid, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knights, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, V. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span> <span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin- 1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6581</span>– <span class="NLM_lpage">6591</span>, <span class="refDoi"> DOI: 10.1021/jm8001263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&issue=20&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.+L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+Smithauthor=N.+M.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-+1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1&doi=10.1021%2Fjm8001263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.%2BL.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-%25201-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D20%26spage%3D6581%26epage%3D6591%26doi%3D10.1021%2Fjm8001263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostomsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalitzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1158%2F1535-7163.MCT-06-0552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17363489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=945-956&issue=3&author=H.+D.+Thomasauthor=C.+R.+Calabreseauthor=M.+A.+Bateyauthor=S.+Cananauthor=Z.+Hostomskyauthor=S.+Kyleauthor=K.+A.+Maegleyauthor=D.+R.+Newellauthor=D.+Skalitzkyauthor=L.+Z.+Wangauthor=S.+E.+Webberauthor=N.+J.+Curtin&title=Preclinical+selection+of+a+novel+poly%28ADP-ribose%29+polymerase+inhibitor+for+clinical+trial&doi=10.1158%2F1535-7163.MCT-06-0552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span></div><div class="casAuthors">Thomas, Huw D.; Calabrese, Christopher R.; Batey, Michael A.; Canan, Stacie; Hostomsky, Zdenek; Kyle, Suzanne; Maegley, Karen A.; Newell, David R.; Skalitzky, Donald; Wang, Lan-Zhen; Webber, Stephen E.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">945-956</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP)-1 (EC 2.4.2.30) is a nuclear enzyme that promotes the base excision repair of DNA breaks.  Inhibition of PARP-1 enhances the efficacy of DNA alkylating agents, topoisomerase I poisons, and ionizing radiation.  Our aim was to identify a PARP inhibitor for clin. trial from a panel of 42 potent PARP inhibitors (Ki, 1.4-15.1 nmol/L) based on the quinazolinone, benzimidazole, tricyclic benzimidazole, tricyclic indole, and tricyclic indole-1-one core structures.  We evaluated chemosensitization of temozolomide and topotecan using LoVo and SW620 human colorectal cells; in vitro radiosensitization was measured using LoVo cells, and the enhancement of antitumor activity of temozolomide was evaluated in mice bearing SW620 xenografts.  Excellent chemopotentiation and radiopotentiation were obsd. in vitro, with 17 of the compds. causing a greater temozolomide and topotecan sensitization than the benchmark inhibitor AG14361 and 10 compds. were more potent radiosensitizers than AG14361.  In tumor-bearing mice, none of the compds. were toxic when given alone, and the antitumor activity of the PARP inhibitor-temozolomide combinations was unrelated to toxicity.  Compds. that were more potent chemosensitizers in vivo than AG14361 were also more potent in vitro, validating in vitro assays as a prescreen.  These studies have identified a compd., AG14447, as a PARP inhibitor with outstanding in vivo chemosensitization potency at tolerable doses, which is at least 10 times more potent than the initial lead, AG14361.  The phosphate salt of AG14447 (AG014699), which has improved aq. soly., has been selected for clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-3D2oL2giLVg90H21EOLACvtfcHk0ljsLf5yD-e9XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D&md5=b451bf2c1fc836cc5a800c2799e5d211</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0552%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCanan%26aufirst%3DS.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520selection%2520of%2520a%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520for%2520clinical%2520trial%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D3%26spage%3D945%26epage%3D956%26doi%3D10.1158%2F1535-7163.MCT-06-0552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinghofer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donawho, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontcheva-Diaz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giranda, V. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/jm801171j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801171j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=514-523&issue=2&author=T.+D.+Penningauthor=G.+D.+Zhuauthor=V.+B.+Gandhiauthor=J.+Gongauthor=X.+Liuauthor=Y.+Shiauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=C.+K.+Donawhoauthor=D.+J.+Frostauthor=V.+Bontcheva-Diazauthor=J.+J.+Bouskaauthor=D.+J.+Osterlingauthor=A.+M.+Olsonauthor=K.+C.+Marshauthor=Y.+Luoauthor=V.+L.+Giranda&title=Discovery+of+the+Poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+2-%5B%28R%29-2-methylpyrrolidin-2-yl%5D-1H-benzimidazole-4-carboxamide+%28ABT-888%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm801171j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm801171j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801171j%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DZhu%26aufirst%3DG.%2BD.%26aulast%3DGandhi%26aufirst%3DV.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DDiscovery%2520of%2520the%2520Poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%25202-%255B%2528R%2529-2-methylpyrrolidin-2-yl%255D-1H-benzimidazole-4-carboxamide%2520%2528ABT-888%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D514%26epage%3D523%26doi%3D10.1021%2Fjm801171j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonk, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Group efficiency: a guideline for hits-to-leads chemistry</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.200800132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1179-1180&issue=8&author=M.+L.+Verdonkauthor=D.+C.+Rees&title=Group+efficiency%3A+a+guideline+for+hits-to-leads+chemistry&doi=10.1002%2Fcmdc.200800132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800132%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DGroup%2520efficiency%253A%2520a%2520guideline%2520for%2520hits-to-leads%2520chemistry%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26issue%3D8%26spage%3D1179%26epage%3D1180%26doi%3D10.1002%2Fcmdc.200800132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcoxen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniatti, C.</span></span> <span> </span><span class="NLM_article-title">Niraparib: a poly(ADP-ribose) polymerase (PARP) inhibitor for the treatment of tumors with defective homologous recombination</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1021/jm5018237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3302-3314&issue=8&author=P.+Jonesauthor=K.+Wilcoxenauthor=M.+Rowleyauthor=C.+Toniatti&title=Niraparib%3A+a+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+for+the+treatment+of+tumors+with+defective+homologous+recombination&doi=10.1021%2Fjm5018237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm5018237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018237%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DWilcoxen%26aufirst%3DK.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DToniatti%26aufirst%3DC.%26atitle%3DNiraparib%253A%2520a%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520tumors%2520with%2520defective%2520homologous%2520recombination%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D8%26spage%3D3302%26epage%3D3314%26doi%3D10.1021%2Fjm5018237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi-Scharber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, L. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-te trahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, talazoparib), a novel, highly potent, and orally efficacious poly(ADP-ribose) polymerase-1/2 inhibitor, as an anticancer agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=335-357&issue=1&author=B.+Wangauthor=D.+Chuauthor=Y.+Fengauthor=Y.+Shenauthor=M.+Aoyagi-Scharberauthor=L.+E.+Post&title=Discovery+and+characterization+of+%288S%2C9R%29-5-fluoro-8-%284-fluorophenyl%29-9-%281-methyl-1H-1%2C2%2C4-triazol-5-yl%29-2%2C7%2C8%2C9-te+trahydro-3H-pyrido%5B4%2C3%2C2-de%5Dphthalazin-3-one+%28BMN+673%2C+talazoparib%29%2C+a+novel%2C+highly+potent%2C+and+orally+efficacious+poly%28ADP-ribose%29+polymerase-1%2F2+inhibitor%2C+as+an+anticancer+agent&doi=10.1021%2Facs.jmedchem.5b01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01498%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAoyagi-Scharber%26aufirst%3DM.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%25288S%252C9R%2529-5-fluoro-8-%25284-fluorophenyl%2529-9-%25281-methyl-1H-1%252C2%252C4-triazol-5-yl%2529-2%252C7%252C8%252C9-te%2520trahydro-3H-pyrido%255B4%252C3%252C2-de%255Dphthalazin-3-one%2520%2528BMN%2520673%252C%2520talazoparib%2529%252C%2520a%2520novel%252C%2520highly%2520potent%252C%2520and%2520orally%2520efficacious%2520poly%2528ADP-ribose%2529%2520polymerase-1%252F2%2520inhibitor%252C%2520as%2520an%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D1%26spage%3D335%26epage%3D357%26doi%3D10.1021%2Facs.jmedchem.5b01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaspy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachdev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henshaw, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herriott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span> <span> </span><span class="NLM_article-title">Phase I, dose-escalation, two-part trial of the PARP Inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1158%2F2159-8290.CD-16-1250" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=620-629&issue=6&author=J.+de+Bonoauthor=R.+K.+Ramanathanauthor=L.+Minaauthor=R.+Chughauthor=J.+Glaspyauthor=S.+Rafiiauthor=S.+Kayeauthor=J.+Sachdevauthor=J.+Heymachauthor=D.+C.+Smithauthor=J.+W.+Henshawauthor=A.+Herriottauthor=M.+Pattersonauthor=N.+J.+Curtinauthor=L.+A.+Byersauthor=Z.+A.+Wainberg&title=Phase+I%2C+dose-escalation%2C+two-part+trial+of+the+PARP+Inhibitor+talazoparib+in+patients+with+advanced+germline+BRCA1%2F2+mutations+and+selected+sporadic+cancers&doi=10.1158%2F2159-8290.CD-16-1250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1250%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBono%26aufirst%3DJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DMina%26aufirst%3DL.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DGlaspy%26aufirst%3DJ.%26aulast%3DRafii%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DSachdev%26aufirst%3DJ.%26aulast%3DHeymach%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DHenshaw%26aufirst%3DJ.%2BW.%26aulast%3DHerriott%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DByers%26aufirst%3DL.%2BA.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26atitle%3DPhase%2520I%252C%2520dose-escalation%252C%2520two-part%2520trial%2520of%2520the%2520PARP%2520Inhibitor%2520talazoparib%2520in%2520patients%2520with%2520advanced%2520germline%2520BRCA1%252F2%2520mutations%2520and%2520selected%2520sporadic%2520cancers%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26issue%3D6%26spage%3D620%26epage%3D629%26doi%3D10.1158%2F2159-8290.CD-16-1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the HIV integration process: past, present, and the future</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1021/jm400674a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400674a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaru73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=539-566&issue=3&author=R.+Di+Santo&title=Inhibiting+the+HIV+integration+process%3A+past%2C+present%2C+and+the+future&doi=10.1021%2Fjm400674a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the HIV Integration Process: Past, Present, and the Future</span></div><div class="casAuthors">Di Santo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-566</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HIV integrase (IN) catalyzes the insertion into the genome of the infected human cell of viral DNA produced by the retro-transcription process.  The discovery of raltegravir validated the existence of the IN, which is a new target in the field of anti-HIV drug research.  The mechanism of catalysis of IN is depicted, and the characteristics of the inhibitors of the catalytic site of this viral enzyme are reported.  The role played by the resistance is elucidated, as well as the possibility of bypassing this problem.  New approaches to block the integration process are depicted as future perspectives, such as development of allosteric IN inhibitors, dual inhibitors targeting both IN and other enzymes, inhibitors of enzymes that activate IN, activators of IN activity, as well as a gene therapy approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYPzsc8lcnCLVg90H21EOLACvtfcHk0lhujhXf7hS1jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaru73E&md5=f09410a9b2a67cd9b7a93111ef5757e5</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm400674a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400674a%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DInhibiting%2520the%2520HIV%2520integration%2520process%253A%2520past%252C%2520present%252C%2520and%2520the%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D3%26spage%3D539%26epage%3D566%26doi%3D10.1021%2Fjm400674a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felock, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryelski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5453</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1126/science.287.5453.646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.287.5453.646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10649997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=646-650&issue=5453&author=D.+J.+Hazudaauthor=P.+Felockauthor=M.+Witmerauthor=A.+Wolfeauthor=K.+Stillmockauthor=J.+A.+Groblerauthor=A.+Espesethauthor=L.+Gabryelskiauthor=W.+Schleifauthor=C.+Blauauthor=M.+D.+Miller&title=Inhibitors+of+strand+transfer+that+prevent+integration+and+inhibit+HIV-1+replication+in+cells&doi=10.1126%2Fscience.287.5453.646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter; Witmer, Marc; Wolfe, Abigail; Stillmock, Kara; Grobler, Jay A.; Espeseth, Amy; Gabryelski, Lori; Schleif, William; Blau, Carol; Miller, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5453</span>),
    <span class="NLM_cas:pages">646-650</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Integrase is essential for human immunodeficiency virus-type 1 (HIV-1) replication; however, potent inhibition of the isolated enzyme in biochem. assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration.  In this report, we describe diketo acid inhibitors of HIV-1 integrase that manifest antiviral activity as a consequence of their effect on integration.  The antiviral activity of these compds. is due exclusively to inhibition of one of the two catalytic functions of integrase, strand transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLfQNYMkTCVrVg90H21EOLACvtfcHk0lg4e6zCAhZJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVyjtQ%253D%253D&md5=d160c8fa31a9ca0a3530dceab66a892c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5453.646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5453.646%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DGabryelski%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DBlau%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26atitle%3DInhibitors%2520of%2520strand%2520transfer%2520that%2520prevent%2520integration%2520and%2520inhibit%2520HIV-1%2520replication%2520in%2520cells%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5453%26spage%3D646%26epage%3D650%26doi%3D10.1126%2Fscience.287.5453.646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassa, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span> <span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6646</span>– <span class="NLM_lpage">6649</span>, <span class="refDoi"> DOI: 10.1021/jm060854f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&issue=23&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profiles+in+preclinical+species&doi=10.1021%2Fjm060854f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D23%26spage%3D6646%26epage%3D6649%26doi%3D10.1021%2Fjm060854f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassa, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.10.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=350-353&issue=2&author=A.+Petrocchiauthor=U.+Kochauthor=V.+G.+Matassaauthor=B.+Paciniauthor=K.+A.+Stillmockauthor=V.+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3A+SAR+around+the+amide+moiety&doi=10.1016%2Fj.bmcl.2006.10.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253A%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D2%26spage%3D350%26epage%3D353%26doi%3D10.1016%2Fj.bmcl.2006.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&issue=18&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0lgM288jiuXHVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5916</span>, <span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&issue=14&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D14%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama-Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1135</span>, <span class="refDoi"> DOI: 10.1021/jm301550c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&issue=3&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles&doi=10.1021%2Fjm301550c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D1124%26epage%3D1135%26doi%3D10.1021%2Fjm301550c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8735</span>– <span class="NLM_lpage">8744</span>, <span class="refDoi"> DOI: 10.1021/jm3010459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&issue=20&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore&doi=10.1021%2Fjm3010459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D20%26spage%3D8735%26epage%3D8744%26doi%3D10.1021%2Fjm3010459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aramaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamataka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinkai, H.</span></span> <span> </span><span class="NLM_article-title">Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4869</span>– <span class="NLM_lpage">4882</span>, <span class="refDoi"> DOI: 10.1021/jm900460z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900460z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4869-4882&issue=15&author=M.+Satoauthor=H.+Kawakamiauthor=T.+Motomuraauthor=H.+Aramakiauthor=T.+Matsudaauthor=M.+Yamashitaauthor=Y.+Itoauthor=Y.+Matsuzakiauthor=K.+Yamatakaauthor=S.+Ikedaauthor=H.+Shinkai&title=Quinolone+carboxylic+acids+as+a+novel+monoketo+acid+class+of+human+immunodeficiency+virus+type+1+integrase+inhibitors&doi=10.1021%2Fjm900460z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone Carboxylic Acids as a Novel Monoketo Acid Class of Human Immunodeficiency Virus Type 1 Integrase Inhibitors</span></div><div class="casAuthors">Sato, Motohide; Kawakami, Hiroshi; Motomura, Takahisa; Aramaki, Hisateru; Matsuda, Takashi; Yamashita, Masaki; Ito, Yoshiharu; Matsuzaki, Yuji; Yamataka, Kazunobu; Ikeda, Satoru; Shinkai, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4869-4882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and detailed structure-activity relationship of quinolonecarboxylic acids as a novel monoketo acid class of HIV-1 integrase inhibitors was presented.  Compds. I (R = t-Bu), which showed an IC50 of 5.8 nM in the strand transfer assay and an ED50 of 0.6 nM in the antiviral assay, and I (R = i-Pr), which had an IC50 of 7.2 nM and an ED50 of 0.9 nM, were the most potent compds. in this class.  The monoketo acid I (R = i-Pr) was much more potent at inhibiting integrase-catalyzed strand transfer processes than 3'-processing reactions, as is the case with the keto-enol acids.  Elvitegravir I (R = i-Pr) was chosen as a candidate for further studies and was reported as being in phase 3 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozJb9SzajWHbVg90H21EOLACvtfcHk0liU_MaxMbJRYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGjsr0%253D&md5=2eb5292b5c6e9efa8471f293cc9f6bb0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm900460z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900460z%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DMotomura%26aufirst%3DT.%26aulast%3DAramaki%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DMatsuzaki%26aufirst%3DY.%26aulast%3DYamataka%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DShinkai%26aufirst%3DH.%26atitle%3DQuinolone%2520carboxylic%2520acids%2520as%2520a%2520novel%2520monoketo%2520acid%2520class%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D15%26spage%3D4869%26epage%3D4882%26doi%3D10.1021%2Fjm900460z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naderi-Oboodi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzechowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strebel, Q.</span></span> <span> </span><span class="NLM_article-title">DNA compatible multistep synthesis and applications to DNA encoded libraries</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1623-1632&issue=8&author=A.+L.+Satzauthor=J.+Caiauthor=Y.+Chenauthor=R.+Goodnowauthor=F.+Gruberauthor=A.+Kowalczykauthor=A.+Petersenauthor=G.+Naderi-Oboodiauthor=L.+Orzechowskiauthor=Q.+Strebel&title=DNA+compatible+multistep+synthesis+and+applications+to+DNA+encoded+libraries&doi=10.1021%2Facs.bioconjchem.5b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries</span></div><div class="casAuthors">Satz, Alexander Lee; Cai, Jianping; Chen, Yi; Goodnow, Robert; Gruber, Felix; Kowalczyk, Agnieszka; Petersen, Ann; Naderi-Oboodi, Goli; Orzechowski, Lucja; Strebel, Quentin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1623-1632</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complex mixts. of DNA encoded small mols. may be readily interrogated via high-throughput sequencing.  These DNA encoded libraries (DELs) are commonly used to discover mols. that interact with pharmaceutically relevant proteins.  The chem. diversity displayed by the library is key to successful discovery of potent, novel, and drug-like chem. matter.  The small mol. moieties of DELs are generally synthesized though a multistep process, and each chem. step is accomplished while it is simultaneously attached to an encoding DNA oligomer.  Hence, library chem. diversity is often limited to DNA compatible synthetic reactions.  Herein, protocols for 24 reactions are provided that have been optimized for high-throughput prodn. of DELs.  These protocols detail the multistep synthesis of benzimidazoles, imidazolidinones, quinazolinones, isoindolinones, thiazoles, and imidazopyridines.  Addnl., protocols are provided for a diverse range of useful chem. reactions including BOC deprotection (under pH neutral conditions), carbamylation, and Sonogashira coupling.  Last, step-by-step protocols for synthesizing functionalized DELs from trichloronitropyrimidine and trichloropyrimidine scaffolds are detailed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreALJfu1k6grVg90H21EOLACvtfcHk0li-kOJnLqbk6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFKktLo%253D&md5=1b25e8a1d11c46b2da47494c92ea5ca5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00239%26sid%3Dliteratum%253Aachs%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGoodnow%26aufirst%3DR.%26aulast%3DGruber%26aufirst%3DF.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DNaderi-Oboodi%26aufirst%3DG.%26aulast%3DOrzechowski%26aufirst%3DL.%26aulast%3DStrebel%26aufirst%3DQ.%26atitle%3DDNA%2520compatible%2520multistep%2520synthesis%2520and%2520applications%2520to%2520DNA%2520encoded%2520libraries%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D8%26spage%3D1623%26epage%3D1632%26doi%3D10.1021%2Facs.bioconjchem.5b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakskjær, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietvorst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmkvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kořínek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röhm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sløk, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, N. J. V.</span></span> <span> </span><span class="NLM_article-title">Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1039/C6MD00241B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC6MD00241B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1332-1339&issue=7&author=L.+K.+Petersenauthor=P.+Blakskj%C3%A6rauthor=A.+Chaikuadauthor=A.+B.+Christensenauthor=J.+Dietvorstauthor=J.+Holmkvistauthor=S.+Knappauthor=M.+Ko%C5%99%C3%ADnekauthor=L.+K.+Larsenauthor=A.+E.+Pedersenauthor=S.+R%C3%B6hmauthor=F.+A.+Sl%C3%B8kauthor=N.+J.+V.+Hansen&title=Novel+p38%CE%B1+MAP+kinase+inhibitors+identified+from+yoctoReactor+DNA-encoded+small+molecule+library&doi=10.1039%2FC6MD00241B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1039%2FC6MD00241B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00241B%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DL.%2BK.%26aulast%3DBlakskj%25C3%25A6r%26aufirst%3DP.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DA.%2BB.%26aulast%3DDietvorst%26aufirst%3DJ.%26aulast%3DHolmkvist%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKo%25C5%2599%25C3%25ADnek%26aufirst%3DM.%26aulast%3DLarsen%26aufirst%3DL.%2BK.%26aulast%3DPedersen%26aufirst%3DA.%2BE.%26aulast%3DR%25C3%25B6hm%26aufirst%3DS.%26aulast%3DSl%25C3%25B8k%26aufirst%3DF.%2BA.%26aulast%3DHansen%26aufirst%3DN.%2BJ.%2BV.%26atitle%3DNovel%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%2520identified%2520from%2520yoctoReactor%2520DNA-encoded%2520small%2520molecule%2520library%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D7%26spage%3D1332%26epage%3D1339%26doi%3D10.1039%2FC6MD00241B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">The drug-maker’s guide to the galaxy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>549</i></span> (<span class="NLM_issue">7673</span>),  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/549445a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2F549445a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28959982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FjsFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=549&publication_year=2017&pages=445-447&issue=7673&author=A.+Mullard&title=The+drug-maker%E2%80%99s+guide+to+the+galaxy&doi=10.1038%2F549445a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-maker's guide to the galaxy</span></div><div class="casAuthors">Mullard Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">549</span>
        (<span class="NLM_cas:issue">7673</span>),
    <span class="NLM_cas:pages">445-447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSItGWG-TCuJEg6wdEZmT2rfW6udTcc2eZmop0gPsPWvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FjsFSmtA%253D%253D&md5=4ff8347906c8f3b459d05a5fe7ad0b56</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2F549445a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F549445a%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DThe%2520drug-maker%25E2%2580%2599s%2520guide%2520to%2520the%2520galaxy%26jtitle%3DNature%26date%3D2017%26volume%3D549%26issue%3D7673%26spage%3D445%26epage%3D447%26doi%3D10.1038%2F549445a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&issue=4&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lhCdCfholsrAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D4%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-Encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&issue=5&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-Encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lhGe27BVD4nVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-Encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1038/cdd.2012.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fcdd.2012.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23197293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=185-187&issue=2&author=P.+Vandenabeeleauthor=S.+Grootjansauthor=N.+Callewaertauthor=N.+Takahashi&title=Necrostatin-1+blocks+both+RIPK1+and+IDO%3A+consequences+for+the+study+of+cell+death+in+experimental+disease+models&doi=10.1038%2Fcdd.2012.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models</span></div><div class="casAuthors">Vandenabeele, P.; Grootjans, S.; Callewaert, N.; Takahashi, N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-187</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This paper discusses necrostatin-1 (Nec-1) blocks both RIPK1 and IDO, consequences for the study of cell death in exptl. disease models.  Activity and specificity of Necrostatin-1, small mol. inhibitor of RIP1 kinase in cell death and differentiation.  The result shows RIPK1/necroptosis targeting as a central theme in biomedical research on inflammatory and degenerative disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7iSg-eNwF2LVg90H21EOLACvtfcHk0liCHrGguSjiYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVygsw%253D%253D&md5=7713eb2ac9832ef8c498cef21055c44d</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2012.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2012.151%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DN.%26atitle%3DNecrostatin-1%2520blocks%2520both%2520RIPK1%2520and%2520IDO%253A%2520consequences%2520for%2520the%2520study%2520of%2520cell%2520death%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D185%26epage%3D187%26doi%3D10.1038%2Fcdd.2012.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1465</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.11.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1455-1465&issue=5&author=K.+Wangauthor=J.+Liauthor=A.+Degterevauthor=E.+Hsuauthor=J.+Yuanauthor=C.+Yuan&title=Structure-activity+relationship+analysis+of+a+novel+necroptosis+inhibitor%2C+necrostatin-5&doi=10.1016%2Fj.bmcl.2006.11.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520a%2520novel%2520necroptosis%2520inhibitor%252C%2520necrostatin-5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D5%26spage%3D1455%26epage%3D1465%26doi%3D10.1016%2Fj.bmcl.2006.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0lgUbfZ_appOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.1021/ml400382p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1238-1243&issue=12&author=P.+A.+Harrisauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=K.+M.+Kahlerauthor=R.+Lehrauthor=J.+D.+Lichauthor=R.+Nagillaauthor=R.+T.+Nolteauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=M.+C.+Schaefferauthor=A.+Smallwoodauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Discovery+of+small+molecule+RIP1+kinase+inhibitors+for+the+treatment+of+pathologies+associated+with+necroptosis&doi=10.1021%2Fml400382p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fml400382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400382p%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520RIP1%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pathologies%2520associated%2520with%2520necroptosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3D1238%26epage%3D1243%26doi%3D10.1021%2Fml400382p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span> <span> </span><span class="NLM_article-title">Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases</span>. <i>MAP Kinase</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.4081/mk.2015.5508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4081%2Fmk.2015.5508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=24-30&issue=1&author=L.+Xing&title=Clinical+candidates+of+small+molecule+p38+MAPK+inhibitors+for+inflammatory+diseases&doi=10.4081%2Fmk.2015.5508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.4081%2Fmk.2015.5508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Fmk.2015.5508%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26atitle%3DClinical%2520candidates%2520of%2520small%2520molecule%2520p38%2520MAPK%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DMAP%2520Kinase%26date%3D2016%26volume%3D4%26issue%3D1%26spage%3D24%26epage%3D30%26doi%3D10.4081%2Fmk.2015.5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seavers, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/jm049575n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049575n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=414-426&issue=2&author=A.+L.+Gillauthor=M.+Fredericksonauthor=A.+Cleasbyauthor=S.+J.+Woodheadauthor=M.+G.+Carrauthor=A.+J.+Woodheadauthor=M.+T.+Walkerauthor=M.+S.+Congreveauthor=L.+A.+Devineauthor=D.+Tisiauthor=M.+O%E2%80%99Reillyauthor=L.+C.+Seaversauthor=D.+J.+Davisauthor=J.+Curryauthor=R.+Anthonyauthor=A.+Padovaauthor=C.+W.+Murrayauthor=R.+A.+Carrauthor=H.+Jhoti&title=Identification+of+novel+p38alpha+MAP+kinase+inhibitors+using+fragment-based+lead+generation&doi=10.1021%2Fjm049575n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm049575n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049575n%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DR.%26aulast%3DPadova%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520using%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D2%26spage%3D414%26epage%3D426%26doi%3D10.1021%2Fjm049575n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepperle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrufo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickory, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevis-Bal, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5851</span>– <span class="NLM_lpage">5856</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.08.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5851-5856&issue=20&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase&doi=10.1016%2Fj.bmcl.2009.08.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.082%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D20%26spage%3D5851%26epage%3D5856%26doi%3D10.1016%2Fj.bmcl.2009.08.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graneto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlitz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallings, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naraian, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koszyk, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stealey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weier, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mnich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5712</span>– <span class="NLM_lpage">5719</span>, <span class="refDoi"> DOI: 10.1021/jm0611915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5712-5719&issue=23&author=M.+J.+Granetoauthor=R.+G.+Kurumbailauthor=M.+L.+Vazquezauthor=H.+S.+Shiehauthor=J.+L.+Pawlitzauthor=J.+M.+Williamsauthor=W.+C.+Stallingsauthor=L.+Gengauthor=A.+S.+Naraianauthor=F.+J.+Koszykauthor=M.+A.+Stealeyauthor=X.+D.+Xuauthor=R.+M.+Weierauthor=G.+J.+Hansonauthor=R.+J.+Moureyauthor=R.+P.+Comptonauthor=S.+J.+Mnichauthor=G.+D.+Andersonauthor=J.+B.+Monahanauthor=R.+Devraj&title=Synthesis%2C+crystal+structure%2C+and+activity+of+pyrazole-based+inhibitors+of+p38+kinase&doi=10.1021%2Fjm0611915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm0611915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611915%26sid%3Dliteratum%253Aachs%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DPawlitz%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DNaraian%26aufirst%3DA.%2BS.%26aulast%3DKoszyk%26aufirst%3DF.%2BJ.%26aulast%3DStealey%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DDevraj%26aufirst%3DR.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520activity%2520of%2520pyrazole-based%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D23%26spage%3D5712%26epage%3D5719%26doi%3D10.1021%2Fjm0611915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.
K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepperle, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurambail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portanova, J.</span></span> <span> </span><span class="NLM_article-title">Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2634</span>– <span class="NLM_lpage">2638</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2010.02.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2634-2638&issue=8&author=J.%0AK.+Walkerauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=M.+E.+Hepperleauthor=W.+Naingauthor=H.+Shiehauthor=R.+Kurambailauthor=S.+Yangauthor=D.+L.+Flynnauthor=A.+G.+Bensonauthor=D.+M.+Messingauthor=T.+Diceauthor=T.+Kimauthor=R.+J.+Lindmarkauthor=J.+B.+Monahanauthor=J.+Portanova&title=Identification+of+SD-0006%2C+a+potent+diaryl+pyrazole+inhibitor+of+p38+MAP+kinase&doi=10.1016%2Fj.bmcl.2010.02.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DHepperle%26aufirst%3DM.%2BE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DKurambail%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMessing%26aufirst%3DD.%2BM.%26aulast%3DDice%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DLindmark%26aufirst%3DR.%2BJ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DPortanova%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520SD-0006%252C%2520a%2520potent%2520diaryl%2520pyrazole%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2634%26epage%3D2638%26doi%3D10.1016%2Fj.bmcl.2010.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aston, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">p38Alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6257</span>– <span class="NLM_lpage">6269</span>, <span class="refDoi"> DOI: 10.1021/jm9004779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6257-6269&issue=20&author=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=V.+K.+Patelauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=G.+Vitulliauthor=A.+L.+Walker&title=p38Alpha+mitogen-activated+protein+kinase+inhibitors%3A+optimization+of+a+series+of+biphenylamides+to+give+a+molecule+suitable+for+clinical+progression&doi=10.1021%2Fjm9004779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm9004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004779%26sid%3Dliteratum%253Aachs%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3Dp38Alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%253A%2520optimization%2520of%2520a%2520series%2520of%2520biphenylamides%2520to%2520give%2520a%2520molecule%2520suitable%2520for%2520clinical%2520progression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D20%26spage%3D6257%26epage%3D6269%26doi%3D10.1021%2Fjm9004779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mavunkel, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perumattam, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewicki, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugar, S.</span></span> <span> </span><span class="NLM_article-title">Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3087</span>– <span class="NLM_lpage">3090</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00653-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2803%2900653-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3087-3090&issue=18&author=B.+J.+Mavunkelauthor=S.+Chakravartyauthor=J.+J.+Perumattamauthor=G.+R.+Luedtkeauthor=X.+Liangauthor=D.+Limauthor=Y.-j.+Xuauthor=M.+Laneyauthor=D.+Y.+Liuauthor=G.+F.+Schreinerauthor=J.+A.+Lewickiauthor=S.+Dugar&title=Indole-based+heterocyclic+inhibitors+of+p38%CE%B1+MAP+kinase%3A+designing+a+conformationally+restricted+analogue&doi=10.1016%2FS0960-894X%2803%2900653-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900653-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900653-X%26sid%3Dliteratum%253Aachs%26aulast%3DMavunkel%26aufirst%3DB.%2BJ.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DPerumattam%26aufirst%3DJ.%2BJ.%26aulast%3DLuedtke%26aufirst%3DG.%2BR.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DY.-j.%26aulast%3DLaney%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DSchreiner%26aufirst%3DG.%2BF.%26aulast%3DLewicki%26aufirst%3DJ.%2BA.%26aulast%3DDugar%26aufirst%3DS.%26atitle%3DIndole-based%2520heterocyclic%2520inhibitors%2520of%2520p38%25CE%25B1%2520MAP%2520kinase%253A%2520designing%2520a%2520conformationally%2520restricted%2520analogue%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D18%26spage%3D3087%26epage%3D3090%26doi%3D10.1016%2FS0960-894X%2803%2900653-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bemis, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evindar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taslimi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhanisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M. S.</span></span> <span> </span><span class="NLM_article-title">The Discovery of VX-745: A novel and selective p38alpha kinase inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1021/ml2001455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=758-763&issue=10&author=J.+P.+Duffyauthor=E.+M.+Harringtonauthor=F.+G.+Salituroauthor=J.+E.+Cochranauthor=J.+Greenauthor=H.+Gaoauthor=G.+W.+Bemisauthor=G.+Evindarauthor=V.+P.+Galulloauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=K.+P.+Wilsonauthor=S.+F.+Bellonauthor=G.+Chenauthor=P.+Taslimiauthor=P.+Jonesauthor=C.+Huangauthor=S.+Pazhanisamyauthor=Y.+M.+Wangauthor=M.+A.+Murckoauthor=M.+S.+Su&title=The+Discovery+of+VX-745%3A+A+novel+and+selective+p38alpha+kinase+inhibitor&doi=10.1021%2Fml2001455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fml2001455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001455%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DHarrington%26aufirst%3DE.%2BM.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DCochran%26aufirst%3DJ.%2BE.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DGalullo%26aufirst%3DV.%2BP.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DThe%2520Discovery%2520of%2520VX-745%253A%2520A%2520novel%2520and%2520selective%2520p38alpha%2520kinase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D10%26spage%3D758%26epage%3D763%26doi%3D10.1021%2Fml2001455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grob, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1038/nsb770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&issue=4&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site&doi=10.1038%2Fnsb770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26issue%3D4%26spage%3D268%26epage%3D272%26doi%3D10.1038%2Fnsb770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooney, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 1: discovery and binding mode</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.10.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=318-323&issue=1&author=R.+M.+Angellauthor=P.+Bamboroughauthor=A.+Cleasbyauthor=S.+G.+Cockerillauthor=K.+L.+Jonesauthor=C.+J.+Mooneyauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+1%3A+discovery+and+binding+mode&doi=10.1016%2Fj.bmcl.2007.10.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.076%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DMooney%26aufirst%3DC.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25201%253A%2520discovery%2520and%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D318%26epage%3D323%26doi%3D10.1016%2Fj.bmcl.2007.10.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, M.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 2: optimisation and SAR</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.10.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&issue=1&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors+2%3A+optimisation+and+SAR&doi=10.1016%2Fj.bmcl.2007.10.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25202%253A%2520optimisation%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D324%26epage%3D328%26doi%3D10.1016%2Fj.bmcl.2007.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aston, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deBoeck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 3: improvement of cellular and in vivo activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4428</span>– <span class="NLM_lpage">4432</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2008.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18614366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVequ7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4428-4432&issue=15&author=R.+Angellauthor=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=S.+Cockerillauthor=S.+J.+deBoeckauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=S.+Patelauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+3%3A+improvement+of+cellular+and+in+vivo+activity&doi=10.1016%2Fj.bmcl.2008.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity</span></div><div class="casAuthors">Angell, Richard; Aston, Nicola M.; Bamborough, Paul; Buckton, Jacky B.; Cockerill, Stuart; de Boeck, Suzanne J.; Edwards, Chris D.; Holmes, Duncan S.; Jones, Katherine L.; Laine, Dramane I.; Patel, Shila; Smee, Penny A.; Smith, Kathryn J.; Somers, Don O.; Walker, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4428-4432</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The biphenyl amides (BPAs) are a novel series of p38α MAP kinase inhibitor.  The optimization of the series to give compds. that are potent in an in vivo disease model is discussed.  SAR is presented and rationalised with ref. to the crystallog. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT0cyGCATNLVg90H21EOLACvtfcHk0lgjjPAZU4Oj7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVequ7c%253D&md5=89ae52223f0cffd31df2b0d830d40ec5</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%26aulast%3DdeBoeck%26aufirst%3DS.%2BJ.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25203%253A%2520improvement%2520of%2520cellular%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4428%26epage%3D4432%26doi%3D10.1016%2Fj.bmcl.2008.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamford, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flack, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludbrook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4433</span>– <span class="NLM_lpage">4437</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2008.06.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&issue=15&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=M.+J.+Bamfordauthor=C.+W.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+4%3A+DFG-in+and+DFG-out+binding+modes&doi=10.1016%2Fj.bmcl.2008.06.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4433%26epage%3D4437%26doi%3D10.1016%2Fj.bmcl.2008.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrufo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickory, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevis-Bal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamanchili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonder Embse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4066</span>– <span class="NLM_lpage">4071</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.04.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4066-4071&issue=13&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=B.+Devadasauthor=J.+K.+Walkerauthor=T.+L.+Boehmauthor=R.+C.+Durleyauthor=H.+Shiehauthor=L.+Xingauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Balauthor=D.+Messingauthor=J.+Yangauthor=M.+K.+Maoauthor=G.+Yalamanchiliauthor=R.+Vonder+Embseauthor=J.+Hirschauthor=M.+Saabyeauthor=S.+Bonarauthor=E.+Webbauthor=G.+Andersonauthor=J.+B.+Monahan&title=Discovery+of+PH-797804%2C+a+highly+selective+and+potent+inhibitor+of+p38+MAP+kinase&doi=10.1016%2Fj.bmcl.2011.04.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.121%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DM.%2BK.%26aulast%3DYalamanchili%26aufirst%3DG.%26aulast%3DVonder%2BEmbse%26aufirst%3DR.%26aulast%3DHirsch%26aufirst%3DJ.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DBonar%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520PH-797804%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D13%26spage%3D4066%26epage%3D4071%26doi%3D10.1016%2Fj.bmcl.2011.04.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8249</span>– <span class="NLM_lpage">8267</span>, <span class="refDoi"> DOI: 10.1021/jm500973a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500973a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8249-8267&issue=20&author=M.+R.+Finlayauthor=M.+Andertonauthor=S.+Ashtonauthor=P.+Ballardauthor=P.+A.+Bethelauthor=M.+R.+Boxauthor=R.+H.+Bradburyauthor=S.+J.+Brownauthor=S.+Butterworthauthor=A.+Campbellauthor=C.+Chorleyauthor=N.+Colcloughauthor=D.+A.+Crossauthor=G.+S.+Currieauthor=M.+Gristauthor=L.+Hassallauthor=G.+B.+Hillauthor=D.+Jamesauthor=M.+Jamesauthor=P.+Kemmittauthor=T.+Klinowskaauthor=G.+Lamontauthor=S.+G.+Lamontauthor=N.+Martinauthor=H.+L.+McFarlandauthor=M.+J.+Mellorauthor=J.+P.+Ormeauthor=D.+Perkinsauthor=P.+Perkinsauthor=G.+Richmondauthor=P.+Smithauthor=R.+A.+Wardauthor=M.+J.+Waringauthor=D.+Whittakerauthor=S.+Wellsauthor=G.+L.+Wrigley&title=Discovery+of+a+potent+and+selective+EGFR+inhibitor+%28AZD9291%29+of+both+sensitizing+and+T790M+resistance+mutations+that+spares+the+wild+type+form+of+the+receptor&doi=10.1021%2Fjm500973a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor</span></div><div class="casAuthors">Finlay, M. Raymond V.; Anderton, Mark; Ashton, Susan; Ballard, Peter; Bethel, Paul A.; Box, Matthew R.; Bradbury, Robert H.; Brown, Simon J.; Butterworth, Sam; Campbell, Andrew; Chorley, Christopher; Colclough, Nicola; Cross, Darren A. E.; Currie, Gordon S.; Grist, Matthew; Hassall, Lorraine; Hill, George B.; James, Daniel; James, Michael; Kemmitt, Paul; Klinowska, Teresa; Lamont, Gillian; Lamont, Scott G.; Martin, Nathaniel; McFarland, Heather L.; Mellor, Martine J.; Orme, Jonathon P.; Perkins, David; Perkins, Paula; Richmond, Graham; Smith, Peter; Ward, Richard A.; Waring, Michael J.; Whittaker, David; Wells, Stuart; Wrigley, Gail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8249-8267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) inhibitors have been used clin. in the treatment of nonsmall-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) mutations for a no. of years.  Despite encouraging clin. efficacy with these agents, in many patients resistance develops leading to disease progression.  In most cases, this resistance is in the form of the T790M mutation.  In addn., EGFR wild type receptor inhibition inherent with these agents can lead to dose limiting toxicities of rash and diarrhea.  The authors describe herein the evolution of an early, mutant selective lead to the clin. candidate AZD9291 I, an irreversible inhibitor of both EGFR sensitizing (EGFRm+) and T790M resistance mutations with selectivity over the wild type form of the receptor.  Following observations of significant tumor inhibition in preclin. models, the clin. candidate was administered clin. to patients with T790M pos. EGFR-TKI resistant NSCLC and early efficacy has been obsd., accompanied by an encouraging safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouPAWG9N0Ro7Vg90H21EOLACvtfcHk0ljyWE93x6VLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI&md5=db9db624bb4324c2e22b1ab12035263b</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm500973a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500973a%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DAnderton%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%2BR.%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DChorley%26aufirst%3DC.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMcFarland%26aufirst%3DH.%2BL.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DRichmond%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DG.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520EGFR%2520inhibitor%2520%2528AZD9291%2529%2520of%2520both%2520sensitizing%2520and%2520T790M%2520resistance%2520mutations%2520that%2520spares%2520the%2520wild%2520type%2520form%2520of%2520the%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8249%26epage%3D8267%26doi%3D10.1021%2Fjm500973a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson-Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{(3R,4R)-3-[({5-chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a potent, WT sparing, irreversible inhibitor of T790M-containing EGFR mutants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2005</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2005-2024&issue=5&author=H.+Chengauthor=S.+K.+Nairauthor=B.+W.+Murrayauthor=C.+Almadenauthor=S.+Baileyauthor=S.+Baxiauthor=D.+Behennaauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=J.+L.+Fengauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+D.+Hemkensauthor=A.+Jackson-Fisherauthor=M.+Jalaieauthor=T.+O.+Johnsonauthor=R.+S.+Kaniaauthor=S.+Kephartauthor=J.+Lafontaineauthor=B.+Lunneyauthor=K.+K.+Liuauthor=Z.+Liuauthor=J.+Matthewsauthor=A.+Nagataauthor=S.+Niessenauthor=M.+A.+Ornelasauthor=S.+T.+Orrauthor=M.+Pairishauthor=S.+Plankenauthor=S.+Renauthor=D.+Richterauthor=K.+Ryanauthor=N.+Sachauthor=H.+Shenauthor=T.+Smealauthor=J.+Solowiejauthor=S.+Suttonauthor=K.+Tranauthor=E.+Tsengauthor=W.+Vernierauthor=M.+Wallsauthor=S.+Wangauthor=S.+L.+Weinrichauthor=S.+Xinauthor=H.+Xuauthor=M.+J.+Yinauthor=M.+Zientekauthor=R.+Zhouauthor=J.+C.+Kath&title=Discovery+of+1-%7B%283R%2C4R%29-3-%5B%28%7B5-chloro-2-%5B%281-methyl-1H-pyrazol-4-yl%29amino%5D-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%7Doxy%29methyl%5D-4-methoxypyrrolidin-1-yl%7Dprop-2-en-1-one+%28PF-06459988%29%2C+a+potent%2C+WT+sparing%2C+irreversible+inhibitor+of+T790M-containing+EGFR+mutants&doi=10.1021%2Facs.jmedchem.5b01633"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01633%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%2BD.%26aulast%3DJackson-Fisher%26aufirst%3DA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DLafontaine%26aufirst%3DJ.%26aulast%3DLunney%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DK.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DSach%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DW.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%25201-%257B%25283R%252C4R%2529-3-%255B%2528%257B5-chloro-2-%255B%25281-methyl-1H-pyrazol-4-yl%2529amino%255D-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%257Doxy%2529methyl%255D-4-methoxypyrrolidin-1-yl%257Dprop-2-en-1-one%2520%2528PF-06459988%2529%252C%2520a%2520potent%252C%2520WT%2520sparing%252C%2520irreversible%2520inhibitor%2520of%2520T790M-containing%2520EGFR%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D2005%26epage%3D2024%26doi%3D10.1021%2Facs.jmedchem.5b01633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H- purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through structure-based drug design: a high affinity irreversible inhibitor targeting oncogenic EGFR mutants with selectivity over wild-type EGFR</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3002-3019&issue=7&author=S.+Plankenauthor=D.+C.+Behennaauthor=S.+K.+Nairauthor=T.+O.+Johnsonauthor=A.+Nagataauthor=C.+Almadenauthor=S.+Baileyauthor=T.+E.+Ballardauthor=L.+Bernierauthor=H.+Chengauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=J.+G.+Dealauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+Hemkensauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=J.+Matthewsauthor=B.+W.+Murrayauthor=S.+Niessenauthor=S.+T.+Orrauthor=M.+Pairishauthor=N.+W.+Sachauthor=H.+Shenauthor=M.+Shiauthor=J.+Solowiejauthor=K.+Tranauthor=E.+Tsengauthor=P.+Viciniauthor=Y.+Wangauthor=S.+L.+Weinrichauthor=R.+Zhouauthor=M.+Zientekauthor=L.+Liuauthor=Y.+Luoauthor=S.+Xinauthor=C.+Zhangauthor=J.+Lafontaine&title=Discovery+of+N-%28%283R%2C4R%29-4-fluoro-1-%286-%28%283-methoxy-1-methyl-1H-pyrazol-4-yl%29amino%29-9-methyl-9H-+purin-2-yl%29pyrrolidine-3-yl%29acrylamide+%28PF-06747775%29+through+structure-based+drug+design%3A+a+high+affinity+irreversible+inhibitor+targeting+oncogenic+EGFR+mutants+with+selectivity+over+wild-type+EGFR&doi=10.1021%2Facs.jmedchem.6b01894"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%2BC.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLafontaine%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%2528%25283R%252C4R%2529-4-fluoro-1-%25286-%2528%25283-methoxy-1-methyl-1H-pyrazol-4-yl%2529amino%2529-9-methyl-9H-%2520purin-2-yl%2529pyrrolidine-3-yl%2529acrylamide%2520%2528PF-06747775%2529%2520through%2520structure-based%2520drug%2520design%253A%2520a%2520high%2520affinity%2520irreversible%2520inhibitor%2520targeting%2520oncogenic%2520EGFR%2520mutants%2520with%2520selectivity%2520over%2520wild-type%2520EGFR%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D7%26spage%3D3002%26epage%3D3019%26doi%3D10.1021%2Facs.jmedchem.6b01894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7025</span>– <span class="NLM_lpage">7048</span>, <span class="refDoi"> DOI: 10.1021/jm400822z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400822z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7025-7048&issue=17&author=R.+A.+Wardauthor=M.+J.+Andertonauthor=S.+Ashtonauthor=P.+A.+Bethelauthor=M.+Boxauthor=S.+Butterworthauthor=N.+Colcloughauthor=C.+G.+Chorleyauthor=C.+Chuaquiauthor=D.+A.+Crossauthor=L.+A.+Dakinauthor=J.+E.+Debreczeniauthor=C.+Eberleinauthor=M.+R.+Finlayauthor=G.+B.+Hillauthor=M.+Gristauthor=T.+C.+Klinowskaauthor=C.+Laneauthor=S.+Martinauthor=J.+P.+Ormeauthor=P.+Smithauthor=F.+Wangauthor=M.+J.+Waring&title=Structure-+and+reactivity-based+development+of+covalent+inhibitors+of+the+activating+and+gatekeeper+mutant+forms+of+the+epidermal+growth+factor+receptor+%28EGFR%29&doi=10.1021%2Fjm400822z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm400822z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400822z%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DChorley%26aufirst%3DC.%2BG.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DKlinowska%26aufirst%3DT.%2BC.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DStructure-%2520and%2520reactivity-based%2520development%2520of%2520covalent%2520inhibitors%2520of%2520the%2520activating%2520and%2520gatekeeper%2520mutant%2520forms%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D17%26spage%3D7025%26epage%3D7048%26doi%3D10.1021%2Fjm400822z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kifle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Navigating the kinome</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1038/nchembio.530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21336281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=200-202&issue=4&author=J.+T.+Metzauthor=E.+F.+Johnsonauthor=N.+B.+Soniauthor=P.+J.+Mertaauthor=L.+Kifleauthor=P.+J.+Hajduk&title=Navigating+the+kinome&doi=10.1038%2Fnchembio.530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the kinome</span></div><div class="casAuthors">Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-202</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biol. and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacol.-dependent networks.  Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacol. parameters derived from activity profiling data.  The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is crit. for multitargeted drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgzF9Q0eH87Vg90H21EOLACvtfcHk0lg8hn1xPUh3Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D&md5=09234ec451a4918e5aca6d65e0b65aee</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.530%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DNavigating%2520the%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D4%26spage%3D200%26epage%3D202%26doi%3D10.1038%2Fnchembio.530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazear, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide map of targets of T790M-EGFR-directed covalent inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1400</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chembiol.2017.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28965727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOrtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1388-1400&issue=11&author=S.+Niessenauthor=M.+M.+Dixauthor=S.+Barbasauthor=Z.+E.+Potterauthor=S.+Luauthor=O.+Brodskyauthor=S.+Plankenauthor=D.+Behennaauthor=C.+Almadenauthor=K.+S.+Gajiwalaauthor=K.+Ryanauthor=R.+Ferreauthor=M.+R.+Lazearauthor=M.+M.+Haywardauthor=J.+C.+Kathauthor=B.+F.+Cravatt&title=Proteome-wide+map+of+targets+of+T790M-EGFR-directed+covalent+inhibitors&doi=10.1016%2Fj.chembiol.2017.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">proteome-wide map of targets of t790m-egfr-directed covalent inhibitors</span></div><div class="casAuthors">Niessen, Sherry; Dix, Melissa M.; Barbas, Sabrina; Potter, Zachary E.; Lu, Shuyan; Brodsky, Oleg; Planken, Simon; Behenna, Douglas; Almaden, Chau; Gajiwala, Ketan S.; Ryan, Kevin; Ferre, RoseAnn; Lazear, Michael R.; Hayward, Matthew M.; Kath, John C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1388-1400.e7</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Patients with non-small cell lung cancers that have kinase-activating epidermal growth factor receptor (EGFR) mutations are highly responsive to first- and second-generation EGFR inhibitors.  However, these patients often relapse due to a secondary, drug-resistant mutation in EGFR whereby the gatekeeper threonine is converted to methionine (T790M).  Several third-generation EGFR inhibitors have been developed that irreversibly inactivate T790M-EGFR while sparing wild-type EGFR, thus reducing epithelium-based toxicities.  Using chem. proteomics, we show here that individual T790M-EGFR inhibitors exhibit strikingly distinct off-target profiles in human cells.  The FDA-approved drug osimertinib (AZD9291), in particular, was found to covalently modify cathepsins in cell and animal models, which correlated with lysosomal accumulation of the drug.  Our findings thus show how chem. proteomics can be used to differentiate covalent kinase inhibitors based on global selectivity profiles in living systems and identify specific off-targets of these inhibitors that may affect drug activity and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP837IUk45tLVg90H21EOLACvtfcHk0lhYPZiQtqJ3Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOrtrnL&md5=dc2db6d29932ffdb991027ba272bd149</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DDix%26aufirst%3DM.%2BM.%26aulast%3DBarbas%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DZ.%2BE.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DBrodsky%26aufirst%3DO.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DLazear%26aufirst%3DM.%2BR.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520map%2520of%2520targets%2520of%2520T790M-EGFR-directed%2520covalent%2520inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26issue%3D11%26spage%3D1388%26epage%3D1400%26doi%3D10.1016%2Fj.chembiol.2017.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lelais, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilje, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anumolu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michellys, P. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R,E)-N-(7-chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imid azol-2-yl)-2-methylisonicotinamide (EGF816), a novel, potent, and WT sparing covalent inhibitor of oncogenic (L858R, ex19del) and resistant (T790M) EGFR mutants for the treatment of EGFR mutant non-small-cell lung cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6671</span>– <span class="NLM_lpage">6689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01985</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01985" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6671-6689&issue=14&author=G.+Lelaisauthor=R.+Eppleauthor=T.+H.+Marsiljeauthor=Y.+O.+Longauthor=M.+McNeillauthor=B.+Chenauthor=W.+Luauthor=J.+Anumoluauthor=S.+Badigerauthor=B.+Bursulayaauthor=M.+DiDonatoauthor=R.+Fongauthor=J.+Juarezauthor=J.+Liauthor=M.+Manuiaauthor=D.+E.+Masonauthor=P.+Gordonauthor=T.+Groesslauthor=K.+Johnsonauthor=Y.+Jiaauthor=S.+Kasibhatlaauthor=C.+Liauthor=J.+Isbellauthor=G.+Spraggonauthor=S.+Benderauthor=P.+Y.+Michellys&title=Discovery+of+%28R%2CE%29-N-%287-chloro-1-%281-%5B4-%28dimethylamino%29but-2-enoyl%5Dazepan-3-yl%29-1H-benzo%5Bd%5Dimid+azol-2-yl%29-2-methylisonicotinamide+%28EGF816%29%2C+a+novel%2C+potent%2C+and+WT+sparing+covalent+inhibitor+of+oncogenic+%28L858R%2C+ex19del%29+and+resistant+%28T790M%29+EGFR+mutants+for+the+treatment+of+EGFR+mutant+non-small-cell+lung+cancers&doi=10.1021%2Facs.jmedchem.5b01985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers</span></div><div class="casAuthors">Lelais, Gerald; Epple, Robert; Marsilje, Thomas H.; Long, Yun O.; McNeill, Matthew; Chen, Bei; Lu, Wenshuo; Anumolu, Jaganmohan; Badiger, Sangamesh; Bursulaya, Badry; DiDonato, Michael; Fong, Rina; Juarez, Jose; Li, Jie; Manuia, Mari; Mason, Daniel E.; Gordon, Perry; Groessl, Todd; Johnson, Kevin; Jia, Yong; Kasibhatla, Shailaja; Li, Chun; Isbell, John; Spraggon, Glen; Bender, Steven; Michellys, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6671-6689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past decade, first and second generation EGFR inhibitors have significantly improved outcomes for lung cancer patients with activating mutations in EGFR.  However, both resistance through a secondary T790M mutation at the gatekeeper residue and dose-limiting toxicities from wild-type (WT) EGFR inhibition ultimately limit the full potential of these therapies to control mutant EGFR-driven tumors and new therapies are urgently needed.  Herein, we describe our approach toward the discovery of 47 (EGF816, nazartinib), a novel, covalent mutant-selective EGFR inhibitor with equipotent activity on both oncogenic and T790M-resistant EGFR mutations.  Through mol. docking studies we converted a mutant-selective high-throughput screening hit (7) into a no. of targeted covalent EGFR inhibitors with equipotent activity across mutants EGFR and good WT-EGFR selectivity.  We used an abbreviated in vivo efficacy study for prioritizing compds. with good tolerability and efficacy that ultimately led to the selection of 47 as the clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpcKsqbwkyp7Vg90H21EOLACvtfcHk0ljMdffPTwPfhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgu77P&md5=c106545d878ab3d675644b47099668a0</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DMcNeill%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAnumolu%26aufirst%3DJ.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJuarez%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DManuia%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DDiscovery%2520of%2520%2528R%252CE%2529-N-%25287-chloro-1-%25281-%255B4-%2528dimethylamino%2529but-2-enoyl%255Dazepan-3-yl%2529-1H-benzo%255Bd%255Dimid%2520azol-2-yl%2529-2-methylisonicotinamide%2520%2528EGF816%2529%252C%2520a%2520novel%252C%2520potent%252C%2520and%2520WT%2520sparing%2520covalent%2520inhibitor%2520of%2520oncogenic%2520%2528L858R%252C%2520ex19del%2529%2520and%2520resistant%2520%2528T790M%2529%2520EGFR%2520mutants%2520for%2520the%2520treatment%2520of%2520EGFR%2520mutant%2520non-small-cell%2520lung%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D14%26spage%3D6671%26epage%3D6689%26doi%3D10.1021%2Facs.jmedchem.5b01985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dela Vega, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lainchbury, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of a noncovalent, mutant-selective epidermal growth factor receptor inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9080</span>– <span class="NLM_lpage">9093</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWlsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9080-9093&issue=19&author=B.+K.+Chanauthor=E.+J.+Hananauthor=K.+K.+Bowmanauthor=M.+C.+Bryanauthor=D.+Burdickauthor=E.+Chanauthor=Y.+Chenauthor=S.+Clausenauthor=T.+Dela+Vegaauthor=J.+Dotsonauthor=C.+Eigenbrotauthor=R.+L.+Elliottauthor=R.+A.+Healdauthor=P.+S.+Jacksonauthor=J.+D.+Knightauthor=H.+Laauthor=M.+D.+Lainchburyauthor=S.+Malekauthor=H.+E.+Purkeyauthor=G.+Schaeferauthor=S.+Schmidtauthor=E.+M.+Sewardauthor=S.+Siderisauthor=L.+Shaoauthor=S.+Wangauthor=S.+K.+Yeapauthor=I.+Yenauthor=C.+Yuauthor=T.+P.+Heffron&title=Discovery+of+a+noncovalent%2C+mutant-selective+epidermal+growth+factor+receptor+inhibitor&doi=10.1021%2Facs.jmedchem.6b00995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Chan, Bryan K.; Hanan, Emily J.; Bowman, Krista K.; Bryan, Marian C.; Burdick, Daniel; Chan, Emily; Chen, Yuan; Clausen, Saundra; Dela Vega, Trisha; Dotson, Jennafer; Eigenbrot, Charles; Elliott, Richard L.; Heald, Robert A.; Jackson, Philip S.; Knight, Jamie D.; La, Hank; Lainchbury, Michael D.; Malek, Shiva; Purkey, Hans E.; Schaefer, Gabriele; Schmidt, Stephen; Seward, Eileen M.; Sideris, Steve; Shao, Lily; Wang, Shumei; Yeap, Siew Kuen; Yen, Ivana; Yu, Christine; Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9080-9093</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors targeting the activating mutants of the epidermal growth factor receptor (EGFR) have found success in the treatment of EGFR mutant pos. nonsmall-cell lung cancer.  A secondary point mutation (T790M) in the inhibitor binding site has been linked to the acquired resistance against those first generation therapeutics.  Herein, the authors describe the lead optimization of a series of reversible, pan-mutant (L858R, del746-750, T790M/L858R, and T790M/del746-750) EGFR inhibitors.  By use of a noncovalent double mutant (T790M/L858R and T790M/del746-750) selective EGFR inhibitor I as a starting point, activities against the single mutants (L858R and del746-750) were introduced through a series of structure-guided modifications.  The in vitro ADME-PK properties of the lead mols. were further optimized through a no. of rational structural changes.  The resulting inhibitor II exhibited excellent cellular activity against both the single and double mutants of EGFR, demonstrating target engagement in vivo and ADME-PK properties that are suitable for further evaluation.  The reversible, noncovalent inhibitors described complement the covalent pan-mutant EGFR inhibitors that have shown encouraging results in recent clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSFhbM4LOYrVg90H21EOLACvtfcHk0lh7mNaAhGyB7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWlsbnL&md5=7b17fcf5fc401843821445cf6e6e9f0b</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00995%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DClausen%26aufirst%3DS.%26aulast%3DDela%2BVega%26aufirst%3DT.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DKnight%26aufirst%3DJ.%2BD.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLainchbury%26aufirst%3DM.%2BD.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DSchaefer%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYeap%26aufirst%3DS.%2BK.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520noncovalent%252C%2520mutant-selective%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9080%26epage%3D9093%26doi%3D10.1021%2Facs.jmedchem.6b00995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eYMdNvT9az4Tbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization and discovery of 5-((5-([1,1′-biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzozic acid (MK-3903): a novel class of benzimidazole-based activators of AMP-activated protein kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9040</span>– <span class="NLM_lpage">9052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9040-9052&issue=21&author=P.+Lanauthor=F.+A.+Romeroauthor=D.+Wodkaauthor=A.+J.+Kassickauthor=Q.+Dangauthor=T.+Gibsonauthor=D.+Cashionauthor=G.+Zhouauthor=Y.+Chenauthor=X.+Zhangauthor=A.+Zhangauthor=Y.+Liauthor=M.+E.+Trujilloauthor=Q.+Shaoauthor=M.+Wuauthor=S.+Xuauthor=H.+Heauthor=D.+MacKennaauthor=J.+Stauntonauthor=K.+T.+Chapmanauthor=A.+Weberauthor=I.+K.+Sebhatauthor=G.+M.+Makara&title=Hit-to-lead+optimization+and+discovery+of+5-%28%285-%28%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29-6-chloro-1H-benzo%5Bd%5Dimidazol-2-yl%29oxy%29-2-methylbenzozic+acid+%28MK-3903%29%3A+a+novel+class+of+benzimidazole-based+activators+of+AMP-activated+protein+kinase&doi=10.1021%2Facs.jmedchem.7b01344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01344%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DP.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DMacKenna%26aufirst%3DD.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DHit-to-lead%2520optimization%2520and%2520discovery%2520of%25205-%2528%25285-%2528%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529-6-chloro-1H-benzo%255Bd%255Dimidazol-2-yl%2529oxy%2529-2-methylbenzozic%2520acid%2520%2528MK-3903%2529%253A%2520a%2520novel%2520class%2520of%2520benzimidazole-based%2520activators%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D21%26spage%3D9040%26epage%3D9052%26doi%3D10.1021%2Facs.jmedchem.7b01344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kekec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dropinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8722: A systemic, direct pan-activator of AMP-activated protein kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=39-44&issue=1&author=D.+Fengauthor=T.+Biftuauthor=F.+A.+Romeroauthor=A.+Kekecauthor=J.+Dropinskiauthor=A.+Kassickauthor=S.+Xuauthor=M.+M.+Kurtzauthor=A.+Gollapudiauthor=Q.+Shaoauthor=X.+Yangauthor=K.+Luauthor=G.+Zhouauthor=D.+Kempauthor=R.+W.+Myersauthor=H.-P.+Guanauthor=M.+E.+Trujilloauthor=C.+Liauthor=A.+Weberauthor=I.+K.+Sebhat&title=Discovery+of+MK-8722%3A+A+systemic%2C+direct+pan-activator+of+AMP-activated+protein+kinase&doi=10.1021%2Facsmedchemlett.7b00417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00417%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DKekec%26aufirst%3DA.%26aulast%3DDropinski%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DKemp%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.-P.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DDiscovery%2520of%2520MK-8722%253A%2520A%2520systemic%252C%2520direct%2520pan-activator%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D39%26epage%3D44%26doi%3D10.1021%2Facsmedchemlett.7b00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahalada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Trotter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conarello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Painter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohm, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFranco Scheuch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">6350</span>),  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1126/science.aah5582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.aah5582" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=507-511&issue=6350&author=R.+W.+Myersauthor=H.+P.+Guanauthor=J.+Ehrhartauthor=A.+Petrovauthor=S.+Prahaladaauthor=E.+Tozzoauthor=X.+Yangauthor=M.+M.+Kurtzauthor=M.+Trujilloauthor=D.+Gonzalez+Trotterauthor=D.+Fengauthor=S.+Xuauthor=G.+Eiermannauthor=M.+A.+Holahanauthor=D.+Rubinsauthor=S.+Conarelloauthor=X.+Niuauthor=S.+C.+Souzaauthor=C.+Millerauthor=J.+Liuauthor=K.+Luauthor=W.+Fengauthor=Y.+Liauthor=R.+E.+Painterauthor=J.+A.+Milliganauthor=H.+Heauthor=F.+Liuauthor=A.+Ogawaauthor=D.+Wisniewskiauthor=R.+J.+Rohmauthor=L.+Wangauthor=M.+Bunzelauthor=Y.+Qianauthor=W.+Zhuauthor=H.+Wangauthor=B.+Bennetauthor=L.+LaFranco+Scheuchauthor=G.+E.+Fernandezauthor=C.+Liauthor=M.+Klimasauthor=G.+Zhouauthor=M.+van+Heekauthor=T.+Biftuauthor=A.+Weberauthor=D.+E.+Kelleyauthor=N.+Thornberryauthor=M.+D.+Erionauthor=D.+M.+Kempauthor=I.+K.+Sebhat&title=Systemic+pan-AMPK+activator+MK-8722+improves+glucose+homeostasis+but+induces+cardiac+hypertrophy&doi=10.1126%2Fscience.aah5582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5582%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DPrahalada%26aufirst%3DS.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DGonzalez%2BTrotter%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DRubins%26aufirst%3DD.%26aulast%3DConarello%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DSouza%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPainter%26aufirst%3DR.%2BE.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DRohm%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBunzel%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBennet%26aufirst%3DB.%26aulast%3DLaFranco%2BScheuch%26aufirst%3DL.%26aulast%3DFernandez%26aufirst%3DG.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DKlimas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DKemp%26aufirst%3DD.%2BM.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DSystemic%2520pan-AMPK%2520activator%2520MK-8722%2520improves%2520glucose%2520homeostasis%2520but%2520induces%2520cardiac%2520hypertrophy%26jtitle%3DScience%26date%3D2017%26volume%3D357%26issue%3D6350%26spage%3D507%26epage%3D511%26doi%3D10.1126%2Fscience.aah5582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&issue=17&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0lhfD4WZpQGdRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D17%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van De Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/jm000407e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&issue=9&author=H.+van+De+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics&doi=10.1021%2Fjm000407e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0ljqzW2sqf0PoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D9%26spage%3D1313%26epage%3D1333%26doi%3D10.1021%2Fjm000407e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span> <span> </span><span class="NLM_article-title">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1596</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27319293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaht73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1596-1608&issue=10&author=J.+G.+Kettleauthor=D.+M.+Wilson&title=Standing+on+the+shoulders+of+giants%3A+a+retrospective+analysis+of+kinase+drug+discovery+at+AstraZeneca&doi=10.1016%2Fj.drudis.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca</span></div><div class="casAuthors">Kettle, Jason G.; Wilson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1596-1608</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sir James Black famously said: 'The most fruitful basis of the discovery of a new drug is to start with an old drug', and this idea has featured in a significant no. of kinase drug discovery programs at AstraZeneca over the past two decades.  Of the marketed kinase inhibitors and various clin. trialled agents, candidate drugs and multiple lead optimization programs delivered over this timeframe at AstraZeneca the overwhelming majority trace their origins back to a small handful of pioneering drug discovery programs.  Importantly, these projects not only laid the foundations of the organisational expertise on how to 'drug' this important target family but also provided a legacy of internal chem. equity that has had a profound influence on the many kinase-focused discovery efforts that have followed.  For agents in late-stage clin. trials today, seemingly the product of rapid discovery phases, the reality is that these are often the products of decades of research.  Crucial to the success of these projects has been the medicinal chemists involved, whose intimate knowledge and expertise around key kinase chem. scaffolds has enabled successful medicinal chem. strategies to be rapidly identified and executed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Iydy47cfvrVg90H21EOLACvtfcHk0ljqzW2sqf0PoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaht73F&md5=487d15ce496bce584f50d0d0fe1543d9</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3DStanding%2520on%2520the%2520shoulders%2520of%2520giants%253A%2520a%2520retrospective%2520analysis%2520of%2520kinase%2520drug%2520discovery%2520at%2520AstraZeneca%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1596%26epage%3D1608%26doi%3D10.1016%2Fj.drudis.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserű, G. M.</span></span> <span> </span><span class="NLM_article-title">Contributions of molecular properties to drug promiscuity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1795</span>, <span class="refDoi"> DOI: 10.1021/jm301514n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301514n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1789-1795&issue=5&author=%C3%81.+Tarcsayauthor=G.+M.+Keser%C5%B1&title=Contributions+of+molecular+properties+to+drug+promiscuity&doi=10.1021%2Fjm301514n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of Molecular Properties to Drug Promiscuity</span></div><div class="casAuthors">Tarcsay, Akos; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In contrast to designed polypharmacol. that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicol.  Characterization of promiscuous compds. enhances the understanding of complex interaction patterns and aids the design of compds. with broader selectivity against off-targets that has a major impact on medicinal chem. outcome.  In this Miniperspective we provide insights to the effect of physicochem. parameters on promiscuity.  Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochem. properties and promiscuity in detail.  In light of these data, lipophilicity and basic character have the highest influence.  On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochem. properties during medicinal chem. optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1J_jqkK3DrVg90H21EOLACvtfcHk0lj0ID9eLnSL2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D&md5=c5763ee1aed897ff19e5a2344b95b9c1</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Fjm301514n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301514n%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3D%25C3%2581.%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26atitle%3DContributions%2520of%2520molecular%2520properties%2520to%2520drug%2520promiscuity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D5%26spage%3D1789%26epage%3D1795%26doi%3D10.1021%2Fjm301514n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Curing hepatitis C virus infection with direct-acting antiviral agents: the arc of a medicinal chemistry triumph</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7311</span>– <span class="NLM_lpage">7351</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7311-7351&issue=16&author=N.+A.+Meanwell&title=Curing+hepatitis+C+virus+infection+with+direct-acting+antiviral+agents%3A+the+arc+of+a+medicinal+chemistry+triumph&doi=10.1021%2Facs.jmedchem.6b00915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DCuring%2520hepatitis%2520C%2520virus%2520infection%2520with%2520direct-acting%2520antiviral%2520agents%253A%2520the%2520arc%2520of%2520a%2520medicinal%2520chemistry%2520triumph%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D16%26spage%3D7311%26epage%3D7351%26doi%3D10.1021%2Facs.jmedchem.6b00915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanowich-Knipp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6074</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm060325b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&issue=20&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.+C.+Chengauthor=Y.+Hsiehauthor=J.+M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-+3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection&doi=10.1021%2Fjm060325b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.%2BM.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-%25203-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D20%26spage%3D6074%26epage%3D6086%26doi%3D10.1021%2Fjm060325b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, P.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1038/nbt.2020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnbt.2020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=993-1003&issue=11&author=A.+D.+Kwongauthor=R.+S.+Kauffmanauthor=P.+Hurterauthor=P.+Mueller&title=Discovery+and+development+of+telaprevir%3A+an+NS3-4A+protease+inhibitor+for+treating+genotype+1+chronic+hepatitis+C+virus&doi=10.1038%2Fnbt.2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2020%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DHurter%26aufirst%3DP.%26aulast%3DMueller%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520telaprevir%253A%2520an%2520NS3-4A%2520protease%2520inhibitor%2520for%2520treating%2520genotype%25201%2520chronic%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D993%26epage%3D1003%26doi%3D10.1038%2Fnbt.2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1356</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1002/anie.200390347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&issue=12&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection&doi=10.1002%2Fanie.200390347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26issue%3D12%26spage%3D1356%26epage%3D1360%26doi%3D10.1002%2Fanie.200390347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand-Maitre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapeyre-Paquette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheaume, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1021/jm0342414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&issue=7&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.+M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure-activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061&doi=10.1021%2Fjm0342414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure-activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1605%26epage%3D1608%26doi%3D10.1021%2Fjm0342414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1021/ja711120r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&issue=14&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.+S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.+L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease&doi=10.1021%2Fja711120r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26issue%3D14%26spage%3D4607%26epage%3D4609%26doi%3D10.1021%2Fja711120r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-1220: A macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1021/ml1002426</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&issue=3&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+A+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure&doi=10.1021%2Fml1002426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520A%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D3%26spage%3D207%26epage%3D212%26doi%3D10.1021%2Fml1002426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1021/jm9015526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&issue=6&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.+S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fjm9015526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2443%26epage%3D2463%26doi%3D10.1021%2Fjm9015526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFilippo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1021/ml300017p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&issue=4&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fml300017p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lg5KuujBpwm_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D4%26spage%3D332%26epage%3D336%26doi%3D10.1021%2Fml300017p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bisceglie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamm, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krefetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E.</span></span> <span> </span><span class="NLM_article-title">GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study</span>. <i>J. Viral Hepat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1111/jvh.12527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fjvh.12527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26957110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOkurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=614-622&issue=8&author=M.+Rodriguez-Torresauthor=S.+Glassauthor=J.+Hillauthor=B.+Freilichauthor=D.+Hassmanauthor=A.+M.+Di+Bisceglieauthor=J.+G.+Taylorauthor=B.+J.+Kirbyauthor=H.+Dvory-Sobolauthor=J.+C.+Yangauthor=D.+Anauthor=L.+M.+Stammauthor=D.+M.+Brainardauthor=S.+Kimauthor=D.+Krefetzauthor=W.+Smithauthor=T.+Marburyauthor=E.+Lawitz&title=GS-9857+in+patients+with+chronic+hepatitis+C+virus+genotype+1-4+infection%3A+a+randomized%2C+double-blind%2C+dose-ranging+phase+1+study&doi=10.1111%2Fjvh.12527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study</span></div><div class="casAuthors">Rodriguez-Torres, M.; Glass, S.; Hill, J.; Freilich, B.; Hassman, D.; Di Bisceglie, A. M.; Taylor, J. G.; Kirby, B. J.; Dvory-Sobol, H.; Yang, J. C.; An, D.; Stamm, L. M.; Brainard, D. M.; Kim, S.; Krefetz, D.; Smith, W.; Marbury, T.; Lawitz, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Viral Hepatitis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-622</span>CODEN:
                <span class="NLM_cas:coden">JVHEER</span>;
        ISSN:<span class="NLM_cas:issn">1365-2893</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Summary : GS-9857, an inhibitor of the hepatitis C virus (HCV) nonstructural protein (NS) 3/4A, demonstrates potent activity against HCV genotypes 1-6 and improved coverage against commonly encountered NS3 resistance-assocd. variants (RAVs).  In this study, the safety, tolerability, antiviral activity and pharmacokinetics (PK) of GS-9857 were evaluated in patients with chronic HCV genotype 1-4 infection.  Patients with genotype 1-4 infection received placebo or once-daily GS-9857 at doses ranging from 50 to 300 mg for 3 days under fasting conditions.  GS-9857 was well tolerated; all reported adverse events (AEs) were mild or moderate in severity.  Diarrhoea and headache were the most commonly reported AEs.  Grade 3 or 4 lab. abnormalities were obsd. in 17% of patients receiving GS-9857; there were no Grade 3 or 4 abnormalities in alanine aminotransferase, aspartate aminotransferase or alk. phosphatase levels.  GS-9857 demonstrated potent antiviral activity in patients with chronic HCV infection, achieving mean and median max. redns. in HCV RNA of ≥3 log10 IU/mL following administration of a 100-mg dose in patients with HCV genotype 1a, 1b, 2, 3 or 4 infection.  The antiviral activity of GS-9857 was unaffected by the presence of pretreatment NS3 RAVs.  In patients with genotype 1-4 infection, GS-9857 exhibited linear PK and was assocd. with a median half-life of 29-42 h, supporting once-daily dosing.  Thus, the tolerability, efficacy and pharmacokinetic profile of GS-9857 support its further evaluation for treatment of patients with chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8oJDwl-bOdbVg90H21EOLACvtfcHk0lgnMI7vZhK9cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOkurbK&md5=257769b545cb4289b8f9fc5298454f91</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Fjvh.12527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjvh.12527%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DGlass%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DFreilich%26aufirst%3DB.%26aulast%3DHassman%26aufirst%3DD.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DKirby%26aufirst%3DB.%2BJ.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DAn%26aufirst%3DD.%26aulast%3DStamm%26aufirst%3DL.%2BM.%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKrefetz%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DW.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLawitz%26aufirst%3DE.%26atitle%3DGS-9857%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520virus%2520genotype%25201-4%2520infection%253A%2520a%2520randomized%252C%2520double-blind%252C%2520dose-ranging%2520phase%25201%2520study%26jtitle%3DJ.%2520Viral%2520Hepat.%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3D614%26epage%3D622%26doi%3D10.1111%2Fjvh.12527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span> <span> </span><span class="NLM_article-title">P0899: Preclinical profile of the pan-genotypic HCV NS3/4A protease inhibitor GS-9857</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">S681</span>, <span class="refDoi"> DOI: 10.1016/S0168-8278(15)31102-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0168-8278%2815%2931102-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=S681&author=J.%0AG.+Taylorauthor=T.+Applebyauthor=O.+Barauskasauthor=X.+Chenauthor=H.+Dvory-Sobolauthor=R.+Gongauthor=J.+Leeauthor=E.+Nejatiauthor=B.+Schultzauthor=Y.+Wangauthor=C.+Yangauthor=M.+Yuauthor=S.+Zipfelauthor=K.+Chan&title=P0899%3A+Preclinical+profile+of+the+pan-genotypic+HCV+NS3%2F4A+protease+inhibitor+GS-9857&doi=10.1016%2FS0168-8278%2815%2931102-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2815%2931102-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252815%252931102-8%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DAppleby%26aufirst%3DT.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNejati%26aufirst%3DE.%26aulast%3DSchultz%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZipfel%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DK.%26atitle%3DP0899%253A%2520Preclinical%2520profile%2520of%2520the%2520pan-genotypic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520GS-9857%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D62%26spage%3DS681%26doi%3D10.1016%2FS0168-8278%2815%2931102-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Riordan, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asatryan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilich, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overcash, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, J.</span></span> <span> </span><span class="NLM_article-title">Potent antiviral activities of the direct-acting antivirals ABT-493 and ABT-530 with three-day monotherapy for hepatitis C virus genotype 1 infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1128/AAC.02264-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02264-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1546-1555&issue=3&author=E.+J.+Lawitzauthor=W.+D.+O%E2%80%99Riordanauthor=A.+Asatryanauthor=B.+L.+Freilichauthor=T.+D.+Boxauthor=J.+S.+Overcashauthor=S.+Lovellauthor=T.+I.+Ngauthor=W.+Liuauthor=A.+Campbellauthor=C.+W.+Linauthor=B.+Yaoauthor=J.+Kort&title=Potent+antiviral+activities+of+the+direct-acting+antivirals+ABT-493+and+ABT-530+with+three-day+monotherapy+for+hepatitis+C+virus+genotype+1+infection&doi=10.1128%2FAAC.02264-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1128%2FAAC.02264-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02264-15%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DW.%2BD.%26aulast%3DAsatryan%26aufirst%3DA.%26aulast%3DFreilich%26aufirst%3DB.%2BL.%26aulast%3DBox%26aufirst%3DT.%2BD.%26aulast%3DOvercash%26aufirst%3DJ.%2BS.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DKort%26aufirst%3DJ.%26atitle%3DPotent%2520antiviral%2520activities%2520of%2520the%2520direct-acting%2520antivirals%2520ABT-493%2520and%2520ABT-530%2520with%2520three-day%2520monotherapy%2520for%2520hepatitis%2520C%2520virus%2520genotype%25201%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D3%26spage%3D1546%26epage%3D1555%26doi%3D10.1128%2FAAC.02264-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmeijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumont-Mauviel, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1021/jm401507s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401507s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1673-1693&issue=5&author=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+O.+Johanssonauthor=M.+D.+Cummingsauthor=O.+Lenzauthor=P.+Raboissonauthor=K.+Simmenauthor=S.+Vendevilleauthor=H.+de+Kockauthor=M.+Nilssonauthor=A.+Horvathauthor=R.+Kalmeijerauthor=G.+de+la+Rosaauthor=M.+Beumont-Mauviel&title=Discovery+and+development+of+simeprevir+%28TMC435%29%2C+a+HCV+NS3%2F4A+protease+inhibitor&doi=10.1021%2Fjm401507s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor</span></div><div class="casAuthors">Rosenquist, Aasa; Samuelsson, Bertil; Johansson, Per-Ola; Cummings, Maxwell D.; Lenz, Oliver; Raboisson, Pierre; Simmen, Kenny; Vendeville, Sandrine; de Kock, Herman; Nilsson, Magnus; Horvath, Andras; Kalmeijer, Ronald; de la Rosa, Guy; Beumont-Mauviel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1673-1693</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus is a blood-borne infection and the leading cause of chronic liver disease (including cirrhosis and cancer) and liver transplantation.  Since the identification of HCV in 1989, there has been an extensive effort to identify and improve treatment options.  An important milestone was reached in 2011 with the approval of the first-generation HCV NS3/4A protease inhibitors.  However, new therapies are needed to improve cure rates, shorten treatment duration, and improve tolerability.  Here we summarize the extensive medicinal chem. effort to develop novel P2 cyclopentane macrocyclic inhibitors guided by HCV NS3 protease assays, the cellular replicon system, structure-based design, and a panel of DMPK assays.  The selection of compd. 29 (simeprevir, TMC435) as clin. candidate was based on its excellent biol., PK, and safety pharmacol. profile.  Compd. 29 has recently been approved for treatment of chronic HCV infection in combination with pegylated interferon-α and ribavirin in Japan, Canada, and USA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCRg3NRRjzrVg90H21EOLACvtfcHk0lg3E_UCnkvl2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D&md5=fd9c1df095e47a111d9680af4c40ccc6</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Fjm401507s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401507s%26sid%3Dliteratum%253Aachs%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DP.%2BO.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DKalmeijer%26aufirst%3DR.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DG.%26aulast%3DBeumont-Mauviel%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520simeprevir%2520%2528TMC435%2529%252C%2520a%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D1673%26epage%3D1693%26doi%3D10.1021%2Fjm401507s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaultier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pithawalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Or, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1128/AAC.04227-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.04227-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=988-997&issue=2&author=T.+Pilot-Matiasauthor=R.+Tripathiauthor=D.+Cohenauthor=I.+Gaultierauthor=T.+Dekhtyarauthor=L.+Luauthor=T.+Reischauthor=M.+Irvinauthor=T.+Hopkinsauthor=R.+Pithawallaauthor=T.+Middletonauthor=T.+Ngauthor=K.+McDanielauthor=Y.+S.+Orauthor=R.+Menonauthor=D.+Kempfauthor=A.+Mollaauthor=C.+Collins&title=In+vitro+and+in+vivo+antiviral+activity+and+resistance+profile+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ABT-450&doi=10.1128%2FAAC.04227-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1128%2FAAC.04227-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04227-14%26sid%3Dliteratum%253Aachs%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DGaultier%26aufirst%3DI.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DHopkins%26aufirst%3DT.%26aulast%3DPithawalla%26aufirst%3DR.%26aulast%3DMiddleton%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DT.%26aulast%3DMcDaniel%26aufirst%3DK.%26aulast%3DOr%26aufirst%3DY.%2BS.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DKempf%26aufirst%3DD.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ABT-450%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D988%26epage%3D997%26doi%3D10.1128%2FAAC.04227-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/jm400887j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&issue=2&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+what+can+medicinal+chemists+learn+from+their+properties%3F&doi=10.1021%2Fjm400887j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?</span></div><div class="casAuthors">Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles are ideal in efforts to tackle difficult targets, but our understanding of what makes them cell permeable and orally bioavailable is limited.  Anal. of approx. 100 macrocyclic drugs and clin. candidates revealed that macrocycles are predominantly used for infectious disease and in oncol. and that most belong to the macrolide or cyclic peptide class.  A significant no. (N = 34) of these macrocycles are administered orally, revealing that oral bioavailability can be obtained at mol. wts. up to and above 1 kDa and polar surface areas ranging toward 250 Å2.  Moreover, insight from a group of de novo designed oral macrocycles in clin. studies and understanding of how cyclosporin A and model cyclic hexapeptides cross cell membranes may unlock wider opportunities in drug discovery.  However, the no. of oral macrocycles is still low and it remains to be seen if they are outliers or if macrocycles will open up novel oral druggable space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaeM2DXwvmiLVg90H21EOLACvtfcHk0ljQLioGBvsHxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI&md5=a3e1743bd5ba34f73d8e78f8cb1bee5f</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520what%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D2%26spage%3D278%26epage%3D295%26doi%3D10.1021%2Fjm400887j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockus, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lexa, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hund, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Probing the physicochemical boundaries of cell permeability and oral bioavailability in lipophilic macrocycles inspired by natural products</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4581</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvV2ku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4581-4589&issue=11&author=A.+T.+Bockusauthor=K.+W.+Lexaauthor=C.+R.+Pyeauthor=A.+S.+Kalgutkarauthor=J.+W.+Gardnerauthor=K.+C.+Hundauthor=W.+M.+Hewittauthor=J.+A.+Schwochertauthor=E.+Glasseyauthor=D.+A.+Priceauthor=A.+M.+Mathiowetzauthor=S.+Lirasauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Probing+the+physicochemical+boundaries+of+cell+permeability+and+oral+bioavailability+in+lipophilic+macrocycles+inspired+by+natural+products&doi=10.1021%2Facs.jmedchem.5b00128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products</span></div><div class="casAuthors">Bockus, Andrew T.; Lexa, Katrina W.; Pye, Cameron R.; Kalgutkar, Amit S.; Gardner, Jarret W.; Hund, Kathryn C. R.; Hewitt, William M.; Schwochert, Joshua A.; Glassey, Emerson; Price, David A.; Mathiowetz, Alan M.; Liras, Spiros; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4581-4589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptide natural products contain a variety of conserved, nonproteinogenic structural elements such as D-amino acids and amide N-methylation.  In addn., many cyclic peptides incorporate γ-amino acids and other elements derived from polyketide synthases.  We hypothesized that the position and orientation of these extended backbone elements impact the ADME properties of these hybrid mols., esp. their ability to cross cell membranes and avoid metabolic degrdn.  Here we report the synthesis of cyclic hexapeptide diastereomers contg. γ-amino acids (e.g., statines) and systematically investigate their structure-permeability relationships.  These compds. were much more water-sol. and, in many cases, were both more membrane permeable and more stable to liver microsomes than a similar non-statine-contg. deriv.  Permeability correlated well with the extent of intramol. hydrogen bonding obsd. in the soln. structures detd. in the low-dielec. solvent CDCl3, and one compd. showed an oral bioavailability of 21% in rat.  Thus, the incorporation of γ-amino acids offers a route to increase backbone diversity and improve ADME properties in cyclic peptide scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXlzvMDhSrerVg90H21EOLACvtfcHk0ljQLioGBvsHxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvV2ku7s%253D&md5=b50bfd139a4abcae5ede988a5b095ce1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00128%26sid%3Dliteratum%253Aachs%26aulast%3DBockus%26aufirst%3DA.%2BT.%26aulast%3DLexa%26aufirst%3DK.%2BW.%26aulast%3DPye%26aufirst%3DC.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DJ.%2BW.%26aulast%3DHund%26aufirst%3DK.%2BC.%26aulast%3DHewitt%26aufirst%3DW.%2BM.%26aulast%3DSchwochert%26aufirst%3DJ.%2BA.%26aulast%3DGlassey%26aufirst%3DE.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DProbing%2520the%2520physicochemical%2520boundaries%2520of%2520cell%2520permeability%2520and%2520oral%2520bioavailability%2520in%2520lipophilic%2520macrocycles%2520inspired%2520by%2520natural%2520products%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D11%26spage%3D4581%26epage%3D4589%26doi%3D10.1021%2Facs.jmedchem.5b00128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chembiol.2014.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25237858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1115-1142&issue=9&author=B.+C.+Doakauthor=B.+Overauthor=F.+Giordanettoauthor=J.+Kihlberg&title=Oral+druggable+space+beyond+the+rule+of+5%3A+insights+from+drugs+and+clinical+candidates&doi=10.1016%2Fj.chembiol.2014.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates</span></div><div class="casAuthors">Doak, Bradley Croy; Over, Bjorn; Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1115-1142</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rule of 5 (Ro5) is a set of in silico guidelines applied to drug discovery to prioritize compds. with an increased likelihood of high oral absorption.  It has been influential in reducing attrition due to poor pharmacokinetics over the last 15 years.  However, strict reliance on the Ro5 may have resulted in lost opportunities, particularly for difficult targets.  To identify opportunities for oral drug discovery beyond the Ro5 (bRo5), we have comprehensively analyzed drugs and clin. candidates with mol. wt. (MW) > 500 Da.  We conclude that oral drugs are found far bRo5 and properties such as intramol. hydrogen bonding, macrocyclization, dosage, and formulations can be used to improve bRo5 bioavailability.  Natural products and structure-based design, often from peptidic leads, are key sources for oral bRo5 drugs.  These insights should help guide the design of oral drugs in bRo5 space, which is of particular interest for difficult targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYqpeA0dh6rVg90H21EOLACvtfcHk0lgfXfbk41LwNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrur7K&md5=b8a88c793572ad48de3809807a4699d8</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DOral%2520druggable%2520space%2520beyond%2520the%2520rule%2520of%25205%253A%2520insights%2520from%2520drugs%2520and%2520clinical%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1115%26epage%3D1142%26doi%3D10.1016%2Fj.chembiol.2014.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villar, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">How proteins bind macrocycles</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.1584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25038790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFygs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=723-731&author=E.+A.+Villarauthor=D.+Beglovauthor=S.+Chennamadhavuniauthor=J.+A.+Porcoauthor=D.+Kozakovauthor=S.+Vajdaauthor=A.+Whitty&title=How+proteins+bind+macrocycles&doi=10.1038%2Fnchembio.1584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">How proteins bind macrocycles</span></div><div class="casAuthors">Villar, Elizabeth A.; Beglov, Dmitri; Chennamadhavuni, Spandan; Porco, John A. Jr; Kozakov, Dima; Vajda, Sandor; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">723-731</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The potential utility of synthetic macrocycles (MCs) as drugs, particularly against low-druggability targets such as protein-protein interactions, has been widely discussed.  There is little information, however, to guide the design of MCs for good target protein-binding activity or bioavailability.  To address this knowledge gap, we analyze the binding modes of a representative set of MC-protein complexes.  The results, combined with consideration of the physicochem. properties of approved macrocyclic drugs, allow us to propose specific guidelines for the design of synthetic MC libraries with structural and physicochem. features likely to favor strong binding to protein targets as well as good bioavailability.  We addnl. provide evidence that large, natural product-derived MCs can bind targets that are not druggable by conventional, drug-like compds., supporting the notion that natural product-inspired synthetic MCs can expand the no. of proteins that are druggable by synthetic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa3yuNCHU5d7Vg90H21EOLACvtfcHk0li_lU3hUmTPtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFygs7jF&md5=0d41fba9267abb3a3d0065487937075a</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1584%26sid%3Dliteratum%253Aachs%26aulast%3DVillar%26aufirst%3DE.%2BA.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DHow%2520proteins%2520bind%2520macrocycles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D723%26epage%3D731%26doi%3D10.1038%2Fnchembio.1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">Suppl. C</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&issue=Suppl.+C&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26issue%3DSuppl.%2520C%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span>Telaprevir
label. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201917lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201917lbl.pdf</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Telaprevir%0Alabel.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2011%2F201917lbl.pdf+%28accessed+February+2%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deon, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrich, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romine, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruediger, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Laurent, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, D. R.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2032</span>, <span class="refDoi"> DOI: 10.1021/jm401836p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401836p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2013-2032&issue=5&author=M.+Belemaauthor=V.+N.+Nguyenauthor=C.+Bachandauthor=D.+H.+Deonauthor=J.+T.+Goodrichauthor=C.+A.+Jamesauthor=R.+Lavoieauthor=O.+D.+Lopezauthor=A.+Martelauthor=J.+L.+Romineauthor=E.+H.+Ruedigerauthor=L.+B.+Snyderauthor=D.+R.+St.+Laurentauthor=F.+Yangauthor=J.+Zhuauthor=H.+S.+Wongauthor=D.+R.+Langleyauthor=S.+P.+Adamsauthor=G.+H.+Cantorauthor=A.+Chimalakondaauthor=A.+Furaauthor=B.+M.+Johnsonauthor=J.+O.+Knipeauthor=D.+D.+Parkerauthor=K.+S.+Santoneauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=D.+R.+O%E2%80%99Boyleauthor=R.+J.+Colonnoauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Hepatitis+C+virus+NS5A+replication+complex+inhibitors%3A+the+discovery+of+daclatasvir&doi=10.1021%2Fjm401836p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fjm401836p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401836p%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DBachand%26aufirst%3DC.%26aulast%3DDeon%26aufirst%3DD.%2BH.%26aulast%3DGoodrich%26aufirst%3DJ.%2BT.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DLavoie%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DMartel%26aufirst%3DA.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DRuediger%26aufirst%3DE.%2BH.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26aulast%3DCantor%26aufirst%3DG.%2BH.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DSantone%26aufirst%3DK.%2BS.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DHepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitors%253A%2520the%2520discovery%2520of%2520daclatasvir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2013%26epage%3D2032%26doi%3D10.1021%2Fjm401836p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5071</span>, <span class="refDoi"> DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&issue=12&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+daclatasvir%2C+a+pan-genotypic+hepatitis+C+virus+NS5A+replication+complex+inhibitor+with+potent+clinical+effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520daclatasvir%252C%2520a%2520pan-genotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitor%2520with%2520potent%2520clinical%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D12%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanenkov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselov, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhbazyan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladinskiy, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladinskaya, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yartseva, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vantskul, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivachtchenko, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koteliansky, V. E.</span></span> <span> </span><span class="NLM_article-title">A comprehensive insight into the chemical space and ADME features of small molecule NS5A inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.2174/1568026616666151120113040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F1568026616666151120113040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26585933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1372-1382&issue=12&author=Y.+A.+Ivanenkovauthor=M.+S.+Veselovauthor=A.+G.+Shakhbazyanauthor=V.+A.+Aladinskiyauthor=A.+V.+Aladinskayaauthor=S.+M.+Yartsevaauthor=A.+G.+Majougaauthor=A.+S.+Vantskulauthor=S.+V.+Leonovauthor=A.+V.+Ivachtchenkoauthor=V.+E.+Koteliansky&title=A+comprehensive+insight+into+the+chemical+space+and+ADME+features+of+small+molecule+NS5A+inhibitors&doi=10.2174%2F1568026616666151120113040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors</span></div><div class="casAuthors">Ivanenkov, Yan A.; Veselov, Mark S.; Shakhbazyan, Artem G.; Aladinskiy, Vladimir A.; Aladinskaya, Anastasia V.; Yartseva, Sofya M.; Majouga, Alexander G.; Vantskul, Anton S.; Leonov, Sergey V.; Ivachtchenko, Alexandre V.; Koteliansky, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1372-1382</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Non-structural 5A (NS5A) protein plays a crucial role in the replication of hepatitis C virus (HCV) and during the past decade has attracted increasing attention as a promising biol. target for the treatment of viral infections and related disorders.  Small-mol. NS5A inhibitors have shown significant antiviral activity in vitro and in vivo.  Several lead mols. are reasonably regarded as novel highly potent drug candidates with favorable ADME features and tolerable side effects.  The first-in-class daclatasvir has recently been launched into the market and 14 novel mols. are currently under evaluation in clin. trials.  From this perspective, we provide an overview of the available chem. space of small-mol. NS5A inhibitors and their PK properties, mainly focusing on the diversity in structure and scaffold representation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFcZPRca9xg7Vg90H21EOLACvtfcHk0lgDdKFY6wmu6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCmsrc%253D&md5=4f6e9bb49e8548fb5461ab2c197a5910</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.2174%2F1568026616666151120113040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666151120113040%26sid%3Dliteratum%253Aachs%26aulast%3DIvanenkov%26aufirst%3DY.%2BA.%26aulast%3DVeselov%26aufirst%3DM.%2BS.%26aulast%3DShakhbazyan%26aufirst%3DA.%2BG.%26aulast%3DAladinskiy%26aufirst%3DV.%2BA.%26aulast%3DAladinskaya%26aufirst%3DA.%2BV.%26aulast%3DYartseva%26aufirst%3DS.%2BM.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DVantskul%26aufirst%3DA.%2BS.%26aulast%3DLeonov%26aufirst%3DS.%2BV.%26aulast%3DIvachtchenko%26aufirst%3DA.%2BV.%26aulast%3DKoteliansky%26aufirst%3DV.%2BE.%26atitle%3DA%2520comprehensive%2520insight%2520into%2520the%2520chemical%2520space%2520and%2520ADME%2520features%2520of%2520small%2520molecule%2520NS5A%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26issue%3D12%26spage%3D1372%26epage%3D1382%26doi%3D10.2174%2F1568026616666151120113040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broyde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBrayer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10031</span>– <span class="NLM_lpage">10043</span>, <span class="refDoi"> DOI: 10.1021/jm501291c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501291c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10031-10043&issue=23&author=J.+H.+Nettlesauthor=R.+A.+Stantonauthor=J.+Broydeauthor=F.+Amblardauthor=H.+Zhangauthor=L.+Zhouauthor=J.+Shiauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=S.+J.+Coatsauthor=J.+J.+Kohlerauthor=R.+F.+Schinazi&title=Asymmetric+binding+to+NS5A+by+daclatasvir+%28BMS-790052%29+and+analogs+suggests+two+novel+modes+of+HCV+inhibition&doi=10.1021%2Fjm501291c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1021%2Fjm501291c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501291c%26sid%3Dliteratum%253Aachs%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DBroyde%26aufirst%3DJ.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DCoats%26aufirst%3DS.%2BJ.%26aulast%3DKohler%26aufirst%3DJ.%2BJ.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DAsymmetric%2520binding%2520to%2520NS5A%2520by%2520daclatasvir%2520%2528BMS-790052%2529%2520and%2520analogs%2520suggests%2520two%2520novel%2520modes%2520of%2520HCV%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D23%26spage%3D10031%26epage%3D10043%26doi%3D10.1021%2Fjm501291c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romine, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Laurent, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, D. R.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of hepatitis C virus NS5A replication complex inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/jm401793m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401793m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1643-1672&issue=5&author=M.+Belemaauthor=O.+D.+Lopezauthor=J.+A.+Benderauthor=J.+L.+Romineauthor=D.+R.+St.+Laurentauthor=D.+R.+Langleyauthor=J.+A.+Lemmauthor=D.+R.+O%E2%80%99Boyleauthor=J.+H.+Sunauthor=C.+Wangauthor=R.+A.+Fridellauthor=N.+A.+Meanwell&title=Discovery+and+development+of+hepatitis+C+virus+NS5A+replication+complex+inhibitors&doi=10.1021%2Fjm401793m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1021%2Fjm401793m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401793m%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520and%2520development%2520of%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D1643%26epage%3D1672%26doi%3D10.1021%2Fjm401793m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspi, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2047</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1021/jm401398x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401398x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2047-2057&issue=5&author=D.%0AA.+DeGoeyauthor=J.+T.+Randolphauthor=D.+Liuauthor=J.+Prattauthor=C.+Hutchinsauthor=P.+Donnerauthor=A.+C.+Kruegerauthor=M.+Matulenkoauthor=S.+Patelauthor=C.+E.+Motterauthor=L.+Nelsonauthor=R.+Keddyauthor=M.+Tufanoauthor=D.+D.+Caspiauthor=P.+Krishnanauthor=N.+Mistryauthor=G.+Koevauthor=T.+J.+Reischauthor=R.+Mondalauthor=T.+Pilot-Matiasauthor=Y.+Gaoauthor=D.+W.+Benoauthor=C.+J.+Maringauthor=A.+Mollaauthor=E.+Dumasauthor=A.+Campbellauthor=L.+Williamsauthor=C.+Collinsauthor=R.+Wagnerauthor=W.+M.+Kati&title=Discovery+of+ABT-267%2C+a+pan-genotypic+inhibitor+of+HCV+NS5A&doi=10.1021%2Fjm401398x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1021%2Fjm401398x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401398x%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DC.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DKrueger%26aufirst%3DA.%2BC.%26aulast%3DMatulenko%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMotter%26aufirst%3DC.%2BE.%26aulast%3DNelson%26aufirst%3DL.%26aulast%3DKeddy%26aufirst%3DR.%26aulast%3DTufano%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%2BD.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%2BJ.%26aulast%3DMondal%26aufirst%3DR.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBeno%26aufirst%3DD.%2BW.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520ABT-267%252C%2520a%2520pan-genotypic%2520inhibitor%2520of%2520HCV%2520NS5A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2047%26epage%3D2057%26doi%3D10.1021%2Fjm401398x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1128/AAC.04226-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.04226-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=979-987&issue=2&author=P.+Krishnanauthor=J.+Beyerauthor=N.+Mistryauthor=G.+Koevauthor=T.+Reischauthor=D.+DeGoeyauthor=W.+Katiauthor=A.+Campbellauthor=L.+Williamsauthor=W.+Xieauthor=C.+Setzeauthor=A.+Mollaauthor=C.+Collinsauthor=T.+Pilot-Matias&title=In+vitro+and+in+vivo+antiviral+activity+and+resistance+profile+of+ombitasvir%2C+an+inhibitor+of+hepatitis+C+virus+NS5A&doi=10.1128%2FAAC.04226-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1128%2FAAC.04226-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04226-14%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DDeGoey%26aufirst%3DD.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DSetze%26aufirst%3DC.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPilot-Matias%26aufirst%3DT.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520ombitasvir%252C%2520an%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS5A%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D979%26epage%3D987%26doi%3D10.1128%2FAAC.04226-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornpropst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2046</span>, <span class="refDoi"> DOI: 10.1021/jm401499g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401499g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2033-2046&issue=5&author=J.+O.+Linkauthor=J.+G.+Taylorauthor=L.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=H.+Liuauthor=D.+Katoauthor=T.+Kirschbergauthor=J.+Sunauthor=N.+Squiresauthor=J.+Parrishauthor=T.+Kellerauthor=Z.+Y.+Yangauthor=C.+Yangauthor=M.+Matlesauthor=Y.+Wangauthor=K.+Wangauthor=G.+Chengauthor=Y.+Tianauthor=E.+Mogalianauthor=E.+Mondouauthor=M.+Cornpropstauthor=J.+Perryauthor=M.+C.+Desai&title=Discovery+of+ledipasvir+%28GS-5885%29%3A+a+potent%2C+once-daily+oral+NS5A+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm401499g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Link, John O.; Taylor, James G.; Xu, Lianhong; Mitchell, Michael; Guo, Hongyan; Liu, Hongtao; Kato, Darryl; Kirschberg, Thorsten; Sun, Jianyu; Squires, Neil; Parrish, Jay; Kellar, Terry; Yang, Zheng-Yu; Yang, Chris; Matles, Mike; Wang, Yujin; Wang, Kelly; Cheng, Guofeng; Tian, Yang; Mogalian, Erik; Mondou, Elsa; Cornpropst, Melanie; Perry, Jason; Desai, Manoj C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2033-2046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of highly potent NS5A inhibitors with an unsym. benzimidazole-difluorofluorene-imidazole core and distal [2.2.1]-azabicyclic ring system was discovered.  Optimization of antiviral potency and pharmacokinetics led to the identification of ledipasvir (GS-5885).  Ledipasvir (GT1a replicon EC50 = 31 pM) has an extended plasma half-life of 37-45 h in healthy volunteers and produces a rapid >3 log viral load redn. in monotherapy at oral doses of 3 mg or greater with once-daily dosing in genotype 1a HCV-infected patients. ledipasvir has been shown to be safe and efficacious, with SVR12 rates up to 100% when used in combination with direct-acting antivirals having complementary mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLazFwyH5rrVg90H21EOLACvtfcHk0lieLIoaO0uEIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I&md5=30cec1d10b7b7dd02faae4fba4b88bd8</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1021%2Fjm401499g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401499g%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DD.%26aulast%3DKirschberg%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DSquires%26aufirst%3DN.%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMatles%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DMondou%26aufirst%3DE.%26aulast%3DCornpropst%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520ledipasvir%2520%2528GS-5885%2529%253A%2520a%2520potent%252C%2520once-daily%2520oral%2520NS5A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2033%26epage%3D2046%26doi%3D10.1021%2Fjm401499g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, A.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and first-in-human pharmacokinetics, safety, and tolerability of velpatasvir, a pangenotypic hepatitis C virus NS5A inhibitor, in healthy subjects</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e02084-16</span>, <span class="refDoi"> DOI: 10.1128/AAC.02084-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02084-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02084-16&issue=5&author=E.+Mogalianauthor=P.+Germanauthor=B.+P.+Kearneyauthor=C.+Y.+Yangauthor=D.+Brainardauthor=J.+Linkauthor=J.+McNallyauthor=L.+Hanauthor=J.+Lingauthor=A.+Mathias&title=Preclinical+pharmacokinetics+and+first-in-human+pharmacokinetics%2C+safety%2C+and+tolerability+of+velpatasvir%2C+a+pangenotypic+hepatitis+C+virus+NS5A+inhibitor%2C+in+healthy+subjects&doi=10.1128%2FAAC.02084-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1128%2FAAC.02084-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02084-16%26sid%3Dliteratum%253Aachs%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DGerman%26aufirst%3DP.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DBrainard%26aufirst%3DD.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DMathias%26aufirst%3DA.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520first-in-human%2520pharmacokinetics%252C%2520safety%252C%2520and%2520tolerability%2520of%2520velpatasvir%252C%2520a%2520pangenotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3De02084-16%26doi%3D10.1128%2FAAC.02084-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&issue=12&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+M.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+an+HCV+NS5A+inhibitor+with+broad+genotype+activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520broad%2520genotype%2520activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In vitro antiviral activity and resistance profile of the next-generation hepatitis C virus NS5A inhibitor pibrentasvir</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e02558-16</span>, <span class="refDoi"> DOI: 10.1128/AAC.02558-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02558-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02558-16&issue=5&author=T.+I.+Ngauthor=P.+Krishnanauthor=T.+Pilot-Matiasauthor=W.+Katiauthor=G.+Schnellauthor=J.+Beyerauthor=T.+Reischauthor=L.+Luauthor=T.+Dekhtyarauthor=M.+Irvinauthor=R.+Tripathiauthor=C.+Maringauthor=J.+T.+Randolphauthor=R.+Wagnerauthor=C.+Collins&title=In+vitro+antiviral+activity+and+resistance+profile+of+the+next-generation+hepatitis+C+virus+NS5A+inhibitor+pibrentasvir&doi=10.1128%2FAAC.02558-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1128%2FAAC.02558-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02558-16%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DSchnell%26aufirst%3DG.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMaring%26aufirst%3DC.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520next-generation%2520hepatitis%2520C%2520virus%2520NS5A%2520inhibitor%2520pibrentasvir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3De02558-16%26doi%3D10.1128%2FAAC.02558-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How big is too big for cell permeability?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1664</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1662-1664&issue=5&author=P.+Matssonauthor=J.+Kihlberg&title=How+big+is+too+big+for+cell+permeability%3F&doi=10.1021%2Facs.jmedchem.7b00237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">How Big Is Too Big for Cell Permeability?</span></div><div class="casAuthors">Matsson, Paer; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1662-1664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Understanding how to design cell permeable ligands for intracellular targets that have difficult binding sites, such as protein-protein interactions, would open vast opportunities for drug discovery.  Interestingly, libraries of cyclic peptides displayed a steep drop-off in membrane permeability at mol. wts. above 1000 Da and it appears likely that this cutoff constitutes an upper size limit also for more drug-like compds.  However, chem. space from 500 to 1000 Da remains virtually unexplored and represents a vast opportunity for those prepd. to venture into new territories of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXxiuvHQSnJLVg90H21EOLACvtfcHk0li73idYa5l3YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlCjtL8%253D&md5=563efb3b4603c33c4a976e88b1c7b514</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00237%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520big%2520is%2520too%2520big%2520for%2520cell%2520permeability%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1662%26epage%3D1664%26doi%3D10.1021%2Facs.jmedchem.7b00237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonehouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wybrow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daverio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiva, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201400046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.201400046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1387-1396&issue=7&author=F.+Wakenhutauthor=T.+D.+Tranauthor=C.+Pickfordauthor=S.+Shawauthor=M.+Westbyauthor=C.+Smith-Burchnellauthor=L.+Watsonauthor=M.+Paradowskiauthor=J.+Milbankauthor=D.+Stonehouseauthor=K.+Cheungauthor=R.+Wybrowauthor=F.+Daverioauthor=S.+Crookauthor=K.+Stathamauthor=D.+Leeseauthor=D.+Steadauthor=F.+Adamauthor=D.+Hayauthor=L.+R.+Robertsauthor=J.+Y.+Chivaauthor=C.+Nicholsauthor=D.+C.+Blakemoreauthor=G.+H.+Goetzauthor=Y.+Cheauthor=I.+Gardnerauthor=S.+Dayalauthor=A.+Pikeauthor=R.+Websterauthor=D.+C.+Pryde&title=The+discovery+of+potent+nonstructural+protein+5A+%28NS5A%29+inhibitors+with+a+unique+resistance+profile-Part+2&doi=10.1002%2Fcmdc.201400046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201400046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201400046%26sid%3Dliteratum%253Aachs%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DL.%26aulast%3DParadowski%26aufirst%3DM.%26aulast%3DMilbank%26aufirst%3DJ.%26aulast%3DStonehouse%26aufirst%3DD.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DWybrow%26aufirst%3DR.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DCrook%26aufirst%3DS.%26aulast%3DStatham%26aufirst%3DK.%26aulast%3DLeese%26aufirst%3DD.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAdam%26aufirst%3DF.%26aulast%3DHay%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DChiva%26aufirst%3DJ.%2BY.%26aulast%3DNichols%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DDayal%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26atitle%3DThe%2520discovery%2520of%2520potent%2520nonstructural%2520protein%25205A%2520%2528NS5A%2529%2520inhibitors%2520with%2520a%2520unique%2520resistance%2520profile-Part%25202%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1387%26epage%3D1396%26doi%3D10.1002%2Fcmdc.201400046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the rule of 5: lessons learned from Abbvie’s drugs and compound collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+A.+DeGoeyauthor=H.+J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+rule+of+5%3A+lessons+learned+from+Abbvie%E2%80%99s+drugs+and+compound+collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520rule%2520of%25205%253A%2520lessons%2520learned%2520from%2520Abbvie%25E2%2580%2599s%2520drugs%2520and%2520compound%2520collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span> <span> </span><span class="NLM_article-title">BCL-2: Long and winding path from discovery to therapeutic target</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.10.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bbrc.2016.10.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=459-469&issue=3&author=R.+L.+Schenkauthor=A.+Strasserauthor=G.+Dewson&title=BCL-2%3A+Long+and+winding+path+from+discovery+to+therapeutic+target&doi=10.1016%2Fj.bbrc.2016.10.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.10.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.10.100%26sid%3Dliteratum%253Aachs%26aulast%3DSchenk%26aufirst%3DR.%2BL.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDewson%26aufirst%3DG.%26atitle%3DBCL-2%253A%2520Long%2520and%2520winding%2520path%2520from%2520discovery%2520to%2520therapeutic%2520target%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26issue%3D3%26spage%3D459%26epage%3D469%26doi%3D10.1016%2Fj.bbrc.2016.10.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm0507532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&issue=2&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-xL+from+NMR+and+parallel+synthesis&doi=10.1021%2Fjm0507532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-xL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D2%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm0507532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6915</span>, <span class="refDoi"> DOI: 10.1021/jm800669s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&issue=21&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+R.+Shoemakerauthor=X.+Songauthor=S.+K.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+D.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins&doi=10.1021%2Fjm800669s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D21%26spage%3D6902%26epage%3D6915%26doi%3D10.1021%2Fjm800669s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.%0AJ.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+S.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.-M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0lj5rXVkENXorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.-M.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span>Venetoclax
label. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Venetoclax%0Alabel.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2016%2F208573s000lbl.pdf+%28accessed+February+2%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorman, R.</span></span> <span> </span><span class="NLM_article-title">The role of lymphatic transport on the systemic bioavailability of the Bcl-2 protein family inhibitors navitoclax (ABT-263) and ABT-199</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.055053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1124%2Fdmd.113.055053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=207-212&issue=2&author=E.+F.+Chooauthor=J.+Boggsauthor=C.+Zhuauthor=J.+W.+Lubachauthor=N.+D.+Catronauthor=G.+Jenkinsauthor=A.+J.+Souersauthor=R.+Voorman&title=The+role+of+lymphatic+transport+on+the+systemic+bioavailability+of+the+Bcl-2+protein+family+inhibitors+navitoclax+%28ABT-263%29+and+ABT-199&doi=10.1124%2Fdmd.113.055053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055053%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DLubach%26aufirst%3DJ.%2BW.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DJenkins%26aufirst%3DG.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DVoorman%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520on%2520the%2520systemic%2520bioavailability%2520of%2520the%2520Bcl-2%2520protein%2520family%2520inhibitors%2520navitoclax%2520%2528ABT-263%2529%2520and%2520ABT-199%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D2%26spage%3D207%26epage%3D212%26doi%3D10.1124%2Fdmd.113.055053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuthalapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freise, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. L.</span></span> <span> </span><span class="NLM_article-title">Effect of low- and high-fat meals on the pharmacokinetics of venetoclax, a selective first-in-class BCL-2 Inhibitor</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1002/jcph.741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjcph.741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27029823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1WkurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1355-1361&issue=11&author=A.+H.+Salemauthor=S.+K.+Agarwalauthor=M.+Dunbarauthor=S.+Nuthalapatiauthor=D.+Chienauthor=K.+J.+Freiseauthor=S.+L.+Wong&title=Effect+of+low-+and+high-fat+meals+on+the+pharmacokinetics+of+venetoclax%2C+a+selective+first-in-class+BCL-2+Inhibitor&doi=10.1002%2Fjcph.741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor</span></div><div class="casAuthors">Salem, Ahmed Hamed; Agarwal, Suresh K.; Dunbar, Martin; Nuthalapati, Silpa; Chien, David; Freise, Kevin J.; Wong, Shekman L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1355-1361</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Venetoclax is a selective, first-in-class, B-cell lymphoma-2 inhibitor that has demonstrated clin. efficacy in several hematol. malignancies.  Two studies evaluated the relative bioavailability of venetoclax in healthy subjects: (1) a bioequivalence study to compare the bioavailability of the film-coated tablet with that of an earlier uncoated tablet and (2) a food effect study to evaluate the effect of food on venetoclax pharmacokinetics.  Both studies were open-label, single-dose, crossover studies.  In the bioequivalence study, 15 subjects received a single dose of venetoclax 50 mg under nonfasting conditions, in each of 2 periods; one period used the uncoated tablet, and the other used the film-coated tablet.  In the food effect study, 24 subjects received a single dose of venetoclax film-coated 100-mg tablet under fasting conditions, after a low-fat breakfast or after a high-fat breakfast in different periods.  The venetoclax film-coated tablet was bioequivalent to the uncoated tablet, which indicates that the film coating does not affect bioavailability.  The median Tmax of venetoclax was delayed by about 2 h when administered with food.  Compared with fasting conditions, Cmax and AUC increased by approx. 3.4-fold following a low-fat breakfast.  High-fat meals increased Cmax and AUC by approx. 50% relative to low-fat meals.  The mean terminal half-life was comparable between the high-fat meal and fasting conditions (19.1 vs. 16.1 h).  Based on these results and the venetoclax exposure-response profile, venetoclax should be administered with food and without specific recommendations for fat content to ensure adequate and consistent bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB0G-6BbtmdLVg90H21EOLACvtfcHk0lj0lIlx6PT5_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1WkurvJ&md5=e50def47958632b2417edcfb2c134b1d</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjcph.741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.741%26sid%3Dliteratum%253Aachs%26aulast%3DSalem%26aufirst%3DA.%2BH.%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26aulast%3DDunbar%26aufirst%3DM.%26aulast%3DNuthalapati%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DFreise%26aufirst%3DK.%2BJ.%26aulast%3DWong%26aufirst%3DS.%2BL.%26atitle%3DEffect%2520of%2520low-%2520and%2520high-fat%2520meals%2520on%2520the%2520pharmacokinetics%2520of%2520venetoclax%252C%2520a%2520selective%2520first-in-class%2520BCL-2%2520Inhibitor%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D56%26issue%3D11%26spage%3D1355%26epage%3D1361%26doi%3D10.1002%2Fjcph.741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2312</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&issue=6&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0lj3dHqnQq8TDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Learning medicinal chemistry absorption, distribution, metabolism, excretion, and toxicity (ADMET) rules from cross-company matched molecular pairs analysis (MMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Kramerauthor=A.+Tingauthor=H.+Zhengauthor=J.+Hertauthor=T.+Schindlerauthor=M.+Stahlauthor=G.+Robbauthor=J.+J.+Crawfordauthor=J.+Blaneyauthor=S.+Montagueauthor=A.+G.+Leachauthor=A.+G.+Dossetterauthor=E.+J.+Griffen&title=Learning+medicinal+chemistry+absorption%2C+distribution%2C+metabolism%2C+excretion%2C+and+toxicity+%28ADMET%29+rules+from+cross-company+matched+molecular+pairs+analysis+%28MMPA%29&doi=10.1021%2Facs.jmedchem.7b00935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00935%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DBlaney%26aufirst%3DJ.%26aulast%3DMontague%26aufirst%3DS.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DLearning%2520medicinal%2520chemistry%2520absorption%252C%2520distribution%252C%2520metabolism%252C%2520excretion%252C%2520and%2520toxicity%2520%2528ADMET%2529%2520rules%2520from%2520cross-company%2520matched%2520molecular%2520pairs%2520analysis%2520%2528MMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1021%2Facs.jmedchem.7b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D. R.</span></span> <span> </span><span class="NLM_article-title">Statistical analysis of the effects of common chemical substituents on ligand potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1021/jm070838y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070838y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=553-564&issue=3&author=P.+J.+Hajdukauthor=D.+R.+Sauer&title=Statistical+analysis+of+the+effects+of+common+chemical+substituents+on+ligand+potency&doi=10.1021%2Fjm070838y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1021%2Fjm070838y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070838y%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSauer%26aufirst%3DD.%2BR.%26atitle%3DStatistical%2520analysis%2520of%2520the%2520effects%2520of%2520common%2520chemical%2520substituents%2520on%2520ligand%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D3%26spage%3D553%26epage%3D564%26doi%3D10.1021%2Fjm070838y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. A.</span></span> <span> </span><span class="NLM_article-title">Improvement in aqueous solubility achieved via small molecular changes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5100</span>– <span class="NLM_lpage">5108</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2017.09.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5100-5108&issue=23&author=M.+A.+Walker&title=Improvement+in+aqueous+solubility+achieved+via+small+molecular+changes&doi=10.1016%2Fj.bmcl.2017.09.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520achieved%2520via%2520small%2520molecular%2520changes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5100%26epage%3D5108%26doi%3D10.1016%2Fj.bmcl.2017.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The medicinal chemist’s toolbox for late stage functionalization of druglike molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&issue=3&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+medicinal+chemist%E2%80%99s+toolbox+for+late+stage+functionalization+of+druglike+molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520medicinal%2520chemist%25E2%2580%2599s%2520toolbox%2520for%2520late%2520stage%2520functionalization%2520of%2520druglike%2520molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26issue%3D3%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis provides opportunities to transform drug discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&issue=4&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+synthesis+provides+opportunities+to+transform+drug+discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0lhc9MDdSkNRpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520synthesis%2520provides%2520opportunities%2520to%2520transform%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26issue%3D4%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&issue=9&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0lhc9MDdSkNRpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Methyl effects on protein-ligand binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4489</span>– <span class="NLM_lpage">4500</span>, <span class="refDoi"> DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&issue=9&author=C.+S.+Leungauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein-ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38α MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0ljAjcCslAR0Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein-ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schonherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">12256</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&issue=47&author=H.+Schonherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C-H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSchonherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C-H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26issue%3D47%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuntz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter-Scott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneeringer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesworth, R.</span></span> <span> </span><span class="NLM_article-title">The importance of being Me: magic methyls, methyltransferase inhibitors, and the discovery of tazemetostat</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1564</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&issue=4&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+importance+of+being+Me%3A+magic+methyls%2C+methyltransferase+inhibitors%2C+and+the+discovery+of+tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span></div><div class="casAuthors">Kuntz, Kevin W.; Campbell, John E.; Keilhack, Heike; Pollock, Roy M.; Knutson, Sarah K.; Porter-Scott, Margaret; Richon, Victoria M.; Sneeringer, Chris J.; Wigle, Tim J.; Allain, Christina J.; Majer, Christina R.; Moyer, Mikel P.; Copeland, Robert A.; Chesworth, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Posttranslational methylation of histones plays a crit. role in gene regulation.  Misregulation of histone methylation can lead to oncogenic transformation.  Enhancer of Zeste homolog 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers.  Tazemetostat, an EHZ2 inhibitor in clin. development, has shown activity in both preclin. models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors.  Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clin. development.  The importance of several Me groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryASbIgMDxAbVg90H21EOLACvtfcHk0lju7c4BCNZIcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D&md5=a26ccc4a0109f57fbb64f7fded8965a1</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520importance%2520of%2520being%2520Me%253A%2520magic%2520methyls%252C%2520methyltransferase%2520inhibitors%252C%2520and%2520the%2520discovery%2520of%2520tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D4%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&issue=21&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lju7c4BCNZIcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative Assessment of the impact of fluorine substitution on p-glycoprotein (p-gp) mediated efflux, permeability, lipophilicity, and metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5284-5296&issue=11&author=M.+Petterssonauthor=X.+Houauthor=M.+Kuhnauthor=T.+T.+Wagerauthor=G.+W.+Kauffmanauthor=P.+R.+Verhoest&title=Quantitative+Assessment+of+the+impact+of+fluorine+substitution+on+p-glycoprotein+%28p-gp%29+mediated+efflux%2C+permeability%2C+lipophilicity%2C+and+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b00027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DQuantitative%2520Assessment%2520of%2520the%2520impact%2520of%2520fluorine%2520substitution%2520on%2520p-glycoprotein%2520%2528p-gp%2529%2520mediated%2520efflux%252C%2520permeability%252C%2520lipophilicity%252C%2520and%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D11%26spage%3D5284%26epage%3D5296%26doi%3D10.1021%2Facs.jmedchem.6b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Chemical structure-related druglike criteria of global approved drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/molecules21010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.3390%2Fmolecules21010075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=75&issue=1&author=F.+Maoauthor=W.+Niauthor=X.+Xuauthor=H.+Wangauthor=J.+Wangauthor=M.+Jiauthor=J.+Li&title=Chemical+structure-related+druglike+criteria+of+global+approved+drugs&doi=10.3390%2Fmolecules21010075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010075%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DChemical%2520structure-related%2520druglike%2520criteria%2520of%2520global%2520approved%2520drugs%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D75%26doi%3D10.3390%2Fmolecules21010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkinshaw, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnert, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guile, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ince, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingall, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortimore, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigby, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teobald, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webborn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span> <span> </span><span class="NLM_article-title">From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6013</span>– <span class="NLM_lpage">6018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.07.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6013-6018&issue=21&author=B.+Springthorpeauthor=A.+Baileyauthor=P.+Bartonauthor=T.+N.+Birkinshawauthor=R.+V.+Bonnertauthor=R.+C.+Brownauthor=D.+Chapmanauthor=J.+Dixonauthor=S.+D.+Guileauthor=R.+G.+Humphriesauthor=S.+F.+Huntauthor=F.+Inceauthor=A.+H.+Ingallauthor=I.+P.+Kirkauthor=P.+D.+Leesonauthor=P.+Leffauthor=R.+J.+Lewisauthor=B.+P.+Martinauthor=D.+F.+McGinnityauthor=M.+P.+Mortimoreauthor=S.+W.+Paineauthor=G.+Pairaudeauauthor=A.+Patelauthor=A.+J.+Rigbyauthor=R.+J.+Rileyauthor=B.+J.+Teobaldauthor=W.+Tomlinsonauthor=P.+J.+Webbornauthor=P.+A.+Willis&title=From+ATP+to+AZD6140%3A+the+discovery+of+an+orally+active+reversible+P2Y12+receptor+antagonist+for+the+prevention+of+thrombosis&doi=10.1016%2Fj.bmcl.2007.07.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DSpringthorpe%26aufirst%3DB.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBirkinshaw%26aufirst%3DT.%2BN.%26aulast%3DBonnert%26aufirst%3DR.%2BV.%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DChapman%26aufirst%3DD.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DGuile%26aufirst%3DS.%2BD.%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DInce%26aufirst%3DF.%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DKirk%26aufirst%3DI.%2BP.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BP.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DMortimore%26aufirst%3DM.%2BP.%26aulast%3DPaine%26aufirst%3DS.%2BW.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DRigby%26aufirst%3DA.%2BJ.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DTeobald%26aufirst%3DB.%2BJ.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DWebborn%26aufirst%3DP.%2BJ.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26atitle%3DFrom%2520ATP%2520to%2520AZD6140%253A%2520the%2520discovery%2520of%2520an%2520orally%2520active%2520reversible%2520P2Y12%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520thrombosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D21%26spage%3D6013%26epage%3D6018%26doi%3D10.1016%2Fj.bmcl.2007.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dower, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrin, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samardjiev, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzupek, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoli ne-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5521</span>– <span class="NLM_lpage">5542</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&issue=13&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.+L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoli+ne-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0liOXS54FrYmdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoli%2520ne-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Code, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raubo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) binders and optimization to high affinity macrocyclic inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4402</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4386-4402&issue=10&author=W.+McCoullauthor=R.+D.+Abramsauthor=E.+Andersonauthor=K.+Bladesauthor=P.+Bartonauthor=M.+Boxauthor=J.+Burgessauthor=K.+Bythauthor=Q.+Caoauthor=C.+Chuaquiauthor=R.+J.+Carbajoauthor=T.+Cheungauthor=E.+Codeauthor=A.+D.+Fergusonauthor=S.+Filleryauthor=N.+O.+Fullerauthor=E.+Ganglauthor=N.+Gaoauthor=M.+Gristauthor=D.+Hargreavesauthor=M.+R.+Howardauthor=J.+Huauthor=P.+D.+Kemmittauthor=J.+E.+Nelsonauthor=N.+O%E2%80%99Connellauthor=D.+B.+Princeauthor=P.+Rauboauthor=P.+B.+Rawlinsauthor=G.+R.+Robbauthor=J.+Shiauthor=M.+J.+Waringauthor=D.+Whittakerauthor=M.+Wylotauthor=X.+Zhu&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+B-Cell+Lymphoma+6+%28BCL6%29+binders+and+optimization+to+high+affinity+macrocyclic+inhibitors&doi=10.1021%2Facs.jmedchem.7b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors</span></div><div class="casAuthors">McCoull, William; Abrams, Roman D.; Anderson, Erica; Blades, Kevin; Barton, Peter; Box, Matthew; Burgess, Jonathan; Byth, Kate; Cao, Qing; Chuaqui, Claudio; Carbajo, Rodrigo J.; Cheung, Tony; Code, Erin; Ferguson, Andrew D.; Fillery, Shaun; Fuller, Nathan O.; Gangl, Eric; Gao, Ning; Grist, Matthew; Hargreaves, David; Howard, Martin R.; Hu, Jun; Kemmitt, Paul D.; Nelson, Jennifer E.; O'Connell, Nichole; Prince, D. Bryan; Raubo, Piotr; Rawlins, Philip B.; Robb, Graeme R.; Shi, Junjie; Waring, Michael J.; Whittaker, David; Wylot, Marta; Zhu, Xiahui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are crit. to test this hypothesis.  We identified a pyrazolo[1,5-a]pyrimidine series of BCL6 binders from a fragment screen in parallel with a virtual screen.  Using structure-based drug design, binding affinity was increased 100000-fold.  This involved displacing crystallog. water, forming new ligand-protein interactions and a macrocyclization to favor the bioactive conformation of the ligands.  Optimization for slow off-rate const. kinetics was conducted as well as improving selectivity against an off-target kinase, CK2.  Potency in a cellular BCL6 assay was further optimized to afford highly selective probe mols.  Only weak antiproliferative effects were obsd. across a no. of DLBCL lines and a multiple myeloma cell line without a clear relationship to BCL6 potency.  As a result, we conclude that the BCL6 hypothesis in DLBCL cancer remains unproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp2OlXAZDFLVg90H21EOLACvtfcHk0lgTocUUgjkaTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D&md5=fc4142453a0580edbf04802e15d4d9aa</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00359%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DR.%2BD.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DBurgess%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DM.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DNelson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DRaubo%26aufirst%3DP.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWylot%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520B-Cell%2520Lymphoma%25206%2520%2528BCL6%2529%2520binders%2520and%2520optimization%2520to%2520high%2520affinity%2520macrocyclic%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D10%26spage%3D4386%26epage%3D4402%26doi%3D10.1021%2Facs.jmedchem.7b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser-Bricker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, S. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez
Morales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troccolo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C.</span></span> <span> </span><span class="NLM_article-title">Design and optimization of benzopiperazines as potent inhibitors of BET bromodomains</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=847-852&issue=8&author=D.+S.+Millanauthor=K.+J.+Kayser-Brickerauthor=M.+W.+Martinauthor=A.+C.+Talbotauthor=S.+E.+R.+Schillerauthor=T.+Herbertzauthor=G.+L.+Williamsauthor=G.+P.+Lukeauthor=S.+Hubbsauthor=M.+A.+Alvarez%0AMoralesauthor=D.+Cardilloauthor=P.+Troccoloauthor=R.+L.+Mendesauthor=C.+McKinnon&title=Design+and+optimization+of+benzopiperazines+as+potent+inhibitors+of+BET+bromodomains&doi=10.1021%2Facsmedchemlett.7b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00191%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DKayser-Bricker%26aufirst%3DK.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DSchiller%26aufirst%3DS.%2BE.%2BR.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DG.%2BL.%26aulast%3DLuke%26aufirst%3DG.%2BP.%26aulast%3DHubbs%26aufirst%3DS.%26aulast%3DAlvarez%2BMorales%26aufirst%3DM.%2BA.%26aulast%3DCardillo%26aufirst%3DD.%26aulast%3DTroccolo%26aufirst%3DP.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMcKinnon%26aufirst%3DC.%26atitle%3DDesign%2520and%2520optimization%2520of%2520benzopiperazines%2520as%2520potent%2520inhibitors%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D8%26spage%3D847%26epage%3D852%26doi%3D10.1021%2Facsmedchemlett.7b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komandla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanouni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyrick, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a small molecule inhibitor of bruton’s tyrosine kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5437</span>– <span class="NLM_lpage">5444</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00734</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00734" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5437-5444&issue=14&author=C.+R.+Smithauthor=D.+R.+Douganauthor=M.+Komandlaauthor=T.+Kanouniauthor=B.+Knightauthor=J.+D.+Lawsonauthor=M.+Sabatauthor=E.+R.+Taylorauthor=P.+Vuauthor=C.+Wyrick&title=Fragment-based+discovery+of+a+small+molecule+inhibitor+of+bruton%E2%80%99s+tyrosine+kinase&doi=10.1021%2Facs.jmedchem.5b00734"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00734%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DKomandla%26aufirst%3DM.%26aulast%3DKanouni%26aufirst%3DT.%26aulast%3DKnight%26aufirst%3DB.%26aulast%3DLawson%26aufirst%3DJ.%2BD.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DE.%2BR.%26aulast%3DVu%26aufirst%3DP.%26aulast%3DWyrick%26aufirst%3DC.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520bruton%25E2%2580%2599s%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D14%26spage%3D5437%26epage%3D5444%26doi%3D10.1021%2Facs.jmedchem.5b00734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edalji, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/mivebresib), a potent and orally available bromodomain and extraterminal domain (BET) family bromodomain inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8369-8384&issue=20&author=K.+F.+McDanielauthor=L.+Wangauthor=T.+Soltwedelauthor=S.+D.+Fidanzeauthor=L.+A.+Hasvoldauthor=D.+Liuauthor=R.+A.+Manteiauthor=J.+K.+Prattauthor=G.+S.+Sheppardauthor=M.+H.+Buiauthor=E.+J.+Faivreauthor=X.+Huangauthor=L.+Liauthor=X.+Linauthor=R.+Wangauthor=S.+E.+Warderauthor=D.+Wilcoxauthor=D.+H.+Albertauthor=T.+J.+Magocauthor=G.+Rajaramanauthor=C.+H.+Parkauthor=C.+W.+Hutchinsauthor=J.+J.+Shenauthor=R.+P.+Edaljiauthor=C.+C.+Sunauthor=R.+Martinauthor=W.+Gaoauthor=S.+Wongauthor=G.+Fangauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Kati&title=Discovery+of+N-%284-%282%2C4-difluorophenoxy%29-3-%286-methyl-7-oxo-6%2C7-dihydro-1H-pyrrolo%5B2%2C3-c%5Dpyridin-4-yl%29phenyl%29ethanesulfonamide+%28ABBV-075%2Fmivebresib%29%2C+a+potent+and+orally+available+bromodomain+and+extraterminal+domain+%28BET%29+family+bromodomain+inhibitor&doi=10.1021%2Facs.jmedchem.7b00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor</span></div><div class="casAuthors">McDaniel, Keith F.; Wang, Le; Soltwedel, Todd; Fidanze, Steven D.; Hasvold, Lisa A.; Liu, Dachun; Mantei, Robert A.; Pratt, John K.; Sheppard, George S.; Bui, Mai H.; Faivre, Emily J.; Huang, Xiaoli; Li, Leiming; Lin, Xiaoyu; Wang, Rongqi; Warder, Scott E.; Wilcox, Denise; Albert, Daniel H.; Magoc, Terrance J.; Rajaraman, Ganesh; Park, Chang H.; Hutchins, Charles W.; Shen, Jianwei J.; Edalji, Rohinton P.; Sun, Chaohong C.; Martin, Ruth; Gao, Wenqing; Wong, Shekman; Fang, Guowei; Elmore, Steven W.; Shen, Yu; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8369-8384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bromodomain and extraterminal domain (BET) bromodomain inhibitors and their examn. in clin. studies, particularly in oncol. settings, has garnered substantial recent interest.  An effort to generate novel BET bromodomain inhibitors with excellent potency and drug metab. and pharmacokinetics (DMPK) properties was initiated based upon elaboration of a simple pyridone core.  Efforts to develop a bidentate interaction with a crit. asparagine residue resulted in the incorporation of a pyrrolopyridone core, which improved potency by 9-19-fold.  Addnl. structure-activity relationship (SAR) efforts aimed both at increasing potency and improving pharmacokinetic properties led to the discovery of the clin. candidate I (ABBV-075/mivebresib), which demonstrates excellent potency in biochem. and cellular assays, advantageous exposures and half-life both in animal models and in humans, and in vivo efficacy in mouse models of cancer progression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-8BkipNknbVg90H21EOLACvtfcHk0ljXDdPmuuahzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF&md5=16ea9e9ade8a22a6e99aeae16fd1bf9c</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DFaivre%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DEdalji%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282%252C4-difluorophenoxy%2529-3-%25286-methyl-7-oxo-6%252C7-dihydro-1H-pyrrolo%255B2%252C3-c%255Dpyridin-4-yl%2529phenyl%2529ethanesulfonamide%2520%2528ABBV-075%252Fmivebresib%2529%252C%2520a%2520potent%2520and%2520orally%2520available%2520bromodomain%2520and%2520extraterminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8369%26epage%3D8384%26doi%3D10.1021%2Facs.jmedchem.7b00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of TAK-272: a novel, potent, and orally active renin inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">938</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00251</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00251" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=933-938&issue=10&author=Y.+Imaedaauthor=H.+Tokuharaauthor=Y.+Fukaseauthor=R.+Kanagawaauthor=Y.+Kajimotoauthor=K.+Kusumotoauthor=M.+Kondoauthor=G.+Snellauthor=C.+A.+Behnkeauthor=T.+Kuroita&title=Discovery+of+TAK-272%3A+a+novel%2C+potent%2C+and+orally+active+renin+inhibitor&doi=10.1021%2Facsmedchemlett.6b00251"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00251%26sid%3Dliteratum%253Aachs%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DKanagawa%26aufirst%3DR.%26aulast%3DKajimoto%26aufirst%3DY.%26aulast%3DKusumoto%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DKuroita%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520TAK-272%253A%2520a%2520novel%252C%2520potent%252C%2520and%2520orally%2520active%2520renin%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D10%26spage%3D933%26epage%3D938%26doi%3D10.1021%2Facsmedchemlett.6b00251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small-molecule reversible factor D Inhibitors demonstrating alternative complement pathway inhibition in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5717</span>– <span class="NLM_lpage">5735</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5717-5735&issue=13&author=E.+Lorthioisauthor=K.+Andersonauthor=A.+Vulpettiauthor=O.+Rogelauthor=F.+Cuminauthor=N.+Ostermannauthor=S.+Steinbacherauthor=A.+Mac+Sweeneyauthor=O.+Delgadoauthor=S.+M.+Liaoauthor=S.+Randlauthor=S.+Rudisserauthor=S.+Dussaugeauthor=K.+Fettisauthor=L.+Kiefferauthor=A.+de+Erkenezauthor=L.+Yangauthor=C.+Hartwiegauthor=U.+A.+Argikarauthor=L.+R.+La+Bonteauthor=R.+Newtonauthor=V.+Kansaraauthor=S.+Flohrauthor=U.+Hommelauthor=B.+Jaffeeauthor=J.+Maibaum&title=Discovery+of+highly+potent+and+selective+small-molecule+reversible+factor+D+Inhibitors+demonstrating+alternative+complement+pathway+inhibition+in+vivo&doi=10.1021%2Facs.jmedchem.7b00425"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00425%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHartwieg%26aufirst%3DC.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKansara%26aufirst%3DV.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small-molecule%2520reversible%2520factor%2520D%2520Inhibitors%2520demonstrating%2520alternative%2520complement%2520pathway%2520inhibition%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5717%26epage%3D5735%26doi%3D10.1021%2Facs.jmedchem.7b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryskin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatlock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyridone-containing 3,4-dihydroisoquinoline-1(2H)-ones as a novel class of enhancer of zeste homolog 2 (EZH2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8306</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8306-8325&issue=18&author=P.+P.+Kungauthor=E.+Ruiauthor=S.+Bergqvistauthor=P.+Binghamauthor=J.+Braganzaauthor=M.+Collinsauthor=M.+Cuiauthor=W.+Diehlauthor=D.+Dinhauthor=C.+Fanauthor=V.+R.+Fantinauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=S.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=G.+Liauthor=K.+A.+Maegleyauthor=I.+McAlpineauthor=L.+Nguyenauthor=S.+Ninkovicauthor=M.+Ornelasauthor=M.+Ryskinauthor=S.+Scalesauthor=S.+Suttonauthor=J.+Tatlockauthor=D.+Verhelleauthor=F.+Wangauthor=P.+Wellsauthor=M.+Wythesauthor=S.+Yamazakiauthor=B.+Yipauthor=X.+Yuauthor=L.+Zehnderauthor=W.+G.+Zhangauthor=R.+A.+Rollinsauthor=M.+Edwards&title=Design+and+synthesis+of+pyridone-containing+3%2C4-dihydroisoquinoline-1%282H%29-ones+as+a+novel+class+of+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors</span></div><div class="casAuthors">Kung, Pei-Pei; Rui, Eugene; Bergqvist, Simon; Bingham, Patrick; Braganza, John; Collins, Michael; Cui, Mei; Diehl, Wade; Dinh, Dac; Fan, Connie; Fantin, Valeria R.; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kephart, Susan; Krivacic, Cody; Kumpf, Robert A.; Li, Gary; Maegley, Karen A.; McAlpine, Indrawan; Nguyen, Lisa; Ninkovic, Sacha; Ornelas, Martha; Ryskin, Michael; Scales, Stephanie; Sutton, Scott; Tatlock, John; Verhelle, Dominique; Wang, Fen; Wells, Peter; Wythes, Martin; Yamazaki, Shinji; Yip, Brian; Yu, Xiu; Zehnder, Luke; Zhang, Wei-Guo; Rollins, Robert A.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8306-8325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new enhancer of zeste homolog 2 (EZH2) inhibitor series comprising a substituted Ph ring joined to a dimethylpyridone moiety via an amide linkage has been designed.  A preferential amide torsion that improved the binding properties of the compds. was identified for this series via computational anal.  Cyclization of the amide linker resulted in a six-membered lactam analog, compd. I.  This transformation significantly improved the ligand efficiency/potency of the cyclized compd. relative to its acyclic analog.  Addnl. optimization of the lactam-contg. EZH2 inhibitors focused on lipophilic efficiency (LipE) improvement, which provided compd. II.  Compd. II displayed improved LipE and on-target potency in both biochem. and cellular readouts relative to compd. I.  Inhibitor II also displayed robust in vivo antitumor growth activity and dose-dependent de-repression of EZH2 target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50CIrIhlikrVg90H21EOLACvtfcHk0ljf681nrWJhgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM&md5=eb6f2b053e5ba2c2d214d847ad8d9f1f</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00515%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DRui%26aufirst%3DE.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DMcAlpine%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DRyskin%26aufirst%3DM.%26aulast%3DScales%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DYip%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridone-containing%25203%252C4-dihydroisoquinoline-1%25282H%2529-ones%2520as%2520a%2520novel%2520class%2520of%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8306%26epage%3D8325%26doi%3D10.1021%2Facs.jmedchem.6b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handlon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaller, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesnitzer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrihew, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, P.</span></span> <span> </span><span class="NLM_article-title">Optimizing ligand efficiency of selective androgen receptor modulators (SARMs)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00377</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00377" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=83-88&issue=1&author=A.+L.+Handlonauthor=L.+T.+Schallerauthor=L.+M.+Leesnitzerauthor=R.+V.+Merrihewauthor=C.+Pooleauthor=J.+C.+Ulrichauthor=J.+W.+Wilsonauthor=R.+Cadillaauthor=P.+Turnbull&title=Optimizing+ligand+efficiency+of+selective+androgen+receptor+modulators+%28SARMs%29&doi=10.1021%2Facsmedchemlett.5b00377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00377%26sid%3Dliteratum%253Aachs%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DSchaller%26aufirst%3DL.%2BT.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DMerrihew%26aufirst%3DR.%2BV.%26aulast%3DPoole%26aufirst%3DC.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DCadilla%26aufirst%3DR.%26aulast%3DTurnbull%26aufirst%3DP.%26atitle%3DOptimizing%2520ligand%2520efficiency%2520of%2520selective%2520androgen%2520receptor%2520modulators%2520%2528SARMs%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D83%26epage%3D88%26doi%3D10.1021%2Facsmedchemlett.5b00377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goosen, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosset, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, B.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7185</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7173-7185&issue=18&author=K.+Futatsugiauthor=D.+W.+Kungauthor=S.+T.+Orrauthor=S.+Cabralauthor=D.+Hepworthauthor=G.+Aspnesauthor=S.+Baderauthor=J.+Bianauthor=M.+Boehmauthor=P.+A.+Carpinoauthor=S.+B.+Coffeyauthor=M.+S.+Dowlingauthor=M.+Herrauthor=W.+Jiaoauthor=S.+Y.+Lavergneauthor=Q.+Liauthor=R.+W.+Clarkauthor=D.+M.+Erionauthor=K.+Kouauthor=K.+Leeauthor=B.+A.+Pabstauthor=S.+M.+Perezauthor=J.+Purkalauthor=C.+C.+Jorgensenauthor=T.+C.+Goosenauthor=J.+R.+Gossetauthor=M.+Niosiauthor=J.+C.+Pettersenauthor=J.+A.+Pfefferkornauthor=K.+Ahnauthor=B.+Goodwin&title=Discovery+and+optimization+of+imidazopyridine-based+inhibitors+of+diacylglycerol+acyltransferase+2+%28DGAT2%29&doi=10.1021%2Facs.jmedchem.5b01006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01006%26sid%3Dliteratum%253Aachs%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DBader%26aufirst%3DS.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DClark%26aufirst%3DR.%2BW.%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DKou%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPabst%26aufirst%3DB.%2BA.%26aulast%3DPerez%26aufirst%3DS.%2BM.%26aulast%3DPurkal%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DC.%2BC.%26aulast%3DGoosen%26aufirst%3DT.%2BC.%26aulast%3DGosset%26aufirst%3DJ.%2BR.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DGoodwin%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520imidazopyridine-based%2520inhibitors%2520of%2520diacylglycerol%2520acyltransferase%25202%2520%2528DGAT2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7173%26epage%3D7185%26doi%3D10.1021%2Facs.jmedchem.5b01006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span> <span> </span><span class="NLM_article-title">Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3626</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.06.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3626-3629&issue=17&author=J.+T.+Bagdanoffauthor=R.+Jainauthor=W.+Hanauthor=D.+Poonauthor=P.+S.+Leeauthor=C.+Bellamacinaauthor=M.+Lindvall&title=Ligand+efficient+tetrahydro-pyrazolopyridines+as+inhibitors+of+ERK2+kinase&doi=10.1016%2Fj.bmcl.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DPoon%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DP.%2BS.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DLigand%2520efficient%2520tetrahydro-pyrazolopyridines%2520as%2520inhibitors%2520of%2520ERK2%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3626%26epage%3D3629%26doi%3D10.1016%2Fj.bmcl.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flattery, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlisi, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labroli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayhood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinness, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roemer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span> <span> </span><span class="NLM_article-title">Can we make small molecules lean? optimization of a highly lipophilic TarO inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3851</span>– <span class="NLM_lpage">3865</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3851-3865&issue=9&author=M.+Mandalauthor=Z.+Tanauthor=C.+Madsen-Dugganauthor=A.+V.+Buevichauthor=J.+P.+Caldwellauthor=R.+Dejesusauthor=A.+Flatteryauthor=C.+G.+Garlisiauthor=C.+Gillauthor=S.+N.+Haauthor=G.+Hoauthor=S.+Koseogluauthor=M.+Labroliauthor=K.+Basuauthor=S.+H.+Leeauthor=L.+Liangauthor=J.+Liuauthor=T.+Mayhoodauthor=D.+McGuinnessauthor=D.+G.+McLarenauthor=X.+Wenauthor=E.+Parmeeauthor=D.+Rindgenauthor=T.+Roemerauthor=P.+Shethauthor=P.+Tawaauthor=J.+Tataauthor=C.+Yangauthor=S.+W.+Yangauthor=L.+Xiaoauthor=H.+Wangauthor=C.+Tanauthor=H.+Tangauthor=P.+Walshauthor=E.+Walshauthor=J.+Wuauthor=J.+Su&title=Can+we+make+small+molecules+lean%3F+optimization+of+a+highly+lipophilic+TarO+inhibitor&doi=10.1021%2Facs.jmedchem.7b00113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00113%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DBuevich%26aufirst%3DA.%2BV.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DDejesus%26aufirst%3DR.%26aulast%3DFlattery%26aufirst%3DA.%26aulast%3DGarlisi%26aufirst%3DC.%2BG.%26aulast%3DGill%26aufirst%3DC.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DHo%26aufirst%3DG.%26aulast%3DKoseoglu%26aufirst%3DS.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMayhood%26aufirst%3DT.%26aulast%3DMcGuinness%26aufirst%3DD.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DParmee%26aufirst%3DE.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DRoemer%26aufirst%3DT.%26aulast%3DSheth%26aufirst%3DP.%26aulast%3DTawa%26aufirst%3DP.%26aulast%3DTata%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BW.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DP.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%26atitle%3DCan%2520we%2520make%2520small%2520molecules%2520lean%253F%2520optimization%2520of%2520a%2520highly%2520lipophilic%2520TarO%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3851%26epage%3D3865%26doi%3D10.1021%2Facs.jmedchem.7b00113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barricklow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whritenour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (R)-6-neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9 H)-one (PF-06462894), an alkyne-lacking metabotropic glutamate receptor 5 negative allosteric modulator profiled in both rat and nonhuman primates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7764</span>– <span class="NLM_lpage">7780</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7764-7780&issue=18&author=A.+F.+Stepanauthor=M.+M.+Claffeyauthor=M.+R.+Reeseauthor=G.+Balanauthor=G.+Barreiroauthor=J.+Barricklowauthor=M.+J.+Bohanonauthor=B.+P.+Boscoeauthor=G.+D.+Capponauthor=L.+K.+Chenardauthor=J.+Cianfrognaauthor=L.+Chenauthor=K.+J.+Coffmanauthor=S.+E.+Drozdaauthor=J.+R.+Dunetzauthor=S.+Ghoshauthor=X.+Houauthor=C.+Houleauthor=K.+Karkiauthor=J.+T.+Lazzaroauthor=J.+Y.+Mancusoauthor=J.+M.+Marcekauthor=E.+L.+Millerauthor=M.+A.+Moenauthor=S.+O%E2%80%99Neilauthor=I.+Sakuradaauthor=M.+Skaddanauthor=V.+Parikhauthor=D.+L.+Smithauthor=P.+Trapaauthor=J.+B.+Tuttleauthor=P.+R.+Verhoestauthor=D.+P.+Walkerauthor=A.+Wonauthor=A.+S.+Wrightauthor=J.+Whritenourauthor=K.+Zasadnyauthor=M.+M.+Zaleskaauthor=L.+Zhangauthor=C.+L.+Shaffer&title=Discovery+and+characterization+of+%28R%29-6-neopentyl-2-%28pyridin-2-ylmethoxy%29-6%2C7-dihydropyrimido%5B2%2C1-c%5D%5B1%2C4%5Doxazin-4%289+H%29-one+%28PF-06462894%29%2C+an+alkyne-lacking+metabotropic+glutamate+receptor+5+negative+allosteric+modulator+profiled+in+both+rat+and+nonhuman+primates&doi=10.1021%2Facs.jmedchem.7b00604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00604%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DBohanon%26aufirst%3DM.%2BJ.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DCappon%26aufirst%3DG.%2BD.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DMarcek%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DE.%2BL.%26aulast%3DMoen%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%26aulast%3DSakurada%26aufirst%3DI.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DWhritenour%26aufirst%3DJ.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%2528R%2529-6-neopentyl-2-%2528pyridin-2-ylmethoxy%2529-6%252C7-dihydropyrimido%255B2%252C1-c%255D%255B1%252C4%255Doxazin-4%25289%2520H%2529-one%2520%2528PF-06462894%2529%252C%2520an%2520alkyne-lacking%2520metabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulator%2520profiled%2520in%2520both%2520rat%2520and%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D18%26spage%3D7764%26epage%3D7780%26doi%3D10.1021%2Facs.jmedchem.7b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, selective, and peripherally restricted pan-Trk inhibitor (PF-06273340) for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">10084</span>– <span class="NLM_lpage">10099</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10084-10099&issue=22&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldron&title=The+discovery+of+a+potent%2C+selective%2C+and+peripherally+restricted+pan-Trk+inhibitor+%28PF-06273340%29+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span></div><div class="casAuthors">Skerratt, Sarah E.; Andrews, Mark; Bagal, Sharan K.; Bilsland, James; Brown, David; Bungay, Peter J.; Cole, Susan; Gibson, Karl R.; Jones, Russell; Morao, Inaki; Nedderman, Angus; Omoto, Kiyoyuki; Robinson, Colin; Ryckmans, Thomas; Skinner, Kimberly; Stupple, Paul; Waldron, Gareth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10084-10099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotrophin family of growth factors, comprised of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4 (NT4), is implicated in the physiol. of chronic pain.  Given the clin. efficacy of anti-NGF monoclonal antibody (mAb) therapies, there is significant interest in the development of small mol. modulators of neurotrophin activity.  Neurotrophins signal through the tropomyosin related kinase (Trk) family of tyrosine kinase receptors, hence Trk kinase inhibition represents a potentially "druggable" point of intervention.  To deliver the safety profile required for chronic, non-life threatening pain indications, highly kinase-selective Trk inhibitors with minimal brain availability are sought.  Herein the authors describe how the use of SBDD, 2D QSAR models and Matched Mol. Pair data in compd. design enabled the delivery of the highly potent, kinase-selective and peripherally restricted clin. candidate PF-06273340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67CFmGAkmRrVg90H21EOLACvtfcHk0ljPnWuXmmcn5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL&md5=f8c904a92c1716062c217fefe2374ce6</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldron%26aufirst%3DG.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520peripherally%2520restricted%2520pan-Trk%2520inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D22%26spage%3D10084%26epage%3D10099%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carswell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belshaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struthers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stribling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzimidazole CYP11B2 inhibitors with in vivo activity in rhesus monkeys</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=573-578&issue=5&author=S.+B.+Hoytauthor=M.+K.+Parkauthor=C.+Londonauthor=Y.+Xiongauthor=J.+Tataauthor=D.+J.+Bennettauthor=A.+Cookeauthor=J.+Caiauthor=E.+Carswellauthor=J.+Robinsonauthor=J.+MacLeanauthor=L.+Brownauthor=S.+Belshawauthor=T.+R.+Clarksonauthor=K.+Liuauthor=G.+B.+Liangauthor=M.+Struthersauthor=D.+Cullyauthor=T.+Wisniewskiauthor=N.+Renauthor=C.+Boppauthor=A.+Sokauthor=T.+Q.+Caiauthor=S.+Striblingauthor=L.+Y.+Paiauthor=X.+Maauthor=J.+Metzgerauthor=A.+Verrasauthor=D.+McMastersauthor=Q.+Chenauthor=E.+Tungauthor=W.+Tangauthor=G.+Salituroauthor=N.+Buistauthor=J.+Kuetheauthor=N.+Riveraauthor=J.+Clemasauthor=G.+Zhouauthor=J.+Gibsonauthor=C.+A.+Maxwellauthor=M.+Lassmanauthor=T.+McLaughlinauthor=J.+Castro-Perezauthor=D.+Szetoauthor=G.+Forrestauthor=R.+Hajduauthor=M.+Rosenbachauthor=A.+Ali&title=Discovery+of+benzimidazole+CYP11B2+inhibitors+with+in+vivo+activity+in+rhesus+monkeys&doi=10.1021%2Facsmedchemlett.5b00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00054%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DPark%26aufirst%3DM.%2BK.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DTata%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCarswell%26aufirst%3DE.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMacLean%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBelshaw%26aufirst%3DS.%26aulast%3DClarkson%26aufirst%3DT.%2BR.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DG.%2BB.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DCully%26aufirst%3DD.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DBopp%26aufirst%3DC.%26aulast%3DSok%26aufirst%3DA.%26aulast%3DCai%26aufirst%3DT.%2BQ.%26aulast%3DStribling%26aufirst%3DS.%26aulast%3DPai%26aufirst%3DL.%2BY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMetzger%26aufirst%3DJ.%26aulast%3DVerras%26aufirst%3DA.%26aulast%3DMcMasters%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DTung%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DBuist%26aufirst%3DN.%26aulast%3DKuethe%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DN.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DC.%2BA.%26aulast%3DLassman%26aufirst%3DM.%26aulast%3DMcLaughlin%26aufirst%3DT.%26aulast%3DCastro-Perez%26aufirst%3DJ.%26aulast%3DSzeto%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520benzimidazole%2520CYP11B2%2520inhibitors%2520with%2520in%2520vivo%2520activity%2520in%2520rhesus%2520monkeys%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.5b00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliushchev, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrent, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarris, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algire, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweis, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M. R.</span></span> <span> </span><span class="NLM_article-title">SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2017.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28254486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Oju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1576-1583&issue=7&author=M.+L.+Curtinauthor=M.+A.+Pliushchevauthor=H.+Q.+Liauthor=M.+Torrentauthor=J.+D.+Dietrichauthor=C.+G.+Jakobauthor=H.+Zhuauthor=H.+Zhaoauthor=Y.+Wangauthor=Z.+Jiauthor=R.+F.+Clarkauthor=K.+A.+Sarrisauthor=S.+Selvarajuauthor=B.+Shawauthor=M.+A.+Algireauthor=Y.+Heauthor=P.+L.+Richardsonauthor=R.+F.+Sweisauthor=C.+Sunauthor=G.+G.+Chiangauthor=M.+R.+Michaelides&title=SAR+of+amino+pyrrolidines+as+potent+and+novel+protein-protein+interaction+inhibitors+of+the+PRC2+complex+through+EED+binding&doi=10.1016%2Fj.bmcl.2017.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding</span></div><div class="casAuthors">Curtin, Michael L.; Pliushchev, Marina A.; Li, Huan-Qiu; Torrent, Maricel; Dietrich, Justin D.; Jakob, Clarissa G.; Zhu, Haizhong; Zhao, Hongyu; Wang, Ying; Ji, Zhiqin; Clark, Richard F.; Sarris, Kathy A.; Selvaraju, Sujatha; Shaw, Bailin; Algire, Mikkel A.; He, Yupeng; Richardson, Paul L.; Sweis, Ramzi F.; Sun, Chaohong; Chiang, Gary G.; Michaelides, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1583</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we disclose SAR studies of a series of dimethylamino pyrrolidines which we recently reported as novel inhibitors of the PRC2 complex through disruption of EED/H3K27me3 binding.  Modification of the indole and benzyl moieties of screening hit 1 provided analogs with substantially improved binding and cellular activities.  This work culminated in the identification of compd. 2, our nanomolar proof-of-concept (PoC) inhibitor which provided on-target tumor growth inhibition in a mouse xenograft model.  X-ray crystal structures of several inhibitors bound in the EED active-site are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkdonJy6cBnbVg90H21EOLACvtfcHk0lgzdAqWpZ8IaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Oju7s%253D&md5=3396f3f4c2d3944237cfde004ac4204b</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DPliushchev%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%2BQ.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DDietrich%26aufirst%3DJ.%2BD.%26aulast%3DJakob%26aufirst%3DC.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DClark%26aufirst%3DR.%2BF.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DSelvaraju%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DAlgire%26aufirst%3DM.%2BA.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DSweis%26aufirst%3DR.%2BF.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DSAR%2520of%2520amino%2520pyrrolidines%2520as%2520potent%2520and%2520novel%2520protein-protein%2520interaction%2520inhibitors%2520of%2520the%2520PRC2%2520complex%2520through%2520EED%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D1576%26epage%3D1583%26doi%3D10.1016%2Fj.bmcl.2017.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djakovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madriaga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss von
Soly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawver, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Moigne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustrow, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9480</span>– <span class="NLM_lpage">9497</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9480-9497&issue=24&author=H.+J.+Zhouauthor=J.+Wangauthor=B.+Yaoauthor=S.+Wongauthor=S.+Djakovicauthor=B.+Kumarauthor=J.+Riceauthor=E.+Valleauthor=F.+Sorianoauthor=M.+K.+Menonauthor=A.+Madriagaauthor=S.+Kiss+von%0ASolyauthor=A.+Kumarauthor=F.+Parlatiauthor=F.+M.+Yakesauthor=L.+Shawverauthor=R.+Le+Moigneauthor=D.+J.+Andersonauthor=M.+Rolfeauthor=D.+Wustrow&title=Discovery+of+a+first-in-class%2C+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+p97+AAA+ATPase+%28CB-5083%29&doi=10.1021%2Facs.jmedchem.5b01346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01346%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DDjakovic%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DB.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DValle%26aufirst%3DE.%26aulast%3DSoriano%26aufirst%3DF.%26aulast%3DMenon%26aufirst%3DM.%2BK.%26aulast%3DMadriaga%26aufirst%3DA.%26aulast%3DKiss%2Bvon%2BSoly%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DShawver%26aufirst%3DL.%26aulast%3DLe%2BMoigne%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DWustrow%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%252C%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520p97%2520AAA%2520ATPase%2520%2528CB-5083%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D24%26spage%3D9480%26epage%3D9497%26doi%3D10.1021%2Facs.jmedchem.5b01346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-Based design of tricyclic NF-kappaB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&issue=2&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.+F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-Based+design+of+tricyclic+NF-kappaB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%2BF.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-Based%2520design%2520of%2520tricyclic%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D2%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, T.</span></span> <span> </span><span class="NLM_article-title">Structural Optimization of ghrelin receptor inverse agonists to improve lipophilicity and avoid mechanism-based CYP3A4 inactivation</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1248/cpb.c15-00285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1248%2Fcpb.c15-00285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=825-832&issue=10&author=B.+Takahashiauthor=H.+Funamiauthor=M.+Shibataauthor=H.+Maruokaauthor=M.+Koyamaauthor=S.+Kankiauthor=T.+Muto&title=Structural+Optimization+of+ghrelin+receptor+inverse+agonists+to+improve+lipophilicity+and+avoid+mechanism-based+CYP3A4+inactivation&doi=10.1248%2Fcpb.c15-00285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c15-00285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c15-00285%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DB.%26aulast%3DFunami%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMaruoka%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DM.%26aulast%3DKanki%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DT.%26atitle%3DStructural%2520Optimization%2520of%2520ghrelin%2520receptor%2520inverse%2520agonists%2520to%2520improve%2520lipophilicity%2520and%2520avoid%2520mechanism-based%2520CYP3A4%2520inactivation%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2015%26volume%3D63%26issue%3D10%26spage%3D825%26epage%3D832%26doi%3D10.1248%2Fcpb.c15-00285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillgrove, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel aza-benzimidazolone mGluR2 PAMs with respect to LLE and PK properties and mitigation of CYP TDI</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=312-317&issue=3&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=M.+J.+Kellyauthor=H.+D.+Lehmanauthor=M.+E.+Laytonauthor=R.+M.+Garbaccioauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=M.+A.+Jacobson&title=Optimization+of+novel+aza-benzimidazolone+mGluR2+PAMs+with+respect+to+LLE+and+PK+properties+and+mitigation+of+CYP+TDI&doi=10.1021%2Facsmedchemlett.5b00459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00459%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DLehman%26aufirst%3DH.%2BD.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DOptimization%2520of%2520novel%2520aza-benzimidazolone%2520mGluR2%2520PAMs%2520with%2520respect%2520to%2520LLE%2520and%2520PK%2520properties%2520and%2520mitigation%2520of%2520CYP%2520TDI%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D312%26epage%3D317%26doi%3D10.1021%2Facsmedchemlett.5b00459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&issue=20&author=K.+Doyleauthor=H.+Lonnauthor=H.+Kackauthor=A.+Van+de+Poelauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPP1+inhibitors+leading+to+an+oxazepane+amidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)</span></div><div class="casAuthors">Doyle, Kevin; Lonn, Hans; Kack, Helena; Van de Poel, Amanda; Swallow, Steve; Gardiner, Philip; Connolly, Stephen; Root, James; Wikell, Cecilia; Dahl, Goran; Stenvall, Kristina; Johannesson, Petra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9457-9472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of second generation DPP1 inhibitors free from aorta binding liabilities found for earlier compd. series was discovered.  This work culminated in the identification of compd. 30 (AZD7986) as a highly potent, reversible, and selective clin. candidate for COPD, with predicted human PK properties suitable for once daily human dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ_YtbyrmtbVg90H21EOLACvtfcHk0lgooNXOV5NozA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF&md5=73daf54da4a47b7b11db53e0b5a98e50</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DLonn%26aufirst%3DH.%26aulast%3DKack%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPoel%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepane%2520amidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D20%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilandt, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imperio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewcock, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of dual leucine zipper kinase (DLK, MAP3K12) with activity in a model of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">8083</span>– <span class="NLM_lpage">8102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00843</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8083-8102&issue=19&author=S.+Patelauthor=W.+J.+Meilandtauthor=R.+I.+Ericksonauthor=J.+Chenauthor=G.+Deshmukhauthor=A.+A.+Estradaauthor=R.+N.+Fujiauthor=P.+Gibbonsauthor=A.+Gustafsonauthor=S.+F.+Harrisauthor=J.+Imperioauthor=W.+Liuauthor=X.+Liuauthor=Y.+Liuauthor=J.+P.+Lyssikatosauthor=C.+Maauthor=J.+Yinauthor=J.+W.+Lewcockauthor=M.+Siu&title=Selective+inhibitors+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29+with+activity+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00843%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMeilandt%26aufirst%3DW.%2BJ.%26aulast%3DErickson%26aufirst%3DR.%2BI.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DImperio%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DSelective%2520inhibitors%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%2520with%2520activity%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D19%26spage%3D8083%26epage%3D8102%26doi%3D10.1021%2Facs.jmedchem.7b00843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishigaya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, S.</span></span> <span> </span><span class="NLM_article-title">Identification of novel 1,2,3,6-tetrahydropyridyl-substituted benzo[d]thiazoles: Lead generation and optimization toward potent and orally active EP1 receptor antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3406</span>– <span class="NLM_lpage">3430</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmc.2017.04.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3406-3430&issue=13&author=K.+Umeiauthor=Y.+Nishigayaauthor=K.+Tataniauthor=Y.+Kohnoauthor=N.+Tanakaauthor=S.+Seto&title=Identification+of+novel+1%2C2%2C3%2C6-tetrahydropyridyl-substituted+benzo%5Bd%5Dthiazoles%3A+Lead+generation+and+optimization+toward+potent+and+orally+active+EP1+receptor+antagonists&doi=10.1016%2Fj.bmc.2017.04.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DUmei%26aufirst%3DK.%26aulast%3DNishigaya%26aufirst%3DY.%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520novel%25201%252C2%252C3%252C6-tetrahydropyridyl-substituted%2520benzo%255Bd%255Dthiazoles%253A%2520Lead%2520generation%2520and%2520optimization%2520toward%2520potent%2520and%2520orally%2520active%2520EP1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3406%26epage%3D3430%26doi%3D10.1016%2Fj.bmc.2017.04.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inatomi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajino, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmc.2017.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3298-3314&issue=13&author=H.+Nishidaauthor=Y.+Arikawaauthor=K.+Hiraseauthor=T.+Imaedaauthor=N.+Inatomiauthor=Y.+Horiauthor=J.+Matsukawaauthor=Y.+Fujiokaauthor=T.+Hamadaauthor=M.+Iidaauthor=M.+Nishitaniauthor=A.+Imanishiauthor=H.+Fukuiauthor=F.+Itohauthor=M.+Kajino&title=Identification+of+a+novel+fluoropyrrole+derivative+as+a+potassium-competitive+acid+blocker+with+long+duration+of+action&doi=10.1016%2Fj.bmc.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DH.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DHirase%26aufirst%3DK.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DInatomi%26aufirst%3DN.%26aulast%3DHori%26aufirst%3DY.%26aulast%3DMatsukawa%26aufirst%3DJ.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DM.%26aulast%3DNishitani%26aufirst%3DM.%26aulast%3DImanishi%26aufirst%3DA.%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKajino%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520fluoropyrrole%2520derivative%2520as%2520a%2520potassium-competitive%2520acid%2520blocker%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3298%26epage%3D3314%26doi%3D10.1016%2Fj.bmc.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutheuil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bousmaqui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, S.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel antagonists to the neurokinin-3 receptor for the treatment of sex-hormone disorders (part II)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00117</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00117" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=736-740&issue=7&author=H.+R.+Hoveydaauthor=G.+L.+Fraserauthor=G.+Dutheuilauthor=M.+El+Bousmaquiauthor=J.+Koracauthor=F.+Lenoirauthor=A.+Lapinauthor=S.+Noel&title=Optimization+of+novel+antagonists+to+the+neurokinin-3+receptor+for+the+treatment+of+sex-hormone+disorders+%28part+II%29&doi=10.1021%2Facsmedchemlett.5b00117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00117%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26aulast%3DDutheuil%26aufirst%3DG.%26aulast%3DEl%2BBousmaqui%26aufirst%3DM.%26aulast%3DKorac%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLapin%26aufirst%3DA.%26aulast%3DNoel%26aufirst%3DS.%26atitle%3DOptimization%2520of%2520novel%2520antagonists%2520to%2520the%2520neurokinin-3%2520receptor%2520for%2520the%2520treatment%2520of%2520sex-hormone%2520disorders%2520%2528part%2520II%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D7%26spage%3D736%26epage%3D740%26doi%3D10.1021%2Facsmedchemlett.5b00117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pretel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1039/C7MD00078B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC7MD00078B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1246-1254&issue=6&author=J.+L.+D%C3%ADazauthor=J.+Corberaauthor=D.+Mart%C3%ADnezauthor=M.+Bordasauthor=C.+Sicreauthor=R.+Pascualauthor=M.+J.+Pretelauthor=A.+P.+Mar%C3%ADnauthor=A.+Monteroauthor=A.+Dordalauthor=I.+Alvarezauthor=C.+Almansa&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+as+sigma-1+receptor+ligands+for+the+treatment+of+pain.+Part+2%3A+Introduction+of+cyclic+substituents+in+position+4&doi=10.1039%2FC7MD00078B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1039%2FC7MD00078B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00078B%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCorbera%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DD.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DSicre%26aufirst%3DC.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DPretel%26aufirst%3DM.%2BJ.%26aulast%3DMar%25C3%25ADn%26aufirst%3DA.%2BP.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DI.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520sigma-1%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain.%2520Part%25202%253A%2520Introduction%2520of%2520cyclic%2520substituents%2520in%2520position%25204%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1246%26epage%3D1254%26doi%3D10.1039%2FC7MD00078B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&issue=5&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+a+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520a%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohls, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPetrillo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monovich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idamakanti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taslimi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunjathoor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. M.</span></span> <span> </span><span class="NLM_article-title">Optimization of allosteric with-no-lysine (WNK) kinase inhibitors and efficacy in rodent hypertension models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7099</span>– <span class="NLM_lpage">7107</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7099-7107&issue=16&author=K.+Yamadaauthor=J.+Levellauthor=T.+Yoonauthor=D.+Kohlsauthor=D.+Yoweauthor=D.+F.+Rigelauthor=H.+Imaseauthor=J.+Yuanauthor=K.+Yasoshimaauthor=K.+DiPetrilloauthor=L.+Monovichauthor=L.+Xuauthor=M.+Zhuauthor=M.+Katoauthor=M.+Jainauthor=N.+Idamakantiauthor=P.+Taslimiauthor=T.+Kawanamiauthor=U.+A.+Argikarauthor=V.+Kunjathoorauthor=X.+Xieauthor=Y.+I.+Yagiauthor=Y.+Iwakiauthor=Z.+Robinsonauthor=H.+M.+Park&title=Optimization+of+allosteric+with-no-lysine+%28WNK%29+kinase+inhibitors+and+efficacy+in+rodent+hypertension+models&doi=10.1021%2Facs.jmedchem.7b00708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00708%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DLevell%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DYowe%26aufirst%3DD.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DImase%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYasoshima%26aufirst%3DK.%26aulast%3DDiPetrillo%26aufirst%3DK.%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DKunjathoor%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYagi%26aufirst%3DY.%2BI.%26aulast%3DIwaki%26aufirst%3DY.%26aulast%3DRobinson%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DH.%2BM.%26atitle%3DOptimization%2520of%2520allosteric%2520with-no-lysine%2520%2528WNK%2529%2520kinase%2520inhibitors%2520and%2520efficacy%2520in%2520rodent%2520hypertension%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D16%26spage%3D7099%26epage%3D7107%26doi%3D10.1021%2Facs.jmedchem.7b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref279"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref279'); return false;" data-citation="" class="refNumLink">279</a></strong><div class="NLM_citation" id="cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargent, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejsing, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthorne, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent free fatty acid 1 receptor agonist with low lipophilicity, low polar surface area, and robust in vivo efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2841</span>– <span class="NLM_lpage">2846</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2841-2846&issue=6&author=S.+V.+Hansenauthor=E.+Christiansenauthor=C.+Urbanauthor=B.+D.+Hudsonauthor=C.+J.+Stockerauthor=M.+E.+Due-Hansenauthor=E.+T.+Wargentauthor=B.+Shimpukadeauthor=R.+Almeidaauthor=C.+S.+Ejsingauthor=M.+A.+Cawthorneauthor=M.+U.+Kassackauthor=G.+Milliganauthor=T.+Ulven&title=Discovery+of+a+potent+free+fatty+acid+1+receptor+agonist+with+low+lipophilicity%2C+low+polar+surface+area%2C+and+robust+in+vivo+efficacy&doi=10.1021%2Facs.jmedchem.5b01962"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01962%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DStocker%26aufirst%3DC.%2BJ.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DWargent%26aufirst%3DE.%2BT.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DAlmeida%26aufirst%3DR.%26aulast%3DEjsing%26aufirst%3DC.%2BS.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520free%2520fatty%2520acid%25201%2520receptor%2520agonist%2520with%2520low%2520lipophilicity%252C%2520low%2520polar%2520surface%2520area%252C%2520and%2520robust%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2841%26epage%3D2846%26doi%3D10.1021%2Facs.jmedchem.5b01962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref280"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref280'); return false;" data-citation="" class="refNumLink">280</a></strong><div class="NLM_citation" id="cit280"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3beta inhibitors for Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1086</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1086-1091&issue=5&author=K.+Fukunagaauthor=D.+Sakaiauthor=K.+Watanabeauthor=K.+Nakayamaauthor=T.+Koharaauthor=H.+Tanakaauthor=S.+Sunadaauthor=M.+Nabenoauthor=M.+Okamotoauthor=K.+Saitoauthor=J.+Eguchiauthor=A.+Moriauthor=S.+Tanakaauthor=K.+Inazawaauthor=T.+Horikawa&title=Discovery+of+novel+2-%28alkylmorpholin-4-yl%29-6-%283-fluoropyridin-4-yl%29-pyrimidin-4%283H%29-ones+as+orally-active+GSK-3beta+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DInazawa%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528alkylmorpholin-4-yl%2529-6-%25283-fluoropyridin-4-yl%2529-pyrimidin-4%25283H%2529-ones%2520as%2520orally-active%2520GSK-3beta%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1086%26epage%3D1091%26doi%3D10.1016%2Fj.bmcl.2015.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref281"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref281'); return false;" data-citation="" class="refNumLink">281</a></strong><div class="NLM_citation" id="cit281"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curwen, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsall, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigwell, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective, orally bioavailable, and efficacious novel 2-(pyrazol-4-ylamino)-pyrimidine inhibitor of the insulin-like growth factor-1 receptor (IGF-1R)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4859</span>– <span class="NLM_lpage">4866</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4859-4866&issue=10&author=S.+L.+Degorceauthor=S.+Boydauthor=J.+O.+Curwenauthor=R.+Ducrayauthor=C.+T.+Halsallauthor=C.+D.+Jonesauthor=F.+Lachauthor=E.+M.+Lenzauthor=M.+Passauthor=S.+Passauthor=C.+Trigwell&title=Discovery+of+a+potent%2C+selective%2C+orally+bioavailable%2C+and+efficacious+novel+2-%28pyrazol-4-ylamino%29-pyrimidine+inhibitor+of+the+insulin-like+growth+factor-1+receptor+%28IGF-1R%29&doi=10.1021%2Facs.jmedchem.6b00203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R)</span></div><div class="casAuthors">Degorce, Sebastien L.; Boyd, Scott; Curwen, Jon O.; Ducray, Richard; Halsall, Christopher T.; Jones, Clifford D.; Lach, Franck; Lenz, Eva M.; Pass, Martin; Pass, Sarah; Trigwell, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4859-4866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of cellular lipophilic ligand efficiency (LLE) in a series of 2-anilino-pyrimidine IGF-1R kinase inhibitors led to the identification of novel 2-(pyrazol-4-ylamino)-pyrimidines with improved physicochem. properties.  Replacement of the imidazo[1,2-a]pyridine group of the previously reported inhibitor 3 with the related pyrazolo[1,5-a]pyridine improved IGF-1R cellular potency.  Substitution of the amino-pyrazole group was key to obtaining excellent kinase selectivity and pharmacokinetic parameters suitable for oral dosing, which led to the discovery of (2R)-1-[4-(4-{[5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinyl]amino}-3,5-dimethyl-1H-pyrazol-1-yl)-1-piperidinyl]-2-hydroxy-1-propanone (AZD9362, 28), a novel, efficacious inhibitor of IGF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP5uHW4VwKWrVg90H21EOLACvtfcHk0liapN-MXvlcKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmtrw%253D&md5=b6b61dbeab93bb0572ab9a11f59bbed2</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00203%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DS.%2BL.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DHalsall%26aufirst%3DC.%2BT.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DLach%26aufirst%3DF.%26aulast%3DLenz%26aufirst%3DE.%2BM.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPass%26aufirst%3DS.%26aulast%3DTrigwell%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%252C%2520and%2520efficacious%2520novel%25202-%2528pyrazol-4-ylamino%2529-pyrimidine%2520inhibitor%2520of%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520%2528IGF-1R%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4859%26epage%3D4866%26doi%3D10.1021%2Facs.jmedchem.6b00203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref282"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref282'); return false;" data-citation="" class="refNumLink">282</a></strong><div class="NLM_citation" id="cit282"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brubaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Close, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mampreian, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bays, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenblatt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesburg, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klappenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. R.</span></span> <span> </span><span class="NLM_article-title">The discovery of 3-((4-chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1 H-pyrazole-4-carboxamide, a highly ligand efficient and efficacious janus kinase 1 selective inhibitor with favorable pharmacokinetic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9676</span>– <span class="NLM_lpage">9690</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01135</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01135" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9676-9690&issue=23&author=T.+Siuauthor=J.+Brubakerauthor=P.+Fullerauthor=L.+Torresauthor=H.+Zengauthor=J.+Closeauthor=D.+M.+Mampreianauthor=F.+Shiauthor=D.+Liuauthor=X.+Fraderaauthor=K.+Johnsonauthor=N.+Baysauthor=E.+Kadicauthor=F.+Heauthor=P.+Goldenblattauthor=L.+Shafferauthor=S.+B.+Patelauthor=C.+A.+Lesburgauthor=C.+Alpertauthor=L.+Doroshauthor=S.+V.+Deshmukhauthor=H.+Yuauthor=J.+Klappenbachauthor=F.+Elwoodauthor=C.+J.+Dinsmoreauthor=R.+Fernandezauthor=L.+Moyauthor=J.+R.+Young&title=The+discovery+of+3-%28%284-chloro-3-methoxyphenyl%29amino%29-1-%28%283R%2C4S%29-4-cyanotetrahydro-2H-pyran-3-yl%29-1+H-pyrazole-4-carboxamide%2C+a+highly+ligand+efficient+and+efficacious+janus+kinase+1+selective+inhibitor+with+favorable+pharmacokinetic+properties&doi=10.1021%2Facs.jmedchem.7b01135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01135%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DBrubaker%26aufirst%3DJ.%26aulast%3DFuller%26aufirst%3DP.%26aulast%3DTorres%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DClose%26aufirst%3DJ.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DKadic%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DGoldenblatt%26aufirst%3DP.%26aulast%3DShaffer%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DAlpert%26aufirst%3DC.%26aulast%3DDorosh%26aufirst%3DL.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DKlappenbach%26aufirst%3DJ.%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DMoy%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520discovery%2520of%25203-%2528%25284-chloro-3-methoxyphenyl%2529amino%2529-1-%2528%25283R%252C4S%2529-4-cyanotetrahydro-2H-pyran-3-yl%2529-1%2520H-pyrazole-4-carboxamide%252C%2520a%2520highly%2520ligand%2520efficient%2520and%2520efficacious%2520janus%2520kinase%25201%2520selective%2520inhibitor%2520with%2520favorable%2520pharmacokinetic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D23%26spage%3D9676%26epage%3D9690%26doi%3D10.1021%2Facs.jmedchem.7b01135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref283"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref283'); return false;" data-citation="" class="refNumLink">283</a></strong><div class="NLM_citation" id="cit283"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2016.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4455-4461&issue=18&author=O.+Reneauthor=B.+P.+Fauberauthor=A.+Barnardauthor=K.+Chapmanauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+oxa-sultams+as+RORc+inverse+agonists+showing+reduced+lipophilicity%2C+improved+selectivity+and+favorable+ADME+properties&doi=10.1016%2Fj.bmcl.2016.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520oxa-sultams%2520as%2520RORc%2520inverse%2520agonists%2520showing%2520reduced%2520lipophilicity%252C%2520improved%2520selectivity%2520and%2520favorable%2520ADME%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D18%26spage%3D4455%26epage%3D4461%26doi%3D10.1016%2Fj.bmcl.2016.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref284"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref284'); return false;" data-citation="" class="refNumLink">284</a></strong><div class="NLM_citation" id="cit284"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derksen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span> <span> </span><span class="NLM_article-title">Optimization of amide-based EP3 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2670</span>– <span class="NLM_lpage">2675</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2016.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2670-2675&issue=11&author=E.+C.+Leeauthor=K.+Futatsugiauthor=J.+T.+Arcariauthor=K.+Bahnckauthor=S.+B.+Coffeyauthor=D.+R.+Derksenauthor=A.+S.+Kalgutkarauthor=P.+M.+Loriaauthor=R.+Sharma&title=Optimization+of+amide-based+EP3+receptor+antagonists&doi=10.1016%2Fj.bmcl.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DArcari%26aufirst%3DJ.%2BT.%26aulast%3DBahnck%26aufirst%3DK.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DOptimization%2520of%2520amide-based%2520EP3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2670%26epage%3D2675%26doi%3D10.1016%2Fj.bmcl.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref285"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref285'); return false;" data-citation="" class="refNumLink">285</a></strong><div class="NLM_citation" id="cit285"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the potent and selective M1 PAM-agonist N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)ben zyl]pyridine-2-carboxamide (PF-06767832): evaluation of efficacy and cholinergic side effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6313</span>– <span class="NLM_lpage">6328</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6313-6328&issue=13&author=J.+E.+Davorenauthor=C.+W.+Leeauthor=M.+Garnseyauthor=M.+A.+Brodneyauthor=J.+Cordesauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=S.+Jenkinsonauthor=G.+W.+Kauffmanauthor=T.+P.+Kenakinauthor=J.+T.+Lazzaroauthor=S.+M.+Lotarskiauthor=Y.+Maoauthor=D.+M.+Nasonauthor=C.+Northcottauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=B.+Pettersenauthor=M.+Popiolekauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=L.+Zhangauthor=S.+Grimwood&title=Discovery+of+the+potent+and+selective+M1+PAM-agonist+N-%5B%283R%2C4S%29-3-hydroxytetrahydro-2H-pyran-4-yl%5D-5-methyl-4-%5B4-%281%2C3-thiazol-4-yl%29ben+zyl%5Dpyridine-2-carboxamide+%28PF-06767832%29%3A+evaluation+of+efficacy+and+cholinergic+side+effects&doi=10.1021%2Facs.jmedchem.6b00544"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCordes%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNorthcott%26aufirst%3DC.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520potent%2520and%2520selective%2520M1%2520PAM-agonist%2520N-%255B%25283R%252C4S%2529-3-hydroxytetrahydro-2H-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529ben%2520zyl%255Dpyridine-2-carboxamide%2520%2528PF-06767832%2529%253A%2520evaluation%2520of%2520efficacy%2520and%2520cholinergic%2520side%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D13%26spage%3D6313%26epage%3D6328%26doi%3D10.1021%2Facs.jmedchem.6b00544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref286"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref286'); return false;" data-citation="" class="refNumLink">286</a></strong><div class="NLM_citation" id="cit286"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemurell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emtenas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broddefalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovdal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryden-Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herslof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigfridsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whatling, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1021/jm501531v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501531v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=897-911&issue=2&author=M.+Lemurellauthor=J.+Ulanderauthor=S.+Winiwarterauthor=A.+Dahlenauthor=O.+Davidssonauthor=H.+Emtenasauthor=J.+Broddefalkauthor=M.+Swansonauthor=D.+Hovdalauthor=A.+T.+Plowrightauthor=A.+Pettersenauthor=M.+Ryden-Landergrenauthor=J.+Barlindauthor=A.+Llinasauthor=M.+Herslofauthor=T.+Drmotaauthor=K.+Sigfridssonauthor=S.+Mosesauthor=C.+Whatling&title=Discovery+of+AZD6642%2C+an+inhibitor+of+5-lipoxygenase+activating+protein+%28FLAP%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm501531v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=10.1021%2Fjm501531v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501531v%26sid%3Dliteratum%253Aachs%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDahlen%26aufirst%3DA.%26aulast%3DDavidsson%26aufirst%3DO.%26aulast%3DEmtenas%26aufirst%3DH.%26aulast%3DBroddefalk%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DM.%26aulast%3DHovdal%26aufirst%3DD.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DRyden-Landergren%26aufirst%3DM.%26aulast%3DBarlind%26aufirst%3DJ.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DSigfridsson%26aufirst%3DK.%26aulast%3DMoses%26aufirst%3DS.%26aulast%3DWhatling%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520AZD6642%252C%2520an%2520inhibitor%2520of%25205-lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D897%26epage%3D911%26doi%3D10.1021%2Fjm501531v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref287"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref287'); return false;" data-citation="" class="refNumLink">287</a></strong><div class="NLM_citation" id="cit287"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(m etheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&issue=11&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28m+etheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528m%2520etheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref288"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref288'); return false;" data-citation="" class="refNumLink">288</a></strong><div class="NLM_citation" id="cit288"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brousseau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaSala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogi, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel piperidine-based inhibitor of cholesteryl ester transfer protein (CETP) that retains activity in hypertriglyceridemic plasma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8466</span>– <span class="NLM_lpage">8481</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8466-8481&issue=20&author=K.+Yamadaauthor=M.+Brousseauauthor=W.+Honmaauthor=A.+Iimuraauthor=H.+Imaseauthor=Y.+Iwakiauthor=T.+Kawanamiauthor=D.+LaSalaauthor=G.+Liangauthor=H.+Mitaniauthor=K.+Nonomuraauthor=O.+Ohmoriauthor=M.+Panauthor=D.+F.+Rigelauthor=I.+Umemuraauthor=K.+Yasoshimaauthor=G.+Zhuauthor=M.+Mogi&title=Discovery+of+a+novel+piperidine-based+inhibitor+of+cholesteryl+ester+transfer+protein+%28CETP%29+that+retains+activity+in+hypertriglyceridemic+plasma&doi=10.1021%2Facs.jmedchem.7b00900"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00900%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DBrousseau%26aufirst%3DM.%26aulast%3DHonma%26aufirst%3DW.%26aulast%3DIimura%26aufirst%3DA.%26aulast%3DImase%26aufirst%3DH.%26aulast%3DIwaki%26aufirst%3DY.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DMitani%26aufirst%3DH.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DYasoshima%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DMogi%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520piperidine-based%2520inhibitor%2520of%2520cholesteryl%2520ester%2520transfer%2520protein%2520%2528CETP%2529%2520that%2520retains%2520activity%2520in%2520hypertriglyceridemic%2520plasma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8466%26epage%3D8481%26doi%3D10.1021%2Facs.jmedchem.7b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref289"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref289'); return false;" data-citation="" class="refNumLink">289</a></strong><div class="NLM_citation" id="cit289"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higueruelo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, W. R.</span></span> <span> </span><span class="NLM_article-title">What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e51742</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0051742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1371%2Fjournal.pone.0051742" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e51742&issue=12&author=A.+P.+Higuerueloauthor=A.+Schreyerauthor=G.+R.+Bickertonauthor=T.+L.+Blundellauthor=W.+R.+Pitt&title=What+can+we+learn+from+the+evolution+of+protein-ligand+interactions+to+aid+the+design+of+new+therapeutics%3F&doi=10.1371%2Fjournal.pone.0051742"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0051742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0051742%26sid%3Dliteratum%253Aachs%26aulast%3DHigueruelo%26aufirst%3DA.%2BP.%26aulast%3DSchreyer%26aufirst%3DA.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DPitt%26aufirst%3DW.%2BR.%26atitle%3DWhat%2520can%2520we%2520learn%2520from%2520the%2520evolution%2520of%2520protein-ligand%2520interactions%2520to%2520aid%2520the%2520design%2520of%2520new%2520therapeutics%253F%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3De51742%26doi%3D10.1371%2Fjournal.pone.0051742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref290"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref290'); return false;" data-citation="" class="refNumLink">290</a></strong><div class="NLM_citation" id="cit290"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muresan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Chemical predictive modelling to improve compound quality</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/nrd4128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24287782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=948-962&issue=12&author=J.+G.+Cummingauthor=A.+M.+Davisauthor=S.+Muresanauthor=M.+Haeberleinauthor=H.+Chen&title=Chemical+predictive+modelling+to+improve+compound+quality&doi=10.1038%2Fnrd4128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical predictive modelling to improve compound quality</span></div><div class="casAuthors">Cumming, John G.; Davis, Andrew M.; Muresan, Sorel; Haeberlein, Markus; Chen, Hongming</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">948-962</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'quality' of small-mol. drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metab., excretion and toxicity) characteristics, is a key factor influencing the chances of success in clin. trials.  Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compds.  Here, we discuss the application of computational methods, particularly quant. structure-activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XwzW0wcxYbVg90H21EOLACvtfcHk0lgnl8lJXurddw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF&md5=e0a4265bb306ae5544d00f3c9e3e4050</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.1038%2Fnrd4128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4128%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DHaeberlein%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DChemical%2520predictive%2520modelling%2520to%2520improve%2520compound%2520quality%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D12%26spage%3D948%26epage%3D962%26doi%3D10.1038%2Fnrd4128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref291"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref291'); return false;" data-citation="" class="refNumLink">291</a></strong><div class="NLM_citation" id="cit291"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aliagas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span> <span> </span><span class="NLM_article-title">Sustainable practices in medicinal chemistry part 2: green by design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5955</span>– <span class="NLM_lpage">5968</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01837</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5955-5968&issue=14&author=I.+Aliagasauthor=R.+Bergerauthor=K.+Goldbergauthor=R.+T.+Nishimuraauthor=J.+Reillyauthor=P.+Richardsonauthor=D.+Richterauthor=E.+C.+Shererauthor=B.+A.+Sparlingauthor=M.+C.+Bryan&title=Sustainable+practices+in+medicinal+chemistry+part+2%3A+green+by+design&doi=10.1021%2Facs.jmedchem.6b01837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01837%26sid%3Dliteratum%253Aachs%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DNishimura%26aufirst%3DR.%2BT.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26atitle%3DSustainable%2520practices%2520in%2520medicinal%2520chemistry%2520part%25202%253A%2520green%2520by%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D14%26spage%3D5955%26epage%3D5968%26doi%3D10.1021%2Facs.jmedchem.6b01837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref292"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref292'); return false;" data-citation="" class="refNumLink">292</a></strong><div class="NLM_citation" id="cit292"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4807</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref292/cit292&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.07.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4802-4807&issue=21&author=C.+F.+Strattonauthor=D.+J.+Newmanauthor=D.+S.+Tan&title=Cheminformatic+comparison+of+approved+drugs+from+natural+product+versus+synthetic+origins&doi=10.1016%2Fj.bmcl.2015.07.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DCheminformatic%2520comparison%2520of%2520approved%2520drugs%2520from%2520natural%2520product%2520versus%2520synthetic%2520origins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4802%26epage%3D4807%26doi%3D10.1016%2Fj.bmcl.2015.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref293"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref293'); return false;" data-citation="" class="refNumLink">293</a></strong><div class="NLM_citation" id="cit293"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, M.</span></span> <span> </span><span class="NLM_article-title">Analysis of physicochemical properties for drugs of natural origin</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1370</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFarsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=1370-1382&issue=6&author=D.+Campauthor=A.+Garavelasauthor=M.+Campitelli&title=Analysis+of+physicochemical+properties+for+drugs+of+natural+origin&doi=10.1021%2Facs.jnatprod.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Physicochemical Properties for Drugs of Natural Origin</span></div><div class="casAuthors">Camp, David; Garavelas, Agatha; Campitelli, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1370-1382</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The impact of time, therapy area, and route of administration on 13 physicochem. properties calcd. for 664 drugs developed from a natural prototype was investigated.  The mean values for the majority of properties sampled over five periods from pre-1900 to 2013 were found to change in a statistically significant manner.  In contrast, lipophilicity and arom. ring count remained relatively const., suggesting that these parameters are the most important for successful prosecution of a natural product drug discovery program if the route of administration is not focused exclusively on oral availability.  An examn. by therapy area revealed that anti-infective agents had the most differences in physicochem. property profiles compared with other areas, particularly with respect to lipophilicity.  However, when this group was removed, the variation between the mean values for lipophilicity and arom. ring count across the remaining therapy areas was again found not to change in a meaningful manner, further highlighting the importance of these two parameters.  The vast majority of drugs with a natural progenitor were formulated for either oral and/or injectable administration.  Injectables were, on av., larger and more polar than drugs developed for oral, topical, and inhalation routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCr9UzS_Dq4rVg90H21EOLACvtfcHk0lhJ4eFTkoRbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFarsLg%253D&md5=2487f8be0be8819c73ce69ce13e60eaa</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DCamp%26aufirst%3DD.%26aulast%3DGaravelas%26aufirst%3DA.%26aulast%3DCampitelli%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520physicochemical%2520properties%2520for%2520drugs%2520of%2520natural%2520origin%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2015%26volume%3D78%26issue%3D6%26spage%3D1370%26epage%3D1382%26doi%3D10.1021%2Facs.jnatprod.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref294"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref294'); return false;" data-citation="" class="refNumLink">294</a></strong><div class="NLM_citation" id="cit294"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edrada-Ebel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">The re-emergence of natural products for drug discovery in the genomics era</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/nrd4510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=111-129&issue=2&author=A.+L.+Harveyauthor=R.+Edrada-Ebelauthor=R.+J.+Quinn&title=The+re-emergence+of+natural+products+for+drug+discovery+in+the+genomics+era&doi=10.1038%2Fnrd4510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">The re-emergence of natural products for drug discovery in the genomics era</span></div><div class="casAuthors">Harvey, Alan L.; Edrada-Ebel, RuAngelie; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Natural products have been a rich source of compds. for drug discovery.  However, their use has diminished in the past two decades, in part because of tech. barriers to screening natural products in high-throughput assays against mol. targets.  Here, we review strategies for natural product screening that harness the recent tech. advances that have reduced these barriers.  We also assess the use of genomic and metabolomic approaches to augment traditional methods of studying natural products, and highlight recent examples of natural products in antimicrobial drug discovery and as inhibitors of protein-protein interactions.  The growing appreciation of functional assays and phenotypic screens may further contribute to a revival of interest in natural products for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQ8QarpZ6orVg90H21EOLACvtfcHk0lhJ4eFTkoRbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D&md5=b871148315dc0623683498fa15205b14</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1038%2Fnrd4510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4510%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26aulast%3DEdrada-Ebel%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520re-emergence%2520of%2520natural%2520products%2520for%2520drug%2520discovery%2520in%2520the%2520genomics%2520era%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D2%26spage%3D111%26epage%3D129%26doi%3D10.1038%2Fnrd4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref295"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref295'); return false;" data-citation="" class="refNumLink">295</a></strong><div class="NLM_citation" id="cit295"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Natural-product-derived fragments for fragment-based ligand discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/nchem.1506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchem.1506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23247173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGktbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=21-28&issue=1&author=B.+Overauthor=S.+Wetzelauthor=C.+Grutterauthor=Y.+Nakaiauthor=S.+Rennerauthor=D.+Rauhauthor=H.+Waldmann&title=Natural-product-derived+fragments+for+fragment-based+ligand+discovery&doi=10.1038%2Fnchem.1506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit295R"><div class="casContent"><span class="casTitleNuber">295</span><div class="casTitle"><span class="NLM_cas:atitle">Natural-product-derived fragments for fragment-based ligand discovery</span></div><div class="casAuthors">Over, Bjoern; Wetzel, Stefan; Gruetter, Christian; Nakai, Yasushi; Renner, Steffen; Rauh, Daniel; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-28</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment-based ligand and drug discovery predominantly employs sp2-rich compds. covering well-explored regions of chem. space.  Despite the ease with which such fragments can be coupled, this focus on flat compds. is widely cited as contributing to the attrition rate of the drug discovery process.  In contrast, biol. validated natural products are rich in stereogenic centers and populate areas of chem. space not occupied by av. synthetic mols.  Here, we have analyzed more than 180,000 natural product structures to arrive at 2,000 clusters of natural-product-derived fragments with high structural diversity, which resemble natural scaffolds and are rich in sp3-configured centers.  The structures of the cluster centers differ from previously explored fragment libraries, but for nearly half of the clusters representative members are com. available.  We validate their usefulness for the discovery of novel ligand and inhibitor types by means of protein X-ray crystallog. and the identification of novel stabilizers of inactive conformations of p38α MAP kinase and of inhibitors of several phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnuK2UxKwD_LVg90H21EOLACvtfcHk0lgOVMFz_OsMsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGktbnO&md5=2aa52aeca6b85346746ed8c21b454293</span></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1506%26sid%3Dliteratum%253Aachs%26aulast%3DOver%26aufirst%3DB.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DRenner%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DNatural-product-derived%2520fragments%2520for%2520fragment-based%2520ligand%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D1%26spage%3D21%26epage%3D28%26doi%3D10.1038%2Fnchem.1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref296"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref296'); return false;" data-citation="" class="refNumLink">296</a></strong><div class="NLM_citation" id="cit296"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S.</span>; <span class="NLM_string-name">Wakchaure, V.</span>; <span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Natural product-derived and natural product-inspired compound collections</span>. In  <i>Natural Products in Medicinal Chemistry</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">80</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527676545.ch02</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2F9783527676545.ch02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-80&author=S.+Rizzo&author=V.+Wakchaure&author=H.+Waldmann&title=Natural+Products+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1002%2F9783527676545.ch02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527676545.ch02%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26atitle%3DNatural%2520product-derived%2520and%2520natural%2520product-inspired%2520compound%2520collections%26btitle%3DNatural%2520Products%2520in%2520Medicinal%2520Chemistry%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2014%26spage%3D43%26epage%3D80%26doi%3D10.1002%2F9783527676545.ch02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref297"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref297'); return false;" data-citation="" class="refNumLink">297</a></strong><div class="NLM_citation" id="cit297"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheshire, D. R.</span></span> <span> </span><span class="NLM_article-title">How well do medicinal chemists learn from experience?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17–18</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21704183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC3MfitFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=817-821&issue=17%E2%80%9318&author=D.+R.+Cheshire&title=How+well+do+medicinal+chemists+learn+from+experience%3F&doi=10.1016%2Fj.drudis.2011.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">How well do medicinal chemists learn from experience?</span></div><div class="casAuthors">Cheshire David R</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">817-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To an outsider, the exploration of thousands of molecules to find a small number of potential candidate drugs must appear enormously wasteful, but many medicinal chemists would defend this waste as unavoidable.  Here, I provide evidence that suggests that modern medicinal chemists are overproductive in that they synthesise many more compounds than are required to achieve the objectives of the project.  The difficulties encountered in finding the data for the analysis presented here prompted the design and implementation of a more rigorous approach to capture the essence of a medicinal chemistry program.  The result, medicinal chemistry knowledge sharing (MeCKS), was designed to capture and communicate emerging issues and their solutions to the medicinal chemistry community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuaFbXMB7kxDToTC3aBaesfW6udTcc2eYn1yNfGObjmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfitFChsg%253D%253D&md5=b069d78032215c2a1bf67f7a81e304e9</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DCheshire%26aufirst%3DD.%2BR.%26atitle%3DHow%2520well%2520do%2520medicinal%2520chemists%2520learn%2520from%2520experience%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D17%25E2%2580%259318%26spage%3D817%26epage%3D821%26doi%3D10.1016%2Fj.drudis.2011.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref298"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref298'); return false;" data-citation="" class="refNumLink">298</a></strong><div class="NLM_citation" id="cit298"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1488</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2017.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28669605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjslKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1478-1488&issue=10&author=G.+Tresadernauthor=F.+J.+R.+Romboutsauthor=D.+Oehlrichauthor=G.+Macdonaldauthor=A.+A.+Trabanco&title=Industrial+medicinal+chemistry+insights%3A+neuroscience+hit+generation+at+Janssen&doi=10.1016%2Fj.drudis.2017.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen</span></div><div class="casAuthors">Tresadern Gary; Rombouts Frederik J R; Oehlrich Daniel; Macdonald Gregor; Trabanco Andres A</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1478-1488</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of medicinal chemistry has changed over the past 10 years.  Chemistry had become one step in a process; funneling the output of high-throughput screening (HTS) on to the next stage.  The goal to identify the ideal clinical compound remains, but the means to achieve this have changed.  Modern medicinal chemistry is responsible for integrating innovation throughout early drug discovery, including new screening paradigms, computational approaches, novel synthetic chemistry, gene-family screening, investigating routes of delivery, and so on.  In this Foundation Review, we show how a successful medicinal chemistry team has a broad impact and requires multidisciplinary expertise in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2t7KCJwTlOjUE-swuRqsHfW6udTcc2eYn1yNfGObjmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjslKlug%253D%253D&md5=3a723af1060ecb28c329bf4c5425f0a9</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DIndustrial%2520medicinal%2520chemistry%2520insights%253A%2520neuroscience%2520hit%2520generation%2520at%2520Janssen%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1478%26epage%3D1488%26doi%3D10.1016%2Fj.drudis.2017.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref299"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref299'); return false;" data-citation="" class="refNumLink">299</a></strong><div class="NLM_citation" id="cit299"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span> <span> </span><span class="NLM_article-title">Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1206</span>, <span class="refDoi"> DOI: 10.1021/mp300476z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300476z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKmsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1191-1206&issue=4&author=K.+H.+Grimeauthor=P.+Bartonauthor=D.+F.+McGinnity&title=Application+of+in+silico%2C+in+vitro+and+preclinical+pharmacokinetic+data+for+the+effective+and+efficient+prediction+of+human+pharmacokinetics&doi=10.1021%2Fmp300476z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics</span></div><div class="casAuthors">Grime, Kenneth H.; Barton, Patrick; McGinnity, Dermot F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1191-1206</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In the present age of pharmaceutical research and development, focused delivery of decision making data is more imperative than ever before.  Resulting from several years' success, failure and consequential learning, this article also proffers advice and guidance on which in vitro and in vivo expts. to perform to facilitate efficient and cost-effective pursuit of candidate drugs with acceptable human pharmacokinetic profiles.  Predictive in silico models are important in directing design toward compds. with the highest probability of having suitable DMPK properties rather than in predicting human pharmacokinetics per se, and the value and utility of such approaches are reviewed with the intention of providing direction to DMPK scientists.  Relating to absorption, distribution, elimination and effective half-life, strategies are described to provide direction in commonly encountered scenarios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbqOxSOn6m7Vg90H21EOLACvtfcHk0lhjAnxzRUxTDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKmsbbE&md5=87d57fba1788724ea47374583dce47bf</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1021%2Fmp300476z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300476z%26sid%3Dliteratum%253Aachs%26aulast%3DGrime%26aufirst%3DK.%2BH.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520in%2520silico%252C%2520in%2520vitro%2520and%2520preclinical%2520pharmacokinetic%2520data%2520for%2520the%2520effective%2520and%2520efficient%2520prediction%2520of%2520human%2520pharmacokinetics%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D4%26spage%3D1191%26epage%3D1206%26doi%3D10.1021%2Fmp300476z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref300"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref300'); return false;" data-citation="" class="refNumLink">300</a></strong><div class="NLM_citation" id="cit300"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, S. A.</span></span> <span> </span><span class="NLM_article-title">Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffmc.15.143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26599348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2351-2369&issue=17&author=T.+Buetersauthor=C.+Gibsonauthor=S.+A.+Visser&title=Optimization+of+human+dose+prediction+by+using+quantitative+and+translational+pharmacology+in+drug+discovery&doi=10.4155%2Ffmc.15.143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery</span></div><div class="casAuthors">Bueters, Tjerk; Gibson, Christopher; G Visser, Sandra A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2351-2369</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In this perspective article, we explain how quant. and translational pharmacol., when well-implemented, is believed to lead to improved clin. candidates and drug targets that are differentiated from current treatment options.  Quant. and translational pharmacol. aims to build and continuously improve the quant. relationship between drug exposure, target engagement, efficacy, safety and its interspecies relationship at every phase of drug discovery.  Drug hunters should consider and apply these concepts to develop compds. with a higher probability of interrogating the clin. biol. hypothesis.  We offer different approaches to set an initial effective concn. or pharmacokinetic-pharmacodynamic target in man and to predict human pharmacokinetics that det. together the predicted human dose and dose schedule.  All concepts are illustrated with ample literature examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy3M0R3KWa1LVg90H21EOLACvtfcHk0lhjAnxzRUxTDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu7%252FO&md5=c30f4756c965a5dbca10d7b5c57b59c9</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.143%26sid%3Dliteratum%253Aachs%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DGibson%26aufirst%3DC.%26aulast%3DVisser%26aufirst%3DS.%2BA.%26atitle%3DOptimization%2520of%2520human%2520dose%2520prediction%2520by%2520using%2520quantitative%2520and%2520translational%2520pharmacology%2520in%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D17%26spage%3D2351%26epage%3D2369%26doi%3D10.4155%2Ffmc.15.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref301"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref301'); return false;" data-citation="" class="refNumLink">301</a></strong><div class="NLM_citation" id="cit301"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">The drug–target residence time model: a 10-year retrospective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2015.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26678621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=87-95&author=R.+A.+Copeland&title=The+drug%E2%80%93target+residence+time+model%3A+a+10-year+retrospective&doi=10.1038%2Fnrd.2015.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-target residence time model: a 10-year retrospective</span></div><div class="casAuthors">Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The drug-target residence time model was first introduced in 2006 and has been broadly adopted across the chem. biol., biotechnol. and pharmaceutical communities.  While traditional in vitro methods view drug-target interactions exclusively in terms of equil. affinity, the residence time model takes into account the conformational dynamics of target macromols. that affect drug binding and dissocn.  The key tenet of this model is that the lifetime (or residence time) of the binary drug-target complex, and not the binding affinity per se, dictates much of the in vivo pharmacol. activity.  Here, this model is revisited and key applications of it over the past 10 years are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNrhp9U8kwLVg90H21EOLACvtfcHk0lhjAnxzRUxTDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnE&md5=23f4a6973d77804292ff0af6c81358c0</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.18%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DThe%2520drug%25E2%2580%2593target%2520residence%2520time%2520model%253A%2520a%252010-year%2520retrospective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D87%26epage%3D95%26doi%3D10.1038%2Fnrd.2015.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref302"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref302'); return false;" data-citation="" class="refNumLink">302</a></strong><div class="NLM_citation" id="cit302"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span> <span> </span><span class="NLM_article-title">Protac-induced protein degradation in drug discovery: breaking the rules or just making new ones?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=444-452&issue=2&author=I.+Churcher&title=Protac-induced+protein+degradation+in+drug+discovery%3A+breaking+the+rules+or+just+making+new+ones%3F&doi=10.1021%2Facs.jmedchem.7b01272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?</span></div><div class="casAuthors">Churcher, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeted protein degrdn., using bifunctional small mols. (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer therapeutic interventions not achievable with existing approaches.  In this perspective, the brief history of the field is surveyed from a drug discovery perspective with a focus on the key advances in knowledge which have led to the definition and exemplification of protein degrdn. concepts, and their resulting applications to medicine discovery.  The approach has the potential to bring disruptive change to drug discovery - the many potential advantages and outstanding challenges which lie ahead of this technol. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9n8I_0MhtkbVg90H21EOLACvtfcHk0lhjAnxzRUxTDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvJ&md5=e60f1777de8bd860c5001137d8583f1f</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01272%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26atitle%3DProtac-induced%2520protein%2520degradation%2520in%2520drug%2520discovery%253A%2520breaking%2520the%2520rules%2520or%2520just%2520making%2520new%2520ones%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D2%26spage%3D444%26epage%3D452%26doi%3D10.1021%2Facs.jmedchem.7b01272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref303"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref303'); return false;" data-citation="" class="refNumLink">303</a></strong><div class="NLM_citation" id="cit303"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Automating drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29242609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=97-113&issue=2&author=G.+Schneider&title=Automating+drug+discovery&doi=10.1038%2Fnrd.2017.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Automating drug discovery</span></div><div class="casAuthors">Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-113</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Small mol. drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compds. including efficacy, pharmacokinetics and safety need to be optimized in parallel to provide drug candidates.  Recent advances in areas such as microfluidics-assisted chem. synthesis and biol. testing, as well as artificial intelligence systems that improve a design hypothesis through feedback anal., are now providing a basis for the introduction of greater automation into aspects of this process.  This could potentially accelerate time frames for compd. discovery and optimization and enable more effective searches of chem. space.  However, such approaches also raise considerable conceptual, tech. and organizational challenges, as well as scepticism about the current hype around them.  This article aims to identify the approaches and technologies that could be implemented robustly by medicinal chemists in the near future and to critically analyze the opportunities and challenges for their more widespread application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyg9gWifCLrVg90H21EOLACvtfcHk0ljdi-LMwL21Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbK&md5=4fc1e441a0a31d7421642eb91fbac8c7</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.232%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DAutomating%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26issue%3D2%26spage%3D97%26epage%3D113%26doi%3D10.1038%2Fnrd.2017.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref304"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref304'); return false;" data-citation="" class="refNumLink">304</a></strong><div class="NLM_citation" id="cit304"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klucznik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulak-Klucznik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymkuć, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowmick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickershauser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewska, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toutchkine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Startek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkovits, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roszak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieredzińska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrksich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trice, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzybowski, B. A.</span></span> <span> </span><span class="NLM_article-title">Efficient syntheses of diverse, medicinally relevant targets planned by computer and executed in the laboratory</span>. <i>Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2018.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chempr.2018.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlyitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=522-532&issue=3&author=T.+Klucznikauthor=B.+Mikulak-Klucznikauthor=M.+P.+McCormackauthor=H.+Limaauthor=S.+Szymku%C4%87author=M.+Bhowmickauthor=K.+Molgaauthor=Y.+Zhouauthor=L.+Rickershauserauthor=E.+P.+Gajewskaauthor=A.+Toutchkineauthor=P.+Dittwaldauthor=M.+P.+Startekauthor=G.+J.+Kirkovitsauthor=R.+Roszakauthor=A.+Adamskiauthor=B.+Sieredzi%C5%84skaauthor=M.+Mrksichauthor=S.+L.+J.+Triceauthor=B.+A.+Grzybowski&title=Efficient+syntheses+of+diverse%2C+medicinally+relevant+targets+planned+by+computer+and+executed+in+the+laboratory&doi=10.1016%2Fj.chempr.2018.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit304R"><div class="casContent"><span class="casTitleNuber">304</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Syntheses of Diverse, Medicinally Relevant Targets Planned by Computer and Executed in the Laboratory</span></div><div class="casAuthors">Klucznik, Tomasz; Mikulak-Klucznik, Barbara; McCormack, Michael P.; Lima, Heather; Szymkuc, Sara; Bhowmick, Manishabrata; Molga, Karol; Zhou, Yubai; Rickershauser, Lindsey; Gajewska, Ewa P.; Toutchkine, Alexei; Dittwald, Piotr; Startek, Michal P.; Kirkovits, Gregory J.; Roszak, Rafal; Adamski, Ariel; Sieredzinska, Bianka; Mrksich, Milan; Trice, Sarah L. J.; Grzybowski, Bartosz A.</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">522-532</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Chematica program was used to autonomously design synthetic pathways to eight structurally diverse targets, including seven com. valuable bioactive substances and one natural product.  All of these computer-planned routes were successfully executed in the lab. and offer significant yield improvements and cost savings over previous approaches, provide alternatives to patented routes, or produce targets that were not synthesized previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOimnTZh2zLVg90H21EOLACvtfcHk0ljdi-LMwL21Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlyitb8%253D&md5=2d5d22d2570ca3e146ba9c25149dfc9e</span></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2018.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKlucznik%26aufirst%3DT.%26aulast%3DMikulak-Klucznik%26aufirst%3DB.%26aulast%3DMcCormack%26aufirst%3DM.%2BP.%26aulast%3DLima%26aufirst%3DH.%26aulast%3DSzymku%25C4%2587%26aufirst%3DS.%26aulast%3DBhowmick%26aufirst%3DM.%26aulast%3DMolga%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRickershauser%26aufirst%3DL.%26aulast%3DGajewska%26aufirst%3DE.%2BP.%26aulast%3DToutchkine%26aufirst%3DA.%26aulast%3DDittwald%26aufirst%3DP.%26aulast%3DStartek%26aufirst%3DM.%2BP.%26aulast%3DKirkovits%26aufirst%3DG.%2BJ.%26aulast%3DRoszak%26aufirst%3DR.%26aulast%3DAdamski%26aufirst%3DA.%26aulast%3DSieredzi%25C5%2584ska%26aufirst%3DB.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DTrice%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DGrzybowski%26aufirst%3DB.%2BA.%26atitle%3DEfficient%2520syntheses%2520of%2520diverse%252C%2520medicinally%2520relevant%2520targets%2520planned%2520by%2520computer%2520and%2520executed%2520in%2520the%2520laboratory%26jtitle%3DChem.%26date%3D2018%26volume%3D4%26issue%3D3%26spage%3D522%26epage%3D532%26doi%3D10.1016%2Fj.chempr.2018.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref305"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref305'); return false;" data-citation="" class="refNumLink">305</a></strong><div class="NLM_citation" id="cit305"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Entering the “big data” era in medicinal chemistry: molecular promiscuity analysis revisited</span>. <i>Future Sci. OA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">FSO179</span>, <span class="refDoi"> DOI: 10.4155/fsoa-2017-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffsoa-2017-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28670471" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=FSO179&issue=2&author=Y.+Huauthor=J.+Bajorath&title=Entering+the+%E2%80%9Cbig+data%E2%80%9D+era+in+medicinal+chemistry%3A+molecular+promiscuity+analysis+revisited&doi=10.4155%2Ffsoa-2017-0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=10.4155%2Ffsoa-2017-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffsoa-2017-0001%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DEntering%2520the%2520%25E2%2580%259Cbig%2520data%25E2%2580%259D%2520era%2520in%2520medicinal%2520chemistry%253A%2520molecular%2520promiscuity%2520analysis%2520revisited%26jtitle%3DFuture%2520Sci.%2520OA%26date%3D2017%26volume%3D3%26issue%3D2%26spage%3DFSO179%26doi%3D10.4155%2Ffsoa-2017-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref306"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref306'); return false;" data-citation="" class="refNumLink">306</a></strong><div class="NLM_citation" id="cit306"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry matters - a call for discipline in our discipline</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">11–12</span>),  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2012.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2012.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22301070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslKrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=538-543&issue=11%E2%80%9312&author=C.+Johnstone&title=Medicinal+chemistry+matters+-+a+call+for+discipline+in+our+discipline&doi=10.1016%2Fj.drudis.2012.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry matters - a call for discipline in our discipline</span></div><div class="casAuthors">Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Medicinal chem. makes a vital contribution to small mol. drug discovery, and the quality of it contributes directly to research effectiveness as well as to downstream costs, speed and survival in development.  In recent years, the discipline of medicinal chem. has evolved and witnessed many noteworthy contributions that propose and offer potential improvements to medicinal chem. practice; however, the impact of these ideas is limited by their acceptance and deployment into every-day activity and, as a result, the quality of medicinal chem. remains variable.  For the good of the industry and the medicinal chem. discipline, there is a need to move from retrospective learning to prospective control of medicinal chem. practice to improve cost effectiveness, probability of success and survival rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr2eM5VpR05bVg90H21EOLACvtfcHk0ljdi-LMwL21Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslKrurg%253D&md5=31d4c1045edccb955b954b10bf6899a3</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DMedicinal%2520chemistry%2520matters%2520-%2520a%2520call%2520for%2520discipline%2520in%2520our%2520discipline%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26issue%3D11%25E2%2580%259312%26spage%3D538%26epage%3D543%26doi%3D10.1016%2Fj.drudis.2012.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278'],'ref279':['cit279'],'ref280':['cit280'],'ref281':['cit281'],'ref282':['cit282'],'ref283':['cit283'],'ref284':['cit284'],'ref285':['cit285'],'ref286':['cit286'],'ref287':['cit287'],'ref288':['cit288'],'ref289':['cit289'],'ref290':['cit290'],'ref291':['cit291'],'ref292':['cit292'],'ref293':['cit293'],'ref294':['cit294'],'ref295':['cit295'],'ref296':['cit296'],'ref297':['cit297'],'ref298':['cit298'],'ref299':['cit299'],'ref300':['cit300'],'ref301':['cit301'],'ref302':['cit302'],'ref303':['cit303'],'ref304':['cit304'],'ref305':['cit305'],'ref306':['cit306']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">György Szabó, Péter Erdélyi, Sándor Kolok, Mónika Vastag, Attila S. Halász, Istvánné Kis-Varga, György I. Lévay, Zoltán Béni, János Kóti, István Greiner, <span class="NLM_string-name hlFld-ContribAuthor">György M. Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Optimization of Dihydropyrazino-Benzimidazolones as Metabotropic Glutamate Receptor-2 Positive Allosteric Modulators against Migraine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8607-8620. <a href="https://doi.org/10.1021/acs.jmedchem.1c00563" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BOptimization%252Bof%252BDihydropyrazino-Benzimidazolones%252Bas%252BMetabotropic%252BGlutamate%252BReceptor-2%252BPositive%252BAllosteric%252BModulators%252Bagainst%252BMigraine%26aulast%3DSzab%25C3%25B3%26aufirst%3DGy%25C3%25B6rgy%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29032021%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8607%26epage%3D8620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Palak Babbar, Pronay Das, Yogavel Manickam, Yash Mankad, Swati Yadav, Suhel Parvez, Amit Sharma, <span class="NLM_string-name hlFld-ContribAuthor">D. Srinivasa Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structural Analysis of Cladosporin-Based Inhibitors of Malaria Parasites. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1777-1794. <a href="https://doi.org/10.1021/acsinfecdis.1c00092" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00092%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructural%252BAnalysis%252Bof%252BCladosporin-Based%252BInhibitors%252Bof%252BMalaria%252BParasites%26aulast%3DBabbar%26aufirst%3DPalak%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23022021%26date%3D12042021%26volume%3D7%26issue%3D6%26spage%3D1777%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul D. Leeson, A. Patricia Bento, Anna Gaulton, Anne Hersey, Emma J. Manners, Chris J. Radoux, <span class="NLM_string-name hlFld-ContribAuthor">Andrew R. Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7210-7230. <a href="https://doi.org/10.1021/acs.jmedchem.1c00416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTarget-Based%252BEvaluation%252Bof%252B%2525E2%252580%25259CDrug-Like%2525E2%252580%25259D%252BProperties%252Band%252BLigand%252BEfficiencies%26aulast%3DLeeson%26aufirst%3DPaul%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D13052021%26volume%3D64%26issue%3D11%26spage%3D7210%26epage%3D7230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Heike J. Wobst</span>. </span><span class="cited-content_cbyCitation_article-title">A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2312-2338. <a href="https://doi.org/10.1021/acs.jmedchem.0c01516" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BDecade%252Bof%252BFDA-Approved%252BDrugs%252B%2525282010%2525E2%252580%2525932019%252529%25253A%252BTrends%252Band%252BFuture%252BDirections%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30082020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2312%26epage%3D2338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher A. Reiher, David P. Schuman, Nicholas Simmons, <span class="NLM_string-name hlFld-ContribAuthor">Scott E. Wolkenberg</span>. </span><span class="cited-content_cbyCitation_article-title">Trends in Hit-to-Lead Optimization Following DNA-Encoded Library Screens. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 343-350. <a href="https://doi.org/10.1021/acsmedchemlett.0c00615" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00615%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTrends%252Bin%252BHit-to-Lead%252BOptimization%252BFollowing%252BDNA-Encoded%252BLibrary%252BScreens%26aulast%3DReiher%26aufirst%3DChristopher%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22112020%26date%3D28012021%26date%3D11022021%26volume%3D12%26issue%3D3%26spage%3D343%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amritansh Bhanot, <span class="NLM_string-name hlFld-ContribAuthor">Sandeep Sundriyal</span>. </span><span class="cited-content_cbyCitation_article-title">Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (9)
                                     , 6424-6437. <a href="https://doi.org/10.1021/acsomega.1c00104" title="DOI URL">https://doi.org/10.1021/acsomega.1c00104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00104%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPhysicochemical%252BProfiling%252Band%252BComparison%252Bof%252BResearch%252BAntiplasmodials%252Band%252BAdvanced%252BStage%252BAntimalarials%252Bwith%252BOral%252BDrugs%26aulast%3DBhanot%26aufirst%3DAmritansh%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D18022021%26date%3D25022021%26volume%3D6%26issue%3D9%26spage%3D6424%26epage%3D6437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert I. Troup, Benjamin Jeffries, Raphael El-Bekri Saudain, Eleni Georgiou, Johanna Fish, James S. Scott, Elisabetta Chiarparin, Charlene Fallan, <span class="NLM_string-name hlFld-ContribAuthor">Bruno Linclau</span>. </span><span class="cited-content_cbyCitation_article-title">Skipped Fluorination Motifs: Synthesis of Building Blocks and Comparison of Lipophilicity Trends with Vicinal and Isolated Fluorination Motifs. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (2)
                                     , 1882-1900. <a href="https://doi.org/10.1021/acs.joc.0c02810" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02810%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSkipped%252BFluorination%252BMotifs%25253A%252BSynthesis%252Bof%252BBuilding%252BBlocks%252Band%252BComparison%252Bof%252BLipophilicity%252BTrends%252Bwith%252BVicinal%252Band%252BIsolated%252BFluorination%252BMotifs%26aulast%3DTroup%26aufirst%3DRobert%2BI.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24112020%26date%3D05012021%26volume%3D86%26issue%3D2%26spage%3D1882%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hans Matter, Christian Buning, Dan Dragos Stefanescu, Sven Ruf, <span class="NLM_string-name hlFld-ContribAuthor">Gerhard Hessler</span>. </span><span class="cited-content_cbyCitation_article-title">Using Graph Databases to Investigate Trends in Structure–Activity Relationship Networks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6120-6134. <a href="https://doi.org/10.1021/acs.jcim.0c00947" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00947%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DUsing%252BGraph%252BDatabases%252Bto%252BInvestigate%252BTrends%252Bin%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BNetworks%26aulast%3DMatter%26aufirst%3DHans%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D27112020%26volume%3D60%26issue%3D12%26spage%3D6120%26epage%3D6134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher P. Tinworth, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Young</span>. </span><span class="cited-content_cbyCitation_article-title">Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10091-10108. <a href="https://doi.org/10.1021/acs.jmedchem.9b01596" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFacts%25252C%252BPatterns%25252C%252Band%252BPrinciples%252Bin%252BDrug%252BDiscovery%25253A%252BAppraising%252Bthe%252BRule%252Bof%252B5%252Bwith%252BMeasured%252BPhysicochemical%252BData%26aulast%3DTinworth%26aufirst%3DChristopher%2BP.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25092019%26date%3D11052020%26date%3D23042020%26volume%3D63%26issue%3D18%26spage%3D10091%26epage%3D10108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lewis D. Pennington, Brian M. Aquila, Younggi Choi, Roman A. Valiulin, <span class="NLM_string-name hlFld-ContribAuthor">Ingo Muegge</span>. </span><span class="cited-content_cbyCitation_article-title">Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8956-8976. <a href="https://doi.org/10.1021/acs.jmedchem.9b02092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositional%252BAnalogue%252BScanning%25253A%252BAn%252BEffective%252BStrategy%252Bfor%252BMultiparameter%252BOptimization%252Bin%252BDrug%252BDesign%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D24042020%26volume%3D63%26issue%3D17%26spage%3D8956%26epage%3D8976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederick W. Goldberg, M. Raymond V. Finlay, Attilla K. T. Ting, David Beattie, Gillian M. Lamont, Charlene Fallan, Gail L. Wrigley, Marianne Schimpl, Martin R. Howard, Beth Williamson, Mercedes Vazquez-Chantada, Derek G. Barratt, Barry R. Davies, Elaine B. Cadogan, Antonio Ramos-Montoya, <span class="NLM_string-name hlFld-ContribAuthor">Emma Dean</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3461-3471. <a href="https://doi.org/10.1021/acs.jmedchem.9b01684" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B7-Methyl-2-%25255B%2525287-methyl%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridin-6-yl%252529amino%25255D-9-%252528tetrahydro-2H-pyran-4-yl%252529-7%25252C9-dihydro-8H-purin-8-one%252B%252528AZD7648%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BDNA-Dependent%252BProtein%252BKinase%252B%252528DNA-PK%252529%252BInhibitor%26aulast%3DGoldberg%26aufirst%3DFrederick%2BW.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11102019%26date%3D15012020%26date%3D18122019%26volume%3D63%26issue%3D7%26spage%3D3461%26epage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer A. Borthwick, Carlos Alemparte, Ian Wall, Benjamin C. Whitehurst, Argyrides Argyrou, Glenn Burley, Paco de Dios-Anton, Laura Guijarro, Maria Candida Monteiro, Fatima Ortega, Colin J Suckling, Julia Castro Pichel, Monica Cacho, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Young</span>. </span><span class="cited-content_cbyCitation_article-title">Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2557-2576. <a href="https://doi.org/10.1021/acs.jmedchem.9b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMycobacterium%252Btuberculosis%252BDecaprenylphosphoryl-%2525CE%2525B2-d-ribose%252BOxidase%252BInhibitors%25253A%252BExpeditious%252BReconstruction%252Bof%252BSuboptimal%252BHits%252Binto%252Ba%252BSeries%252Bwith%252BPotent%252Bin%252BVivo%252BActivity%26aulast%3DBorthwick%26aufirst%3DJennifer%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19092019%26date%3D22012020%26date%3D10012020%26volume%3D63%26issue%3D5%26spage%3D2557%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin Jeffries, Zhong Wang, Hannah R. Felstead, Jean-Yves Le Questel, James S. Scott, Elisabetta Chiarparin, Jérôme Graton, <span class="NLM_string-name hlFld-ContribAuthor">Bruno Linclau</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1002-1031. <a href="https://doi.org/10.1021/acs.jmedchem.9b01172" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01172%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252BInvestigation%252Bof%252BLipophilicity%252BModulation%252Bby%252BAliphatic%252BFluorination%252BMotifs%26aulast%3DJeffries%26aufirst%3DBenjamin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19072019%26date%3D17012020%26date%3D02012020%26volume%3D63%26issue%3D3%26spage%3D1002%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manu De Rycker, David Horn, Bree Aldridge, Richard K. Amewu, Clifton E. Barry, III, Frederick S. Buckner, Sarah Cook, Michael A. J. Ferguson, Nathalie Gobeau, Jennifer Herrmann, Paul Herrling, William Hope, Jennifer Keiser, Maria Jose Lafuente-Monasterio, Paul D. Leeson, Didier Leroy, Ujjini H. Manjunatha, James McCarthy, Timothy J. Miles, Valerie Mizrahi, Olena Moshynets, Jacquin Niles, John P. Overington, John Pottage, Srinivasa P. S. Rao, Kevin D. Read, Isabela Ribeiro, Lynn L. Silver, Jen Southern, Thomas Spangenberg, Shyam Sundar, Caitlin Taylor, Wes Van Voorhis, Nicholas J. White, Susan Wyllie, Paul G. Wyatt, <span class="NLM_string-name hlFld-ContribAuthor">Ian H. Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Setting Our Sights on Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (1)
                                     , 3-13. <a href="https://doi.org/10.1021/acsinfecdis.9b00371" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00371%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DSetting%252BOur%252BSights%252Bon%252BInfectious%252BDiseases%26aulast%3DDe%2BRycker%26aufirst%3DManu%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D25092019%26date%3D06122019%26volume%3D6%26issue%3D1%26spage%3D3%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nenad Manevski, Lloyd King, William R. Pitt, Fabien Lecomte, <span class="NLM_string-name hlFld-ContribAuthor">Francesca Toselli</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10955-10994. <a href="https://doi.org/10.1021/acs.jmedchem.9b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolism%252Bby%252BAldehyde%252BOxidase%25253A%252BDrug%252BDesign%252Band%252BComplementary%252BApproaches%252Bto%252BChallenges%252Bin%252BDrug%252BDiscovery%26aulast%3DManevski%26aufirst%3DNenad%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30052019%26date%3D20082019%26date%3D06082019%26volume%3D62%26issue%3D24%26spage%3D10955%26epage%3D10994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yvett Sosa, Roman Deniskin, I. J. Frame, Matthew S. Steiginga, Deepak Bandyopadhyay, Todd L. Graybill, Lorena A. Kallal, Michael T. Ouellette, Andrew J. Pope, Katherine L. Widdowson, Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Myles H. Akabas</span>. </span><span class="cited-content_cbyCitation_article-title">Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Plasmodium falciparum Parasite Proliferation. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (10)
                                     , 1738-1753. <a href="https://doi.org/10.1021/acsinfecdis.9b00168" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00168%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DIdentification%252Bvia%252Ba%252BParallel%252BHit%252BProgression%252BStrategy%252Bof%252BImproved%252BSmall%252BMolecule%252BInhibitors%252Bof%252Bthe%252BMalaria%252BPurine%252BUptake%252BTransporter%252Bthat%252BInhibit%252BPlasmodium%252Bfalciparum%252BParasite%252BProliferation%26aulast%3DSosa%26aufirst%3DYvett%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07052019%26date%3D14082019%26date%3D02082019%26volume%3D5%26issue%3D10%26spage%3D1738%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher J. Helal, Mark Bundesmann, Susan Hammond, Melissa Holmstrom, Jacquelyn Klug-McLeod, Bruce A. Lefker, Dale McLeod, Chakrapani Subramanyam, Oleg Zakaryants, <span class="NLM_string-name hlFld-ContribAuthor">Sylvie Sakata</span>. </span><span class="cited-content_cbyCitation_article-title">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1104-1109. <a href="https://doi.org/10.1021/acsmedchemlett.9b00205" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuick%252BBuilding%252BBlocks%252B%252528QBB%252529%25253A%252BAn%252BInnovative%252Band%252BEfficient%252BBusiness%252BModel%252BTo%252BSpeed%252BMedicinal%252BChemistry%252BAnalog%252BSynthesis%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06052019%26date%3D05072019%26date%3D18072019%26date%3D05072019%26volume%3D10%26issue%3D8%26spage%3D1104%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, Joy Drobnick, Alberto Gobbi, Aleksandr Kolesnikov, Yongsheng Chen, Naomi Rajapaksa, Chudi Ndubaku, Jianwen Feng, Willy Chang, Ross Francis, Christine Yu, Edna F. Choo, Kevin DeMent, Yingqing Ran, Le An, Claire Emson, Zhiyu Huang, Swathi Sujatha-Bhaskar, Hans Brightbill, Antonio DiPasquale, Jonathan Maher, John Wai, Brent S. McKenzie, Patrick J. Lupardus, Ali A. Zarrin, <span class="NLM_string-name hlFld-ContribAuthor">James R. Kiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 6223-6240. <a href="https://doi.org/10.1021/acs.jmedchem.9b00439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPotent%252Band%252BSelective%252BPyrazolopyrimidine%252BIRAK4%252BInhibitors%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26032019%26date%3D24052019%26date%3D13052019%26volume%3D62%26issue%3D13%26spage%3D6223%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Michael D. Shultz</span>. </span><span class="cited-content_cbyCitation_article-title">Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1701-1714. <a href="https://doi.org/10.1021/acs.jmedchem.8b00686" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00686%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTwo%252BDecades%252Bunder%252Bthe%252BInfluence%252Bof%252Bthe%252BRule%252Bof%252BFive%252Band%252Bthe%252BChanging%252BProperties%252Bof%252BApproved%252BOral%252BDrugs%26aulast%3DShultz%26aufirst%3DMichael%2BD.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30042018%26date%3D27092018%26date%3D13092018%26volume%3D62%26issue%3D4%26spage%3D1701%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bradley
C. Doak, <span class="NLM_string-name hlFld-ContribAuthor">Jan Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclophilin Succumbs to a Macrocyclic Chameleon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9469-9472. <a href="https://doi.org/10.1021/acs.jmedchem.8b01555" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclophilin%252BSuccumbs%252Bto%252Ba%252BMacrocyclic%252BChameleon%26aulast%3DDoak%26aufirst%3DBradley%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05102018%26date%3D25102018%26volume%3D61%26issue%3D21%26spage%3D9469%26epage%3D9472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Bogdan</span>, <span class="hlFld-ContribAuthor ">Nathan J.  Gesmundo</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Webster</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Chemistry Technologies and Applications to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-78. <a href="https://doi.org/10.1002/0471266949.bmc293" title="DOI URL">https://doi.org/10.1002/0471266949.bmc293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc293%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BChemistry%252BTechnologies%252Band%252BApplications%252Bto%252BMedicinal%252BChemistry%26aulast%3DBogdan%26aufirst%3DAndrew%2BR.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D78%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Into the Fray! A Beginner's Guide to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (8)
                                     , 1199-1225. <a href="https://doi.org/10.1002/cmdc.202000929" title="DOI URL">https://doi.org/10.1002/cmdc.202000929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000929%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInto%252Bthe%252BFray%252521%252BA%252BBeginner%252527s%252BGuide%252Bto%252BMedicinal%252BChemistry%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D8%26spage%3D1199%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Herman  Depypere</span>, <span class="hlFld-ContribAuthor ">Christopher  Lademacher</span>, <span class="hlFld-ContribAuthor ">Emad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Graeme L  Fraser</span>. </span><span class="cited-content_cbyCitation_article-title">Fezolinetant in the treatment of vasomotor symptoms associated with menopause. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/13543784.2021.1893305" title="DOI URL">https://doi.org/10.1080/13543784.2021.1893305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2021.1893305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2021.1893305%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DFezolinetant%252Bin%252Bthe%252Btreatment%252Bof%252Bvasomotor%252Bsymptoms%252Bassociated%252Bwith%252Bmenopause%26aulast%3DDepypere%26aufirst%3DHerman%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Ingo  Muegge</span>. </span><span class="cited-content_cbyCitation_article-title">Holistic Drug Design for Multiparameter Optimization in Modern Small Molecule Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>10 </em>, 128003. <a href="https://doi.org/10.1016/j.bmcl.2021.128003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHolistic%252BDrug%252BDesign%252Bfor%252BMultiparameter%252BOptimization%252Bin%252BModern%252BSmall%252BMolecule%252BDrug%252BDiscovery%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2021%26volume%3D10%26spage%3D128003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew R.  Freidel</span>, <span class="hlFld-ContribAuthor ">Roger S.  Armen</span>, . </span><span class="cited-content_cbyCitation_article-title">Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2021,</strong> <em>16 </em>
                                    (2)
                                     , e0246181. <a href="https://doi.org/10.1371/journal.pone.0246181" title="DOI URL">https://doi.org/10.1371/journal.pone.0246181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0246181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0246181%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMapping%252Bmajor%252BSARS-CoV-2%252Bdrug%252Btargets%252Band%252Bassessment%252Bof%252Bdruggability%252Busing%252Bcomputational%252Bfragment%252Bscreening%25253A%252BIdentification%252Bof%252Ban%252Ballosteric%252Bsmall-molecule%252Bbinding%252Bsite%252Bon%252Bthe%252BNsp13%252Bhelicase%26aulast%3DFreidel%26aufirst%3DMatthew%2BR.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D2%26spage%3De0246181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Fullam</span>, <span class="hlFld-ContribAuthor ">Robert J.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Physicochemical properties and
              Mycobacterium tuberculosis
              transporters: keys to efficacious antitubercular drugs?. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 43-56. <a href="https://doi.org/10.1039/D0MD00265H" title="DOI URL">https://doi.org/10.1039/D0MD00265H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00265H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00265H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPhysicochemical%252Bproperties%252Band%252BMycobacterium%252Btuberculosis%252Btransporters%25253A%252Bkeys%252Bto%252Befficacious%252Bantitubercular%252Bdrugs%25253F%26aulast%3DFullam%26aufirst%3DElizabeth%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina D.  Cruz</span>, <span class="hlFld-ContribAuthor ">Pauli  Wrigstedt</span>, <span class="hlFld-ContribAuthor ">Karina  Moslova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Iashin</span>, <span class="hlFld-ContribAuthor ">Heidi  Mäkkylä</span>, <span class="hlFld-ContribAuthor ">Léo  Ghemtio</span>, <span class="hlFld-ContribAuthor ">Sami  Heikkinen</span>, <span class="hlFld-ContribAuthor ">Päivi  Tammela</span>, <span class="hlFld-ContribAuthor ">Jesus E.  Perea-Buceta</span>. </span><span class="cited-content_cbyCitation_article-title">Installation of an aryl boronic acid function into the external section of  -aryl-oxazolidinones: Synthesis and antimicrobial evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113002. <a href="https://doi.org/10.1016/j.ejmech.2020.113002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInstallation%252Bof%252Ban%252Baryl%252Bboronic%252Bacid%252Bfunction%252Binto%252Bthe%252Bexternal%252Bsection%252Bof%252B-aryl-oxazolidinones%25253A%252BSynthesis%252Band%252Bantimicrobial%252Bevaluation%26aulast%3DCruz%26aufirst%3DCristina%2BD.%26date%3D2021%26volume%3D211%26spage%3D113002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Ermondi</span>, <span class="hlFld-ContribAuthor ">Maura  Vallaro</span>, <span class="hlFld-ContribAuthor ">Gilles  Goetz</span>, <span class="hlFld-ContribAuthor ">Marina  Shalaeva</span>, <span class="hlFld-ContribAuthor ">Giulia  Caron</span>. </span><span class="cited-content_cbyCitation_article-title">Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>146 </em>, 105274. <a href="https://doi.org/10.1016/j.ejps.2020.105274" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105274%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DUpdating%252Bthe%252Bportfolio%252Bof%252Bphysicochemical%252Bdescriptors%252Brelated%252Bto%252Bpermeability%252Bin%252Bthe%252Bbeyond%252Bthe%252Brule%252Bof%252B5%252Bchemical%252Bspace%26aulast%3DErmondi%26aufirst%3DGiuseppe%26date%3D2020%26volume%3D146%26spage%3D105274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  Kenny</span>. </span><span class="cited-content_cbyCitation_article-title">The nature of ligand efficiency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2019,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-019-0330-2" title="DOI URL">https://doi.org/10.1186/s13321-019-0330-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-019-0330-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-019-0330-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DThe%252Bnature%252Bof%252Bligand%252Befficiency%26aulast%3DKenny%26aufirst%3DPeter%2BW.%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rick P. C.  Cousins</span>. </span><span class="cited-content_cbyCitation_article-title">Medicines discovery for auditory disorders: Challenges for industry. </span><span class="cited-content_cbyCitation_journal-name">The Journal of the Acoustical Society of America</span><span> <strong>2019,</strong> <em>146 </em>
                                    (5)
                                     , 3652-3667. <a href="https://doi.org/10.1121/1.5132706" title="DOI URL">https://doi.org/10.1121/1.5132706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1121/1.5132706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1121%2F1.5132706%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520the%2520Acoustical%2520Society%2520of%2520America%26atitle%3DMedicines%252Bdiscovery%252Bfor%252Bauditory%252Bdisorders%25253A%252BChallenges%252Bfor%252Bindustry%26aulast%3DCousins%26aufirst%3DRick%2BP.%2BC.%26date%3D2019%26volume%3D146%26issue%3D5%26spage%3D3652%26epage%3D3667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olesya M.  Kuzmina</span>, <span class="hlFld-ContribAuthor ">Martin  Weisel</span>, <span class="hlFld-ContribAuthor ">Arun A.  Narine</span>. </span><span class="cited-content_cbyCitation_article-title">5-Membered Mesoionic Insecticides: Synthesis and Evaluation of 1,3,4-Thiadiazol-4-ium-2-olates with High Affinity for the Insect Nicotinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (31-32)
                                     , 5527-5531. <a href="https://doi.org/10.1002/ejoc.201900637" title="DOI URL">https://doi.org/10.1002/ejoc.201900637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900637%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D5-Membered%252BMesoionic%252BInsecticides%25253A%252BSynthesis%252Band%252BEvaluation%252Bof%252B1%25252C3%25252C4-Thiadiazol-4-ium-2-olates%252Bwith%252BHigh%252BAffinity%252Bfor%252Bthe%252BInsect%252BNicotinic%252BAcetylcholine%252BReceptor%26aulast%3DKuzmina%26aufirst%3DOlesya%2BM.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D31-32%26spage%3D5527%26epage%3D5531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shenaz B.  Bunally</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Robert J.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Using Physicochemical Measurements to Influence Better Compound Design. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 791-801. <a href="https://doi.org/10.1177/2472555219859845" title="DOI URL">https://doi.org/10.1177/2472555219859845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219859845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219859845%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DUsing%252BPhysicochemical%252BMeasurements%252Bto%252BInfluence%252BBetter%252BCompound%252BDesign%26aulast%3DBunally%26aufirst%3DShenaz%2BB.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D791%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joerg  Holenz</span>, <span class="hlFld-ContribAuthor ">Patrick  Stoy</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Lead Generation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 517-524. <a href="https://doi.org/10.1016/j.bmcl.2018.12.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAdvances%252Bin%252BLead%252BGeneration%26aulast%3DHolenz%26aufirst%3DJoerg%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D517%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas  Boström</span>, <span class="hlFld-ContribAuthor ">Dean G.  Brown</span>, <span class="hlFld-ContribAuthor ">Robert J.  Young</span>, <span class="hlFld-ContribAuthor ">György M.  Keserü</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the medicinal chemistry synthetic toolbox. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (10)
                                     , 709-727. <a href="https://doi.org/10.1038/nrd.2018.116" title="DOI URL">https://doi.org/10.1038/nrd.2018.116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2018.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2018.116%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DExpanding%252Bthe%252Bmedicinal%252Bchemistry%252Bsynthetic%252Btoolbox%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJonas%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D10%26spage%3D709%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0052.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization trends and physical properties. (a) Median cLogP and molecular weight of oral drugs and patented compounds: (in black) oral drugs by literature publication<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> decade, updated to mid-2016 launches and restricted to drugs with available oral doses; (in red) median of median target data for 18 companies with >50 compounds patented per target in 2000–2010.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (b) Median cLogP and molecular weight of “start to finish” optimization pairs. In blue: leads to drugs: (A,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> B<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) historical drugs; (C) drugs launched post-1990;<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (D) first in class to follow-on drug.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In red: literature optimizations: (E) early 2000s literature;<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (F) HTS hit-to-lead, 2000s literature;<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (G) 2014 literature not using lipophilicity.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In green: property-aware optimizations: (H) 2014 literature using lipophilicity;<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (I) late 2000s literature using lipophilic ligand efficiency (LLE).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (c) Median cLogP and molecular weight of screening sets and derived compounds: (in green) fragment hits and their optimizations<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and fragment-derived candidate drugs (calculated from the list in ref <a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>); (in red) HTS collections, leads from them, and linked patents [collected HTS and lead 2009 median data from GlaxoSmithKline, Novartis, Sanofi-Aventis, and Wyeth (HTS) and GlaxoSmithKline, Novartis, and Wyeth (leads)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and corresponding median patent data<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> for GlaxoSmithKline, Novartis, and Wyeth, 2000–2010]; (in black) leads from DNA-encoded libraries (calculated from the list in ref <a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>). (d) Median LE and LLE (based on cLogP) values of 480 target-assay pairs having ≥100 published compounds with potency values.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Targets highlighted are discussed in this paper. Figure adapted from ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Generic potency versus lipophilicity plot, with parallel lines showing constant LLE values and thresholds for an illustrative desirable potency of 10 nM or pIC<sub>50</sub> > 8 and cLogP < 3. A case can be made for lower activity thresholds for more hydrophilic compounds, based on their likely higher drug efficiency.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery of CCR5 Antagonists Based on the <i>N</i>-Phenylpropylpiperidine Pharmacophore (in Red), from Hit or Lead to Candidate Drug<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Compounds selected are those highlighted in the inventors’ publications. (a) <b>1</b> maraviroc (Pfizer); (b) <b>5</b> AZD5672 (AstraZeneca); (c) <b>3</b> MrKA (Merck); (d) <b>4</b> GSK163929 (GSK). AV = antiviral potency.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plots of CCR5 antagonist pIC<sub>50</sub> values versus and cLogP (a) and heavy atom count (b). Values are from CHEMBL and the literature. The key compounds in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> are connected to show the discovery trajectories for each candidate drug. The percentages of compounds in the background CCR5 data having better combined LE and LLE versus the candidate drugs are the following: maraviroc <b>1</b>, 2.7%; AZD5672 <b>5</b>, 1.4%; MrKA <b>3</b>, 14%; GSK 163929 <b>4</b>, 54%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) pKi<sub>50</sub> vs cPFI and (b) LE vs LLE (pIC<sub>50</sub> – cLogP) plot for representative factor Xa inhibitors described in ref <a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a>, with four marketed drugs (diamonds) and illustrative examples from the BMS (blue) and GSK program highlighted (candidates, stars; hit, cross; others, circles). Betrixaban was the most recently approved drug, which is a low dose oral molecule (taken 80 mg u.i.d. with food) with relatively poor predicted physical properties, but has a high LLE of 6.3 (based on cLogP).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PDE-V inhibitors (a) pIC<sub>50</sub> vs cPFI and (b) LE vs LLE (cLogP derived) of PDE-V inhibitors in ChEMBL with three marketed drugs sildenafil, vardenafil, tadalafil (hits, ×; drugs, stars) and illustrative examples from the second-generation program (<b>27</b> PF-489791 = triangle). It is interesting to note a relatively narrow band of ligand efficiency in the second-generation series once the two key substituents were identified.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Activity, Efficiency, and Calculated PFI Data for the Second Generation PDE-V Inhibitors That Led to PF-489791 <b>27</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Representative Activity, Efficiency, and Calculated PFI Data for Hits and Key Intermediates En Route to the Three Marketed PDE-V Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Discovery of AZD 3839 <b>36</b> from Early Fragment Hits, Isocytosines <b>34</b> and <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery trajectories of <b>40</b> and <b>36</b>, using <i>K</i><sub>i</sub> values, and properties of other BACE-1 inhibitors: (a) potency vs cLogP; (b) potency vs HA count. Note inhibitor affinity linearly increases up to HA count of ∼20, and sub-10 nM affinity is seen over a wide lipophilicity range (cLogP of 1–6). The “% better” LE and LLE values versus background data are the following: verubecestat <b>40</b>, 0.0%; AZD3293 <b>45</b>, 0.5%; LY2811376 <b>48</b>, 1.7%; LY2886721 <b>46</b>, 2.0%; RG7129 <b>47</b>, 5.2%; AZD3839 <b>36</b>, 6.4%. Data are <i>K</i><sub>i</sub> and IC<sub>50</sub> values from CHEMBL (<i>n</i> = 5490).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Discovery of Verubecesat <b>40</b> from Fragment <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Note the aryl amidine framework in red in the hit is retained in the drug candidate.</p></p></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) pIC<sub>50</sub> vs PFI and (b) LE vs LLE (based on cLogP) plot for three series of GSK BCATm inhibitors derived from fragment guided optimization (green)<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and two ELT series (orange<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> and blue<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a>): fragments, +; key hybrids, △; hits, ×; best balanced exemplars, stars.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Summary of Fragment Guided Optimization Indicating Hits from Fragment Screen and HTS, Plus ELT Off-DNA Hits <b>59</b> and <b>60</b> (Colored as in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Key Compounds in the Discovery of Poly(ADP-ribose) Polymerase-1 (PARP-1) and PARP-2 Inhibitors, as an Example of Progression of Leadlike Chemical Starting Points<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Discovery of olaparib (<b>62</b>) from the medium throughput screening hit, phthalazine-2-one <b>68</b>.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> (b) Benzimidazole amides <b>61</b> and <b>65</b>, reported in 2000,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> were developed to provide rucaparib (<b>63</b>)<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> and inspired the discoveries of veliparib (<b>64</b>)<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and niraparib (<b>66</b>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Attempts to merge <b>68</b> and <b>65</b> by cyclizing <b>68</b> to an indolenine led instead to <b>72</b>, which was optimized to talazoparib (<b>67</b>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Open arrows are design steps; closed arrows are optimization steps.</p></p></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery trajectories of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Data are p<i>K</i><sub>i</sub> (<i>n</i> = 359) and pIC<sub>50</sub> (<i>n</i> = 1520) values from CHEMBL. The discovery trajectories for the drugs in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a> are shown; all are IC<sub>50</sub> values except for rucaparib where <i>K</i><sub>i</sub> values are used. Note that potency of >8 is achievable in the cLogP range −0.5 to 5.0. In contrast, the maximum achievable potency increases linearly as the HA count increases to ∼20 and then does not increase further.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. HIV Integrase Drug Discovery, Showing Key Lead Compounds and Their Properties</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. HIV integrase trajectories shown on a background literature data of mean IC<sub>50</sub> values (all HCV replicons/mutants) from CHEMBL (<i>n</i> = 1877): (a) potency vs cLogP; (b) potency vs HA count. Structures are shown in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plot of calculated Chrom log <i>D</i><sub>7.4</sub> versus calculated molar refraction (cmr, a good surrogate for size; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf" class="ext-link">Supporting Information Figures S.1 and S.2</a>) for exemplars in the ELT review<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (×), overlaid on a GSK training set of marketed oral dug molecules with % bioavailability of >30% (green ○) and <30% (red ○). The solid line is a statistically derived linear discriminant function (LDF), which differentiates higher from lower bioavailability; the dotted lines (LDF values of ±0.3) represent regions where the predictivity has borderline confidence based on the underlying statistics of the model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. RIP-1 FP pIC<sub>50</sub> versus calculated PFI data: candidate <b>82</b> (purple star), ELT hit <b>80</b> (blue ×), analogs of these compounds in the hits to lead (yellow triangles) and LO disclosures (green circles). Hinge binding series related to the in vivo active <b>83</b> (red). The lines representing ligand lipophilic efficiency are based on pIC<sub>50</sub> – cPFI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. RIP-1 LE vs LLE data colored as <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. Cross lines are LE = 0.35 and LLE (pIC<sub>50</sub> – cLogP) = 5.0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. RIP-1 LE vs LLE derived from measured Chrom log <i>P</i> data: star is <b>82</b>, ELT hit X is <b>80</b>, colors as in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. Cross lines are LE = 0.35 and LLE (pIC<sub>50</sub> – mChrom log P) = 3.0 (lipophilicities not measured for <b>83</b> and analogs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Measured vs predicted Chrom log <i>D</i><sub>7.4</sub> values in the necrostatin-site series including <b>82</b> and <b>80</b> (line of unity and line of best fit, <i>r</i><sup>2</sup> = 0.969). Colors as in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. pIC50 vs HAC for the P38α compounds, illustrating the marked difference in tactics achieved in the GSK optimization to losmapimod (<b>88</b>) (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. pIC<sub>50</sub> vs cLogP for the P38α compounds, noting that except for the Boehringer molecule <b>91</b> (blue), most optimizations were achieved with modest increases in cLogP (or a decrease in one Pfizer example, <b>86</b> (red)). The Vipergen ELT product <b>81</b> (light purple) scores well in this analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. pIC<sub>50</sub> vs cPFI for the P38α compounds, where the focus on properties was evident at Pfizer (red) and GSK (green). The Pfizer reductions (<b>86</b>, <b>87</b>) (red) were achieved by lipophilicity modulation. Removal of two aromatic rings was the most notable feature of the optimization leading to <b>88</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. LE vs LLE for the P38α compounds, where the focus on properties and efficiency gave molecules from Pfizer (red) and GSK (green) (<b>86</b>, <b>87</b>, <b>88</b>) at the top right of the graph where the % better than values are optimal. In terms of LLE the Vipergen compound <b>81</b> scores well.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0033.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Issues Overcome in the Discoveries of EGFR Double Mutant Candidates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Hinge binding sites shown by blue arrows.</p></p></figure><figure data-id="fig19" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Cellular EGFR double mutant potencies versus measured log <i>D</i> for compounds cited in the discoveries of <b>98</b>, <b>99</b>, and <b>100</b>. LLE<sub>D</sub> = cell pIC<sub>50</sub> – log <i>D</i><sub>7.4</sub>. The “% better” LE and LLE values (based on cLogP) versus background data from CHEMBL (<i>n</i> = 544, not shown) are the following: osimertinib <b>98</b>, 39%; PF-06459988 <b>99</b>, 4.6%; PF-06747775 <b>100</b>, 0.5%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0034.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Discovery of AMPK Kinase Activators in Merck and Pfizer</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Trajectories in LE vs LLE space of the Merck and Pfizer AMPK kinase projects. Structures are shown in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>. LLE = α2β1γ1 EC<sub>50</sub> – cLogP. EC<sub>50</sub> of the HTS hit <b>106</b> is approximated to 40 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0035.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Second Generation Macrocyclic HCV NS3/4A Protease Inhibitors and Human Doses<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Blue structures retain the BILN-2061 <b>113</b> substructure, and red compounds have Merck substructure <b>114</b> in common. Simeprevir, paritaprevir, grazoprevir, voxilaprevir, and glecaprevir are approved by the FDA. Vaniprevir is approved in Japan.</p></p></figure><figure data-id="fig21" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Discovery trajectories of macrocyclic inhibitors of HCV NS3/4A protease from the lead BILN-2061 <b>113</b>: (a) potency vs cLogP; (b) potency vs HA count. The “% better” LE and LLE values versus the background of NS3/4A inhibitors from CHEMBL (<i>n</i> = 1305) are improved with the macrocycles versus the first generation drug telaprevir <b>112</b> (36%): simeprevir <b>119</b>, 8.7%; glecaprevir <b>118</b>, 11%; paritaprevir <b>120</b>, 14%; voxilaprevir <b>117</b>, 15%; grazoprevir <b>116</b>, 17%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0036.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Discovery of Daclatasvir <b>125</b> from Screening Hit <b>121</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Trajectory in LE and LLE space for discovery of daclarasvir (<b>125</b>) and values for the other NS5A inhibitors derived from <b>125</b>. The background data show <b>125</b> substructures from CHEMBL (<i>n</i> = 356; the assay is phenotypic and full CHEMBL searches retrieve non-NS5A antivirals).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch13" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0037.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Discovery, Timelines (from Patents), and Optimization Strategy of BCL-2 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Trajectory of the discovery of venetoclax (<b>131</b>): (a) potency vs cLogP; (b) potency vs HA count. Structures are shown in <a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>. The background data are BCL-2 compounds extracted from CHEMBL (<i>n</i> = 699). The <i>K</i><sub>i</sub> for <b>131</b> is reported to be <0.01 nM; a value of 0.01 nM is used in the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/medium/jm-2018-00180d_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Optimization trajectories according to hit properties, exemplified with a generic potency versus lipophilicity plot showing “ideal” oral druglikeness range as the goal. Fragment (a) or leadlike (b) starting points can be “grown” into optimal druglike space. For typical HTS hits, seeking reduced lipophilicity from the outset (c) will develop improved leadlike characteristics and new SAR. Increasing potency by increasing lipophilicity of HTS hits (d) is risky, since lipophilicity will have to be reduced ultimately and could be difficult if potency depends on it. With potent lipophilic hits, seeking to reduce lipophilicity (e) is the most viable approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00180/20180802/images/large/jm-2018-00180d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00180&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 306 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macarron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirovic, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garyantes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paslay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span></span> <span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1038/nrd3368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&issue=3&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research&doi=10.1038%2Fnrd3368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0lgfMHG0JN8zHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D3%26spage%3D188%26epage%3D195%26doi%3D10.1038%2Fnrd3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bleicher, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanine, A. I.</span></span> <span> </span><span class="NLM_article-title">Hit and lead generation: beyond high-throughput screening</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1038/nrd1086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd1086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=12750740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=369-378&issue=5&author=K.+H.+Bleicherauthor=H.+J.+Bohmauthor=K.+Mullerauthor=A.+I.+Alanine&title=Hit+and+lead+generation%3A+beyond+high-throughput+screening&doi=10.1038%2Fnrd1086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A guide to drug discovery: Hit and lead generation: beyond high-throughput screening</span></div><div class="casAuthors">Bleicher, Konrad H.; Boehm, Hans-Joachim; Mueller, Klaus; Alanine, Alexander I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-378</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of small-mol. modulators of protein function, and the process of transforming these into high-content lead series, are key activities in modern drug discovery.  The decisions taken during this process have far-reaching consequences for success later in lead optimization and even more crucially in clin. development.  Recently, there has been an increased focus on these activities due to escalating downstream costs resulting from high clin. failure rates.  In addn., the vast emerging opportunities from efforts in functional genomics and proteomics demands a departure from the linear process of identification, evaluation and refinement activities towards a more integrated parallel process.  This calls for flexible, fast and cost-effective strategies to meet the demands of producing high-content lead series with improved prospects for clin. success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9IQCsTR8tobVg90H21EOLACvtfcHk0lgfMHG0JN8zHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtb8%253D&md5=b54e55c1f0d34fbd172c8aa9b996591d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1086%26sid%3Dliteratum%253Aachs%26aulast%3DBleicher%26aufirst%3DK.%2BH.%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DAlanine%26aufirst%3DA.%2BI.%26atitle%3DHit%2520and%2520lead%2520generation%253A%2520beyond%2520high-throughput%2520screening%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D5%26spage%3D369%26epage%3D378%26doi%3D10.1038%2Fnrd1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinker, A.</span></span> <span> </span><span class="NLM_article-title">Components of successful lead generation</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/1568026053828411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F1568026053828411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15892684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=421-439&issue=4&author=A.+Davisauthor=D.+Keelingauthor=J.+Steeleauthor=N.+Tomkinsonauthor=A.+Tinker&title=Components+of+successful+lead+generation&doi=10.2174%2F1568026053828411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Components of successful lead generation</span></div><div class="casAuthors">Davis, Andrew M.; Keeling, David J.; Steele, John; Tomkinson, Nicholas P.; Tinker, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-439</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review aims to give an overview of current good practice in the prosecution of Lead Generation.  It will assess experiences across the field as judged from the contents of the limited no. of peer-review disclosures to date.  It will also rely heavily on the experiences of the authors from many campaigns within this organization.  Its focus will be on the assembly of an appropriate compd. collection for application in High Throughput Screening (HTS), the prosecution of HTS, the profiling of HTS output and, lastly the Hit-to-Lead optimization of selected HTS output.  Excluded from the scope are detailed aspects of library design [1], parallel synthesis [2], virtual library applications [3], virtual screening [4] and fragment screening [5] approaches, all of which have been the subject of recent reviews.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox5UYz5NF4m7Vg90H21EOLACvtfcHk0liRk_hvZdccnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFGhtL4%253D&md5=ef29c85464f4ecbc63787210fda1b778</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053828411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053828411%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DKeeling%26aufirst%3DD.%26aulast%3DSteele%26aufirst%3DJ.%26aulast%3DTomkinson%26aufirst%3DN.%26aulast%3DTinker%26aufirst%3DA.%26atitle%3DComponents%2520of%2520successful%2520lead%2520generation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26issue%3D4%26spage%3D421%26epage%3D439%26doi%3D10.2174%2F1568026053828411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&issue=7&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+analysis+of+the+attrition+of+drug+candidates+from+four+major+pharmaceutical+companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0liRk_hvZdccnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520attrition%2520of%2520drug%2520candidates%2520from%2520four%2520major%2520pharmaceutical%2520companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D7%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0liRk_hvZdccnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Druglike properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&issue=1&author=C.+A.+Lipinski&title=Druglike+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eZ_CprnFv4XU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDruglike%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26issue%3D1%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">A sorcerer’s apprentice and the rule of five: from rule-of-thumb to commandment and beyond</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23–24</span>),  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2007.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2007.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18061876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2sjivVGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=995-997&issue=23%E2%80%9324&author=C.+Abad-Zapatero&title=A+sorcerer%E2%80%99s+apprentice+and+the+rule+of+five%3A+from+rule-of-thumb+to+commandment+and+beyond&doi=10.1016%2Fj.drudis.2007.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond</span></div><div class="casAuthors">Abad-Zapatero Cele</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">995-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4k8xMsSJHYGLFM_lbR1VmfW6udTcc2eZzCWb74EeyELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjivVGrtQ%253D%253D&md5=d09c56d696d2977f7a4e5f16992631a4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DA%2520sorcerer%25E2%2580%2599s%2520apprentice%2520and%2520the%2520rule%2520of%2520five%253A%2520from%2520rule-of-thumb%2520to%2520commandment%2520and%2520beyond%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26issue%3D23%25E2%2580%259324%26spage%3D995%26epage%3D997%26doi%3D10.1016%2Fj.drudis.2007.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Graaf, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegner, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, S. D.</span></span> <span> </span><span class="NLM_article-title">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9–10</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22227532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=419-424&issue=9%E2%80%9310&author=P.+Morganauthor=P.+H.+Van+Der+Graafauthor=J.+Arrowsmithauthor=D.+E.+Feltnerauthor=K.+S.+Drummondauthor=C.+D.+Wegnerauthor=S.+D.+Street&title=Can+the+flow+of+medicines+be+improved%3F+Fundamental+pharmacokinetic+and+pharmacological+principles+toward+improving+Phase+II+survival&doi=10.1016%2Fj.drudis.2011.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival</span></div><div class="casAuthors">Morgan, Paul; Van Der Graaf, Piet H.; Arrowsmith, John; Feltner, Doug E.; Drummond, Kira S.; Wegner, Craig D.; Street, Steve D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">419-424</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In an effort to uncover systematic learnings that can be applied to improve compd. survival, an anal. was performed on data from Phase II decisions for 44 programs at Pfizer.  It was found that not only were the majority of failures caused by lack of efficacy but also that, in a large no. of cases (43%), it was not possible to conclude whether the mechanism had been tested adequately.  A key finding was that an integrated understanding of the fundamental pharmacokinetic/pharmacodynamic principles of exposure at the site of action, target binding and expression of functional pharmacol. activity (termed together as the three Pillars of survival') all det. the likelihood of candidate survival in Phase II trials and improve the chance of progression to Phase III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFyWWmU_ARMLVg90H21EOLACvtfcHk0ljxPmbSqGovOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslymurk%253D&md5=18816036124edb3d50c4e063fdc40614</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DVan%2BDer%2BGraaf%26aufirst%3DP.%2BH.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DFeltner%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DK.%2BS.%26aulast%3DWegner%26aufirst%3DC.%2BD.%26aulast%3DStreet%26aufirst%3DS.%2BD.%26atitle%3DCan%2520the%2520flow%2520of%2520medicines%2520be%2520improved%253F%2520Fundamental%2520pharmacokinetic%2520and%2520pharmacological%2520principles%2520toward%2520improving%2520Phase%2520II%2520survival%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26issue%3D9%25E2%2580%259310%26spage%3D419%26epage%3D424%26doi%3D10.1016%2Fj.drudis.2011.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satterthwaite, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24833294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&issue=6&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five-dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework</span></div><div class="casAuthors">Cook, David; Brown, Dearg; Alexander, Robert; March, Ruth; Morgan, Paul; Satterthwaite, Gemma; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Maintaining research and development (R&D) productivity at a sustainable level is one of the main challenges currently facing the pharmaceutical industry.  In this article, we discuss the results of a comprehensive longitudinal review of AstraZeneca's small-mol. drug projects from 2005 to 2010.  The anal. allowed us to establish a framework based on the five most important tech. determinants of project success and pipeline quality, which we describe as the five 'R's: the right target, the right patient, the right tissue, the right safety and the right com. potential.  A sixth factor - the right culture - is also crucial in encouraging effective decision-making based on these tech. determinants.  AstraZeneca is currently applying this framework to guide its R&D teams, and although it is too early to demonstrate whether this has improved the company's R&D productivity, we present our data and anal. here in the hope that it may assist the industry overall in addressing this key challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yhPFZOUNO7Vg90H21EOLACvtfcHk0ljxPmbSqGovOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D&md5=746a86c7223f170f7e6c4f9817760e5b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five-dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. J.</span></span> <span> </span><span class="NLM_article-title">Quality guidelines for oral drug candidates: dose, solubility and lipophilicity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1727</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27423371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1719-1727&issue=10&author=M.+K.+Baylissauthor=J.+Butlerauthor=P.+L.+Feldmanauthor=D.+V.+Greenauthor=P.+D.+Leesonauthor=M.+R.+Palovichauthor=A.+J.+Taylor&title=Quality+guidelines+for+oral+drug+candidates%3A+dose%2C+solubility+and+lipophilicity&doi=10.1016%2Fj.drudis.2016.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quality guidelines for oral drug candidates: dose, solubility and lipophilicity</span></div><div class="casAuthors">Bayliss, Martin K.; Butler, James; Feldman, Paul L.; Green, Darren V. S.; Leeson, Paul D.; Palovich, Michael R.; Taylor, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1719-1727</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In an attempt to seek increased understanding of compd. attributes that influence successful drug pipeline progression, GlaxoSmithKline's portfolio of oral candidates was compared with ref. sets of marketed oral drugs.  The approach differs from other attrition studies by explicitly focusing on choosing 'the right compd.' by applying relevant, exptl. derived properties.  The anal. led to four proposed compd. quality categories, created by combining specific criteria for three measures: dose, soly. and the property forecast index, a composite measure of lipophilicity using chromatog. detd. Log D and aromaticity.  The 'three properties' provide benchmarked guidelines for project teams to use when seeking and selecting clin. candidates, because they reflect the property distribution of marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMpjV3EZ_4rVg90H21EOLACvtfcHk0ljM-b94dXMqaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisb%252FK&md5=d9d145b1ee399b6ad54cdc55fff43c48</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DM.%2BK.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DP.%2BL.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DPalovich%26aufirst%3DM.%2BR.%26aulast%3DTaylor%26aufirst%3DA.%2BJ.%26atitle%3DQuality%2520guidelines%2520for%2520oral%2520drug%2520candidates%253A%2520dose%252C%2520solubility%2520and%2520lipophilicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1719%26epage%3D1727%26doi%3D10.1016%2Fj.drudis.2016.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamren, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matcham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettetal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowden, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Impact of a five-dimensional framework on R&D productivity at AstraZeneca</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29348681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=167-181&issue=3&author=P.+Morganauthor=D.+G.+Brownauthor=S.+Lennardauthor=M.+J.+Andertonauthor=J.+C.+Barrettauthor=U.+Erikssonauthor=M.+Fidockauthor=B.+Hamrenauthor=A.+Johnsonauthor=R.+E.+Marchauthor=J.+Matchamauthor=J.+Mettetalauthor=D.+J.+Nichollsauthor=S.+Platzauthor=S.+Reesauthor=M.+A.+Snowdenauthor=M.+N.+Pangalos&title=Impact+of+a+five-dimensional+framework+on+R%26D+productivity+at+AstraZeneca&doi=10.1038%2Fnrd.2017.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of a five-dimensional framework on R&D productivity at AstraZeneca</span></div><div class="casAuthors">Morgan, Paul; Brown, Dean G.; Lennard, Simon; Anderton, Mark J.; Barrett, J. Carl; Eriksson, Ulf; Fidock, Mark; Hamren, Bengt; Johnson, Anthony; March, Ruth E.; Matcham, James; Mettetal, Jerome; Nicholls, David J.; Platz, Stefan; Rees, Steve; Snowden, Michael A.; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">In 2011, AstraZeneca embarked on a major revision of its research and development (R&D) strategy with the aim of improving R&D productivity, which was below industry avs. in 2005-2010.  A cornerstone of the revised strategy was to focus decision-making on five tech. determinants (the right target, right tissue, right safety, right patient and right com. potential).  In this article, we describe the progress made using this '5R framework' in the hope that our experience could be useful to other companies tackling R&D productivity issues.  We focus on the evolution of our approach to target validation, hit and lead optimization, pharmacokinetic/pharmacodynamic modeling and drug safety testing, which have helped improve the quality of candidate drug nomination, as well as the development of the right culture, where 'truth seeking' is encouraged by more rigorous and quant. decision-making.  We also discuss where the approach has failed and the lessons learned.  Overall, the continued evolution and application of the 5R framework are beginning to have an impact, with success rates from candidate drug nomination to phase III completion improving from 4% in 2005-2010 to 19% in 2012-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwdx6OlRZpzrVg90H21EOLACvtfcHk0ljM-b94dXMqaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SitL4%253D&md5=06906e0bc59dc715941998660a514ffe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.244%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DLennard%26aufirst%3DS.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DEriksson%26aufirst%3DU.%26aulast%3DFidock%26aufirst%3DM.%26aulast%3DHamren%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DMarch%26aufirst%3DR.%2BE.%26aulast%3DMatcham%26aufirst%3DJ.%26aulast%3DMettetal%26aufirst%3DJ.%26aulast%3DNicholls%26aufirst%3DD.%2BJ.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DSnowden%26aufirst%3DM.%2BA.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DImpact%2520of%2520a%2520five-dimensional%2520framework%2520on%2520R%2526D%2520productivity%2520at%2520AstraZeneca%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D167%26epage%3D181%26doi%3D10.1038%2Fnrd.2017.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, T. R.</span></span> <span> </span><span class="NLM_article-title">On the connection between chemical constitution and physiological action; with special reference to the physiological action of the salts of the ammonium bases derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia</span>. <i>J. Anat. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1868</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17230757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FotlyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1868&pages=224-242&issue=2&author=A.+C.+Brownauthor=T.+R.+Fraser&title=On+the+connection+between+chemical+constitution+and+physiological+action%3B+with+special+reference+to+the+physiological+action+of+the+salts+of+the+ammonium+bases+derived+from+Strychnia%2C+Brucia%2C+Thebaia%2C+Codeia%2C+Morphia%2C+and+Nicotia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">On the Connection between Chemical Constitution and Physiological Action; with special reference to the Physiological Action of the Salts of the Ammonium Bases derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia</span></div><div class="casAuthors">Brown A C; Fraser T R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of anatomy and physiology</span>
        (<span class="NLM_cas:date">1868</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdcJThMZbycw5nADWVYHg1fW6udTcc2ebtlMt4InHZRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FotlyjtQ%253D%253D&md5=e564284cb1cf489e53aaf6a8890bd7ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BC.%26aulast%3DFraser%26aufirst%3DT.%2BR.%26atitle%3DOn%2520the%2520connection%2520between%2520chemical%2520constitution%2520and%2520physiological%2520action%253B%2520with%2520special%2520reference%2520to%2520the%2520physiological%2520action%2520of%2520the%2520salts%2520of%2520the%2520ammonium%2520bases%2520derived%2520from%2520Strychnia%252C%2520Brucia%252C%2520Thebaia%252C%2520Codeia%252C%2520Morphia%252C%2520and%2520Nicotia%26jtitle%3DJ.%2520Anat.%2520Physiol.%26date%3D1868%26volume%3D2%26issue%3D2%26spage%3D224%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&issue=9&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0lj31x-1tBphxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D9%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Physical properties in drug design</span>. In  <i>Tactics in Contemporary Drug Design</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>, Ed.; <span class="NLM_publisher-name">Springer Berlin Heidelberg</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">68</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2F7355_2013_35" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=1-68&author=R.+J.+Youngauthor=N.+A.+Meanwell&title=Tactics+in+Contemporary+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2F7355_2013_35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2013_35%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DPhysical%2520properties%2520in%2520drug%2520design%26btitle%3DTactics%2520in%2520Contemporary%2520Drug%2520Design%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26pub%3DSpringer%2520Berlin%2520Heidelberg%26date%3D2014%26spage%3D1%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J.</span></span> <span> </span><span class="NLM_article-title">Probing the links between in vitro potency, ADMET and physicochemical parameters</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nrd3367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21358739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFemsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=197-208&issue=3&author=M.+P.+Gleesonauthor=A.+Herseyauthor=D.+Montanariauthor=J.+Overington&title=Probing+the+links+between+in+vitro+potency%2C+ADMET+and+physicochemical+parameters&doi=10.1038%2Fnrd3367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the links between in vitro potency, ADMET and physicochemical parameters</span></div><div class="casAuthors">Gleeson, M. Paul; Hersey, Anne; Montanari, Dino; Overington, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-208</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A common underlying assumption in current drug discovery strategies is that compds. with higher in vitro potency at their target(s) have greater potential to translate into successful, low-dose therapeutics.  This has led to the development of screening cascades with in vitro potency embedded as an early filter.  However, this approach is beginning to be questioned, given the bias in physicochem. properties that it can introduce early in lead generation and optimization, which is due to the often diametrically opposed relationship between physicochem. parameters assocd. with high in vitro potency and those assocd. with desirable absorption, distribution, metab., excretion and toxicity (ADMET) characteristics.  Here, we describe analyses that probe these issues further using the ChEMBL database, which includes more than 500,000 drug discovery and marketed oral drug compds.  Key findings include: first, that oral drugs seldom possess nanomolar potency (50 nM on av.); second, that many oral drugs have considerable off-target activity; and third, that in vitro potency does not correlate strongly with the therapeutic dose.  These findings suggest that the perceived benefit of high in vitro potency may be negated by poorer ADMET properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOslFSgIkUbVg90H21EOLACvtfcHk0lj31x-1tBphxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFemsr8%253D&md5=e275044516e9b0245b71c9603477ef74</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd3367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3367%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DOverington%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520links%2520between%2520in%2520vitro%2520potency%252C%2520ADMET%2520and%2520physicochemical%2520parameters%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D3%26spage%3D197%26epage%3D208%26doi%3D10.1038%2Fnrd3367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&issue=4&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lj31x-1tBphxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span>; <span class="NLM_string-name">Leeson, P. D.</span>; <span class="NLM_string-name">Waterbeemd, H. v. d.</span></span> <span> </span><span class="NLM_article-title">Physicochemical properties and compound quality</span>. In  <i>The Handbook of Medicinal Chemistry: Principles and Practice</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span>, <span class="NLM_string-name">Ward, S.
E.</span></span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">31</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2F9781782621836-00001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1-31&author=M.+P.+Gleeson&author=P.+D.+Leeson&author=H.+v.+d.+Waterbeemdauthor=A.+Davis&author=S.%0AE.+Ward&title=The+Handbook+of+Medicinal+Chemistry%3A+Principles+and+Practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2F9781782621836-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781782621836-00001%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DPhysicochemical%2520properties%2520and%2520compound%2520quality%26btitle%3DThe%2520Handbook%2520of%2520Medicinal%2520Chemistry%253A%2520Principles%2520and%2520Practice%26aulast%3DDavis%26aufirst%3DA.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2015%26spage%3D1%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug design: an update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in nontraditional drug space</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.6b00043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.6b00043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=564-616&issue=4&author=N.+A.+Meanwell&title=Improving+drug+design%3A+an+update+on+recent+applications+of+efficiency+metrics%2C+strategies+for+replacing+problematic+elements%2C+and+compounds+in+nontraditional+drug+space&doi=10.1021%2Facs.chemrestox.6b00043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">564-616</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug discovery and development is a complex and lengthy enterprise that suffers from high rates of candidate attrition at all stages of the process.  The phys., biol., and toxicol. properties of a drug candidate are inextricably linked to its structure, and once a mol. has been synthesized, all subsequent studies along the development path are focused only on assessing and understanding its properties in greater detail.  Unfortunately, a full prediction of the biol. properties of a mol. from an anal. of its 2- or 3-dimensional structure is currently beyond our expertise.  This backdrop mandates that considerable care be taken at the design stage if a mol. is to be successful in testing a mechanistic concept underlying a disease process and to progress into late stage clin. trials and, ultimately, marketing approval.  While there are multiple potential causes of candidate attrition, an introspective anal. of drug design practices over the past decade has focused attention on the perception that contemporary mols. are unnecessarily obese, burdened by high mol. wt. and excessive lipophilicity.  This practice is believed to have its roots in the singular pursuit of enhancing potency during lead optimization rather than adopting a more holistic approach to drug design that gives broader consideration to how structural features affect developability properties.  In an effort to provide the medicinal chem. community with practical guideposts to enhancing compd. quality in the drug design phase and which can readily be applied, a series of efficiency indexes have been proposed that attempt to define aspects of compd. quality in the context of a series of physicochem. parameters.  Of these metrics, lipophilic ligand efficiency (LLE or LipE), which provides an index of the dependence of the potency of a mol. on its intrinsic lipophilicity, has been characterized as the most robust metric that has potential for broad-based application.  In this review, after describing the background literature behind the derivation of efficiency metrics and approaches to assessing compd. aesthetics, synopses of some recent practical application in lead optimization campaigns are presented.  However, mols. that fall into space beyond that assocd. with traditional drug-like properties are an important part of the current and future landscape, exemplified by the summary of direct acting hepatitis C virus NS3 and NS5A inhibitors that have transformed clin. therapy for this chronic disease.  While drug development in nontraditional drug-like space is more challenging and the rules for compd. quality will be different with much still to be understood, careful and disciplined drug design practices will be an essential element of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotJb_EhGoW7Vg90H21EOLACvtfcHk0ljWEEB4Y87v0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCrs7Y%253D&md5=aef48399fb698b5f958c1cc11e1d25aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520design%253A%2520an%2520update%2520on%2520recent%2520applications%2520of%2520efficiency%2520metrics%252C%2520strategies%2520for%2520replacing%2520problematic%2520elements%252C%2520and%2520compounds%2520in%2520nontraditional%2520drug%2520space%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616%26doi%3D10.1021%2Facs.chemrestox.6b00043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkroth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span> <span> </span><span class="NLM_article-title">Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1002/jps.2600760902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.2600760902" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1987&pages=663-687&issue=9&author=C.+Hanschauthor=J.+P.+Bjorkrothauthor=A.+Leo&title=Hydrophobicity+and+central+nervous+system+agents%3A+on+the+principle+of+minimal+hydrophobicity+in+drug+design&doi=10.1002%2Fjps.2600760902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600760902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600760902%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DBjorkroth%26aufirst%3DJ.%2BP.%26aulast%3DLeo%26aufirst%3DA.%26atitle%3DHydrophobicity%2520and%2520central%2520nervous%2520system%2520agents%253A%2520on%2520the%2520principle%2520of%2520minimal%2520hydrophobicity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1987%26volume%3D76%26issue%3D9%26spage%3D663%26epage%3D687%26doi%3D10.1002%2Fjps.2600760902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T.</span></span> <span> </span><span class="NLM_article-title">The design of leadlike combinatorial libraries</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3743</span>– <span class="NLM_lpage">3748</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=3743-3748&issue=24&author=S.+J.+Teagueauthor=A.+M.+Davisauthor=P.+D.+Leesonauthor=T.+Oprea&title=The+design+of+leadlike+combinatorial+libraries&doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991216%252938%253A24%253C3743%253A%253AAID-ANIE3743%253E3.0.CO%253B2-U%26sid%3Dliteratum%253Aachs%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DOprea%26aufirst%3DT.%26atitle%3DThe%2520design%2520of%2520leadlike%2520combinatorial%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26issue%3D24%26spage%3D3743%26epage%3D3748%26doi%3D10.1002%2F%28SICI%291521-3773%2819991216%2938%3A24%3C3743%3A%3AAID-ANIE3743%3E3.0.CO%3B2-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span> <span> </span><span class="NLM_article-title">Pursuing the leadlikeness concept in pharmaceutical research</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2004.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.cbpa.2004.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15183323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslWqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=255-263&issue=3&author=M.+M.+Hannauthor=T.+I.+Oprea&title=Pursuing+the+leadlikeness+concept+in+pharmaceutical+research&doi=10.1016%2Fj.cbpa.2004.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pursuing the leadlikeness concept in pharmaceutical research</span></div><div class="casAuthors">Hann, Mike M.; Oprea, Tudor I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Lipinski and others, through concepts such as drug-likeness, re-focussed drug discovery back to the principles of medicinal chem. in the high-throughput era as key to reducing attrition.  More recently, the need to go further in defining what makes a good lead has been recognized with the concept of leadlikeness.  Leadlikeness implies cut-off values in the physico-chem. profile of chem. libraries such that they have reduced complexity (e.g. MW below <400) and other more restricted properties.  We examine these concepts in the context of Virtual (theor. possible), Tangible (chem. feasible) and Real (phys. available) worlds of mols.  In a thought expt., we take the HTS concept to the extreme: screening an estd. 60 million Global Collection' on 5000 targets and realizing that perhaps millions of drug candidates might be found that could not possibly be handled in reality.  Sampling of the Virtual and Tangible worlds is therefore a necessity.  We show that the world of Reals is significantly under-sampled as the MW of compds. increases.  This supports the design and screening of reduced complexity' (leadlike) compd. libraries, preferably with synthetic handles available for rapid chem. iteration and detected as interesting by careful screening or biophys. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd8ecCArzZ2bVg90H21EOLACvtfcHk0lgHdfBs7sp4xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslWqsrk%253D&md5=c78783585a60d3deee3b0513fe7300e9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2004.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2004.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26atitle%3DPursuing%2520the%2520leadlikeness%2520concept%2520in%2520pharmaceutical%2520research%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2004%26volume%3D8%26issue%3D3%26spage%3D255%26epage%3D263%26doi%3D10.1016%2Fj.cbpa.2004.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, G.</span></span> <span> </span><span class="NLM_article-title">Molecular complexity and its impact on the probability of finding leads for drug discovery</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">864</span>, <span class="refDoi"> DOI: 10.1021/ci000403i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci000403i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=856-864&issue=3&author=M.+M.+Hannauthor=A.+R.+Leachauthor=G.+Harper&title=Molecular+complexity+and+its+impact+on+the+probability+of+finding+leads+for+drug+discovery&doi=10.1021%2Fci000403i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery</span></div><div class="casAuthors">Hann, Michael M.; Leach, Andrew R.; Harper, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">856-864</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a simple model of ligand-receptor interactions, the interactions between ligands and receptors of varying complexities are studied and the probabilities of binding calcd.  It is obsd. that as the systems become more complex the chance of observing a useful interaction for a randomly chosen ligand falls dramatically.  The implications of this for the design of combinatorial libraries is explored.  A large set of drug leads and optimized compds. is profiled using several different properties relevant to mol. recognition.  The changes obsd. for these properties during the drug optimization phase support the hypothesis that less complex mols. are more common starting points for the discovery of drugs.  An extreme example of the use of simple mols. for directed screening against thrombin is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ed40mt9qb7Vg90H21EOLACvtfcHk0lgHdfBs7sp4xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFynt7w%253D&md5=e89e76c8fb83fc5012369ae30f20e6b7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fci000403i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000403i%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHarper%26aufirst%3DG.%26atitle%3DMolecular%2520complexity%2520and%2520its%2520impact%2520on%2520the%2520probability%2520of%2520finding%2520leads%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26issue%3D3%26spage%3D856%26epage%3D864%26doi%3D10.1021%2Fci000403i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular complexity and fragment-based drug discovery: ten years on</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2011.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.cbpa.2011.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21665521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=489-496&issue=4&author=A.+R.+Leachauthor=M.+M.+Hann&title=Molecular+complexity+and+fragment-based+drug+discovery%3A+ten+years+on&doi=10.1016%2Fj.cbpa.2011.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular complexity and fragment-based drug discovery: ten years on</span></div><div class="casAuthors">Leach, Andrew R.; Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-496</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We review the concept of mol. complexity in the context of the very simple model of mol. interactions that we introduced over 10 years ago.  A summary is presented of efforts to validate this simple model using screening data.  The relationship between the complexity model and the problem of sampling chem. space is discussed, together with the relevance of these theor. concepts to fragment-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcMgTT6eLC7Vg90H21EOLACvtfcHk0li0uGM6EnKR8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCltrg%253D&md5=19c2d65de80a8bab1059468828da6ce2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520complexity%2520and%2520fragment-based%2520drug%2520discovery%253A%2520ten%2520years%2520on%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26issue%3D4%26spage%3D489%26epage%3D496%26doi%3D10.1016%2Fj.cbpa.2011.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">A ‘Rule of three’ for fragment-based lead discovery?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&issue=19&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%98Rule+of+three%E2%80%99+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2ebcnZDHtAkdIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%2598Rule%2520of%2520three%25E2%2580%2599%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26issue%3D19%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&issue=6&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D6%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&issue=2&author=A.%0AL.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lhenLx4EDCjAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarparin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunhuck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span> <span> </span><span class="NLM_article-title">In vitro measurement of drug efficiency index to aid early lead optimization</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4169</span>, <span class="refDoi"> DOI: 10.1002/jps.23305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.23305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=4155-4169&issue=11&author=K.+Valkoauthor=E.+Chiarparinauthor=S.+Nunhuckauthor=D.+Montanari&title=In+vitro+measurement+of+drug+efficiency+index+to+aid+early+lead+optimization&doi=10.1002%2Fjps.23305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fjps.23305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23305%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DChiarparin%26aufirst%3DE.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DMontanari%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520measurement%2520of%2520drug%2520efficiency%2520index%2520to%2520aid%2520early%2520lead%2520optimization%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26issue%3D11%26spage%3D4155%26epage%3D4169%26doi%3D10.1002%2Fjps.23305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland 2: complexity and promiscuity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1039/c2md20347b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc2md20347b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=515-519&issue=3&author=F.+Lovering&title=Escape+from+flatland+2%3A+complexity+and+promiscuity&doi=10.1039%2Fc2md20347b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland 2: complexity and promiscuity</span></div><div class="casAuthors">Lovering, Frank</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-519</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toxicity plays a major role in attrition in the clinic and promiscuity has been linked to toxicity.  A no. of mol. descriptors have been identified that contribute to promiscuity including ionization and logP.  In this study we report on the relationship between complexity, as measured by two descriptors [fraction sp3 (Fsp3) where Fsp3 = (no. of sp3 hybridized carbons/total carbon count) and chiral carbon count], and promiscuity as well as Cyp450 inhibition.  We find that increasing complexity reduces promiscuity and Cyp450 inhibition.  As an understanding of key property descriptors has helped the pharmaceutical industry to address some of the deficiencies of compds. as pertains to bioavailability, awareness of the descriptors that impact promiscuity should allow us to better address toxicity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJfDH0430P-bVg90H21EOLACvtfcHk0lhenLx4EDCjAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D&md5=c03d3b99da22a684cbbbb00fb1633342</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc2md20347b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20347b%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26atitle%3DEscape%2520from%2520flatland%25202%253A%2520complexity%2520and%2520promiscuity%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D3%26spage%3D515%26epage%3D519%26doi%3D10.1039%2Fc2md20347b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhenLx4EDCjAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability—Are too many aromatic rings a liability in drug design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1020</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&issue=21%E2%80%9322&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%94Are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0liFpZ5Zt7gG3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2594Are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26issue%3D21%25E2%2580%259322%26spage%3D1011%26epage%3D1020%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo-and hetero-aromatic and-aliphatic ring types</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&issue=3&author=T.+J.+Ritchieauthor=S.+J.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-and+hetero-aromatic+and-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0lh-DFWR0PvxbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-and%2520hetero-aromatic%2520and-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D3%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J.</span></span> <span> </span><span class="NLM_article-title">Physicochemical descriptors of aromatic character and their use in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7215</span>, <span class="refDoi"> DOI: 10.1021/jm500515d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500515d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7206-7215&issue=17&author=T.+J.+Ritchieauthor=S.+J.+Macdonald&title=Physicochemical+descriptors+of+aromatic+character+and+their+use+in+drug+discovery&doi=10.1021%2Fjm500515d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500515d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500515d%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%26atitle%3DPhysicochemical%2520descriptors%2520of%2520aromatic%2520character%2520and%2520their%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D17%26spage%3D7206%26epage%3D7215%26doi%3D10.1021%2Fjm500515d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M.
J.</span></span> <span> </span><span class="NLM_article-title">Defining optimum lipophilicity and molecular weight ranges for drug candidates - molecular weight dependent lower logD limits based on permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2844</span>– <span class="NLM_lpage">2851</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2844-2851&author=M.%0AJ.+Waring&title=Defining+optimum+lipophilicity+and+molecular+weight+ranges+for+drug+candidates+-+molecular+weight+dependent+lower+logD+limits+based+on+permeability&doi=10.1016%2Fj.bmcl.2009.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520optimum%2520lipophilicity%2520and%2520molecular%2520weight%2520ranges%2520for%2520drug%2520candidates%2520-%2520molecular%2520weight%2520dependent%2520lower%2520logD%2520limits%2520based%2520on%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2844%26epage%3D2851%26doi%3D10.1016%2Fj.bmcl.2009.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5560</span>– <span class="NLM_lpage">5564</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabow, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buurma, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narduolo, S.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric pairs reveal that key medicinal chemistry parameters vary more than simple physical property based models can explain</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1039/c2md20010d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc2md20010d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=528-540&issue=5&author=A.+G.+Leachauthor=E.+A.+Pillingauthor=A.+A.+Rabowauthor=S.+Tomasiauthor=N.+Asaadauthor=N.+J.+Buurmaauthor=A.+Ballardauthor=S.+Narduolo&title=Enantiomeric+pairs+reveal+that+key+medicinal+chemistry+parameters+vary+more+than+simple+physical+property+based+models+can+explain&doi=10.1039%2Fc2md20010d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc2md20010d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20010d%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DPilling%26aufirst%3DE.%2BA.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DTomasi%26aufirst%3DS.%26aulast%3DAsaad%26aufirst%3DN.%26aulast%3DBuurma%26aufirst%3DN.%2BJ.%26aulast%3DBallard%26aufirst%3DA.%26aulast%3DNarduolo%26aufirst%3DS.%26atitle%3DEnantiomeric%2520pairs%2520reveal%2520that%2520key%2520medicinal%2520chemistry%2520parameters%2520vary%2520more%2520than%2520simple%2520physical%2520property%2520based%2520models%2520can%2520explain%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D5%26spage%3D528%26epage%3D540%26doi%3D10.1039%2Fc2md20010d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&issue=3&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liQ0kHc5ovY5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26issue%3D3%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span> <span> </span><span class="NLM_article-title">Acidic and basic drugs in medicinal chemistry: a perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1021/jm501000a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501000a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOnt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9701-9717&issue=23&author=P.+S.+Charifsonauthor=W.+P.+Walters&title=Acidic+and+basic+drugs+in+medicinal+chemistry%3A+a+perspective&doi=10.1021%2Fjm501000a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic and Basic Drugs in Medicinal Chemistry: A Perspective</span></div><div class="casAuthors">Charifson, Paul S.; Walters, W. Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The acid/base properties of a mol. are among the most fundamental for drug action.  However, they are often overlooked in a prospective design manner unless it has been established that a certain ionization state (e.g., quaternary base or presence of a carboxylic acid) appears to be required for activity.  In medicinal chem. optimization programs it is relatively common to attenuate basicity to circumvent undesired effects such as lack of biol. selectivity or safety risks such as hERG or phospholipidosis.  However, teams may not prospectively explore a range of carefully chosen compd. pKa values as part of an overall chem. strategy or design hypothesis.  This review summarizes the potential advantages and disadvantages of both acidic and basic drugs and provides some new analyses based on recently available public data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDorb0LfJ8PrVg90H21EOLACvtfcHk0liQ0kHc5ovY5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOnt7jN&md5=51a3cb91be42ddd1a784afe737c64c60</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm501000a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501000a%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DWalters%26aufirst%3DW.%2BP.%26atitle%3DAcidic%2520and%2520basic%2520drugs%2520in%2520medicinal%2520chemistry%253A%2520a%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D23%26spage%3D9701%26epage%3D9717%26doi%3D10.1021%2Fjm501000a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of druglike concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&issue=11&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+druglike+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520druglike%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P.
D.</span></span> <span> </span><span class="NLM_article-title">Molecular inflation, attrition and the rule of five</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">Suppl. C</span>),  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.addr.2016.01.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=22-33&issue=Suppl.+C&author=P.%0AD.+Leeson&title=Molecular+inflation%2C+attrition+and+the+rule+of+five&doi=10.1016%2Fj.addr.2016.01.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMolecular%2520inflation%252C%2520attrition%2520and%2520the%2520rule%2520of%2520five%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26issue%3DSuppl.%2520C%26spage%3D22%26epage%3D33%26doi%3D10.1016%2Fj.addr.2016.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&issue=9&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0ljzOgS_jRC4FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D9%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&issue=2&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0ljzOgS_jRC4FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D2%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Is There a difference between leads and drugs? A historical perspective</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1021/ci010366a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci010366a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=1308-1315&issue=5&author=T.+I.+Opreaauthor=A.+M.+Davisauthor=S.+J.+Teagueauthor=P.+D.+Leeson&title=Is+There+a+difference+between+leads+and+drugs%3F+A+historical+perspective&doi=10.1021%2Fci010366a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Is There a Difference between Leads and Drugs? A Historical Perspective</span></div><div class="casAuthors">Oprea, Tudor I.; Davis, Andrew M.; Teague, Simon J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To be considered for further development, lead structures should display the following properties: (1) simple chem. features, amenable for chem. optimization; (2) membership to an established SAR series; (3) favorable patent situation; and (4) good absorption, distribution, metab., and excretion (ADME) properties.  There are two distinct categories of leads: those that lack any therapeutic use (i.e., "pure" leads), and those that are marketed drugs themselves but have been altered to yield novel drugs.  We have previously analyzed the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748).  Here, we report results based on an extended dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are drugs that are not presumably used as leads.  We examd. the following properties: MW (mol. wt.), CMR (the calcd. mol. refractivity), RNG (the no. of rings), RTB (the no. of rotatable bonds), the no. of hydrogen bond donors (HDO) and acceptors (HAC), the calcd. logarithm of the n-octanol/water partition (CLogP), the calcd. logarithm of the distribution coeff. at pH 7.4 (LogD74), the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).  The following differences were obsd. between the medians of drugs and leads: ΔMW = 69; ΔCMR = 1.8; ΔRNG = ΔHAC =1; ΔRTB = 2; ΔCLogP = 0.43; ΔLogD74 = 0.97; ΔHDO = 0; ΔDFPS = 0.15; ΔPPFS = 0.12.  Lead structures exhibit, on the av., less mol. complexity (less MW, less no. of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower druglike scores).  These findings indicate that the process of optimizing a lead into a drug results in more complex structures.  This information should be used in the design of novel combinatorial libraries that are aimed at lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4E0R8n7tLrVg90H21EOLACvtfcHk0li9F_MDnFRCsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Okt7s%253D&md5=422b9cf937168d9c2f3d1c8429648ea0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci010366a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010366a%26sid%3Dliteratum%253Aachs%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DIs%2520There%2520a%2520difference%2520between%2520leads%2520and%2520drugs%253F%2520A%2520historical%2520perspective%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26issue%3D5%26spage%3D1308%26epage%3D1315%26doi%3D10.1021%2Fci010366a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span> <span> </span><span class="NLM_article-title">An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2986</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1021/jm100118x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100118x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2986-2997&issue=7&author=E.+Perola&title=An+analysis+of+the+binding+efficiencies+of+drugs+and+their+leads+in+successful+drug+discovery+programs&doi=10.1021%2Fjm100118x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm100118x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100118x%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26atitle%3DAn%2520analysis%2520of%2520the%2520binding%2520efficiencies%2520of%2520drugs%2520and%2520their%2520leads%2520in%2520successful%2520drug%2520discovery%2520programs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2986%26epage%3D2997%26doi%3D10.1021%2Fjm100118x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span> <span> </span><span class="NLM_article-title">Follow-on drugs: how far should chemists look?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">15–16</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21658467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=722-732&issue=15%E2%80%9316&author=F.+Giordanettoauthor=J.+Bostromauthor=C.+Tyrchan&title=Follow-on+drugs%3A+how+far+should+chemists+look%3F&doi=10.1016%2Fj.drudis.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Follow-on drugs: how far should chemists look?</span></div><div class="casAuthors">Giordanetto Fabrizio; Bostrom Jonas; Tyrchan Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">722-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A major remark made by observers relates to the focus of the pharmaceutical industry on 'me-too' drugs rather than 'first-in-class' drugs, the latter are considered to be 'truly' innovative medicines.  Although the subject is heavily debated, chemists in project teams around the globe are routinely following up compounds from competitors.  An important strategic consideration is the degree of chemical modification of the original structure required for success.  Here, we present an analysis of the DiMasi and Faden set of first-in-class and follow-on drug pairs (n=74); showing that 70% of them are structurally very similar, meaning that they are characterized by minimal structural variations.  This highlights the fact that even simple atomic variations can cause drastic changes in molecular properties responsible for therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-qG0lyy9NOLt9HypzAgQfW6udTcc2ebyEgoPHmDwLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D&md5=dd6c836d380d44bb7c704e3bd39cc99e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26atitle%3DFollow-on%2520drugs%253A%2520how%2520far%2520should%2520chemists%2520look%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D15%25E2%2580%259316%26spage%3D722%26epage%3D732%26doi%3D10.1016%2Fj.drudis.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span> <span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm0512185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&issue=10&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds&doi=10.1021%2Fjm0512185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D10%26spage%3D2969%26epage%3D2978%26doi%3D10.1021%2Fjm0512185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1038/nrd2796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&issue=3&author=G.%0AM.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates&doi=10.1038%2Fnrd2796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eYp13S12kL5c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D3%26spage%3D203%26epage%3D212%26doi%3D10.1038%2Fnrd2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&issue=7&author=P.%0AD.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0lg6O90UecQlOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D7%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span> <span> </span><span class="NLM_article-title">The influence of the “organizational factor” on compound quality in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1038/nrd3552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=749-765&author=P.+D.+Leesonauthor=S.+A.+St-Gallay&title=The+influence+of+the+%E2%80%9Corganizational+factor%E2%80%9D+on+compound+quality+in+drug+discovery&doi=10.1038%2Fnrd3552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnrd3552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3552%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26atitle%3DThe%2520influence%2520of%2520the%2520%25E2%2580%259Corganizational%2520factor%25E2%2580%259D%2520on%2520compound%2520quality%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D749%26epage%3D765%26doi%3D10.1038%2Fnrd3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery grows up</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1038/nrd3926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23274457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFOi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=5-7&issue=1&author=M.+Baker&title=Fragment-based+lead+discovery+grows+up&doi=10.1038%2Fnrd3926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery grows up</span></div><div class="casAuthors">Baker, Monya</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-7</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">With multiple drug candidates in the clinic that originated from fragment-based lead discovery, the approach of starting small has become big.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxKfzq4txN2bVg90H21EOLACvtfcHk0lg6O90UecQlOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFOi&md5=854c670bd7388d04f76867d5818a5191</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnrd3926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3926%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DM.%26atitle%3DFragment-based%2520lead%2520discovery%2520grows%2520up%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D1%26spage%3D5%26epage%3D7%26doi%3D10.1038%2Fnrd3926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Efficient exploration of chemical space by fragment-based screening</span>. <i>Prog. Biophys. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2014.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.pbiomolbio.2014.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25268064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ymu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=82-91&issue=2%E2%80%933&author=R.+J.+Hallauthor=P.+N.+Mortensonauthor=C.+W.+Murray&title=Efficient+exploration+of+chemical+space+by+fragment-based+screening&doi=10.1016%2Fj.pbiomolbio.2014.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient exploration of chemical space by fragment-based screening</span></div><div class="casAuthors">Hall, Richard J.; Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Screening methods seek to sample a vast chem. space in order to identify starting points for further chem. optimization.  Fragment based drug discovery exploits the superior sampling of chem. space that can be achieved when the mol. wt. is restricted.  Here we show that com. available fragment space is still relatively poorly sampled and argue for highly sensitive screening methods to allow the detection of smaller fragments.  We analyze the properties of our fragment library vs. the properties of X-ray hits derived from the library.  We particularly consider properties related to the degree of planarity of the fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdghyX93HMZLVg90H21EOLACvtfcHk0li0UsvNvFO-rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ymu7zO&md5=a63e451443207393b781d3d68b10bcd1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2014.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2014.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DR.%2BJ.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DEfficient%2520exploration%2520of%2520chemical%2520space%2520by%2520fragment-based%2520screening%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D116%26issue%3D2%25E2%2580%25933%26spage%3D82%26epage%3D91%26doi%3D10.1016%2Fj.pbiomolbio.2014.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, J. L.</span></span> <span> </span><span class="NLM_article-title">The chemical space project</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1021/ar500432k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500432k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=722-730&issue=3&author=J.+L.+Reymond&title=The+chemical+space+project&doi=10.1021%2Far500432k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemical Space Project</span></div><div class="casAuthors">Reymond, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">722-730</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the simplest questions that can be asked about mol. diversity is how many org. mols. are possible in total.  To answer this question, my research group has computationally enumerated all possible org. mols. up to a certain size to gain an unbiased insight into the entire chem. space.  Our latest database, GDB-17, contains 166.4 billion mols. of up to 17 atoms of C, N, O, S, and halogens, by far the largest small mol. database reported to date.  Mols. allowed by valency rules but unstable or nonsynthesizable due to strained topologies or reactive functional groups were not considered, which reduced the enumeration by at least 10 orders of magnitude and was essential to arrive at a manageable database size.  Despite these restrictions, GDB-17 is highly relevant with respect to known mols.  Beyond enumeration, understanding and exploiting GDBs (generated databases) led us to develop methods for virtual screening and visualization of very large databases in the form of a "periodic system of mols." comprising six different fingerprint spaces, with web-browsers for nearest neighbor searches, and the MQN- and SMIfp-Mapplet application for exploring color-coded principal component maps of GDB and other large databases.  Proof-of-concept applications of GDB for drug discovery were realized by combining virtual screening with chem. synthesis and activity testing for neurotransmitter receptor and transporter ligands.  One surprising lesson from using GDB for drug analog searches is the incredible depth of chem. space, i.e., the fact that millions of very close analogs of any mol. can be readily identified by nearest-neighbor searches in the MQN-space of the various GDBs.  The chem. space project has opened an unprecedented door on chem. diversity.  Ongoing and yet unmet challenges concern enumerating mols. beyond 17 atoms and synthesizing GDB mols. with innovative scaffolds and pharmacophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxJYiz7ZE3ALVg90H21EOLACvtfcHk0li0UsvNvFO-rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWisb4%253D&md5=d3199b2273a0e8d92a4b1ffa59c6dffc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Far500432k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500432k%26sid%3Dliteratum%253Aachs%26aulast%3DReymond%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520chemical%2520space%2520project%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26issue%3D3%26spage%3D722%26epage%3D730%26doi%3D10.1021%2Far500432k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tickle, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Fragment-based lead discovery using X-ray crystallography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1021/jm0495778</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0495778" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=403-413&issue=2&author=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=A.+Cleasbyauthor=M.+Fredericksonauthor=I.+J.+Tickleauthor=H.+Jhoti&title=Fragment-based+lead+discovery+using+X-ray+crystallography&doi=10.1021%2Fjm0495778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0495778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0495778%26sid%3Dliteratum%253Aachs%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DFragment-based%2520lead%2520discovery%2520using%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D2%26spage%3D403%26epage%3D413%26doi%3D10.1021%2Fjm0495778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">How are fragments optimized? A retrospective analysis of 145 fragment optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2478</span>– <span class="NLM_lpage">2486</span>, <span class="refDoi"> DOI: 10.1021/jm301851v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301851v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2478-2486&issue=6&author=G.%0AG.+Ferenczyauthor=G.+M.+Keseru&title=How+are+fragments+optimized%3F+A+retrospective+analysis+of+145+fragment+optimizations&doi=10.1021%2Fjm301851v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm301851v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301851v%26sid%3Dliteratum%253Aachs%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DHow%2520are%2520fragments%2520optimized%253F%2520A%2520retrospective%2520analysis%2520of%2520145%2520fragment%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D6%26spage%3D2478%26epage%3D2486%26doi%3D10.1021%2Fjm301851v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics guided lead discovery and optimization</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">21–22</span>),  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20801227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=919-932&issue=21%E2%80%9322&author=G.%0AG.+Ferenczyauthor=G.+M.+Keseru&title=Thermodynamics+guided+lead+discovery+and+optimization&doi=10.1016%2Fj.drudis.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamics guided lead discovery and optimization</span></div><div class="casAuthors">Ferenczy, Gyoergy G.; Keseru, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">919-932</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The documented unfavorable changes of physicochem. properties during lead discovery and optimization prompted us to investigate the present practice of medicinal chem. optimization from a thermodn. perspective.  Basic principles of binding thermodn. suggest that discriminating between enthalpy-driven and entropy-driven optimizations could be beneficial.  We hypothesize that entropy-driven optimizations might be responsible for the undesirable trend obsd. in physicochem. properties.  Consequently, we suggest that enthalpy-driven optimizations are preferred because they provide better quality compds.  Monitoring binding thermodn. during optimization programs initiated from thermodynamically characterized hits or leads, therefore, could improve the success of discovery programs.  Here, we summarize common industry practices for tackling optimization challenges and review how the assessment of binding thermodn. could support medicinal chem. efforts.  This review focuses on the thermodn. basis of the unfavorable changes obsd. in physicochem. properties in lead discovery and optimization programs and suggests that monitoring binding thermodn. could contribute to an improvement in the quality of compds. identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVvS8oK_KMrbVg90H21EOLACvtfcHk0li0UsvNvFO-rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsrfI&md5=fc4a9091229212bb9a845ef9d9e747c3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DThermodynamics%2520guided%2520lead%2520discovery%2520and%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D21%25E2%2580%259322%26spage%3D919%26epage%3D932%26doi%3D10.1016%2Fj.drudis.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span> <span> </span><span class="NLM_article-title">A thermodynamic approach to the affinity optimization of drug candidates</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2009.00880.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fj.1747-0285.2009.00880.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=19793186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlehu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=468-472&issue=5&author=E.+Freire&title=A+thermodynamic+approach+to+the+affinity+optimization+of+drug+candidates&doi=10.1111%2Fj.1747-0285.2009.00880.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A thermodynamic approach to the affinity optimization of drug candidates</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">468-472</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">High throughput screening and other techniques commonly used to identify lead candidates for drug development usually yield compds. with binding affinities to their intended targets in the mid-micromolar range.  The affinity of these mols. needs to be improved by several orders of magnitude before they become viable drug candidates.  Traditionally, this task has been accomplished by establishing structure activity relationships to guide chem. modifications and improve the binding affinity of the compds.  As the binding affinity is a function of two quantities, the binding enthalpy and the binding entropy, it is evident that a more efficient optimization would be accomplished if both quantities were considered and improved simultaneously.  Here, an optimization algorithm based upon enthalpic and entropic information generated by Isothermal Titrn. Calorimetry is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphbjArg6CTsLVg90H21EOLACvtfcHk0liyhHDdwU4vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlehu7vI&md5=c927114da9f3bfdde1002f039165706b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00880.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00880.x%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DA%2520thermodynamic%2520approach%2520to%2520the%2520affinity%2520optimization%2520of%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26issue%3D5%26spage%3D468%26epage%3D472%26doi%3D10.1111%2Fj.1747-0285.2009.00880.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladbury, J. E.</span></span> <span> </span><span class="NLM_article-title">The thermodynamics of protein-ligand interaction and solvation: insights for ligand design</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>384</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.09.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.jmb.2008.09.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18930735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2008&pages=1002-1017&issue=4&author=T.+S.+Olssonauthor=M.+A.+Williamsauthor=W.+R.+Pittauthor=J.+E.+Ladbury&title=The+thermodynamics+of+protein-ligand+interaction+and+solvation%3A+insights+for+ligand+design&doi=10.1016%2Fj.jmb.2008.09.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design</span></div><div class="casAuthors">Olsson, Tjelvar S. G.; Williams, Mark A.; Pitt, William R.; Ladbury, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1002-1017</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Isothermal titrn. calorimetry is able to provide accurate information on the thermodn. contributions of enthalpy and entropy changes to free energies of binding.  The Structure/Calorimetry of Reported Protein Interactions Online (SCORPIO) database of published isothermal titrn. calorimetry studies and structural information on the interactions between proteins and small-mol. ligands is used here to reveal general thermodn. properties of protein-ligand interactions and to investigate correlations with changes in solvation.  The overwhelming majority of interactions are found to be enthalpically favored.  Synthetic inhibitors and biol. ligands form two distinct subpopulations in the data, with the former having greater av. affinity due to more favorable entropy changes on binding.  The greatest correlation is found between the binding free energy and apolar surface burial upon complex formation.  However, the free energy contribution per unit area buried is only 30-50% of that expected from earlier studies of transfer free energies of small mols.  A simple probability-based estimator for the maximal affinity of a binding site in terms of its apolar surface area is proposed.  Polar surface area burial also contributes substantially to affinity but is difficult to express in terms of unit area due to the small variation in the amt. of polar surface buried and a tendency for cancellation of its enthalpic and entropic contributions.  Conventionally, the contribution of apolar desolvation to affinity is attributed to gain of entropy due to solvent release.  Although data presented here are supportive of this notion, because the correlation of entropy change with apolar surface burial is relatively weak, it cannot, on present evidence, be confidently considered to be correct.  Further, thermodn. changes arising from small differences between ligands binding to individual proteins are relatively large and, in general, uncorrelated with changes in solvation, suggesting that trends identified across widely differing proteins are of limited use in explaining or predicting the effects of ligand modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xdclY7Rk_bVg90H21EOLACvtfcHk0liyhHDdwU4vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWls7zO&md5=f9d6d3e8a7fd85d7ff7a6dc6acf7309b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.09.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.09.073%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DT.%2BS.%26aulast%3DWilliams%26aufirst%3DM.%2BA.%26aulast%3DPitt%26aufirst%3DW.%2BR.%26aulast%3DLadbury%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520thermodynamics%2520of%2520protein-ligand%2520interaction%2520and%2520solvation%253A%2520insights%2520for%2520ligand%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D384%26issue%3D4%26spage%3D1002%26epage%3D1017%26doi%3D10.1016%2Fj.jmb.2008.09.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franzini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span> <span> </span><span class="NLM_article-title">Chemical space of DNA-encoded libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6629</span>– <span class="NLM_lpage">6644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6629-6644&issue=14&author=R.+M.+Franziniauthor=C.+Randolph&title=Chemical+space+of+DNA-encoded+libraries&doi=10.1021%2Facs.jmedchem.5b01874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space of DNA-Encoded Libraries</span></div><div class="casAuthors">Franzini, Raphael M.; Randolph, Cassie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6629-6644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, DNA-encoded chem. libraries (DECLs) have attracted considerable attention as a potential discovery tool in drug development.  Screening encoded libraries may offer advantages over conventional hit discovery approaches and has the potential to complement such methods in pharmaceutical research.  As a result of the increased application of encoded libraries in drug discovery, a growing no. of hit compds. are emerging in scientific literature.  In this review we evaluate reported encoded library-derived structures and identify general trends of these compds. in relation to library design parameters.  We in particular emphasize the combinatorial nature of these libraries.  Generally, the reported mols. demonstrate the ability of this technol. to afford hits suitable for further lead development, and on the basis of them, we derive guidelines for DECL design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLvieeEe9dd7Vg90H21EOLACvtfcHk0liyhHDdwU4vmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D&md5=f037f9866a0161730c9f34a105ca34c8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01874%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DR.%2BM.%26aulast%3DRandolph%26aufirst%3DC.%26atitle%3DChemical%2520space%2520of%2520DNA-encoded%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D14%26spage%3D6629%26epage%3D6644%26doi%3D10.1021%2Facs.jmedchem.5b01874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rafferty, M. F.</span></span> <span> </span><span class="NLM_article-title">No denying it: medicinal chemistry training is in big trouble</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10859</span>– <span class="NLM_lpage">10864</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00741</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00741" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10859-10864&issue=24&author=M.+F.+Rafferty&title=No+denying+it%3A+medicinal+chemistry+training+is+in+big+trouble&doi=10.1021%2Facs.jmedchem.6b00741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">No Denying It: Medicinal Chemistry Training Is in Big Trouble</span></div><div class="casAuthors">Rafferty, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10859-10864</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There has been little consensus between the pharmaceutical industry and academic communities concerning the best approach to train medicinal chemists for drug discovery.  For decades the pharmaceutical industry has shown preference for synthetic org. graduates over candidates with degrees from medicinal chem. programs on the assumption that medicinal chem. expertise will be acquired on the job.  However, ongoing changes to pharmaceutical drug discovery organizations and practices threaten to undermine this training model.  There is a compelling argument to be made for establishment of a strong industry-academic partnership to train new candidates with sophisticated knowledge of contemporary drug design concepts and techniques to ensure that the future needs of both industry and academic drug discovery research can be served.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgSt0oxSWvabVg90H21EOLACvtfcHk0lj11VSURCEq1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmsLjO&md5=7c5583586b8d6939bc2a52cb4a033455</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00741%26sid%3Dliteratum%253Aachs%26aulast%3DRafferty%26aufirst%3DM.%2BF.%26atitle%3DNo%2520denying%2520it%253A%2520medicinal%2520chemistry%2520training%2520is%2520in%2520big%2520trouble%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D10859%26epage%3D10864%26doi%3D10.1021%2Facs.jmedchem.6b00741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span> <span> </span><span class="NLM_article-title">Time-related differences in the physical property profiles of oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">6338</span>– <span class="NLM_lpage">6348</span>, <span class="refDoi"> DOI: 10.1021/jm049717d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049717d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6338-6348&issue=25&author=P.+D.+Leesonauthor=A.+M.+Davis&title=Time-related+differences+in+the+physical+property+profiles+of+oral+drugs&doi=10.1021%2Fjm049717d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Related Differences in the Physical Property Profiles of Oral Drugs</span></div><div class="casAuthors">Leeson, Paul D.; Davis, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6338-6348</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Comparisons of the calcd. physicochem. properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral drug-like phys. properties.  In contrast, mean values of mol. wt. and the nos. of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%).  Anal. of the 1983-2002 oral drugs by therapy area shows that anti-infectives and nervous system drugs have the most extreme phys. property profiles.  Cardiovascular drugs show increasing mol. wt. with year of publication, primarily a consequence of focusing on clin. proven mechanisms, with limited chem. diversity.  Drug classes other than anti-infectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irresp. of the drug's target.  The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtNkiWH6Bl6bVg90H21EOLACvtfcHk0lj11VSURCEq1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1Sksbg%253D&md5=edd5cceab1ccfe3542cb4df180e3c160</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm049717d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049717d%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26atitle%3DTime-related%2520differences%2520in%2520the%2520physical%2520property%2520profiles%2520of%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D25%26spage%3D6338%26epage%3D6348%26doi%3D10.1021%2Fjm049717d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Gallay, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">Impact of ion class and time on oral drug molecular properties</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1039/C0MD00157K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC0MD00157K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-105&author=P.+D.+Leesonauthor=S.+A.+St-Gallayauthor=M.+C.+Wenlock&title=Impact+of+ion+class+and+time+on+oral+drug+molecular+properties&doi=10.1039%2FC0MD00157K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of ion class and time on oral drug molecular properties</span></div><div class="casAuthors">Leeson, Paul D.; St-Gallay, Stephen A.; Wenlock, Mark C.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-105</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Using databases of oral drugs and recent compds. from the patents of major pharmaceutical companies, trends in mol. properties over time are identified.  It is shown that the phys. property profiles of oral drugs are not abs., but depend on both ion class and the time of the drug invention.  Properties examd. include lipophilicity, mol. wt., hydrogen bond donors and acceptors, polar surface area, aromaticity, chirality and tetrahedral (sp3) carbon atom count.  Lipophilicity is increasing over time in oral drugs that are neutral or acidic, but not in basic drugs, and has been converging in all ion classes towards a common const. range since the 1960s.  In contrast, mol. wt. is increasing over time in all ion classes.  Hydrogen bond donors (OH + NH group count) are stable over time but hydrogen bond acceptors (O + N atom count) are increasing over time.  It is shown that measures using sp3 atom and arom. atom counts are inversely related and a new parameter, Ar atom count - sp3 atom count (Ar-sp3), describing shape or arom./aliph. balance, is introduced.  Ar-sp3 is const. over time in oral drugs, but is higher in patented compds., independently of mol. wt. and lipophilicity.  The ion classes in patent compds. occupy distinct mol. wt./lipophilicity/shape chem. space.  These properties are significantly increased vs. oral drugs, with the exception of the most recently discovered acidic drugs, and occur in most, but not all target classes.  While ceilings for lipophilicity in acids and neutral compds. may not have been reached, the design of potential drug mols. with reduced ADMET risk is indicated by a seeking a better balance between lipophilicity, 3-dimensionality and aromaticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8hD5yPUXDCbVg90H21EOLACvtfcHk0lga1VNrEiocCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbo%253D&md5=06f976e54fe8783d0f5ebabc3915620d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC0MD00157K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MD00157K%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSt-Gallay%26aufirst%3DS.%2BA.%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26atitle%3DImpact%2520of%2520ion%2520class%2520and%2520time%2520on%2520oral%2520drug%2520molecular%2520properties%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D105%26doi%3D10.1039%2FC0MD00157K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1039/c1md00017a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery&doi=10.1039%2Fc1md00017a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0lga1VNrEiocCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355%26doi%3D10.1039%2Fc1md00017a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/nrd3701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22543468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=355-365&issue=5&author=M.+M.+Hannauthor=G.+M.+Keseru&title=Finding+the+sweet+spot%3A+the+role+of+nature+and+nurture+in+medicinal+chemistry&doi=10.1038%2Fnrd3701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span></div><div class="casAuthors">Hann, Michael M.; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Given its position at the heart of small-mol. drug discovery, medicinal chem. has an important role in tackling the well-known productivity challenges in pharmaceutical research and development.  In recent years, extensive analyses of successful and failed discovery compds. and drug candidates have improved our understanding of the role of physicochem. properties in drug attrition.  Based on the clarified challenges in finding the 'sweet spot' in medicinal chem. programs, we suggest that this goal can be achieved through a combination of first identifying chem. starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization.  Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chem. practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURciGjB2A3LVg90H21EOLACvtfcHk0liHOvggTy9FuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D&md5=90170e3f4e69e52bfa38667df380516a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrd3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3701%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DFinding%2520the%2520sweet%2520spot%253A%2520the%2520role%2520of%2520nature%2520and%2520nurture%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D5%26spage%3D355%26epage%3D365%26doi%3D10.1038%2Fnrd3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span> <span> </span><span class="NLM_article-title">Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4443</span>– <span class="NLM_lpage">4458</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01409</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01409" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4443-4458&issue=10&author=D.+G.+Brownauthor=J.+Bostrom&title=Analysis+of+past+and+present+synthetic+methodologies+on+medicinal+chemistry%3A+where+have+all+the+new+reactions+gone%3F&doi=10.1021%2Facs.jmedchem.5b01409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?</span></div><div class="casAuthors">Brown, Dean G.; Bostrom, Jonas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4443-4458</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An anal. of chem. reactions used in current medicinal chem. (2014), three decades ago (1984), and in natural product total synthesis has been conducted.  The anal. revealed that of the current most frequently used synthetic reactions, none were discovered within the past 20 years and only two in the 1980s and 1990s (Suzuki-Miyaura and Buchwald-Hartwig).  This suggests an inherent high bar of impact for new synthetic reactions in drug discovery.  The most frequently used reactions were amide bond formation, Suzuki-Miyaura coupling, and SNAr reactions, most likely due to com. availability of reagents, high chemoselectivity, and a pressure on delivery.  The authors show that these practices result in overpopulation of certain types of mol. shapes to the exclusion of others using simple PMI plots.  The authors hope that these results will help catalyze improvements in integration of new synthetic methodologies as well as new library design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLWvt5DxktAbVg90H21EOLACvtfcHk0liHOvggTy9FuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsrzM&md5=fd56ba8418f6d4e8c271f4e977ee2a93</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01409%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBostrom%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520past%2520and%2520present%2520synthetic%2520methodologies%2520on%2520medicinal%2520chemistry%253A%2520where%2520have%2520all%2520the%2520new%2520reactions%2520gone%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4443%26epage%3D4458%26doi%3D10.1021%2Facs.jmedchem.5b01409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.4.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&issue=4&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery&doi=10.1517%2F17460441.2.4.469"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26issue%3D4%26spage%3D469%26epage%3D488%26doi%3D10.1517%2F17460441.2.4.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&issue=10&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYw_57fxv6zNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26issue%3D10%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency metrics considered harmful</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s10822-014-9757-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs10822-014-9757-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=699-710&issue=7&author=P.+W.+Kennyauthor=A.+Leitaoauthor=C.+A.+Montanari&title=Ligand+efficiency+metrics+considered+harmful&doi=10.1007%2Fs10822-014-9757-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs10822-014-9757-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-014-9757-8%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520efficiency%2520metrics%2520considered%2520harmful%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26issue%3D7%26spage%3D699%26epage%3D710%26doi%3D10.1007%2Fs10822-014-9757-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting expectations in molecular optimizations: strengths and limitations of commonly used composite parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+expectations+in+molecular+optimizations%3A+strengths+and+limitations+of+commonly+used+composite+parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0ljuzeTmw13VcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520expectations%2520in%2520molecular%2520optimizations%253A%2520strengths%2520and%2520limitations%2520of%2520commonly%2520used%2520composite%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Improving the plausibility of success with inefficient metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1021/ml4004638</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVajtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2-5&issue=1&author=M.+D.+Shultz&title=Improving+the+plausibility+of+success+with+inefficient+metrics&doi=10.1021%2Fml4004638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Plausibility of Success with Inefficient Metrics</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-5</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  To increase the probability of success in drug discovery, the concept of drug-like properties was introduced.  Efficiency metrics that normalize potency against these properties could help reach drug-like space more efficiently.  Potential reasons for the inefficient use of metrics and suboptimal decision making are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokUcqughsg0LVg90H21EOLACvtfcHk0lhcPUc7Lug8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVajtLjP&md5=de1493d6fa4e894b078b8b020ad4b3eb</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fml4004638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004638%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DImproving%2520the%2520plausibility%2520of%2520success%2520with%2520inefficient%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D1%26spage%3D2%26epage%3D5%26doi%3D10.1021%2Fml4004638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span> <span> </span><span class="NLM_article-title">Assessing the lipophilicity of fragments and early hits</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s10822-011-9435-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs10822-011-9435-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21614595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=663-667&issue=7&author=P.+N.+Mortensonauthor=C.+W.+Murray&title=Assessing+the+lipophilicity+of+fragments+and+early+hits&doi=10.1007%2Fs10822-011-9435-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the lipophilicity of fragments and early hits</span></div><div class="casAuthors">Mortenson, Paul N.; Murray, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A key challenge in many drug discovery programs is to accurately assess the potential value of screening hits.  This is particularly true in fragment-based drug design (FBDD), where the hits often bind relatively weakly, but are correspondingly small.  Ligand efficiency (LE) considers both the potency and the size of the mol., and enables us to est. whether or not an initial hit is likely to be optimizable to a potent, druglike lead.  While size is a key property that needs to be controlled in a small mol. drug, there are a no. of addnl. properties that should also be considered.  Lipophilicity is amongst the most important of these addnl. properties, and here we present a new efficiency index (LLEAT) that combines lipophilicity, size and potency.  The index is intuitively defined, and has been designed to have the same target value and dynamic range as LE, making it easily interpretable by medicinal chemists.  Monitoring both LE and LLEAT should help both in the selection of more promising fragment hits, and controlling mol. wt. and lipophilicity during optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnbfcwp30BrVg90H21EOLACvtfcHk0lhcPUc7Lug8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSqtbnL&md5=e6d68046d3d20bd2ea088ce218451c25</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9435-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9435-z%26sid%3Dliteratum%253Aachs%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26atitle%3DAssessing%2520the%2520lipophilicity%2520of%2520fragments%2520and%2520early%2520hits%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2011%26volume%3D25%26issue%3D7%26spage%3D663%26epage%3D667%26doi%3D10.1007%2Fs10822-011-9435-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, R. C.</span></span> <span> </span><span class="NLM_article-title">Group additivity in ligand binding affinity: an alternative approach to ligand efficiency</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3093</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.7b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKmtb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=3086-3093&issue=12&author=C.+H.+Reynoldsauthor=R.+C.+Reynolds&title=Group+additivity+in+ligand+binding+affinity%3A+an+alternative+approach+to+ligand+efficiency&doi=10.1021%2Facs.jcim.7b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand Efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Reynolds, Ryan C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3086-3093</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Group additivity is a concept that has been successfully applied to a variety of thermochem. and kinetic properties.  This includes drug discovery, where functional group additivity is often assumed in ligand binding.  Ligand efficiency can be recast as a special case of group additivity where ΔG/HA is the group equiv. (HA is the no. of nonhydrogen atoms in a ligand).  Anal. of a large data set of protein-ligand binding affinities (Ki) for diverse targets shows that in general ligand binding is distinctly nonlinear.  It is possible to create a group equiv. scheme for ligand binding, but only in the context of closely related proteins, at least with regard to size.  This finding has broad implications for drug design from both exptl. and computational points of view.  It also offers a path forward for a more general scheme to assess the efficiency of ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra-RkF5xQLcbVg90H21EOLACvtfcHk0lifAhrEo3lHlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKmtb7N&md5=ef5cb4cf3216dedc72445df7d900821b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00381%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DGroup%2520additivity%2520in%2520ligand%2520binding%2520affinity%253A%2520an%2520alternative%2520approach%2520to%2520ligand%2520efficiency%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26issue%3D12%26spage%3D3086%26epage%3D3093%26doi%3D10.1021%2Facs.jcim.7b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5992</span>– <span class="NLM_lpage">6000</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2013.08.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24054120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5992-6000&author=M.+D.+Shultz&title=The+thermodynamic+basis+for+the+use+of+lipophilic+efficiency+%28LipE%29+in+enthalpic+optimizations&doi=10.1016%2Fj.bmcl.2013.08.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5992-6000</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Approaches to improve the efficiency of mol. optimizations have received great attention and numerous efficiency metrics have been introduced to assist in this effort.  Optimization of properties is equally important to optimization of potency and therefore these metrics contain potency vs. property calcns.  Widespread use of a metric does not guarantee its accuracy and a further understanding of which, if any, metric increases the probability of success was sought.  An anal. of LE, LELP and LipE based on theor. and exptl. data was performed demonstrating that LipE most strongly correlates with compd. quality as defined by enthalpy-driven binding.  The basis for the prioritization of LipE over other metrics in enthalpic optimizations is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobuMO74LdKnbVg90H21EOLACvtfcHk0lifAhrEo3lHlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns73P&md5=23d948d1135eeefdfebc60846f28ec2b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.030%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DThe%2520thermodynamic%2520basis%2520for%2520the%2520use%2520of%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520in%2520enthalpic%2520optimizations%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5992%26epage%3D6000%26doi%3D10.1016%2Fj.bmcl.2013.08.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyiri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1021/jm201388p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&issue=3&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality&doi=10.1021%2Fjm201388p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D3%26spage%3D1252%26epage%3D1260%26doi%3D10.1021%2Fjm201388p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freeman-Cook, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffmc.12.208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23360135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=113-115&author=K.+D.+Freeman-Cookauthor=R.+L.+Hoffmanauthor=T.+W.+Johnson&title=Lipophilic+efficiency%3A+the+most+important+efficiency+metric+in+medicinal+chemistry&doi=10.4155%2Ffmc.12.208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic efficiency: the most important efficiency metric in medicinal chemistry</span></div><div class="casAuthors">Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review is given on the crit. role of lipophilicity in drug discovery and optimization of general absorption, distribution, metab. and excretion properties, toxicol. profiles and ultimately pharmacol. response.  Math. equations are presented concerning the impact of lipophilicity on the dose and the calcn. of the lipophilic ligand efficiency (LipE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhEHH7Hf1qbVg90H21EOLACvtfcHk0lhhd2UdG9tPPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aiu7g%253D&md5=36170decfa1f1e3ef09ecf772322a210</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.208%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman-Cook%26aufirst%3DK.%2BD.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26atitle%3DLipophilic%2520efficiency%253A%2520the%2520most%2520important%2520efficiency%2520metric%2520in%2520medicinal%2520chemistry%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D113%26epage%3D115%26doi%3D10.4155%2Ffmc.12.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferenczy, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27916639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2mtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=681-689&issue=4&author=G.+Williamsauthor=G.+G.+Ferenczyauthor=J.+Ulanderauthor=G.+M.+Keseru&title=Binding+thermodynamics+discriminates+fragments+from+druglike+compounds%3A+a+thermodynamic+description+of+fragment-based+drug+discovery&doi=10.1016%2Fj.drudis.2016.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery</span></div><div class="casAuthors">Williams, Glyn; Ferenczy, Gyorgy G.; Ulander, Johan; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">681-689</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Small is beautiful reducing the size and complexity of chem. starting points for drug design allows better sampling of chem. space, reveals the most energetically important interactions within protein-binding sites and can lead to improvements in the physicochem. properties of the final drug.  The impact of fragment-based drug discovery (FBDD) on recent drug discovery projects and our improved knowledge of the structural and thermodn. details of ligand binding has prompted us to explore the relationships between ligand-binding thermodn. and FBDD.  Information on binding thermodn. can give insights into the contributions to protein-ligand interactions and could therefore be used to prioritise compds. with a high degree of specificity in forming key interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTKkCmjC-T97Vg90H21EOLACvtfcHk0ljHlE-TsKkBcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2mtLbL&md5=070fe84d5a511b8d7acad48dd8d05057</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DFerenczy%26aufirst%3DG.%2BG.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DBinding%2520thermodynamics%2520discriminates%2520fragments%2520from%2520druglike%2520compounds%253A%2520a%2520thermodynamic%2520description%2520of%2520fragment-based%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26issue%3D4%26spage%3D681%26epage%3D689%26doi%3D10.1016%2Fj.drudis.2016.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenlock, M. C.</span></span> <span> </span><span class="NLM_article-title">Profiling the estimated plasma concentrations of 215 marketed oral drugs</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1039/C5MD00583C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC5MD00583C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=706-719&issue=4&author=M.+C.+Wenlock&title=Profiling+the+estimated+plasma+concentrations+of+215+marketed+oral+drugs&doi=10.1039%2FC5MD00583C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1039%2FC5MD00583C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00583C%26sid%3Dliteratum%253Aachs%26aulast%3DWenlock%26aufirst%3DM.%2BC.%26atitle%3DProfiling%2520the%2520estimated%2520plasma%2520concentrations%2520of%2520215%2520marketed%2520oral%2520drugs%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D706%26epage%3D719%26doi%3D10.1039%2FC5MD00583C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidgeon, C.</span></span> <span> </span><span class="NLM_article-title">In vitro membrane binding and protein binding (IAM MB/PB technology) to estimate in vivo distribution: applications in early drug discovery</span>. <i>ADMET DMPK</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.5599/admet.5.1.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.5599%2Fadmet.5.1.373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=14-38&issue=1&author=K.+L.+Valkoauthor=S.+P.+Teagueauthor=C.+Pidgeon&title=In+vitro+membrane+binding+and+protein+binding+%28IAM+MB%2FPB+technology%29+to+estimate+in+vivo+distribution%3A+applications+in+early+drug+discovery&doi=10.5599%2Fadmet.5.1.373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.5599%2Fadmet.5.1.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5599%252Fadmet.5.1.373%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%2BL.%26aulast%3DTeague%26aufirst%3DS.%2BP.%26aulast%3DPidgeon%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520membrane%2520binding%2520and%2520protein%2520binding%2520%2528IAM%2520MB%252FPB%2520technology%2529%2520to%2520estimate%2520in%2520vivo%2520distribution%253A%2520applications%2520in%2520early%2520drug%2520discovery%26jtitle%3DADMET%2520DMPK%26date%3D2017%26volume%3D5%26issue%3D1%26spage%3D14%26epage%3D38%26doi%3D10.5599%2Fadmet.5.1.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span> <span> </span><span class="NLM_article-title">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">18281</span>– <span class="NLM_lpage">18289</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207759109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1073%2Fpnas.1207759109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22988103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18281-18289&issue=45&author=M.+McTigueauthor=B.+W.+Murrayauthor=J.+H.+Chenauthor=Y.+L.+Dengauthor=J.+Solowiejauthor=R.+S.+Kania&title=Molecular+conformations%2C+interactions%2C+and+properties+associated+with+drug+efficiency+and+clinical+performance+among+VEGFR+TK+inhibitors&doi=10.1073%2Fpnas.1207759109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors</span></div><div class="casAuthors">McTigue, Michele; Murray, Brion William; Chen, Jeffrey H.; Deng, Ya-Li; Solowiej, James; Kania, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18281-18289, S18281/1-S18281/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Analyses of compds. in clin. development have shown that ligand efficient-mols. with privileged phys. properties and low dose are less likely to fail in the various stages of clin. testing, have fewer postapproval withdrawals, and are less likely to receive black box safety warnings.  However, detailed side-by-side examn. of mol. interactions and properties within single drug classes are lacking.  As a class, VEGF receptor tyrosine kinase inhibitors (VEGFR TKIs) have changed the landscape of how cancer is treated, particularly in clear cell renal cell carcinoma, which is molecularly linked to the VEGF signaling axis.  Despite the clear role of the mol. target, member mols. of this validated drug class exhibit distinct clin. efficacy and safety profiles in comparable renal cell carcinoma clin. studies.  The first head-to-head randomized phase III comparative study between active VEGFR TKIs has confirmed significant differences in clin. performance.  To elucidate how fundamental drug potency-efficiency is achieved and impacts differentiation within the VEGFR TKI class, we detd. potencies, time dependence, selectivities, and X-ray structures of the drug-kinase complexes using a VEGFR2 TK construct inclusive of the important juxtamembrane domain.  Collectively, the studies elucidate unique drug-kinase interactions that are dependent on distinct juxtamembrane domain conformations, resulting in significant potency and ligand efficiency differences.  The identified structural trends are consistent with in vitro measurements, which translate well to clin. performance, underscoring a principle that may be broadly applicable to prospective drug design for optimal in vivo performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsIUWiD4sXtbVg90H21EOLACvtfcHk0liMjoKIS2XXrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslymtb3I&md5=4a5ec677298a8c924c0f9557ca688a79</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207759109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207759109%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26atitle%3DMolecular%2520conformations%252C%2520interactions%252C%2520and%2520properties%2520associated%2520with%2520drug%2520efficiency%2520and%2520clinical%2520performance%2520among%2520VEGFR%2520TK%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D45%26spage%3D18281%26epage%3D18289%26doi%3D10.1073%2Fpnas.1207759109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tõnisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The target landscape of clinical kinase drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span> (<span class="NLM_issue">6367</span>),  <span class="NLM_fpage">eaan4368</span>, <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&pages=eaan4368&issue=6367&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.-A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.-K.+Garzauthor=B.-O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+T%C3%B5nissonauthor=K.+Kramerauthor=K.+G%C3%B6tzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.-C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+M%C3%A9dardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+target+landscape+of+clinical+kinase+drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.-A.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.-K.%26aulast%3DGohlke%26aufirst%3DB.-O.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DT%25C3%25B5nisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.-C.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DM%25C3%25A9dard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520target%2520landscape%2520of%2520clinical%2520kinase%2520drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26issue%3D6367%26spage%3Deaan4368%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6228</span>– <span class="NLM_lpage">6235</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.08.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6228-6235&issue=21&author=R.+J.+Young&title=The+successful+quest+for+oral+factor+Xa+inhibitors%3B+learnings+for+all+of+medicinal+chemistry%3F&doi=10.1016%2Fj.bmcl.2011.08.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520successful%2520quest%2520for%2520oral%2520factor%2520Xa%2520inhibitors%253B%2520learnings%2520for%2520all%2520of%2520medicinal%2520chemistry%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6228%26epage%3D6235%26doi%3D10.1016%2Fj.bmcl.2011.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planey, S. L.</span></span> <span> </span><span class="NLM_article-title">The influence of lipophilicity in drug discovery and design</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">875</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.714363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1517%2F17460441.2012.714363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22992175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=863-875&issue=10&author=J.+A.+Arnottauthor=S.+L.+Planey&title=The+influence+of+lipophilicity+in+drug+discovery+and+design&doi=10.1517%2F17460441.2012.714363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lipophilicity in drug discovery and design</span></div><div class="casAuthors">Arnott, John A.; Planey, Sonia Lobo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of lipophilicity in drug discovery and design is a crit. one.  Lipophilicity is a key physicochem. property that plays a crucial role in detg. ADMET (absorption, distribution, metab., excretion, and toxicity) properties and the overall suitability of drug candidates.  There is increasing evidence to suggest that control of physicochem. properties such as lipophilicity, within a defined optimal range, can improve compd. quality and the likelihood of therapeutic success.Areas covered: This review focuses on understanding lipophilicity, techniques used to measure lipophilicity, and summarizes the importance of lipophilicity in drug discovery and development, including a discussion of its impact on individual ADMET parameters as well as its overall influence on the drug discovery and design process, specifically within the past 15 years.Expert opinion: A current review of the literature reveals a continued reliance on the synthesis of novel structures with increased potency, rather than a focus on maintaining optimal physicochem. properties assocd. with ADMET throughout drug optimization.  Particular attention to the optimum region of lipophilicity, as well as monitoring of lipophilic efficiency indexes, may contribute significantly to the overall quality of candidate drugs at different stages of discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWJgvv9yK87Vg90H21EOLACvtfcHk0lhFoWfie0GAzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ&md5=4dc5d7268216c9a59fcbd841fbf66735</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.714363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.714363%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DJ.%2BA.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26atitle%3DThe%2520influence%2520of%2520lipophilicity%2520in%2520drug%2520discovery%2520and%2520design%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26issue%3D10%26spage%3D863%26epage%3D875%26doi%3D10.1517%2F17460441.2012.714363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">15–16</span>),  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&issue=15%E2%80%9316&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity&doi=10.1016%2Fj.drudis.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0lhFoWfie0GAzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26issue%3D15%25E2%2580%259316%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.drudis.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17–18</span>),  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&issue=17%E2%80%9318&author=R.+J.+Youngauthor=D.+V.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lhlUJSsPZIFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D17%25E2%2580%259318%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mannhold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poda, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Calculation of molecular lipophilicity: state-of-the-art and comparison of logP methods on more than 96,000 compounds</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1002/jps.21494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.21494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18683876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1eisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=861-893&author=R.+Mannholdauthor=G.+I.+Podaauthor=C.+Ostermannauthor=I.+V.+Tetko&title=Calculation+of+molecular+lipophilicity%3A+state-of-the-art+and+comparison+of+logP+methods+on+more+than+96%2C000+compounds&doi=10.1002%2Fjps.21494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Calculation of molecular lipophilicity: state-of-the-art and comparison of logP methods on more than 96,000 compounds</span></div><div class="casAuthors">Mannhold, Raimund; Poda, Gennadiy I.; Ostermann, Cluade; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">861-893</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  We first review the state-of-the-art in development of logP prediction approaches falling in two major categories: substructure-based and property-based methods.  Then, we compare the predictive power of representative methods for one public (N = 266) and two in house datasets from Nycomed (N = 882) and Pfizer (N = 95809).  A total of 30 and 18 methods were tested for public and industrial datasets, resp.  Accuracy of models declined with the no. of nonhydrogen atoms.  The Arithmetic Av. Model (AAM), which predicts the same value (the arithmetic mean) for all compds., was used as a baseline model for comparison.  Methods with Root Mean Squared Error (RMSE) greater than RMSE produced by the AAM were considered as unacceptable.  The majority of analyzed methods produced reasonable results for the public dataset but only seven methods were successful on the both in house datasets.  We proposed a simple equation based on the no. of carbon atoms, NC, and the no. of hetero atoms, NHET: logP = 1.46(+0.02) + 0.11(±0.001) NC - 0.11(±0.001) NHEET.  This equation outperformed a large no. of programs benchmarked in this study.  Factors influencing the accuracy of logP predictions were elucidated and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR3RAtmKwEZ7Vg90H21EOLACvtfcHk0lhlUJSsPZIFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1eisLo%253D&md5=8ae19379316c226dc75ec057006b0e8c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fjps.21494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21494%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DOstermann%26aufirst%3DC.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DCalculation%2520of%2520molecular%2520lipophilicity%253A%2520state-of-the-art%2520and%2520comparison%2520of%2520logP%2520methods%2520on%2520more%2520than%252096%252C000%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D861%26epage%3D893%26doi%3D10.1002%2Fjps.21494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhan, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendoloski, J. J.</span></span> <span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods:  an analysis of ALOGP and CLOGP methods</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3772</span>, <span class="refDoi"> DOI: 10.1021/jp980230o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&issue=21&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A%E2%80%89+an+analysis+of+ALOGP+and+CLOGP+methods&doi=10.1021%2Fjp980230o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%25E2%2580%2589%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26issue%3D21%26spage%3D3762%26epage%3D3772%26doi%3D10.1021%2Fjp980230o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crippen, G. M.</span></span> <span> </span><span class="NLM_article-title">Prediction of physicochemical parameters by atomic contributions</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1021/ci990307l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci990307l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1WjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=868-873&issue=5&author=S.+A.+Wildmanauthor=G.+M.+Crippen&title=Prediction+of+physicochemical+parameters+by+atomic+contributions&doi=10.1021%2Fci990307l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Physicochemical Parameters by Atomic Contributions</span></div><div class="casAuthors">Wildman, Scott A.; Crippen, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">868-873</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a new atom type classification system for use in atom-based calcn. of partition coeff. (log P) and molar refractivity (MR) designed in part to address published concerns of previous at. methods.  The 68 at. contributions to log P have been detd. by fitting an extensive training set of 9920 mols., with r2 = 0.918 and σ = 0.677.  A sep. set of 3412 mols. was used for the detn. of contributions to MR with r2 = 0.997 and σ = 1.43.  Both calcns. are shown to have high predictive ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBe2sxWdEMsbVg90H21EOLACvtfcHk0lhlUJSsPZIFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1WjtbY%253D&md5=5eb46da66f7861906be7078f0b7e1b95</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fci990307l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci990307l%26sid%3Dliteratum%253Aachs%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DCrippen%26aufirst%3DG.%2BM.%26atitle%3DPrediction%2520of%2520physicochemical%2520parameters%2520by%2520atomic%2520contributions%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1999%26volume%3D39%26issue%3D5%26spage%3D868%26epage%3D873%26doi%3D10.1021%2Fci990307l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christmann-Franck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span> <span> </span><span class="NLM_article-title">Time-trajectories in efficiency maps as effective guides for drug discovery efforts</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1002/minf.201000158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fminf.201000158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27466765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=137-144&issue=2%E2%80%933&author=S.+Christmann-Franckauthor=D.+Cravoauthor=C.+Abad-Zapatero&title=Time-trajectories+in+efficiency+maps+as+effective+guides+for+drug+discovery+efforts&doi=10.1002%2Fminf.201000158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Time-Trajectories in Efficiency Maps as Effective Guides for Drug Discovery Efforts</span></div><div class="casAuthors">Christmann-Franck, Serge; Cravo, Daniel; Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This article summarizes the definitions of the most relevant ligand efficiency indexes (LEIs), present the initial and the most recent two-dimensional maps in the LEIs space, and introduce a representation of the drug discovery effort as a 'time-trajectory' in these maps.  It is suggested that this representation is a means to fruitfully complement the traditional SAR tables by permitting to follow the design sequence of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9vzDkfOSLB7Vg90H21EOLACvtfcHk0ljd8svAi_aFTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wru7w%253D&md5=1ca530e1d2760b73439768e7ae65a059</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000158%26sid%3Dliteratum%253Aachs%26aulast%3DChristmann-Franck%26aufirst%3DS.%26aulast%3DCravo%26aufirst%3DD.%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DTime-trajectories%2520in%2520efficiency%2520maps%2520as%2520effective%2520guides%2520for%2520drug%2520discovery%2520efforts%26jtitle%3DMol.%2520Inf.%26date%3D2011%26volume%3D30%26issue%3D2%25E2%2580%25933%26spage%3D137%26epage%3D144%26doi%3D10.1002%2Fminf.201000158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, R. D.</span></span> <span> </span><span class="NLM_article-title">BC(DEF) parameters. 1. The intrinsic dimensionality of intermolecular interactions in the liquid state</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1021/ja00526a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00526a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=1837-1849&issue=6&author=R.+D.+Cramer&title=BC%28DEF%29+parameters.+1.+The+intrinsic+dimensionality+of+intermolecular+interactions+in+the+liquid+state&doi=10.1021%2Fja00526a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja00526a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00526a013%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DR.%2BD.%26atitle%3DBC%2528DEF%2529%2520parameters.%25201.%2520The%2520intrinsic%2520dimensionality%2520of%2520intermolecular%2520interactions%2520in%2520the%2520liquid%2520state%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26issue%3D6%26spage%3D1837%26epage%3D1849%26doi%3D10.1021%2Fja00526a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadha, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. C.</span></span> <span> </span><span class="NLM_article-title">Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of Seiler</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1002/jps.2600830806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjps.2600830806" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1085-1100&issue=8&author=M.+H.+Abrahamauthor=H.+S.+Chadhaauthor=G.+S.+Whitingauthor=R.+C.+Mitchell&title=Hydrogen+bonding.+32.+An+analysis+of+water-octanol+and+water-alkane+partitioning+and+the+delta+log+P+parameter+of+Seiler&doi=10.1002%2Fjps.2600830806"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600830806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600830806%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DChadha%26aufirst%3DH.%2BS.%26aulast%3DWhiting%26aufirst%3DG.%2BS.%26aulast%3DMitchell%26aufirst%3DR.%2BC.%26atitle%3DHydrogen%2520bonding.%252032.%2520An%2520analysis%2520of%2520water-octanol%2520and%2520water-alkane%2520partitioning%2520and%2520the%2520delta%2520log%2520P%2520parameter%2520of%2520Seiler%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26issue%3D8%26spage%3D1085%26epage%3D1100%26doi%3D10.1002%2Fjps.2600830806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pye, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Nonclassical size dependence of permeation defines bounds for passive adsorption of large drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslajtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1665-1672&issue=5&author=C.+R.+Pyeauthor=W.+M.+Hewittauthor=J.+Schwochertauthor=T.+D.+Haddadauthor=C.+E.+Townsendauthor=L.+Etienneauthor=Y.+Laoauthor=C.+Limberakisauthor=A.+Furukawaauthor=A.+M.+Mathiowetzauthor=D.+A.+Priceauthor=S.+Lirasauthor=R.+S.+Lokey&title=Nonclassical+size+dependence+of+permeation+defines+bounds+for+passive+adsorption+of+large+drug+molecules&doi=10.1021%2Facs.jmedchem.6b01483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules</span></div><div class="casAuthors">Pye, Cameron R.; Hewitt, William M.; Schwochert, Joshua; Haddad, Terra D.; Townsend, Chad E.; Etienne, Lyns; Lao, Yongtong; Limberakis, Chris; Furukawa, Akihiro; Mathiowetz, Alan M.; Price, David A.; Liras, Spiros; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1665-1672</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a growing no. of intracellular protein-protein interactions (PPI's) with potential therapeutic importance that demand larger ligands than those that neatly fit into most common criteria for "drug-likeness".  Macrocyclic peptides pro-vide the large surface area required to inhibit PPIs and, in principle, avoid many of the pitfalls assocd. with peptides, including low stability and membrane permeability.  However, the design of passively cell-permeable mols. in this space remains a great challenge due to the poorly understood roles of mol. size and lipophilicity in detg. passive membrane permeability above MW ∼500.  Using split-pool combinatorial synthesis, we constructed a library of cyclic, per-N-methlyated peptides spanning a wide range of calcd. lipohilicities (0 < AlogP < 8) and mol. wts. (∼800 Da < MW < ∼1200 Da).  Assaying mixts. of compds. using the Parallel Artificial Membrane Assay (PAMPA) revealed a steep drop-off in apparent passive permeability with increasing size and a bilinear relationship with lipophilicity.  We obsd. a size dependence of permeability that is in stark disagreement with current permeation models.  The lipophilicities required to overcome this size penalty led to poor aq. soly., effectively bounding the chem. space of likely passively permeable mols.  This understanding provides a new set of design criteria for achieving permeability in larger mol. size regimes and suggests an operational cut-off beyond which passive permeability is constrained by a sharply increasing penalty on permeation through the system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXD-PeEQUtu7Vg90H21EOLACvtfcHk0lg7_tioCm5WGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslajtw%253D%253D&md5=7b51a3c8fe24560c9445d8d32bf3b70f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01483%26sid%3Dliteratum%253Aachs%26aulast%3DPye%26aufirst%3DC.%2BR.%26aulast%3DHewitt%26aufirst%3DW.%2BM.%26aulast%3DSchwochert%26aufirst%3DJ.%26aulast%3DHaddad%26aufirst%3DT.%2BD.%26aulast%3DTownsend%26aufirst%3DC.%2BE.%26aulast%3DEtienne%26aufirst%3DL.%26aulast%3DLao%26aufirst%3DY.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DFurukawa%26aufirst%3DA.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DNonclassical%2520size%2520dependence%2520of%2520permeation%2520defines%2520bounds%2520for%2520passive%2520adsorption%2520of%2520large%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1665%26epage%3D1672%26doi%3D10.1021%2Facs.jmedchem.6b01483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span>; <span class="NLM_string-name">Armour, D.</span></span> <span> </span><span class="NLM_article-title">The Discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS</span>. In  <i>Progress in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F. D.</span>, <span class="NLM_string-name">Lawton, G.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2005</span>; Vol.  <span class="NLM_volume">43</span>, pp  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">271</span>, DOI: <span class="refDoi"> DOI: 10.1016/S0079-6468(05)43007-6</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0079-6468%2805%2943007-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=239-271&author=A.+Wood&author=D.+Armourauthor=F.+D.+King&author=G.+Lawton&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2943007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252943007-6%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520the%2520CCR5%2520receptor%2520antagonist%252C%2520UK-427%252C857%252C%2520a%2520new%2520agent%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%2520and%2520AIDS%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DKing%26aufirst%3DF.%2BD.%26pub%3DElsevier%26date%3D2005%26volume%3D43%26spage%3D239%26epage%3D271%26doi%3D10.1016%2FS0079-6468%2805%2943007-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corless, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perruccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platts, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydr o-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/jm100978n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100978n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=67-77&issue=1&author=P.+A.+Stuppleauthor=D.+V.+Batchelorauthor=M.+Corlessauthor=P.+K.+Dorrauthor=D.+Ellisauthor=D.+R.+Fenwickauthor=S.+R.+Galanauthor=R.+M.+Jonesauthor=H.+J.+Masonauthor=D.+S.+Middletonauthor=M.+Perrosauthor=F.+Perruccioauthor=M.+Y.+Plattsauthor=D.+C.+Prydeauthor=D.+Rodriguesauthor=N.+N.+Smithauthor=P.+T.+Stephensonauthor=R.+Websterauthor=M.+Westbyauthor=A.+Wood&title=An+imidazopiperidine+series+of+CCR5+antagonists+for+the+treatment+of+HIV%3A+the+discovery+of+N-%7B%281S%29-1-%283-fluorophenyl%29-3-%5B%283-endo%29-3-%285-isobutyryl-2-methyl-4%2C5%2C6%2C7-tetrahydr+o-1H-imidazo%5B4%2C5-c%5Dpyridin-1-yl%29-8-azabicyclo%5B3.2.1%5Doct-8-yl%5Dpropyl%7Dacetamide+%28PF-232798%29&doi=10.1021%2Fjm100978n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm100978n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100978n%26sid%3Dliteratum%253Aachs%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%2BV.%26aulast%3DCorless%26aufirst%3DM.%26aulast%3DDorr%26aufirst%3DP.%2BK.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DFenwick%26aufirst%3DD.%2BR.%26aulast%3DGalan%26aufirst%3DS.%2BR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMason%26aufirst%3DH.%2BJ.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DPlatts%26aufirst%3DM.%2BY.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DN.%2BN.%26aulast%3DStephenson%26aufirst%3DP.%2BT.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DAn%2520imidazopiperidine%2520series%2520of%2520CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%253A%2520the%2520discovery%2520of%2520N-%257B%25281S%2529-1-%25283-fluorophenyl%2529-3-%255B%25283-endo%2529-3-%25285-isobutyryl-2-methyl-4%252C5%252C6%252C7-tetrahydr%2520o-1H-imidazo%255B4%252C5-c%255Dpyridin-1-yl%2529-8-azabicyclo%255B3.2.1%255Doct-8-yl%255Dpropyl%257Dacetamide%2520%2528PF-232798%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D67%26epage%3D77%26doi%3D10.1021%2Fjm100978n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkowitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivnichny, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danzeisen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span> <span> </span><span class="NLM_article-title">Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2003.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=941-945&issue=4&author=D.+M.+Shenauthor=M.+Shuauthor=C.+A.+Willoughbyauthor=S.+Shahauthor=C.+L.+Lynchauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=K.+T.+Chapmanauthor=L.+Malkowitzauthor=M.+S.+Springerauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=S.+J.+Sicilianoauthor=K.+Lyonsauthor=J.+V.+Pivnichnyauthor=G.+Y.+Kweiauthor=A.+Carellaauthor=G.+Carverauthor=K.+Holmesauthor=W.+A.+Schleifauthor=R.+Danzeisenauthor=D.+Hazudaauthor=J.+Kesslerauthor=J.+Linebergerauthor=M.+D.+Millerauthor=E.+A.+Emini&title=Antagonists+of+human+CCR5+receptor+containing+4-%28pyrazolyl%29piperidine+side+chains.+Part+2%3A+Discovery+of+potent%2C+selective%2C+and+orally+bioavailable+compounds&doi=10.1016%2Fj.bmcl.2003.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BM.%26aulast%3DShu%26aufirst%3DM.%26aulast%3DWilloughby%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSiciliano%26aufirst%3DS.%2BJ.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DAntagonists%2520of%2520human%2520CCR5%2520receptor%2520containing%25204-%2528pyrazolyl%2529piperidine%2520side%2520chains.%2520Part%25202%253A%2520Discovery%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D4%26spage%3D941%26epage%3D945%26doi%3D10.1016%2Fj.bmcl.2003.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwei, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliff, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didolkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>304</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.045096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1124%2Fjpet.102.045096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=12604693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1eis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=1161-1171&issue=3&author=S.+Kumarauthor=G.+Y.+Kweiauthor=G.+K.+Poonauthor=S.+A.+Iliffauthor=Y.+Wangauthor=Q.+Chenauthor=R.+B.+Franklinauthor=V.+Didolkarauthor=R.+W.+Wangauthor=M.+Yamazakiauthor=S.+H.+Chiuauthor=J.+H.+Linauthor=P.+G.+Pearsonauthor=T.+A.+Baillie&title=Pharmacokinetics+and+interactions+of+a+novel+antagonist+of+chemokine+receptor+5+%28CCR5%29+with+ritonavir+in+rats+and+monkeys%3A+role+of+CYP3A+and+P-glycoprotein&doi=10.1124%2Fjpet.102.045096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: Role of CYP3A and P-glycoprotein</span></div><div class="casAuthors">Kumar, Sanjeev; Kwei, Gloria Y.; Poon, Grace K.; Iliff, Susan A.; Wang, Yanfeng; Chen, Qing; Franklin, Ronald B.; Didolkar, Varsha; Wang, Regina W.; Yamazaki, Masayo; Chiu, Shuet-Hing Lee; Lin, Jiunn H.; Pearson, Paul G.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1161-1171</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mechanisms of pharmacokinetic interactions of a novel anti-human immunodeficiency virus (anti-HIV-1) antagonist of chemokine receptor 5 (CCR5) [2-(R)-[N-methyl-N-(1-(R)-3-(S)-((4- (3-benzyl-1-ethyl-(1H)-pyrazol-5-yl) piperidin-1-yl)methyl)-4-(S)-(3- fluorophenyl)cyclopent-1-yl)amino]-3-methylbutanoic acid (MRK-1)] with ritonavir were evaluated in rats and monkeys.  MRK-1 was a good substrate for the human (MDR1) and mouse (Mdr1a) multidrug resistance protein transporters and was metabolized by CYP3A isoenzymes in rat, monkey, and human liver microsomes.  Both the in vitro MDR1-mediated transport and oxidative metab. of MRK-1 were inhibited by ritonavir.  Although the systemic pharmacokinetics of MRK-1 in rats and monkeys were linear, the oral bioavailability increased with an increase in dose from 2 to 10 mg/kg.  The area under the plasma concn.-time curve (AUC) of MRK-1 was increased 4- to 6-fold when a 2 or 10 mg/kg dose was orally coadministered with 10 mg/kg ritonavir.  Further pharmacokinetic studies in rats indicated that P-glycoprotein (P-gp) inhibition by ritonavir increased the intestinal absorption of 2 mg/kg MRK-1 maximally by ∼30 to 40%, and a major component of the interaction likely resulted from its reduced systemic clearance via the inhibition of CYP3A isoenzymes.  Oral coadministration of quinidine (10 and 30 mg/kg) increased both the extent and the first-order rate of absorption of MRK-1 (2 mg/kg) by ∼40 to 50% and ∼100 to 300%, resp., in rats, thus further substantiating the role of P-gp in modulating the intestinal absorption of MRK-1 in this species.  At the 10 mg/kg MRK-1 dose, however, the entire increase in its AUC upon coadministration with ritonavir or quinidine could be attributed to a reduced systemic clearance, and no effects on intestinal absorption were apparent.  In contrast to rats, the effects of P-gp in detg. the intestinal absorption of MRK-1 appeared less significant in rhesus monkeys at either dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_bgeg7trkiLVg90H21EOLACvtfcHk0lhjVdibd0EQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1eis70%253D&md5=8183cf909cd56e35df74a56281cf9fc9</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.045096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.045096%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKwei%26aufirst%3DG.%2BY.%26aulast%3DPoon%26aufirst%3DG.%2BK.%26aulast%3DIliff%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DFranklin%26aufirst%3DR.%2BB.%26aulast%3DDidolkar%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DR.%2BW.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DChiu%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DPharmacokinetics%2520and%2520interactions%2520of%2520a%2520novel%2520antagonist%2520of%2520chemokine%2520receptor%25205%2520%2528CCR5%2529%2520with%2520ritonavir%2520in%2520rats%2520and%2520monkeys%253A%2520role%2520of%2520CYP3A%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26issue%3D3%26spage%3D1161%26epage%3D1171%26doi%3D10.1124%2Fjpet.102.045096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danehower, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elitzin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, M.</span></span> <span> </span><span class="NLM_article-title">Biological and structural characterization of rotamers of C-C chemokine receptor type 5 (CCR5) inhibitor GSK214096</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1021/ml5004124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1296-1299&issue=12&author=W.+M.+Kazmierskiauthor=S.+Danehowerauthor=M.+Duanauthor=R.+G.+Ferrisauthor=V.+Elitzinauthor=D.+Minickauthor=M.+Sharpauthor=E.+Stewartauthor=M.+Villeneuve&title=Biological+and+structural+characterization+of+rotamers+of+C-C+chemokine+receptor+type+5+%28CCR5%29+inhibitor+GSK214096&doi=10.1021%2Fml5004124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fml5004124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004124%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DDanehower%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%2BG.%26aulast%3DElitzin%26aufirst%3DV.%26aulast%3DMinick%26aufirst%3DD.%26aulast%3DSharp%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DE.%26aulast%3DVilleneuve%26aufirst%3DM.%26atitle%3DBiological%2520and%2520structural%2520characterization%2520of%2520rotamers%2520of%2520C-C%2520chemokine%2520receptor%2520type%25205%2520%2528CCR5%2529%2520inhibitor%2520GSK214096%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1296%26epage%3D1299%26doi%3D10.1021%2Fml5004124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J.</span></span> <span> </span><span class="NLM_article-title">Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.12.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1655-1659&issue=4&author=J.+G.+Cummingauthor=H.+Tuckerauthor=J.+Oldfieldauthor=C.+Fieldingauthor=A.+Hightonauthor=A.+Faullauthor=M.+Wildauthor=D.+Brownauthor=S.+Wellsauthor=J.+Shaw&title=Balancing+hERG+affinity+and+absorption+in+the+discovery+of+AZD5672%2C+an+orally+active+CCR5+antagonist+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmcl.2011.12.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DFielding%26aufirst%3DC.%26aulast%3DHighton%26aufirst%3DA.%26aulast%3DFaull%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DJ.%26atitle%3DBalancing%2520hERG%2520affinity%2520and%2520absorption%2520in%2520the%2520discovery%2520of%2520AZD5672%252C%2520an%2520orally%2520active%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1655%26epage%3D1659%26doi%3D10.1016%2Fj.bmcl.2011.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornwell, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span> <span> </span><span class="NLM_article-title">Investigating the mechanistic basis for hepatic toxicity induced by an experimental chemokine receptor 5 (CCR5) antagonist using a compendium of gene expression profiles</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1080/01926230701383194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1080%2F01926230701383194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17654398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=576-588&issue=4&author=P.+D.+Cornwellauthor=R.+G.+Ulrich&title=Investigating+the+mechanistic+basis+for+hepatic+toxicity+induced+by+an+experimental+chemokine+receptor+5+%28CCR5%29+antagonist+using+a+compendium+of+gene+expression+profiles&doi=10.1080%2F01926230701383194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating the Mechanistic Basis for Hepatic Toxicity Induced by an Experimental Chemokine Receptor 5 (CCR5) Antagonist Using a Compendium of Gene Expression Profiles</span></div><div class="casAuthors">Cornwell, Paul D.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">576-588</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A compendium of hepatic gene expression signatures was used to identify a mechanistic basis for the hepatic toxicity of an exptl. CCR5 antagonist (MrkA).  Development of MrkA, a potential HIV therapeutic, was discontinued due to hepatotoxicity in preclin. studies.  Rats were treated with MrkA at 3 dose levels (50, 250, and 500 mg/kg) for 1, 3, or 7 days.  Hepatic toxicity (vacuolation, consistent with steatosis, and elevated serum transaminase levels) was obsd. at 250 and 500 mg/kg, but not at 50 mg/kg.  Hepatic gene expression profiles were compared to a compendium of hepatic expression profiles.  MrkA was similar to 3 β-oxidn. inhibitors (valproate, cyclopropane carboxylate, pivalate), 8 PPARα agonists (fenofibrate, bezafibrate and 6 fibrate analogs), and 3 other diverse compds. (diethylnitrosamine, microcystin LR & actinomycin D).  These data indicate MrkA to be a mitochondrial inhibitor, and activation of PPARα-regulated transcription was thought to be due to an accumulation of endogenous ligands.  While mitochondrial inhibition was likely responsible for steatosis, canonical pathway anal. revealed that progression to liver injury may be mediated by activation of the innate immune system primarily through NF-kB pathways.  These results demonstrate the utility of a gene expression response compendium in developing transcriptional biomarkers and identifying the mechanistic basis for toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu3ygIjrif37Vg90H21EOLACvtfcHk0lizy7-ii7wX8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFSrs70%253D&md5=659478a939da2531873cdf1485aca09e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F01926230701383194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701383194%26sid%3Dliteratum%253Aachs%26aulast%3DCornwell%26aufirst%3DP.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DInvestigating%2520the%2520mechanistic%2520basis%2520for%2520hepatic%2520toxicity%2520induced%2520by%2520an%2520experimental%2520chemokine%2520receptor%25205%2520%2528CCR5%2529%2520antagonist%2520using%2520a%2520compendium%2520of%2520gene%2520expression%2520profiles%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D576%26epage%3D588%26doi%3D10.1080%2F01926230701383194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerlag, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vencovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekanecz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braddock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3154</span>– <span class="NLM_lpage">3160</span>, <span class="refDoi"> DOI: 10.1002/art.27652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fart.27652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20662070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3154-3160&issue=11&author=D.+M.+Gerlagauthor=S.+Hollisauthor=M.+Laytonauthor=J.+Vencovskyauthor=Z.+Szekaneczauthor=M.+Braddockauthor=P.+P.+Tak&title=Preclinical+and+clinical+investigation+of+a+CCR5+antagonist%2C+AZD5672%2C+in+patients+with+rheumatoid+arthritis+receiving+methotrexate&doi=10.1002%2Fart.27652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate</span></div><div class="casAuthors">Gerlag, Danielle M.; Hollis, Sally; Layton, Mark; Vencovsky, Jiri; Szekanecz, Zoltan; Braddock, Martin; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3154-3160</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To investigate both the preclin. effects of blocking the chemokine receptor CCR5 and the clin. effects of this approach on the signs and symptoms of rheumatoid arthritis (RA) in patients with active disease.  Methods. Preclin. evaluations of AZD5672, a small-mol. antagonist of CCR5, were performed, including studies of ligand binding and chemotaxis.  The pharmacokinetics of AZD5672 were assessed in both single- and multiple-dose studies in healthy volunteers.  A randomized, placebo-controlled, phase IIb study was conducted in patients with active RA receiving methotrexate.  Treatment arms were AZD5672 (20, 50, 100, or 150 mg orally, once daily), matched placebo, or open-label etanercept (50 mg s.c., once weekly).  The primary end point was the proportion of patients achieving a 20% improvement response on the American College of Rheumatol. improvement criteria (ACR20) at week 12.  Secondary end points included the ACR20 over time, as well as 50% (ACR50) and 70% (ACR70) improvement responses, changes in individual components of the ACR improvement criteria, and disease activity measured with the Disease Activity Score based on the 28-joint count.  Results. AZD5672 was a highly potent and selective antagonist of CCR5, displaying nonproportional steady-state pharmacokinetics while inhibiting internalization of CCR5 in an ex vivo macrophage inflammatory protein 1β stimulation assay in which AZD5672 was evaluated over the 20-150-mg dose range.  In the phase IIb study testing this dose range in patients with RA (n = 371 patients randomized to received treatment), AZD5672 was generally well tolerated, with no unexpected adverse events.  There was no statistically significant difference in the proportion of patients achieving an ACR20 response at week 12 between those receiving any dose of AZD5672 and those receiving placebo; etanercept was significantly more efficacious than AZD5672 and placebo.  Conclusion. Despite a clear rationale for targeting CCR5, this clin. study showed that AZD5672, administered orally, did not have any clin. benefit, suggesting that CCR5 antagonism alone is unlikely to be a viable therapeutic strategy in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMtJlWPEReLVg90H21EOLACvtfcHk0lizy7-ii7wX8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFahsrrP&md5=78b9ccb1c6e3fd325a5abe24c703751b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fart.27652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27652%26sid%3Dliteratum%253Aachs%26aulast%3DGerlag%26aufirst%3DD.%2BM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DVencovsky%26aufirst%3DJ.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DPreclinical%2520and%2520clinical%2520investigation%2520of%2520a%2520CCR5%2520antagonist%252C%2520AZD5672%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520receiving%2520methotrexate%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D11%26spage%3D3154%26epage%3D3160%26doi%3D10.1002%2Fart.27652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemoine, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span> <span> </span><span class="NLM_article-title">Small molecule antagonists of the chemokine receptor CCR5</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.2174/156802610791561219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F156802610791561219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=20536424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSktb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1299-1338&issue=13&author=R.+C.+Lemoineauthor=J.+Wanner&title=Small+molecule+antagonists+of+the+chemokine+receptor+CCR5&doi=10.2174%2F156802610791561219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule antagonists of the chemokine receptor CCR5</span></div><div class="casAuthors">Lemoine, Remy C.; Wanner, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1299-1338</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review will focus on the discovery and clin. development of small mol. antagonists of CCR5 for the treatment of HIV-1/AIDS, as well as for the potential treatment of inflammatory diseases.  In particular, we will focus on the specific medicinal chem. problems that were faced during the discovery of the mols.  We will also describe limited data from clin. development phases focusing on specific issues that arose during the clin. trials.  Finally, we will touch on the mechanism of action of CCR5 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRvsf2tx0zVLVg90H21EOLACvtfcHk0lgTdgARbZJB0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSktb7F&md5=ed99662e8895e84757d6900a7c8c3fb8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.2174%2F156802610791561219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791561219%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DR.%2BC.%26aulast%3DWanner%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520antagonists%2520of%2520the%2520chemokine%2520receptor%2520CCR5%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26issue%3D13%26spage%3D1299%26epage%3D1338%26doi%3D10.2174%2F156802610791561219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horuk, R.</span></span> <span> </span><span class="NLM_article-title">Chemokine receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9363</span>– <span class="NLM_lpage">9392</span>, <span class="refDoi"> DOI: 10.1021/jm300682j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300682j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9363-9392&issue=22&author=J.+Peaseauthor=R.+Horuk&title=Chemokine+receptor+antagonists&doi=10.1021%2Fjm300682j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine Receptor Antagonists</span></div><div class="casAuthors">Pease, James; Horuk, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9363-9392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Millions suffer from autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and asthma.  Because of their important role in host defense, chemokine receptors have been closely scrutinized as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGh07JisdDNrVg90H21EOLACvtfcHk0lgTdgARbZJB0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLvK&md5=f0bcefb613d599cd45c110660f846dd7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm300682j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300682j%26sid%3Dliteratum%253Aachs%26aulast%3DPease%26aufirst%3DJ.%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DChemokine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D22%26spage%3D9363%26epage%3D9392%26doi%3D10.1021%2Fjm300682j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of CCR5 receptor antagonists for the treatment of HIV infection: hit-to-lead studies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200600031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.200600031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=706-709&issue=7&author=D.+Armourauthor=M.+J.+de+Grootauthor=M.+Edwardsauthor=M.+Perrosauthor=D.+A.+Priceauthor=B.+L.+Stammenauthor=A.+Wood&title=The+discovery+of+CCR5+receptor+antagonists+for+the+treatment+of+HIV+infection%3A+hit-to-lead+studies&doi=10.1002%2Fcmdc.200600031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600031%26sid%3Dliteratum%253Aachs%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DEdwards%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520CCR5%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%253A%2520hit-to-lead%2520studies%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26issue%3D7%26spage%3D706%26epage%3D709%26doi%3D10.1002%2Fcmdc.200600031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4633</span>– <span class="NLM_lpage">4637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.06.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4633-4637&issue=17&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+HERG+affinity+in+the+discovery+of+the+CCR5+antagonist+maraviroc&doi=10.1016%2Fj.bmcl.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520HERG%2520affinity%2520in%2520the%2520discovery%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D17%26spage%3D4633%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2008.03137.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fj.1365-2125.2008.03137.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18333867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Cgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=60-67&issue=Suppl.+1&author=S.+Abelauthor=D.+Russellauthor=L.+A.+Whitlockauthor=C.+E.+Ridgwayauthor=A.+N.+Neddermanauthor=D.+K.+Walker&title=Assessment+of+the+absorption%2C+metabolism+and+absolute+bioavailability+of+maraviroc+in+healthy+male+subjects&doi=10.1111%2Fj.1365-2125.2008.03137.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects</span></div><div class="casAuthors">Abel, Samantha; Russell, Deborah; Whitlock, Lyndsey A.; Ridgway, Caroline E.; Nedderman, Angus N. R.; Walker, Donald K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Two studies were conducted to: (i) quantify the amt. of drug-related radioactivity in blood, plasma, urine and feces following a 14C-labeled dose of maraviroc; and (ii) investigate the pharmacokinetics, safety and tolerability of i.v. maraviroc and det. the abs. bioavailability of oral maraviroc.  Metabolite profiling was also conducted.  Data from both of these studies were used to construct a mass-balance model for maraviroc.  Study 1 was an open-label study in three healthy male subjects.  All subjects received a single 300-mg oral soln. dose of 14C-labeled maraviroc.  Study 2 included two cohorts of subjects.  Cohort 1 involved a double-blind (third party open), four-way crossover study where eight subjects received escalating i.v. doses of maraviroc (3, 10 and 30 mg) with placebo insertion.  Cohort 2 involved an open, two-way crossover study where 12 subjects received 30 mg maraviroc by i.v. infusion and 100 mg maraviroc orally in random order.  In study 1, blood samples and all urine and feces were collected up to at least 120 h postdose.  In study 2, blood samples were taken at intervals up to 48 h postdose.  Urine was also collected up to 24 h postdose in cohort 1 only.  After oral administration in study 1, maraviroc was rapidly absorbed with a plasma Tmax reached by 2 h postdose for all three subjects.  The max. concns. of radioactivity also occurred within 2 h for all subjects.  There was a higher amt. of radioactivity in plasma than in blood (blood/plasma ratio ∼0.6 for AUCt and Cmax).  Unchanged maraviroc was the major circulating component in plasma, accounting for ∼42% of the circulating radioactivity.  Following a 300-mg 14C-labeled maraviroc dose, means of 76.4% and 19.6% of radioactivity were recovered in the feces and urine, resp.  The mean total recovery of dosed radioactivity was 96%, with the majority of radioactivity being recovered within 96 h postdose.  Profiling of the urine and feces showed similar and extensive metab. in all subjects.  Unchanged maraviroc was the major excreted component (33%).  The major metabolic pathways were detd. and involved oxidn. and N-dealkylation.  I.v. doses of maraviroc (3-30 mg) were well tolerated in study 2, and drug exposure was approx. proportional to dose within the studied range.  Approx. 23% of total clearance (44 l h-1) was accounted for by renal clearance (10.2 l h-1).  Mean vol. of distribution at steady state was 194 l.  Abs. bioavailability of a 100-mg oral tablet dose, by comparison with a 30-mg i.v. dose, was calcd. to be 23.1%.  Maraviroc is rapidly absorbed and extensively metabolized, although unchanged maraviroc is the major circulating component in plasma and is the major excreted component after oral dosing.  The pharmacokinetics of maraviroc after i.v. administration is approx. proportional over the dose range studied.  Renal clearance contributes 23% of total clearance.  The abs. bioavailability of 100 mg oral maraviroc is 23%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_haZCWmuLi7Vg90H21EOLACvtfcHk0lg5aRVQYidkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Cgt7k%253D&md5=304dfef653a9fe80b4a102550e9e0d23</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2008.03137.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2008.03137.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DWhitlock%26aufirst%3DL.%2BA.%26aulast%3DRidgway%26aufirst%3DC.%2BE.%26aulast%3DNedderman%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DAssessment%2520of%2520the%2520absorption%252C%2520metabolism%2520and%2520absolute%2520bioavailability%2520of%2520maraviroc%2520in%2520healthy%2520male%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D65%26issue%3DSuppl.%25201%26spage%3D60%26epage%3D67%26doi%3D10.1111%2Fj.1365-2125.2008.03137.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deval, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dioszegi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravendran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vauquelin, G.</span></span> <span> </span><span class="NLM_article-title">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3364</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1111/bph.12683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fbph.12683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24628038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3364-3375&issue=14&author=D.+C.+Swinneyauthor=P.+Beavisauthor=K.+T.+Chuangauthor=Y.+Zhengauthor=I.+Leeauthor=P.+Geeauthor=J.+Devalauthor=D.+M.+Rotsteinauthor=M.+Dioszegiauthor=P.+Ravendranauthor=J.+Zhangauthor=S.+Sankuratriauthor=R.+Kondruauthor=G.+Vauquelin&title=A+study+of+the+molecular+mechanism+of+binding+kinetics+and+long+residence+times+of+human+CCR5+receptor+small+molecule+allosteric+ligands&doi=10.1111%2Fbph.12683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span></div><div class="casAuthors">Swinney, David C.; Beavis, Paul; Chuang, Kai-Ting; Zheng, Yue; Lee, Ina; Gee, Peter; Deval, Jerome; Rotstein, David M.; Dioszegi, Marianna; Ravendran, Palani; Zhang, Jun; Sankuratri, Surya; Kondru, Rama; Vauquelin, Georges</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3364-3375</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The human CCR5 receptor is a co-receptor for HIV-1 infection and a target for anti-viral therapy.  A greater understanding of the binding kinetics of small mol. allosteric ligand interactions with CCR5 will lead to a better understanding of the binding process and may help discover new mols. that avoid resistance.  Exptl. Approach : Using [3H] maraviroc as a radioligand, a no. of different binding protocols were employed in conjunction with simulations to det. rate consts., kinetic mechanism and mutant kinetic fingerprints for wild-type and mutant human CCR5 with maraviroc, aplaviroc and vicriviroc.  Key Results : Kinetic characterization of maraviroc binding to the wild-type CCR5 was consistent with a two-step kinetic mechanism that involved an initial receptor-ligand complex (RA), which transitioned to a more stable complex, R'A, with at least a 13-fold increase in affinity.  The dissocn. rate from R'A, k-2, was 1.2 × 10-3 min-1.  The maraviroc time-dependent transition was influenced by F85L, W86A, Y108A, I198A and Y251A mutations of CCR5.  Conclusions and Implications : The interaction between maraviroc and CCR5 proceeded according to a multi-step kinetic mechanism, whereby initial mass action binding and later reorganizations of the initial maraviroc-receptor complex lead to a complex with longer residence time.  Site-directed mutagenesis identified a kinetic fingerprint of residues that affected the binding kinetics, leading to the conclusion that allosteric ligand binding to CCR5 involved the rearrangement of the binding site in a manner specific to each allosteric ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ko1PQQH-V7Vg90H21EOLACvtfcHk0lg5aRVQYidkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK&md5=400071d4fb6418a133752ddcd95a0d9c</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fbph.12683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12683%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DBeavis%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DK.%2BT.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DRavendran%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DVauquelin%26aufirst%3DG.%26atitle%3DA%2520study%2520of%2520the%2520molecular%2520mechanism%2520of%2520binding%2520kinetics%2520and%2520long%2520residence%2520times%2520of%2520human%2520CCR5%2520receptor%2520small%2520molecule%2520allosteric%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D14%26spage%3D3364%26epage%3D3375%26doi%3D10.1111%2Fbph.12683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span> (<span class="NLM_issue">6152</span>),  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&issue=6152&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0lha2eTsn3KlJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26issue%3D6152%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 1: Discovery and initial SAR of 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.10.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2004.10.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=25-28&issue=1&author=J.+N.+Burrowsauthor=J.+G.+Cummingauthor=S.+M.+Filleryauthor=G.+A.+Hamlinauthor=J.+A.+Hudsonauthor=R.+J.+Jacksonauthor=S.+McLaughlinauthor=J.+S.+Shaw&title=Modulators+of+the+human+CCR5+receptor.+Part+1%3A+Discovery+and+initial+SAR+of+1-%283%2C3-diphenylpropyl%29-piperidinyl+amides+and+ureas&doi=10.1016%2Fj.bmcl.2004.10.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.10.044%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DFillery%26aufirst%3DS.%2BM.%26aulast%3DHamlin%26aufirst%3DG.%2BA.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DJackson%26aufirst%3DR.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25201%253A%2520Discovery%2520and%2520initial%2520SAR%2520of%25201-%25283%252C3-diphenylpropyl%2529-piperidinyl%2520amides%2520and%2520ureas%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D1%26spage%3D25%26epage%3D28%26doi%3D10.1016%2Fj.bmcl.2004.10.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5012</span>– <span class="NLM_lpage">5015</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2005.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5012-5015&issue=22&author=J.+G.+Cummingauthor=A.+E.+Cooperauthor=K.+Grimeauthor=C.+J.+Loganauthor=S.+McLaughlinauthor=J.+Oldfieldauthor=J.+S.+Shawauthor=H.+Tuckerauthor=J.+Winterauthor=D.+Whittaker&title=Modulators+of+the+human+CCR5+receptor.+Part+2%3A+SAR+of+substituted+1-%283%2C3-diphenylpropyl%29-piperidinyl+phenylacetamides&doi=10.1016%2Fj.bmcl.2005.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DC.%2BJ.%26aulast%3DMcLaughlin%26aufirst%3DS.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DJ.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25202%253A%2520SAR%2520of%2520substituted%25201-%25283%252C3-diphenylpropyl%2529-piperidinyl%2520phenylacetamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D22%26spage%3D5012%26epage%3D5015%26doi%3D10.1016%2Fj.bmcl.2005.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span> <span> </span><span class="NLM_article-title">Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3533</span>– <span class="NLM_lpage">3536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.03.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.03.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3533-3536&issue=13&author=J.+G.+Cummingauthor=S.+J.+Brownauthor=A.+E.+Cooperauthor=A.+W.+Faullauthor=A.+P.+Flynnauthor=K.+Grimeauthor=J.+Oldfieldauthor=J.+S.+Shawauthor=E.+Shepherdauthor=H.+Tuckerauthor=D.+Whittaker&title=Modulators+of+the+human+CCR5+receptor.+Part+3%3A+SAR+of+substituted+1-%5B3-%284-methanesulfonylphenyl%29-3-phenylpropyl%5D-piperidinyl+phenylacetamides&doi=10.1016%2Fj.bmcl.2006.03.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DCooper%26aufirst%3DA.%2BE.%26aulast%3DFaull%26aufirst%3DA.%2BW.%26aulast%3DFlynn%26aufirst%3DA.%2BP.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DOldfield%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DShepherd%26aufirst%3DE.%26aulast%3DTucker%26aufirst%3DH.%26aulast%3DWhittaker%26aufirst%3DD.%26atitle%3DModulators%2520of%2520the%2520human%2520CCR5%2520receptor.%2520Part%25203%253A%2520SAR%2520of%2520substituted%25201-%255B3-%25284-methanesulfonylphenyl%2529-3-phenylpropyl%255D-piperidinyl%2520phenylacetamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D13%26spage%3D3533%26epage%3D3536%26doi%3D10.1016%2Fj.bmcl.2006.03.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finke, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oates, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budhu, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkowitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugherty, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danzeisen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emini, E. A.</span></span> <span> </span><span class="NLM_article-title">Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure–activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00637-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2800%2900637-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=259-264&issue=2&author=C.+P.+Dornauthor=P.+E.+Finkeauthor=B.+Oatesauthor=R.+J.+Budhuauthor=S.+G.+Millsauthor=M.+MacCossauthor=L.+Malkowitzauthor=M.+S.+Springerauthor=B.+L.+Daughertyauthor=S.+L.+Gouldauthor=J.+A.+DeMartinoauthor=S.+J.+Sicilianoauthor=A.+Carellaauthor=G.+Carverauthor=K.+Holmesauthor=R.+Danzeisenauthor=D.+Hazudaauthor=J.+Kesslerauthor=J.+Linebergerauthor=M.+Millerauthor=W.+A.+Schleifauthor=E.+A.+Emini&title=Antagonists+of+the+human+CCR5+receptor+as+anti-HIV-1+agents.+Part+1%3A+Discovery+and+initial+structure%E2%80%93activity+relationships+for+1-amino-2-phenyl-4-%28piperidin-1-yl%29butanes&doi=10.1016%2FS0960-894X%2800%2900637-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900637-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900637-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DOates%26aufirst%3DB.%26aulast%3DBudhu%26aufirst%3DR.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMalkowitz%26aufirst%3DL.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DDaugherty%26aufirst%3DB.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BL.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DSiciliano%26aufirst%3DS.%2BJ.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DCarver%26aufirst%3DG.%26aulast%3DHolmes%26aufirst%3DK.%26aulast%3DDanzeisen%26aufirst%3DR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DKessler%26aufirst%3DJ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DEmini%26aufirst%3DE.%2BA.%26atitle%3DAntagonists%2520of%2520the%2520human%2520CCR5%2520receptor%2520as%2520anti-HIV-1%2520agents.%2520Part%25201%253A%2520Discovery%2520and%2520initial%2520structure%25E2%2580%2593activity%2520relationships%2520for%25201-amino-2-phenyl-4-%2528piperidin-1-yl%2529butanes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26issue%3D2%26spage%3D259%26epage%3D264%26doi%3D10.1016%2FS0960-894X%2800%2900637-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deanda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones-Hertzog, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngman, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6538</span>– <span class="NLM_lpage">6546</span>, <span class="refDoi"> DOI: 10.1021/jm800598a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800598a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6538-6546&issue=20&author=W.+M.+Kazmierskiauthor=C.+Aquinoauthor=B.+A.+Chauderauthor=F.+Deandaauthor=R.+Ferrisauthor=D.+K.+Jones-Hertzogauthor=T.+Kenakinauthor=C.+S.+Kobleauthor=C.+Watsonauthor=P.+Wheelanauthor=H.+Yangauthor=M.+Youngman&title=Discovery+of+bioavailable+4%2C4-disubstituted+piperidines+as+potent+ligands+of+the+chemokine+receptor+5+and+inhibitors+of+the+human+immunodeficiency+virus-1&doi=10.1021%2Fjm800598a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm800598a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800598a%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DAquino%26aufirst%3DC.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DDeanda%26aufirst%3DF.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DJones-Hertzog%26aufirst%3DD.%2BK.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520bioavailable%25204%252C4-disubstituted%2520piperidines%2520as%2520potent%2520ligands%2520of%2520the%2520chemokine%2520receptor%25205%2520and%2520inhibitors%2520of%2520the%2520human%2520immunodeficiency%2520virus-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D20%26spage%3D6538%26epage%3D6546%26doi%3D10.1021%2Fjm800598a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmierski, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koble, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peckham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaltenstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wire, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svolto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngman, M.</span></span> <span> </span><span class="NLM_article-title">Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1021/jm200279v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200279v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3756-3767&issue=11&author=W.+M.+Kazmierskiauthor=D.+L.+Andersonauthor=C.+Aquinoauthor=B.+A.+Chauderauthor=M.+Duanauthor=R.+Ferrisauthor=T.+Kenakinauthor=C.+S.+Kobleauthor=D.+G.+Langauthor=M.+S.+McIntyreauthor=J.+Peckhamauthor=C.+Watsonauthor=P.+Wheelanauthor=A.+Spaltensteinauthor=M.+B.+Wireauthor=A.+Svoltoauthor=M.+Youngman&title=Novel+4%2C4-disubstituted+piperidine-based+C-C+chemokine+receptor-5+inhibitors+with+high+potency+against+human+immunodeficiency+virus-1+and+an+improved+human+ether-a-go-go+related+gene+%28hERG%29+profile&doi=10.1021%2Fjm200279v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm200279v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200279v%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DAquino%26aufirst%3DC.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DFerris%26aufirst%3DR.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DLang%26aufirst%3DD.%2BG.%26aulast%3DMcIntyre%26aufirst%3DM.%2BS.%26aulast%3DPeckham%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DWire%26aufirst%3DM.%2BB.%26aulast%3DSvolto%26aufirst%3DA.%26aulast%3DYoungman%26aufirst%3DM.%26atitle%3DNovel%25204%252C4-disubstituted%2520piperidine-based%2520C-C%2520chemokine%2520receptor-5%2520inhibitors%2520with%2520high%2520potency%2520against%2520human%2520immunodeficiency%2520virus-1%2520and%2520an%2520improved%2520human%2520ether-a-go-go%2520related%2520gene%2520%2528hERG%2529%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D11%26spage%3D3756%26epage%3D3767%26doi%3D10.1021%2Fjm200279v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perzborn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roehrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubitza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misselwitz, F.</span></span> <span> </span><span class="NLM_article-title">The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1038/nrd3185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd3185" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=61-75&issue=1&author=E.+Perzbornauthor=S.+Roehrigauthor=A.+Straubauthor=D.+Kubitzaauthor=F.+Misselwitz&title=The+discovery+and+development+of+rivaroxaban%2C+an+oral%2C+direct+factor+Xa+inhibitor&doi=10.1038%2Fnrd3185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fnrd3185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3185%26sid%3Dliteratum%253Aachs%26aulast%3DPerzborn%26aufirst%3DE.%26aulast%3DRoehrig%26aufirst%3DS.%26aulast%3DStraub%26aufirst%3DA.%26aulast%3DKubitza%26aufirst%3DD.%26aulast%3DMisselwitz%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520rivaroxaban%252C%2520an%2520oral%252C%2520direct%2520factor%2520Xa%2520inhibitor%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D1%26spage%3D61%26epage%3D75%26doi%3D10.1038%2Fnrd3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor</span>. <i>J. Thromb. Thrombolysis</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1007/s11239-011-0551-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2Fs11239-011-0551-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21318583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFSqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=478-492&issue=4&author=P.+C.+Wongauthor=D.+J.+Pintoauthor=D.+Zhang&title=Preclinical+discovery+of+apixaban%2C+a+direct+and+orally+bioavailable+factor+Xa+inhibitor&doi=10.1007%2Fs11239-011-0551-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor</span></div><div class="casAuthors">Wong, Pancras C.; Pinto, Donald J. P.; Zhang, Donglu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">478-492</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Apixaban (BMS-562247; 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide), a direct inhibitor of activated factor X (FXa), is in development for the prevention and treatment of various thromboembolic diseases.  With an inhibitory const. of 0.08 nM for human FXa, apixaban has greater than 30,000-fold selectivity for FXa over other human coagulation proteases.  It produces a rapid onset of inhibition of FXa with assocn. rate const. of 20 μM-1/s approx. and inhibits free as well as prothrombinase- and clot-bound FXa activity in vitro.  Apixaban also inhibits FXa from rabbits, rats and dogs, an activity which parallels its antithrombotic potency in these species.  Although apixaban has no direct effects on platelet aggregation, it indirectly inhibits this process by reducing thrombin generation.  Pre-clin. studies of apixaban in animal models have demonstrated dose-dependent antithrombotic efficacy at doses that preserved hemostasis.  Apixaban improves pre-clin. antithrombotic activity, without excessive increases in bleeding times, when added on top of aspirin or aspirin plus clopidogrel at their clin. relevant doses.  Apixaban has good bioavailability, low clearance and a small vol. of distribution in animals and humans, and a low potential for drug-drug interactions.  Elimination pathways for apixaban include renal excretion, metab. and biliary/intestinal excretion.  Although a sulfate conjugate of O-demethyl apixaban (O-demethyl apixaban sulfate) has been identified as the major circulating metabolite of apixaban in humans, it is inactive against human FXa.  Together, these non-clin. findings have established the favorable pharmacol. profile of apixaban, and support the potential use of apixaban in the clinic for the prevention and treatment of various thromboembolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosf70y5okLwbVg90H21EOLACvtfcHk0lh-iO6a-2L0ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFSqtb4%253D&md5=97a2b3fa9a43f0eda48f19ba6e015d84</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs11239-011-0551-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11239-011-0551-3%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DPreclinical%2520discovery%2520of%2520apixaban%252C%2520a%2520direct%2520and%2520orally%2520bioavailable%2520factor%2520Xa%2520inhibitor%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2011%26volume%3D31%26issue%3D4%26spage%3D478%26epage%3D492%26doi%3D10.1007%2Fs11239-011-0551-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, R. A.</span></span> <span> </span><span class="NLM_article-title">Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease</span>. <i>Thromb. Haemostasis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1182</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1160/TH04-05-0289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1160%2FTH04-05-0289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=15583722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptFOrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=1182-1193&issue=6&author=R.+C.+Beckerauthor=J.+Alexanderauthor=C.+K.+Dykeauthor=R.+A.+Harrington&title=Development+of+DX-9065a%2C+a+novel+direct+factor+Xa+antagonist%2C+in+cardiovascular+disease&doi=10.1160%2FTH04-05-0289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease</span></div><div class="casAuthors">Becker, Richard C.; Alexander, John; Dyke, Christopher K.; Harrington, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1182-1193</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  The development of anticoagulants for treating patients with atherothrombotic disorders of the arterial circulatory system has focused, either directly or indirectly, on thrombin - a pleuripotential effector enzyme with prothrombotic and proinflammatory properties.  The pivotal role of factor (f) Xa in thrombin generation, coupled with its direct cellular effects and widely recognized limitations of currently available anticoagulants, has led to the development of pharmacol. inhibitors of this important protease.  The following review focuses on DX-9065a - first in a class of direct, selective and reversible fXa antagonists - and its potential applications in the management of patients with cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpepKXfPUOGTbVg90H21EOLACvtfcHk0lja_b963oBqzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptFOrtg%253D%253D&md5=7a3651eac9cc89c33c1b4d42df5bb682</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1160%2FTH04-05-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH04-05-0289%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DAlexander%26aufirst%3DJ.%26aulast%3DDyke%26aufirst%3DC.%2BK.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26atitle%3DDevelopment%2520of%2520DX-9065a%252C%2520a%2520novel%2520direct%2520factor%2520Xa%2520antagonist%252C%2520in%2520cardiovascular%2520disease%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D92%26issue%3D6%26spage%3D1182%26epage%3D1193%26doi%3D10.1160%2FTH04-05-0289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfsten, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clizbe, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchaleelaha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambing, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarborough, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenz amide, a highly potent, selective, and orally efficacious factor Xa inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2179</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.02.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2179-2185&issue=8&author=P.+Zhangauthor=W.+Huangauthor=L.+Wangauthor=L.+Baoauthor=Z.+J.+Jiaauthor=S.+M.+Bauerauthor=E.+A.+Goldmanauthor=G.+D.+Probstauthor=Y.+Songauthor=T.+Suauthor=J.+Fanauthor=Y.+Wuauthor=W.+Liauthor=J.+Woolfreyauthor=U.+Sinhaauthor=P.+W.+Wongauthor=S.+T.+Edwardsauthor=A.+E.+Arfstenauthor=L.+A.+Clizbeauthor=J.+Kanterauthor=A.+Pandeyauthor=G.+Parkauthor=A.+Hutchaleelahaauthor=J.+L.+Lambingauthor=S.+J.+Hollenbachauthor=R.+M.+Scarboroughauthor=B.+Y.+Zhu&title=Discovery+of+betrixaban+%28PRT054021%29%2C+N-%285-chloropyridin-2-yl%29-2-%284-%28N%2CN-dimethylcarbamimidoyl%29benzamido%29-5-methoxybenz+amide%2C+a+highly+potent%2C+selective%2C+and+orally+efficacious+factor+Xa+inhibitor&doi=10.1016%2Fj.bmcl.2009.02.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DGoldman%26aufirst%3DE.%2BA.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWoolfrey%26aufirst%3DJ.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DWong%26aufirst%3DP.%2BW.%26aulast%3DEdwards%26aufirst%3DS.%2BT.%26aulast%3DArfsten%26aufirst%3DA.%2BE.%26aulast%3DClizbe%26aufirst%3DL.%2BA.%26aulast%3DKanter%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DHutchaleelaha%26aufirst%3DA.%26aulast%3DLambing%26aufirst%3DJ.%2BL.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DDiscovery%2520of%2520betrixaban%2520%2528PRT054021%2529%252C%2520N-%25285-chloropyridin-2-yl%2529-2-%25284-%2528N%252CN-dimethylcarbamimidoyl%2529benzamido%2529-5-methoxybenz%2520amide%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520factor%2520Xa%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D2179%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2009.02.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfon amides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1021/jm060870c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060870c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1546-1557&issue=7&author=C.+Chanauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=L.+Chaudryauthor=C.+W.+Chungauthor=M.+A.+Converyauthor=J.+N.+Hamblinauthor=L.+Johnstoneauthor=H.+A.+Kellyauthor=S.+Kleanthousauthor=A.+Patikisauthor=C.+Patelauthor=A.+J.+Patemanauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Westonauthor=C.+Whitworthauthor=R.+J.+Youngauthor=P.+Zhou&title=Factor+Xa+inhibitors%3A+S1+binding+interactions+of+a+series+of+N-%7B%283S%29-1-%5B%281S%29-1-methyl-2-morpholin-4-yl-2-oxoethyl%5D-2-oxopyrrolidin-3-yl%7Dsulfon+amides&doi=10.1021%2Fjm060870c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm060870c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060870c%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DJohnstone%26aufirst%3DL.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DPatikis%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DFactor%2520Xa%2520inhibitors%253A%2520S1%2520binding%2520interactions%2520of%2520a%2520series%2520of%2520N-%257B%25283S%2529-1-%255B%25281S%2529-1-methyl-2-morpholin-4-yl-2-oxoethyl%255D-2-oxopyrrolidin-3-yl%257Dsulfon%2520amides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D7%26spage%3D1546%26epage%3D1557%26doi%3D10.1021%2Fjm060870c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exall, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLay, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethke, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1588</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1588-1592&issue=6&author=N.+S.+Watsonauthor=C.+Adamsauthor=D.+Beltonauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=L.+Chaudryauthor=C.+Chanauthor=M.+A.+Converyauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=J.+D.+Harlingauthor=S.+Irvineauthor=W.+R.+Irvingauthor=S.+Kleanthousauthor=I.+M.+McLayauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=T.+J.+Roethkeauthor=S.+Sengerauthor=G.+J.+Stelmanauthor=J.+R.+Toomeyauthor=R.+I.+Westauthor=C.+Whittakerauthor=P.+Zhouauthor=R.+J.+Young&title=The+discovery+of+potent+and+long-acting+oral+factor+Xa+inhibitors+with+tetrahydroisoquinoline+and+benzazepine+P4+motifs&doi=10.1016%2Fj.bmcl.2011.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DBelton%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DIrvine%26aufirst%3DS.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMcLay%26aufirst%3DI.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DStelman%26aufirst%3DG.%2BJ.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWest%26aufirst%3DR.%2BI.%26aulast%3DWhittaker%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520potent%2520and%2520long-acting%2520oral%2520factor%2520Xa%2520inhibitors%2520with%2520tetrahydroisoquinoline%2520and%2520benzazepine%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D1588%26epage%3D1592%26doi%3D10.1016%2Fj.bmcl.2011.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbaut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul King, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18054228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Sqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=23-27&issue=1&author=R.+J.+Youngauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=C.+Chanauthor=M.+Charbautauthor=C.+W.+Chungauthor=M.+A.+Converyauthor=H.+A.+Kellyauthor=N.+Paul+Kingauthor=S.+Kleanthousauthor=A.+M.+Masonauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Weston&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+pyrrolidin-2-ones+with+biaryl+P4+motifs&doi=10.1016%2Fj.bmcl.2007.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs</span></div><div class="casAuthors">Young, Robert J.; Borthwick, Alan D.; Brown, David; Burns-Kurtis, Cynthia L.; Campbell, Matthew; Chan, Chuen; Charbaut, Marie; Chung, Chun-wa; Convery, Maire A.; Kelly, Henry A.; King, N. Paul; Kleanthous, Savvas; Mason, Andrew M.; Pateman, Anthony J.; Patikis, Angela N.; Pinto, Ivan L.; Pollard, Derek R.; Senger, Stefan; Shah, Gita P.; Toomey, John R.; Watson, Nigel S.; Weston, Helen E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors.  By incorporating biaryl P4 groups, a series of highly potent inhibitors, e.g., I, was obtained with encouraging oral pharmacokinetic profiles and significant but sub-optimal anticoagulant activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodg91ZXDFpYrVg90H21EOLACvtfcHk0lh5IZIVCPMFww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Sqtg%253D%253D&md5=a5f6a28d12df20bca8578f42d374fc80</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharbaut%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DPaul%2BKing%26aufirst%3DN.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520pyrrolidin-2-ones%2520with%2520biaryl%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D23%26epage%3D27%26doi%3D10.1016%2Fj.bmcl.2007.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbaut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diallo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortense, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.11.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=28-33&issue=1&author=R.+J.+Youngauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=C.+Chanauthor=M.+Charbautauthor=M.+A.+Converyauthor=H.+Dialloauthor=E.+Hortenseauthor=W.+R.+Irvingauthor=H.+A.+Kellyauthor=N.+P.+Kingauthor=S.+Kleanthousauthor=A.+M.+Masonauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=S.+Sengerauthor=G.+P.+Shahauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=H.+E.+Westonauthor=P.+Zhou&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+biaryl+pyrrolidin-2-ones+incorporating+basic+heterocyclic+motifs&doi=10.1016%2Fj.bmcl.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DCharbaut%26aufirst%3DM.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DHortense%26aufirst%3DE.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520biaryl%2520pyrrolidin-2-ones%2520incorporating%2520basic%2520heterocyclic%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D28%26epage%3D33%26doi%3D10.1016%2Fj.bmcl.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleanthous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns-Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarte, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hortense, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pateman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patikis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethka, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toomey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.11.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=618-622&issue=2&author=S.+Kleanthousauthor=A.+D.+Borthwickauthor=D.+Brownauthor=C.+L.+Burns-Kurtisauthor=M.+Campbellauthor=L.+Chaudryauthor=C.+Chanauthor=M.+O.+Clarteauthor=M.+A.+Converyauthor=J.+D.+Harlingauthor=E.+Hortenseauthor=W.+R.+Irvingauthor=S.+Irvineauthor=A.+J.+Patemanauthor=A.+N.+Patikisauthor=I.+L.+Pintoauthor=D.+R.+Pollardauthor=T.+J.+Roethkaauthor=S.+Sengerauthor=G.+P.+Shahauthor=G.+J.+Stelmanauthor=J.+R.+Toomeyauthor=N.+S.+Watsonauthor=R.+I.+Westauthor=C.+Whittakerauthor=P.+Zhouauthor=R.+J.+Young&title=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+pyrrolidin-2-ones+with+monoaryl+P4+motifs&doi=10.1016%2Fj.bmcl.2009.11.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.077%26sid%3Dliteratum%253Aachs%26aulast%3DKleanthous%26aufirst%3DS.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBurns-Kurtis%26aufirst%3DC.%2BL.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DClarte%26aufirst%3DM.%2BO.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DHortense%26aufirst%3DE.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DIrvine%26aufirst%3DS.%26aulast%3DPateman%26aufirst%3DA.%2BJ.%26aulast%3DPatikis%26aufirst%3DA.%2BN.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DPollard%26aufirst%3DD.%2BR.%26aulast%3DRoethka%26aufirst%3DT.%2BJ.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DStelman%26aufirst%3DG.%2BJ.%26aulast%3DToomey%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DWest%26aufirst%3DR.%2BI.%26aulast%3DWhittaker%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DStructure%2520and%2520property%2520based%2520design%2520of%2520factor%2520Xa%2520inhibitors%253A%2520pyrrolidin-2-ones%2520with%2520monoaryl%2520P4%2520motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D618%26epage%3D622%26doi%3D10.1016%2Fj.bmcl.2009.11.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtis, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchee, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3784</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.04.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3784-3788&issue=14&author=N.+S.+Watsonauthor=D.+Brownauthor=M.+Campbellauthor=C.+Chanauthor=L.+Chaudryauthor=M.+A.+Converyauthor=R.+Fenwickauthor=J.+N.+Hamblinauthor=C.+Haslamauthor=H.+A.+Kellyauthor=N.+P.+Kingauthor=C.+L.+Kurtisauthor=A.+R.+Leachauthor=G.+R.+Mancheeauthor=A.+M.+Masonauthor=C.+Mitchellauthor=C.+Patelauthor=V.+K.+Patelauthor=S.+Sengerauthor=G.+P.+Shahauthor=H.+E.+Westonauthor=C.+Whitworthauthor=R.+J.+Young&title=Design+and+synthesis+of+orally+active+pyrrolidin-2-one-based+factor+Xa+inhibitors&doi=10.1016%2Fj.bmcl.2006.04.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.053%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DN.%2BS.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DChaudry%26aufirst%3DL.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DFenwick%26aufirst%3DR.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DHaslam%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DH.%2BA.%26aulast%3DKing%26aufirst%3DN.%2BP.%26aulast%3DKurtis%26aufirst%3DC.%2BL.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DManchee%26aufirst%3DG.%2BR.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DMitchell%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DG.%2BP.%26aulast%3DWeston%26aufirst%3DH.%2BE.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520orally%2520active%2520pyrrolidin-2-one-based%2520factor%2520Xa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D14%26spage%3D3784%26epage%3D3788%26doi%3D10.1016%2Fj.bmcl.2006.04.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Palmer, M. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of the long-acting PDE5 inhibitor PF-489791 for the treatment of pulmonary hypertension</span>. In  <i>Accounts in Drug Discovery: Case Studies in Medicinal Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span>, <span class="NLM_string-name">Carter, P.</span>, <span class="NLM_string-name">Cheng, P.</span>, <span class="NLM_string-name">Zahler, R.</span></span>, Eds.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>, <span class="NLM_year">2010</span>; Chapter 8, pp  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">182</span>, DOI: <span class="refDoi"> DOI: 10.1039/9781849731980-00166</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2F9781849731980-00166" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=166-182&author=A.+S.+Bell&author=M.+J.+Palmerauthor=J.+Barrish&author=P.+Carter&author=P.+Cheng&author=R.+Zahler&title=Accounts+in+Drug+Discovery%3A+Case+Studies+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2F9781849731980-00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731980-00166%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DThe%2520discovery%2520of%2520the%2520long-acting%2520PDE5%2520inhibitor%2520PF-489791%2520for%2520the%2520treatment%2520of%2520pulmonary%2520hypertension%26btitle%3DAccounts%2520in%2520Drug%2520Discovery%253A%2520Case%2520Studies%2520in%2520Medicinal%2520Chemistry%26aulast%3DBarrish%26aufirst%3DJ.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2010%26spage%3D166%26epage%3D182%26doi%3D10.1039%2F9781849731980-00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span> <span> </span><span class="NLM_article-title">Design of second generation phosphodiesterase 5 inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.2174/156802607779941288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F156802607779941288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17305582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=405-419&issue=4&author=M.+Palmerauthor=A.+Bellauthor=D.+Foxauthor=D.+Brown&title=Design+of+second+generation+phosphodiesterase+5+inhibitors&doi=10.2174%2F156802607779941288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Design of second generation phosphodiesterase 5 inhibitors</span></div><div class="casAuthors">Palmer, Michael J.; Bell, Andrew S.; Fox, David N. A.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The clin. significance of phosphodiesterase 5 (PDE5) inhibition is increasingly understood following the pioneering work with sildenafil, and the continuing development programs for both sildenafil and other marketed inhibitors.  Since the initial launch of sildenafil for male erectile dysfunction (MED), approval has now been granted for treatment of pulmonary hypertension, while ongoing studies have indicated the potential of PDE5 inhibition for the treatment of a range of addnl. indications including cardioprotection, memory retention and diabetes.  Many of these addnl. indications are best suited to chronic oral dosing and emphasize the need for highly selective inhibitors with extended duration of action.  This article will focus on a research program aimed at the discovery of improved second-generation PDE5 inhibitors.  Essential features of these new PDE5 inhibitors would be enhanced selectivity across the whole PDE family and pharmacokinetics compatible with once daily dosing.  Key elements used in this program are high throughput screening (HTS), exploitation of co-crystal structural information for bound inhibitor in the PDE5 active site, and employment of parallel chem. to speed progress.  Under the guidance of co-crystal structural information, a non-selective HTS hit with poor physicochem. was initially modified using parallel chem. to give a lead compd. (3) that established a new PDE5 inhibitor series.  Notably, (3) displayed physicochem. compatible with a long plasma half-life, and wide chem. scope.  Subsequent optimization of (3) using crystal structure information to guide design, led rapidly to highly potent and selective PDE5 inhibitors (47, 50).  Continued focus on phys. properties through ligand efficiency evaluation and lipophilicity (cLogP), maintained the inherently desirable physicochem. of the initial lead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodkBVE07EUs7Vg90H21EOLACvtfcHk0licdgJNzuSKlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gs70%253D&md5=89706f83e903a5c98ea5309857540253</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2174%2F156802607779941288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607779941288%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26atitle%3DDesign%2520of%2520second%2520generation%2520phosphodiesterase%25205%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D405%26epage%3D419%26doi%3D10.2174%2F156802607779941288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P.</span></span> <span> </span><span class="NLM_article-title">Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1819</span>– <span class="NLM_lpage">1824</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(96)00323-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2F0960-894X%2896%2900323-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1819-1824&issue=15&author=N.+K.+Terrettauthor=A.+S.+Bellauthor=D.+Brownauthor=P.+Ellis&title=Sildenafil+%28VIAGRATM%29%2C+a+potent+and+selective+inhibitor+of+type+5+cGMP+phosphodiesterase+with+utility+for+the+treatment+of+male+erectile+dysfunction&doi=10.1016%2F0960-894X%2896%2900323-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2896%2900323-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252896%252900323-X%26sid%3Dliteratum%253Aachs%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DP.%26atitle%3DSildenafil%2520%2528VIAGRATM%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520type%25205%2520cGMP%2520phosphodiesterase%2520with%2520utility%2520for%2520the%2520treatment%2520of%2520male%2520erectile%2520dysfunction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26issue%3D15%26spage%3D1819%26epage%3D1824%26doi%3D10.1016%2F0960-894X%2896%2900323-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haning, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewöhner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Es-Sayed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lampe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, E.</span></span> <span> </span><span class="NLM_article-title">Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00030-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2802%2900030-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=865-868&issue=6&author=H.+Haningauthor=U.+Niew%C3%B6hnerauthor=T.+Schenkeauthor=M.+Es-Sayedauthor=G.+Schmidtauthor=T.+Lampeauthor=E.+Bischoff&title=Imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4%283H%29-ones%2C+a+new+class+of+potent+PDE+5+inhibitors&doi=10.1016%2FS0960-894X%2802%2900030-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900030-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900030-6%26sid%3Dliteratum%253Aachs%26aulast%3DHaning%26aufirst%3DH.%26aulast%3DNiew%25C3%25B6hner%26aufirst%3DU.%26aulast%3DSchenke%26aufirst%3DT.%26aulast%3DEs-Sayed%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DLampe%26aufirst%3DT.%26aulast%3DBischoff%26aufirst%3DE.%26atitle%3DImidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4%25283H%2529-ones%252C%2520a%2520new%2520class%2520of%2520potent%2520PDE%25205%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D6%26spage%3D865%26epage%3D868%26doi%3D10.1016%2FS0960-894X%2802%2900030-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier
de Gouville, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudiniere, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1:5,6,11,11a-tetrahydro-1H-imidazo[1′,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1021/jm030056e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030056e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4525-4532&issue=21&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.+C.+Le+Monnier%0Ade+Gouvilleauthor=H.+Costeauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudiniere&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+1%3A5%2C6%2C11%2C11a-tetrahydro-1H-imidazo%5B1%E2%80%B2%2C5%E2%80%B2%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C3%282H%29-dione+analogues&doi=10.1021%2Fjm030056e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm030056e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030056e%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudiniere%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25201%253A5%252C6%252C11%252C11a-tetrahydro-1H-imidazo%255B1%25E2%2580%25B2%252C5%25E2%2580%25B2%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C3%25282H%2529-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D21%26spage%3D4525%26epage%3D4532%26doi%3D10.1021%2Fjm030056e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span>; <span class="NLM_string-name">Cárdenas, E. L.</span>; <span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">The design, development, and evaluation of BACE1 inhibitors for the treatment of Alzheimer’s disease</span>. In  <i>Alzheimer’s Disease II</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, M. S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, DOI: <span class="refDoi"> DOI: 10.1007/7355_2016_16</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1007%2F7355_2016_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=27-85&author=A.+K.+Ghosh&author=E.+L.+C%C3%A1rdenas&author=H.+L.+Osswaldauthor=M.+S.+Wolfe&title=Alzheimer%E2%80%99s+Disease+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1007%2F7355_2016_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2016_16%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26atitle%3DThe%2520design%252C%2520development%252C%2520and%2520evaluation%2520of%2520BACE1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520II%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2016%26spage%3D27%26epage%3D85%26doi%3D10.1007%2F7355_2016_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&issue=9&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">BACE-1 Inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=619-637&author=F.+Pratiauthor=G.+Bottegoniauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=BACE-1+Inhibitors%3A+from+recent+single-target+molecules+to+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; Bottegoni, Giovanni; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer's disease (AD), leading to many small-mol. and biol. drug candidates.  One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors.  The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment.  It also suggests new possibilities for discovering BACE-1-targeted compds. with more complex mechanisms of actions and improved efficacy.  Herein, the authors review the major advances in BACE-1 drug discovery, from single-target small mol. inhibitors to multitarget compds.  The authors discuss these compds. as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIKti01PzWrVg90H21EOLACvtfcHk0liJTVY5ETgBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO&md5=a30fe7a54f34206355c6380eb9eacbe4</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DBACE-1%2520Inhibitors%253A%2520from%2520recent%2520single-target%2520molecules%2520to%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D619%26epage%3D637%26doi%3D10.1021%2Facs.jmedchem.7b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deinum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel warhead against beta-secretase through fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5903</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1021/jm070825k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&issue=24&author=S.+Geschwindnerauthor=L.+L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+Folmer&title=Discovery+of+a+novel+warhead+against+beta-secretase+through+fragment-based+lead+generation&doi=10.1021%2Fjm070825k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520beta-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D5903%26epage%3D5911%26doi%3D10.1021%2Fjm070825k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustavsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radesater, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploeger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falting, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">49</span>),  <span class="NLM_fpage">41245</span>– <span class="NLM_lpage">41257</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&issue=49&author=F.+Jeppssonauthor=S.+Eketjallauthor=J.+Jansonauthor=S.+Karlstromauthor=S.+Gustavssonauthor=L.+L.+Olssonauthor=A.+C.+Radesaterauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.+M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+Falting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+Alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketjall%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstrom%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DFalting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D49%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aharony, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koether, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumrine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spear, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span> <span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">5912</span>– <span class="NLM_lpage">5925</span>, <span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&issue=24&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+beta-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520beta-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D24%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-a beta-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&issue=23&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-a+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-a%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2449</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&issue=7&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor&doi=10.1016%2Fj.bmcl.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lhCkRZ0tozARg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D2444%26epage%3D2449%26doi%3D10.1016%2Fj.bmcl.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Abeta reduction</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&issue=11&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">BACE inhibitor bust in Alzheimer trial</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">155</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.43" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=155&issue=3&author=A.+Mullard&title=BACE+inhibitor+bust+in+Alzheimer+trial&doi=10.1038%2Fnrd.2017.43"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.43%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DBACE%2520inhibitor%2520bust%2520in%2520Alzheimer%2520trial%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D3%26spage%3D155%26doi%3D10.1038%2Fnrd.2017.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Structurally diverse mitochondrial branched chain aminotransferase (BCATm) leads with varying binding modes identified by fragment screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2452</span>– <span class="NLM_lpage">2467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01607</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01607" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2452-2467&issue=6&author=J.+A.+Borthwickauthor=N.+Ancellinauthor=S.+M.+Bertrandauthor=R.+P.+Binghamauthor=P.+S.+Carterauthor=C.+W.+Chungauthor=I.+Churcherauthor=N.+Dodicauthor=C.+Fournierauthor=P.+L.+Francisauthor=A.+Hobbsauthor=C.+Jamiesonauthor=S.+D.+Pickettauthor=S.+E.+Smithauthor=D.+O.+Somersauthor=C.+Spitzfadenauthor=C.+J.+Sucklingauthor=R.+J.+Young&title=Structurally+diverse+mitochondrial+branched+chain+aminotransferase+%28BCATm%29+leads+with+varying+binding+modes+identified+by+fragment+screening&doi=10.1021%2Facs.jmedchem.5b01607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01607%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DJ.%2BA.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DS.%2BM.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DStructurally%2520diverse%2520mitochondrial%2520branched%2520chain%2520aminotransferase%2520%2528BCATm%2529%2520leads%2520with%2520varying%2520binding%2520modes%2520identified%2520by%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2452%26epage%3D2467%26doi%3D10.1021%2Facs.jmedchem.5b01607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borthwick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gummer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitzfaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of in vivo active mitochondrial branched-chain aminotransferase (BCATm) inhibitors by hybridizing fragment and HTS hits</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7140</span>– <span class="NLM_lpage">7163</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7140-7163&issue=18&author=S.+M.+Bertrandauthor=N.+Ancellinauthor=B.+Beaufilsauthor=R.+P.+Binghamauthor=J.+A.+Borthwickauthor=A.+B.+Boullayauthor=E.+Boursierauthor=P.+S.+Carterauthor=C.+W.+Chungauthor=I.+Churcherauthor=N.+Dodicauthor=M.+H.+Fouchetauthor=C.+Fournierauthor=P.+L.+Francisauthor=L.+A.+Gummerauthor=K.+Herryauthor=A.+Hobbsauthor=C.+I.+Hobbsauthor=P.+Homesauthor=C.+Jamiesonauthor=E.+Nicodemeauthor=S.+D.+Pickettauthor=I.+H.+Reidauthor=G.+L.+Simpsonauthor=L.+A.+Sloanauthor=S.+E.+Smithauthor=D.+O.+Somersauthor=C.+Spitzfadenauthor=C.+J.+Sucklingauthor=K.+Valkoauthor=Y.+Washioauthor=R.+J.+Young&title=The+discovery+of+in+vivo+active+mitochondrial+branched-chain+aminotransferase+%28BCATm%29+inhibitors+by+hybridizing+fragment+and+HTS+hits&doi=10.1021%2Facs.jmedchem.5b00313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00313%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DS.%2BM.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBeaufils%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DBorthwick%26aufirst%3DJ.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DFrancis%26aufirst%3DP.%2BL.%26aulast%3DGummer%26aufirst%3DL.%2BA.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DReid%26aufirst%3DI.%2BH.%26aulast%3DSimpson%26aufirst%3DG.%2BL.%26aulast%3DSloan%26aufirst%3DL.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DSpitzfaden%26aufirst%3DC.%26aulast%3DSuckling%26aufirst%3DC.%2BJ.%26aulast%3DValko%26aufirst%3DK.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520in%2520vivo%2520active%2520mitochondrial%2520branched-chain%2520aminotransferase%2520%2528BCATm%2529%2520inhibitors%2520by%2520hybridizing%2520fragment%2520and%2520HTS%2520hits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7140%26epage%3D7163%26doi%3D10.1021%2Facs.jmedchem.5b00313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundersingh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothier
Kaushansky, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Discovery, SAR, and X-ray binding mode study of BCATm inhibitors from a novel DNA-encoded library</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=919-924&issue=8&author=H.+Dengauthor=J.+Zhouauthor=F.+S.+Sundersinghauthor=J.+Summerfieldauthor=D.+Somersauthor=J.+A.+Messerauthor=A.+L.+Satzauthor=N.+Ancellinauthor=C.+C.+Arico-Muendelauthor=K.+L.+Sargent+Bedardauthor=A.+Beljeanauthor=S.+L.+Belyanskayaauthor=R.+Binghamauthor=S.+E.+Smithauthor=E.+Boursierauthor=P.+Carterauthor=P.+A.+Centrellaauthor=M.+A.+Clarkauthor=C.+W.+Chungauthor=C.+P.+Davieauthor=J.+L.+Deloreyauthor=Y.+Dingauthor=G.+J.+Franklinauthor=L.+C.+Gradyauthor=K.+Herryauthor=C.+Hobbsauthor=C.+S.+Kollmannauthor=B.+A.+Morganauthor=L.+J.+Pothier%0AKaushanskyauthor=Q.+Zhou&title=Discovery%2C+SAR%2C+and+X-ray+binding+mode+study+of+BCATm+inhibitors+from+a+novel+DNA-encoded+library&doi=10.1021%2Facsmedchemlett.5b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, SAR, and X-ray Binding Mode Study of BCATm Inhibitors from a Novel DNA-Encoded Library</span></div><div class="casAuthors">Deng, Hongfeng; Zhou, Jingye; Sundersingh, Flora S.; Summerfield, Jennifer; Somers, Don; Messer, Jeffrey A.; Satz, Alexander L.; Ancellin, Nicolas; Arico-Muendel, Christopher C.; Bedard, Katie L.; Beljean, Arthur; Belyanskaya, Svetlana L.; Bingham, Ryan; Smith, Sarah E.; Boursier, Eric; Carter, Paul; Centrella, Paolo A.; Clark, Matthew A.; Chung, Chun-wa; Davie, Christopher P.; Delorey, Jennifer L.; Ding, Yun; Franklin, G. Joseph; Grady, LaShadric C.; Herry, Kenny; Hobbs, Clare; Kollmann, Christopher S.; Morgan, Barry A.; Kaushansky, Laura J.; Zhou, Quan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">919-924</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a potential target for obesity, human BCATm was screened against more than 14 billion DNA encoded compds. of distinct scaffolds followed by off-DNA synthesis and activity confirmation.  As a consequence, several series of BCATm inhibitors were discovered.  One representative compd. I from a novel compd. library synthesized via on-DNA Suzuki-Miyaura cross-coupling showed BCATm inhibitory activity with IC50 = 2.0 μM.  A protein crystal structure of I revealed that it binds to BCATm within the catalytic site adjacent to the PLP cofactor.  The identification of this novel inhibitor series plus the establishment of a BCATm protein structure provided a good starting point for future structure-based discovery of BCATm inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxzUuENOvoCrVg90H21EOLACvtfcHk0ljtUqbbZ42-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77L&md5=85fb50b6ee9c5b4ed3d1afd0bc9face6</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00179%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DSundersingh%26aufirst%3DF.%2BS.%26aulast%3DSummerfield%26aufirst%3DJ.%26aulast%3DSomers%26aufirst%3DD.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DSargent%2BBedard%26aufirst%3DK.%2BL.%26aulast%3DBeljean%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBingham%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DDelorey%26aufirst%3DJ.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DKollmann%26aufirst%3DC.%2BS.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DPothier%2BKaushansky%26aufirst%3DL.%2BJ.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DDiscovery%252C%2520SAR%252C%2520and%2520X-ray%2520binding%2520mode%2520study%2520of%2520BCATm%2520inhibitors%2520from%2520a%2520novel%2520DNA-encoded%2520library%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D8%26spage%3D919%26epage%3D924%26doi%3D10.1021%2Facsmedchemlett.5b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundersingh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beljean, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boursier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of potent, selective, and in vivo efficacious 2-aryl benzimidazole BCATm inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=379-384&issue=4&author=H.+Dengauthor=J.+Zhouauthor=F.+Sundersinghauthor=J.+A.+Messerauthor=D.+O.+Somersauthor=M.+Ajakaneauthor=C.+C.+Arico-Muendelauthor=A.+Beljeanauthor=S.+L.+Belyanskayaauthor=R.+Binghamauthor=E.+Blazenskyauthor=A.+B.+Boullayauthor=E.+Boursierauthor=J.+Chaiauthor=P.+Carterauthor=C.+W.+Chungauthor=A.+Dauganauthor=Y.+Dingauthor=K.+Herryauthor=C.+Hobbsauthor=E.+Humphriesauthor=C.+Kollmannauthor=V.+L.+Nguyenauthor=E.+Nicodemeauthor=S.+E.+Smithauthor=N.+Dodicauthor=N.+Ancellin&title=Discovery+and+optimization+of+potent%2C+selective%2C+and+in+vivo+efficacious+2-aryl+benzimidazole+BCATm+inhibitors&doi=10.1021%2Facsmedchemlett.5b00389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00389%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DSundersingh%26aufirst%3DF.%26aulast%3DMesser%26aufirst%3DJ.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DBeljean%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DBingham%26aufirst%3DR.%26aulast%3DBlazensky%26aufirst%3DE.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHerry%26aufirst%3DK.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DHumphries%26aufirst%3DE.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDodic%26aufirst%3DN.%26aulast%3DAncellin%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%252C%2520selective%252C%2520and%2520in%2520vivo%2520efficacious%25202-aryl%2520benzimidazole%2520BCATm%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D379%26epage%3D384%26doi%3D10.1021%2Facsmedchemlett.5b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almassy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvert, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostomsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span> <span> </span><span class="NLM_article-title">Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4084</span>– <span class="NLM_lpage">4097</span>, <span class="refDoi"> DOI: 10.1021/jm000950v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000950v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4084-4097&issue=22&author=A.+W.+Whiteauthor=R.+Almassyauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=R.+J.+Griffinauthor=Z.+Hostomskyauthor=K.+Maegleyauthor=D.+R.+Newellauthor=S.+Srinivasanauthor=B.+T.+Golding&title=Resistance-modifying+agents.+9.+Synthesis+and+biological+properties+of+benzimidazole+inhibitors+of+the+DNA+repair+enzyme+poly%28ADP-ribose%29+polymerase&doi=10.1021%2Fjm000950v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm000950v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000950v%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BW.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DResistance-modifying%2520agents.%25209.%2520Synthesis%2520and%2520biological%2520properties%2520of%2520benzimidazole%2520inhibitors%2520of%2520the%2520DNA%2520repair%2520enzyme%2520poly%2528ADP-ribose%2529%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D22%26spage%3D4084%26epage%3D4097%26doi%3D10.1021%2Fjm000950v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menear, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockcroft, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copsey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cranston, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drzewiecki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaid, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrigan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knights, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, V. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N. M.</span></span> <span> </span><span class="NLM_article-title">4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin- 1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6581</span>– <span class="NLM_lpage">6591</span>, <span class="refDoi"> DOI: 10.1021/jm8001263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6581-6591&issue=20&author=K.+A.+Menearauthor=C.+Adcockauthor=R.+Boulterauthor=X.+L.+Cockcroftauthor=L.+Copseyauthor=A.+Cranstonauthor=K.+J.+Dillonauthor=J.+Drzewieckiauthor=S.+Garmanauthor=S.+Gomezauthor=H.+Javaidauthor=F.+Kerriganauthor=C.+Knightsauthor=A.+Lauauthor=V.+M.+Lohauthor=I.+T.+Matthewsauthor=S.+Mooreauthor=M.+J.+O%E2%80%99Connorauthor=G.+C.+Smithauthor=N.+M.+Martin&title=4-%5B3-%284-Cyclopropanecarbonylpiperazine-1-carbonyl%29-4-fluorobenzyl%5D-2H-phthalazin-+1-one%3A+a+novel+bioavailable+inhibitor+of+poly%28ADP-ribose%29+polymerase-1&doi=10.1021%2Fjm8001263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm8001263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001263%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DAdcock%26aufirst%3DC.%26aulast%3DBoulter%26aufirst%3DR.%26aulast%3DCockcroft%26aufirst%3DX.%2BL.%26aulast%3DCopsey%26aufirst%3DL.%26aulast%3DCranston%26aufirst%3DA.%26aulast%3DDillon%26aufirst%3DK.%2BJ.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DGarman%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DJavaid%26aufirst%3DH.%26aulast%3DKerrigan%26aufirst%3DF.%26aulast%3DKnights%26aufirst%3DC.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DLoh%26aufirst%3DV.%2BM.%26aulast%3DMatthews%26aufirst%3DI.%2BT.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DMartin%26aufirst%3DN.%2BM.%26atitle%3D4-%255B3-%25284-Cyclopropanecarbonylpiperazine-1-carbonyl%2529-4-fluorobenzyl%255D-2H-phthalazin-%25201-one%253A%2520a%2520novel%2520bioavailable%2520inhibitor%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D20%26spage%3D6581%26epage%3D6591%26doi%3D10.1021%2Fjm8001263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostomsky, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalitzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1158%2F1535-7163.MCT-06-0552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=17363489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=945-956&issue=3&author=H.+D.+Thomasauthor=C.+R.+Calabreseauthor=M.+A.+Bateyauthor=S.+Cananauthor=Z.+Hostomskyauthor=S.+Kyleauthor=K.+A.+Maegleyauthor=D.+R.+Newellauthor=D.+Skalitzkyauthor=L.+Z.+Wangauthor=S.+E.+Webberauthor=N.+J.+Curtin&title=Preclinical+selection+of+a+novel+poly%28ADP-ribose%29+polymerase+inhibitor+for+clinical+trial&doi=10.1158%2F1535-7163.MCT-06-0552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial</span></div><div class="casAuthors">Thomas, Huw D.; Calabrese, Christopher R.; Batey, Michael A.; Canan, Stacie; Hostomsky, Zdenek; Kyle, Suzanne; Maegley, Karen A.; Newell, David R.; Skalitzky, Donald; Wang, Lan-Zhen; Webber, Stephen E.; Curtin, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">945-956</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerase (PARP)-1 (EC 2.4.2.30) is a nuclear enzyme that promotes the base excision repair of DNA breaks.  Inhibition of PARP-1 enhances the efficacy of DNA alkylating agents, topoisomerase I poisons, and ionizing radiation.  Our aim was to identify a PARP inhibitor for clin. trial from a panel of 42 potent PARP inhibitors (Ki, 1.4-15.1 nmol/L) based on the quinazolinone, benzimidazole, tricyclic benzimidazole, tricyclic indole, and tricyclic indole-1-one core structures.  We evaluated chemosensitization of temozolomide and topotecan using LoVo and SW620 human colorectal cells; in vitro radiosensitization was measured using LoVo cells, and the enhancement of antitumor activity of temozolomide was evaluated in mice bearing SW620 xenografts.  Excellent chemopotentiation and radiopotentiation were obsd. in vitro, with 17 of the compds. causing a greater temozolomide and topotecan sensitization than the benchmark inhibitor AG14361 and 10 compds. were more potent radiosensitizers than AG14361.  In tumor-bearing mice, none of the compds. were toxic when given alone, and the antitumor activity of the PARP inhibitor-temozolomide combinations was unrelated to toxicity.  Compds. that were more potent chemosensitizers in vivo than AG14361 were also more potent in vitro, validating in vitro assays as a prescreen.  These studies have identified a compd., AG14447, as a PARP inhibitor with outstanding in vivo chemosensitization potency at tolerable doses, which is at least 10 times more potent than the initial lead, AG14361.  The phosphate salt of AG14447 (AG014699), which has improved aq. soly., has been selected for clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk-3D2oL2giLVg90H21EOLACvtfcHk0ljqH75wGgEmKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2nurw%253D&md5=b451bf2c1fc836cc5a800c2799e5d211</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0552%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DCalabrese%26aufirst%3DC.%2BR.%26aulast%3DBatey%26aufirst%3DM.%2BA.%26aulast%3DCanan%26aufirst%3DS.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DKyle%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPreclinical%2520selection%2520of%2520a%2520novel%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitor%2520for%2520clinical%2520trial%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D3%26spage%3D945%26epage%3D956%26doi%3D10.1158%2F1535-7163.MCT-06-0552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinghofer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donawho, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontcheva-Diaz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giranda, V. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/jm801171j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801171j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=514-523&issue=2&author=T.+D.+Penningauthor=G.+D.+Zhuauthor=V.+B.+Gandhiauthor=J.+Gongauthor=X.+Liuauthor=Y.+Shiauthor=V.+Klinghoferauthor=E.+F.+Johnsonauthor=C.+K.+Donawhoauthor=D.+J.+Frostauthor=V.+Bontcheva-Diazauthor=J.+J.+Bouskaauthor=D.+J.+Osterlingauthor=A.+M.+Olsonauthor=K.+C.+Marshauthor=Y.+Luoauthor=V.+L.+Giranda&title=Discovery+of+the+Poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+2-%5B%28R%29-2-methylpyrrolidin-2-yl%5D-1H-benzimidazole-4-carboxamide+%28ABT-888%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm801171j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm801171j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801171j%26sid%3Dliteratum%253Aachs%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DZhu%26aufirst%3DG.%2BD.%26aulast%3DGandhi%26aufirst%3DV.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DKlinghofer%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DBontcheva-Diaz%26aufirst%3DV.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26atitle%3DDiscovery%2520of%2520the%2520Poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%25202-%255B%2528R%2529-2-methylpyrrolidin-2-yl%255D-1H-benzimidazole-4-carboxamide%2520%2528ABT-888%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D514%26epage%3D523%26doi%3D10.1021%2Fjm801171j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonk, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Group efficiency: a guideline for hits-to-leads chemistry</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.200800132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1179-1180&issue=8&author=M.+L.+Verdonkauthor=D.+C.+Rees&title=Group+efficiency%3A+a+guideline+for+hits-to-leads+chemistry&doi=10.1002%2Fcmdc.200800132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800132%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DGroup%2520efficiency%253A%2520a%2520guideline%2520for%2520hits-to-leads%2520chemistry%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26issue%3D8%26spage%3D1179%26epage%3D1180%26doi%3D10.1002%2Fcmdc.200800132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcoxen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniatti, C.</span></span> <span> </span><span class="NLM_article-title">Niraparib: a poly(ADP-ribose) polymerase (PARP) inhibitor for the treatment of tumors with defective homologous recombination</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1021/jm5018237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3302-3314&issue=8&author=P.+Jonesauthor=K.+Wilcoxenauthor=M.+Rowleyauthor=C.+Toniatti&title=Niraparib%3A+a+poly%28ADP-ribose%29+polymerase+%28PARP%29+inhibitor+for+the+treatment+of+tumors+with+defective+homologous+recombination&doi=10.1021%2Fjm5018237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm5018237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018237%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DWilcoxen%26aufirst%3DK.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DToniatti%26aufirst%3DC.%26atitle%3DNiraparib%253A%2520a%2520poly%2528ADP-ribose%2529%2520polymerase%2520%2528PARP%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520tumors%2520with%2520defective%2520homologous%2520recombination%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D8%26spage%3D3302%26epage%3D3314%26doi%3D10.1021%2Fjm5018237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi-Scharber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, L. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-te trahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, talazoparib), a novel, highly potent, and orally efficacious poly(ADP-ribose) polymerase-1/2 inhibitor, as an anticancer agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=335-357&issue=1&author=B.+Wangauthor=D.+Chuauthor=Y.+Fengauthor=Y.+Shenauthor=M.+Aoyagi-Scharberauthor=L.+E.+Post&title=Discovery+and+characterization+of+%288S%2C9R%29-5-fluoro-8-%284-fluorophenyl%29-9-%281-methyl-1H-1%2C2%2C4-triazol-5-yl%29-2%2C7%2C8%2C9-te+trahydro-3H-pyrido%5B4%2C3%2C2-de%5Dphthalazin-3-one+%28BMN+673%2C+talazoparib%29%2C+a+novel%2C+highly+potent%2C+and+orally+efficacious+poly%28ADP-ribose%29+polymerase-1%2F2+inhibitor%2C+as+an+anticancer+agent&doi=10.1021%2Facs.jmedchem.5b01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01498%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAoyagi-Scharber%26aufirst%3DM.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%25288S%252C9R%2529-5-fluoro-8-%25284-fluorophenyl%2529-9-%25281-methyl-1H-1%252C2%252C4-triazol-5-yl%2529-2%252C7%252C8%252C9-te%2520trahydro-3H-pyrido%255B4%252C3%252C2-de%255Dphthalazin-3-one%2520%2528BMN%2520673%252C%2520talazoparib%2529%252C%2520a%2520novel%252C%2520highly%2520potent%252C%2520and%2520orally%2520efficacious%2520poly%2528ADP-ribose%2529%2520polymerase-1%252F2%2520inhibitor%252C%2520as%2520an%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D1%26spage%3D335%26epage%3D357%26doi%3D10.1021%2Facs.jmedchem.5b01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaspy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachdev, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henshaw, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herriott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span> <span> </span><span class="NLM_article-title">Phase I, dose-escalation, two-part trial of the PARP Inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">620</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-16-1250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1158%2F2159-8290.CD-16-1250" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=620-629&issue=6&author=J.+de+Bonoauthor=R.+K.+Ramanathanauthor=L.+Minaauthor=R.+Chughauthor=J.+Glaspyauthor=S.+Rafiiauthor=S.+Kayeauthor=J.+Sachdevauthor=J.+Heymachauthor=D.+C.+Smithauthor=J.+W.+Henshawauthor=A.+Herriottauthor=M.+Pattersonauthor=N.+J.+Curtinauthor=L.+A.+Byersauthor=Z.+A.+Wainberg&title=Phase+I%2C+dose-escalation%2C+two-part+trial+of+the+PARP+Inhibitor+talazoparib+in+patients+with+advanced+germline+BRCA1%2F2+mutations+and+selected+sporadic+cancers&doi=10.1158%2F2159-8290.CD-16-1250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-1250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-1250%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBono%26aufirst%3DJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DMina%26aufirst%3DL.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DGlaspy%26aufirst%3DJ.%26aulast%3DRafii%26aufirst%3DS.%26aulast%3DKaye%26aufirst%3DS.%26aulast%3DSachdev%26aufirst%3DJ.%26aulast%3DHeymach%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DHenshaw%26aufirst%3DJ.%2BW.%26aulast%3DHerriott%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DM.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DByers%26aufirst%3DL.%2BA.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26atitle%3DPhase%2520I%252C%2520dose-escalation%252C%2520two-part%2520trial%2520of%2520the%2520PARP%2520Inhibitor%2520talazoparib%2520in%2520patients%2520with%2520advanced%2520germline%2520BRCA1%252F2%2520mutations%2520and%2520selected%2520sporadic%2520cancers%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26issue%3D6%26spage%3D620%26epage%3D629%26doi%3D10.1158%2F2159-8290.CD-16-1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the HIV integration process: past, present, and the future</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1021/jm400674a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400674a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaru73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=539-566&issue=3&author=R.+Di+Santo&title=Inhibiting+the+HIV+integration+process%3A+past%2C+present%2C+and+the+future&doi=10.1021%2Fjm400674a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the HIV Integration Process: Past, Present, and the Future</span></div><div class="casAuthors">Di Santo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-566</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HIV integrase (IN) catalyzes the insertion into the genome of the infected human cell of viral DNA produced by the retro-transcription process.  The discovery of raltegravir validated the existence of the IN, which is a new target in the field of anti-HIV drug research.  The mechanism of catalysis of IN is depicted, and the characteristics of the inhibitors of the catalytic site of this viral enzyme are reported.  The role played by the resistance is elucidated, as well as the possibility of bypassing this problem.  New approaches to block the integration process are depicted as future perspectives, such as development of allosteric IN inhibitors, dual inhibitors targeting both IN and other enzymes, inhibitors of enzymes that activate IN, activators of IN activity, as well as a gene therapy approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYPzsc8lcnCLVg90H21EOLACvtfcHk0lhauTqshPwdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaru73E&md5=f09410a9b2a67cd9b7a93111ef5757e5</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm400674a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400674a%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DInhibiting%2520the%2520HIV%2520integration%2520process%253A%2520past%252C%2520present%252C%2520and%2520the%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D3%26spage%3D539%26epage%3D566%26doi%3D10.1021%2Fjm400674a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felock, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabryelski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleif, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5453</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1126/science.287.5453.646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.287.5453.646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10649997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=646-650&issue=5453&author=D.+J.+Hazudaauthor=P.+Felockauthor=M.+Witmerauthor=A.+Wolfeauthor=K.+Stillmockauthor=J.+A.+Groblerauthor=A.+Espesethauthor=L.+Gabryelskiauthor=W.+Schleifauthor=C.+Blauauthor=M.+D.+Miller&title=Inhibitors+of+strand+transfer+that+prevent+integration+and+inhibit+HIV-1+replication+in+cells&doi=10.1126%2Fscience.287.5453.646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter; Witmer, Marc; Wolfe, Abigail; Stillmock, Kara; Grobler, Jay A.; Espeseth, Amy; Gabryelski, Lori; Schleif, William; Blau, Carol; Miller, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5453</span>),
    <span class="NLM_cas:pages">646-650</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Integrase is essential for human immunodeficiency virus-type 1 (HIV-1) replication; however, potent inhibition of the isolated enzyme in biochem. assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration.  In this report, we describe diketo acid inhibitors of HIV-1 integrase that manifest antiviral activity as a consequence of their effect on integration.  The antiviral activity of these compds. is due exclusively to inhibition of one of the two catalytic functions of integrase, strand transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLfQNYMkTCVrVg90H21EOLACvtfcHk0lhauTqshPwdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVyjtQ%253D%253D&md5=d160c8fa31a9ca0a3530dceab66a892c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5453.646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5453.646%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DGabryelski%26aufirst%3DL.%26aulast%3DSchleif%26aufirst%3DW.%26aulast%3DBlau%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26atitle%3DInhibitors%2520of%2520strand%2520transfer%2520that%2520prevent%2520integration%2520and%2520inhibit%2520HIV-1%2520replication%2520in%2520cells%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5453%26spage%3D646%26epage%3D650%26doi%3D10.1126%2Fscience.287.5453.646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassa, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span> <span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">6646</span>– <span class="NLM_lpage">6649</span>, <span class="refDoi"> DOI: 10.1021/jm060854f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&issue=23&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profiles+in+preclinical+species&doi=10.1021%2Fjm060854f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D23%26spage%3D6646%26epage%3D6649%26doi%3D10.1021%2Fjm060854f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassa, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.10.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=350-353&issue=2&author=A.+Petrocchiauthor=U.+Kochauthor=V.+G.+Matassaauthor=B.+Paciniauthor=K.+A.+Stillmockauthor=V.+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3A+SAR+around+the+amide+moiety&doi=10.1016%2Fj.bmcl.2006.10.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253A%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D2%26spage%3D350%26epage%3D353%26doi%3D10.1016%2Fj.bmcl.2006.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&issue=18&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0lhauTqshPwdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5916</span>, <span class="refDoi"> DOI: 10.1021/jm400645w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&issue=14&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29&doi=10.1021%2Fjm400645w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D14%26spage%3D5901%26epage%3D5916%26doi%3D10.1021%2Fjm400645w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherhead, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama-Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garvey, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1135</span>, <span class="refDoi"> DOI: 10.1021/jm301550c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&issue=3&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles&doi=10.1021%2Fjm301550c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D1124%26epage%3D1135%26doi%3D10.1021%2Fjm301550c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, T.</span></span> <span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8735</span>– <span class="NLM_lpage">8744</span>, <span class="refDoi"> DOI: 10.1021/jm3010459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&issue=20&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore&doi=10.1021%2Fjm3010459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D20%26spage%3D8735%26epage%3D8744%26doi%3D10.1021%2Fjm3010459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aramaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamataka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinkai, H.</span></span> <span> </span><span class="NLM_article-title">Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4869</span>– <span class="NLM_lpage">4882</span>, <span class="refDoi"> DOI: 10.1021/jm900460z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900460z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4869-4882&issue=15&author=M.+Satoauthor=H.+Kawakamiauthor=T.+Motomuraauthor=H.+Aramakiauthor=T.+Matsudaauthor=M.+Yamashitaauthor=Y.+Itoauthor=Y.+Matsuzakiauthor=K.+Yamatakaauthor=S.+Ikedaauthor=H.+Shinkai&title=Quinolone+carboxylic+acids+as+a+novel+monoketo+acid+class+of+human+immunodeficiency+virus+type+1+integrase+inhibitors&doi=10.1021%2Fjm900460z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolone Carboxylic Acids as a Novel Monoketo Acid Class of Human Immunodeficiency Virus Type 1 Integrase Inhibitors</span></div><div class="casAuthors">Sato, Motohide; Kawakami, Hiroshi; Motomura, Takahisa; Aramaki, Hisateru; Matsuda, Takashi; Yamashita, Masaki; Ito, Yoshiharu; Matsuzaki, Yuji; Yamataka, Kazunobu; Ikeda, Satoru; Shinkai, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4869-4882</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and detailed structure-activity relationship of quinolonecarboxylic acids as a novel monoketo acid class of HIV-1 integrase inhibitors was presented.  Compds. I (R = t-Bu), which showed an IC50 of 5.8 nM in the strand transfer assay and an ED50 of 0.6 nM in the antiviral assay, and I (R = i-Pr), which had an IC50 of 7.2 nM and an ED50 of 0.9 nM, were the most potent compds. in this class.  The monoketo acid I (R = i-Pr) was much more potent at inhibiting integrase-catalyzed strand transfer processes than 3'-processing reactions, as is the case with the keto-enol acids.  Elvitegravir I (R = i-Pr) was chosen as a candidate for further studies and was reported as being in phase 3 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozJb9SzajWHbVg90H21EOLACvtfcHk0liJuFwtvD9Lww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGjsr0%253D&md5=2eb5292b5c6e9efa8471f293cc9f6bb0</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm900460z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900460z%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DMotomura%26aufirst%3DT.%26aulast%3DAramaki%26aufirst%3DH.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DMatsuzaki%26aufirst%3DY.%26aulast%3DYamataka%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DShinkai%26aufirst%3DH.%26atitle%3DQuinolone%2520carboxylic%2520acids%2520as%2520a%2520novel%2520monoketo%2520acid%2520class%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D15%26spage%3D4869%26epage%3D4882%26doi%3D10.1021%2Fjm900460z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Satz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naderi-Oboodi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzechowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strebel, Q.</span></span> <span> </span><span class="NLM_article-title">DNA compatible multistep synthesis and applications to DNA encoded libraries</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=1623-1632&issue=8&author=A.+L.+Satzauthor=J.+Caiauthor=Y.+Chenauthor=R.+Goodnowauthor=F.+Gruberauthor=A.+Kowalczykauthor=A.+Petersenauthor=G.+Naderi-Oboodiauthor=L.+Orzechowskiauthor=Q.+Strebel&title=DNA+compatible+multistep+synthesis+and+applications+to+DNA+encoded+libraries&doi=10.1021%2Facs.bioconjchem.5b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries</span></div><div class="casAuthors">Satz, Alexander Lee; Cai, Jianping; Chen, Yi; Goodnow, Robert; Gruber, Felix; Kowalczyk, Agnieszka; Petersen, Ann; Naderi-Oboodi, Goli; Orzechowski, Lucja; Strebel, Quentin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1623-1632</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complex mixts. of DNA encoded small mols. may be readily interrogated via high-throughput sequencing.  These DNA encoded libraries (DELs) are commonly used to discover mols. that interact with pharmaceutically relevant proteins.  The chem. diversity displayed by the library is key to successful discovery of potent, novel, and drug-like chem. matter.  The small mol. moieties of DELs are generally synthesized though a multistep process, and each chem. step is accomplished while it is simultaneously attached to an encoding DNA oligomer.  Hence, library chem. diversity is often limited to DNA compatible synthetic reactions.  Herein, protocols for 24 reactions are provided that have been optimized for high-throughput prodn. of DELs.  These protocols detail the multistep synthesis of benzimidazoles, imidazolidinones, quinazolinones, isoindolinones, thiazoles, and imidazopyridines.  Addnl., protocols are provided for a diverse range of useful chem. reactions including BOC deprotection (under pH neutral conditions), carbamylation, and Sonogashira coupling.  Last, step-by-step protocols for synthesizing functionalized DELs from trichloronitropyrimidine and trichloropyrimidine scaffolds are detailed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreALJfu1k6grVg90H21EOLACvtfcHk0lioNxnNTeQvUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFKktLo%253D&md5=1b25e8a1d11c46b2da47494c92ea5ca5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00239%26sid%3Dliteratum%253Aachs%26aulast%3DSatz%26aufirst%3DA.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGoodnow%26aufirst%3DR.%26aulast%3DGruber%26aufirst%3DF.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DNaderi-Oboodi%26aufirst%3DG.%26aulast%3DOrzechowski%26aufirst%3DL.%26aulast%3DStrebel%26aufirst%3DQ.%26atitle%3DDNA%2520compatible%2520multistep%2520synthesis%2520and%2520applications%2520to%2520DNA%2520encoded%2520libraries%26jtitle%3DBioconjugate%2520Chem.%26date%3D2015%26volume%3D26%26issue%3D8%26spage%3D1623%26epage%3D1632%26doi%3D10.1021%2Facs.bioconjchem.5b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakskjær, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietvorst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmkvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kořínek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röhm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sløk, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, N. J. V.</span></span> <span> </span><span class="NLM_article-title">Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1039/C6MD00241B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC6MD00241B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1332-1339&issue=7&author=L.+K.+Petersenauthor=P.+Blakskj%C3%A6rauthor=A.+Chaikuadauthor=A.+B.+Christensenauthor=J.+Dietvorstauthor=J.+Holmkvistauthor=S.+Knappauthor=M.+Ko%C5%99%C3%ADnekauthor=L.+K.+Larsenauthor=A.+E.+Pedersenauthor=S.+R%C3%B6hmauthor=F.+A.+Sl%C3%B8kauthor=N.+J.+V.+Hansen&title=Novel+p38%CE%B1+MAP+kinase+inhibitors+identified+from+yoctoReactor+DNA-encoded+small+molecule+library&doi=10.1039%2FC6MD00241B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1039%2FC6MD00241B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00241B%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DL.%2BK.%26aulast%3DBlakskj%25C3%25A6r%26aufirst%3DP.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DA.%2BB.%26aulast%3DDietvorst%26aufirst%3DJ.%26aulast%3DHolmkvist%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKo%25C5%2599%25C3%25ADnek%26aufirst%3DM.%26aulast%3DLarsen%26aufirst%3DL.%2BK.%26aulast%3DPedersen%26aufirst%3DA.%2BE.%26aulast%3DR%25C3%25B6hm%26aufirst%3DS.%26aulast%3DSl%25C3%25B8k%26aufirst%3DF.%2BA.%26aulast%3DHansen%26aufirst%3DN.%2BJ.%2BV.%26atitle%3DNovel%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitors%2520identified%2520from%2520yoctoReactor%2520DNA-encoded%2520small%2520molecule%2520library%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D7%26spage%3D1332%26epage%3D1339%26doi%3D10.1039%2FC6MD00241B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">The drug-maker’s guide to the galaxy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>549</i></span> (<span class="NLM_issue">7673</span>),  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/549445a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2F549445a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28959982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FjsFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=549&publication_year=2017&pages=445-447&issue=7673&author=A.+Mullard&title=The+drug-maker%E2%80%99s+guide+to+the+galaxy&doi=10.1038%2F549445a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-maker's guide to the galaxy</span></div><div class="casAuthors">Mullard Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">549</span>
        (<span class="NLM_cas:issue">7673</span>),
    <span class="NLM_cas:pages">445-447</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSItGWG-TCuJEg6wdEZmT2rfW6udTcc2eY-OTCI5MWWTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FjsFSmtA%253D%253D&md5=4ff8347906c8f3b459d05a5fe7ad0b56</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1038%2F549445a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F549445a%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DThe%2520drug-maker%25E2%2580%2599s%2520guide%2520to%2520the%2520galaxy%26jtitle%3DNature%26date%3D2017%26volume%3D549%26issue%3D7673%26spage%3D445%26epage%3D447%26doi%3D10.1038%2F549445a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&issue=4&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0ljdOrubRzji6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D4%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-Encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&issue=5&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-Encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0ljdOrubRzji6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-Encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1038/cdd.2012.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fcdd.2012.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23197293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=185-187&issue=2&author=P.+Vandenabeeleauthor=S.+Grootjansauthor=N.+Callewaertauthor=N.+Takahashi&title=Necrostatin-1+blocks+both+RIPK1+and+IDO%3A+consequences+for+the+study+of+cell+death+in+experimental+disease+models&doi=10.1038%2Fcdd.2012.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models</span></div><div class="casAuthors">Vandenabeele, P.; Grootjans, S.; Callewaert, N.; Takahashi, N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-187</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This paper discusses necrostatin-1 (Nec-1) blocks both RIPK1 and IDO, consequences for the study of cell death in exptl. disease models.  Activity and specificity of Necrostatin-1, small mol. inhibitor of RIP1 kinase in cell death and differentiation.  The result shows RIPK1/necroptosis targeting as a central theme in biomedical research on inflammatory and degenerative disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7iSg-eNwF2LVg90H21EOLACvtfcHk0lgQFYgjZXLmhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVygsw%253D%253D&md5=7713eb2ac9832ef8c498cef21055c44d</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2012.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2012.151%26sid%3Dliteratum%253Aachs%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DN.%26atitle%3DNecrostatin-1%2520blocks%2520both%2520RIPK1%2520and%2520IDO%253A%2520consequences%2520for%2520the%2520study%2520of%2520cell%2520death%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26issue%3D2%26spage%3D185%26epage%3D187%26doi%3D10.1038%2Fcdd.2012.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1465</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2006.11.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1455-1465&issue=5&author=K.+Wangauthor=J.+Liauthor=A.+Degterevauthor=E.+Hsuauthor=J.+Yuanauthor=C.+Yuan&title=Structure-activity+relationship+analysis+of+a+novel+necroptosis+inhibitor%2C+necrostatin-5&doi=10.1016%2Fj.bmcl.2006.11.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.11.056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DE.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520analysis%2520of%2520a%2520novel%2520necroptosis%2520inhibitor%252C%2520necrostatin-5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D5%26spage%3D1455%26epage%3D1465%26doi%3D10.1016%2Fj.bmcl.2006.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0lgQFYgjZXLmhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1243</span>, <span class="refDoi"> DOI: 10.1021/ml400382p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1238-1243&issue=12&author=P.+A.+Harrisauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=K.+M.+Kahlerauthor=R.+Lehrauthor=J.+D.+Lichauthor=R.+Nagillaauthor=R.+T.+Nolteauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=M.+C.+Schaefferauthor=A.+Smallwoodauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=Discovery+of+small+molecule+RIP1+kinase+inhibitors+for+the+treatment+of+pathologies+associated+with+necroptosis&doi=10.1021%2Fml400382p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fml400382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400382p%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520RIP1%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pathologies%2520associated%2520with%2520necroptosis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3D1238%26epage%3D1243%26doi%3D10.1021%2Fml400382p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span> <span> </span><span class="NLM_article-title">Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases</span>. <i>MAP Kinase</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.4081/mk.2015.5508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4081%2Fmk.2015.5508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=24-30&issue=1&author=L.+Xing&title=Clinical+candidates+of+small+molecule+p38+MAPK+inhibitors+for+inflammatory+diseases&doi=10.4081%2Fmk.2015.5508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.4081%2Fmk.2015.5508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Fmk.2015.5508%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26atitle%3DClinical%2520candidates%2520of%2520small%2520molecule%2520p38%2520MAPK%2520inhibitors%2520for%2520inflammatory%2520diseases%26jtitle%3DMAP%2520Kinase%26date%3D2016%26volume%3D4%26issue%3D1%26spage%3D24%26epage%3D30%26doi%3D10.4081%2Fmk.2015.5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seavers, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/jm049575n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049575n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=414-426&issue=2&author=A.+L.+Gillauthor=M.+Fredericksonauthor=A.+Cleasbyauthor=S.+J.+Woodheadauthor=M.+G.+Carrauthor=A.+J.+Woodheadauthor=M.+T.+Walkerauthor=M.+S.+Congreveauthor=L.+A.+Devineauthor=D.+Tisiauthor=M.+O%E2%80%99Reillyauthor=L.+C.+Seaversauthor=D.+J.+Davisauthor=J.+Curryauthor=R.+Anthonyauthor=A.+Padovaauthor=C.+W.+Murrayauthor=R.+A.+Carrauthor=H.+Jhoti&title=Identification+of+novel+p38alpha+MAP+kinase+inhibitors+using+fragment-based+lead+generation&doi=10.1021%2Fjm049575n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm049575n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049575n%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DWoodhead%26aufirst%3DS.%2BJ.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DAnthony%26aufirst%3DR.%26aulast%3DPadova%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520novel%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520using%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D2%26spage%3D414%26epage%3D426%26doi%3D10.1021%2Fjm049575n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepperle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrufo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickory, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevis-Bal, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5851</span>– <span class="NLM_lpage">5856</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2009.08.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5851-5856&issue=20&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+B.+Monahanauthor=T.+L.+Boehmauthor=J.+K.+Walkerauthor=B.+Devadasauthor=R.+C.+Durleyauthor=R.+Kurumbailauthor=H.+Shiehauthor=L.+Xingauthor=M.+Hepperleauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Bal&title=Discovery+of+N-substituted+pyridinones+as+potent+and+selective+inhibitors+of+p38+kinase&doi=10.1016%2Fj.bmcl.2009.08.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.082%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520N-substituted%2520pyridinones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D20%26spage%3D5851%26epage%3D5856%26doi%3D10.1016%2Fj.bmcl.2009.08.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graneto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlitz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallings, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naraian, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koszyk, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stealey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weier, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mnich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5712</span>– <span class="NLM_lpage">5719</span>, <span class="refDoi"> DOI: 10.1021/jm0611915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5712-5719&issue=23&author=M.+J.+Granetoauthor=R.+G.+Kurumbailauthor=M.+L.+Vazquezauthor=H.+S.+Shiehauthor=J.+L.+Pawlitzauthor=J.+M.+Williamsauthor=W.+C.+Stallingsauthor=L.+Gengauthor=A.+S.+Naraianauthor=F.+J.+Koszykauthor=M.+A.+Stealeyauthor=X.+D.+Xuauthor=R.+M.+Weierauthor=G.+J.+Hansonauthor=R.+J.+Moureyauthor=R.+P.+Comptonauthor=S.+J.+Mnichauthor=G.+D.+Andersonauthor=J.+B.+Monahanauthor=R.+Devraj&title=Synthesis%2C+crystal+structure%2C+and+activity+of+pyrazole-based+inhibitors+of+p38+kinase&doi=10.1021%2Fjm0611915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm0611915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611915%26sid%3Dliteratum%253Aachs%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DPawlitz%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DNaraian%26aufirst%3DA.%2BS.%26aulast%3DKoszyk%26aufirst%3DF.%2BJ.%26aulast%3DStealey%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DDevraj%26aufirst%3DR.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520activity%2520of%2520pyrazole-based%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D23%26spage%3D5712%26epage%3D5719%26doi%3D10.1021%2Fjm0611915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.
K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepperle, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurambail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portanova, J.</span></span> <span> </span><span class="NLM_article-title">Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2634</span>– <span class="NLM_lpage">2638</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2010.02.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2634-2638&issue=8&author=J.%0AK.+Walkerauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=M.+E.+Hepperleauthor=W.+Naingauthor=H.+Shiehauthor=R.+Kurambailauthor=S.+Yangauthor=D.+L.+Flynnauthor=A.+G.+Bensonauthor=D.+M.+Messingauthor=T.+Diceauthor=T.+Kimauthor=R.+J.+Lindmarkauthor=J.+B.+Monahanauthor=J.+Portanova&title=Identification+of+SD-0006%2C+a+potent+diaryl+pyrazole+inhibitor+of+p38+MAP+kinase&doi=10.1016%2Fj.bmcl.2010.02.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DHepperle%26aufirst%3DM.%2BE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DKurambail%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMessing%26aufirst%3DD.%2BM.%26aulast%3DDice%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DLindmark%26aufirst%3DR.%2BJ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DPortanova%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520SD-0006%252C%2520a%2520potent%2520diaryl%2520pyrazole%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2634%26epage%3D2638%26doi%3D10.1016%2Fj.bmcl.2010.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aston, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">p38Alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6257</span>– <span class="NLM_lpage">6269</span>, <span class="refDoi"> DOI: 10.1021/jm9004779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6257-6269&issue=20&author=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=V.+K.+Patelauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=G.+Vitulliauthor=A.+L.+Walker&title=p38Alpha+mitogen-activated+protein+kinase+inhibitors%3A+optimization+of+a+series+of+biphenylamides+to+give+a+molecule+suitable+for+clinical+progression&doi=10.1021%2Fjm9004779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm9004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004779%26sid%3Dliteratum%253Aachs%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3Dp38Alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%253A%2520optimization%2520of%2520a%2520series%2520of%2520biphenylamides%2520to%2520give%2520a%2520molecule%2520suitable%2520for%2520clinical%2520progression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D20%26spage%3D6257%26epage%3D6269%26doi%3D10.1021%2Fjm9004779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mavunkel, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perumattam, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewicki, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugar, S.</span></span> <span> </span><span class="NLM_article-title">Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3087</span>– <span class="NLM_lpage">3090</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00653-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0960-894X%2803%2900653-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3087-3090&issue=18&author=B.+J.+Mavunkelauthor=S.+Chakravartyauthor=J.+J.+Perumattamauthor=G.+R.+Luedtkeauthor=X.+Liangauthor=D.+Limauthor=Y.-j.+Xuauthor=M.+Laneyauthor=D.+Y.+Liuauthor=G.+F.+Schreinerauthor=J.+A.+Lewickiauthor=S.+Dugar&title=Indole-based+heterocyclic+inhibitors+of+p38%CE%B1+MAP+kinase%3A+designing+a+conformationally+restricted+analogue&doi=10.1016%2FS0960-894X%2803%2900653-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900653-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900653-X%26sid%3Dliteratum%253Aachs%26aulast%3DMavunkel%26aufirst%3DB.%2BJ.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DPerumattam%26aufirst%3DJ.%2BJ.%26aulast%3DLuedtke%26aufirst%3DG.%2BR.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DY.-j.%26aulast%3DLaney%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DSchreiner%26aufirst%3DG.%2BF.%26aulast%3DLewicki%26aufirst%3DJ.%2BA.%26aulast%3DDugar%26aufirst%3DS.%26atitle%3DIndole-based%2520heterocyclic%2520inhibitors%2520of%2520p38%25CE%25B1%2520MAP%2520kinase%253A%2520designing%2520a%2520conformationally%2520restricted%2520analogue%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D18%26spage%3D3087%26epage%3D3090%26doi%3D10.1016%2FS0960-894X%2803%2900653-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bemis, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evindar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germann, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taslimi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazhanisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M. S.</span></span> <span> </span><span class="NLM_article-title">The Discovery of VX-745: A novel and selective p38alpha kinase inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">758</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1021/ml2001455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=758-763&issue=10&author=J.+P.+Duffyauthor=E.+M.+Harringtonauthor=F.+G.+Salituroauthor=J.+E.+Cochranauthor=J.+Greenauthor=H.+Gaoauthor=G.+W.+Bemisauthor=G.+Evindarauthor=V.+P.+Galulloauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=K.+P.+Wilsonauthor=S.+F.+Bellonauthor=G.+Chenauthor=P.+Taslimiauthor=P.+Jonesauthor=C.+Huangauthor=S.+Pazhanisamyauthor=Y.+M.+Wangauthor=M.+A.+Murckoauthor=M.+S.+Su&title=The+Discovery+of+VX-745%3A+A+novel+and+selective+p38alpha+kinase+inhibitor&doi=10.1021%2Fml2001455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fml2001455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001455%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DHarrington%26aufirst%3DE.%2BM.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DCochran%26aufirst%3DJ.%2BE.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DEvindar%26aufirst%3DG.%26aulast%3DGalullo%26aufirst%3DV.%2BP.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DPazhanisamy%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DThe%2520Discovery%2520of%2520VX-745%253A%2520A%2520novel%2520and%2520selective%2520p38alpha%2520kinase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D10%26spage%3D758%26epage%3D763%26doi%3D10.1021%2Fml2001455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grob, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1038/nsb770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&issue=4&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site&doi=10.1038%2Fnsb770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26issue%3D4%26spage%3D268%26epage%3D272%26doi%3D10.1038%2Fnsb770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooney, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 1: discovery and binding mode</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.10.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=318-323&issue=1&author=R.+M.+Angellauthor=P.+Bamboroughauthor=A.+Cleasbyauthor=S.+G.+Cockerillauthor=K.+L.+Jonesauthor=C.+J.+Mooneyauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+1%3A+discovery+and+binding+mode&doi=10.1016%2Fj.bmcl.2007.10.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.076%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DMooney%26aufirst%3DC.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25201%253A%2520discovery%2520and%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D318%26epage%3D323%26doi%3D10.1016%2Fj.bmcl.2007.10.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, M.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 2: optimisation and SAR</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.10.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&issue=1&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors+2%3A+optimisation+and+SAR&doi=10.1016%2Fj.bmcl.2007.10.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25202%253A%2520optimisation%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D324%26epage%3D328%26doi%3D10.1016%2Fj.bmcl.2007.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aston, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckton, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deBoeck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 3: improvement of cellular and in vivo activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4428</span>– <span class="NLM_lpage">4432</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2008.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=18614366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVequ7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4428-4432&issue=15&author=R.+Angellauthor=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=S.+Cockerillauthor=S.+J.+deBoeckauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=S.+Patelauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+3%3A+improvement+of+cellular+and+in+vivo+activity&doi=10.1016%2Fj.bmcl.2008.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity</span></div><div class="casAuthors">Angell, Richard; Aston, Nicola M.; Bamborough, Paul; Buckton, Jacky B.; Cockerill, Stuart; de Boeck, Suzanne J.; Edwards, Chris D.; Holmes, Duncan S.; Jones, Katherine L.; Laine, Dramane I.; Patel, Shila; Smee, Penny A.; Smith, Kathryn J.; Somers, Don O.; Walker, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4428-4432</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The biphenyl amides (BPAs) are a novel series of p38α MAP kinase inhibitor.  The optimization of the series to give compds. that are potent in an in vivo disease model is discussed.  SAR is presented and rationalised with ref. to the crystallog. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT0cyGCATNLVg90H21EOLACvtfcHk0liFhB_jk2SGvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVequ7c%253D&md5=89ae52223f0cffd31df2b0d830d40ec5</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%26aulast%3DdeBoeck%26aufirst%3DS.%2BJ.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25203%253A%2520improvement%2520of%2520cellular%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4428%26epage%3D4432%26doi%3D10.1016%2Fj.bmcl.2008.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamford, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockerill, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flack, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludbrook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span> <span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4433</span>– <span class="NLM_lpage">4437</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2008.06.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&issue=15&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=M.+J.+Bamfordauthor=C.+W.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+4%3A+DFG-in+and+DFG-out+binding+modes&doi=10.1016%2Fj.bmcl.2008.06.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4433%26epage%3D4437%26doi%3D10.1016%2Fj.bmcl.2008.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durley, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerome, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrufo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Promo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickory, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevis-Bal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalamanchili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonder Embse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saabye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4066</span>– <span class="NLM_lpage">4071</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2011.04.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4066-4071&issue=13&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=B.+Devadasauthor=J.+K.+Walkerauthor=T.+L.+Boehmauthor=R.+C.+Durleyauthor=H.+Shiehauthor=L.+Xingauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Balauthor=D.+Messingauthor=J.+Yangauthor=M.+K.+Maoauthor=G.+Yalamanchiliauthor=R.+Vonder+Embseauthor=J.+Hirschauthor=M.+Saabyeauthor=S.+Bonarauthor=E.+Webbauthor=G.+Andersonauthor=J.+B.+Monahan&title=Discovery+of+PH-797804%2C+a+highly+selective+and+potent+inhibitor+of+p38+MAP+kinase&doi=10.1016%2Fj.bmcl.2011.04.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.121%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DM.%2BK.%26aulast%3DYalamanchili%26aufirst%3DG.%26aulast%3DVonder%2BEmbse%26aufirst%3DR.%26aulast%3DHirsch%26aufirst%3DJ.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DBonar%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520PH-797804%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D13%26spage%3D4066%26epage%3D4071%26doi%3D10.1016%2Fj.bmcl.2011.04.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8249</span>– <span class="NLM_lpage">8267</span>, <span class="refDoi"> DOI: 10.1021/jm500973a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500973a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8249-8267&issue=20&author=M.+R.+Finlayauthor=M.+Andertonauthor=S.+Ashtonauthor=P.+Ballardauthor=P.+A.+Bethelauthor=M.+R.+Boxauthor=R.+H.+Bradburyauthor=S.+J.+Brownauthor=S.+Butterworthauthor=A.+Campbellauthor=C.+Chorleyauthor=N.+Colcloughauthor=D.+A.+Crossauthor=G.+S.+Currieauthor=M.+Gristauthor=L.+Hassallauthor=G.+B.+Hillauthor=D.+Jamesauthor=M.+Jamesauthor=P.+Kemmittauthor=T.+Klinowskaauthor=G.+Lamontauthor=S.+G.+Lamontauthor=N.+Martinauthor=H.+L.+McFarlandauthor=M.+J.+Mellorauthor=J.+P.+Ormeauthor=D.+Perkinsauthor=P.+Perkinsauthor=G.+Richmondauthor=P.+Smithauthor=R.+A.+Wardauthor=M.+J.+Waringauthor=D.+Whittakerauthor=S.+Wellsauthor=G.+L.+Wrigley&title=Discovery+of+a+potent+and+selective+EGFR+inhibitor+%28AZD9291%29+of+both+sensitizing+and+T790M+resistance+mutations+that+spares+the+wild+type+form+of+the+receptor&doi=10.1021%2Fjm500973a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor</span></div><div class="casAuthors">Finlay, M. Raymond V.; Anderton, Mark; Ashton, Susan; Ballard, Peter; Bethel, Paul A.; Box, Matthew R.; Bradbury, Robert H.; Brown, Simon J.; Butterworth, Sam; Campbell, Andrew; Chorley, Christopher; Colclough, Nicola; Cross, Darren A. E.; Currie, Gordon S.; Grist, Matthew; Hassall, Lorraine; Hill, George B.; James, Daniel; James, Michael; Kemmitt, Paul; Klinowska, Teresa; Lamont, Gillian; Lamont, Scott G.; Martin, Nathaniel; McFarland, Heather L.; Mellor, Martine J.; Orme, Jonathon P.; Perkins, David; Perkins, Paula; Richmond, Graham; Smith, Peter; Ward, Richard A.; Waring, Michael J.; Whittaker, David; Wells, Stuart; Wrigley, Gail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8249-8267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) inhibitors have been used clin. in the treatment of nonsmall-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) mutations for a no. of years.  Despite encouraging clin. efficacy with these agents, in many patients resistance develops leading to disease progression.  In most cases, this resistance is in the form of the T790M mutation.  In addn., EGFR wild type receptor inhibition inherent with these agents can lead to dose limiting toxicities of rash and diarrhea.  The authors describe herein the evolution of an early, mutant selective lead to the clin. candidate AZD9291 I, an irreversible inhibitor of both EGFR sensitizing (EGFRm+) and T790M resistance mutations with selectivity over the wild type form of the receptor.  Following observations of significant tumor inhibition in preclin. models, the clin. candidate was administered clin. to patients with T790M pos. EGFR-TKI resistant NSCLC and early efficacy has been obsd., accompanied by an encouraging safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouPAWG9N0Ro7Vg90H21EOLACvtfcHk0lhZ8fKCWig0yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KhurrI&md5=db9db624bb4324c2e22b1ab12035263b</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fjm500973a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500973a%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DAnderton%26aufirst%3DM.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%2BR.%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DChorley%26aufirst%3DC.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DJames%26aufirst%3DM.%26aulast%3DKemmitt%26aufirst%3DP.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMcFarland%26aufirst%3DH.%2BL.%26aulast%3DMellor%26aufirst%3DM.%2BJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DRichmond%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DG.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520EGFR%2520inhibitor%2520%2528AZD9291%2529%2520of%2520both%2520sensitizing%2520and%2520T790M%2520resistance%2520mutations%2520that%2520spares%2520the%2520wild%2520type%2520form%2520of%2520the%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8249%26epage%3D8267%26doi%3D10.1021%2Fjm500973a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson-Fisher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{(3R,4R)-3-[({5-chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a potent, WT sparing, irreversible inhibitor of T790M-containing EGFR mutants</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2005</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2005-2024&issue=5&author=H.+Chengauthor=S.+K.+Nairauthor=B.+W.+Murrayauthor=C.+Almadenauthor=S.+Baileyauthor=S.+Baxiauthor=D.+Behennaauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=J.+L.+Fengauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+D.+Hemkensauthor=A.+Jackson-Fisherauthor=M.+Jalaieauthor=T.+O.+Johnsonauthor=R.+S.+Kaniaauthor=S.+Kephartauthor=J.+Lafontaineauthor=B.+Lunneyauthor=K.+K.+Liuauthor=Z.+Liuauthor=J.+Matthewsauthor=A.+Nagataauthor=S.+Niessenauthor=M.+A.+Ornelasauthor=S.+T.+Orrauthor=M.+Pairishauthor=S.+Plankenauthor=S.+Renauthor=D.+Richterauthor=K.+Ryanauthor=N.+Sachauthor=H.+Shenauthor=T.+Smealauthor=J.+Solowiejauthor=S.+Suttonauthor=K.+Tranauthor=E.+Tsengauthor=W.+Vernierauthor=M.+Wallsauthor=S.+Wangauthor=S.+L.+Weinrichauthor=S.+Xinauthor=H.+Xuauthor=M.+J.+Yinauthor=M.+Zientekauthor=R.+Zhouauthor=J.+C.+Kath&title=Discovery+of+1-%7B%283R%2C4R%29-3-%5B%28%7B5-chloro-2-%5B%281-methyl-1H-pyrazol-4-yl%29amino%5D-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%7Doxy%29methyl%5D-4-methoxypyrrolidin-1-yl%7Dprop-2-en-1-one+%28PF-06459988%29%2C+a+potent%2C+WT+sparing%2C+irreversible+inhibitor+of+T790M-containing+EGFR+mutants&doi=10.1021%2Facs.jmedchem.5b01633"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01633%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBaxi%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%2BD.%26aulast%3DJackson-Fisher%26aufirst%3DA.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DLafontaine%26aufirst%3DJ.%26aulast%3DLunney%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DK.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%2BA.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DSach%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DW.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DM.%2BJ.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%25201-%257B%25283R%252C4R%2529-3-%255B%2528%257B5-chloro-2-%255B%25281-methyl-1H-pyrazol-4-yl%2529amino%255D-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%257Doxy%2529methyl%255D-4-methoxypyrrolidin-1-yl%257Dprop-2-en-1-one%2520%2528PF-06459988%2529%252C%2520a%2520potent%252C%2520WT%2520sparing%252C%2520irreversible%2520inhibitor%2520of%2520T790M-containing%2520EGFR%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D5%26spage%3D2005%26epage%3D2024%26doi%3D10.1021%2Facs.jmedchem.5b01633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H- purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through structure-based drug design: a high affinity irreversible inhibitor targeting oncogenic EGFR mutants with selectivity over wild-type EGFR</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3002-3019&issue=7&author=S.+Plankenauthor=D.+C.+Behennaauthor=S.+K.+Nairauthor=T.+O.+Johnsonauthor=A.+Nagataauthor=C.+Almadenauthor=S.+Baileyauthor=T.+E.+Ballardauthor=L.+Bernierauthor=H.+Chengauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=J.+G.+Dealauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+Hemkensauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=J.+Matthewsauthor=B.+W.+Murrayauthor=S.+Niessenauthor=S.+T.+Orrauthor=M.+Pairishauthor=N.+W.+Sachauthor=H.+Shenauthor=M.+Shiauthor=J.+Solowiejauthor=K.+Tranauthor=E.+Tsengauthor=P.+Viciniauthor=Y.+Wangauthor=S.+L.+Weinrichauthor=R.+Zhouauthor=M.+Zientekauthor=L.+Liuauthor=Y.+Luoauthor=S.+Xinauthor=C.+Zhangauthor=J.+Lafontaine&title=Discovery+of+N-%28%283R%2C4R%29-4-fluoro-1-%286-%28%283-methoxy-1-methyl-1H-pyrazol-4-yl%29amino%29-9-methyl-9H-+purin-2-yl%29pyrrolidine-3-yl%29acrylamide+%28PF-06747775%29+through+structure-based+drug+design%3A+a+high+affinity+irreversible+inhibitor+targeting+oncogenic+EGFR+mutants+with+selectivity+over+wild-type+EGFR&doi=10.1021%2Facs.jmedchem.6b01894"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%2BC.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLafontaine%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%2528%25283R%252C4R%2529-4-fluoro-1-%25286-%2528%25283-methoxy-1-methyl-1H-pyrazol-4-yl%2529amino%2529-9-methyl-9H-%2520purin-2-yl%2529pyrrolidine-3-yl%2529acrylamide%2520%2528PF-06747775%2529%2520through%2520structure-based%2520drug%2520design%253A%2520a%2520high%2520affinity%2520irreversible%2520inhibitor%2520targeting%2520oncogenic%2520EGFR%2520mutants%2520with%2520selectivity%2520over%2520wild-type%2520EGFR%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D7%26spage%3D3002%26epage%3D3019%26doi%3D10.1021%2Facs.jmedchem.6b01894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorley, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7025</span>– <span class="NLM_lpage">7048</span>, <span class="refDoi"> DOI: 10.1021/jm400822z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400822z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7025-7048&issue=17&author=R.+A.+Wardauthor=M.+J.+Andertonauthor=S.+Ashtonauthor=P.+A.+Bethelauthor=M.+Boxauthor=S.+Butterworthauthor=N.+Colcloughauthor=C.+G.+Chorleyauthor=C.+Chuaquiauthor=D.+A.+Crossauthor=L.+A.+Dakinauthor=J.+E.+Debreczeniauthor=C.+Eberleinauthor=M.+R.+Finlayauthor=G.+B.+Hillauthor=M.+Gristauthor=T.+C.+Klinowskaauthor=C.+Laneauthor=S.+Martinauthor=J.+P.+Ormeauthor=P.+Smithauthor=F.+Wangauthor=M.+J.+Waring&title=Structure-+and+reactivity-based+development+of+covalent+inhibitors+of+the+activating+and+gatekeeper+mutant+forms+of+the+epidermal+growth+factor+receptor+%28EGFR%29&doi=10.1021%2Fjm400822z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm400822z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400822z%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BA.%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DAshton%26aufirst%3DS.%26aulast%3DBethel%26aufirst%3DP.%2BA.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DChorley%26aufirst%3DC.%2BG.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DEberlein%26aufirst%3DC.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DKlinowska%26aufirst%3DT.%2BC.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DStructure-%2520and%2520reactivity-based%2520development%2520of%2520covalent%2520inhibitors%2520of%2520the%2520activating%2520and%2520gatekeeper%2520mutant%2520forms%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D17%26spage%3D7025%26epage%3D7048%26doi%3D10.1021%2Fjm400822z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kifle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Navigating the kinome</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1038/nchembio.530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21336281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=200-202&issue=4&author=J.+T.+Metzauthor=E.+F.+Johnsonauthor=N.+B.+Soniauthor=P.+J.+Mertaauthor=L.+Kifleauthor=P.+J.+Hajduk&title=Navigating+the+kinome&doi=10.1038%2Fnchembio.530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the kinome</span></div><div class="casAuthors">Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-202</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biol. and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacol.-dependent networks.  Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacol. parameters derived from activity profiling data.  The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is crit. for multitargeted drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgzF9Q0eH87Vg90H21EOLACvtfcHk0lgR_FtxXHI2wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D&md5=09234ec451a4918e5aca6d65e0b65aee</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.530%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DNavigating%2520the%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D4%26spage%3D200%26epage%3D202%26doi%3D10.1038%2Fnchembio.530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazear, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide map of targets of T790M-EGFR-directed covalent inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1400</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chembiol.2017.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28965727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOrtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1388-1400&issue=11&author=S.+Niessenauthor=M.+M.+Dixauthor=S.+Barbasauthor=Z.+E.+Potterauthor=S.+Luauthor=O.+Brodskyauthor=S.+Plankenauthor=D.+Behennaauthor=C.+Almadenauthor=K.+S.+Gajiwalaauthor=K.+Ryanauthor=R.+Ferreauthor=M.+R.+Lazearauthor=M.+M.+Haywardauthor=J.+C.+Kathauthor=B.+F.+Cravatt&title=Proteome-wide+map+of+targets+of+T790M-EGFR-directed+covalent+inhibitors&doi=10.1016%2Fj.chembiol.2017.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">proteome-wide map of targets of t790m-egfr-directed covalent inhibitors</span></div><div class="casAuthors">Niessen, Sherry; Dix, Melissa M.; Barbas, Sabrina; Potter, Zachary E.; Lu, Shuyan; Brodsky, Oleg; Planken, Simon; Behenna, Douglas; Almaden, Chau; Gajiwala, Ketan S.; Ryan, Kevin; Ferre, RoseAnn; Lazear, Michael R.; Hayward, Matthew M.; Kath, John C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1388-1400.e7</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Patients with non-small cell lung cancers that have kinase-activating epidermal growth factor receptor (EGFR) mutations are highly responsive to first- and second-generation EGFR inhibitors.  However, these patients often relapse due to a secondary, drug-resistant mutation in EGFR whereby the gatekeeper threonine is converted to methionine (T790M).  Several third-generation EGFR inhibitors have been developed that irreversibly inactivate T790M-EGFR while sparing wild-type EGFR, thus reducing epithelium-based toxicities.  Using chem. proteomics, we show here that individual T790M-EGFR inhibitors exhibit strikingly distinct off-target profiles in human cells.  The FDA-approved drug osimertinib (AZD9291), in particular, was found to covalently modify cathepsins in cell and animal models, which correlated with lysosomal accumulation of the drug.  Our findings thus show how chem. proteomics can be used to differentiate covalent kinase inhibitors based on global selectivity profiles in living systems and identify specific off-targets of these inhibitors that may affect drug activity and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP837IUk45tLVg90H21EOLACvtfcHk0lgR_FtxXHI2wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOrtrnL&md5=dc2db6d29932ffdb991027ba272bd149</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DDix%26aufirst%3DM.%2BM.%26aulast%3DBarbas%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DZ.%2BE.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DBrodsky%26aufirst%3DO.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DLazear%26aufirst%3DM.%2BR.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-wide%2520map%2520of%2520targets%2520of%2520T790M-EGFR-directed%2520covalent%2520inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26issue%3D11%26spage%3D1388%26epage%3D1400%26doi%3D10.1016%2Fj.chembiol.2017.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lelais, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilje, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anumolu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michellys, P. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R,E)-N-(7-chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imid azol-2-yl)-2-methylisonicotinamide (EGF816), a novel, potent, and WT sparing covalent inhibitor of oncogenic (L858R, ex19del) and resistant (T790M) EGFR mutants for the treatment of EGFR mutant non-small-cell lung cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6671</span>– <span class="NLM_lpage">6689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01985</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01985" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6671-6689&issue=14&author=G.+Lelaisauthor=R.+Eppleauthor=T.+H.+Marsiljeauthor=Y.+O.+Longauthor=M.+McNeillauthor=B.+Chenauthor=W.+Luauthor=J.+Anumoluauthor=S.+Badigerauthor=B.+Bursulayaauthor=M.+DiDonatoauthor=R.+Fongauthor=J.+Juarezauthor=J.+Liauthor=M.+Manuiaauthor=D.+E.+Masonauthor=P.+Gordonauthor=T.+Groesslauthor=K.+Johnsonauthor=Y.+Jiaauthor=S.+Kasibhatlaauthor=C.+Liauthor=J.+Isbellauthor=G.+Spraggonauthor=S.+Benderauthor=P.+Y.+Michellys&title=Discovery+of+%28R%2CE%29-N-%287-chloro-1-%281-%5B4-%28dimethylamino%29but-2-enoyl%5Dazepan-3-yl%29-1H-benzo%5Bd%5Dimid+azol-2-yl%29-2-methylisonicotinamide+%28EGF816%29%2C+a+novel%2C+potent%2C+and+WT+sparing+covalent+inhibitor+of+oncogenic+%28L858R%2C+ex19del%29+and+resistant+%28T790M%29+EGFR+mutants+for+the+treatment+of+EGFR+mutant+non-small-cell+lung+cancers&doi=10.1021%2Facs.jmedchem.5b01985"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers</span></div><div class="casAuthors">Lelais, Gerald; Epple, Robert; Marsilje, Thomas H.; Long, Yun O.; McNeill, Matthew; Chen, Bei; Lu, Wenshuo; Anumolu, Jaganmohan; Badiger, Sangamesh; Bursulaya, Badry; DiDonato, Michael; Fong, Rina; Juarez, Jose; Li, Jie; Manuia, Mari; Mason, Daniel E.; Gordon, Perry; Groessl, Todd; Johnson, Kevin; Jia, Yong; Kasibhatla, Shailaja; Li, Chun; Isbell, John; Spraggon, Glen; Bender, Steven; Michellys, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6671-6689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the past decade, first and second generation EGFR inhibitors have significantly improved outcomes for lung cancer patients with activating mutations in EGFR.  However, both resistance through a secondary T790M mutation at the gatekeeper residue and dose-limiting toxicities from wild-type (WT) EGFR inhibition ultimately limit the full potential of these therapies to control mutant EGFR-driven tumors and new therapies are urgently needed.  Herein, we describe our approach toward the discovery of 47 (EGF816, nazartinib), a novel, covalent mutant-selective EGFR inhibitor with equipotent activity on both oncogenic and T790M-resistant EGFR mutations.  Through mol. docking studies we converted a mutant-selective high-throughput screening hit (7) into a no. of targeted covalent EGFR inhibitors with equipotent activity across mutants EGFR and good WT-EGFR selectivity.  We used an abbreviated in vivo efficacy study for prioritizing compds. with good tolerability and efficacy that ultimately led to the selection of 47 as the clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpcKsqbwkyp7Vg90H21EOLACvtfcHk0lgbwMxxJh-Lsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgu77P&md5=c106545d878ab3d675644b47099668a0</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DMcNeill%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAnumolu%26aufirst%3DJ.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJuarez%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DManuia%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26atitle%3DDiscovery%2520of%2520%2528R%252CE%2529-N-%25287-chloro-1-%25281-%255B4-%2528dimethylamino%2529but-2-enoyl%255Dazepan-3-yl%2529-1H-benzo%255Bd%255Dimid%2520azol-2-yl%2529-2-methylisonicotinamide%2520%2528EGF816%2529%252C%2520a%2520novel%252C%2520potent%252C%2520and%2520WT%2520sparing%2520covalent%2520inhibitor%2520of%2520oncogenic%2520%2528L858R%252C%2520ex19del%2529%2520and%2520resistant%2520%2528T790M%2529%2520EGFR%2520mutants%2520for%2520the%2520treatment%2520of%2520EGFR%2520mutant%2520non-small-cell%2520lung%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D14%26spage%3D6671%26epage%3D6689%26doi%3D10.1021%2Facs.jmedchem.5b01985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dela Vega, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lainchbury, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeap, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of a noncovalent, mutant-selective epidermal growth factor receptor inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9080</span>– <span class="NLM_lpage">9093</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWlsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9080-9093&issue=19&author=B.+K.+Chanauthor=E.+J.+Hananauthor=K.+K.+Bowmanauthor=M.+C.+Bryanauthor=D.+Burdickauthor=E.+Chanauthor=Y.+Chenauthor=S.+Clausenauthor=T.+Dela+Vegaauthor=J.+Dotsonauthor=C.+Eigenbrotauthor=R.+L.+Elliottauthor=R.+A.+Healdauthor=P.+S.+Jacksonauthor=J.+D.+Knightauthor=H.+Laauthor=M.+D.+Lainchburyauthor=S.+Malekauthor=H.+E.+Purkeyauthor=G.+Schaeferauthor=S.+Schmidtauthor=E.+M.+Sewardauthor=S.+Siderisauthor=L.+Shaoauthor=S.+Wangauthor=S.+K.+Yeapauthor=I.+Yenauthor=C.+Yuauthor=T.+P.+Heffron&title=Discovery+of+a+noncovalent%2C+mutant-selective+epidermal+growth+factor+receptor+inhibitor&doi=10.1021%2Facs.jmedchem.6b00995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor</span></div><div class="casAuthors">Chan, Bryan K.; Hanan, Emily J.; Bowman, Krista K.; Bryan, Marian C.; Burdick, Daniel; Chan, Emily; Chen, Yuan; Clausen, Saundra; Dela Vega, Trisha; Dotson, Jennafer; Eigenbrot, Charles; Elliott, Richard L.; Heald, Robert A.; Jackson, Philip S.; Knight, Jamie D.; La, Hank; Lainchbury, Michael D.; Malek, Shiva; Purkey, Hans E.; Schaefer, Gabriele; Schmidt, Stephen; Seward, Eileen M.; Sideris, Steve; Shao, Lily; Wang, Shumei; Yeap, Siew Kuen; Yen, Ivana; Yu, Christine; Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9080-9093</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors targeting the activating mutants of the epidermal growth factor receptor (EGFR) have found success in the treatment of EGFR mutant pos. nonsmall-cell lung cancer.  A secondary point mutation (T790M) in the inhibitor binding site has been linked to the acquired resistance against those first generation therapeutics.  Herein, the authors describe the lead optimization of a series of reversible, pan-mutant (L858R, del746-750, T790M/L858R, and T790M/del746-750) EGFR inhibitors.  By use of a noncovalent double mutant (T790M/L858R and T790M/del746-750) selective EGFR inhibitor I as a starting point, activities against the single mutants (L858R and del746-750) were introduced through a series of structure-guided modifications.  The in vitro ADME-PK properties of the lead mols. were further optimized through a no. of rational structural changes.  The resulting inhibitor II exhibited excellent cellular activity against both the single and double mutants of EGFR, demonstrating target engagement in vivo and ADME-PK properties that are suitable for further evaluation.  The reversible, noncovalent inhibitors described complement the covalent pan-mutant EGFR inhibitors that have shown encouraging results in recent clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSFhbM4LOYrVg90H21EOLACvtfcHk0lgbwMxxJh-Lsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWlsbnL&md5=7b17fcf5fc401843821445cf6e6e9f0b</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00995%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DClausen%26aufirst%3DS.%26aulast%3DDela%2BVega%26aufirst%3DT.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DKnight%26aufirst%3DJ.%2BD.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLainchbury%26aufirst%3DM.%2BD.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DSchaefer%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYeap%26aufirst%3DS.%2BK.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520noncovalent%252C%2520mutant-selective%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9080%26epage%3D9093%26doi%3D10.1021%2Facs.jmedchem.6b00995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eYLQ94bowWUEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization and discovery of 5-((5-([1,1′-biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzozic acid (MK-3903): a novel class of benzimidazole-based activators of AMP-activated protein kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9040</span>– <span class="NLM_lpage">9052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9040-9052&issue=21&author=P.+Lanauthor=F.+A.+Romeroauthor=D.+Wodkaauthor=A.+J.+Kassickauthor=Q.+Dangauthor=T.+Gibsonauthor=D.+Cashionauthor=G.+Zhouauthor=Y.+Chenauthor=X.+Zhangauthor=A.+Zhangauthor=Y.+Liauthor=M.+E.+Trujilloauthor=Q.+Shaoauthor=M.+Wuauthor=S.+Xuauthor=H.+Heauthor=D.+MacKennaauthor=J.+Stauntonauthor=K.+T.+Chapmanauthor=A.+Weberauthor=I.+K.+Sebhatauthor=G.+M.+Makara&title=Hit-to-lead+optimization+and+discovery+of+5-%28%285-%28%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29-6-chloro-1H-benzo%5Bd%5Dimidazol-2-yl%29oxy%29-2-methylbenzozic+acid+%28MK-3903%29%3A+a+novel+class+of+benzimidazole-based+activators+of+AMP-activated+protein+kinase&doi=10.1021%2Facs.jmedchem.7b01344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01344%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DP.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DMacKenna%26aufirst%3DD.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DHit-to-lead%2520optimization%2520and%2520discovery%2520of%25205-%2528%25285-%2528%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529-6-chloro-1H-benzo%255Bd%255Dimidazol-2-yl%2529oxy%2529-2-methylbenzozic%2520acid%2520%2528MK-3903%2529%253A%2520a%2520novel%2520class%2520of%2520benzimidazole-based%2520activators%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D21%26spage%3D9040%26epage%3D9052%26doi%3D10.1021%2Facs.jmedchem.7b01344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kekec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dropinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8722: A systemic, direct pan-activator of AMP-activated protein kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=39-44&issue=1&author=D.+Fengauthor=T.+Biftuauthor=F.+A.+Romeroauthor=A.+Kekecauthor=J.+Dropinskiauthor=A.+Kassickauthor=S.+Xuauthor=M.+M.+Kurtzauthor=A.+Gollapudiauthor=Q.+Shaoauthor=X.+Yangauthor=K.+Luauthor=G.+Zhouauthor=D.+Kempauthor=R.+W.+Myersauthor=H.-P.+Guanauthor=M.+E.+Trujilloauthor=C.+Liauthor=A.+Weberauthor=I.+K.+Sebhat&title=Discovery+of+MK-8722%3A+A+systemic%2C+direct+pan-activator+of+AMP-activated+protein+kinase&doi=10.1021%2Facsmedchemlett.7b00417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00417%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DKekec%26aufirst%3DA.%26aulast%3DDropinski%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DKemp%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.-P.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DDiscovery%2520of%2520MK-8722%253A%2520A%2520systemic%252C%2520direct%2520pan-activator%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D39%26epage%3D44%26doi%3D10.1021%2Facsmedchemlett.7b00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahalada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Trotter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conarello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Painter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohm, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFranco Scheuch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">6350</span>),  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1126/science.aah5582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1126%2Fscience.aah5582" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=507-511&issue=6350&author=R.+W.+Myersauthor=H.+P.+Guanauthor=J.+Ehrhartauthor=A.+Petrovauthor=S.+Prahaladaauthor=E.+Tozzoauthor=X.+Yangauthor=M.+M.+Kurtzauthor=M.+Trujilloauthor=D.+Gonzalez+Trotterauthor=D.+Fengauthor=S.+Xuauthor=G.+Eiermannauthor=M.+A.+Holahanauthor=D.+Rubinsauthor=S.+Conarelloauthor=X.+Niuauthor=S.+C.+Souzaauthor=C.+Millerauthor=J.+Liuauthor=K.+Luauthor=W.+Fengauthor=Y.+Liauthor=R.+E.+Painterauthor=J.+A.+Milliganauthor=H.+Heauthor=F.+Liuauthor=A.+Ogawaauthor=D.+Wisniewskiauthor=R.+J.+Rohmauthor=L.+Wangauthor=M.+Bunzelauthor=Y.+Qianauthor=W.+Zhuauthor=H.+Wangauthor=B.+Bennetauthor=L.+LaFranco+Scheuchauthor=G.+E.+Fernandezauthor=C.+Liauthor=M.+Klimasauthor=G.+Zhouauthor=M.+van+Heekauthor=T.+Biftuauthor=A.+Weberauthor=D.+E.+Kelleyauthor=N.+Thornberryauthor=M.+D.+Erionauthor=D.+M.+Kempauthor=I.+K.+Sebhat&title=Systemic+pan-AMPK+activator+MK-8722+improves+glucose+homeostasis+but+induces+cardiac+hypertrophy&doi=10.1126%2Fscience.aah5582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5582%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DPrahalada%26aufirst%3DS.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DGonzalez%2BTrotter%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DRubins%26aufirst%3DD.%26aulast%3DConarello%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DSouza%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPainter%26aufirst%3DR.%2BE.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DRohm%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBunzel%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBennet%26aufirst%3DB.%26aulast%3DLaFranco%2BScheuch%26aufirst%3DL.%26aulast%3DFernandez%26aufirst%3DG.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DKlimas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DKemp%26aufirst%3DD.%2BM.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DSystemic%2520pan-AMPK%2520activator%2520MK-8722%2520improves%2520glucose%2520homeostasis%2520but%2520induces%2520cardiac%2520hypertrophy%26jtitle%3DScience%26date%3D2017%26volume%3D357%26issue%3D6350%26spage%3D507%26epage%3D511%26doi%3D10.1126%2Fscience.aah5582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&issue=17&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0lgJzX2Cyo9eaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D17%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van De Waterbeemd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. K.</span></span> <span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1333</span>, <span class="refDoi"> DOI: 10.1021/jm000407e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&issue=9&author=H.+van+De+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics&doi=10.1021%2Fjm000407e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0lgJzX2Cyo9eaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D9%26spage%3D1313%26epage%3D1333%26doi%3D10.1021%2Fjm000407e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span> <span> </span><span class="NLM_article-title">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1596</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27319293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaht73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1596-1608&issue=10&author=J.+G.+Kettleauthor=D.+M.+Wilson&title=Standing+on+the+shoulders+of+giants%3A+a+retrospective+analysis+of+kinase+drug+discovery+at+AstraZeneca&doi=10.1016%2Fj.drudis.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca</span></div><div class="casAuthors">Kettle, Jason G.; Wilson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1596-1608</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sir James Black famously said: 'The most fruitful basis of the discovery of a new drug is to start with an old drug', and this idea has featured in a significant no. of kinase drug discovery programs at AstraZeneca over the past two decades.  Of the marketed kinase inhibitors and various clin. trialled agents, candidate drugs and multiple lead optimization programs delivered over this timeframe at AstraZeneca the overwhelming majority trace their origins back to a small handful of pioneering drug discovery programs.  Importantly, these projects not only laid the foundations of the organisational expertise on how to 'drug' this important target family but also provided a legacy of internal chem. equity that has had a profound influence on the many kinase-focused discovery efforts that have followed.  For agents in late-stage clin. trials today, seemingly the product of rapid discovery phases, the reality is that these are often the products of decades of research.  Crucial to the success of these projects has been the medicinal chemists involved, whose intimate knowledge and expertise around key kinase chem. scaffolds has enabled successful medicinal chem. strategies to be rapidly identified and executed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Iydy47cfvrVg90H21EOLACvtfcHk0lj7NC7ZfoyqKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaht73F&md5=487d15ce496bce584f50d0d0fe1543d9</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26atitle%3DStanding%2520on%2520the%2520shoulders%2520of%2520giants%253A%2520a%2520retrospective%2520analysis%2520of%2520kinase%2520drug%2520discovery%2520at%2520AstraZeneca%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1596%26epage%3D1608%26doi%3D10.1016%2Fj.drudis.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarcsay, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserű, G. M.</span></span> <span> </span><span class="NLM_article-title">Contributions of molecular properties to drug promiscuity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1795</span>, <span class="refDoi"> DOI: 10.1021/jm301514n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301514n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1789-1795&issue=5&author=%C3%81.+Tarcsayauthor=G.+M.+Keser%C5%B1&title=Contributions+of+molecular+properties+to+drug+promiscuity&doi=10.1021%2Fjm301514n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of Molecular Properties to Drug Promiscuity</span></div><div class="casAuthors">Tarcsay, Akos; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In contrast to designed polypharmacol. that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicol.  Characterization of promiscuous compds. enhances the understanding of complex interaction patterns and aids the design of compds. with broader selectivity against off-targets that has a major impact on medicinal chem. outcome.  In this Miniperspective we provide insights to the effect of physicochem. parameters on promiscuity.  Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochem. properties and promiscuity in detail.  In light of these data, lipophilicity and basic character have the highest influence.  On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochem. properties during medicinal chem. optimizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1J_jqkK3DrVg90H21EOLACvtfcHk0lj7NC7ZfoyqKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ehug%253D%253D&md5=c5763ee1aed897ff19e5a2344b95b9c1</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Fjm301514n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301514n%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3D%25C3%2581.%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26atitle%3DContributions%2520of%2520molecular%2520properties%2520to%2520drug%2520promiscuity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D5%26spage%3D1789%26epage%3D1795%26doi%3D10.1021%2Fjm301514n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Curing hepatitis C virus infection with direct-acting antiviral agents: the arc of a medicinal chemistry triumph</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7311</span>– <span class="NLM_lpage">7351</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00915</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7311-7351&issue=16&author=N.+A.+Meanwell&title=Curing+hepatitis+C+virus+infection+with+direct-acting+antiviral+agents%3A+the+arc+of+a+medicinal+chemistry+triumph&doi=10.1021%2Facs.jmedchem.6b00915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DCuring%2520hepatitis%2520C%2520virus%2520infection%2520with%2520direct-acting%2520antiviral%2520agents%253A%2520the%2520arc%2520of%2520a%2520medicinal%2520chemistry%2520triumph%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D16%26spage%3D7311%26epage%3D7351%26doi%3D10.1021%2Facs.jmedchem.6b00915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanowich-Knipp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6074</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm060325b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&issue=20&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.+C.+Chengauthor=Y.+Hsiehauthor=J.+M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-+3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection&doi=10.1021%2Fjm060325b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.%2BM.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-%25203-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D20%26spage%3D6074%26epage%3D6086%26doi%3D10.1021%2Fjm060325b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, P.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1038/nbt.2020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnbt.2020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=993-1003&issue=11&author=A.+D.+Kwongauthor=R.+S.+Kauffmanauthor=P.+Hurterauthor=P.+Mueller&title=Discovery+and+development+of+telaprevir%3A+an+NS3-4A+protease+inhibitor+for+treating+genotype+1+chronic+hepatitis+C+virus&doi=10.1038%2Fnbt.2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2020%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DHurter%26aufirst%3DP.%26aulast%3DMueller%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520development%2520of%2520telaprevir%253A%2520an%2520NS3-4A%2520protease%2520inhibitor%2520for%2520treating%2520genotype%25201%2520chronic%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D993%26epage%3D1003%26doi%3D10.1038%2Fnbt.2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1356</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1002/anie.200390347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&issue=12&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection&doi=10.1002%2Fanie.200390347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26issue%3D12%26spage%3D1356%26epage%3D1360%26doi%3D10.1002%2Fanie.200390347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand-Maitre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapeyre-Paquette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheaume, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1021/jm0342414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&issue=7&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.+M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure-activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061&doi=10.1021%2Fjm0342414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure-activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D7%26spage%3D1605%26epage%3D1608%26doi%3D10.1021%2Fjm0342414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1021/ja711120r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&issue=14&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.+S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.+L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease&doi=10.1021%2Fja711120r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26issue%3D14%26spage%3D4607%26epage%3D4609%26doi%3D10.1021%2Fja711120r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-1220: A macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1021/ml1002426</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&issue=3&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+A+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure&doi=10.1021%2Fml1002426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520A%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D3%26spage%3D207%26epage%3D212%26doi%3D10.1021%2Fml1002426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1021/jm9015526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&issue=6&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.+S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fjm9015526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2443%26epage%3D2463%26doi%3D10.1021%2Fjm9015526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiFilippo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1021/ml300017p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&issue=4&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fml300017p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lhwcleF6lDEjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D4%26spage%3D332%26epage%3D336%26doi%3D10.1021%2Fml300017p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Torres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bisceglie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamm, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krefetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E.</span></span> <span> </span><span class="NLM_article-title">GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study</span>. <i>J. Viral Hepat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1111/jvh.12527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1111%2Fjvh.12527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26957110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOkurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=614-622&issue=8&author=M.+Rodriguez-Torresauthor=S.+Glassauthor=J.+Hillauthor=B.+Freilichauthor=D.+Hassmanauthor=A.+M.+Di+Bisceglieauthor=J.+G.+Taylorauthor=B.+J.+Kirbyauthor=H.+Dvory-Sobolauthor=J.+C.+Yangauthor=D.+Anauthor=L.+M.+Stammauthor=D.+M.+Brainardauthor=S.+Kimauthor=D.+Krefetzauthor=W.+Smithauthor=T.+Marburyauthor=E.+Lawitz&title=GS-9857+in+patients+with+chronic+hepatitis+C+virus+genotype+1-4+infection%3A+a+randomized%2C+double-blind%2C+dose-ranging+phase+1+study&doi=10.1111%2Fjvh.12527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study</span></div><div class="casAuthors">Rodriguez-Torres, M.; Glass, S.; Hill, J.; Freilich, B.; Hassman, D.; Di Bisceglie, A. M.; Taylor, J. G.; Kirby, B. J.; Dvory-Sobol, H.; Yang, J. C.; An, D.; Stamm, L. M.; Brainard, D. M.; Kim, S.; Krefetz, D.; Smith, W.; Marbury, T.; Lawitz, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Viral Hepatitis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-622</span>CODEN:
                <span class="NLM_cas:coden">JVHEER</span>;
        ISSN:<span class="NLM_cas:issn">1365-2893</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Summary : GS-9857, an inhibitor of the hepatitis C virus (HCV) nonstructural protein (NS) 3/4A, demonstrates potent activity against HCV genotypes 1-6 and improved coverage against commonly encountered NS3 resistance-assocd. variants (RAVs).  In this study, the safety, tolerability, antiviral activity and pharmacokinetics (PK) of GS-9857 were evaluated in patients with chronic HCV genotype 1-4 infection.  Patients with genotype 1-4 infection received placebo or once-daily GS-9857 at doses ranging from 50 to 300 mg for 3 days under fasting conditions.  GS-9857 was well tolerated; all reported adverse events (AEs) were mild or moderate in severity.  Diarrhoea and headache were the most commonly reported AEs.  Grade 3 or 4 lab. abnormalities were obsd. in 17% of patients receiving GS-9857; there were no Grade 3 or 4 abnormalities in alanine aminotransferase, aspartate aminotransferase or alk. phosphatase levels.  GS-9857 demonstrated potent antiviral activity in patients with chronic HCV infection, achieving mean and median max. redns. in HCV RNA of ≥3 log10 IU/mL following administration of a 100-mg dose in patients with HCV genotype 1a, 1b, 2, 3 or 4 infection.  The antiviral activity of GS-9857 was unaffected by the presence of pretreatment NS3 RAVs.  In patients with genotype 1-4 infection, GS-9857 exhibited linear PK and was assocd. with a median half-life of 29-42 h, supporting once-daily dosing.  Thus, the tolerability, efficacy and pharmacokinetic profile of GS-9857 support its further evaluation for treatment of patients with chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8oJDwl-bOdbVg90H21EOLACvtfcHk0lhwcleF6lDEjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOkurbK&md5=257769b545cb4289b8f9fc5298454f91</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Fjvh.12527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjvh.12527%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DGlass%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DFreilich%26aufirst%3DB.%26aulast%3DHassman%26aufirst%3DD.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DKirby%26aufirst%3DB.%2BJ.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DAn%26aufirst%3DD.%26aulast%3DStamm%26aufirst%3DL.%2BM.%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKrefetz%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DW.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DLawitz%26aufirst%3DE.%26atitle%3DGS-9857%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520virus%2520genotype%25201-4%2520infection%253A%2520a%2520randomized%252C%2520double-blind%252C%2520dose-ranging%2520phase%25201%2520study%26jtitle%3DJ.%2520Viral%2520Hepat.%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3D614%26epage%3D622%26doi%3D10.1111%2Fjvh.12527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvory-Sobol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span> <span> </span><span class="NLM_article-title">P0899: Preclinical profile of the pan-genotypic HCV NS3/4A protease inhibitor GS-9857</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">S681</span>, <span class="refDoi"> DOI: 10.1016/S0168-8278(15)31102-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2FS0168-8278%2815%2931102-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=S681&author=J.%0AG.+Taylorauthor=T.+Applebyauthor=O.+Barauskasauthor=X.+Chenauthor=H.+Dvory-Sobolauthor=R.+Gongauthor=J.+Leeauthor=E.+Nejatiauthor=B.+Schultzauthor=Y.+Wangauthor=C.+Yangauthor=M.+Yuauthor=S.+Zipfelauthor=K.+Chan&title=P0899%3A+Preclinical+profile+of+the+pan-genotypic+HCV+NS3%2F4A+protease+inhibitor+GS-9857&doi=10.1016%2FS0168-8278%2815%2931102-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2815%2931102-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252815%252931102-8%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DAppleby%26aufirst%3DT.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDvory-Sobol%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNejati%26aufirst%3DE.%26aulast%3DSchultz%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZipfel%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DK.%26atitle%3DP0899%253A%2520Preclinical%2520profile%2520of%2520the%2520pan-genotypic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520GS-9857%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D62%26spage%3DS681%26doi%3D10.1016%2FS0168-8278%2815%2931102-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Riordan, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asatryan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilich, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overcash, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kort, J.</span></span> <span> </span><span class="NLM_article-title">Potent antiviral activities of the direct-acting antivirals ABT-493 and ABT-530 with three-day monotherapy for hepatitis C virus genotype 1 infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1128/AAC.02264-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02264-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1546-1555&issue=3&author=E.+J.+Lawitzauthor=W.+D.+O%E2%80%99Riordanauthor=A.+Asatryanauthor=B.+L.+Freilichauthor=T.+D.+Boxauthor=J.+S.+Overcashauthor=S.+Lovellauthor=T.+I.+Ngauthor=W.+Liuauthor=A.+Campbellauthor=C.+W.+Linauthor=B.+Yaoauthor=J.+Kort&title=Potent+antiviral+activities+of+the+direct-acting+antivirals+ABT-493+and+ABT-530+with+three-day+monotherapy+for+hepatitis+C+virus+genotype+1+infection&doi=10.1128%2FAAC.02264-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1128%2FAAC.02264-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02264-15%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DW.%2BD.%26aulast%3DAsatryan%26aufirst%3DA.%26aulast%3DFreilich%26aufirst%3DB.%2BL.%26aulast%3DBox%26aufirst%3DT.%2BD.%26aulast%3DOvercash%26aufirst%3DJ.%2BS.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DKort%26aufirst%3DJ.%26atitle%3DPotent%2520antiviral%2520activities%2520of%2520the%2520direct-acting%2520antivirals%2520ABT-493%2520and%2520ABT-530%2520with%2520three-day%2520monotherapy%2520for%2520hepatitis%2520C%2520virus%2520genotype%25201%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D3%26spage%3D1546%26epage%3D1555%26doi%3D10.1128%2FAAC.02264-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmeijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumont-Mauviel, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1021/jm401507s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401507s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1673-1693&issue=5&author=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+O.+Johanssonauthor=M.+D.+Cummingsauthor=O.+Lenzauthor=P.+Raboissonauthor=K.+Simmenauthor=S.+Vendevilleauthor=H.+de+Kockauthor=M.+Nilssonauthor=A.+Horvathauthor=R.+Kalmeijerauthor=G.+de+la+Rosaauthor=M.+Beumont-Mauviel&title=Discovery+and+development+of+simeprevir+%28TMC435%29%2C+a+HCV+NS3%2F4A+protease+inhibitor&doi=10.1021%2Fjm401507s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor</span></div><div class="casAuthors">Rosenquist, Aasa; Samuelsson, Bertil; Johansson, Per-Ola; Cummings, Maxwell D.; Lenz, Oliver; Raboisson, Pierre; Simmen, Kenny; Vendeville, Sandrine; de Kock, Herman; Nilsson, Magnus; Horvath, Andras; Kalmeijer, Ronald; de la Rosa, Guy; Beumont-Mauviel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1673-1693</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus is a blood-borne infection and the leading cause of chronic liver disease (including cirrhosis and cancer) and liver transplantation.  Since the identification of HCV in 1989, there has been an extensive effort to identify and improve treatment options.  An important milestone was reached in 2011 with the approval of the first-generation HCV NS3/4A protease inhibitors.  However, new therapies are needed to improve cure rates, shorten treatment duration, and improve tolerability.  Here we summarize the extensive medicinal chem. effort to develop novel P2 cyclopentane macrocyclic inhibitors guided by HCV NS3 protease assays, the cellular replicon system, structure-based design, and a panel of DMPK assays.  The selection of compd. 29 (simeprevir, TMC435) as clin. candidate was based on its excellent biol., PK, and safety pharmacol. profile.  Compd. 29 has recently been approved for treatment of chronic HCV infection in combination with pegylated interferon-α and ribavirin in Japan, Canada, and USA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCRg3NRRjzrVg90H21EOLACvtfcHk0liV7vn9wfJjEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D&md5=fd9c1df095e47a111d9680af4c40ccc6</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Fjm401507s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401507s%26sid%3Dliteratum%253Aachs%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DP.%2BO.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DKalmeijer%26aufirst%3DR.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DG.%26aulast%3DBeumont-Mauviel%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520simeprevir%2520%2528TMC435%2529%252C%2520a%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D1673%26epage%3D1693%26doi%3D10.1021%2Fjm401507s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaultier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pithawalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Or, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1128/AAC.04227-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.04227-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=988-997&issue=2&author=T.+Pilot-Matiasauthor=R.+Tripathiauthor=D.+Cohenauthor=I.+Gaultierauthor=T.+Dekhtyarauthor=L.+Luauthor=T.+Reischauthor=M.+Irvinauthor=T.+Hopkinsauthor=R.+Pithawallaauthor=T.+Middletonauthor=T.+Ngauthor=K.+McDanielauthor=Y.+S.+Orauthor=R.+Menonauthor=D.+Kempfauthor=A.+Mollaauthor=C.+Collins&title=In+vitro+and+in+vivo+antiviral+activity+and+resistance+profile+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ABT-450&doi=10.1128%2FAAC.04227-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1128%2FAAC.04227-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04227-14%26sid%3Dliteratum%253Aachs%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DGaultier%26aufirst%3DI.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DHopkins%26aufirst%3DT.%26aulast%3DPithawalla%26aufirst%3DR.%26aulast%3DMiddleton%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DT.%26aulast%3DMcDaniel%26aufirst%3DK.%26aulast%3DOr%26aufirst%3DY.%2BS.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DKempf%26aufirst%3DD.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ABT-450%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D988%26epage%3D997%26doi%3D10.1128%2FAAC.04227-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/jm400887j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&issue=2&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+what+can+medicinal+chemists+learn+from+their+properties%3F&doi=10.1021%2Fjm400887j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?</span></div><div class="casAuthors">Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles are ideal in efforts to tackle difficult targets, but our understanding of what makes them cell permeable and orally bioavailable is limited.  Anal. of approx. 100 macrocyclic drugs and clin. candidates revealed that macrocycles are predominantly used for infectious disease and in oncol. and that most belong to the macrolide or cyclic peptide class.  A significant no. (N = 34) of these macrocycles are administered orally, revealing that oral bioavailability can be obtained at mol. wts. up to and above 1 kDa and polar surface areas ranging toward 250 Å2.  Moreover, insight from a group of de novo designed oral macrocycles in clin. studies and understanding of how cyclosporin A and model cyclic hexapeptides cross cell membranes may unlock wider opportunities in drug discovery.  However, the no. of oral macrocycles is still low and it remains to be seen if they are outliers or if macrocycles will open up novel oral druggable space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaeM2DXwvmiLVg90H21EOLACvtfcHk0ljn9WAmvJiVLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI&md5=a3e1743bd5ba34f73d8e78f8cb1bee5f</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520what%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D2%26spage%3D278%26epage%3D295%26doi%3D10.1021%2Fjm400887j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockus, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lexa, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hund, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwochert, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Probing the physicochemical boundaries of cell permeability and oral bioavailability in lipophilic macrocycles inspired by natural products</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4581</span>– <span class="NLM_lpage">4589</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvV2ku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4581-4589&issue=11&author=A.+T.+Bockusauthor=K.+W.+Lexaauthor=C.+R.+Pyeauthor=A.+S.+Kalgutkarauthor=J.+W.+Gardnerauthor=K.+C.+Hundauthor=W.+M.+Hewittauthor=J.+A.+Schwochertauthor=E.+Glasseyauthor=D.+A.+Priceauthor=A.+M.+Mathiowetzauthor=S.+Lirasauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Probing+the+physicochemical+boundaries+of+cell+permeability+and+oral+bioavailability+in+lipophilic+macrocycles+inspired+by+natural+products&doi=10.1021%2Facs.jmedchem.5b00128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products</span></div><div class="casAuthors">Bockus, Andrew T.; Lexa, Katrina W.; Pye, Cameron R.; Kalgutkar, Amit S.; Gardner, Jarret W.; Hund, Kathryn C. R.; Hewitt, William M.; Schwochert, Joshua A.; Glassey, Emerson; Price, David A.; Mathiowetz, Alan M.; Liras, Spiros; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4581-4589</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptide natural products contain a variety of conserved, nonproteinogenic structural elements such as D-amino acids and amide N-methylation.  In addn., many cyclic peptides incorporate γ-amino acids and other elements derived from polyketide synthases.  We hypothesized that the position and orientation of these extended backbone elements impact the ADME properties of these hybrid mols., esp. their ability to cross cell membranes and avoid metabolic degrdn.  Here we report the synthesis of cyclic hexapeptide diastereomers contg. γ-amino acids (e.g., statines) and systematically investigate their structure-permeability relationships.  These compds. were much more water-sol. and, in many cases, were both more membrane permeable and more stable to liver microsomes than a similar non-statine-contg. deriv.  Permeability correlated well with the extent of intramol. hydrogen bonding obsd. in the soln. structures detd. in the low-dielec. solvent CDCl3, and one compd. showed an oral bioavailability of 21% in rat.  Thus, the incorporation of γ-amino acids offers a route to increase backbone diversity and improve ADME properties in cyclic peptide scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXlzvMDhSrerVg90H21EOLACvtfcHk0ljn9WAmvJiVLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvV2ku7s%253D&md5=b50bfd139a4abcae5ede988a5b095ce1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00128%26sid%3Dliteratum%253Aachs%26aulast%3DBockus%26aufirst%3DA.%2BT.%26aulast%3DLexa%26aufirst%3DK.%2BW.%26aulast%3DPye%26aufirst%3DC.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DJ.%2BW.%26aulast%3DHund%26aufirst%3DK.%2BC.%26aulast%3DHewitt%26aufirst%3DW.%2BM.%26aulast%3DSchwochert%26aufirst%3DJ.%2BA.%26aulast%3DGlassey%26aufirst%3DE.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DProbing%2520the%2520physicochemical%2520boundaries%2520of%2520cell%2520permeability%2520and%2520oral%2520bioavailability%2520in%2520lipophilic%2520macrocycles%2520inspired%2520by%2520natural%2520products%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D11%26spage%3D4581%26epage%3D4589%26doi%3D10.1021%2Facs.jmedchem.5b00128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chembiol.2014.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25237858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1115-1142&issue=9&author=B.+C.+Doakauthor=B.+Overauthor=F.+Giordanettoauthor=J.+Kihlberg&title=Oral+druggable+space+beyond+the+rule+of+5%3A+insights+from+drugs+and+clinical+candidates&doi=10.1016%2Fj.chembiol.2014.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates</span></div><div class="casAuthors">Doak, Bradley Croy; Over, Bjorn; Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1115-1142</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rule of 5 (Ro5) is a set of in silico guidelines applied to drug discovery to prioritize compds. with an increased likelihood of high oral absorption.  It has been influential in reducing attrition due to poor pharmacokinetics over the last 15 years.  However, strict reliance on the Ro5 may have resulted in lost opportunities, particularly for difficult targets.  To identify opportunities for oral drug discovery beyond the Ro5 (bRo5), we have comprehensively analyzed drugs and clin. candidates with mol. wt. (MW) > 500 Da.  We conclude that oral drugs are found far bRo5 and properties such as intramol. hydrogen bonding, macrocyclization, dosage, and formulations can be used to improve bRo5 bioavailability.  Natural products and structure-based design, often from peptidic leads, are key sources for oral bRo5 drugs.  These insights should help guide the design of oral drugs in bRo5 space, which is of particular interest for difficult targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYqpeA0dh6rVg90H21EOLACvtfcHk0ljn9WAmvJiVLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrur7K&md5=b8a88c793572ad48de3809807a4699d8</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DOral%2520druggable%2520space%2520beyond%2520the%2520rule%2520of%25205%253A%2520insights%2520from%2520drugs%2520and%2520clinical%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D1115%26epage%3D1142%26doi%3D10.1016%2Fj.chembiol.2014.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villar, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chennamadhavuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span> <span> </span><span class="NLM_article-title">How proteins bind macrocycles</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchembio.1584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25038790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFygs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=723-731&author=E.+A.+Villarauthor=D.+Beglovauthor=S.+Chennamadhavuniauthor=J.+A.+Porcoauthor=D.+Kozakovauthor=S.+Vajdaauthor=A.+Whitty&title=How+proteins+bind+macrocycles&doi=10.1038%2Fnchembio.1584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">How proteins bind macrocycles</span></div><div class="casAuthors">Villar, Elizabeth A.; Beglov, Dmitri; Chennamadhavuni, Spandan; Porco, John A. Jr; Kozakov, Dima; Vajda, Sandor; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">723-731</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The potential utility of synthetic macrocycles (MCs) as drugs, particularly against low-druggability targets such as protein-protein interactions, has been widely discussed.  There is little information, however, to guide the design of MCs for good target protein-binding activity or bioavailability.  To address this knowledge gap, we analyze the binding modes of a representative set of MC-protein complexes.  The results, combined with consideration of the physicochem. properties of approved macrocyclic drugs, allow us to propose specific guidelines for the design of synthetic MC libraries with structural and physicochem. features likely to favor strong binding to protein targets as well as good bioavailability.  We addnl. provide evidence that large, natural product-derived MCs can bind targets that are not druggable by conventional, drug-like compds., supporting the notion that natural product-inspired synthetic MCs can expand the no. of proteins that are druggable by synthetic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa3yuNCHU5d7Vg90H21EOLACvtfcHk0liZZicGaoHKbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFygs7jF&md5=0d41fba9267abb3a3d0065487937075a</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1584%26sid%3Dliteratum%253Aachs%26aulast%3DVillar%26aufirst%3DE.%2BA.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DChennamadhavuni%26aufirst%3DS.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DHow%2520proteins%2520bind%2520macrocycles%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D723%26epage%3D731%26doi%3D10.1038%2Fnchembio.1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Cell permeability beyond the rule of 5</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">Suppl. C</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.addr.2016.03.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=42-61&issue=Suppl.+C&author=P.+Matssonauthor=B.+C.+Doakauthor=B.+Overauthor=J.+Kihlberg&title=Cell+permeability+beyond+the+rule+of+5&doi=10.1016%2Fj.addr.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DCell%2520permeability%2520beyond%2520the%2520rule%2520of%25205%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D101%26issue%3DSuppl.%2520C%26spage%3D42%26epage%3D61%26doi%3D10.1016%2Fj.addr.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span>Telaprevir
label. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201917lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201917lbl.pdf</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Telaprevir%0Alabel.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2011%2F201917lbl.pdf+%28accessed+February+2%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deon, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrich, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romine, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruediger, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Laurent, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, D. R.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, L. G.</span></span> <span> </span><span class="NLM_article-title">Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2032</span>, <span class="refDoi"> DOI: 10.1021/jm401836p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401836p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2013-2032&issue=5&author=M.+Belemaauthor=V.+N.+Nguyenauthor=C.+Bachandauthor=D.+H.+Deonauthor=J.+T.+Goodrichauthor=C.+A.+Jamesauthor=R.+Lavoieauthor=O.+D.+Lopezauthor=A.+Martelauthor=J.+L.+Romineauthor=E.+H.+Ruedigerauthor=L.+B.+Snyderauthor=D.+R.+St.+Laurentauthor=F.+Yangauthor=J.+Zhuauthor=H.+S.+Wongauthor=D.+R.+Langleyauthor=S.+P.+Adamsauthor=G.+H.+Cantorauthor=A.+Chimalakondaauthor=A.+Furaauthor=B.+M.+Johnsonauthor=J.+O.+Knipeauthor=D.+D.+Parkerauthor=K.+S.+Santoneauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=D.+R.+O%E2%80%99Boyleauthor=R.+J.+Colonnoauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Hepatitis+C+virus+NS5A+replication+complex+inhibitors%3A+the+discovery+of+daclatasvir&doi=10.1021%2Fjm401836p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fjm401836p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401836p%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DBachand%26aufirst%3DC.%26aulast%3DDeon%26aufirst%3DD.%2BH.%26aulast%3DGoodrich%26aufirst%3DJ.%2BT.%26aulast%3DJames%26aufirst%3DC.%2BA.%26aulast%3DLavoie%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DMartel%26aufirst%3DA.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DRuediger%26aufirst%3DE.%2BH.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26aulast%3DCantor%26aufirst%3DG.%2BH.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DSantone%26aufirst%3DK.%2BS.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DHepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitors%253A%2520the%2520discovery%2520of%2520daclatasvir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2013%26epage%3D2032%26doi%3D10.1021%2Fjm401836p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5071</span>, <span class="refDoi"> DOI: 10.1021/jm500335h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500335h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5057-5071&issue=12&author=M.+Belemaauthor=N.+A.+Meanwell&title=Discovery+of+daclatasvir%2C+a+pan-genotypic+hepatitis+C+virus+NS5A+replication+complex+inhibitor+with+potent+clinical+effect&doi=10.1021%2Fjm500335h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1021%2Fjm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500335h%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520of%2520daclatasvir%252C%2520a%2520pan-genotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitor%2520with%2520potent%2520clinical%2520effect%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D12%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Fjm500335h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanenkov, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veselov, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhbazyan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladinskiy, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aladinskaya, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yartseva, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vantskul, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivachtchenko, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koteliansky, V. E.</span></span> <span> </span><span class="NLM_article-title">A comprehensive insight into the chemical space and ADME features of small molecule NS5A inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1372</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.2174/1568026616666151120113040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.2174%2F1568026616666151120113040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26585933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1372-1382&issue=12&author=Y.+A.+Ivanenkovauthor=M.+S.+Veselovauthor=A.+G.+Shakhbazyanauthor=V.+A.+Aladinskiyauthor=A.+V.+Aladinskayaauthor=S.+M.+Yartsevaauthor=A.+G.+Majougaauthor=A.+S.+Vantskulauthor=S.+V.+Leonovauthor=A.+V.+Ivachtchenkoauthor=V.+E.+Koteliansky&title=A+comprehensive+insight+into+the+chemical+space+and+ADME+features+of+small+molecule+NS5A+inhibitors&doi=10.2174%2F1568026616666151120113040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors</span></div><div class="casAuthors">Ivanenkov, Yan A.; Veselov, Mark S.; Shakhbazyan, Artem G.; Aladinskiy, Vladimir A.; Aladinskaya, Anastasia V.; Yartseva, Sofya M.; Majouga, Alexander G.; Vantskul, Anton S.; Leonov, Sergey V.; Ivachtchenko, Alexandre V.; Koteliansky, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1372-1382</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Non-structural 5A (NS5A) protein plays a crucial role in the replication of hepatitis C virus (HCV) and during the past decade has attracted increasing attention as a promising biol. target for the treatment of viral infections and related disorders.  Small-mol. NS5A inhibitors have shown significant antiviral activity in vitro and in vivo.  Several lead mols. are reasonably regarded as novel highly potent drug candidates with favorable ADME features and tolerable side effects.  The first-in-class daclatasvir has recently been launched into the market and 14 novel mols. are currently under evaluation in clin. trials.  From this perspective, we provide an overview of the available chem. space of small-mol. NS5A inhibitors and their PK properties, mainly focusing on the diversity in structure and scaffold representation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFcZPRca9xg7Vg90H21EOLACvtfcHk0lhfbSdZMN-Smg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCmsrc%253D&md5=4f6e9bb49e8548fb5461ab2c197a5910</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.2174%2F1568026616666151120113040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666151120113040%26sid%3Dliteratum%253Aachs%26aulast%3DIvanenkov%26aufirst%3DY.%2BA.%26aulast%3DVeselov%26aufirst%3DM.%2BS.%26aulast%3DShakhbazyan%26aufirst%3DA.%2BG.%26aulast%3DAladinskiy%26aufirst%3DV.%2BA.%26aulast%3DAladinskaya%26aufirst%3DA.%2BV.%26aulast%3DYartseva%26aufirst%3DS.%2BM.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DVantskul%26aufirst%3DA.%2BS.%26aulast%3DLeonov%26aufirst%3DS.%2BV.%26aulast%3DIvachtchenko%26aufirst%3DA.%2BV.%26aulast%3DKoteliansky%26aufirst%3DV.%2BE.%26atitle%3DA%2520comprehensive%2520insight%2520into%2520the%2520chemical%2520space%2520and%2520ADME%2520features%2520of%2520small%2520molecule%2520NS5A%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26issue%3D12%26spage%3D1372%26epage%3D1382%26doi%3D10.2174%2F1568026616666151120113040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nettles, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broyde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBrayer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10031</span>– <span class="NLM_lpage">10043</span>, <span class="refDoi"> DOI: 10.1021/jm501291c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501291c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10031-10043&issue=23&author=J.+H.+Nettlesauthor=R.+A.+Stantonauthor=J.+Broydeauthor=F.+Amblardauthor=H.+Zhangauthor=L.+Zhouauthor=J.+Shiauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=S.+J.+Coatsauthor=J.+J.+Kohlerauthor=R.+F.+Schinazi&title=Asymmetric+binding+to+NS5A+by+daclatasvir+%28BMS-790052%29+and+analogs+suggests+two+novel+modes+of+HCV+inhibition&doi=10.1021%2Fjm501291c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1021%2Fjm501291c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501291c%26sid%3Dliteratum%253Aachs%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DBroyde%26aufirst%3DJ.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DCoats%26aufirst%3DS.%2BJ.%26aulast%3DKohler%26aufirst%3DJ.%2BJ.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DAsymmetric%2520binding%2520to%2520NS5A%2520by%2520daclatasvir%2520%2528BMS-790052%2529%2520and%2520analogs%2520suggests%2520two%2520novel%2520modes%2520of%2520HCV%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D23%26spage%3D10031%26epage%3D10043%26doi%3D10.1021%2Fjm501291c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romine, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Laurent, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Boyle, D. R.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of hepatitis C virus NS5A replication complex inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1672</span>, <span class="refDoi"> DOI: 10.1021/jm401793m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401793m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1643-1672&issue=5&author=M.+Belemaauthor=O.+D.+Lopezauthor=J.+A.+Benderauthor=J.+L.+Romineauthor=D.+R.+St.+Laurentauthor=D.+R.+Langleyauthor=J.+A.+Lemmauthor=D.+R.+O%E2%80%99Boyleauthor=J.+H.+Sunauthor=C.+Wangauthor=R.+A.+Fridellauthor=N.+A.+Meanwell&title=Discovery+and+development+of+hepatitis+C+virus+NS5A+replication+complex+inhibitors&doi=10.1021%2Fjm401793m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1021%2Fjm401793m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401793m%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DDiscovery%2520and%2520development%2520of%2520hepatitis%2520C%2520virus%2520NS5A%2520replication%2520complex%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D1643%26epage%3D1672%26doi%3D10.1021%2Fjm401793m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matulenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspi, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2047</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1021/jm401398x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401398x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2047-2057&issue=5&author=D.%0AA.+DeGoeyauthor=J.+T.+Randolphauthor=D.+Liuauthor=J.+Prattauthor=C.+Hutchinsauthor=P.+Donnerauthor=A.+C.+Kruegerauthor=M.+Matulenkoauthor=S.+Patelauthor=C.+E.+Motterauthor=L.+Nelsonauthor=R.+Keddyauthor=M.+Tufanoauthor=D.+D.+Caspiauthor=P.+Krishnanauthor=N.+Mistryauthor=G.+Koevauthor=T.+J.+Reischauthor=R.+Mondalauthor=T.+Pilot-Matiasauthor=Y.+Gaoauthor=D.+W.+Benoauthor=C.+J.+Maringauthor=A.+Mollaauthor=E.+Dumasauthor=A.+Campbellauthor=L.+Williamsauthor=C.+Collinsauthor=R.+Wagnerauthor=W.+M.+Kati&title=Discovery+of+ABT-267%2C+a+pan-genotypic+inhibitor+of+HCV+NS5A&doi=10.1021%2Fjm401398x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1021%2Fjm401398x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401398x%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPratt%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DC.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DKrueger%26aufirst%3DA.%2BC.%26aulast%3DMatulenko%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMotter%26aufirst%3DC.%2BE.%26aulast%3DNelson%26aufirst%3DL.%26aulast%3DKeddy%26aufirst%3DR.%26aulast%3DTufano%26aufirst%3DM.%26aulast%3DCaspi%26aufirst%3DD.%2BD.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%2BJ.%26aulast%3DMondal%26aufirst%3DR.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBeno%26aufirst%3DD.%2BW.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520ABT-267%252C%2520a%2520pan-genotypic%2520inhibitor%2520of%2520HCV%2520NS5A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2047%26epage%3D2057%26doi%3D10.1021%2Fjm401398x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1128/AAC.04226-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.04226-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=979-987&issue=2&author=P.+Krishnanauthor=J.+Beyerauthor=N.+Mistryauthor=G.+Koevauthor=T.+Reischauthor=D.+DeGoeyauthor=W.+Katiauthor=A.+Campbellauthor=L.+Williamsauthor=W.+Xieauthor=C.+Setzeauthor=A.+Mollaauthor=C.+Collinsauthor=T.+Pilot-Matias&title=In+vitro+and+in+vivo+antiviral+activity+and+resistance+profile+of+ombitasvir%2C+an+inhibitor+of+hepatitis+C+virus+NS5A&doi=10.1128%2FAAC.04226-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1128%2FAAC.04226-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04226-14%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DMistry%26aufirst%3DN.%26aulast%3DKoev%26aufirst%3DG.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DDeGoey%26aufirst%3DD.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DSetze%26aufirst%3DC.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPilot-Matias%26aufirst%3DT.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520ombitasvir%252C%2520an%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS5A%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D979%26epage%3D987%26doi%3D10.1128%2FAAC.04226-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornpropst, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2046</span>, <span class="refDoi"> DOI: 10.1021/jm401499g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401499g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2033-2046&issue=5&author=J.+O.+Linkauthor=J.+G.+Taylorauthor=L.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=H.+Liuauthor=D.+Katoauthor=T.+Kirschbergauthor=J.+Sunauthor=N.+Squiresauthor=J.+Parrishauthor=T.+Kellerauthor=Z.+Y.+Yangauthor=C.+Yangauthor=M.+Matlesauthor=Y.+Wangauthor=K.+Wangauthor=G.+Chengauthor=Y.+Tianauthor=E.+Mogalianauthor=E.+Mondouauthor=M.+Cornpropstauthor=J.+Perryauthor=M.+C.+Desai&title=Discovery+of+ledipasvir+%28GS-5885%29%3A+a+potent%2C+once-daily+oral+NS5A+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection&doi=10.1021%2Fjm401499g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection</span></div><div class="casAuthors">Link, John O.; Taylor, James G.; Xu, Lianhong; Mitchell, Michael; Guo, Hongyan; Liu, Hongtao; Kato, Darryl; Kirschberg, Thorsten; Sun, Jianyu; Squires, Neil; Parrish, Jay; Kellar, Terry; Yang, Zheng-Yu; Yang, Chris; Matles, Mike; Wang, Yujin; Wang, Kelly; Cheng, Guofeng; Tian, Yang; Mogalian, Erik; Mondou, Elsa; Cornpropst, Melanie; Perry, Jason; Desai, Manoj C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2033-2046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of highly potent NS5A inhibitors with an unsym. benzimidazole-difluorofluorene-imidazole core and distal [2.2.1]-azabicyclic ring system was discovered.  Optimization of antiviral potency and pharmacokinetics led to the identification of ledipasvir (GS-5885).  Ledipasvir (GT1a replicon EC50 = 31 pM) has an extended plasma half-life of 37-45 h in healthy volunteers and produces a rapid >3 log viral load redn. in monotherapy at oral doses of 3 mg or greater with once-daily dosing in genotype 1a HCV-infected patients. ledipasvir has been shown to be safe and efficacious, with SVR12 rates up to 100% when used in combination with direct-acting antivirals having complementary mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLazFwyH5rrVg90H21EOLACvtfcHk0liiFjlYkt0bqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb3I&md5=30cec1d10b7b7dd02faae4fba4b88bd8</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1021%2Fjm401499g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401499g%26sid%3Dliteratum%253Aachs%26aulast%3DLink%26aufirst%3DJ.%2BO.%26aulast%3DTaylor%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DD.%26aulast%3DKirschberg%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DSquires%26aufirst%3DN.%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMatles%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DMondou%26aufirst%3DE.%26aulast%3DCornpropst%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520ledipasvir%2520%2528GS-5885%2529%253A%2520a%2520potent%252C%2520once-daily%2520oral%2520NS5A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D2033%26epage%3D2046%26doi%3D10.1021%2Fjm401499g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogalian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brainard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, A.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and first-in-human pharmacokinetics, safety, and tolerability of velpatasvir, a pangenotypic hepatitis C virus NS5A inhibitor, in healthy subjects</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e02084-16</span>, <span class="refDoi"> DOI: 10.1128/AAC.02084-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02084-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02084-16&issue=5&author=E.+Mogalianauthor=P.+Germanauthor=B.+P.+Kearneyauthor=C.+Y.+Yangauthor=D.+Brainardauthor=J.+Linkauthor=J.+McNallyauthor=L.+Hanauthor=J.+Lingauthor=A.+Mathias&title=Preclinical+pharmacokinetics+and+first-in-human+pharmacokinetics%2C+safety%2C+and+tolerability+of+velpatasvir%2C+a+pangenotypic+hepatitis+C+virus+NS5A+inhibitor%2C+in+healthy+subjects&doi=10.1128%2FAAC.02084-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1128%2FAAC.02084-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02084-16%26sid%3Dliteratum%253Aachs%26aulast%3DMogalian%26aufirst%3DE.%26aulast%3DGerman%26aufirst%3DP.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DBrainard%26aufirst%3DD.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DMcNally%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DMathias%26aufirst%3DA.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520first-in-human%2520pharmacokinetics%252C%2520safety%252C%2520and%2520tolerability%2520of%2520velpatasvir%252C%2520a%2520pangenotypic%2520hepatitis%2520C%2520virus%2520NS5A%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3De02084-16%26doi%3D10.1128%2FAAC.02084-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&issue=12&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+M.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+an+HCV+NS5A+inhibitor+with+broad+genotype+activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520broad%2520genotype%2520activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilot-Matias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhtyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maring, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C.</span></span> <span> </span><span class="NLM_article-title">In vitro antiviral activity and resistance profile of the next-generation hepatitis C virus NS5A inhibitor pibrentasvir</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e02558-16</span>, <span class="refDoi"> DOI: 10.1128/AAC.02558-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1128%2FAAC.02558-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e02558-16&issue=5&author=T.+I.+Ngauthor=P.+Krishnanauthor=T.+Pilot-Matiasauthor=W.+Katiauthor=G.+Schnellauthor=J.+Beyerauthor=T.+Reischauthor=L.+Luauthor=T.+Dekhtyarauthor=M.+Irvinauthor=R.+Tripathiauthor=C.+Maringauthor=J.+T.+Randolphauthor=R.+Wagnerauthor=C.+Collins&title=In+vitro+antiviral+activity+and+resistance+profile+of+the+next-generation+hepatitis+C+virus+NS5A+inhibitor+pibrentasvir&doi=10.1128%2FAAC.02558-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1128%2FAAC.02558-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02558-16%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DT.%2BI.%26aulast%3DKrishnan%26aufirst%3DP.%26aulast%3DPilot-Matias%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DSchnell%26aufirst%3DG.%26aulast%3DBeyer%26aufirst%3DJ.%26aulast%3DReisch%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDekhtyar%26aufirst%3DT.%26aulast%3DIrvin%26aufirst%3DM.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DMaring%26aufirst%3DC.%26aulast%3DRandolph%26aufirst%3DJ.%2BT.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DCollins%26aufirst%3DC.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520next-generation%2520hepatitis%2520C%2520virus%2520NS5A%2520inhibitor%2520pibrentasvir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3De02558-16%26doi%3D10.1128%2FAAC.02558-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How big is too big for cell permeability?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1664</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1662-1664&issue=5&author=P.+Matssonauthor=J.+Kihlberg&title=How+big+is+too+big+for+cell+permeability%3F&doi=10.1021%2Facs.jmedchem.7b00237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">How Big Is Too Big for Cell Permeability?</span></div><div class="casAuthors">Matsson, Paer; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1662-1664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Understanding how to design cell permeable ligands for intracellular targets that have difficult binding sites, such as protein-protein interactions, would open vast opportunities for drug discovery.  Interestingly, libraries of cyclic peptides displayed a steep drop-off in membrane permeability at mol. wts. above 1000 Da and it appears likely that this cutoff constitutes an upper size limit also for more drug-like compds.  However, chem. space from 500 to 1000 Da remains virtually unexplored and represents a vast opportunity for those prepd. to venture into new territories of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXxiuvHQSnJLVg90H21EOLACvtfcHk0lgwMf6Zio2vGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlCjtL8%253D&md5=563efb3b4603c33c4a976e88b1c7b514</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00237%26sid%3Dliteratum%253Aachs%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520big%2520is%2520too%2520big%2520for%2520cell%2520permeability%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D1662%26epage%3D1664%26doi%3D10.1021%2Facs.jmedchem.7b00237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickford, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paradowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonehouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wybrow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daverio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiva, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201400046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fcmdc.201400046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1387-1396&issue=7&author=F.+Wakenhutauthor=T.+D.+Tranauthor=C.+Pickfordauthor=S.+Shawauthor=M.+Westbyauthor=C.+Smith-Burchnellauthor=L.+Watsonauthor=M.+Paradowskiauthor=J.+Milbankauthor=D.+Stonehouseauthor=K.+Cheungauthor=R.+Wybrowauthor=F.+Daverioauthor=S.+Crookauthor=K.+Stathamauthor=D.+Leeseauthor=D.+Steadauthor=F.+Adamauthor=D.+Hayauthor=L.+R.+Robertsauthor=J.+Y.+Chivaauthor=C.+Nicholsauthor=D.+C.+Blakemoreauthor=G.+H.+Goetzauthor=Y.+Cheauthor=I.+Gardnerauthor=S.+Dayalauthor=A.+Pikeauthor=R.+Websterauthor=D.+C.+Pryde&title=The+discovery+of+potent+nonstructural+protein+5A+%28NS5A%29+inhibitors+with+a+unique+resistance+profile-Part+2&doi=10.1002%2Fcmdc.201400046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201400046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201400046%26sid%3Dliteratum%253Aachs%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DTran%26aufirst%3DT.%2BD.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DL.%26aulast%3DParadowski%26aufirst%3DM.%26aulast%3DMilbank%26aufirst%3DJ.%26aulast%3DStonehouse%26aufirst%3DD.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DWybrow%26aufirst%3DR.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DCrook%26aufirst%3DS.%26aulast%3DStatham%26aufirst%3DK.%26aulast%3DLeese%26aufirst%3DD.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAdam%26aufirst%3DF.%26aulast%3DHay%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DChiva%26aufirst%3DJ.%2BY.%26aulast%3DNichols%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DDayal%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26atitle%3DThe%2520discovery%2520of%2520potent%2520nonstructural%2520protein%25205A%2520%2528NS5A%2529%2520inhibitors%2520with%2520a%2520unique%2520resistance%2520profile-Part%25202%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1387%26epage%3D1396%26doi%3D10.1002%2Fcmdc.201400046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the rule of 5: lessons learned from Abbvie’s drugs and compound collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=D.+A.+DeGoeyauthor=H.+J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+rule+of+5%3A+lessons+learned+from+Abbvie%E2%80%99s+drugs+and+compound+collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520rule%2520of%25205%253A%2520lessons%2520learned%2520from%2520Abbvie%25E2%2580%2599s%2520drugs%2520and%2520compound%2520collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewson, G.</span></span> <span> </span><span class="NLM_article-title">BCL-2: Long and winding path from discovery to therapeutic target</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.10.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bbrc.2016.10.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=459-469&issue=3&author=R.+L.+Schenkauthor=A.+Strasserauthor=G.+Dewson&title=BCL-2%3A+Long+and+winding+path+from+discovery+to+therapeutic+target&doi=10.1016%2Fj.bbrc.2016.10.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.10.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.10.100%26sid%3Dliteratum%253Aachs%26aulast%3DSchenk%26aufirst%3DR.%2BL.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDewson%26aufirst%3DG.%26atitle%3DBCL-2%253A%2520Long%2520and%2520winding%2520path%2520from%2520discovery%2520to%2520therapeutic%2520target%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26issue%3D3%26spage%3D459%26epage%3D469%26doi%3D10.1016%2Fj.bbrc.2016.10.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augeri, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betebenner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bures, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landis, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm0507532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&issue=2&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-xL+from+NMR+and+parallel+synthesis&doi=10.1021%2Fjm0507532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-xL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D2%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm0507532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruncko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adickes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6915</span>, <span class="refDoi"> DOI: 10.1021/jm800669s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&issue=21&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+R.+Shoemakerauthor=X.+Songauthor=S.+K.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+D.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins&doi=10.1021%2Fjm800669s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D21%26spage%3D6902%26epage%3D6915%26doi%3D10.1021%2Fjm800669s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boghaert, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackler, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enschede, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecker, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitten, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleksijew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahir, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humerickhouse, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span> <span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1038/nm.3048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnm.3048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23291630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.%0AJ.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+S.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.-M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets&doi=10.1038%2Fnm.3048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span></div><div class="casAuthors">Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process.  This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis.  The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-XL), which has shown clin. efficacy in some BCL-2-dependent hematol. cancers.  However, concomitant on-target thrombocytopenia caused by BCL-XL inhibition limits the efficacy achievable with this agent.  Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199.  This compd. inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets.  A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h.  These data indicate that selective pharmacol. inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematol. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7P7koWwJHLVg90H21EOLACvtfcHk0ljeBbayv0qIHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslagtQ%253D%253D&md5=6a24b72303eb2062da653f1f61ac74fb</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1038%2Fnm.3048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3048%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.-M.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208%26doi%3D10.1038%2Fnm.3048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span>Venetoclax
label. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf" class="extLink">https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf</a> (accessed February 2, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Venetoclax%0Alabel.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2016%2F208573s000lbl.pdf+%28accessed+February+2%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catron, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voorman, R.</span></span> <span> </span><span class="NLM_article-title">The role of lymphatic transport on the systemic bioavailability of the Bcl-2 protein family inhibitors navitoclax (ABT-263) and ABT-199</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.055053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1124%2Fdmd.113.055053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=207-212&issue=2&author=E.+F.+Chooauthor=J.+Boggsauthor=C.+Zhuauthor=J.+W.+Lubachauthor=N.+D.+Catronauthor=G.+Jenkinsauthor=A.+J.+Souersauthor=R.+Voorman&title=The+role+of+lymphatic+transport+on+the+systemic+bioavailability+of+the+Bcl-2+protein+family+inhibitors+navitoclax+%28ABT-263%29+and+ABT-199&doi=10.1124%2Fdmd.113.055053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055053%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DLubach%26aufirst%3DJ.%2BW.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DJenkins%26aufirst%3DG.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DVoorman%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520on%2520the%2520systemic%2520bioavailability%2520of%2520the%2520Bcl-2%2520protein%2520family%2520inhibitors%2520navitoclax%2520%2528ABT-263%2529%2520and%2520ABT-199%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26issue%3D2%26spage%3D207%26epage%3D212%26doi%3D10.1124%2Fdmd.113.055053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salem, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuthalapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freise, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. L.</span></span> <span> </span><span class="NLM_article-title">Effect of low- and high-fat meals on the pharmacokinetics of venetoclax, a selective first-in-class BCL-2 Inhibitor</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1002/jcph.741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fjcph.741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=27029823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1WkurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1355-1361&issue=11&author=A.+H.+Salemauthor=S.+K.+Agarwalauthor=M.+Dunbarauthor=S.+Nuthalapatiauthor=D.+Chienauthor=K.+J.+Freiseauthor=S.+L.+Wong&title=Effect+of+low-+and+high-fat+meals+on+the+pharmacokinetics+of+venetoclax%2C+a+selective+first-in-class+BCL-2+Inhibitor&doi=10.1002%2Fjcph.741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor</span></div><div class="casAuthors">Salem, Ahmed Hamed; Agarwal, Suresh K.; Dunbar, Martin; Nuthalapati, Silpa; Chien, David; Freise, Kevin J.; Wong, Shekman L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1355-1361</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Venetoclax is a selective, first-in-class, B-cell lymphoma-2 inhibitor that has demonstrated clin. efficacy in several hematol. malignancies.  Two studies evaluated the relative bioavailability of venetoclax in healthy subjects: (1) a bioequivalence study to compare the bioavailability of the film-coated tablet with that of an earlier uncoated tablet and (2) a food effect study to evaluate the effect of food on venetoclax pharmacokinetics.  Both studies were open-label, single-dose, crossover studies.  In the bioequivalence study, 15 subjects received a single dose of venetoclax 50 mg under nonfasting conditions, in each of 2 periods; one period used the uncoated tablet, and the other used the film-coated tablet.  In the food effect study, 24 subjects received a single dose of venetoclax film-coated 100-mg tablet under fasting conditions, after a low-fat breakfast or after a high-fat breakfast in different periods.  The venetoclax film-coated tablet was bioequivalent to the uncoated tablet, which indicates that the film coating does not affect bioavailability.  The median Tmax of venetoclax was delayed by about 2 h when administered with food.  Compared with fasting conditions, Cmax and AUC increased by approx. 3.4-fold following a low-fat breakfast.  High-fat meals increased Cmax and AUC by approx. 50% relative to low-fat meals.  The mean terminal half-life was comparable between the high-fat meal and fasting conditions (19.1 vs. 16.1 h).  Based on these results and the venetoclax exposure-response profile, venetoclax should be administered with food and without specific recommendations for fat content to ensure adequate and consistent bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB0G-6BbtmdLVg90H21EOLACvtfcHk0lgs2TLOk1uibQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1WkurvJ&md5=e50def47958632b2417edcfb2c134b1d</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjcph.741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.741%26sid%3Dliteratum%253Aachs%26aulast%3DSalem%26aufirst%3DA.%2BH.%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26aulast%3DDunbar%26aufirst%3DM.%26aulast%3DNuthalapati%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DFreise%26aufirst%3DK.%2BJ.%26aulast%3DWong%26aufirst%3DS.%2BL.%26atitle%3DEffect%2520of%2520low-%2520and%2520high-fat%2520meals%2520on%2520the%2520pharmacokinetics%2520of%2520venetoclax%252C%2520a%2520selective%2520first-in-class%2520BCL-2%2520Inhibitor%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D56%26issue%3D11%26spage%3D1355%26epage%3D1361%26doi%3D10.1002%2Fjcph.741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2312</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&issue=6&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0lgs2TLOk1uibQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montague, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossetter, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Learning medicinal chemistry absorption, distribution, metabolism, excretion, and toxicity (ADMET) rules from cross-company matched molecular pairs analysis (MMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Kramerauthor=A.+Tingauthor=H.+Zhengauthor=J.+Hertauthor=T.+Schindlerauthor=M.+Stahlauthor=G.+Robbauthor=J.+J.+Crawfordauthor=J.+Blaneyauthor=S.+Montagueauthor=A.+G.+Leachauthor=A.+G.+Dossetterauthor=E.+J.+Griffen&title=Learning+medicinal+chemistry+absorption%2C+distribution%2C+metabolism%2C+excretion%2C+and+toxicity+%28ADMET%29+rules+from+cross-company+matched+molecular+pairs+analysis+%28MMPA%29&doi=10.1021%2Facs.jmedchem.7b00935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00935%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DBlaney%26aufirst%3DJ.%26aulast%3DMontague%26aufirst%3DS.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DLearning%2520medicinal%2520chemistry%2520absorption%252C%2520distribution%252C%2520metabolism%252C%2520excretion%252C%2520and%2520toxicity%2520%2528ADMET%2529%2520rules%2520from%2520cross-company%2520matched%2520molecular%2520pairs%2520analysis%2520%2528MMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1021%2Facs.jmedchem.7b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D. R.</span></span> <span> </span><span class="NLM_article-title">Statistical analysis of the effects of common chemical substituents on ligand potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1021/jm070838y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070838y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=553-564&issue=3&author=P.+J.+Hajdukauthor=D.+R.+Sauer&title=Statistical+analysis+of+the+effects+of+common+chemical+substituents+on+ligand+potency&doi=10.1021%2Fjm070838y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1021%2Fjm070838y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070838y%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DSauer%26aufirst%3DD.%2BR.%26atitle%3DStatistical%2520analysis%2520of%2520the%2520effects%2520of%2520common%2520chemical%2520substituents%2520on%2520ligand%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D3%26spage%3D553%26epage%3D564%26doi%3D10.1021%2Fjm070838y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. A.</span></span> <span> </span><span class="NLM_article-title">Improvement in aqueous solubility achieved via small molecular changes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5100</span>– <span class="NLM_lpage">5108</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2017.09.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5100-5108&issue=23&author=M.+A.+Walker&title=Improvement+in+aqueous+solubility+achieved+via+small+molecular+changes&doi=10.1016%2Fj.bmcl.2017.09.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520achieved%2520via%2520small%2520molecular%2520changes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5100%26epage%3D5108%26doi%3D10.1016%2Fj.bmcl.2017.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The medicinal chemist’s toolbox for late stage functionalization of druglike molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&issue=3&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+medicinal+chemist%E2%80%99s+toolbox+for+late+stage+functionalization+of+druglike+molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520medicinal%2520chemist%25E2%2580%2599s%2520toolbox%2520for%2520late%2520stage%2520functionalization%2520of%2520druglike%2520molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26issue%3D3%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic synthesis provides opportunities to transform drug discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&issue=4&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+synthesis+provides+opportunities+to+transform+drug+discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0li09tBbRsnooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520synthesis%2520provides%2520opportunities%2520to%2520transform%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26issue%3D4%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&issue=9&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0li09tBbRsnooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Methyl effects on protein-ligand binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4489</span>– <span class="NLM_lpage">4500</span>, <span class="refDoi"> DOI: 10.1021/jm3003697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4489-4500&issue=9&author=C.+S.+Leungauthor=S.+S.+Leungauthor=J.+Tirado-Rivesauthor=W.+L.+Jorgensen&title=Methyl+effects+on+protein-ligand+binding&doi=10.1021%2Fjm3003697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl Effects on Protein-Ligand Binding</span></div><div class="casAuthors">Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian; Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4489-4500</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of addn. of a Me group to a lead compd. on biol. activity are examd.  A literature anal. of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event.  Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water mols., and changes in conformational energetics.  The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calcns. for Me replacements in inhibitor series for p38α MAP kinase, ACK1, PTP1B, and thrombin.  Me substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change.  The greatest improvements in activity arise from coupling the conformational gain with the burial of the Me group in a hydrophobic region of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0Czyhgy6KbVg90H21EOLACvtfcHk0li09tBbRsnooA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsV2iu7Y%253D&md5=0ea58d9c1bf845d383931b6a017f9b37</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1021%2Fjm3003697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003697%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BS.%26aulast%3DLeung%26aufirst%3DS.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DMethyl%2520effects%2520on%2520protein-ligand%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D4489%26epage%3D4500%26doi%3D10.1021%2Fjm3003697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schonherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">12256</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&issue=47&author=H.+Schonherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C-H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSchonherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C-H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26issue%3D47%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuntz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter-Scott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneeringer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesworth, R.</span></span> <span> </span><span class="NLM_article-title">The importance of being Me: magic methyls, methyltransferase inhibitors, and the discovery of tazemetostat</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1556</span>– <span class="NLM_lpage">1564</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&issue=4&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+importance+of+being+Me%3A+magic+methyls%2C+methyltransferase+inhibitors%2C+and+the+discovery+of+tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span></div><div class="casAuthors">Kuntz, Kevin W.; Campbell, John E.; Keilhack, Heike; Pollock, Roy M.; Knutson, Sarah K.; Porter-Scott, Margaret; Richon, Victoria M.; Sneeringer, Chris J.; Wigle, Tim J.; Allain, Christina J.; Majer, Christina R.; Moyer, Mikel P.; Copeland, Robert A.; Chesworth, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Posttranslational methylation of histones plays a crit. role in gene regulation.  Misregulation of histone methylation can lead to oncogenic transformation.  Enhancer of Zeste homolog 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers.  Tazemetostat, an EHZ2 inhibitor in clin. development, has shown activity in both preclin. models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors.  Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clin. development.  The importance of several Me groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryASbIgMDxAbVg90H21EOLACvtfcHk0lgU1mO6jl7V-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D&md5=a26ccc4a0109f57fbb64f7fded8965a1</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520importance%2520of%2520being%2520Me%253A%2520magic%2520methyls%252C%2520methyltransferase%2520inhibitors%252C%2520and%2520the%2520discovery%2520of%2520tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D4%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&issue=21&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lgU1mO6jl7V-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative Assessment of the impact of fluorine substitution on p-glycoprotein (p-gp) mediated efflux, permeability, lipophilicity, and metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5284-5296&issue=11&author=M.+Petterssonauthor=X.+Houauthor=M.+Kuhnauthor=T.+T.+Wagerauthor=G.+W.+Kauffmanauthor=P.+R.+Verhoest&title=Quantitative+Assessment+of+the+impact+of+fluorine+substitution+on+p-glycoprotein+%28p-gp%29+mediated+efflux%2C+permeability%2C+lipophilicity%2C+and+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b00027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DQuantitative%2520Assessment%2520of%2520the%2520impact%2520of%2520fluorine%2520substitution%2520on%2520p-glycoprotein%2520%2528p-gp%2529%2520mediated%2520efflux%252C%2520permeability%252C%2520lipophilicity%252C%2520and%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D11%26spage%3D5284%26epage%3D5296%26doi%3D10.1021%2Facs.jmedchem.6b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Chemical structure-related druglike criteria of global approved drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/molecules21010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.3390%2Fmolecules21010075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=75&issue=1&author=F.+Maoauthor=W.+Niauthor=X.+Xuauthor=H.+Wangauthor=J.+Wangauthor=M.+Jiauthor=J.+Li&title=Chemical+structure-related+druglike+criteria+of+global+approved+drugs&doi=10.3390%2Fmolecules21010075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010075%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DChemical%2520structure-related%2520druglike%2520criteria%2520of%2520global%2520approved%2520drugs%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D75%26doi%3D10.3390%2Fmolecules21010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkinshaw, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnert, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guile, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphries, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ince, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingall, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortimore, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paine, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigby, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teobald, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webborn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, P. A.</span></span> <span> </span><span class="NLM_article-title">From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6013</span>– <span class="NLM_lpage">6018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2007.07.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6013-6018&issue=21&author=B.+Springthorpeauthor=A.+Baileyauthor=P.+Bartonauthor=T.+N.+Birkinshawauthor=R.+V.+Bonnertauthor=R.+C.+Brownauthor=D.+Chapmanauthor=J.+Dixonauthor=S.+D.+Guileauthor=R.+G.+Humphriesauthor=S.+F.+Huntauthor=F.+Inceauthor=A.+H.+Ingallauthor=I.+P.+Kirkauthor=P.+D.+Leesonauthor=P.+Leffauthor=R.+J.+Lewisauthor=B.+P.+Martinauthor=D.+F.+McGinnityauthor=M.+P.+Mortimoreauthor=S.+W.+Paineauthor=G.+Pairaudeauauthor=A.+Patelauthor=A.+J.+Rigbyauthor=R.+J.+Rileyauthor=B.+J.+Teobaldauthor=W.+Tomlinsonauthor=P.+J.+Webbornauthor=P.+A.+Willis&title=From+ATP+to+AZD6140%3A+the+discovery+of+an+orally+active+reversible+P2Y12+receptor+antagonist+for+the+prevention+of+thrombosis&doi=10.1016%2Fj.bmcl.2007.07.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DSpringthorpe%26aufirst%3DB.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBirkinshaw%26aufirst%3DT.%2BN.%26aulast%3DBonnert%26aufirst%3DR.%2BV.%26aulast%3DBrown%26aufirst%3DR.%2BC.%26aulast%3DChapman%26aufirst%3DD.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DGuile%26aufirst%3DS.%2BD.%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DInce%26aufirst%3DF.%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DKirk%26aufirst%3DI.%2BP.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BP.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DMortimore%26aufirst%3DM.%2BP.%26aulast%3DPaine%26aufirst%3DS.%2BW.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DRigby%26aufirst%3DA.%2BJ.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DTeobald%26aufirst%3DB.%2BJ.%26aulast%3DTomlinson%26aufirst%3DW.%26aulast%3DWebborn%26aufirst%3DP.%2BJ.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26atitle%3DFrom%2520ATP%2520to%2520AZD6140%253A%2520the%2520discovery%2520of%2520an%2520orally%2520active%2520reversible%2520P2Y12%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520thrombosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D21%26spage%3D6013%26epage%3D6018%26doi%3D10.1016%2Fj.bmcl.2007.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dower, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrin, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samardjiev, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzupek, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoli ne-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5521</span>– <span class="NLM_lpage">5542</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&issue=13&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.+L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoli+ne-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0lhhAGop17NGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoli%2520ne-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Code, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raubo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) binders and optimization to high affinity macrocyclic inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4402</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4386-4402&issue=10&author=W.+McCoullauthor=R.+D.+Abramsauthor=E.+Andersonauthor=K.+Bladesauthor=P.+Bartonauthor=M.+Boxauthor=J.+Burgessauthor=K.+Bythauthor=Q.+Caoauthor=C.+Chuaquiauthor=R.+J.+Carbajoauthor=T.+Cheungauthor=E.+Codeauthor=A.+D.+Fergusonauthor=S.+Filleryauthor=N.+O.+Fullerauthor=E.+Ganglauthor=N.+Gaoauthor=M.+Gristauthor=D.+Hargreavesauthor=M.+R.+Howardauthor=J.+Huauthor=P.+D.+Kemmittauthor=J.+E.+Nelsonauthor=N.+O%E2%80%99Connellauthor=D.+B.+Princeauthor=P.+Rauboauthor=P.+B.+Rawlinsauthor=G.+R.+Robbauthor=J.+Shiauthor=M.+J.+Waringauthor=D.+Whittakerauthor=M.+Wylotauthor=X.+Zhu&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+B-Cell+Lymphoma+6+%28BCL6%29+binders+and+optimization+to+high+affinity+macrocyclic+inhibitors&doi=10.1021%2Facs.jmedchem.7b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors</span></div><div class="casAuthors">McCoull, William; Abrams, Roman D.; Anderson, Erica; Blades, Kevin; Barton, Peter; Box, Matthew; Burgess, Jonathan; Byth, Kate; Cao, Qing; Chuaqui, Claudio; Carbajo, Rodrigo J.; Cheung, Tony; Code, Erin; Ferguson, Andrew D.; Fillery, Shaun; Fuller, Nathan O.; Gangl, Eric; Gao, Ning; Grist, Matthew; Hargreaves, David; Howard, Martin R.; Hu, Jun; Kemmitt, Paul D.; Nelson, Jennifer E.; O'Connell, Nichole; Prince, D. Bryan; Raubo, Piotr; Rawlins, Philip B.; Robb, Graeme R.; Shi, Junjie; Waring, Michael J.; Whittaker, David; Wylot, Marta; Zhu, Xiahui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are crit. to test this hypothesis.  We identified a pyrazolo[1,5-a]pyrimidine series of BCL6 binders from a fragment screen in parallel with a virtual screen.  Using structure-based drug design, binding affinity was increased 100000-fold.  This involved displacing crystallog. water, forming new ligand-protein interactions and a macrocyclization to favor the bioactive conformation of the ligands.  Optimization for slow off-rate const. kinetics was conducted as well as improving selectivity against an off-target kinase, CK2.  Potency in a cellular BCL6 assay was further optimized to afford highly selective probe mols.  Only weak antiproliferative effects were obsd. across a no. of DLBCL lines and a multiple myeloma cell line without a clear relationship to BCL6 potency.  As a result, we conclude that the BCL6 hypothesis in DLBCL cancer remains unproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp2OlXAZDFLVg90H21EOLACvtfcHk0lhqrmEZZ309rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D&md5=fc4142453a0580edbf04802e15d4d9aa</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00359%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DR.%2BD.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DBurgess%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DM.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DNelson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DRaubo%26aufirst%3DP.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWylot%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520B-Cell%2520Lymphoma%25206%2520%2528BCL6%2529%2520binders%2520and%2520optimization%2520to%2520high%2520affinity%2520macrocyclic%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D10%26spage%3D4386%26epage%3D4402%26doi%3D10.1021%2Facs.jmedchem.7b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser-Bricker, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, S. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez
Morales, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troccolo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C.</span></span> <span> </span><span class="NLM_article-title">Design and optimization of benzopiperazines as potent inhibitors of BET bromodomains</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">847</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=847-852&issue=8&author=D.+S.+Millanauthor=K.+J.+Kayser-Brickerauthor=M.+W.+Martinauthor=A.+C.+Talbotauthor=S.+E.+R.+Schillerauthor=T.+Herbertzauthor=G.+L.+Williamsauthor=G.+P.+Lukeauthor=S.+Hubbsauthor=M.+A.+Alvarez%0AMoralesauthor=D.+Cardilloauthor=P.+Troccoloauthor=R.+L.+Mendesauthor=C.+McKinnon&title=Design+and+optimization+of+benzopiperazines+as+potent+inhibitors+of+BET+bromodomains&doi=10.1021%2Facsmedchemlett.7b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00191%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DKayser-Bricker%26aufirst%3DK.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DSchiller%26aufirst%3DS.%2BE.%2BR.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DG.%2BL.%26aulast%3DLuke%26aufirst%3DG.%2BP.%26aulast%3DHubbs%26aufirst%3DS.%26aulast%3DAlvarez%2BMorales%26aufirst%3DM.%2BA.%26aulast%3DCardillo%26aufirst%3DD.%26aulast%3DTroccolo%26aufirst%3DP.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMcKinnon%26aufirst%3DC.%26atitle%3DDesign%2520and%2520optimization%2520of%2520benzopiperazines%2520as%2520potent%2520inhibitors%2520of%2520BET%2520bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D8%26spage%3D847%26epage%3D852%26doi%3D10.1021%2Facsmedchemlett.7b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komandla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanouni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyrick, C.</span></span> <span> </span><span class="NLM_article-title">Fragment-based discovery of a small molecule inhibitor of bruton’s tyrosine kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5437</span>– <span class="NLM_lpage">5444</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00734</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00734" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5437-5444&issue=14&author=C.+R.+Smithauthor=D.+R.+Douganauthor=M.+Komandlaauthor=T.+Kanouniauthor=B.+Knightauthor=J.+D.+Lawsonauthor=M.+Sabatauthor=E.+R.+Taylorauthor=P.+Vuauthor=C.+Wyrick&title=Fragment-based+discovery+of+a+small+molecule+inhibitor+of+bruton%E2%80%99s+tyrosine+kinase&doi=10.1021%2Facs.jmedchem.5b00734"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00734%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DKomandla%26aufirst%3DM.%26aulast%3DKanouni%26aufirst%3DT.%26aulast%3DKnight%26aufirst%3DB.%26aulast%3DLawson%26aufirst%3DJ.%2BD.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DE.%2BR.%26aulast%3DVu%26aufirst%3DP.%26aulast%3DWyrick%26aufirst%3DC.%26atitle%3DFragment-based%2520discovery%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520bruton%25E2%2580%2599s%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D14%26spage%3D5437%26epage%3D5444%26doi%3D10.1021%2Facs.jmedchem.5b00734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edalji, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/mivebresib), a potent and orally available bromodomain and extraterminal domain (BET) family bromodomain inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8369-8384&issue=20&author=K.+F.+McDanielauthor=L.+Wangauthor=T.+Soltwedelauthor=S.+D.+Fidanzeauthor=L.+A.+Hasvoldauthor=D.+Liuauthor=R.+A.+Manteiauthor=J.+K.+Prattauthor=G.+S.+Sheppardauthor=M.+H.+Buiauthor=E.+J.+Faivreauthor=X.+Huangauthor=L.+Liauthor=X.+Linauthor=R.+Wangauthor=S.+E.+Warderauthor=D.+Wilcoxauthor=D.+H.+Albertauthor=T.+J.+Magocauthor=G.+Rajaramanauthor=C.+H.+Parkauthor=C.+W.+Hutchinsauthor=J.+J.+Shenauthor=R.+P.+Edaljiauthor=C.+C.+Sunauthor=R.+Martinauthor=W.+Gaoauthor=S.+Wongauthor=G.+Fangauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Kati&title=Discovery+of+N-%284-%282%2C4-difluorophenoxy%29-3-%286-methyl-7-oxo-6%2C7-dihydro-1H-pyrrolo%5B2%2C3-c%5Dpyridin-4-yl%29phenyl%29ethanesulfonamide+%28ABBV-075%2Fmivebresib%29%2C+a+potent+and+orally+available+bromodomain+and+extraterminal+domain+%28BET%29+family+bromodomain+inhibitor&doi=10.1021%2Facs.jmedchem.7b00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor</span></div><div class="casAuthors">McDaniel, Keith F.; Wang, Le; Soltwedel, Todd; Fidanze, Steven D.; Hasvold, Lisa A.; Liu, Dachun; Mantei, Robert A.; Pratt, John K.; Sheppard, George S.; Bui, Mai H.; Faivre, Emily J.; Huang, Xiaoli; Li, Leiming; Lin, Xiaoyu; Wang, Rongqi; Warder, Scott E.; Wilcox, Denise; Albert, Daniel H.; Magoc, Terrance J.; Rajaraman, Ganesh; Park, Chang H.; Hutchins, Charles W.; Shen, Jianwei J.; Edalji, Rohinton P.; Sun, Chaohong C.; Martin, Ruth; Gao, Wenqing; Wong, Shekman; Fang, Guowei; Elmore, Steven W.; Shen, Yu; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8369-8384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bromodomain and extraterminal domain (BET) bromodomain inhibitors and their examn. in clin. studies, particularly in oncol. settings, has garnered substantial recent interest.  An effort to generate novel BET bromodomain inhibitors with excellent potency and drug metab. and pharmacokinetics (DMPK) properties was initiated based upon elaboration of a simple pyridone core.  Efforts to develop a bidentate interaction with a crit. asparagine residue resulted in the incorporation of a pyrrolopyridone core, which improved potency by 9-19-fold.  Addnl. structure-activity relationship (SAR) efforts aimed both at increasing potency and improving pharmacokinetic properties led to the discovery of the clin. candidate I (ABBV-075/mivebresib), which demonstrates excellent potency in biochem. and cellular assays, advantageous exposures and half-life both in animal models and in humans, and in vivo efficacy in mouse models of cancer progression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-8BkipNknbVg90H21EOLACvtfcHk0lhqrmEZZ309rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF&md5=16ea9e9ade8a22a6e99aeae16fd1bf9c</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DFaivre%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DEdalji%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282%252C4-difluorophenoxy%2529-3-%25286-methyl-7-oxo-6%252C7-dihydro-1H-pyrrolo%255B2%252C3-c%255Dpyridin-4-yl%2529phenyl%2529ethanesulfonamide%2520%2528ABBV-075%252Fmivebresib%2529%252C%2520a%2520potent%2520and%2520orally%2520available%2520bromodomain%2520and%2520extraterminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8369%26epage%3D8384%26doi%3D10.1021%2Facs.jmedchem.7b00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of TAK-272: a novel, potent, and orally active renin inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">938</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00251</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00251" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=933-938&issue=10&author=Y.+Imaedaauthor=H.+Tokuharaauthor=Y.+Fukaseauthor=R.+Kanagawaauthor=Y.+Kajimotoauthor=K.+Kusumotoauthor=M.+Kondoauthor=G.+Snellauthor=C.+A.+Behnkeauthor=T.+Kuroita&title=Discovery+of+TAK-272%3A+a+novel%2C+potent%2C+and+orally+active+renin+inhibitor&doi=10.1021%2Facsmedchemlett.6b00251"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00251%26sid%3Dliteratum%253Aachs%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DKanagawa%26aufirst%3DR.%26aulast%3DKajimoto%26aufirst%3DY.%26aulast%3DKusumoto%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DBehnke%26aufirst%3DC.%2BA.%26aulast%3DKuroita%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520TAK-272%253A%2520a%2520novel%252C%2520potent%252C%2520and%2520orally%2520active%2520renin%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D10%26spage%3D933%26epage%3D938%26doi%3D10.1021%2Facsmedchemlett.6b00251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small-molecule reversible factor D Inhibitors demonstrating alternative complement pathway inhibition in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5717</span>– <span class="NLM_lpage">5735</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5717-5735&issue=13&author=E.+Lorthioisauthor=K.+Andersonauthor=A.+Vulpettiauthor=O.+Rogelauthor=F.+Cuminauthor=N.+Ostermannauthor=S.+Steinbacherauthor=A.+Mac+Sweeneyauthor=O.+Delgadoauthor=S.+M.+Liaoauthor=S.+Randlauthor=S.+Rudisserauthor=S.+Dussaugeauthor=K.+Fettisauthor=L.+Kiefferauthor=A.+de+Erkenezauthor=L.+Yangauthor=C.+Hartwiegauthor=U.+A.+Argikarauthor=L.+R.+La+Bonteauthor=R.+Newtonauthor=V.+Kansaraauthor=S.+Flohrauthor=U.+Hommelauthor=B.+Jaffeeauthor=J.+Maibaum&title=Discovery+of+highly+potent+and+selective+small-molecule+reversible+factor+D+Inhibitors+demonstrating+alternative+complement+pathway+inhibition+in+vivo&doi=10.1021%2Facs.jmedchem.7b00425"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00425%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHartwieg%26aufirst%3DC.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKansara%26aufirst%3DV.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small-molecule%2520reversible%2520factor%2520D%2520Inhibitors%2520demonstrating%2520alternative%2520complement%2520pathway%2520inhibition%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5717%26epage%3D5735%26doi%3D10.1021%2Facs.jmedchem.7b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryskin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatlock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyridone-containing 3,4-dihydroisoquinoline-1(2H)-ones as a novel class of enhancer of zeste homolog 2 (EZH2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8306</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8306-8325&issue=18&author=P.+P.+Kungauthor=E.+Ruiauthor=S.+Bergqvistauthor=P.+Binghamauthor=J.+Braganzaauthor=M.+Collinsauthor=M.+Cuiauthor=W.+Diehlauthor=D.+Dinhauthor=C.+Fanauthor=V.+R.+Fantinauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=S.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=G.+Liauthor=K.+A.+Maegleyauthor=I.+McAlpineauthor=L.+Nguyenauthor=S.+Ninkovicauthor=M.+Ornelasauthor=M.+Ryskinauthor=S.+Scalesauthor=S.+Suttonauthor=J.+Tatlockauthor=D.+Verhelleauthor=F.+Wangauthor=P.+Wellsauthor=M.+Wythesauthor=S.+Yamazakiauthor=B.+Yipauthor=X.+Yuauthor=L.+Zehnderauthor=W.+G.+Zhangauthor=R.+A.+Rollinsauthor=M.+Edwards&title=Design+and+synthesis+of+pyridone-containing+3%2C4-dihydroisoquinoline-1%282H%29-ones+as+a+novel+class+of+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors</span></div><div class="casAuthors">Kung, Pei-Pei; Rui, Eugene; Bergqvist, Simon; Bingham, Patrick; Braganza, John; Collins, Michael; Cui, Mei; Diehl, Wade; Dinh, Dac; Fan, Connie; Fantin, Valeria R.; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kephart, Susan; Krivacic, Cody; Kumpf, Robert A.; Li, Gary; Maegley, Karen A.; McAlpine, Indrawan; Nguyen, Lisa; Ninkovic, Sacha; Ornelas, Martha; Ryskin, Michael; Scales, Stephanie; Sutton, Scott; Tatlock, John; Verhelle, Dominique; Wang, Fen; Wells, Peter; Wythes, Martin; Yamazaki, Shinji; Yip, Brian; Yu, Xiu; Zehnder, Luke; Zhang, Wei-Guo; Rollins, Robert A.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8306-8325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new enhancer of zeste homolog 2 (EZH2) inhibitor series comprising a substituted Ph ring joined to a dimethylpyridone moiety via an amide linkage has been designed.  A preferential amide torsion that improved the binding properties of the compds. was identified for this series via computational anal.  Cyclization of the amide linker resulted in a six-membered lactam analog, compd. I.  This transformation significantly improved the ligand efficiency/potency of the cyclized compd. relative to its acyclic analog.  Addnl. optimization of the lactam-contg. EZH2 inhibitors focused on lipophilic efficiency (LipE) improvement, which provided compd. II.  Compd. II displayed improved LipE and on-target potency in both biochem. and cellular readouts relative to compd. I.  Inhibitor II also displayed robust in vivo antitumor growth activity and dose-dependent de-repression of EZH2 target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50CIrIhlikrVg90H21EOLACvtfcHk0lh8npPa8CXfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM&md5=eb6f2b053e5ba2c2d214d847ad8d9f1f</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00515%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DRui%26aufirst%3DE.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DMcAlpine%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DRyskin%26aufirst%3DM.%26aulast%3DScales%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DYip%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridone-containing%25203%252C4-dihydroisoquinoline-1%25282H%2529-ones%2520as%2520a%2520novel%2520class%2520of%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8306%26epage%3D8325%26doi%3D10.1021%2Facs.jmedchem.6b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handlon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaller, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leesnitzer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrihew, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, P.</span></span> <span> </span><span class="NLM_article-title">Optimizing ligand efficiency of selective androgen receptor modulators (SARMs)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00377</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00377" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=83-88&issue=1&author=A.+L.+Handlonauthor=L.+T.+Schallerauthor=L.+M.+Leesnitzerauthor=R.+V.+Merrihewauthor=C.+Pooleauthor=J.+C.+Ulrichauthor=J.+W.+Wilsonauthor=R.+Cadillaauthor=P.+Turnbull&title=Optimizing+ligand+efficiency+of+selective+androgen+receptor+modulators+%28SARMs%29&doi=10.1021%2Facsmedchemlett.5b00377"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00377%26sid%3Dliteratum%253Aachs%26aulast%3DHandlon%26aufirst%3DA.%2BL.%26aulast%3DSchaller%26aufirst%3DL.%2BT.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DMerrihew%26aufirst%3DR.%2BV.%26aulast%3DPoole%26aufirst%3DC.%26aulast%3DUlrich%26aufirst%3DJ.%2BC.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DCadilla%26aufirst%3DR.%26aulast%3DTurnbull%26aufirst%3DP.%26atitle%3DOptimizing%2520ligand%2520efficiency%2520of%2520selective%2520androgen%2520receptor%2520modulators%2520%2528SARMs%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D83%26epage%3D88%26doi%3D10.1021%2Facsmedchemlett.5b00377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavergne, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabst, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goosen, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosset, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfefferkorn, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, B.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7185</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7173-7185&issue=18&author=K.+Futatsugiauthor=D.+W.+Kungauthor=S.+T.+Orrauthor=S.+Cabralauthor=D.+Hepworthauthor=G.+Aspnesauthor=S.+Baderauthor=J.+Bianauthor=M.+Boehmauthor=P.+A.+Carpinoauthor=S.+B.+Coffeyauthor=M.+S.+Dowlingauthor=M.+Herrauthor=W.+Jiaoauthor=S.+Y.+Lavergneauthor=Q.+Liauthor=R.+W.+Clarkauthor=D.+M.+Erionauthor=K.+Kouauthor=K.+Leeauthor=B.+A.+Pabstauthor=S.+M.+Perezauthor=J.+Purkalauthor=C.+C.+Jorgensenauthor=T.+C.+Goosenauthor=J.+R.+Gossetauthor=M.+Niosiauthor=J.+C.+Pettersenauthor=J.+A.+Pfefferkornauthor=K.+Ahnauthor=B.+Goodwin&title=Discovery+and+optimization+of+imidazopyridine-based+inhibitors+of+diacylglycerol+acyltransferase+2+%28DGAT2%29&doi=10.1021%2Facs.jmedchem.5b01006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01006%26sid%3Dliteratum%253Aachs%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DAspnes%26aufirst%3DG.%26aulast%3DBader%26aufirst%3DS.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DLavergne%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DClark%26aufirst%3DR.%2BW.%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DKou%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPabst%26aufirst%3DB.%2BA.%26aulast%3DPerez%26aufirst%3DS.%2BM.%26aulast%3DPurkal%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DC.%2BC.%26aulast%3DGoosen%26aufirst%3DT.%2BC.%26aulast%3DGosset%26aufirst%3DJ.%2BR.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPfefferkorn%26aufirst%3DJ.%2BA.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DGoodwin%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520imidazopyridine-based%2520inhibitors%2520of%2520diacylglycerol%2520acyltransferase%25202%2520%2528DGAT2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7173%26epage%3D7185%26doi%3D10.1021%2Facs.jmedchem.5b01006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamacina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span> <span> </span><span class="NLM_article-title">Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3626</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.06.063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3626-3629&issue=17&author=J.+T.+Bagdanoffauthor=R.+Jainauthor=W.+Hanauthor=D.+Poonauthor=P.+S.+Leeauthor=C.+Bellamacinaauthor=M.+Lindvall&title=Ligand+efficient+tetrahydro-pyrazolopyridines+as+inhibitors+of+ERK2+kinase&doi=10.1016%2Fj.bmcl.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DPoon%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DP.%2BS.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DLigand%2520efficient%2520tetrahydro-pyrazolopyridines%2520as%2520inhibitors%2520of%2520ERK2%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3626%26epage%3D3629%26doi%3D10.1016%2Fj.bmcl.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flattery, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlisi, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseoglu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labroli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayhood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuinness, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roemer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span> <span> </span><span class="NLM_article-title">Can we make small molecules lean? optimization of a highly lipophilic TarO inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3851</span>– <span class="NLM_lpage">3865</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3851-3865&issue=9&author=M.+Mandalauthor=Z.+Tanauthor=C.+Madsen-Dugganauthor=A.+V.+Buevichauthor=J.+P.+Caldwellauthor=R.+Dejesusauthor=A.+Flatteryauthor=C.+G.+Garlisiauthor=C.+Gillauthor=S.+N.+Haauthor=G.+Hoauthor=S.+Koseogluauthor=M.+Labroliauthor=K.+Basuauthor=S.+H.+Leeauthor=L.+Liangauthor=J.+Liuauthor=T.+Mayhoodauthor=D.+McGuinnessauthor=D.+G.+McLarenauthor=X.+Wenauthor=E.+Parmeeauthor=D.+Rindgenauthor=T.+Roemerauthor=P.+Shethauthor=P.+Tawaauthor=J.+Tataauthor=C.+Yangauthor=S.+W.+Yangauthor=L.+Xiaoauthor=H.+Wangauthor=C.+Tanauthor=H.+Tangauthor=P.+Walshauthor=E.+Walshauthor=J.+Wuauthor=J.+Su&title=Can+we+make+small+molecules+lean%3F+optimization+of+a+highly+lipophilic+TarO+inhibitor&doi=10.1021%2Facs.jmedchem.7b00113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00113%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DBuevich%26aufirst%3DA.%2BV.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DDejesus%26aufirst%3DR.%26aulast%3DFlattery%26aufirst%3DA.%26aulast%3DGarlisi%26aufirst%3DC.%2BG.%26aulast%3DGill%26aufirst%3DC.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DHo%26aufirst%3DG.%26aulast%3DKoseoglu%26aufirst%3DS.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMayhood%26aufirst%3DT.%26aulast%3DMcGuinness%26aufirst%3DD.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DParmee%26aufirst%3DE.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DRoemer%26aufirst%3DT.%26aulast%3DSheth%26aufirst%3DP.%26aulast%3DTawa%26aufirst%3DP.%26aulast%3DTata%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BW.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DP.%26aulast%3DWalsh%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%26atitle%3DCan%2520we%2520make%2520small%2520molecules%2520lean%253F%2520optimization%2520of%2520a%2520highly%2520lipophilic%2520TarO%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D9%26spage%3D3851%26epage%3D3865%26doi%3D10.1021%2Facs.jmedchem.7b00113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reese, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barricklow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohanon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappon, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianfrogna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcek, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whritenour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (R)-6-neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9 H)-one (PF-06462894), an alkyne-lacking metabotropic glutamate receptor 5 negative allosteric modulator profiled in both rat and nonhuman primates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7764</span>– <span class="NLM_lpage">7780</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00604</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00604" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7764-7780&issue=18&author=A.+F.+Stepanauthor=M.+M.+Claffeyauthor=M.+R.+Reeseauthor=G.+Balanauthor=G.+Barreiroauthor=J.+Barricklowauthor=M.+J.+Bohanonauthor=B.+P.+Boscoeauthor=G.+D.+Capponauthor=L.+K.+Chenardauthor=J.+Cianfrognaauthor=L.+Chenauthor=K.+J.+Coffmanauthor=S.+E.+Drozdaauthor=J.+R.+Dunetzauthor=S.+Ghoshauthor=X.+Houauthor=C.+Houleauthor=K.+Karkiauthor=J.+T.+Lazzaroauthor=J.+Y.+Mancusoauthor=J.+M.+Marcekauthor=E.+L.+Millerauthor=M.+A.+Moenauthor=S.+O%E2%80%99Neilauthor=I.+Sakuradaauthor=M.+Skaddanauthor=V.+Parikhauthor=D.+L.+Smithauthor=P.+Trapaauthor=J.+B.+Tuttleauthor=P.+R.+Verhoestauthor=D.+P.+Walkerauthor=A.+Wonauthor=A.+S.+Wrightauthor=J.+Whritenourauthor=K.+Zasadnyauthor=M.+M.+Zaleskaauthor=L.+Zhangauthor=C.+L.+Shaffer&title=Discovery+and+characterization+of+%28R%29-6-neopentyl-2-%28pyridin-2-ylmethoxy%29-6%2C7-dihydropyrimido%5B2%2C1-c%5D%5B1%2C4%5Doxazin-4%289+H%29-one+%28PF-06462894%29%2C+an+alkyne-lacking+metabotropic+glutamate+receptor+5+negative+allosteric+modulator+profiled+in+both+rat+and+nonhuman+primates&doi=10.1021%2Facs.jmedchem.7b00604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00604%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DBohanon%26aufirst%3DM.%2BJ.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DCappon%26aufirst%3DG.%2BD.%26aulast%3DChenard%26aufirst%3DL.%2BK.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DMarcek%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DE.%2BL.%26aulast%3DMoen%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%26aulast%3DSakurada%26aufirst%3DI.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DWhritenour%26aufirst%3DJ.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%2528R%2529-6-neopentyl-2-%2528pyridin-2-ylmethoxy%2529-6%252C7-dihydropyrimido%255B2%252C1-c%255D%255B1%252C4%255Doxazin-4%25289%2520H%2529-one%2520%2528PF-06462894%2529%252C%2520an%2520alkyne-lacking%2520metabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulator%2520profiled%2520in%2520both%2520rat%2520and%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D18%26spage%3D7764%26epage%3D7780%26doi%3D10.1021%2Facs.jmedchem.7b00604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, selective, and peripherally restricted pan-Trk inhibitor (PF-06273340) for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">10084</span>– <span class="NLM_lpage">10099</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10084-10099&issue=22&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldron&title=The+discovery+of+a+potent%2C+selective%2C+and+peripherally+restricted+pan-Trk+inhibitor+%28PF-06273340%29+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span></div><div class="casAuthors">Skerratt, Sarah E.; Andrews, Mark; Bagal, Sharan K.; Bilsland, James; Brown, David; Bungay, Peter J.; Cole, Susan; Gibson, Karl R.; Jones, Russell; Morao, Inaki; Nedderman, Angus; Omoto, Kiyoyuki; Robinson, Colin; Ryckmans, Thomas; Skinner, Kimberly; Stupple, Paul; Waldron, Gareth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10084-10099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotrophin family of growth factors, comprised of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4 (NT4), is implicated in the physiol. of chronic pain.  Given the clin. efficacy of anti-NGF monoclonal antibody (mAb) therapies, there is significant interest in the development of small mol. modulators of neurotrophin activity.  Neurotrophins signal through the tropomyosin related kinase (Trk) family of tyrosine kinase receptors, hence Trk kinase inhibition represents a potentially "druggable" point of intervention.  To deliver the safety profile required for chronic, non-life threatening pain indications, highly kinase-selective Trk inhibitors with minimal brain availability are sought.  Herein the authors describe how the use of SBDD, 2D QSAR models and Matched Mol. Pair data in compd. design enabled the delivery of the highly potent, kinase-selective and peripherally restricted clin. candidate PF-06273340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67CFmGAkmRrVg90H21EOLACvtfcHk0ljtr44AROTJzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL&md5=f8c904a92c1716062c217fefe2374ce6</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldron%26aufirst%3DG.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520peripherally%2520restricted%2520pan-Trk%2520inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D22%26spage%3D10084%26epage%3D10099%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carswell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belshaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struthers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stribling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzimidazole CYP11B2 inhibitors with in vivo activity in rhesus monkeys</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">578</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=573-578&issue=5&author=S.+B.+Hoytauthor=M.+K.+Parkauthor=C.+Londonauthor=Y.+Xiongauthor=J.+Tataauthor=D.+J.+Bennettauthor=A.+Cookeauthor=J.+Caiauthor=E.+Carswellauthor=J.+Robinsonauthor=J.+MacLeanauthor=L.+Brownauthor=S.+Belshawauthor=T.+R.+Clarksonauthor=K.+Liuauthor=G.+B.+Liangauthor=M.+Struthersauthor=D.+Cullyauthor=T.+Wisniewskiauthor=N.+Renauthor=C.+Boppauthor=A.+Sokauthor=T.+Q.+Caiauthor=S.+Striblingauthor=L.+Y.+Paiauthor=X.+Maauthor=J.+Metzgerauthor=A.+Verrasauthor=D.+McMastersauthor=Q.+Chenauthor=E.+Tungauthor=W.+Tangauthor=G.+Salituroauthor=N.+Buistauthor=J.+Kuetheauthor=N.+Riveraauthor=J.+Clemasauthor=G.+Zhouauthor=J.+Gibsonauthor=C.+A.+Maxwellauthor=M.+Lassmanauthor=T.+McLaughlinauthor=J.+Castro-Perezauthor=D.+Szetoauthor=G.+Forrestauthor=R.+Hajduauthor=M.+Rosenbachauthor=A.+Ali&title=Discovery+of+benzimidazole+CYP11B2+inhibitors+with+in+vivo+activity+in+rhesus+monkeys&doi=10.1021%2Facsmedchemlett.5b00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00054%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DPark%26aufirst%3DM.%2BK.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DTata%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCarswell%26aufirst%3DE.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMacLean%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBelshaw%26aufirst%3DS.%26aulast%3DClarkson%26aufirst%3DT.%2BR.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DG.%2BB.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DCully%26aufirst%3DD.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DBopp%26aufirst%3DC.%26aulast%3DSok%26aufirst%3DA.%26aulast%3DCai%26aufirst%3DT.%2BQ.%26aulast%3DStribling%26aufirst%3DS.%26aulast%3DPai%26aufirst%3DL.%2BY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMetzger%26aufirst%3DJ.%26aulast%3DVerras%26aufirst%3DA.%26aulast%3DMcMasters%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DTung%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DBuist%26aufirst%3DN.%26aulast%3DKuethe%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DN.%26aulast%3DClemas%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DC.%2BA.%26aulast%3DLassman%26aufirst%3DM.%26aulast%3DMcLaughlin%26aufirst%3DT.%26aulast%3DCastro-Perez%26aufirst%3DJ.%26aulast%3DSzeto%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520benzimidazole%2520CYP11B2%2520inhibitors%2520with%2520in%2520vivo%2520activity%2520in%2520rhesus%2520monkeys%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D573%26epage%3D578%26doi%3D10.1021%2Facsmedchemlett.5b00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliushchev, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrent, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarris, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Algire, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweis, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M. R.</span></span> <span> </span><span class="NLM_article-title">SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1576</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2017.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28254486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Oju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1576-1583&issue=7&author=M.+L.+Curtinauthor=M.+A.+Pliushchevauthor=H.+Q.+Liauthor=M.+Torrentauthor=J.+D.+Dietrichauthor=C.+G.+Jakobauthor=H.+Zhuauthor=H.+Zhaoauthor=Y.+Wangauthor=Z.+Jiauthor=R.+F.+Clarkauthor=K.+A.+Sarrisauthor=S.+Selvarajuauthor=B.+Shawauthor=M.+A.+Algireauthor=Y.+Heauthor=P.+L.+Richardsonauthor=R.+F.+Sweisauthor=C.+Sunauthor=G.+G.+Chiangauthor=M.+R.+Michaelides&title=SAR+of+amino+pyrrolidines+as+potent+and+novel+protein-protein+interaction+inhibitors+of+the+PRC2+complex+through+EED+binding&doi=10.1016%2Fj.bmcl.2017.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding</span></div><div class="casAuthors">Curtin, Michael L.; Pliushchev, Marina A.; Li, Huan-Qiu; Torrent, Maricel; Dietrich, Justin D.; Jakob, Clarissa G.; Zhu, Haizhong; Zhao, Hongyu; Wang, Ying; Ji, Zhiqin; Clark, Richard F.; Sarris, Kathy A.; Selvaraju, Sujatha; Shaw, Bailin; Algire, Mikkel A.; He, Yupeng; Richardson, Paul L.; Sweis, Ramzi F.; Sun, Chaohong; Chiang, Gary G.; Michaelides, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1576-1583</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we disclose SAR studies of a series of dimethylamino pyrrolidines which we recently reported as novel inhibitors of the PRC2 complex through disruption of EED/H3K27me3 binding.  Modification of the indole and benzyl moieties of screening hit 1 provided analogs with substantially improved binding and cellular activities.  This work culminated in the identification of compd. 2, our nanomolar proof-of-concept (PoC) inhibitor which provided on-target tumor growth inhibition in a mouse xenograft model.  X-ray crystal structures of several inhibitors bound in the EED active-site are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkdonJy6cBnbVg90H21EOLACvtfcHk0ljDVPb0toK9Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Oju7s%253D&md5=3396f3f4c2d3944237cfde004ac4204b</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DPliushchev%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DH.%2BQ.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DDietrich%26aufirst%3DJ.%2BD.%26aulast%3DJakob%26aufirst%3DC.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DClark%26aufirst%3DR.%2BF.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DSelvaraju%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DAlgire%26aufirst%3DM.%2BA.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DSweis%26aufirst%3DR.%2BF.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DSAR%2520of%2520amino%2520pyrrolidines%2520as%2520potent%2520and%2520novel%2520protein-protein%2520interaction%2520inhibitors%2520of%2520the%2520PRC2%2520complex%2520through%2520EED%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D1576%26epage%3D1583%26doi%3D10.1016%2Fj.bmcl.2017.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djakovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madriaga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss von
Soly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawver, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Moigne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolfe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustrow, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">9480</span>– <span class="NLM_lpage">9497</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9480-9497&issue=24&author=H.+J.+Zhouauthor=J.+Wangauthor=B.+Yaoauthor=S.+Wongauthor=S.+Djakovicauthor=B.+Kumarauthor=J.+Riceauthor=E.+Valleauthor=F.+Sorianoauthor=M.+K.+Menonauthor=A.+Madriagaauthor=S.+Kiss+von%0ASolyauthor=A.+Kumarauthor=F.+Parlatiauthor=F.+M.+Yakesauthor=L.+Shawverauthor=R.+Le+Moigneauthor=D.+J.+Andersonauthor=M.+Rolfeauthor=D.+Wustrow&title=Discovery+of+a+first-in-class%2C+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+p97+AAA+ATPase+%28CB-5083%29&doi=10.1021%2Facs.jmedchem.5b01346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01346%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DDjakovic%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DB.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DValle%26aufirst%3DE.%26aulast%3DSoriano%26aufirst%3DF.%26aulast%3DMenon%26aufirst%3DM.%2BK.%26aulast%3DMadriaga%26aufirst%3DA.%26aulast%3DKiss%2Bvon%2BSoly%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DShawver%26aufirst%3DL.%26aulast%3DLe%2BMoigne%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DWustrow%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%252C%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520p97%2520AAA%2520ATPase%2520%2528CB-5083%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D24%26spage%3D9480%26epage%3D9497%26doi%3D10.1021%2Facs.jmedchem.5b01346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-Based design of tricyclic NF-kappaB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&issue=2&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.+F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-Based+design+of+tricyclic+NF-kappaB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%2BF.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-Based%2520design%2520of%2520tricyclic%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D2%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muto, T.</span></span> <span> </span><span class="NLM_article-title">Structural Optimization of ghrelin receptor inverse agonists to improve lipophilicity and avoid mechanism-based CYP3A4 inactivation</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1248/cpb.c15-00285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1248%2Fcpb.c15-00285" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=825-832&issue=10&author=B.+Takahashiauthor=H.+Funamiauthor=M.+Shibataauthor=H.+Maruokaauthor=M.+Koyamaauthor=S.+Kankiauthor=T.+Muto&title=Structural+Optimization+of+ghrelin+receptor+inverse+agonists+to+improve+lipophilicity+and+avoid+mechanism-based+CYP3A4+inactivation&doi=10.1248%2Fcpb.c15-00285"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c15-00285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c15-00285%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DB.%26aulast%3DFunami%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMaruoka%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DM.%26aulast%3DKanki%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DT.%26atitle%3DStructural%2520Optimization%2520of%2520ghrelin%2520receptor%2520inverse%2520agonists%2520to%2520improve%2520lipophilicity%2520and%2520avoid%2520mechanism-based%2520CYP3A4%2520inactivation%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2015%26volume%3D63%26issue%3D10%26spage%3D825%26epage%3D832%26doi%3D10.1248%2Fcpb.c15-00285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillgrove, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel aza-benzimidazolone mGluR2 PAMs with respect to LLE and PK properties and mitigation of CYP TDI</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=312-317&issue=3&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=M.+J.+Kellyauthor=H.+D.+Lehmanauthor=M.+E.+Laytonauthor=R.+M.+Garbaccioauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=M.+A.+Jacobson&title=Optimization+of+novel+aza-benzimidazolone+mGluR2+PAMs+with+respect+to+LLE+and+PK+properties+and+mitigation+of+CYP+TDI&doi=10.1021%2Facsmedchemlett.5b00459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00459%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DLehman%26aufirst%3DH.%2BD.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DOptimization%2520of%2520novel%2520aza-benzimidazolone%2520mGluR2%2520PAMs%2520with%2520respect%2520to%2520LLE%2520and%2520PK%2520properties%2520and%2520mitigation%2520of%2520CYP%2520TDI%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D312%26epage%3D317%26doi%3D10.1021%2Facsmedchemlett.5b00459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&issue=20&author=K.+Doyleauthor=H.+Lonnauthor=H.+Kackauthor=A.+Van+de+Poelauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPP1+inhibitors+leading+to+an+oxazepane+amidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)</span></div><div class="casAuthors">Doyle, Kevin; Lonn, Hans; Kack, Helena; Van de Poel, Amanda; Swallow, Steve; Gardiner, Philip; Connolly, Stephen; Root, James; Wikell, Cecilia; Dahl, Goran; Stenvall, Kristina; Johannesson, Petra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9457-9472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of second generation DPP1 inhibitors free from aorta binding liabilities found for earlier compd. series was discovered.  This work culminated in the identification of compd. 30 (AZD7986) as a highly potent, reversible, and selective clin. candidate for COPD, with predicted human PK properties suitable for once daily human dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ_YtbyrmtbVg90H21EOLACvtfcHk0liLhVIIfSCYKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF&md5=73daf54da4a47b7b11db53e0b5a98e50</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DLonn%26aufirst%3DH.%26aulast%3DKack%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPoel%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepane%2520amidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D20%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meilandt, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imperio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewcock, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibitors of dual leucine zipper kinase (DLK, MAP3K12) with activity in a model of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">8083</span>– <span class="NLM_lpage">8102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00843</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8083-8102&issue=19&author=S.+Patelauthor=W.+J.+Meilandtauthor=R.+I.+Ericksonauthor=J.+Chenauthor=G.+Deshmukhauthor=A.+A.+Estradaauthor=R.+N.+Fujiauthor=P.+Gibbonsauthor=A.+Gustafsonauthor=S.+F.+Harrisauthor=J.+Imperioauthor=W.+Liuauthor=X.+Liuauthor=Y.+Liuauthor=J.+P.+Lyssikatosauthor=C.+Maauthor=J.+Yinauthor=J.+W.+Lewcockauthor=M.+Siu&title=Selective+inhibitors+of+dual+leucine+zipper+kinase+%28DLK%2C+MAP3K12%29+with+activity+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00843%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DMeilandt%26aufirst%3DW.%2BJ.%26aulast%3DErickson%26aufirst%3DR.%2BI.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DImperio%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DSelective%2520inhibitors%2520of%2520dual%2520leucine%2520zipper%2520kinase%2520%2528DLK%252C%2520MAP3K12%2529%2520with%2520activity%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D19%26spage%3D8083%26epage%3D8102%26doi%3D10.1021%2Facs.jmedchem.7b00843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishigaya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, S.</span></span> <span> </span><span class="NLM_article-title">Identification of novel 1,2,3,6-tetrahydropyridyl-substituted benzo[d]thiazoles: Lead generation and optimization toward potent and orally active EP1 receptor antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3406</span>– <span class="NLM_lpage">3430</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmc.2017.04.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3406-3430&issue=13&author=K.+Umeiauthor=Y.+Nishigayaauthor=K.+Tataniauthor=Y.+Kohnoauthor=N.+Tanakaauthor=S.+Seto&title=Identification+of+novel+1%2C2%2C3%2C6-tetrahydropyridyl-substituted+benzo%5Bd%5Dthiazoles%3A+Lead+generation+and+optimization+toward+potent+and+orally+active+EP1+receptor+antagonists&doi=10.1016%2Fj.bmc.2017.04.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DUmei%26aufirst%3DK.%26aulast%3DNishigaya%26aufirst%3DY.%26aulast%3DTatani%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520novel%25201%252C2%252C3%252C6-tetrahydropyridyl-substituted%2520benzo%255Bd%255Dthiazoles%253A%2520Lead%2520generation%2520and%2520optimization%2520toward%2520potent%2520and%2520orally%2520active%2520EP1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3406%26epage%3D3430%26doi%3D10.1016%2Fj.bmc.2017.04.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inatomi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajino, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3298</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref274/cit274&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmc.2017.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3298-3314&issue=13&author=H.+Nishidaauthor=Y.+Arikawaauthor=K.+Hiraseauthor=T.+Imaedaauthor=N.+Inatomiauthor=Y.+Horiauthor=J.+Matsukawaauthor=Y.+Fujiokaauthor=T.+Hamadaauthor=M.+Iidaauthor=M.+Nishitaniauthor=A.+Imanishiauthor=H.+Fukuiauthor=F.+Itohauthor=M.+Kajino&title=Identification+of+a+novel+fluoropyrrole+derivative+as+a+potassium-competitive+acid+blocker+with+long+duration+of+action&doi=10.1016%2Fj.bmc.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DNishida%26aufirst%3DH.%26aulast%3DArikawa%26aufirst%3DY.%26aulast%3DHirase%26aufirst%3DK.%26aulast%3DImaeda%26aufirst%3DT.%26aulast%3DInatomi%26aufirst%3DN.%26aulast%3DHori%26aufirst%3DY.%26aulast%3DMatsukawa%26aufirst%3DJ.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DM.%26aulast%3DNishitani%26aufirst%3DM.%26aulast%3DImanishi%26aufirst%3DA.%26aulast%3DFukui%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DF.%26aulast%3DKajino%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520fluoropyrrole%2520derivative%2520as%2520a%2520potassium-competitive%2520acid%2520blocker%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3298%26epage%3D3314%26doi%3D10.1016%2Fj.bmc.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoveyda, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutheuil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Bousmaqui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, S.</span></span> <span> </span><span class="NLM_article-title">Optimization of novel antagonists to the neurokinin-3 receptor for the treatment of sex-hormone disorders (part II)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00117</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00117" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=736-740&issue=7&author=H.+R.+Hoveydaauthor=G.+L.+Fraserauthor=G.+Dutheuilauthor=M.+El+Bousmaquiauthor=J.+Koracauthor=F.+Lenoirauthor=A.+Lapinauthor=S.+Noel&title=Optimization+of+novel+antagonists+to+the+neurokinin-3+receptor+for+the+treatment+of+sex-hormone+disorders+%28part+II%29&doi=10.1021%2Facsmedchemlett.5b00117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00117%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DH.%2BR.%26aulast%3DFraser%26aufirst%3DG.%2BL.%26aulast%3DDutheuil%26aufirst%3DG.%26aulast%3DEl%2BBousmaqui%26aufirst%3DM.%26aulast%3DKorac%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLapin%26aufirst%3DA.%26aulast%3DNoel%26aufirst%3DS.%26atitle%3DOptimization%2520of%2520novel%2520antagonists%2520to%2520the%2520neurokinin-3%2520receptor%2520for%2520the%2520treatment%2520of%2520sex-hormone%2520disorders%2520%2528part%2520II%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D7%26spage%3D736%26epage%3D740%26doi%3D10.1021%2Facsmedchemlett.5b00117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pretel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dordal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almansa, C.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1254</span>, <span class="refDoi"> DOI: 10.1039/C7MD00078B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1039%2FC7MD00078B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1246-1254&issue=6&author=J.+L.+D%C3%ADazauthor=J.+Corberaauthor=D.+Mart%C3%ADnezauthor=M.+Bordasauthor=C.+Sicreauthor=R.+Pascualauthor=M.+J.+Pretelauthor=A.+P.+Mar%C3%ADnauthor=A.+Monteroauthor=A.+Dordalauthor=I.+Alvarezauthor=C.+Almansa&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+as+sigma-1+receptor+ligands+for+the+treatment+of+pain.+Part+2%3A+Introduction+of+cyclic+substituents+in+position+4&doi=10.1039%2FC7MD00078B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1039%2FC7MD00078B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00078B%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BL.%26aulast%3DCorbera%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DD.%26aulast%3DBordas%26aufirst%3DM.%26aulast%3DSicre%26aufirst%3DC.%26aulast%3DPascual%26aufirst%3DR.%26aulast%3DPretel%26aufirst%3DM.%2BJ.%26aulast%3DMar%25C3%25ADn%26aufirst%3DA.%2BP.%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DDordal%26aufirst%3DA.%26aulast%3DAlvarez%26aufirst%3DI.%26aulast%3DAlmansa%26aufirst%3DC.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520sigma-1%2520receptor%2520ligands%2520for%2520the%2520treatment%2520of%2520pain.%2520Part%25202%253A%2520Introduction%2520of%2520cyclic%2520substituents%2520in%2520position%25204%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1246%26epage%3D1254%26doi%3D10.1039%2FC7MD00078B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&issue=5&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+a+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520a%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohls, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPetrillo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monovich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idamakanti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taslimi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunjathoor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. M.</span></span> <span> </span><span class="NLM_article-title">Optimization of allosteric with-no-lysine (WNK) kinase inhibitors and efficacy in rodent hypertension models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7099</span>– <span class="NLM_lpage">7107</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7099-7107&issue=16&author=K.+Yamadaauthor=J.+Levellauthor=T.+Yoonauthor=D.+Kohlsauthor=D.+Yoweauthor=D.+F.+Rigelauthor=H.+Imaseauthor=J.+Yuanauthor=K.+Yasoshimaauthor=K.+DiPetrilloauthor=L.+Monovichauthor=L.+Xuauthor=M.+Zhuauthor=M.+Katoauthor=M.+Jainauthor=N.+Idamakantiauthor=P.+Taslimiauthor=T.+Kawanamiauthor=U.+A.+Argikarauthor=V.+Kunjathoorauthor=X.+Xieauthor=Y.+I.+Yagiauthor=Y.+Iwakiauthor=Z.+Robinsonauthor=H.+M.+Park&title=Optimization+of+allosteric+with-no-lysine+%28WNK%29+kinase+inhibitors+and+efficacy+in+rodent+hypertension+models&doi=10.1021%2Facs.jmedchem.7b00708"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00708%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DLevell%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DYowe%26aufirst%3DD.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DImase%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DYasoshima%26aufirst%3DK.%26aulast%3DDiPetrillo%26aufirst%3DK.%26aulast%3DMonovich%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DKunjathoor%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYagi%26aufirst%3DY.%2BI.%26aulast%3DIwaki%26aufirst%3DY.%26aulast%3DRobinson%26aufirst%3DZ.%26aulast%3DPark%26aufirst%3DH.%2BM.%26atitle%3DOptimization%2520of%2520allosteric%2520with-no-lysine%2520%2528WNK%2529%2520kinase%2520inhibitors%2520and%2520efficacy%2520in%2520rodent%2520hypertension%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D16%26spage%3D7099%26epage%3D7107%26doi%3D10.1021%2Facs.jmedchem.7b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref279"><div class="reference"><strong class="refLabel"><a href="#ref279" class="rightTabRefNumLink">279</a></strong><div class="NLM_citation" id="rightTab-cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Due-Hansen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargent, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimpukade, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejsing, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthorne, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent free fatty acid 1 receptor agonist with low lipophilicity, low polar surface area, and robust in vivo efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2841</span>– <span class="NLM_lpage">2846</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2841-2846&issue=6&author=S.+V.+Hansenauthor=E.+Christiansenauthor=C.+Urbanauthor=B.+D.+Hudsonauthor=C.+J.+Stockerauthor=M.+E.+Due-Hansenauthor=E.+T.+Wargentauthor=B.+Shimpukadeauthor=R.+Almeidaauthor=C.+S.+Ejsingauthor=M.+A.+Cawthorneauthor=M.+U.+Kassackauthor=G.+Milliganauthor=T.+Ulven&title=Discovery+of+a+potent+free+fatty+acid+1+receptor+agonist+with+low+lipophilicity%2C+low+polar+surface+area%2C+and+robust+in+vivo+efficacy&doi=10.1021%2Facs.jmedchem.5b01962"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01962%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DStocker%26aufirst%3DC.%2BJ.%26aulast%3DDue-Hansen%26aufirst%3DM.%2BE.%26aulast%3DWargent%26aufirst%3DE.%2BT.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DAlmeida%26aufirst%3DR.%26aulast%3DEjsing%26aufirst%3DC.%2BS.%26aulast%3DCawthorne%26aufirst%3DM.%2BA.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520free%2520fatty%2520acid%25201%2520receptor%2520agonist%2520with%2520low%2520lipophilicity%252C%2520low%2520polar%2520surface%2520area%252C%2520and%2520robust%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2841%26epage%3D2846%26doi%3D10.1021%2Facs.jmedchem.5b01962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref280"><div class="reference"><strong class="refLabel"><a href="#ref280" class="rightTabRefNumLink">280</a></strong><div class="NLM_citation" id="rightTab-cit280"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inazawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3beta inhibitors for Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1086</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1086-1091&issue=5&author=K.+Fukunagaauthor=D.+Sakaiauthor=K.+Watanabeauthor=K.+Nakayamaauthor=T.+Koharaauthor=H.+Tanakaauthor=S.+Sunadaauthor=M.+Nabenoauthor=M.+Okamotoauthor=K.+Saitoauthor=J.+Eguchiauthor=A.+Moriauthor=S.+Tanakaauthor=K.+Inazawaauthor=T.+Horikawa&title=Discovery+of+novel+2-%28alkylmorpholin-4-yl%29-6-%283-fluoropyridin-4-yl%29-pyrimidin-4%283H%29-ones+as+orally-active+GSK-3beta+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DInazawa%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528alkylmorpholin-4-yl%2529-6-%25283-fluoropyridin-4-yl%2529-pyrimidin-4%25283H%2529-ones%2520as%2520orally-active%2520GSK-3beta%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1086%26epage%3D1091%26doi%3D10.1016%2Fj.bmcl.2015.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref281"><div class="reference"><strong class="refLabel"><a href="#ref281" class="rightTabRefNumLink">281</a></strong><div class="NLM_citation" id="rightTab-cit281"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curwen, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducray, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsall, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigwell, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective, orally bioavailable, and efficacious novel 2-(pyrazol-4-ylamino)-pyrimidine inhibitor of the insulin-like growth factor-1 receptor (IGF-1R)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4859</span>– <span class="NLM_lpage">4866</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4859-4866&issue=10&author=S.+L.+Degorceauthor=S.+Boydauthor=J.+O.+Curwenauthor=R.+Ducrayauthor=C.+T.+Halsallauthor=C.+D.+Jonesauthor=F.+Lachauthor=E.+M.+Lenzauthor=M.+Passauthor=S.+Passauthor=C.+Trigwell&title=Discovery+of+a+potent%2C+selective%2C+orally+bioavailable%2C+and+efficacious+novel+2-%28pyrazol-4-ylamino%29-pyrimidine+inhibitor+of+the+insulin-like+growth+factor-1+receptor+%28IGF-1R%29&doi=10.1021%2Facs.jmedchem.6b00203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R)</span></div><div class="casAuthors">Degorce, Sebastien L.; Boyd, Scott; Curwen, Jon O.; Ducray, Richard; Halsall, Christopher T.; Jones, Clifford D.; Lach, Franck; Lenz, Eva M.; Pass, Martin; Pass, Sarah; Trigwell, Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4859-4866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of cellular lipophilic ligand efficiency (LLE) in a series of 2-anilino-pyrimidine IGF-1R kinase inhibitors led to the identification of novel 2-(pyrazol-4-ylamino)-pyrimidines with improved physicochem. properties.  Replacement of the imidazo[1,2-a]pyridine group of the previously reported inhibitor 3 with the related pyrazolo[1,5-a]pyridine improved IGF-1R cellular potency.  Substitution of the amino-pyrazole group was key to obtaining excellent kinase selectivity and pharmacokinetic parameters suitable for oral dosing, which led to the discovery of (2R)-1-[4-(4-{[5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-2-pyrimidinyl]amino}-3,5-dimethyl-1H-pyrazol-1-yl)-1-piperidinyl]-2-hydroxy-1-propanone (AZD9362, 28), a novel, efficacious inhibitor of IGF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP5uHW4VwKWrVg90H21EOLACvtfcHk0ljj0qLPxOXk8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmtrw%253D&md5=b6b61dbeab93bb0572ab9a11f59bbed2</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00203%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DS.%2BL.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DHalsall%26aufirst%3DC.%2BT.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DLach%26aufirst%3DF.%26aulast%3DLenz%26aufirst%3DE.%2BM.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPass%26aufirst%3DS.%26aulast%3DTrigwell%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%252C%2520and%2520efficacious%2520novel%25202-%2528pyrazol-4-ylamino%2529-pyrimidine%2520inhibitor%2520of%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520%2528IGF-1R%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D10%26spage%3D4859%26epage%3D4866%26doi%3D10.1021%2Facs.jmedchem.6b00203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref282"><div class="reference"><strong class="refLabel"><a href="#ref282" class="rightTabRefNumLink">282</a></strong><div class="NLM_citation" id="rightTab-cit282"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brubaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Close, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mampreian, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fradera, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bays, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenblatt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesburg, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klappenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. R.</span></span> <span> </span><span class="NLM_article-title">The discovery of 3-((4-chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1 H-pyrazole-4-carboxamide, a highly ligand efficient and efficacious janus kinase 1 selective inhibitor with favorable pharmacokinetic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">9676</span>– <span class="NLM_lpage">9690</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01135</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01135" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9676-9690&issue=23&author=T.+Siuauthor=J.+Brubakerauthor=P.+Fullerauthor=L.+Torresauthor=H.+Zengauthor=J.+Closeauthor=D.+M.+Mampreianauthor=F.+Shiauthor=D.+Liuauthor=X.+Fraderaauthor=K.+Johnsonauthor=N.+Baysauthor=E.+Kadicauthor=F.+Heauthor=P.+Goldenblattauthor=L.+Shafferauthor=S.+B.+Patelauthor=C.+A.+Lesburgauthor=C.+Alpertauthor=L.+Doroshauthor=S.+V.+Deshmukhauthor=H.+Yuauthor=J.+Klappenbachauthor=F.+Elwoodauthor=C.+J.+Dinsmoreauthor=R.+Fernandezauthor=L.+Moyauthor=J.+R.+Young&title=The+discovery+of+3-%28%284-chloro-3-methoxyphenyl%29amino%29-1-%28%283R%2C4S%29-4-cyanotetrahydro-2H-pyran-3-yl%29-1+H-pyrazole-4-carboxamide%2C+a+highly+ligand+efficient+and+efficacious+janus+kinase+1+selective+inhibitor+with+favorable+pharmacokinetic+properties&doi=10.1021%2Facs.jmedchem.7b01135"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01135%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DBrubaker%26aufirst%3DJ.%26aulast%3DFuller%26aufirst%3DP.%26aulast%3DTorres%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DClose%26aufirst%3DJ.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DFradera%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DBays%26aufirst%3DN.%26aulast%3DKadic%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DGoldenblatt%26aufirst%3DP.%26aulast%3DShaffer%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DAlpert%26aufirst%3DC.%26aulast%3DDorosh%26aufirst%3DL.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DKlappenbach%26aufirst%3DJ.%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DMoy%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520discovery%2520of%25203-%2528%25284-chloro-3-methoxyphenyl%2529amino%2529-1-%2528%25283R%252C4S%2529-4-cyanotetrahydro-2H-pyran-3-yl%2529-1%2520H-pyrazole-4-carboxamide%252C%2520a%2520highly%2520ligand%2520efficient%2520and%2520efficacious%2520janus%2520kinase%25201%2520selective%2520inhibitor%2520with%2520favorable%2520pharmacokinetic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D23%26spage%3D9676%26epage%3D9690%26doi%3D10.1021%2Facs.jmedchem.7b01135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref283"><div class="reference"><strong class="refLabel"><a href="#ref283" class="rightTabRefNumLink">283</a></strong><div class="NLM_citation" id="rightTab-cit283"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2016.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4455-4461&issue=18&author=O.+Reneauthor=B.+P.+Fauberauthor=A.+Barnardauthor=K.+Chapmanauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+oxa-sultams+as+RORc+inverse+agonists+showing+reduced+lipophilicity%2C+improved+selectivity+and+favorable+ADME+properties&doi=10.1016%2Fj.bmcl.2016.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520oxa-sultams%2520as%2520RORc%2520inverse%2520agonists%2520showing%2520reduced%2520lipophilicity%252C%2520improved%2520selectivity%2520and%2520favorable%2520ADME%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D18%26spage%3D4455%26epage%3D4461%26doi%3D10.1016%2Fj.bmcl.2016.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref284"><div class="reference"><strong class="refLabel"><a href="#ref284" class="rightTabRefNumLink">284</a></strong><div class="NLM_citation" id="rightTab-cit284"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futatsugi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcari, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derksen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span> <span> </span><span class="NLM_article-title">Optimization of amide-based EP3 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2670</span>– <span class="NLM_lpage">2675</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2016.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2670-2675&issue=11&author=E.+C.+Leeauthor=K.+Futatsugiauthor=J.+T.+Arcariauthor=K.+Bahnckauthor=S.+B.+Coffeyauthor=D.+R.+Derksenauthor=A.+S.+Kalgutkarauthor=P.+M.+Loriaauthor=R.+Sharma&title=Optimization+of+amide-based+EP3+receptor+antagonists&doi=10.1016%2Fj.bmcl.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DArcari%26aufirst%3DJ.%2BT.%26aulast%3DBahnck%26aufirst%3DK.%26aulast%3DCoffey%26aufirst%3DS.%2BB.%26aulast%3DDerksen%26aufirst%3DD.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DOptimization%2520of%2520amide-based%2520EP3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2670%26epage%3D2675%26doi%3D10.1016%2Fj.bmcl.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref285"><div class="reference"><strong class="refLabel"><a href="#ref285" class="rightTabRefNumLink">285</a></strong><div class="NLM_citation" id="rightTab-cit285"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davoren, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnsey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugolenski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgerton, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotarski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottebaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon-Ferrer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of the potent and selective M1 PAM-agonist N-[(3R,4S)-3-hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)ben zyl]pyridine-2-carboxamide (PF-06767832): evaluation of efficacy and cholinergic side effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6313</span>– <span class="NLM_lpage">6328</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6313-6328&issue=13&author=J.+E.+Davorenauthor=C.+W.+Leeauthor=M.+Garnseyauthor=M.+A.+Brodneyauthor=J.+Cordesauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=A.+R.+Harrisauthor=C.+J.+Helalauthor=S.+Jenkinsonauthor=G.+W.+Kauffmanauthor=T.+P.+Kenakinauthor=J.+T.+Lazzaroauthor=S.+M.+Lotarskiauthor=Y.+Maoauthor=D.+M.+Nasonauthor=C.+Northcottauthor=L.+Nottebaumauthor=S.+V.+O%E2%80%99Neilauthor=B.+Pettersenauthor=M.+Popiolekauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=L.+Zhangauthor=S.+Grimwood&title=Discovery+of+the+potent+and+selective+M1+PAM-agonist+N-%5B%283R%2C4S%29-3-hydroxytetrahydro-2H-pyran-4-yl%5D-5-methyl-4-%5B4-%281%2C3-thiazol-4-yl%29ben+zyl%5Dpyridine-2-carboxamide+%28PF-06767832%29%3A+evaluation+of+efficacy+and+cholinergic+side+effects&doi=10.1021%2Facs.jmedchem.6b00544"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCordes%26aufirst%3DJ.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DNorthcott%26aufirst%3DC.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DPettersen%26aufirst%3DB.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520the%2520potent%2520and%2520selective%2520M1%2520PAM-agonist%2520N-%255B%25283R%252C4S%2529-3-hydroxytetrahydro-2H-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529ben%2520zyl%255Dpyridine-2-carboxamide%2520%2528PF-06767832%2529%253A%2520evaluation%2520of%2520efficacy%2520and%2520cholinergic%2520side%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D13%26spage%3D6313%26epage%3D6328%26doi%3D10.1021%2Facs.jmedchem.6b00544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref286"><div class="reference"><strong class="refLabel"><a href="#ref286" class="rightTabRefNumLink">286</a></strong><div class="NLM_citation" id="rightTab-cit286"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemurell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emtenas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broddefalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovdal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryden-Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herslof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigfridsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whatling, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1021/jm501531v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501531v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=897-911&issue=2&author=M.+Lemurellauthor=J.+Ulanderauthor=S.+Winiwarterauthor=A.+Dahlenauthor=O.+Davidssonauthor=H.+Emtenasauthor=J.+Broddefalkauthor=M.+Swansonauthor=D.+Hovdalauthor=A.+T.+Plowrightauthor=A.+Pettersenauthor=M.+Ryden-Landergrenauthor=J.+Barlindauthor=A.+Llinasauthor=M.+Herslofauthor=T.+Drmotaauthor=K.+Sigfridssonauthor=S.+Mosesauthor=C.+Whatling&title=Discovery+of+AZD6642%2C+an+inhibitor+of+5-lipoxygenase+activating+protein+%28FLAP%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm501531v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=10.1021%2Fjm501531v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501531v%26sid%3Dliteratum%253Aachs%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDahlen%26aufirst%3DA.%26aulast%3DDavidsson%26aufirst%3DO.%26aulast%3DEmtenas%26aufirst%3DH.%26aulast%3DBroddefalk%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DM.%26aulast%3DHovdal%26aufirst%3DD.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DRyden-Landergren%26aufirst%3DM.%26aulast%3DBarlind%26aufirst%3DJ.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DSigfridsson%26aufirst%3DK.%26aulast%3DMoses%26aufirst%3DS.%26aulast%3DWhatling%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520AZD6642%252C%2520an%2520inhibitor%2520of%25205-lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D897%26epage%3D911%26doi%3D10.1021%2Fjm501531v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref287"><div class="reference"><strong class="refLabel"><a href="#ref287" class="rightTabRefNumLink">287</a></strong><div class="NLM_citation" id="rightTab-cit287"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(m etheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&issue=11&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28m+etheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528m%2520etheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref288"><div class="reference"><strong class="refLabel"><a href="#ref288" class="rightTabRefNumLink">288</a></strong><div class="NLM_citation" id="rightTab-cit288"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brousseau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaSala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umemura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogi, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel piperidine-based inhibitor of cholesteryl ester transfer protein (CETP) that retains activity in hypertriglyceridemic plasma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8466</span>– <span class="NLM_lpage">8481</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00900</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00900" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8466-8481&issue=20&author=K.+Yamadaauthor=M.+Brousseauauthor=W.+Honmaauthor=A.+Iimuraauthor=H.+Imaseauthor=Y.+Iwakiauthor=T.+Kawanamiauthor=D.+LaSalaauthor=G.+Liangauthor=H.+Mitaniauthor=K.+Nonomuraauthor=O.+Ohmoriauthor=M.+Panauthor=D.+F.+Rigelauthor=I.+Umemuraauthor=K.+Yasoshimaauthor=G.+Zhuauthor=M.+Mogi&title=Discovery+of+a+novel+piperidine-based+inhibitor+of+cholesteryl+ester+transfer+protein+%28CETP%29+that+retains+activity+in+hypertriglyceridemic+plasma&doi=10.1021%2Facs.jmedchem.7b00900"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00900%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DBrousseau%26aufirst%3DM.%26aulast%3DHonma%26aufirst%3DW.%26aulast%3DIimura%26aufirst%3DA.%26aulast%3DImase%26aufirst%3DH.%26aulast%3DIwaki%26aufirst%3DY.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DMitani%26aufirst%3DH.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DYasoshima%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DMogi%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520piperidine-based%2520inhibitor%2520of%2520cholesteryl%2520ester%2520transfer%2520protein%2520%2528CETP%2529%2520that%2520retains%2520activity%2520in%2520hypertriglyceridemic%2520plasma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D20%26spage%3D8466%26epage%3D8481%26doi%3D10.1021%2Facs.jmedchem.7b00900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref289"><div class="reference"><strong class="refLabel"><a href="#ref289" class="rightTabRefNumLink">289</a></strong><div class="NLM_citation" id="rightTab-cit289"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higueruelo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, W. R.</span></span> <span> </span><span class="NLM_article-title">What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e51742</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0051742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1371%2Fjournal.pone.0051742" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e51742&issue=12&author=A.+P.+Higuerueloauthor=A.+Schreyerauthor=G.+R.+Bickertonauthor=T.+L.+Blundellauthor=W.+R.+Pitt&title=What+can+we+learn+from+the+evolution+of+protein-ligand+interactions+to+aid+the+design+of+new+therapeutics%3F&doi=10.1371%2Fjournal.pone.0051742"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0051742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0051742%26sid%3Dliteratum%253Aachs%26aulast%3DHigueruelo%26aufirst%3DA.%2BP.%26aulast%3DSchreyer%26aufirst%3DA.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DPitt%26aufirst%3DW.%2BR.%26atitle%3DWhat%2520can%2520we%2520learn%2520from%2520the%2520evolution%2520of%2520protein-ligand%2520interactions%2520to%2520aid%2520the%2520design%2520of%2520new%2520therapeutics%253F%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3De51742%26doi%3D10.1371%2Fjournal.pone.0051742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref290"><div class="reference"><strong class="refLabel"><a href="#ref290" class="rightTabRefNumLink">290</a></strong><div class="NLM_citation" id="rightTab-cit290"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muresan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Chemical predictive modelling to improve compound quality</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1038/nrd4128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=24287782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=948-962&issue=12&author=J.+G.+Cummingauthor=A.+M.+Davisauthor=S.+Muresanauthor=M.+Haeberleinauthor=H.+Chen&title=Chemical+predictive+modelling+to+improve+compound+quality&doi=10.1038%2Fnrd4128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical predictive modelling to improve compound quality</span></div><div class="casAuthors">Cumming, John G.; Davis, Andrew M.; Muresan, Sorel; Haeberlein, Markus; Chen, Hongming</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">948-962</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'quality' of small-mol. drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metab., excretion and toxicity) characteristics, is a key factor influencing the chances of success in clin. trials.  Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compds.  Here, we discuss the application of computational methods, particularly quant. structure-activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XwzW0wcxYbVg90H21EOLACvtfcHk0lilQKFEwOQM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGrtLjF&md5=e0a4265bb306ae5544d00f3c9e3e4050</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.1038%2Fnrd4128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4128%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BG.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DHaeberlein%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DChemical%2520predictive%2520modelling%2520to%2520improve%2520compound%2520quality%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D12%26spage%3D948%26epage%3D962%26doi%3D10.1038%2Fnrd4128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref291"><div class="reference"><strong class="refLabel"><a href="#ref291" class="rightTabRefNumLink">291</a></strong><div class="NLM_citation" id="rightTab-cit291"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aliagas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, M. C.</span></span> <span> </span><span class="NLM_article-title">Sustainable practices in medicinal chemistry part 2: green by design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5955</span>– <span class="NLM_lpage">5968</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01837</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5955-5968&issue=14&author=I.+Aliagasauthor=R.+Bergerauthor=K.+Goldbergauthor=R.+T.+Nishimuraauthor=J.+Reillyauthor=P.+Richardsonauthor=D.+Richterauthor=E.+C.+Shererauthor=B.+A.+Sparlingauthor=M.+C.+Bryan&title=Sustainable+practices+in+medicinal+chemistry+part+2%3A+green+by+design&doi=10.1021%2Facs.jmedchem.6b01837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01837%26sid%3Dliteratum%253Aachs%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DNishimura%26aufirst%3DR.%2BT.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26atitle%3DSustainable%2520practices%2520in%2520medicinal%2520chemistry%2520part%25202%253A%2520green%2520by%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D14%26spage%3D5955%26epage%3D5968%26doi%3D10.1021%2Facs.jmedchem.6b01837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref292"><div class="reference"><strong class="refLabel"><a href="#ref292" class="rightTabRefNumLink">292</a></strong><div class="NLM_citation" id="rightTab-cit292"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4807</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref292/cit292&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.bmcl.2015.07.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4802-4807&issue=21&author=C.+F.+Strattonauthor=D.+J.+Newmanauthor=D.+S.+Tan&title=Cheminformatic+comparison+of+approved+drugs+from+natural+product+versus+synthetic+origins&doi=10.1016%2Fj.bmcl.2015.07.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DCheminformatic%2520comparison%2520of%2520approved%2520drugs%2520from%2520natural%2520product%2520versus%2520synthetic%2520origins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4802%26epage%3D4807%26doi%3D10.1016%2Fj.bmcl.2015.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref293"><div class="reference"><strong class="refLabel"><a href="#ref293" class="rightTabRefNumLink">293</a></strong><div class="NLM_citation" id="rightTab-cit293"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, M.</span></span> <span> </span><span class="NLM_article-title">Analysis of physicochemical properties for drugs of natural origin</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1370</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFarsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=1370-1382&issue=6&author=D.+Campauthor=A.+Garavelasauthor=M.+Campitelli&title=Analysis+of+physicochemical+properties+for+drugs+of+natural+origin&doi=10.1021%2Facs.jnatprod.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of Physicochemical Properties for Drugs of Natural Origin</span></div><div class="casAuthors">Camp, David; Garavelas, Agatha; Campitelli, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1370-1382</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The impact of time, therapy area, and route of administration on 13 physicochem. properties calcd. for 664 drugs developed from a natural prototype was investigated.  The mean values for the majority of properties sampled over five periods from pre-1900 to 2013 were found to change in a statistically significant manner.  In contrast, lipophilicity and arom. ring count remained relatively const., suggesting that these parameters are the most important for successful prosecution of a natural product drug discovery program if the route of administration is not focused exclusively on oral availability.  An examn. by therapy area revealed that anti-infective agents had the most differences in physicochem. property profiles compared with other areas, particularly with respect to lipophilicity.  However, when this group was removed, the variation between the mean values for lipophilicity and arom. ring count across the remaining therapy areas was again found not to change in a meaningful manner, further highlighting the importance of these two parameters.  The vast majority of drugs with a natural progenitor were formulated for either oral and/or injectable administration.  Injectables were, on av., larger and more polar than drugs developed for oral, topical, and inhalation routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCr9UzS_Dq4rVg90H21EOLACvtfcHk0liz1rTqCJcnVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFarsLg%253D&md5=2487f8be0be8819c73ce69ce13e60eaa</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DCamp%26aufirst%3DD.%26aulast%3DGaravelas%26aufirst%3DA.%26aulast%3DCampitelli%26aufirst%3DM.%26atitle%3DAnalysis%2520of%2520physicochemical%2520properties%2520for%2520drugs%2520of%2520natural%2520origin%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2015%26volume%3D78%26issue%3D6%26spage%3D1370%26epage%3D1382%26doi%3D10.1021%2Facs.jnatprod.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref294"><div class="reference"><strong class="refLabel"><a href="#ref294" class="rightTabRefNumLink">294</a></strong><div class="NLM_citation" id="rightTab-cit294"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edrada-Ebel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">The re-emergence of natural products for drug discovery in the genomics era</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/nrd4510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd4510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=25614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=111-129&issue=2&author=A.+L.+Harveyauthor=R.+Edrada-Ebelauthor=R.+J.+Quinn&title=The+re-emergence+of+natural+products+for+drug+discovery+in+the+genomics+era&doi=10.1038%2Fnrd4510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">The re-emergence of natural products for drug discovery in the genomics era</span></div><div class="casAuthors">Harvey, Alan L.; Edrada-Ebel, RuAngelie; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Natural products have been a rich source of compds. for drug discovery.  However, their use has diminished in the past two decades, in part because of tech. barriers to screening natural products in high-throughput assays against mol. targets.  Here, we review strategies for natural product screening that harness the recent tech. advances that have reduced these barriers.  We also assess the use of genomic and metabolomic approaches to augment traditional methods of studying natural products, and highlight recent examples of natural products in antimicrobial drug discovery and as inhibitors of protein-protein interactions.  The growing appreciation of functional assays and phenotypic screens may further contribute to a revival of interest in natural products for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQ8QarpZ6orVg90H21EOLACvtfcHk0liz1rTqCJcnVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D&md5=b871148315dc0623683498fa15205b14</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1038%2Fnrd4510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4510%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26aulast%3DEdrada-Ebel%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520re-emergence%2520of%2520natural%2520products%2520for%2520drug%2520discovery%2520in%2520the%2520genomics%2520era%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D2%26spage%3D111%26epage%3D129%26doi%3D10.1038%2Fnrd4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref295"><div class="reference"><strong class="refLabel"><a href="#ref295" class="rightTabRefNumLink">295</a></strong><div class="NLM_citation" id="rightTab-cit295"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grutter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Natural-product-derived fragments for fragment-based ligand discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/nchem.1506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnchem.1506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=23247173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGktbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=21-28&issue=1&author=B.+Overauthor=S.+Wetzelauthor=C.+Grutterauthor=Y.+Nakaiauthor=S.+Rennerauthor=D.+Rauhauthor=H.+Waldmann&title=Natural-product-derived+fragments+for+fragment-based+ligand+discovery&doi=10.1038%2Fnchem.1506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit295R"><div class="casContent"><span class="casTitleNuber">295</span><div class="casTitle"><span class="NLM_cas:atitle">Natural-product-derived fragments for fragment-based ligand discovery</span></div><div class="casAuthors">Over, Bjoern; Wetzel, Stefan; Gruetter, Christian; Nakai, Yasushi; Renner, Steffen; Rauh, Daniel; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-28</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment-based ligand and drug discovery predominantly employs sp2-rich compds. covering well-explored regions of chem. space.  Despite the ease with which such fragments can be coupled, this focus on flat compds. is widely cited as contributing to the attrition rate of the drug discovery process.  In contrast, biol. validated natural products are rich in stereogenic centers and populate areas of chem. space not occupied by av. synthetic mols.  Here, we have analyzed more than 180,000 natural product structures to arrive at 2,000 clusters of natural-product-derived fragments with high structural diversity, which resemble natural scaffolds and are rich in sp3-configured centers.  The structures of the cluster centers differ from previously explored fragment libraries, but for nearly half of the clusters representative members are com. available.  We validate their usefulness for the discovery of novel ligand and inhibitor types by means of protein X-ray crystallog. and the identification of novel stabilizers of inactive conformations of p38α MAP kinase and of inhibitors of several phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnuK2UxKwD_LVg90H21EOLACvtfcHk0liz1rTqCJcnVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGktbnO&md5=2aa52aeca6b85346746ed8c21b454293</span></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1506%26sid%3Dliteratum%253Aachs%26aulast%3DOver%26aufirst%3DB.%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DRenner%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DNatural-product-derived%2520fragments%2520for%2520fragment-based%2520ligand%2520discovery%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26issue%3D1%26spage%3D21%26epage%3D28%26doi%3D10.1038%2Fnchem.1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref296"><div class="reference"><strong class="refLabel"><a href="#ref296" class="rightTabRefNumLink">296</a></strong><div class="NLM_citation" id="rightTab-cit296"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S.</span>; <span class="NLM_string-name">Wakchaure, V.</span>; <span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Natural product-derived and natural product-inspired compound collections</span>. In  <i>Natural Products in Medicinal Chemistry</i>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">80</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527676545.ch02</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1002%2F9783527676545.ch02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-80&author=S.+Rizzo&author=V.+Wakchaure&author=H.+Waldmann&title=Natural+Products+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1002%2F9783527676545.ch02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527676545.ch02%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26atitle%3DNatural%2520product-derived%2520and%2520natural%2520product-inspired%2520compound%2520collections%26btitle%3DNatural%2520Products%2520in%2520Medicinal%2520Chemistry%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2014%26spage%3D43%26epage%3D80%26doi%3D10.1002%2F9783527676545.ch02" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref297"><div class="reference"><strong class="refLabel"><a href="#ref297" class="rightTabRefNumLink">297</a></strong><div class="NLM_citation" id="rightTab-cit297"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheshire, D. R.</span></span> <span> </span><span class="NLM_article-title">How well do medicinal chemists learn from experience?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">17–18</span>),  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2011.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=21704183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC3MfitFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=817-821&issue=17%E2%80%9318&author=D.+R.+Cheshire&title=How+well+do+medicinal+chemists+learn+from+experience%3F&doi=10.1016%2Fj.drudis.2011.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">How well do medicinal chemists learn from experience?</span></div><div class="casAuthors">Cheshire David R</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">817-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To an outsider, the exploration of thousands of molecules to find a small number of potential candidate drugs must appear enormously wasteful, but many medicinal chemists would defend this waste as unavoidable.  Here, I provide evidence that suggests that modern medicinal chemists are overproductive in that they synthesise many more compounds than are required to achieve the objectives of the project.  The difficulties encountered in finding the data for the analysis presented here prompted the design and implementation of a more rigorous approach to capture the essence of a medicinal chemistry program.  The result, medicinal chemistry knowledge sharing (MeCKS), was designed to capture and communicate emerging issues and their solutions to the medicinal chemistry community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuaFbXMB7kxDToTC3aBaesfW6udTcc2eZdvGKHAkpZxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfitFChsg%253D%253D&md5=b069d78032215c2a1bf67f7a81e304e9</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DCheshire%26aufirst%3DD.%2BR.%26atitle%3DHow%2520well%2520do%2520medicinal%2520chemists%2520learn%2520from%2520experience%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26issue%3D17%25E2%2580%259318%26spage%3D817%26epage%3D821%26doi%3D10.1016%2Fj.drudis.2011.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref298"><div class="reference"><strong class="refLabel"><a href="#ref298" class="rightTabRefNumLink">298</a></strong><div class="NLM_citation" id="rightTab-cit298"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1488</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2017.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28669605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjslKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1478-1488&issue=10&author=G.+Tresadernauthor=F.+J.+R.+Romboutsauthor=D.+Oehlrichauthor=G.+Macdonaldauthor=A.+A.+Trabanco&title=Industrial+medicinal+chemistry+insights%3A+neuroscience+hit+generation+at+Janssen&doi=10.1016%2Fj.drudis.2017.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen</span></div><div class="casAuthors">Tresadern Gary; Rombouts Frederik J R; Oehlrich Daniel; Macdonald Gregor; Trabanco Andres A</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1478-1488</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of medicinal chemistry has changed over the past 10 years.  Chemistry had become one step in a process; funneling the output of high-throughput screening (HTS) on to the next stage.  The goal to identify the ideal clinical compound remains, but the means to achieve this have changed.  Modern medicinal chemistry is responsible for integrating innovation throughout early drug discovery, including new screening paradigms, computational approaches, novel synthetic chemistry, gene-family screening, investigating routes of delivery, and so on.  In this Foundation Review, we show how a successful medicinal chemistry team has a broad impact and requires multidisciplinary expertise in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2t7KCJwTlOjUE-swuRqsHfW6udTcc2ebw0w9UorBvdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjslKlug%253D%253D&md5=3a723af1060ecb28c329bf4c5425f0a9</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DIndustrial%2520medicinal%2520chemistry%2520insights%253A%2520neuroscience%2520hit%2520generation%2520at%2520Janssen%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1478%26epage%3D1488%26doi%3D10.1016%2Fj.drudis.2017.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref299"><div class="reference"><strong class="refLabel"><a href="#ref299" class="rightTabRefNumLink">299</a></strong><div class="NLM_citation" id="rightTab-cit299"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span> <span> </span><span class="NLM_article-title">Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1206</span>, <span class="refDoi"> DOI: 10.1021/mp300476z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300476z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKmsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1191-1206&issue=4&author=K.+H.+Grimeauthor=P.+Bartonauthor=D.+F.+McGinnity&title=Application+of+in+silico%2C+in+vitro+and+preclinical+pharmacokinetic+data+for+the+effective+and+efficient+prediction+of+human+pharmacokinetics&doi=10.1021%2Fmp300476z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics</span></div><div class="casAuthors">Grime, Kenneth H.; Barton, Patrick; McGinnity, Dermot F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1191-1206</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In the present age of pharmaceutical research and development, focused delivery of decision making data is more imperative than ever before.  Resulting from several years' success, failure and consequential learning, this article also proffers advice and guidance on which in vitro and in vivo expts. to perform to facilitate efficient and cost-effective pursuit of candidate drugs with acceptable human pharmacokinetic profiles.  Predictive in silico models are important in directing design toward compds. with the highest probability of having suitable DMPK properties rather than in predicting human pharmacokinetics per se, and the value and utility of such approaches are reviewed with the intention of providing direction to DMPK scientists.  Relating to absorption, distribution, elimination and effective half-life, strategies are described to provide direction in commonly encountered scenarios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbqOxSOn6m7Vg90H21EOLACvtfcHk0lggNBHFFajaaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKmsbbE&md5=87d57fba1788724ea47374583dce47bf</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1021%2Fmp300476z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300476z%26sid%3Dliteratum%253Aachs%26aulast%3DGrime%26aufirst%3DK.%2BH.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520in%2520silico%252C%2520in%2520vitro%2520and%2520preclinical%2520pharmacokinetic%2520data%2520for%2520the%2520effective%2520and%2520efficient%2520prediction%2520of%2520human%2520pharmacokinetics%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26issue%3D4%26spage%3D1191%26epage%3D1206%26doi%3D10.1021%2Fmp300476z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref300"><div class="reference"><strong class="refLabel"><a href="#ref300" class="rightTabRefNumLink">300</a></strong><div class="NLM_citation" id="rightTab-cit300"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, S. A.</span></span> <span> </span><span class="NLM_article-title">Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.4155/fmc.15.143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffmc.15.143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26599348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2351-2369&issue=17&author=T.+Buetersauthor=C.+Gibsonauthor=S.+A.+Visser&title=Optimization+of+human+dose+prediction+by+using+quantitative+and+translational+pharmacology+in+drug+discovery&doi=10.4155%2Ffmc.15.143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery</span></div><div class="casAuthors">Bueters, Tjerk; Gibson, Christopher; G Visser, Sandra A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2351-2369</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In this perspective article, we explain how quant. and translational pharmacol., when well-implemented, is believed to lead to improved clin. candidates and drug targets that are differentiated from current treatment options.  Quant. and translational pharmacol. aims to build and continuously improve the quant. relationship between drug exposure, target engagement, efficacy, safety and its interspecies relationship at every phase of drug discovery.  Drug hunters should consider and apply these concepts to develop compds. with a higher probability of interrogating the clin. biol. hypothesis.  We offer different approaches to set an initial effective concn. or pharmacokinetic-pharmacodynamic target in man and to predict human pharmacokinetics that det. together the predicted human dose and dose schedule.  All concepts are illustrated with ample literature examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy3M0R3KWa1LVg90H21EOLACvtfcHk0lggNBHFFajaaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu7%252FO&md5=c30f4756c965a5dbca10d7b5c57b59c9</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.143%26sid%3Dliteratum%253Aachs%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DGibson%26aufirst%3DC.%26aulast%3DVisser%26aufirst%3DS.%2BA.%26atitle%3DOptimization%2520of%2520human%2520dose%2520prediction%2520by%2520using%2520quantitative%2520and%2520translational%2520pharmacology%2520in%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D17%26spage%3D2351%26epage%3D2369%26doi%3D10.4155%2Ffmc.15.143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref301"><div class="reference"><strong class="refLabel"><a href="#ref301" class="rightTabRefNumLink">301</a></strong><div class="NLM_citation" id="rightTab-cit301"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">The drug–target residence time model: a 10-year retrospective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2015.18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=26678621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=87-95&author=R.+A.+Copeland&title=The+drug%E2%80%93target+residence+time+model%3A+a+10-year+retrospective&doi=10.1038%2Fnrd.2015.18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The drug-target residence time model: a 10-year retrospective</span></div><div class="casAuthors">Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-95</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The drug-target residence time model was first introduced in 2006 and has been broadly adopted across the chem. biol., biotechnol. and pharmaceutical communities.  While traditional in vitro methods view drug-target interactions exclusively in terms of equil. affinity, the residence time model takes into account the conformational dynamics of target macromols. that affect drug binding and dissocn.  The key tenet of this model is that the lifetime (or residence time) of the binary drug-target complex, and not the binding affinity per se, dictates much of the in vivo pharmacol. activity.  Here, this model is revisited and key applications of it over the past 10 years are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNrhp9U8kwLVg90H21EOLACvtfcHk0liagSCUHKmGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrurnE&md5=23f4a6973d77804292ff0af6c81358c0</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.18%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DThe%2520drug%25E2%2580%2593target%2520residence%2520time%2520model%253A%2520a%252010-year%2520retrospective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D87%26epage%3D95%26doi%3D10.1038%2Fnrd.2015.18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref302"><div class="reference"><strong class="refLabel"><a href="#ref302" class="rightTabRefNumLink">302</a></strong><div class="NLM_citation" id="rightTab-cit302"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span> <span> </span><span class="NLM_article-title">Protac-induced protein degradation in drug discovery: breaking the rules or just making new ones?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=444-452&issue=2&author=I.+Churcher&title=Protac-induced+protein+degradation+in+drug+discovery%3A+breaking+the+rules+or+just+making+new+ones%3F&doi=10.1021%2Facs.jmedchem.7b01272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?</span></div><div class="casAuthors">Churcher, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">444-452</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeted protein degrdn., using bifunctional small mols. (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer therapeutic interventions not achievable with existing approaches.  In this perspective, the brief history of the field is surveyed from a drug discovery perspective with a focus on the key advances in knowledge which have led to the definition and exemplification of protein degrdn. concepts, and their resulting applications to medicine discovery.  The approach has the potential to bring disruptive change to drug discovery - the many potential advantages and outstanding challenges which lie ahead of this technol. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9n8I_0MhtkbVg90H21EOLACvtfcHk0liagSCUHKmGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbvJ&md5=e60f1777de8bd860c5001137d8583f1f</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01272%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26atitle%3DProtac-induced%2520protein%2520degradation%2520in%2520drug%2520discovery%253A%2520breaking%2520the%2520rules%2520or%2520just%2520making%2520new%2520ones%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D2%26spage%3D444%26epage%3D452%26doi%3D10.1021%2Facs.jmedchem.7b01272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref303"><div class="reference"><strong class="refLabel"><a href="#ref303" class="rightTabRefNumLink">303</a></strong><div class="NLM_citation" id="rightTab-cit303"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Automating drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1038%2Fnrd.2017.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=29242609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=97-113&issue=2&author=G.+Schneider&title=Automating+drug+discovery&doi=10.1038%2Fnrd.2017.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Automating drug discovery</span></div><div class="casAuthors">Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-113</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Small mol. drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compds. including efficacy, pharmacokinetics and safety need to be optimized in parallel to provide drug candidates.  Recent advances in areas such as microfluidics-assisted chem. synthesis and biol. testing, as well as artificial intelligence systems that improve a design hypothesis through feedback anal., are now providing a basis for the introduction of greater automation into aspects of this process.  This could potentially accelerate time frames for compd. discovery and optimization and enable more effective searches of chem. space.  However, such approaches also raise considerable conceptual, tech. and organizational challenges, as well as scepticism about the current hype around them.  This article aims to identify the approaches and technologies that could be implemented robustly by medicinal chemists in the near future and to critically analyze the opportunities and challenges for their more widespread application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyg9gWifCLrVg90H21EOLACvtfcHk0liagSCUHKmGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbK&md5=4fc1e441a0a31d7421642eb91fbac8c7</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.232%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DAutomating%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26issue%3D2%26spage%3D97%26epage%3D113%26doi%3D10.1038%2Fnrd.2017.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref304"><div class="reference"><strong class="refLabel"><a href="#ref304" class="rightTabRefNumLink">304</a></strong><div class="NLM_citation" id="rightTab-cit304"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klucznik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulak-Klucznik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymkuć, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhowmick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickershauser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewska, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toutchkine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Startek, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkovits, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roszak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieredzińska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrksich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trice, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzybowski, B. A.</span></span> <span> </span><span class="NLM_article-title">Efficient syntheses of diverse, medicinally relevant targets planned by computer and executed in the laboratory</span>. <i>Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2018.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.chempr.2018.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlyitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=522-532&issue=3&author=T.+Klucznikauthor=B.+Mikulak-Klucznikauthor=M.+P.+McCormackauthor=H.+Limaauthor=S.+Szymku%C4%87author=M.+Bhowmickauthor=K.+Molgaauthor=Y.+Zhouauthor=L.+Rickershauserauthor=E.+P.+Gajewskaauthor=A.+Toutchkineauthor=P.+Dittwaldauthor=M.+P.+Startekauthor=G.+J.+Kirkovitsauthor=R.+Roszakauthor=A.+Adamskiauthor=B.+Sieredzi%C5%84skaauthor=M.+Mrksichauthor=S.+L.+J.+Triceauthor=B.+A.+Grzybowski&title=Efficient+syntheses+of+diverse%2C+medicinally+relevant+targets+planned+by+computer+and+executed+in+the+laboratory&doi=10.1016%2Fj.chempr.2018.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit304R"><div class="casContent"><span class="casTitleNuber">304</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Syntheses of Diverse, Medicinally Relevant Targets Planned by Computer and Executed in the Laboratory</span></div><div class="casAuthors">Klucznik, Tomasz; Mikulak-Klucznik, Barbara; McCormack, Michael P.; Lima, Heather; Szymkuc, Sara; Bhowmick, Manishabrata; Molga, Karol; Zhou, Yubai; Rickershauser, Lindsey; Gajewska, Ewa P.; Toutchkine, Alexei; Dittwald, Piotr; Startek, Michal P.; Kirkovits, Gregory J.; Roszak, Rafal; Adamski, Ariel; Sieredzinska, Bianka; Mrksich, Milan; Trice, Sarah L. J.; Grzybowski, Bartosz A.</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">522-532</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Chematica program was used to autonomously design synthetic pathways to eight structurally diverse targets, including seven com. valuable bioactive substances and one natural product.  All of these computer-planned routes were successfully executed in the lab. and offer significant yield improvements and cost savings over previous approaches, provide alternatives to patented routes, or produce targets that were not synthesized previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOimnTZh2zLVg90H21EOLACvtfcHk0liagSCUHKmGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlyitb8%253D&md5=2d5d22d2570ca3e146ba9c25149dfc9e</span></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2018.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKlucznik%26aufirst%3DT.%26aulast%3DMikulak-Klucznik%26aufirst%3DB.%26aulast%3DMcCormack%26aufirst%3DM.%2BP.%26aulast%3DLima%26aufirst%3DH.%26aulast%3DSzymku%25C4%2587%26aufirst%3DS.%26aulast%3DBhowmick%26aufirst%3DM.%26aulast%3DMolga%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DRickershauser%26aufirst%3DL.%26aulast%3DGajewska%26aufirst%3DE.%2BP.%26aulast%3DToutchkine%26aufirst%3DA.%26aulast%3DDittwald%26aufirst%3DP.%26aulast%3DStartek%26aufirst%3DM.%2BP.%26aulast%3DKirkovits%26aufirst%3DG.%2BJ.%26aulast%3DRoszak%26aufirst%3DR.%26aulast%3DAdamski%26aufirst%3DA.%26aulast%3DSieredzi%25C5%2584ska%26aufirst%3DB.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DTrice%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DGrzybowski%26aufirst%3DB.%2BA.%26atitle%3DEfficient%2520syntheses%2520of%2520diverse%252C%2520medicinally%2520relevant%2520targets%2520planned%2520by%2520computer%2520and%2520executed%2520in%2520the%2520laboratory%26jtitle%3DChem.%26date%3D2018%26volume%3D4%26issue%3D3%26spage%3D522%26epage%3D532%26doi%3D10.1016%2Fj.chempr.2018.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref305"><div class="reference"><strong class="refLabel"><a href="#ref305" class="rightTabRefNumLink">305</a></strong><div class="NLM_citation" id="rightTab-cit305"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Entering the “big data” era in medicinal chemistry: molecular promiscuity analysis revisited</span>. <i>Future Sci. OA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">FSO179</span>, <span class="refDoi"> DOI: 10.4155/fsoa-2017-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.4155%2Ffsoa-2017-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=28670471" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=FSO179&issue=2&author=Y.+Huauthor=J.+Bajorath&title=Entering+the+%E2%80%9Cbig+data%E2%80%9D+era+in+medicinal+chemistry%3A+molecular+promiscuity+analysis+revisited&doi=10.4155%2Ffsoa-2017-0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=10.4155%2Ffsoa-2017-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffsoa-2017-0001%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DEntering%2520the%2520%25E2%2580%259Cbig%2520data%25E2%2580%259D%2520era%2520in%2520medicinal%2520chemistry%253A%2520molecular%2520promiscuity%2520analysis%2520revisited%26jtitle%3DFuture%2520Sci.%2520OA%26date%3D2017%26volume%3D3%26issue%3D2%26spage%3DFSO179%26doi%3D10.4155%2Ffsoa-2017-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref306"><div class="reference"><strong class="refLabel"><a href="#ref306" class="rightTabRefNumLink">306</a></strong><div class="NLM_citation" id="rightTab-cit306"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry matters - a call for discipline in our discipline</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">11–12</span>),  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2012.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=10.1016%2Fj.drudis.2012.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=22301070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslKrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=538-543&issue=11%E2%80%9312&author=C.+Johnstone&title=Medicinal+chemistry+matters+-+a+call+for+discipline+in+our+discipline&doi=10.1016%2Fj.drudis.2012.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry matters - a call for discipline in our discipline</span></div><div class="casAuthors">Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">538-543</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Medicinal chem. makes a vital contribution to small mol. drug discovery, and the quality of it contributes directly to research effectiveness as well as to downstream costs, speed and survival in development.  In recent years, the discipline of medicinal chem. has evolved and witnessed many noteworthy contributions that propose and offer potential improvements to medicinal chem. practice; however, the impact of these ideas is limited by their acceptance and deployment into every-day activity and, as a result, the quality of medicinal chem. remains variable.  For the good of the industry and the medicinal chem. discipline, there is a need to move from retrospective learning to prospective control of medicinal chem. practice to improve cost effectiveness, probability of success and survival rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr2eM5VpR05bVg90H21EOLACvtfcHk0lgONG6GTbxuWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslKrurg%253D&md5=31d4c1045edccb955b954b10bf6899a3</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DMedicinal%2520chemistry%2520matters%2520-%2520a%2520call%2520for%2520discipline%2520in%2520our%2520discipline%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26issue%3D11%25E2%2580%259312%26spage%3D538%26epage%3D543%26doi%3D10.1016%2Fj.drudis.2012.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d53e4889-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00180">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04373"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00180">10.1021/acs.jmedchem.8b00180</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Correlation of selectivity parameters, data of <a id="rightTab-" class=" internalNav" href="#fig10">Figure <a id="rightTab-" class=" internalNav" href="#fig10">10</a></a> vs MW, and correlation of MW with refraction (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00180/suppl_file/jm8b00180_si_001.pdf">jm8b00180_si_001.pdf (302.06 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-15%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00180%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00180" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667986b24f0a191d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
